[
    {
        "realidx": "10135926",
        "question": "Patients transported by helicopter often require advanced airway management. The purpose of this study was to determine whether or not the in-flight environment of air medical transport in a BO-105 helicopter impairs the ability of flight nurses to perform oral endotracheal intubation.\nThe study was conducted in an MBB BO-105 helicopter.\nFlight nurses performed three manikin intubations in each of the two study environments: on an emergency department stretcher and in-flight in the BO-105 helicopter.\nThe mean time required for in-flight intubation (25.9 +/- 10.9 seconds) was significantly longer than the corresponding time (13.2 +/- 2.8 seconds) required for intubation in the control setting (ANOVA, F = 38.7, p<.001). All intubations performed in the control setting were placed correctly in the trachea; there were two (6.7%) esophageal intubations in the in-flight setting. The difference in appropriate endotracheal intubation between the two settings was not significant (chi 2 = 0.3; p>0.05).\nIs oral endotracheal intubation efficacy impaired in the helicopter environment?",
        "answer": "yes",
        "answer_rationale": "Oral endotracheal intubation in the in-flight setting of the BO-105 helicopter takes approximately twice as long as intubation in a ground setting. The results support pre-flight intubation of patients who appear likely to require urgent intubation during air medical transport in the BO-105 helicopter.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether oral endotracheal intubation efficacy is impaired in the helicopter environment based on the study provided.\n\nFirst, I need to look at the key results from the study. The mean time for in-flight intubation was 25.9 seconds with a pretty wide standard deviation, compared to 13.2 seconds in the control setting. The p-value here is less than 0.001, which means the difference in time is statistically significant. So, the time taken is definitely longer in the helicopter.\n\nNext, looking at the success rate. All control intubations were correct, but there were two esophageal intubations (6.7%) in the helicopter. However, the chi-square test showed the difference wasn't significant (p>0.05). That means even though there were some errors in the helicopter, the rate isn't statistically different from the control's 0% error. \n\nThe question is about efficacy. Efficacy could be measured by both time and success rate. The time is worse, but the success rate isn't significantly different. The study's conclusion would hinge on what's considered impairment. If impairment includes time, then yes. But the options are yes, no, maybe. The question specifically asks if efficacy is impaired. Since the success rate didn't reach significance, maybe the main impairment is the time, but the question might be focusing on the success. Wait, the options are (A) yes (B) no (C) maybe. The study says the difference in appropriate placement wasn't significant. So the efficacy in terms of correct placement isn't impaired. But the time is longer. However, the question is about efficacy. Efficacy usually refers to effectiveness, so correct placement. Since that wasn't significantly different, maybe the answer is B) no. But the time is longer, which could be part of efficacy. Hmm. Wait, the question is whether efficacy is impaired. The study's results: the time is longer (so maybe less efficient but not efficacy?), and the error rate wasn't significant. So efficacy (correct placement) isn't impaired, but efficiency (time) is. The question is about efficacy, so the answer would be B) no. Because the correct placement wasn't significantly worse. The two esophageal were not enough to be significant. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 357,
            "completion_tokens": 501
        },
        "time_elapsed": 7.890184640884399
    },
    {
        "realidx": "10158597",
        "question": "To evaluate the effectiveness of the role of a discharge coordinator whose sole responsibility was to plan and coordinate the discharge of patients from medical wards.\nAn intervention study in which the quality of discharge planning was assessed before and after the introduction of a discharge coordinator. Patients were interviewed on the ward before discharge and seven to 10 days after being discharged home.\nThe three medical wards at the Homerton Hospital in Hackney, East London.\n600 randomly sampled adult patients admitted to the medical wards of the study hospital, who were resident in the district (but not in institutions), were under the care of physicians (excluding psychiatry), and were discharged home from one of the medical wards. The sampling was conducted in three study phases, over 18 months.\nPhase I comprised base line data collection; in phase II data were collected after the introduction of the district discharge planning policy and a discharge form (checklist) for all patients; in phase III data were collected after the introduction of the discharge coordinator.\nThe quality and out come of discharge planning. Readmission rates, duration of stay, appropriateness of days of care, patients' health and satisfaction, problems after discharge, and receipt of services.\nThe discharge coordinator resulted in an improved discharge planning process, and there was a reduction in problems experienced by patients after discharge, and in perceived need for medical and healthcare services. There was no evidence that the discharge coordinator resulted in a more timely or effective provision of community services after discharge, or that the appropriateness or efficiency of bed use was improved.\nDoes a dedicated discharge coordinator improve the quality of hospital discharge?",
        "answer": "yes",
        "answer_rationale": "The introduction of a discharge coordinator improved the quality of discharge planning, but at additional cost.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a dedicated discharge coordinator improves the quality of hospital discharge based on the study described.\n\nFirst, I need to recall the details from the provided information. The study had three phases: Phase I was baseline, Phase II introduced a discharge planning policy and checklist, and Phase III added a discharge coordinator. The outcomes measured included the quality of discharge planning, readmission rates, patient satisfaction, problems after discharge, and more.\n\nThe results mentioned that the discharge coordinator led to improved discharge planning processes. Also, patients had fewer problems after discharge and less perceived need for medical services post-discharge. However, there was no improvement in timely community services, bed use efficiency, or shorter stays.\n\nThe key here is the question specifically about the quality of hospital discharge. The study states that the coordinator improved the discharge planning process and reduced post-discharge issues. Since quality of discharge planning is directly mentioned as improved, that's a strong indicator. The other factors like bed use or community service timing didn't improve, but the question isn't about those. The main point is the quality, which the study says was better with the coordinator. So the answer should be yes, option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 413,
            "completion_tokens": 251
        },
        "time_elapsed": 3.706115961074829
    },
    {
        "realidx": "10173769",
        "question": "To consider whether the Barthel Index alone provides sufficient information about the long term outcome of stroke.\nCross sectional follow up study with a structured interview questionnaire and measures of impairment, disability, handicap, and general health. The scales used were the hospital anxiety and depression scale, mini mental state examination, Barthel index, modified Rankin scale, London handicap scale, Frenchay activities index, SF36, Nottingham health profile, life satisfaction index, and the caregiver strain index.\nSouth east London.\nPeople, and their identified carers, resident in south east London in 1989-90 when they had their first in a life-time stroke aged under 75 years.\nObservational study.\nComparison and correlation of the individual Barthel index scores with the scores on other outcome measures.\nOne hundred and twenty three (42%) people were known to be alive, of whom 106 (86%) were interviewed. The median age was 71 years (range 34-79). The mean interval between the stroke and follow up was 4.9 years. The rank correlation coefficients between the Barthel and the different dimensions of the SF36 ranged from r = 0.217 (with the role emotional dimension) to r = 0.810 (with the physical functioning dimension); with the Nottingham health profile the range was r = -0.189 (with the sleep dimension, NS) to r = -0.840 (with the physical mobility dimension); with the hospital and anxiety scale depression component the coefficient was r = -0.563, with the life satisfaction index r = 0.361, with the London handicap scale r = 0.726 and with the Frenchay activities index r = 0.826.\nLonger term quality of life and outcome in stroke patients: is the Barthel index alone an adequate measure of outcome?",
        "answer": "yes",
        "answer_rationale": "The place of the Barthel index as the standard outcome measure for populations of stroke patients is still justified for long term follow up, and may be a proxy for different outcome measures intended for the assessment of other domains.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the Barthel Index alone is sufficient for assessing the long-term outcome of stroke patients. The study provided compares the Barthel Index with several other outcome measures.\n\nFirst, I need to recall what the Barthel Index measures. It's primarily about activities of daily living (ADLs), like mobility and self-care. But the question is about long-term outcome, which might involve more aspects like emotional health, social functioning, etc.\n\nLooking at the study results: The correlations between Barthel and other scales vary. For example, it had a high correlation with physical functioning (SF36's 0.810) and physical mobility (Nottingham's -0.840). But with the role emotional dimension of SF36, it was only 0.217, which is low. Also, the hospital anxiety scale had a -0.563, which is moderate. The life satisfaction index was 0.361, another moderate correlation. \n\nSince the correlations are strong for physical aspects but weaker for emotional, social, or psychological factors, the Barthel Index might not capture the full picture. The study's conclusion would likely suggest that other measures are needed alongside Barthel for a comprehensive long-term outcome assessment. Therefore, the answer should be \"no\" because the Barthel alone isn't sufficient.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 489,
            "completion_tokens": 290
        },
        "time_elapsed": 4.044736862182617
    },
    {
        "realidx": "10201555",
        "question": "Serum chloride level is routinely assayed in clinical laboratories in the management of patients with kidney disorders and with metabolic diseases. It is a biological parameter that is easily, precisely and relatively cheaply measured. The epidemiological features of serum chloride levels have not been studied before.\nFor the random sample of men and women from the Belgian Interuniversity Research on Nutrition and Health aged 25-74 years, free of symptomatic coronary heart disease at baseline, serum chloride concentrations were measured, among those of other electrolytes. The cohort was followed up for 10 years with respect to subsequent cause-specific mortality.\nThe results are based on observations of 4793 men and 4313 women. According to Cox regression analysis serum chloride level was one of the strongest predictors of total, cardiovascular disease (CVD) and non-CVD mortalities independently of age, body mass index, sex, smoking, systolic blood pressure, levels of total and high-density lipoprotein cholesterol, uric acid, serum creatinine and serum total proteins and intake of diuretics. This relation was proved to be independent of levels of other serum electrolytes and similar for men and women. The estimated adjusted risk ratio for CVD death for subjects with a serum chloride level<or =100 mmol/l compared with those with levels above that limit was 1.65 (95% confidence interval 1.06-2.57) for men and 2.16 (95% confidence interval 1.11-4.22) for women. The study of adjusted risk ratios for four groups of subjects defined on the basis of their baseline serum chloride levels revealed a decreasing log-linear 'dose-response' relation to total and cardiovascular mortalities.\nIs low serum chloride level a risk factor for cardiovascular mortality?",
        "answer": "yes",
        "answer_rationale": "This s the first report from a population-based study to indicate that there is an association between serum chloride level and the incidence of total, CVD and non-CVD mortalities. The risk ratio for CVD mortality associated with a low serum chloride level was comparable to or higher than those observed for well-established CVD risk factors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether low serum chloride level is a risk factor for cardiovascular mortality based on the provided study.\n\nFirst, I need to recall what the study found. The question mentions that the study used Cox regression analysis and found serum chloride as a strong predictor of total, CVD, and non-CVD mortalities. The key part here is the adjusted risk ratios. For CVD death, the risk ratio for those with chloride \u2264100 mmol/l compared to above that was 1.65 in men and 2.16 in women. Both of these ratios are above 1, which suggests an increased risk. The confidence intervals for both also don't include 1 (since the lower bounds are 1.06 and 1.11), meaning the results are statistically significant. \n\nAdditionally, the study mentions a 'dose-response' relation, meaning as chloride levels decrease, the risk increases. This supports the idea that lower chloride is associated with higher cardiovascular mortality. The question is whether low chloride is a risk factor. Since the study shows an independent association with higher mortality when chloride is low, the answer should be yes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 263
        },
        "time_elapsed": 4.060457944869995
    },
    {
        "realidx": "10223070",
        "question": "To critically assess the evidence that appendiceal perforation is a risk factor for subsequent tubal infertility or ectopic pregnancy.\nEpidemiologic studies investigating the relationship between appendectomy and infertility or ectopic pregnancy were identified by searching the MEDLINE database from 1966 to 1997. Appropriate citations were also extracted from a manual search of the bibliographies of selected papers.\nTwenty-three articles were retrieved. Only 4 presented original data including comparisons to a nonexposed control group and they form the basis for this study.\nBecause the raw data or specific techniques of data analysis were not always explicitly described, indices of risk for exposure were extracted from the data as presented and were analysed without attempting to convert them to a common measure.\nArticles were assessed according to the criteria of the Evidence-Based Medicine Working Group for evaluating articles on harm. Review of the literature yielded estimates of the risk of adverse fertility outcomes ranging from 1.6 (95% confidence interval [CI] 1.1 to 2.5) for ectopic pregnancy after an appendectomy to 4.8 (95% CI 1.5 to 14.9) for tubal infertility from perforation of the appendix. Recall bias, and poor adjustment for confounding variables in some reports, weakened the validity of the studies.\nIs perforation of the appendix a risk factor for tubal infertility and ectopic pregnancy?",
        "answer": "maybe",
        "answer_rationale": "The methodologic weaknesses of the studies do not permit acceptance of increased risk of tubal pregnancy or infertility as a consequence of perforation of the appendix, so a causal relationship cannot be supported by the data currently available. Only a well-designed case-control study with unbiased ascertainment of exposure and adjustment for confounding variables will provide a definitive answer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether appendiceal perforation is a risk factor for tubal infertility and ectopic pregnancy. The provided information is from a study that looked into this by reviewing existing literature up to 1997.\n\nFirst, I need to parse the key points from the study summary. They found 23 articles, but only 4 had original data with control groups. The main results mentioned are risk estimates: 1.6 (with a CI of 1.1-2.5) for ectopic pregnancy after appendectomy and 4.8 (CI 1.5-14.9) for tubal infertility from perforation. The confidence intervals for both don't include 1, which means the risks are statistically significant. However, the study also points out weaknesses like recall bias and poor adjustment for confounders, which might affect the validity.\n\nThe question is specifically about perforation, not just appendectomy. The higher risk for tubal infertility from perforation (4.8) is notable. Even though there are methodological issues, the fact that the confidence intervals don't include 1 suggests that there is some evidence supporting the association. The options are yes, no, maybe. Since the study's results, despite their flaws, show increased risk with perforation, the answer would lean towards yes. But the \"maybe\" might come from the study's limitations. However, in evidence-based terms, even with some bias, if the data shows a significant association, the answer is likely yes. The question is whether perforation is a risk factor, and the study's higher risk for tubal infertility from perforation supports that. So the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 360
        },
        "time_elapsed": 5.239008903503418
    },
    {
        "realidx": "10331115",
        "question": "All currently available atypical antipsychotics have, at clinically relevant doses: i) high serotonin (5-HT)2 occupancy; ii) greater 5-HT2 than dopamine (D)2 occupancy; and iii) a higher incidence of extrapyramidal side effects when their D2 occupancy exceeds 80%. A review of pharmacologic and behavioral data suggested that amoxapine should also conform to this profile; therefore, we undertook a positron-emission tomography (PET) study of its 5-HT2 and D2 occupancy.\nSeven healthy volunteers received 50-250 mg/day of amoxapine for 5 days and then had [11C]-raclopride and [18F]-setoperone PET scans.\n5-HT2 receptors showed near saturation at doses of 100 mg/day and above. The D2 receptor occupancies showed a dose-dependent increase, never exceeding 80%; at all doses 5-HT2 occupancy exceeded D2 occupancy.\nIs amoxapine an atypical antipsychotic?",
        "answer": "yes",
        "answer_rationale": "PET data show that amoxapine's profile is very similar to that of the established atypical antipsychotics. These data, together with amoxapine's in vitro pharmacologic profile, effectiveness in animal models, and efficacy in psychotic depression raise the possibility of amoxapine as an \"atypical\" antipsychotic agent in the treatment of schizophrenia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. So, the question is whether amoxapine is an atypical antipsychotic based on the study described. Let me start by recalling what defines an atypical antipsychotic. From what I remember, atypical antipsychotics are characterized by their higher affinity for serotonin 5-HT2 receptors compared to dopamine D2 receptors. This is thought to contribute to their lower incidence of extrapyramidal side effects (EPS) compared to typical antipsychotics, which have higher D2 occupancy and thus more EPS.\n\nThe question mentions that all currently available atypical antipsychotics have three features at clinically relevant doses: \ni) high 5-HT2 occupancy, \nii) greater 5-HT2 than D2 occupancy, \niii) higher EPS incidence when D2 occupancy exceeds 80%. \n\nThe study on amoxapine found that at 100 mg/day and above, 5-HT2 receptors were near saturation. The D2 occupancy increased with dose but never went over 80%. Also, at all doses, 5-HT2 occupancy was higher than D2. \n\nSo, comparing to the criteria: \ni) Amoxapine does have high 5-HT2 occupancy (since it's near saturation at 100mg+). \nii) The 5-HT2 is greater than D2, which matches. \niii) Since D2 never went over 80%, the third point about EPS when D2 exceeds 80% isn't met here, but the question states that the third point is a characteristic of atypicals. Wait, the third point says that atypicals have a higher incidence of EPS when their D2 occupancy exceeds 80%. So, if D2 doesn't go over 80%, then maybe that's part of why they have lower EPS. \n\nThe review suggested amoxapine would conform to the atypical profile, and the study's results fit the first two criteria. Since the study shows that 5-HT2 is higher than D2 occupancy and D2 doesn't exceed 80%, which aligns with the atypical profile. Therefore, the answer should be yes (A). But wait, amoxapine is actually a tricyclic antidepressant, but maybe in higher doses it's used as an antipsychotic. However, according to the given data, the study's results fit the criteria for atypical ant",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 313,
            "completion_tokens": 512
        },
        "time_elapsed": 6.132612466812134
    },
    {
        "realidx": "10375486",
        "question": "to describe variation in utilisation of carotid endarterectomy (CEA) within two English health regions and explore relationships between use, need and proximity to services.\nconsecutive case series of operations. Comparison at a population level with district stroke mortality, hospital admissions and material deprivation.\nstandardised utilisation rates for CEA and measures of inter-district variability. Spearman's rank correlation coefficients for associations between variables.\nvariation in utilisation rates was considerable (14-fold difference across district populations). More individuals had bilateral surgery in the Yorkshire region than in the Northern (11.7% vs. 5.5%, p=0.002). There was no association between utilisation rates for CEA and district stroke mortality (r=-0.06, 95% CI -0.41 to 0.30) or admission rates for stroke (r=0.17, 95% CI -0.2 to 0.49). There was a strong relationship between residence in districts where services were located and higher utilisation. Rates of CEA were lowest in the regions' most affluent wards.\nAre variations in the use of carotid endarterectomy explained by population Need?",
        "answer": "no",
        "answer_rationale": "use of CEA varies widely, depending on area of residence. Variation is not a consequence of differences in need, but reflects clinical practice and supply of services. There is evidence to suggest unmet need for CEA.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether variations in the use of carotid endarterectomy (CEA) are explained by population need. The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided in the study summary. The study compared two English health regions. They looked at utilization rates of CEA, stroke mortality, hospital admissions for stroke, and material deprivation. The key findings here are that there was a 14-fold difference in CEA use across districts. They also found no association between CEA utilization and stroke mortality (correlation coefficient r = -0.06) or stroke admission rates (r = 0.17). Both of those p-values are not statistically significant since the confidence intervals include zero. \n\nAdditionally, the study noted that there was a strong relationship between where the services were located (i.e., proximity) and higher utilization. Also, interestingly, the most affluent areas had lower CEA rates. \n\nThe question is about whether the variation is due to \"need.\" The variables they checked for need would be things like stroke mortality and admission rates, which are indicators of how much stroke is present in the population. Since the correlations between CEA use and those need factors were not significant (the r values are close to zero and the CIs include zero), that suggests that need isn't driving the variation. Instead, the proximity to the service and possibly socioeconomic factors (like affluence) are more related. \n\nSo the answer should be \"no\" because the study found no association between need (stroke metrics) and CEA use. The variation is more about where the services are located and maybe deprivation levels, not the actual need as measured by stroke outcomes.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 343,
            "completion_tokens": 365
        },
        "time_elapsed": 4.571271896362305
    },
    {
        "realidx": "10381996",
        "question": "To determine whether the use of empiric chest radiography (CXR) is of significant value in detecting clinically unsuspected acute chest syndrome (ACS) in febrile patients with sickle cell disease (SCD).\nPatients with SCD presenting to the emergency department and hematology clinic with temperature greater than or equal to 38 degrees C were prospectively evaluated using a physician-completed questionnaire. The questionnaire included inquiries into the patient's physical signs and symptoms and the physician's clinical impression for the presence of ACS. The questionnaire was completed before obtaining CXR results in all patients.\nSeventy-three patients with SCD with 96 febrile events were evaluated over a 1-year period. Twenty-four percent (23/96) of the patients had CXR evidence of ACS. On the basis of the questionnaire data, 61% (14/23) of ACS cases were not clinically suspected by the evaluating physician before obtaining CXR. Comparing the patients with and without ACS revealed that, with the exception of splinting (4/23 [17%] versus 0/73 [0%]), no symptom or physical examination finding helped to identify which patients had ACS. Fifty-seven percent of patients with ACS had completely normal findings on physical examination. The presentation of patients with clinically detected versus clinically unsuspected ACS also did not differ significantly. Length of hospitalization, oxygen use, and need for transfusion were the same in both the unsuspected and detected ACS groups. Overall physician sensitivity for predicting ACS was only 39%, and diagnostic accuracy did not improve significantly with increasing levels of pediatric training.\nClinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough?",
        "answer": "no",
        "answer_rationale": "ACS is common in patients with SCD who present with fever and was grossly underestimated by evaluating physicians. History and physical examination appear to be of little value in defining which febrile patients require CXR. In view of the mortality and morbidity associated with ACS, empiric CXR should be considered when evaluating a febrile patient with SCD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The main point is whether empiric chest radiography is of significant value in detecting clinically unsuspected ACS in febrile SCD patients. The study's results show that 24% of the febrile events had CXR evidence of ACS. But here's the kicker: 61% of those ACS cases weren't suspected by the physicians before the CXR. That's a big number. Also, the physical exam wasn't helpful except for splinting, which was only present in 17% of ACS cases. Over half of the ACS patients had normal physical exams. Plus, the clinical presentation didn't differ between suspected and unsuspected cases. The docs' sensitivity was only 39%, which is really low. Even with more training, accuracy didn't improve much. So, if the clinicians aren't good at detecting ACS clinically, then the CXR is valuable because it's catching a lot they're missing. The question is asking if the empiric CXR is of significant value. Since the study shows that a lot of cases are missed without it, the answer should be that the clinician assessment isn't accurate enough, so the CXR is needed. So the answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 448,
            "completion_tokens": 262
        },
        "time_elapsed": 3.5363404750823975
    },
    {
        "realidx": "10401824",
        "question": "Laparoscopic techniques can be used to treat patients whose antireflux surgery has failed.\nCase series.\nTwo academic medical centers.\nForty-six consecutive patients, of whom 21 were male and 25 were female (mean age, 55.6 years; range, 15-80 years). Previous antireflux procedures were laparoscopic (21 patients), laparotomy (21 patients), thoracotomy (3 patients), and thoracoscopy (1 patient).\nThe cause of failure, operative and postoperative morbidity, and the level of follow-up satisfaction were determined for all patients.\nThe causes of failure were hiatal herniation (31 patients [67%]), fundoplication breakdown (20 patients [43%]), fundoplication slippage (9 patients [20%]), tight fundoplication (5 patients [11%]), misdiagnosed achalasia (2 patients [4%]), and displaced Angelchik prosthesis (2 patients [4%]). Twenty-two patients (48%) had more than 1 cause. Laparoscopic reoperative procedures were Nissen fundoplication (n = 22), Toupet fundoplication (n = 13), paraesophageal hernia repair (n = 4), Dor procedure (n = 2), Angelchik prosthesis removal (n = 2), Heller myotomy (n = 2), and the takedown of a wrap (n = 1). In addition, 18 patients required crural repair and 13 required paraesophageal hernia repair. The mean +/- SEM duration of surgery was 3.5+/-1.1 hours. Operative complications were fundus tear (n = 8), significant bleeding (n = 4), bougie perforation (n = 1), small bowel enterotomy (n = 1), and tension pneumothorax (n = 1). The conversion rate (from laparoscopic to an open procedure) was 20% overall (9 patients) but 0% in the last 10 patients. Mortality was 0%. The mean +/- SEM hospital stay was 2.3+/-0.9 days for operations completed laparoscopically. Follow-up was possible in 35 patients (76%) at 17.2+/-11.8 months. The well-being score (1 best; 10, worst) was 8.6+/-2.1 before and 2.9+/-2.4 after surgery (P<.001). Thirty-one (89%) of 35 patients were satisfied with their decision to have reoperation.\nIs laparoscopic reoperation for failed antireflux surgery feasible?",
        "answer": "yes",
        "answer_rationale": "Antireflux surgery failures are most commonly associated with hiatal herniation, followed by the breakdown of the fundoplication. The laparoscopic approach may be used successfully to treat patients with failed antireflux operations. Good results were achieved despite the technical difficulty of the procedures.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether laparoscopic reoperation for failed antireflux surgery is feasible based on the provided case series.\n\nFirst, I need to understand what the study's results indicate. The study involved 46 patients who had previous antireflux surgeries that failed. They underwent laparoscopic reoperations. The key points from the data are:\n\n- The causes of failure included hiatal herniation, fundoplication issues, etc. Many had multiple causes.\n- The reoperations included various procedures like Nissen, Toupet, hernia repairs, etc. \n- Complications occurred in some patients: fundus tears, bleeding, etc. The conversion rate to open surgery was 20% overall but 0% in the last 10 patients. No mortality.\n- Hospital stay was about 2.3 days for those who stayed laparoscopic.\n- Follow-up showed a significant improvement in well-being scores (from 8.6 to 2.9) and 89% satisfaction.\n\nFeasibility here likely refers to whether the procedure can be successfully and safely performed. The study shows that they were able to perform these reoperations laparoscopically, even though there were some complications and conversions. However, the conversion rate decreased over time, suggesting that with experience, it's manageable. The low mortality and high patient satisfaction also point towards feasibility. The fact that they were able to perform the surgeries and get good outcomes supports that it's feasible. So the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 677,
            "completion_tokens": 324
        },
        "time_elapsed": 3.919811725616455
    },
    {
        "realidx": "10456814",
        "question": "Although desflurane is commonly used to control surgically induced hypertension, its effects on left ventricular (LV) function have not been investigated in this clinical situation. The purpose of the present study was to evaluate the LV function response to desflurane, when used to control intraoperative hypertension.\nIn 50 patients, scheduled for vascular surgery, anesthesia was induced with sufentanil 0.5 microg/kg, midazolam 0.3 mg/kg and atracurium 0.5 mg/kg. After tracheal intubation, anesthesia was maintained with increments of drugs with controlled ventilation (N2O/O2=60/40%) until the start of surgery. A 5 Mhz transesophageal echocardiography (TEE) probe was inserted after intubation. Pulmonary artery catheter and TEE measurements were obtained after induction (to)(control value), at surgical incision (t1) if it was associated with an increase in systolic arterial pressure (SAP) greater than 140 mmHg (hypertension) and after control of hemodynamic parameters by administration of desflurane (return of systolic arterial pressure to within 20% of the control value) (t2) in a fresh gas flow of 31/ min.\nSixteen patients developed hypertension at surgical incision. SAP was controlled by desflurane in all 16 patients. Afterload assessed by systemic vascular resistance index (SVRI), end-systolic wall-stress (ESWS) and left-ventricular stroke work index (LVSWI) increased with incision until the hypertension returned to post-induction values with mean end-tidal concentration of 5.1+/-0.7% desflurane. No change in heart rate, cardiac index, mean pulmonary arterial pressure, stroke volume, end-diastolic and end-systolic cross-sectional areas, fractional area change and left ventricular circumferential fiber shortening was noted when desflurane was added to restore blood pressure.\nDoes desflurane alter left ventricular function when used to control surgical stimulation during aortic surgery?",
        "answer": "no",
        "answer_rationale": "This study demonstrates that in patients at risk for cardiac morbidity undergoing vascular surgery, desflurane is effective to control intraoperative hypertension without fear of major cardiac depressant effect.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether desflurane alters left ventricular function when used to control hypertension during aortic surgery. The study described involved 50 patients undergoing vascular surgery. They induced anesthesia with a few drugs and then maintained it with others until surgery started. They used TEE and pulmonary artery catheters to measure various parameters.\n\nThe key part here is the results. The study found that in the 16 patients who had hypertension at incision, desflurane successfully controlled their blood pressure. The afterload parameters like SVRI, ESWS, and LVSWI increased at incision but returned to baseline with desflurane. However, the question is about LV function. The passage then states that when desflurane was added, there were no changes in several LV function parameters: heart rate, cardiac index, stroke volume, end-diastolic and end-systolic areas, fractional area change, and fiber shortening. All these are measures of LV function. Since none of these changed, that suggests desflurane didn't alter LV function. The answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 541,
            "completion_tokens": 240
        },
        "time_elapsed": 3.1125564575195312
    },
    {
        "realidx": "10490564",
        "question": "To determine whether anginal episodes might be related to extremes of hypotension in patients with ischaemic heart disease taking drugs to treat angina and heart failure.\nObservational study of patients with ischaemic heart disease attending an urban tertiary referral cardiology centre.\nA selected patient population was enrolled, having: angina on one or more hypotensive cardiovascular medications; hypotension on clinic or ambulatory measurement; and a resting ECG suitable for ambulatory monitoring. Patients had echocardiography, ambulatory blood pressure monitoring, and Holter monitoring. Hypotension induced ischaemic (HII) events were defined as episodes of ST segment ischaemia occurring at least one minute after an ambulatory blood pressure measurement (systolic/diastolic) below 100/65 mm Hg during the day, or 90/50 mm Hg at night.\n25 suitable patients were enrolled, and 107 hypotensive events were documented. 40 ST events occurred in 14 patients, of which a quarter were symptomatic. Fourteen HII events occurred in eight patients, with 13 of the 14 preceded by a fall in diastolic pressure (median diastolic pressure 57.5 mm Hg, interquartile range 11, maximum 72 mm Hg, minimum 45 mm Hg), and six preceded by a fall in systolic pressure (chi(2) = 11.9, p<0.001). ST events were significantly associated with preceding hypotensive events (chi(2) = 40.2, p<0.0001). Patients with HII events were more frequently taking multiple hypotensive drug regimens (8/8 v 9/17, chi(2) = 5.54, p = 0.022).\nHypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?",
        "answer": "yes",
        "answer_rationale": "In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether profound hypotensive events can cause myocardial ischemic events in patients with coronary disease. The study provided gives some details to help answer this.\n\nFirst, the study enrolled 25 patients with ischemic heart disease who were on hypotensive meds. They monitored their blood pressure and heart activity. The key points here are the definitions: HII events are ST segment changes after blood pressure drops below certain thresholds. They found 14 HII events in 8 patients. Importantly, most of these HII events were preceded by a drop in diastolic pressure. Also, there's a significant association between ST events and preceding hypotensive events (chi-square 40.2, p<0.0001). That's a strong statistical link. Additionally, patients with HII were more likely on multiple meds, which might contribute to the hypotension.\n\nThe question is whether profound hypotension can cause ischemia. The study shows that when BP drops (especially diastolic), ischemic events (ST changes) occur, and there's a significant association. The answer should be yes because the data supports that hypotension is linked to these events. The options are A, B, C. The study's results indicate a causal relationship here, so the answer is A (yes).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 515,
            "completion_tokens": 286
        },
        "time_elapsed": 3.4198174476623535
    },
    {
        "realidx": "10548670",
        "question": "The National Institutes of Health Stroke Scale (NIHSS) is a valid, reproducible scale that measures neurological deficit. Of 42 possible points, 7 points are directly related to measurement of language compared with only 2 points related to neglect.\nWe examined the placebo arm of the NINDS t-PA stroke trial to test the hypothesis that the total volume of cerebral infarction in patients with right hemisphere strokes would be greater than the volume of cerebral infarction in patients with left hemisphere strokes who have similar NIHSS scores. The volume of stroke was determined by computerized image analysis of CT films and CT images stored on computer tape and optical disks. Cube-root transformation of lesion volume was performed for each CT. Transformed lesion volume was analyzed in a logistic regression model to predict volume of stroke by NIHSS score for each hemisphere. Spearman rank correlation was used to determine the relation between the NIHSS score and lesion volume.\nThe volume for right hemisphere stroke was statistically greater than the volume for left hemisphere strokes, adjusting for the baseline NIHSS (P<0. 001). For each 5-point category of the NIHSS score<20, the median volume of right hemisphere strokes was approximately double the median volume of left hemisphere strokes. For example, for patients with a left hemisphere stroke and a 24-hour NIHSS score of 16 to 20, the median volume of cerebral infarction was 48 mL (interquartile range 14 to 111 mL) as compared with 133 mL (interquartile range 81 to 208 mL) for patients with a right hemisphere stroke (P<0.001). The median volume of a right hemisphere stroke was roughly equal to the median volume of a left hemisphere stroke in the next highest 5-point category of the NIHSS. The Spearman rank correlation between the 24-hour NIHSS score and 3-month lesion volume was 0.72 for patients with left hemisphere stroke and 0.71 for patients with right hemisphere stroke.\nDoes the National Institutes of Health Stroke Scale favor left hemisphere strokes?",
        "answer": "yes",
        "answer_rationale": "For a given NIHSS score, the median volume of right hemisphere strokes is consistently larger than the median volume of left hemisphere strokes. The clinical implications of our finding need further exploration.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the NIH Stroke Scale (NIHSS) favors left hemisphere strokes. The options are yes, no, or maybe.\n\nFirst, I need to recall what the NIHSS measures. From the question, it's mentioned that the NIHSS has 42 points, with 7 points for language (left hemisphere function) and 2 for neglect (right hemisphere). So, language deficits are more heavily weighted. \n\nThe study compared right and left hemisphere strokes. The results showed that for similar NIHSS scores, right hemisphere strokes had a larger volume. For example, a left hemisphere stroke with a score of 16-20 had a median volume of 48 mL, while a right hemisphere stroke with the same score had 133 mL. This suggests that the same NIHSS score corresponds to a bigger lesion in the right hemisphere. \n\nThe question is whether the scale \"favors\" left hemisphere strokes. If the scale gives more points for language issues (left hemisphere), then even a smaller lesion in the left hemisphere might result in a similar NIHSS score as a larger right hemisphere lesion. So, the NIHSS might be more sensitive to left hemisphere deficits because of the higher point allocation for language. Therefore, the scale might overrepresent the impact of left hemisphere strokes compared to right, meaning it \"favors\" them in terms of scoring. \n\nThe study's findings show that right hemisphere strokes need to be larger to reach the same NIHSS score. This implies that the NIHSS is capturing more deficits in left hemisphere strokes due to the language components. So the answer would be yes, the NIHSS favors left hemisphere strokes because the same score can be achieved with smaller lesions there. \n\nLooking at the options, the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 534,
            "completion_tokens": 376
        },
        "time_elapsed": 4.748668193817139
    },
    {
        "realidx": "10749257",
        "question": "The United States Food and Drug Administration implemented federal regulations governing mammography under the Mammography Quality Standards Act (MQSA) of 1992. During 1995, its first year in implementation, we examined the impact of the MQSA on the quality of mammography in North Carolina.\nAll mammography facilities were inspected during 1993-1994, and again in 1995. Both inspections evaluated mean glandular radiation dose, phantom image evaluation, darkroom fog, and developer temperature. Two mammography health specialists employed by the North Carolina Division of Radiation Protection performed all inspections and collected and codified data.\nThe percentage of facilities that met quality standards increased from the first inspection to the second inspection. Phantom scores passing rate was 31.6% versus 78.2%; darkroom fog passing rate was 74.3% versus 88.5%; and temperature difference passing rate was 62.4% versus 86.9%.\nHas the mammography quality standards act affected the mammography quality in North Carolina?",
        "answer": "yes",
        "answer_rationale": "In 1995, the first year that the MQSA was in effect, there was a significant improvement in the quality of mammography in North Carolina. This improvement probably resulted from facilities' compliance with federal regulations.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the Mammography Quality Standards Act (MQSA) has affected mammography quality in North Carolina. The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided. The MQSA was implemented in 1992, and the study looked at the first year of implementation, 1995. They inspected facilities in 1993-1994 and again in 1995. The key data points are the passing rates for different quality metrics before and after.\n\nThe percentages given show significant increases across all the evaluated categories. For phantom scores, it went from 31.6% to 78.2%. That's a big jump. Darkroom fog improved from 74.3% to 88.5%, and temperature difference from 62.4% to 86.9%. All these are clear increases. \n\nThe question is whether the MQSA caused this improvement. The study's design compares the same facilities before and after the implementation. Since the percentages went up after the Act was in place, it's reasonable to infer that the MQSA had a positive effect. The answer should be yes. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 317,
            "completion_tokens": 281
        },
        "time_elapsed": 3.4324846267700195
    },
    {
        "realidx": "10781708",
        "question": "Most studies on thrombosis prophylaxis focus on postoperative venous thrombosis. In medical wards thrombosis prophylaxis is generally restricted to patients who are immobilised. Our primary aim was to investigate the incidence of venous thrombosis in a general internal ward, to assess whether more rigorous prophylaxis would be feasible.\nWe investigated the incidence of venous thrombosis in patients hospitalised from 1992 to 1996 and related our findings to literature reports.\nThe incidence of symptomatic venous thrombosis in internal patients during hospitalisation was 39/6332 (0.6%). Among these 39 patients, 24 had a malignancy, whereas 876 out of all 6332 patients had a known malignancy. So, the incidence in this group with cancer was 2.7% compared with 0.3% (15/5456) in the non-cancer group (relative risk for venous thrombosis due to malignancy was 10.0 (95%C.I. 5.3-18.9).\nThrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense?",
        "answer": "no",
        "answer_rationale": "The incidence of venous thrombosis during hospitalisation in a department of general internal medicine is low and does not justify prophylaxis in all internal patients. Cancer is a strong risk factor for hospital-acquired thrombosis in the medical ward. Further studies may answer the question as to whether thrombosis prophylaxis in this subgroup is feasible.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about venous thrombosis in medical wards and whether prophylaxis for all patients is necessary. The key points from the study are the incidence rates. The overall incidence was 0.6%, but when broken down, cancer patients had a 2.7% rate, while non-cancer patients were at 0.3%. The relative risk is 10 times higher for those with malignancy.\n\nThe question is asking if prophylaxis for all patients makes sense. The data shows that the risk is significantly higher in cancer patients. The current practice is to give prophylaxis only to immobilized patients. But the study's results suggest that cancer patients are at much higher risk. However, the majority of the patients (876 out of 6332) had cancer, but even so, the absolute incidence in cancer patients is 2.7%, which is higher but not extremely common. \n\nIf you give prophylaxis to everyone, you might be over-treating the non-cancer group where the incidence is low (0.3%). The relative risk is high, but the absolute numbers are low. So maybe targeting prophylaxis to high-risk groups like cancer patients would be more efficient. The study's conclusion seems to question whether prophylaxis for all is necessary, given that the overall incidence is low except in cancer cases. Therefore, the answer is probably B) no, because prophylaxis for all isn't justified when the risk is concentrated in a subgroup. But I need to make sure I'm not missing anything. The options are yes, no, maybe. The study's data supports that only a subset (cancer patients) have a significantly higher risk, so prophylaxis for all might not be warranted. So the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 355,
            "completion_tokens": 380
        },
        "time_elapsed": 4.474233388900757
    },
    {
        "realidx": "10798511",
        "question": "Physical examination to detect abdominal injuries has been considered unreliable in alcohol-intoxicated trauma patients. Computed tomography (CT) plays the primary role in these abdominal evaluations.\nWe reviewed medical records of all blunt trauma patients admitted to our trauma service from January 1, 1992, to March 31, 1998. Study patients had a blood alcohol level>or =80 mg/dL, Glasgow Coma Scale (GCS) score of 15, and unremarkable abdominal examination.\nOf 324 patients studied, 317 (98%) had CT scans negative for abdominal injury. Abdominal injuries were identified in 7 patients (2%), with only 2 (0.6%) requiring abdominal exploration. A significant association was found between major chest injury and abdominal injury.\nBlunt trauma in intoxicated patients: is computed tomography of the abdomen always necessary?",
        "answer": "no",
        "answer_rationale": "The incidence of abdominal injury in intoxicated, hemodynamically stable, blunt trauma patients with a normal abdominal examination and normal mentation is low. Physical examination and attention to clinical risk factors allow accurate abdominal evaluation without CT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether CT scans of the abdomen are always necessary for intoxicated blunt trauma patients based on the study provided.\n\nFirst, I need to understand the study's findings. The study looked at patients with a blood alcohol level of 80 mg/dL or higher, a GCS of 15 (which means they were fully awake and oriented), and an unremarkable abdominal exam. Out of 324 patients, 317 (98%) had negative CT scans. Only 7 (2%) had abdominal injuries, and just 2 of those needed surgery. Also, there was a significant link between major chest injuries and abdominal injuries.\n\nThe key points here are that the patients were alert (GCS 15), had normal physical exams, and most didn't have injuries. The question is whether CT is always needed. The study suggests that in this specific group, the rate of injury is very low. Since the abdominal exam was normal and they were conscious, maybe CT isn't always necessary. However, the fact that 2% had injuries, even if most didn't need surgery, might argue for still using CT. But the question is whether it's \"always\" necessary. Since the majority didn't need it, but there's a small risk, the answer might be \"maybe\" (C) or \"no\" (B). Wait, the options are (A) yes, (B) no, (C) maybe. The study shows that in these specific cases (intoxicated, GCS 15, normal exam), the injury rate is low. So maybe in those cases, CT isn't always needed. The conclusion might suggest that when those criteria are met, CT might not be necessary, but if there's a major chest injury (since that's associated with abdominal injury), then maybe you should do it. So the answer would be B (no) because in the study's population, CT wasn't always necessary since most were negative. But the question is phrased as \"is CT always necessary?\" Given that in this group, it's not always needed (since 98% were negative), the answer would be B (no). Alternatively, maybe the presence of chest injury complicates it, so \"maybe\" (C). But the question is about whether it's \"always\" necessary. Since in some cases (those with normal exams, etc.) it's not needed, the answer is B. The",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 279,
            "completion_tokens": 512
        },
        "time_elapsed": 5.837948322296143
    },
    {
        "realidx": "10834864",
        "question": "Avascular necrosis of bone (AVN) is a well known complication in patients with systemic lupus erythematosus (SLE).\nTo investigate the role of antiphospholipid antibody status (IgM and IgG anticardiolipin antibodies and lupus anticoagulant) with adjustment for corticosteroid use as risk factors for the development of AVN.\nA cohort of 265 patients receiving long term follow up in our SLE clinic from 1978 to 1998 was analysed. Patients with AVN complications were detected and then matched for age, sex, ethnicity, duration of disease, and organ disease with two other patients with SLE. A further 31 patients were chosen at random for the analysis.\nEleven patients had AVN, giving a point prevalence of 4%. There were no significant differences demonstrable in the presence of individual antiphospholipid antibodies (aPL) or their combination between the group with AVN or the two control groups.\nRisk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?",
        "answer": "no",
        "answer_rationale": "Incorporating an adjustment for corticosteroid use we were unable to show a link between the presence of aPL and the development of AVN in patients with SLE.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether antiphospholipid antibodies play a role as a risk factor for avascular necrosis (AVN) in SLE patients, based on the study described.\n\nFirst, I need to recall what the study found. The study looked at 265 SLE patients over many years. They found 11 cases of AVN, which is a 4% prevalence. Then they compared these patients with AVN to two control groups matched for various factors like age, sex, etc., and also included 31 random patients. The key result here is that there were no significant differences in the presence of individual antiphospholipid antibodies (like IgM and IgG anticardiolipin or lupus anticoagulant) between the AVN group and the controls. \n\nThe question is whether the study supports a role for aPL as a risk factor. Since the study found no significant differences in aPL presence between the groups, that would suggest that these antibodies aren't a significant risk factor here. The options are yes, no, maybe. The answer should be \"no\" because the study didn't find a link. But wait, maybe there's a nuance. The study adjusted for corticosteroid use, which is a known risk factor for AVN. The fact that even after adjusting for that, the aPL didn't show a difference, so the conclusion is that aPL aren't the main factors here. So the correct answer is B (no). The options are labeled (A) yes, (B) no, (C) maybe. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 337,
            "completion_tokens": 349
        },
        "time_elapsed": 4.380282878875732
    },
    {
        "realidx": "10877371",
        "question": "Phacodonesis can occur in pseudoexfoliation syndrome because of impaired zonular support. This study investigates whether the increased mobility of the lens influences anterior chamber depth in patients with pseudoexfoliation while assuming a prone position.\nCentral anterior chamber depth was measured in 39 patients with clinically apparent unilateral pseudoexfoliation and elevated intraocular pressure. Patients were placed in a face-up position for 5 minutes, at which time anterior chamber depth and axial length were measured by A scan, and intraocular pressure was measured by Tonopen (Oculab, La Jolla, CA) in both eyes. The measurements were repeated on both eyes after 5 minutes in a face-down position.\nNo significant differences in intraocular pressure or axial length between the prone and supine positions were found in either eye. Anterior chamber depth in eyes with pseudoexfoliation decreased from a mean of 3.08 mm in the supine position to a mean of 2.95 mm in the prone position, whereas mean anterior chamber depth in the fellow eyes decreased from 3.01 mm to 2.97 mm. The decrease in anterior chamber depth when facing down in the eyes with pseudoexfoliation was significantly greater than in the fellow eyes.\nDoes head positioning influence anterior chamber depth in pseudoexfoliation syndrome?",
        "answer": "yes",
        "answer_rationale": "In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether head positioning influences anterior chamber depth in pseudoexfoliation syndrome. The study provided gives some data to help answer this.\n\nFirst, I need to recall what phacodonesis is. It's lens shaking due to weakened zonules, which are the fibers that hold the lens in place. In pseudoexfoliation syndrome, these zonules are impaired, leading to lens instability. The study's hypothesis is that this mobility might affect the anterior chamber depth when the patient changes position.\n\nLooking at the study details: they measured central anterior chamber depth in 39 patients with unilateral pseudoexfoliation. They compared supine (face-up) and prone (face-down) positions. The key results are that in the pseudoexfoliation eyes, the anterior chamber depth decreased more when moving to the prone position compared to the fellow eyes. Specifically, the pseudoexfoliation eyes went from 3.08 to 2.95 mm, while the fellow eyes only decreased from 3.01 to 2.97 mm. The difference between the two eyes' changes was significant.\n\nThe question is whether head positioning (prone vs supine) affects anterior chamber depth in these patients. Since the study shows a greater decrease in the affected eyes when prone, that suggests that yes, positioning does influence it. The control eyes (fellow eyes without pseudoexfoliation) also had a small decrease, but the change was more pronounced in the pseudoexfoliation eyes. This indicates that the condition's zonular weakness makes the anterior chamber depth more susceptible to positional changes. \n\nThe options are A (yes), B (no), C (maybe). The study's results clearly show a significant difference, so the answer should be A. The other options don't fit because the data supports a definite yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 363,
            "completion_tokens": 389
        },
        "time_elapsed": 4.590936183929443
    },
    {
        "realidx": "10922093",
        "question": "The use of open access endoscopy is increasing. Its effect on the adequacy of patient informed consent, procedure acceptance and the impact on subsequent communication/transfer of procedure results to the patient have not been evaluated. The aim of our study was to compare the extent of preknowledge of procedures and test explanation, patient medical complexity, information transfer and overall patient satisfaction between a patient group referred for outpatient open access endoscopy versus a patient group from a gastrointestinal (GI) subspecialty clinic.\nInformation was obtained from all patients presenting for outpatient upper and lower endoscopy by using a 1-page questionnaire. Patients from the two groups who had an outpatient upper/lower endoscopic procedure were contacted by phone after the procedure to obtain information with a standardized questionnaire.\nThe open access patients reported receiving significantly less information to help them identify the procedure (p<0.01) and less explanation concerning the nature of the procedure than the group of patients referred from the subspecialty clinic (p<0.005). There was no difference between the two groups in satisfaction scores for examinations performed under conscious sedation. For flexible sigmoidoscopy without sedation, however, the GI clinic patient group were more satisfied with their procedure. The majority of patients, regardless of access, were more likely to receive endoscopic results from a gastroenterologist than the referring physician. Furthermore, the patients in the GI clinic group who underwent colonoscopy felt significantly better at follow-up.\nDoes open access endoscopy close the door to an adequately informed patient?",
        "answer": "yes",
        "answer_rationale": "Patients undergoing open access procedures are less likely to be properly informed about their endoscopic procedure. Our results indicate that with open access endoscopy, a defined mechanism needs to be in place for communication of endoscopic results to the patient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study compared open access endoscopy patients with those referred from a GI subspecialty clinic. The key points from the study are that open access patients received significantly less information about the procedure's nature and identification (p<0.01 and p<0.005). However, satisfaction scores were similar for procedures with sedation, except for flexible sigmoidoscopy without sedation where GI clinic patients were more satisfied. Also, most patients got results from a gastroenterologist, and GI clinic colonoscopy patients felt better post-procedure.\n\nThe question is whether open access endoscopy closes the door to adequately informed patients. The study shows that open access patients had less information provided. Since informed consent requires adequate information, the answer would lean towards \"yes\" if the lack of info means they aren't adequately informed. But the options are (A) yes, (B) no, (C) maybe. The study's results indicate that open access patients had less explanation, which suggests their informed consent might be inadequate. So the answer should be A) yes. Wait, but maybe the question is tricky. The study's aim was to see if open access affects informed consent adequacy. Since they found less info given, that implies that open access might lead to less adequate informed consent. Therefore, the answer is A. But wait, the options are (A) yes, meaning that open access does close the door (i.e., it prevents adequate informed consent). The study's findings support that, so the answer is A. Alternatively, maybe the answer is B) no, but the data shows that open access patients had less info. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 401,
            "completion_tokens": 355
        },
        "time_elapsed": 4.335777044296265
    },
    {
        "realidx": "10966943",
        "question": "The records of 465 patients with an established diagnosis of age related macular degeneration who had attended a specialist macular clinic between 1990 and 1998 were scrutinised. A full clinical examination and standardised refraction had been carried out in 189 of these cases on a minimum of two occasions. Cases were looked for where an improvement of one or more lines of either distance or near acuity was recorded in the eye unaffected by macular disease. In each one of these cases the improvement in visual acuity could not be attributed to treatment of other existing pathology.\n12 such cases were detected. In nine of these the eye showing improvement of acuity had a history of amblyopia. The mean improvement in distance and near acuity in amblyopic eyes by 12 months was 3.3 and 1.9 lines logMAR respectively. The improvement in acuity generally occurred between 1 and 12 months from baseline and remained stable over the period of follow up.\nAmblyopia: is visual loss permanent?",
        "answer": "no",
        "answer_rationale": "Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss in the fellow eye and the improvement appears to be sustained.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether amblyopia causes permanent visual loss. The options are yes, no, or maybe. \n\nFirst, I need to look at the provided study details. The study looked at 465 patients with age-related macular degeneration (AMD). Out of these, 189 had multiple clinical exams. They were checking for cases where the unaffected eye (so the one not affected by AMD) showed improved visual acuity, and this improvement wasn't due to other treatments.\n\nThey found 12 cases where improvement happened. In 9 of those, the eye that improved had a history of amblyopia. The mean improvement in distance and near acuity was 3.3 and 1.9 lines on the logMAR chart. The improvement happened between 1-12 months and stayed stable.\n\nSo, the key point here is that in these amblyopic eyes, there was measurable improvement in visual acuity without any specific treatment mentioned. The question is whether amblyopia's visual loss is permanent. The study's results suggest that even in adults with amblyopia (since AMD is more common in older adults), there can be some improvement. Traditionally, amblyopia is thought to be treatable in children but less so in adults. However, this study shows that adults can still have some recovery, which challenges the idea that it's always permanent.\n\nTherefore, the answer would be \"no\" because the study found cases where improvement occurred, indicating that the visual loss isn't always permanent. The correct option is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 311,
            "completion_tokens": 332
        },
        "time_elapsed": 4.207683563232422
    },
    {
        "realidx": "10973547",
        "question": "It is generally assumed, that patients with Werlhof's disease (WD) are at increased risk for bleeding complications when undergoing cardiac surgery with extracorporeal circulation. Therefore we performed this case control study to estimate the real risk for bleeding complications of these patients.\nBetween 05/95 and 07/98, ten patients with WD (eight males, two females) underwent cardiac surgery employing extracorporeal circulation (WD-group). Five of these patients with platelet counts below 80/nl were treated by immunoglobulins preoperatively. Each patient with WD was matched to five patients without WD (no-WD-group) using diagnosis, age, gender, ejection fraction, number of distal anastomosis and body-mass-index as matching criteria.\nMean number of platelet counts were significant lower in the WD-group than in the no-WD-group despite a significant increase of platelet counts after immunoglobulin treatment (54/nl-->112/nl, P=0.018). On the day before, directly after and on the first day after surgery they were 141/nl vs. 215/nl (P=0.012), 75/nl vs. 147/nl (P=0.001) and 93/nl vs. 136/nl (P=0.009). Accordingly, patients of the WD-group received significantly more platelet concentrates than patients of the no-WD-group (mean number of platelet concentrates: 2.3 versus 0.7, P=0.007). Total drainage loss via the mediastinal chest tubes was almost identical (1197 ml in the no-WD-group and 1140 ml in the WD-group). One patient of each group suffered from a bleeding complication requiring reexploration. Three patients of the no-WD-group (6%) and one patient of the WD-group (10%) expired postoperatively unrelated to WD.\nAre patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?",
        "answer": "no",
        "answer_rationale": "Patients with WD may possibly undergo cardiac surgery without a markedly enhanced risk for bleeding complications despite a more than usual transfusion requirement and significantly lower platelet counts perioperatively.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether patients with Werlhof's disease (WD) are at an increased risk for bleeding complications during cardiac surgery with extracorporeal circulation. The study provided gives some data to analyze.\n\nFirst, I need to recall what Werlhof's disease is. From what I remember, Werlhof's disease is another term for thrombotic thrombocytopenic purpura (TTP), which is a rare blood disorder characterized by platelet clumping and low platelet counts. Since TTP involves platelet consumption, it's logical to think that these patients might have bleeding risks, especially during surgeries that involve extracorporeal circulation, which can be traumatic to blood cells and clotting factors.\n\nLooking at the study details: They compared 10 WD patients with 50 non-WD patients (since each WD patient was matched to five controls). The key points from the data:\n\n- Platelet counts in WD group were significantly lower even after immunoglobulin treatment. Even after treatment, their platelet counts were around 112/nl, which is still lower than the control group's 215/nl pre-op. Lower platelets could contribute to bleeding, but the treatment helped a bit.\n\n- The WD group received more platelet transfusions (2.3 vs 0.7), which might be a proactive measure due to their lower platelet counts. However, the actual bleeding outcomes (drainage loss) were almost the same between groups (1197 vs 1140 ml). That's interesting because if they had lower platelets, you might expect more bleeding, but the drainage was similar.\n\n- The number of bleeding complications requiring reexploration was one in each group. So the complication rate here is the same (10% in WD vs 2% in no-WD, but since the WD group had 10 patients and the control had 50, the absolute numbers are 1 vs 1, but percentages would be 10% vs 2%). However, the question is about increased risk. The complication rate in WD is higher but the sample size is small. The study mentions that three controls (6%) and one WD (10%) died, but deaths were unrelated to WD.\n\nThe key here is that despite lower platelets and more transfusions, the actual bleeding outcomes (drainage and reexploration) didn't show a significant difference",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 538,
            "completion_tokens": 512
        },
        "time_elapsed": 5.637522220611572
    },
    {
        "realidx": "11035130",
        "question": "It is postulated that some aspects of methotrexate toxicity may be related to its action as an anti-folate. Folic acid (FA) is often given as an adjunct to methotrexate therapy, but there is no conclusive proof that it decreases the toxicity of methotrexate and there is a theoretical risk that it may decrease the efficacy of methotrexate.\nTo look at the effect of stopping FA supplementation in UK rheumatoid arthritis (RA) patients established on methotrexate<20 mg weekly and FA 5 mg daily, to report all toxicity (including absolute changes in haematological and liver enzyme indices) and to report changes in the efficacy of methotrexate.\nIn a prospective, randomized, double-blind, placebo-controlled study, 75 patients who were established on methotrexate<20 mg weekly and FA 5 mg daily were asked to stop their FA and were randomized to one of two groups: placebo or FA 5 mg daily. Patients were evaluated for treatment toxicity and efficacy before entry and then at intervals of 3 months for 1 yr.\nOverall, 25 (33%) patients concluded the study early, eight (21%) in the group remaining on FA and 17 (46%) in the placebo group (P = 0.02). Two patients in the placebo group discontinued because of neutropenia. At 9 months there was an increased incidence of nausea in the placebo group (45 vs. 7%, P = 0.001). The placebo group had significantly lower disease activity on a few of the variables measured, but these were probably not of clinical significance.\nDo patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?",
        "answer": "yes",
        "answer_rationale": "It is important to continue FA supplementation over the long term in patients on methotrexate and FA in order to prevent them discontinuing treatment because of mouth ulcers or nausea and vomiting. Our data suggest that FA supplementation is also helpful in preventing neutropenia, with very little loss of efficacy of methotrexate.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether RA patients on methotrexate and 5mg daily folic acid need to continue the folic acid long term. The study mentioned here is a randomized, double-blind, placebo-controlled trial. So that's a good quality study.\n\nThe study had 75 patients. They stopped FA and randomized to either continue FA 5mg or placebo. The main points from the results: 33% stopped early. More in the placebo group (46% vs 21%, p=0.02). That's a significant difference. The placebo group had more discontinuations, including two due to neutropenia. Also, at 9 months, nausea was higher in placebo (45% vs 7%, p=0.001). But the efficacy part: the placebo group had lower disease activity on some variables, but not clinically significant.\n\nSo the question is, do they need to continue FA? The options are yes, no, maybe. The study shows that stopping FA (placebo group) led to more toxicity (more discontinuations, neutropenia, nausea) but the efficacy wasn't really affected in a meaningful way. Since the toxicity went up when they stopped FA, that suggests that continuing FA might help reduce toxicity. But the study's results show that when they stopped FA (placebo), there was more toxicity. So the conclusion would be that continuing FA is beneficial to prevent these toxicities. Therefore, the answer would be (A) yes. Wait, but the question is phrased as \"need to continue\". The study's results support that stopping leads to more toxicity, so they should continue, so answer A. But wait, the options are (A) yes, (B) no, (C) maybe. The study's results show that stopping FA (placebo) led to more adverse events and more discontinuations. So the conclusion is that continuing FA is better to prevent toxicity, so they do need to continue. So the answer is A. But wait, the question says \"there is no conclusive proof that it decreases the toxicity\" in the initial statement. However, the study here found that when they stopped FA, there was more toxicity. So maybe the study does provide some evidence. The answer should be yes, they need to continue. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 494
        },
        "time_elapsed": 6.288568496704102
    },
    {
        "realidx": "11079675",
        "question": "The purpose of this study is to evaluate right ventricular (RV) volume and function after pulmonary valve replacement (PVR) and to address the issue of optimal surgical timing in these patients.\nChronic pulmonary regurgitation (PR) following repair of tetralogy of Fallot (TOF) leads to RV dilation and an increased incidence of sudden cardiac death in adult patients.\nWe studied 25 consecutive adult patients who underwent PVR for significant PR late after repair of TOF. Radionuclide angiography was performed in all at a mean of 8.2 months (+/- 8 months) before PVR and repeated at a mean of 28.0 months (+/- 22.8 months) after the operation. Right ventricular (RV) end-systolic volume (RVESV), RV end-diastolic volume (RVEDV) and RV ejection fraction (RVEF) were measured.\nMean RVEDV, RVESV and RVEF remained unchanged after PVR (227.1 ml versus 214.9 ml, p = 0.74; 157.4 ml versus 155.4 ml, p = 0.94; 35.6% versus 34.7%, p = 0.78, respectively). Of the 10 patients with RVEF>or = 0.40 before PVR, 5 patients (50%) maintained a RVEF>or = 0.40 following PVR, whereas only 2 out of 15 patients (13%) with pre-operative values<0.40 reached an RVEF>or = 0.40 postoperatively (p<0.001).\nPulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late?",
        "answer": "yes",
        "answer_rationale": "Right ventricular recovery following PVR for chronic significant pulmonary regurgitation after repair of TOF may be compromised in the adult population. In order to maintain adequate RV contractility, pulmonary valve implant in these patients should be considered before RV function deteriorates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about evaluating the right ventricular (RV) volume and function after pulmonary valve replacement (PVR) in patients who had repair for tetralogy of Fallot (TOF). The main issue they're addressing is whether the timing of the surgery is optimal.\n\nThe key findings from the study are that the RV volumes (RVEDV and RVESV) and ejection fraction (RVEF) didn't change significantly after PVR. The p-values for all those measurements were not statistically significant (p=0.74, 0.94, 0.78), which means there's no significant difference before and after the surgery. \n\nBut then there's a breakdown: among patients with pre-op RVEF \u226540%, half maintained that post-op. However, for those with pre-op RVEF <40%, only 13% improved to \u226540% after surgery. The p-value here is <0.001, indicating a significant difference between these groups. \n\nThe question is asking if operating too late (so the answer options are yes, no, maybe). The study's results suggest that if you wait until the RV function is already compromised (RVEF <40%), then PVR doesn't help much in improving it. The fact that those with better pre-op function had a better chance of maintaining it, but those with worse function didn't improve much implies that maybe the surgery should be done earlier before the RV function deteriorates too much. \n\nThe title of the study is posing the question: \"are we operating too late?\" The data supports that maybe they are, because waiting until the RV function is already low (like <40%) doesn't lead to improvement. So the answer would be (A) yes, we are operating too late. \n\nAlternatively, if the study showed that even with late surgery there was improvement, the answer might be no. But since the RV function didn't improve overall and especially in those with worse pre-op function, it suggests that the timing is suboptimal. Hence, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 488,
            "completion_tokens": 446
        },
        "time_elapsed": 5.792956829071045
    },
    {
        "realidx": "11138995",
        "question": "Alexithymia is presumed to play an important predisposing role in the pathogenesis of medically unexplained physical symptoms. However, no research on alexithymia has been done among general medical outpatients who present with medically unexplained physical symptoms as their main problem and in which anxiety and depression have been considered as possible confounding factors. This study investigated whether patients with medically unexplained physical symptoms are more alexithymic than those with explained symptoms and whether, in patients with unexplained symptoms, alexithymia is associated with subjective health experience and use of medical services.\nWe conducted a cross-sectional study among patients attending an internal medicine outpatient clinic. All patients were given a standardized interview and completed a number of questionnaires.\nAfter complete physical examinations, 169 of 321 patients had unexplained physical symptoms according to two independent raters. Patients with medically unexplained symptoms more often had a mental disorder, but overall they were not more alexithymic. In patients with unexplained physical symptoms, alexithymia was not associated with subjective health experience or use of medical services. However, patients with both unexplained symptoms and a mental disorder who also denied any possible connection between emotional problems and their physical symptoms did have more alexithymic traits.\nIs alexithymia a risk factor for unexplained physical symptoms in general medical outpatients?",
        "answer": "no",
        "answer_rationale": "In the majority of patients with medically unexplained physical symptoms, alexithymia does not play a role of clinical significance. Patients with unexplained physical symptoms are heterogeneous with respect to psychiatric syndrome pathology and probably also with respect to personality pathology.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether alexithymia is a risk factor for unexplained physical symptoms in general medical outpatients based on the provided study.\n\nFirst, I need to recall what the study found. The study compared patients with medically unexplained symptoms (MUPS) to those with explained symptoms. The key points from the study's results are:\n\n1. Patients with MUPS more often had a mental disorder, but overall, they weren't more alexithymic than those with explained symptoms. \n2. In the group with unexplained symptoms, alexithymia wasn't linked to their health experience or use of medical services. \n3. However, a subgroup existed: those with MUPS and a mental disorder who denied a connection between emotional issues and their physical symptoms did show more alexithymic traits.\n\nThe question is whether alexithymia is a risk factor for MUPS. A risk factor would mean that having alexithymia increases the likelihood of developing MUPS. But the study's main finding was that overall, patients with MUPS weren't more alexithymic. The association only appeared in a specific subgroup (those with mental disorders and denial of emotional connection). \n\nSince the study didn't find a general increased prevalence of alexithymia in all MUPS patients, the answer would lean towards \"no\" because the overall conclusion doesn't support alexithymia as a broad risk factor. The subgroup result might suggest a possible association in certain cases, but the question is about general outpatients. The study's main result says \"overall they were not more alexithymic,\" so the correct answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 366,
            "completion_tokens": 349
        },
        "time_elapsed": 4.346303701400757
    },
    {
        "realidx": "11146778",
        "question": "The APACHE II (Acute Physiology and Chronic Health Evaluation II) score used as an intensive care unit (ICU) admission score in emergency surgical patients is not independent of the effects of treatment and might lead to considerable bias in the comparability of defined groups of patients and in the evaluation of treatment policies. Postoperative monitoring with the APACHE II score is clinically irrelevant.\nInception cohort study.\nSecondary referral center.\nEighty-five consecutive emergency surgical patients admitted to the surgical ICU in 1999. The APACHE II score was calculated before surgery; after admission to the ICU; and on postoperative days 3, 7, and 10.\nAPACHE II scores and predicted and observed mortality rates.\nThe mean +/- SD APACHE II score of 24.2 +/- 8.3 at admission to the ICU was approximately 36% greater than the initial APACHE II score of 17.8 +/- 7.7, a difference that was highly statistically significant (P<.001). The overall mortality of 32% favorably corresponds with the predicted mortality of 34% according to the initial APACHE II score. However, the predicted mortality of 50% according to the APACHE II score at admission to the ICU was significantly different from the observed mortality rate (P =.02). In 40 long-term patients (>/=10 days in the ICU), the difference between the APACHE II scores of survivors and patients who died was statistically significant on day 10 (P =.04).\nRisk stratification in emergency surgical patients: is the APACHE II score a reliable marker of physiological impairment?",
        "answer": "yes",
        "answer_rationale": "For risk stratification in emergency surgical patients, it is essential to measure the APACHE II score before surgical treatment. Longitudinal APACHE II scoring reveals continuous improvement of the score in surviving patients but has no therapeutic relevance in the individual patient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the APACHE II score is a reliable marker of physiological impairment in emergency surgical patients based on the provided study.\n\nFirst, I need to recall what the APACHE II score is used for. It's a tool to assess the severity of illness in ICU patients, helping predict mortality and guide resource allocation. The question is about its reliability in this specific context.\n\nLooking at the study details: They followed 85 emergency surgical patients. The APACHE II was calculated before surgery, on ICU admission, and on postoperative days 3,7,10. The key findings were that the ICU admission score was 36% higher than the pre-surgery score, which was significant. The overall mortality (32%) matched the predicted 34% from the initial score. However, the ICU admission score's predicted mortality (50%) was significantly different from observed (32%, P=0.02). Also, in long-term patients, the day 10 scores showed a significant difference between survivors and non-survivors.\n\nThe question is about reliability as a marker of physiological impairment. The study's results show that the APACHE II score changes over time, especially after treatment. The initial score before surgery correlated well with actual mortality, but the ICU admission score overestimated mortality. This suggests that the score might be influenced by treatment effects, making it less reliable when measured after treatment has been applied. The fact that the admission score was higher could mean that the treatment itself (like surgery) affects the physiology, making the post-treatment score not independent of treatment. The study's conclusion seems to question the reliability of using APACHE II postoperatively because it's influenced by interventions, leading to possible bias in comparing groups or evaluating treatments. The statement in the question also mentions that postoperative monitoring with APACHE II is clinically irrelevant, which aligns with the study's findings. Therefore, the answer would be that it's not reliable (B) because the score is affected by treatment, leading to discrepancies between predicted and observed outcomes when measured after treatment.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 435,
            "completion_tokens": 436
        },
        "time_elapsed": 5.00019383430481
    },
    {
        "realidx": "11411430",
        "question": "The purpose of this study is to determine if baseline antral follicle assessment may serve as additional information in predicting in vitro fertilization outcome.\nProspective, descriptive preliminary study of in vitro fertilization outcome. From July 1998 to July 1999, 224 patients underwent antral follicle assessment (follicle 2-6 mm in diameter) on baseline of the planned, stimulated in vitro fertilization cycle. The outcomes were analyzed with respect to antral follicle assessment (<or = 6 or>6), basal cycle day 3 follicle stimulated hormone (<or = 10 or>10 IU/L) and maternal age (<or = 35 or>35 years).\nThe clinical pregnancy rate was significantly higher in the group with baseline antral follicle>6 compared to that in the group with antral follicle<or = 6 (51% vs. 19%, respectively). Controlling for patient age, and basal follicle stimulated hormone, the pregnancy rate was significantly higher in the group with antral follicle>6 compared to that in the group with antral follicle<or = 6. The cancellation rate was significantly increased with advancing maternal age, elevated basal follicle stimulated hormone levels, and baseline antral follicle<or = 6. The cancellation rate was significantly higher in the group with antral follicle<or = 6 compared to that in the group with antral follicle>or = 6 (33% vs. 1%, respectively).\nAntral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?",
        "answer": "maybe",
        "answer_rationale": "In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether antral follicle count can predict IVF outcomes better than age and FSH. The options are yes, no, maybe.\n\nFirst, I need to look at the results given. The study says that the clinical pregnancy rate was significantly higher when the antral follicle count was over 6 compared to 6 or under (51% vs 19%). Even when controlling for age and FSH, the pregnancy rate was still higher in the higher antral follicle group. That suggests antral follicle count is a good predictor. \n\nThen, the cancellation rate was much higher in the group with \u22646 antral follicles (33% vs 1%). So, the antral follicle count seems to be a strong indicator here. The question is whether it's a better predictor than age and FSH. The study mentions that even when controlling for age and FSH, the antral follicle count still showed significance. That implies that antral follicle count adds independent predictive value beyond age and FSH. \n\nBut wait, the question is if it's a \"better\" predictor than those factors. The study shows that antral follicle count is significant even when adjusting for age and FSH, which might mean it's at least as good, but does it surpass them? The cancellation rate was linked to all three factors: age, FSH, and antral follicles. So maybe all three are important, but the antral count is an additional factor. The question is whether it's a better predictor. The results show that when considering antral follicles, the prediction is better than when not considering them. Since controlling for age and FSH didn't negate the effect of antral follicles, it might be that antral follicle count is an independent and possibly stronger predictor. \n\nAlternatively, maybe the study doesn't directly compare the predictive power but shows that it's an additional factor. The wording of the question is tricky. The options are yes, no, maybe. The study's conclusion seems to support that antral follicle assessment is a useful predictor, even when age and FSH are considered. So the answer might be yes, it is a better predictor. But I need to check if the study actually states that it's better than the others or just that it's an additional factor. The question is phrased as \"is",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 447,
            "completion_tokens": 512
        },
        "time_elapsed": 6.348010778427124
    },
    {
        "realidx": "11438275",
        "question": "It is generally believed that positioning of the patient in a head-down tilt (Trendelenberg position) decreases the likelihood of a venous air embolism during liver resection.\nThe physiological effect of variation in horizontal attitude on central and hepatic venous pressure was measured in 10 patients during liver surgery. Hemodynamic indices were recorded with the operating table in the horizontal, 20 degrees head-up and 20 degrees head-down positions.\nThere was no demonstrable pressure gradient between the hepatic and central venous levels in any of the positions. The absolute pressures did, however, vary in a predictable way, being highest in the head-down and lowest during head-up tilt. However, on no occasion was a negative intraluminal pressure recorded.\nDoes patient position during liver surgery influence the risk of venous air embolism?",
        "answer": "no",
        "answer_rationale": "The effect on venous pressures caused by the change in patient positioning alone during liver surgery does not affect the risk of venous air embolism.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether patient position during liver surgery affects the risk of venous air embolism (VAE). The question refers to a study where they measured central and hepatic venous pressures in different positions: horizontal, 20 degrees head-up (Trendelenburg inverted), and 20 degrees head-down (Trendelenberg). \n\nThe key points from the study are that there was no pressure gradient between hepatic and central veins in any position. The absolute pressures were highest in head-down and lowest in head-up. Also, no negative intraluminal pressures were recorded.\n\nNow, the common belief is that Trendelenberg (head-down) reduces VAE risk. But the study's results need to be considered. VAE risk might be influenced by pressure gradients. If the hepatic veins are at a lower pressure than the central veins, air might be more likely to enter. But the study says there's no gradient between them in any position. So the pressure difference isn't there. \n\nSince the pressures are highest in head-down, maybe that higher pressure could help prevent air from entering because the venous system is under higher pressure, making it harder for air to enter. But the absence of a gradient might mean that the position doesn't create the necessary pressure difference to either prevent or promote embolism. Also, since no negative pressures were found, that might mean that suction of air isn't happening because pressures don't drop below atmospheric. \n\nThe question is whether position influences the risk. The study's results show that while pressures vary, there's no gradient between hepatic and central veins. Since the gradient is what might drive air into the system, the lack of gradient across positions would mean that the position doesn't affect the risk. Therefore, the answer would be B (no), because the study's findings don't support that position changes affect the risk as the critical factor (pressure gradient) isn't present. The initial belief might be based on assumptions that aren't supported here.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 263,
            "completion_tokens": 422
        },
        "time_elapsed": 4.933590888977051
    },
    {
        "realidx": "11458136",
        "question": "By requiring or encouraging enrollees to obtain a usual source of care, managed care programs hope to improve access to care without incurring higher costs.\n(1) To examine the effects of managed care on the likelihood of low-income persons having a usual source of care and a usual physician, and; (2) To examine the association between usual source of care and access.\nCross-sectional survey of households conducted during 1996 and 1997.\nA nationally representative sample of 14,271 low-income persons.\nUsual source of care, usual physician, managed care enrollment, managed care penetration.\nHigh managed care penetration in the community is associated with a lower likelihood of having a usual source of care for uninsured persons (54.8% vs. 62.2% in low penetration areas) as well as a lower likelihood of having a usual physician (60% vs. 72.8%). Managed care has only marginal effects on the likelihood of having a usual source of care for privately insured and Medicaid beneficiaries. Having a usual physician substantially reduces unmet medical needs for the insured but less so for the uninsured.\nDoes managed care enable more low income persons to identify a usual source of care?",
        "answer": "maybe",
        "answer_rationale": "Having a usual physician can be an effective tool in improving access to care for low-income populations, although it is most effective when combined with insurance coverage. However, the effectiveness of managed care in linking more low-income persons to a medical home is uncertain, and may have unintended consequences for uninsured persons.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether managed care enables more low-income persons to identify a usual source of care. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study had two parts: examining the effect of managed care on having a usual source of care and a usual physician, and the association between that source and access. The results mention that high managed care penetration in the community is linked to a lower likelihood of having a usual source of care for the uninsured. Specifically, 54.8% vs. 62.2% in low penetration areas. Also, for the insured (privately insured and Medicaid), the effect was only marginal. \n\nThe key point here is that for the uninsured, managed care penetration actually correlates with a decrease in having a usual source. For the insured, it's only a marginal effect. The question is about low-income persons in general. Since the uninsured are part of the low-income group (as they were surveyed in a low-income sample), and the data shows that managed care is associated with lower likelihood for them, the overall effect might be negative. The question is whether managed care \"enables more\" people to have a usual source. Since for the uninsured it's worse, and for the insured only a small effect, the answer would be no. The study's results don't support that managed care increases the likelihood for low-income individuals overall. The answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 342,
            "completion_tokens": 312
        },
        "time_elapsed": 3.9280078411102295
    },
    {
        "realidx": "11481172",
        "question": "The authors sought to determine whether the manic/mixed episode distinction in patients with bipolar disorder runs true over time.\nOver an 11-year period, the observed distribution of manic and mixed episodes (N=1,224) for patients with three or more entries in the management information system of a community mental health center (N=241) was compared to the expected distribution determined by averaging 1,000 randomly generated simulations.\nEpisodes were consistent (all manic or all mixed) in significantly more patients than would be expected by chance.\nDoes the manic/mixed episode distinction in bipolar disorder patients run true over time?",
        "answer": "yes",
        "answer_rationale": "These data suggest a pattern of diagnostic stability over time for manic and mixed episodes in patients with bipolar disorder. Careful prospective studies of this issue are needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether the distinction between manic and mixed episodes in bipolar disorder patients remains consistent over time. The key point here is that they compared the actual data from patients over 11 years with simulations.\n\nThe results say that episodes were consistent (all manic or all mixed) in more patients than expected by chance. That means that if it were random, you'd expect some variation, but the fact that more patients had all one type suggests a pattern. So the distinction does run true over time because the same type of episodes kept occurring in these patients more often than random chance would allow. Therefore, the answer should be yes, which is option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 220,
            "completion_tokens": 147
        },
        "time_elapsed": 2.1816110610961914
    },
    {
        "realidx": "11481599",
        "question": "The purpose of this study was to delineate early respiratory predictors of mortality in children with hemato-oncology malignancy who developed acute respiratory distress syndrome (ARDS).\nWe conducted a retrospective chart review of children with malignant and ARDS who needed mechanical ventilation and were admitted to a pediatric intensive care unit from January 1987 to January 1997.\nSeventeen children with ARDS and malignancy aged 10.5 +/- 5.1 years were identified. Six of the 17 children (35.3%) survived. Sepsis syndrome was present in 70.6% of all the children. Peak inspiratory pressure, positive end-expiratory pressure (PEEP), and ventilation index values could distinguish outcome by day 3. A significant relationship between respiratory data and outcome related to efficiency of oxygenation, as determined by PaO(2)/FIO(2) and P(A-a)O(2), was present from day 8 after onset of mechanical ventilation.\nAcute respiratory distress syndrome in children with malignancy--can we predict outcome?",
        "answer": "yes",
        "answer_rationale": "Peak inspiratory pressure, PEEP, and ventilation index values could distinguish survivors from nonsurvivors by day 3. This may assist in early application of supportive nonconventional therapies in children with malignancy and ARDS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about finding early respiratory predictors of mortality in children with hemato-oncology malignancies who developed ARDS. The key points from the study are that they looked at 17 children, and 6 survived. They found that by day 3, parameters like peak inspiratory pressure, PEEP, and ventilation index could distinguish outcome. Then, from day 8, the oxygenation efficiency measures like PaO2/FiO2 and P(A-a)O2 were significantly related to outcome.\n\nThe question is asking if we can predict the outcome of ARDS in these children based on the study. The options are yes, no, maybe. The study's results show that certain respiratory parameters were able to differentiate survivors from non-survivors by specific days (day 3 and day 8). That suggests that there are identifiable predictors, so the answer should be yes. The fact that they could distinguish outcome using these metrics indicates that prediction is possible. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 315,
            "completion_tokens": 217
        },
        "time_elapsed": 3.3443799018859863
    },
    {
        "realidx": "11483547",
        "question": "To determine the incidence and severity of acute side effects from the use of polyvalent antivenin in victims of rattlesnake bites.\nWe retrospectively reviewed the records of all patients who presented with rattlesnake bites to a university teaching hospital during an 11-year period. From patient medical records, we extracted demographic data, clinical measurements, and outcomes during emergency department evaluation and subsequent hospitalization. Data regarding serum sickness were not collected.\nPrimary outcome variables were the occurrence of immediate hypersensitivity reaction to antivenin, the type of reaction, permanent disability at hospital discharge, and mortality.\nWe identified a total of 73 patients with rattlesnake bites during the study period. Bite envenomation was graded as nonenvenomated, 7 patients (10%); mild, 23 patients (32%); moderate, 32 patients (44%); and severe, 11 patients (15%). We identified 65 patients who received antivenin. Antivenin doses ranged from 1 to 30 vials per patient (mean, 12.0 +/- 6.0), for a total of 777 vials. In 43 patients (66%), 10 or more vials of antivenin were given. The mean number of vials of antivenin given to each snakebite grade were as follows: mild, 8.4 (+/-4.0); moderate, 11.8 (+/-5.7); and severe, 18.7 (+/-6.3). No deaths, amputations, or permanent disability from snakebite occurred in the patients receiving antivenin. Acute side effects of antivenin-occurring within the first 6 hours after administration-were seen in 12 patients (18%; 95% confidence interval, 10%-30%). Acute side effects consisted solely of urticaria in all but 1 patient (2%; 95% confidence interval, 0%-8%). This patient had a history of previous antivenin reaction and required a short course of intravenous epinephrine for blood pressure support. No other complications occurred.\nDoes the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects?",
        "answer": "no",
        "answer_rationale": "The administration of polyvalent Crotalidae antivenin is safe. Acute hypersensitivity, when it occurs, consists solely in most cases of urticaria. Serious side effects are uncommon.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the aggressive use of polyvalent antivenin for rattlesnake bites results in serious acute side effects. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study reviewed 73 patients with rattlesnake bites over 11 years. Out of these, 65 received antivenin. The key points here are the outcomes related to side effects. The primary outcomes included immediate hypersensitivity reactions, type of reaction, permanent disability, and mortality. \n\nThe results mention that no deaths, amputations, or permanent disability from the snakebite occurred in those who got antivenin. Now, focusing on acute side effects within the first 6 hours: 12 patients (18%) had reactions. But the description says that all but one had urticaria (hives), which is typically not life-threatening. The one exception had a history of previous reaction and needed IV epinephrine for blood pressure. However, the question is about \"serious\" acute side effects. \n\nEpinephrine for blood pressure could indicate a more severe reaction, like anaphylaxis. But the study's conclusion here might consider that as manageable and not leading to permanent issues. The answer options are yes, no, maybe. The study states that the acute side effects were mostly hives, and the one more severe case was managed. The question is whether these are considered \"serious.\" The study's own conclusion might lean towards the antivenin not causing serious issues since there were no deaths or permanent disabilities. The answer is probably B) no, because the serious side effects weren't observed except maybe that one case, but the overall conclusion from the data given would say that serious ones aren't common. The options don't have a \"mostly no but some cases,\" so based on the data presented, the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 577,
            "completion_tokens": 404
        },
        "time_elapsed": 5.115711450576782
    },
    {
        "realidx": "11567820",
        "question": "To test the hypothesis that increasing the nerve length within the treatment volume for trigeminal neuralgia radiosurgery would improve pain relief.\nEighty-seven patients with typical trigeminal neuralgia were randomized to undergo retrogasserian gamma knife radiosurgery (75 Gy maximal dose with 4-mm diameter collimators) using either one (n = 44) or two (n = 43) isocenters. The median follow-up was 26 months (range 1-36).\nPain relief was complete in 57 patients (45 without medication and 12 with low-dose medication), partial in 15, and minimal in another 15 patients. The actuarial rate of obtaining complete pain relief (with or without medication) was 67.7% +/- 5.1%. The pain relief was identical for one- and two-isocenter radiosurgery. Pain relapsed in 30 of 72 responding patients. Facial numbness and mild and severe paresthesias developed in 8, 5, and 1 two-isocenter patients vs. 3, 4, and 0 one-isocenter patients, respectively (p = 0.23). Improved pain relief correlated with younger age (p = 0.025) and fewer prior procedures (p = 0.039) and complications (numbness or paresthesias) correlated with the nerve length irradiated (p = 0.018).\nDoes increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery?",
        "answer": "no",
        "answer_rationale": "Increasing the treatment volume to include a longer nerve length for trigeminal neuralgia radiosurgery does not significantly improve pain relief but may increase complications.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether increasing the nerve length within the treatment volume improves trigeminal neuralgia radiosurgery based on the provided study.\n\nFirst, I need to recall the details from the study. The study randomized 87 patients into two groups: one with one isocenter and the other with two isocenters. The two-isocenter group would presumably cover a longer segment of the nerve. The main outcomes were pain relief and complications like numbness or paresthesias.\n\nThe key results mentioned are that pain relief was identical between the one- and two-isocenter groups. The actuarial rate for complete pain relief was 67.7%, but there's no difference between the groups. However, the study also noted that complications (like facial numbness and paresthesias) were more common in the two-isocenter group. The p-value for complications related to nerve length was 0.018, which is statistically significant. \n\nThe question is specifically about whether increased nerve length (which the two-isocenter approach would do) improves the treatment. Since the pain relief was the same between groups, but complications were higher with more nerve length treated, the answer would be that increasing the nerve length doesn't improve pain relief. The study's conclusion here is that there's no benefit in terms of pain relief from increasing the treatment volume, even though there's a higher risk of complications. \n\nSo the correct answer should be (B) no. The study's results show that the pain relief wasn't better with the longer nerve treatment, so the hypothesis isn't supported.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 425,
            "completion_tokens": 340
        },
        "time_elapsed": 4.594560146331787
    },
    {
        "realidx": "11570976",
        "question": "Sulfasalazine is a widely used anti-inflammatory agent in the treatment of inflammatory bowel disease and several rheumatological disorders. Although as many as 20% of treated patients may experience reversible, dose-dependent side effects, less frequent but potentially severe, systemic reactions have also been reported.\nA severe systemic reaction to sulfasalazine developed in a 21-year old female with rheumatoid arthritis characterized by eosinophilia, granulomatous enteritis and myelotoxicity, cholestatic hepatitis, and seizures. The clinical course and management of this patient are presented as well as a review of the incidence and outcome of severe systemic reactions to sulfasalazine.\nIs it Crohn's disease?",
        "answer": "maybe",
        "answer_rationale": "Granulomatous myelotoxicity and enteritis developed in a 21 year old female within 3 weeks of initiating sulfasalazine for rheumatoid arthritis. Following a short course of corticosteroids, the patient had resolution of her cholestatic hepatitis, rash, eosinophilia, and gastrointestinal symptoms with no residual manifestations at 7 months follow-up. Although severe reactions to sulfasalazine are rare and unpredictable, practicing physicians should be aware of unusual clinical presentations of toxicity when prescribing sulfasalazine.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the described case is Crohn's disease. The patient is a 21-year-old female with rheumatoid arthritis who developed a severe systemic reaction to sulfasalazine. The symptoms mentioned include eosinophilia, granulomatous enteritis, myelotoxicity, cholestatic hepatitis, and seizures.\n\nFirst, I need to recall what Crohn's disease typically presents with. Crohn's is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, often causing symptoms like abdominal pain, diarrhea, weight loss, and sometimes extraintestinal manifestations. However, the key here is the reaction to the medication, not the underlying condition.\n\nThe question states that the patient has rheumatoid arthritis, which is a rheumatological disorder. Sulfasalazine is used for both IBD and rheumatoid arthritis. The severe reaction described\u2014eosinophilia, granulomatous enteritis, etc.\u2014sounds like a drug-induced reaction rather than the natural progression of Crohn's or rheumatoid arthritis. The article mentions that these are severe systemic reactions to the drug, not the disease itself. \n\nCrohn's disease wouldn't present with myelotoxicity or seizures as primary symptoms. The combination of eosinophilia and granulomatous enteritis could be part of a hypersensitivity reaction. The question is whether the scenario is describing Crohn's. Since the patient has rheumatoid arthritis and the symptoms are due to a drug reaction, the answer should be no. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 236,
            "completion_tokens": 335
        },
        "time_elapsed": 3.956448554992676
    },
    {
        "realidx": "11833948",
        "question": "To detemine the relationship between delay in transfer to rehabilitation wards and outcome for patients aged over 75 years with fracture of the proximal femur.\nAn observational study in a district general hospital of all patients admitted to hospital aged over 75 years with fracture of the proximal femur over 3 1/2 years. Outcome data collected included the number of patients discharged back to their usual residence and total hospital length of stay related to age, gender, usual residence and delay in transfer to a rehabilitation ward.\n58% of 455 patients were transferred to a rehabilitation ward. For those patients who were transferred to a rehabilitation ward only age predicted discharge to a more dependent residence. The relative risk for discharge to a more dependent residence for people aged over 85 years compared to younger people was 1.47 (95% CI 1.15-1.88). Delay in transfer to rehabilitation was associated with a longer total hospital length of stay of 0.64 (95% CI 0.23-1.05) days per day of delay in transfer.\nDoes a delay in transfer to a rehabilitation unit for older people affect outcome after fracture of the proximal femur?",
        "answer": "yes",
        "answer_rationale": "Delay in transfer to a rehabilitation ward was associated with a disproportionate increase in total hospital length of stay for patients aged over 75 with fracture of the proximal femur.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a delay in transferring older patients (over 75) with a proximal femur fracture to a rehabilitation unit affects their outcome. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study was observational, covering 455 patients over 3.5 years. They looked at factors like age, gender, residence, and delay in transfer. The key outcomes were discharge back to usual residence and hospital length of stay.\n\nThe results mentioned that 58% were transferred to rehab. For those who went to rehab, age was a predictor of being discharged to a more dependent place. The relative risk for those over 85 was 1.47, which is significant since the CI doesn't include 1. But the question is about delay in transfer. \n\nThe critical part here is the last sentence: \"Delay in transfer to rehabilitation was associated with a longer total hospital length of stay of 0.64 (95% CI 0.23-1.05) days per day of delay in transfer.\" The confidence interval here doesn't include zero (since 0.23 to 1.05 are all positive), which means the association is statistically significant. So each day of delay adds about 0.64 days to the total stay. \n\nThe question is about the effect on \"outcome.\" The outcome here includes both discharge location and length of stay. Since the delay leads to longer hospital stays, that's an adverse outcome. Therefore, the answer should be yes, a delay does affect the outcome. \n\nWait, but the options are (A) yes, (B) no, (C) maybe. The study shows a significant association between delay and longer stay. So the answer is A. The other part about age affecting discharge to a more dependent residence is also there, but the question specifically asks about the delay's effect. The data on length of stay directly answers that. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 345,
            "completion_tokens": 431
        },
        "time_elapsed": 5.206454038619995
    },
    {
        "realidx": "11862129",
        "question": "To determine if clinical variables assessed in relation to Albuterol aerosol treatments accurately identify children with pathologic radiographs during their initial episode of bronchospasm.\nA prospective convenience sample of children with a first episode of wheezing. Data collected included demographics, baseline and post-treatment clinical score and physical examination, number of aerosols, requirement for supplemental oxygen, and disposition. Chest radiographs were obtained and interpreted, and patients were divided into 2 groups based on a pathologic versus nonpathologic radiograph interpretation. Chi2 testing was performed for categoric variables, and the student t test was performed for continuous variables. A discriminant analysis was used to develop a model.\nPathologic radiographs were identified in 61 patients (9%). Between groups, a significant difference was noted for pretreatment oxygen saturation only. Clinical score, respiratory rate, and presence of rales both pretreatment and posttreatment were not significantly different between groups. The discriminant analysis correctly predicted 90% of nonpathologic radiographs but only 15% of pathologic radiographs.\nDo clinical variables predict pathologic radiographs in the first episode of wheezing?",
        "answer": "no",
        "answer_rationale": "Clinical variables, either isolated or as components of a model, could not identify all children with pathologic radiographs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether clinical variables can predict pathologic radiographs in children's first episode of wheezing. The study mentioned here looked at various factors like oxygen saturation, clinical scores, respiratory rate, presence of rales, etc.\n\nThe key results from the study are that pretreatment oxygen saturation was the only significant difference between the groups. However, when they used discriminant analysis, the model correctly predicted 90% of nonpathologic cases but only 15% of the pathologic ones. That's a big discrepancy. \n\nSo, even though oxygen saturation was different, the discriminant model wasn't good at predicting pathologic radiographs. Since the question is whether clinical variables predict pathologic radiographs, the low prediction rate (15%) for pathologic cases suggests that these variables aren't effective predictors. The high 90% for nonpathologic might balance it out overall, but the main point is the poor performance for the pathologic group. \n\nThe options are yes, no, maybe. The study's results indicate that the variables aren't good predictors, especially for the pathologic cases. So the answer should be no. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 329,
            "completion_tokens": 254
        },
        "time_elapsed": 3.3570313453674316
    },
    {
        "realidx": "11867487",
        "question": "To examine the attitudes of players and coaches to the use of protective headgear, particularly with respect to the prevention of concussion.\nA questionnaire designed to assess attitudes to headgear was administered to 63 players from four different Canadian teams, each representing a different level of play (high school, university, community club, national). In addition, coaches from all four levels were questioned about team policies and their personal opinions about the use of headgear to prevent concussion.\nAlthough the players tended to believe that the headgear could prevent concussion (62%), the coaches were less convinced (33%). Despite the players' belief that headgear offers protection against concussion, only a minority reported wearing headgear (27%) and few (24%) felt that its use should be made mandatory. Common reasons for not wearing headgear were \"its use is not mandatory\", \"it is uncomfortable\", and \"it costs too much\".\nDoes rugby headgear prevent concussion?",
        "answer": "maybe",
        "answer_rationale": "Although most players in the study believe that rugby headgear may prevent concussion, only a minority reported wearing it. Coaches tended to be less convinced than the players that rugby headgear can prevent concussion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether rugby headgear prevents concussion based on the provided study. The options are yes, no, or maybe.\n\nFirst, I need to look at the information given. The study surveyed players and coaches. Players thought headgear could prevent concussions (62% believed that), but coaches were less convinced at 33%. However, the key point here is that the question is about whether the headgear actually prevents concussions, not just people's beliefs. \n\nThe study's results show a discrepancy between players' beliefs and coaches' opinions. But the actual data from the study doesn't provide evidence one way or the other about the effectiveness of the headgear. The question is asking for a factual answer based on the information given. The passage doesn't present any data on actual concussion rates or studies proving prevention. It only reports attitudes and usage rates. \n\nThe options are (A) yes, (B) no, (C) maybe. Since the study's purpose was to examine attitudes, not to test the effectiveness, there's no conclusive evidence provided here. The correct answer would be \"maybe\" because the information given doesn't confirm or deny the effectiveness definitively. The players think it does, but coaches are skeptical, and usage is low. The study's data doesn't include empirical results on concussion prevention, so the answer can't be a definitive yes or no. Therefore, the answer should be C.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 282,
            "completion_tokens": 303
        },
        "time_elapsed": 3.9729533195495605
    },
    {
        "realidx": "11926574",
        "question": "Hepatitis G virus can cause chronic infection in man but the role of this agent in chronic liver disease is poorly understood. Little is known about the relation of another newly discovered agent, the TT virus, with chronic liver disease.AIM: To investigate the rate of infection with hepatitis G virus and TT virus in patients with cryptogenic chronic liver disease.\nA total of 23 subjects with chronically raised alanine transaminase and a liver biopsy in whom all known causes of liver disease had been excluded, and 40 subjects with hepatitis C virus-related chronic liver disease.\nEvaluation of anti-hepatitis G virus by enzyme immunoassay. Hepatitis G virus-RNA by polymerase chain reaction with primers from the 5' NC and NS5a regions. TT virus-DNA by nested polymerase chain reaction with primers from the ORF1 region. Results. Hepatitis G virus-RNA was detected in 4 out of 23 patients with cryptogenic chronic hepatitis and in 6 out of 40 with hepatitis C virus chronic hepatitis (17.4% vs 15% p=ns). At least one marker of hepatitis G virus infection (hepatitis G virus-RNA and/or anti-hepatitis G virus, mostly mutually exclusive) was present in 6 out of 23 patients with cryptogenic hepatitis and 16 out of 40 with hepatitis C virus liver disease (26. 1% vs 40% p=ns). T virus-DNA was present in serum in 3 subjects, 1 with cryptogenic and 2 with hepatitis C virus-related chronic liver disease. Demographic and clinical features, including stage and grade of liver histology, were comparable between hepatitis G virus-infected and uninfected subjects. Severe liver damage [chronic hepatitis with fibrosis or cirrhosis) were significantly more frequent in subjects with hepatitis C virus liver disease.\nAre hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?",
        "answer": "no",
        "answer_rationale": "In Southern Italy, hepatitis G virus infection is widespread among patients with chronic hepatitis, independently of parenteral risk factors. Its frequency in subjects with cryptogenic liver disease parallels that observed in hepatitis C virus chronic liver disease, thus ruling out an aetiologic role of hepatitis G virus. TT virus infection is uncommon in patients with cryptogenic or hepatitis C virus-related liver disease who do not have a history of parenteral exposure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Hepatitis G virus (HGV) and TT virus are involved in cryptogenic chronic liver disease based on the provided study.\n\nFirst, I need to recall what cryptogenic means here. It refers to cases where all known causes of liver disease have been excluded. The study looked at 23 patients with cryptogenic chronic liver disease and 40 with HCV-related disease. They tested for HGV RNA, anti-HGV, and TT virus DNA.\n\nThe results showed that HGV RNA was found in 4 out of 23 (17.4%) cryptogenic patients and 6 out of 40 (15%) HCV patients. The p-value was not significant (p=ns), meaning no statistical difference between the groups. When considering any HGV marker (RNA or antibodies), 26.1% of cryptogenic vs 40% HCV had it, still not significant. TT virus was present in 1 cryptogenic and 2 HCV patients. \n\nThe study also mentions that demographic and clinical features, including liver histology severity, didn't differ between HGV-infected and uninfected in their groups. However, severe liver damage was more in HCV, which makes sense since HCV is a known cause.\n\nThe key point is whether HGV or TT are involved in cryptogenic cases. Since the infection rates in cryptogenic weren't higher than in HCV patients (which is a known cause), and the p-values were not significant, it suggests that these viruses aren't significantly linked to cryptogenic cases. The study's aim was to see if these viruses explain cryptogenic cases, but the results don't show a strong association. The answer would likely be \"no\" because there's no significant evidence here to implicate them. The options are (A) yes, (B) no, (C) maybe. The data doesn't support a yes, and since the question is about involvement, the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 501,
            "completion_tokens": 421
        },
        "time_elapsed": 4.867697477340698
    },
    {
        "realidx": "11943048",
        "question": "To compare analgesic management of daily pain for dying nursing home residents enrolled and not enrolled in Medicare hospice.\nRetrospective, comparative cohort study.\nOver 800 nursing homes in Kansas, Maine, Mississippi, New York, and South Dakota.\nA subset of residents with daily pain near the end of life taken from a matched cohort of hospice (2,644) and nonhospice (7,929) nursing home residents who had at least two resident assessments (Minimum Data Sets (MDSs)) completed, their last between 1992 and 1996, and who died before April 1997. The daily pain subset consisted of 709 hospice and 1,326 nonhospice residents.\nDetailed drug use data contained on the last MDS before death were used to examine analgesic management of daily pain. Guidelines from the American Medical Directors Association (AMDA) were used to identify analgesics not recommended for use in managing chronic pain in long-term care settings. The study outcome, regular treatment of daily pain, examined whether patients received any analgesic, other than those not recommended by AMDA, at least twice a day for each day of documented daily pain (i.e., 7 days before date of last MDS).\nFifteen percent of hospice residents and 23% of nonhospice residents in daily pain received no analgesics (odds ratio (OR) = 0.57, 95% confidence interval (CI) = 0.45-0.74). A lower proportion of hospice residents (21%) than of nonhospice residents (29%) received analgesics not recommended by AMDA (OR = 0.65, 95% CI =0.52-0.80). Overall, acetaminophen (not in combination with other drugs) was used most frequently for nonhospice residents (25% of 1,673 prescriptions), whereas morphine derivatives were used most frequently for hospice residents (30% of 1,058 prescriptions). Fifty-one percent of hospice residents and 33% of nonhospice residents received regular treatment for daily pain. Controlling for clinical confounders, hospice residents were twice as likely as nonhospice residents to receive regular treatment for daily pain (adjusted odds ratio = 2.08, 95% CI = 1.68-2.56).\nDoes receipt of hospice care in nursing homes improve the management of pain at the end of life?",
        "answer": "yes",
        "answer_rationale": "Findings suggest that analgesic management of daily pain is better for nursing home residents enrolled in hospice than for those not enrolled in hospice.The prescribing practices portrayed by this study reveal that many dying nursing home residents in daily pain are receiving no analgesic treatment or are receiving analgesic treatment inconsistent with AMDA and other pain management guidelines. Improving the analgesic management of pain in nursing homes is essential if high-quality end-of-life care in nursing homes is to be achieved.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether hospice care in nursing homes improves pain management at the end of life. The study provided gives some key data points.\n\nFirst, the study compared hospice and non-hospice residents. The main outcome was \"regular treatment of daily pain,\" which means getting analgesics (excluding those not recommended) twice a day for each day of pain in the week before the last assessment.\n\nLooking at the results: 15% of hospice residents vs. 23% non-hospice didn't get any analgesics. That suggests hospice patients were less likely to have no treatment. Also, hospice had lower use of non-recommended drugs (21% vs 29%). \n\nThe big point is the last sentence: After adjusting for other factors, hospice residents were twice as likely (OR 2.08) to get regular pain treatment. The confidence interval (1.68-2.56) doesn't include 1, so it's statistically significant. \n\nSo the answer should be yes (A), because the data shows hospice care is associated with better pain management. The options are A, B, C. The study's conclusion supports that hospice improves management.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 645,
            "completion_tokens": 267
        },
        "time_elapsed": 3.3371617794036865
    },
    {
        "realidx": "11955750",
        "question": "To show the results of treating posterior uveal melanomas with 106Ru plaque beta-ray radiotherapy and to review and discuss the literature concerning the optimal apical dose prescription (100 vs. 160 Gy).\nForty-eight patients with uveal melanomas (median height 3.85 mm + 1 mm sclera) were treated with ruthenium plaques. The median apical dose was 120 Gy, the median scleral dose 546 Gy.\nAfter 5.8 years of follow-up, the overall 5-year survival rate was 90%, the disease specific 5-year survival rate was 92% (3 patients alive with metastasis). Six percent received a second ruthenium application, 10% of the eyes had to be enucleated. Local control was achieved in 90% of the patients with conservative therapy alone. Central or paracentral tumors showed 50% of the pretherapeutic vision after 4 years, and 80% of the vision was preserved in those with peripheral tumors. The main side effects were mostly an uncomplicated retinopathy (30%); macular degeneration or scarring led to poor central vision in 30% of cases.\nDoes escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?",
        "answer": "no",
        "answer_rationale": "Brachytherapy with ruthenium applicators is an effective therapy for small- and medium-size posterior uveal melanomas. Our results are comparable to other series. The treatment outcome does not seem to be capable of improvement by increasing the apical dose. An internationally accepted model for defining the dosage in brachytherapy is needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether increasing the apical dose changes the treatment outcome when using 106Ru plaques for posterior choroidal melanomas. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentions that the median apical dose was 120 Gy, and the scleral dose was 546 Gy. The outcomes after 5.8 years include 90% overall survival, 92% disease-specific survival, with some enucleations and local control rates. The question is about whether escalating the dose (like going from 100 to 160 Gy as discussed in the literature) affects outcomes.\n\nThe key here is that the study's median apical dose was 120 Gy, which is between the 100 and 160 Gy options mentioned. The results show good local control (90%) and survival rates. The side effects like retinopathy were present but maybe not worse than expected. The study doesn't compare 100 vs 160 directly; it just uses 120. The literature review part is about discussing which dose is better, but the data here doesn't show a direct comparison. Since the study's own results don't test both doses, they can't conclude if escalating (to 160) would change outcomes. The answer might be \"maybe\" because the study's dose is in between, and the literature is being reviewed, but the actual data here doesn't show a direct comparison. Alternatively, if the current results are good without using 160, maybe higher doses aren't needed, but the question is about whether escalation (changing the dose upwards) affects outcomes. Since the study didn't test that, the answer might be \"maybe\" because there's no direct evidence here. Wait, but the options are yes, no, maybe. The study's own data uses 120, so they aren't comparing 100 vs 160. The question is whether escalating (like going to 160) changes outcomes. Since the study's results are with 120, and the literature is being reviewed, but the study's own data doesn't address the 100 vs 160 comparison. Therefore, the answer would be \"maybe\" because the study's results don't provide a direct answer. Alternatively, maybe the",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 385,
            "completion_tokens": 512
        },
        "time_elapsed": 5.742083549499512
    },
    {
        "realidx": "11970923",
        "question": "The prevalence of retinal haemorrhages after convulsions is not well established. As these haemorrhages are considered characteristic of child abuse, we investigated their occurrence after convulsive episodes to see whether the finding of haemorrhage should prompt further investigation.\nProspective study of 153 children (aged 2 months to 2 years), seen in the emergency department after a convulsive episode. After a thorough history and physical examination, a retinal examination was performed by an ophthalmologist. If findings were positive, further investigation was undertaken to rule out systemic disorder or child abuse.\nOne child was found with unilateral retinal haemorrhages following an episode of a simple febrile convulsion. A thorough investigation uncovered no other reason for this finding.\nConvulsions and retinal haemorrhage: should we look further?",
        "answer": "yes",
        "answer_rationale": "Retinal haemorrhages following a convulsive episode are rare. Such a finding should trigger an extensive search for other reasons, including child abuse.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The study is about whether retinal hemorrhages after convulsions in children should lead to further investigation, especially since these hemorrhages are a sign of child abuse. The study looked at 153 kids between 2 months and 2 years who had convulsions. An ophthalmologist checked their retinas. If they found something, they did more tests to rule out other issues like abuse or systemic disorders.\n\nThe key point here is that only one child had unilateral retinal hemorrhages after a simple febrile convulsion. But after thorough investigation, they found no other cause. So the question is, does this mean we should still look further when we find such hemorrhages?\n\nThe options are yes, no, maybe. The study's purpose was to see if finding hemorrhages after a convulsion should prompt more investigation. Since in this case, even though they found the hemorrhage, there was no other cause found, but the hemorrhage occurred in a child with a simple febrile seizure. The fact that it's rare (only one out of 153) might suggest that it's possible even in non-abuse cases. However, since the hemorrhage is a sign of abuse, but here it occurred without other causes, maybe the answer is that you still need to investigate further because even though it's rare, it can happen without abuse, but you can't be sure without checking. Wait, but the study's conclusion might be that since it can occur even in simple cases, maybe you don't need to investigate further? Because the presence alone isn't enough to suspect abuse if it can happen in normal convulsions. The question is asking whether the finding should prompt further investigation. The study found that even in a normal convulsion case, there was a hemorrhage, so maybe the answer is B (no), because the study shows that it can occur without abuse, so you don't have to automatically investigate further. But the options are (A) yes, (B) no, (C) maybe. The study's result shows that in one case, there was a hemorrhage but no other cause. So perhaps the conclusion is that even in non-abusive cases, it can happen, so the presence doesn't necessarily mean abuse, so maybe you don't need to investigate further. Therefore, the answer would be B (no). But wait, the question is phrased as \"should we look further?\" The study's point was to",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 264,
            "completion_tokens": 512
        },
        "time_elapsed": 6.256706953048706
    },
    {
        "realidx": "11977907",
        "question": "A side-to-side difference in systolic brachial arterial blood pressure is a common finding in subclavian artery stenosis and is frequently used as a screening tool for subclavian steal syndrome (SSS). It was the goal of this retrospective study to investigate the relationship between different vertebral artery waveform types and the side-to-side difference in systolic blood pressure in patients with sonographically proven SSS.\nThe records of 1860 patients from the Neuroultrasound Laboratory between January 2000 and December 2000 were screened for the diagnosis of SSS in the final ultrasound report. In all patients, bilateral brachial arterial blood pressure was measured in a sitting position prior to the ultrasound examination. Vertebral artery waveforms were classified as (1) systolic deceleration, (2) alternating flow, and (3) complete reversal at rest. Blood pressure difference as calculated by normal-side blood pressure minus lesion-side blood pressure was compared with the 3 Doppler waveform types.\nSSS was found in 51 of 1860 (2.7%) ultrasonography studies of 49 patients (17 men, 32 women; mean age 65.3 +/- 10.5 years). Two patients (4%) had bilateral SSS. In 3 patients (6%), SSS was related to an innominate artery stenosis. Waveform analysis showed a completely reversed flow in 16 (31%), an alternating flow in 24 (47%), and a systolic deceleration in 11 (22%) cases. Systolic blood pressure difference was significantly higher in the complete reversal and alternating groups than in the systolic deceleration group (P<.001).\nSubclavian steal syndrome: can the blood pressure difference between arms predict the severity of steal?",
        "answer": "yes",
        "answer_rationale": "Brachial systolic blood pressure difference is related to the severity of SSS and can be used as a screening tool for SSS. However, it performed better in severe steal than milder steal phenomena.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the blood pressure difference between arms can predict the severity of steal in Subclavian Steal Syndrome (SSS). The options are yes, no, or maybe.\n\nFirst, I need to recall what the study found. The question mentions a retrospective study of 1860 patients, with 51 cases of SSS. They classified vertebral artery waveforms into three types: systolic deceleration, alternating flow, and complete reversal. The blood pressure difference was calculated as the normal side minus the lesion side. \n\nThe key result here is that the systolic blood pressure difference was significantly higher in the complete reversal and alternating groups compared to the systolic deceleration group (P<.001). So, the more severe the waveform abnormality (like complete reversal being worse than systolic deceleration), the higher the blood pressure difference between the arms. \n\nThe question is whether the BP difference can predict the severity. Since the study shows that higher differences correlate with more severe waveform types (reversal and alternating being more severe than deceleration), that suggests that the BP difference does indicate severity. So the answer should be yes, which is option A. \n\nWait, but I need to make sure I'm not missing anything. The options are (A) yes, (B) no, (C) maybe. The study's results directly support that there's a significant difference in BP based on the waveform severity. Therefore, the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 480,
            "completion_tokens": 319
        },
        "time_elapsed": 3.744886875152588
    },
    {
        "realidx": "12006913",
        "question": "Studies on coronary risk factors in men and women are mainly based on mortality data and few compare results of both sexes with consistent study design and diagnostic criteria. This study assesses the major risk factors for coronary events in men and women from the Reykjavik Study.\nWithin a prospective, population-based cohort study individuals without history of myocardial infarction were identified and the relative risk of baseline variables was assessed in relation to verified myocardial infarction or coronary death during follow-up.\nOf the 9681 women and 8888 men who attended risk assessment from 1967-1991, with follow-up period of up to 28 years, 706 women and 1700 men suffered a non-fatal myocardial infarction or coronary death.\nSerum cholesterol was a significant risk factor for both sexes, with hazard ratios (HR) decreasing with age. Systolic blood pressure was a stronger risk factor for women as was ECG-confirmed left ventricular hypertrophy (women HR 2.89, 95% confidence interval [CI] 1.67-5.01; men HR 1.11 [CI 0.86-1.43]). Fasting blood glucose>or =6.7 mmol/L identified significantly higher risk for women (HR 2.65) than men (HR 2.08) as did self-reported diabetes. Triglyceride risk was significantly higher for women and decreased significantly with age. Smoking increased risk two- to five-fold, increasing with dose, for women, which was significantly higher than the doubling in risk for men.\nDo lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men?",
        "answer": "no",
        "answer_rationale": "This large study of the major risk factors compared between the sexes demonstrates similar relative risk of myocardial infarction associated with cholesterol for both sexes, however, the relative risk is higher in women for many other risk factors such as smoking, diabetes, elevated triglycerides and left ventricular hypertrophy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men based on the study described.\n\nFirst, I need to recall the details from the provided study summary. The study compared risk factors between men and women. Let me go through each factor mentioned:\n\n1. **Serum Cholesterol (a lipid factor):** The study says it was a significant risk factor for both sexes, but the hazard ratios decreased with age. However, it doesn't explicitly state that the HR was the same for both. The question is about equality, so maybe the fact that it's significant in both but the HR's relation to age might differ? Wait, the problem is whether the risk conferred is equal. The text just says it's significant for both, but maybe the magnitude isn't compared here. Hmm, need to check other factors.\n\n2. **Systolic Blood Pressure:** The study mentions that systolic BP was a stronger risk factor for women. The HR for women was 2.89 vs. 1.11 for men. That's a big difference. So here, BP is a stronger risk in women. So this factor doesn't have equal risk between sexes.\n\n3. **Diabetes (fasting glucose and self-reported):** For fasting blood glucose \u22656.7 mmol/L, women had a HR of 2.65 vs. 2.08 in men. So again, higher in women. Similarly, self-reported diabetes also showed higher risk for women. So diabetes as a risk factor is more impactful in women.\n\n4. **Triglycerides:** The text says triglyceride risk was significantly higher for women and decreased with age. So triglycerides (another lipid) have a higher risk in women. So lipids here (triglycerides) are more risky for women than men.\n\n5. **Smoking:** Smoking increased risk 2- to 5-fold for women, which was significantly higher than the doubling in men. So smoking's effect is stronger in women.\n\nSo putting this all together, the question is whether these factors (lipids, BP, diabetes, smoking) have equal risk in both sexes. The study shows that for systolic BP, diabetes (both glucose and self-reported), triglycerides, and smoking, the risk is higher in women. Only serum cholesterol's HR was significant in both but the question is about equality",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 464,
            "completion_tokens": 512
        },
        "time_elapsed": 5.669069766998291
    },
    {
        "realidx": "12040336",
        "question": "The role of early revascularization among patients with acute myocardial infarction complicated by cardiogenic shock remains controversial. Angioplasty registries, while suggesting a benefit, are subject to selection bias, and clinical trials have been underpowered to detect early benefits. If an invasive strategy is beneficial in this population, patients admitted to hospitals with onsite coronary revascularization might be expected to have a better prognosis. We sought to determine whether access to cardiovascular resources at the admitting hospital influenced the prognosis of patients with acute myocardial infarction complicated by cardiogenic shock.\nBy use of the Cooperative Cardiovascular Project database (a retrospective medical record review of Medicare patients discharged with acute myocardial infarction), we identified patients aged>or =65 years whose myocardial infarction was complicated by cardiogenic shock.\nOf the 601 patients with cardiogenic shock, 287 (47.8%) were admitted to hospitals without revascularization services and 314 (52.2%) were admitted to hospitals with coronary angioplasty and coronary artery bypass surgery facilities. Clinical characteristics were similar across the subgroups. Patients admitted to hospitals with revascularization services were more likely to undergo coronary revascularization during the index hospitalization and during the first month after acute myocardial infarction. After adjustment for demographic, clinical, hospital, and treatment strategies, the presence of onsite revascularization services was not associated with a significantly lower 30-day (odds ratio 0.83, 95% CI 0.47, 1.45) or 1-year mortality (odds ratio 0.91, 95% CI 0.49, 1.72).\nCardiogenic shock complicating acute myocardial infarction in elderly patients: does admission to a tertiary center improve survival?",
        "answer": "no",
        "answer_rationale": "In a community-based cohort, patients with acute myocardial infarction complicated by cardiogenic shock did not have significantly different adjusted 30-day and 1-year mortality, irrespective of the revascularization capabilities of the admitting hospital.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether admission to a tertiary center (which I assume has onsite revascularization services) improves survival in elderly patients with cardiogenic shock complicating an acute myocardial infarction.\n\nLooking at the provided study details: The study used the Cooperative Cardiovascular Project database, focusing on patients over 65 withAMI and cardiogenic shock. They were split into two groups: those admitted to hospitals with revascularization services (angioplasty and bypass) and those without. The key results after adjustment for various factors showed that the presence of onsite revascularization wasn't significantly associated with lower 30-day or 1-year mortality. The odds ratios were 0.83 (CI 0.47-1.45) and 0.91 (CI 0.49-1.72), respectively. Since the confidence intervals include 1, the results aren't statistically significant. \n\nSo the study's conclusion here is that having those services didn't lead to better survival. The question is whether going to a tertiary center (which has these services) improves survival. Since the answer from the study is no, the correct answer should be B) no. The options are A yes, B no, C maybe. The study's results don't support an improvement, so B is the answer.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 474,
            "completion_tokens": 286
        },
        "time_elapsed": 3.5871076583862305
    },
    {
        "realidx": "12070552",
        "question": "A tonsillectomy audit was carried out and compared with other studies, to emphasize the role of antibiotics.\nThis study was carried out at North West Armed Forces Hospital, Tabuk, Kingdom of Saudi Arabia, during the year January 1999 through to December 1999. This is a retrospective study of patients who had tonsillectomy with or with adenoidectomy, the topics audited included indication for surgery, grade of surgeon, method of surgery, length of hospital stay, complications and the use of postoperative antibiotics.\nA total of 185 patients underwent tonsillectomy with or without adenoidectomy. The patients age ranged between 2 years to 53 years and the majority were children. In our audit we found no difference with regard to grade of surgeons, method of hemostasis in the outcome of surgery. Moreover, postoperative antibiotics had no role in pain control, postoperative fever, secondary hemorrhage or reduction in hospital stay. The administration of analgesics on the basis of, as required, had poor pain control.\nDo antibiotics decrease post-tonsillectomy morbidity?",
        "answer": "no",
        "answer_rationale": "Post tonsillectomy antibiotics did not prove to have a role in minimizing postoperative morbidity. Moreover, analgesics given on the basis of as required had a limited value.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether antibiotics decrease post-tonsillectomy morbidity based on the provided study.\n\nFirst, I need to recall what the study found. The question mentions that the audit looked at several factors including the use of postoperative antibiotics. The key point here is the result regarding antibiotics. The passage states: \"postoperative antibiotics had no role in pain control, postoperative fever, secondary hemorrhage or reduction in hospital stay.\" \n\nSo, the study's conclusion is that antibiotics didn't make a difference in those specific outcomes. The options are yes, no, or maybe. Since the study found no beneficial effect, the answer should be \"no\". \n\nWait, but I should make sure I'm not missing anything. The question is about morbidity, which refers to the presence of disease or\u4e0d\u826f\u72b6\u6001. The outcomes mentioned (fever, hemorrhage, pain, hospital stay) are all indicators of morbidity. Since antibiotics didn't affect any of these, the answer is definitely B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 322,
            "completion_tokens": 218
        },
        "time_elapsed": 2.9774110317230225
    },
    {
        "realidx": "12090319",
        "question": "To determine the necessity of pelvic computed tomography (CT) in patients of renal cell carcinoma (RCC).\nWe reviewed the records of 400 patients of RCC, who underwent treatment at our institution between January 1988 and February 2001. These patients were evaluated pre-operatively with ultrasonograms (USG) and contrast enhanced CT scan of the abdomen and pelvis. USG or CT scans of these cases were reviewed for presence of pathology in the pelvis, which were classified into 3 categories viz; benign and likely to be insignificant, benign and likely to be significant; and malignant.\nOf the 400 cases, 114 were stage I, 68 were stage II, 99 were stage III and 119 were stage IV. In all patients, tumour was identified in the kidney on preoperative CT scan. Fourteen patients (3.5%) had an abnormality on pelvic CT. Five (1.25%) had category 1, three (0.75%) had category 2 and six (1.5%) had category 3 abnormality on pelvic CT. However, all these abnormalities in pelvis were detected prior to CT by other investigations (USG or plain x-ray). Of the six cases with malignant findings, two had superficial bladder cancer, one had RCC in a pelvic kidney and three had bone metastases in the pelvis.\nIs there a need for pelvic CT scan in cases of renal cell carcinoma?",
        "answer": "no",
        "answer_rationale": "Pelvic CT does not offer additional information in the vast majority of cases with RCC and should be performed selectively. Thus the cost of diagnostic imaging in RCC can be reduced.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a need for a pelvic CT scan in cases of renal cell carcinoma (RCC) based on the provided study.\n\nFirst, I need to understand the study's findings. The study looked at 400 RCC patients who had pre-operative ultrasounds (USG) and CT scans of the abdomen and pelvis. The pelvic CT findings were categorized into three: benign and insignificant, benign but significant, and malignant. \n\nOut of 400 patients, 14 (3.5%) had some pelvic abnormality on CT. Breaking that down, category 1 (benign, insignificant) had 5, category 2 (benign, significant) had 3, and category 3 (malignant) had 6. However, importantly, all these pelvic abnormalities were already detected by other tests like USG or plain X-rays before the CT scan was done. \n\nThe key point here is that the pelvic CT didn't find anything new that wasn't already detected by other, less invasive or less radiation-heavy methods. For the six malignant cases, two were bladder cancer, one was RCC in a pelvic kidney (which might be known given the kidney's location?), and three had bone metastases. But since all were found prior via other imaging, the pelvic CT didn't add new information. \n\nThe question is whether a pelvic CT is necessary. Since the abnormalities were already found by USG or X-ray, which are part of the standard workup, the pelvic CT might not be adding value. The argument against doing it would be that it's redundant, exposes the patient to more radiation, and perhaps unnecessary cost. \n\nThe options are yes, no, maybe. The study's results suggest that pelvic CT isn't necessary because all findings were already detected by other means. So the answer would be B (no). But wait, maybe there's a nuance. For example, maybe in some cases, the pelvic CT is needed even if other tests found something? But the question is about the necessity. Since the study shows that in their cohort, the pelvic CT didn't find anything new, the conclusion would be that it's not necessary. So the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 401,
            "completion_tokens": 467
        },
        "time_elapsed": 5.404565334320068
    },
    {
        "realidx": "12094116",
        "question": "The purpose of this study was to identify the relationships between leg muscle power and sprinting speed with changes of direction.\nthe study was designed to describe relationships between physical qualities and a component of sports performance.\ntesting was conducted in an indoor sports hall and a biomechanics laboratory.\n15 male participants were required to be free of injury and have recent experience competing in sports involving sprints with changes of direction.\nsubjects were timed in 8 m sprints in a straight line and with various changes of direction. They were also tested for bilateral and unilateral leg extensor muscle concentric power output by an isokinetic squat and reactive strength by a drop jump.\nThe correlations between concentric power and straight sprinting speed were non-significant whereas the relationships between reactive strength and straight speed were statistically significant. Correlations between muscle power and speed while changing direction were generally low and non-significant for concentric leg power with some moderate and significant (p<0.05) coefficients found for reactive strength. The participants who turned faster to one side tended to have a reactive strength dominance in the leg responsible for the push-off action.\nIs muscle power related to running speed with changes of direction?",
        "answer": "yes",
        "answer_rationale": "The relationships between leg muscle power and change-of-direction speed were not consistent. Reactive strength as measured by the drop jump appears to have some importance for lateral change-of-direction speed, possibly because of similar push-off actions. It was concluded that reactive strength of the leg extensor muscles has some importance in change-of-direction performance but the other technical and perceptual factors than influence agility performance should also be considered.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether muscle power is related to running speed with changes of direction based on the study described.\n\nFirst, I need to recall the details from the study provided. The study looked at leg muscle power (both concentric and reactive strength) and how they relate to sprinting speed, especially during changes of direction. \n\nThe key results mentioned are that the correlations between concentric power (which is the type of muscle contraction where the muscle shortens, like in a squat) and straight sprinting speed were non-significant. That means there wasn't a strong statistical link there. However, for reactive strength (which is about the ability to quickly switch from eccentric to concentric muscle actions, like in a drop jump), the relationships with straight speed were significant. \n\nNow, when it comes to changing direction, the correlations between muscle power and speed were generally low and non-significant for concentric leg power. But there were some moderate and significant correlations for reactive strength. Also, the participants who turned faster on one side had a reactive strength dominance in the leg used for pushing off during the turn. \n\nThe question specifically asks about muscle power's relation to speed during changes of direction. The options are yes, no, maybe. \n\nThe study found that concentric power (a type of muscle power) didn't show a significant relationship with directional changes. However, reactive strength, which is another aspect of muscle power, did show significant correlations. But the question is about \"muscle power\" in general. Since reactive strength is a component of muscle power, the answer might depend on whether the question considers reactive strength as part of muscle power. \n\nThe options are a bit tricky here. The study says that for changes of direction, the correlations for concentric power were low and non-significant, but reactive strength had some significant moderate coefficients. Since reactive strength is a type of muscle power (specifically related to the ability to produce force quickly after a stretch), it's part of overall muscle power. Therefore, the answer would be \"yes\" because there is a significant relationship with reactive strength. However, if the question is specifically referring to concentric power, then it's no. But the question just says \"muscle power\" generally. \n\nLooking back at the options, the answer should be yes because the study found that reactive strength (a component of muscle power) was related. The non-significant results were for concentric power, but since there's a significant component (reactive",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 328,
            "completion_tokens": 512
        },
        "time_elapsed": 5.759717702865601
    },
    {
        "realidx": "12098035",
        "question": "We tested the hypothesis that the treatment of patients with acute cholecystitis (AC) would be improved under the care of laparoscopic specialists.\nThe records of patients undergoing cholecystectomy for AC from 1 January 1996 to 31 December 1998 were reviewed retrospectively. Of 170 patients, 48 were cared for by three laparoscopic specialists (LS group), whereas 122 were treated by nine general surgeons who perform only laparoscopic cholecystectomy (LC) (GS group). The rates of successful LC, complications, and length of hospital stay were compared. Multivariate analysis was used to control for baseline differences.\nThe patients in the GS group were older (median age, 63 vs 53 years; p = 0.01). In all, 31 LS patients (65%), as compared with 44 GS patients (36%), had successful laparoscopic treatment (p = 0.001). The operating time was the same (median, 70 min). The proportion of patients with postoperative complications was similar in the two groups (37% in the GS vs 31% in the LS group; p = 0.6). The median postoperative hospital stay (3 vs 5 days; p<0.01) was shorter in the LS group. On logistic regression analysis, significant predictors of a successful laparoscopic operation included LS group (p<0.01) and age (p = 0). Predictors of prolonged length of hospital stay were age (p<0.01) and comorbidity score (p<0.01), with LS group status not a significant factor (p = 0.21).\nDoes a special interest in laparoscopy affect the treatment of acute cholecystitis?",
        "answer": "yes",
        "answer_rationale": "Patients with AC are more likely to undergo successful LC if cared for by a surgeon with an interest in laparoscopy. However, length of hospital stay is influenced more by patient factors in a multivariate model.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a special interest in laparoscopy affects the treatment of acute cholecystitis based on the provided study.\n\nFirst, I need to recall the study's findings. The study compared two groups: the LS group (laparoscopic specialists) and the GS group (general surgeons). The key results mentioned are:\n\n- Success rate of laparoscopic cholecystectomy was higher in the LS group (65% vs 36%, p=0.001). That's a big difference, so that's a strong point.\n- Complication rates were similar between the two groups (37% vs 31%, p=0.6), so no significant difference there.\n- Hospital stay was shorter in the LS group (3 vs 5 days, p<0.01). But the logistic regression later says that LS group wasn't a significant predictor for hospital stay, which might be because of other factors like age and comorbidities.\n\nThe question is whether the special interest (i.e., being a laparoscopic specialist) affects treatment. The success rate is a major outcome here. Since the LS group had significantly higher success rates, that suggests that their special interest does make a difference. The other factors like complications and hospital stay (adjusted for other variables) might not be as directly impacted, but the success rate is a key treatment outcome. \n\nThe options are yes, no, maybe. The study's results show that the LS group had better success, so the answer should be yes. The fact that hospital stay wasn't a significant factor in regression might be a distractor, but the main point is the success of the procedure. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 482,
            "completion_tokens": 363
        },
        "time_elapsed": 4.258966445922852
    },
    {
        "realidx": "12121321",
        "question": "Mossy fibers are the sole excitatory projection from dentate gyrus granule cells to the hippocampus, forming part of the trisynaptic hippocampal circuit. They undergo significant plasticity during epileptogenesis and have been implicated in seizure generation. Mossy fibers are a highly unusual projection in the mammalian brain; in addition to glutamate, they release adenosine, dynorphin, zinc, and possibly other peptides. Mossy fiber terminals also show intense immunoreactivity for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), and immunoreactivity for GAD67. The purpose of this review is to present physiologic evidence of GABA release by mossy fibers and its modulation by epileptic activity.\nWe used hippocampal slices from 3- to 5-week-old guinea pigs and made whole-cell voltage clamp recordings from CA3 pyramidal cells. We placed stimulating electrodes in stratum granulosum and adjusted their position in order to recruit mossy fiber to CA3 projections.\nWe have shown that electrical stimuli that recruit dentate granule cells elicit monosynaptic GABAA receptor-mediated synaptic signals in CA3 pyramidal neurons. These inhibitory signals satisfy the criteria that distinguish mossy fiber-CA3 synapses: high sensitivity to metabotropic glutamate-receptor agonists, facilitation during repetitive stimulation, and N-methyl-D-aspartate (NMDA) receptor-independent long-term potentiation.\nDo mossy fibers release GABA?",
        "answer": "yes",
        "answer_rationale": "We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether mossy fibers release GABA. The provided text is a summary of a study and some background info.\n\nFirst, I need to recall what mossy fibers are. From the question, they're described as the sole excitatory projection from dentate gyrus granule cells to the hippocampus. But the question is about GABA release. The text mentions that mossy fiber terminals show intense immunoreactivity for GABA and GAD67, which is an enzyme involved in GABA synthesis. That's a strong hint that they might release GABA.\n\nThe study part says they used hippocampal slices and recorded from CA3 cells. When they stimulated the mossy fibers, they found monosynaptic GABAA receptor-mediated signals. GABAA receptors are the main mediators of inhibitory signals from GABA. The results also mention that these inhibitory signals meet criteria specific to mossy fiber-CA3 synapses, like sensitivity to mGluR agonists and NMDA-independent LTP. \n\nSo the key points here are the presence of GABA and GAD67 in the terminals, and the experimental evidence showing GABAergic signals. The question is whether they release GABA. The study's results directly show that stimulating mossy fibers leads to GABA release because the response is via GABAA receptors. \n\nThe options are yes, no, maybe. The answer should be yes (A) because the evidence from both the immunoreactivity and the electrophysiological recordings supports GABA release by mossy fibers. The text's purpose is to present evidence of GABA release, so the answer is definitely yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 403,
            "completion_tokens": 354
        },
        "time_elapsed": 4.218796968460083
    },
    {
        "realidx": "12145243",
        "question": "Type 2 diabetes may be present for several years before diagnosis, by which time many patients have already developed diabetic complications. Earlier detection and treatment may reduce this burden, but evidence to support this approach is lacking.\nGlycemic control and clinical and surrogate outcomes were compared for 5,088 of 5,102 U.K. Diabetes Prospective Study participants according to whether they had low (<140 mg/dl [<7.8 mmol/l]), intermediate (140 to<180 mg/dl [7.8 to<10.0 mmol/l]), or high (>or =180 mg/dl [>or =10 mmol/l]) fasting plasma glucose (FPG) levels at diagnosis. Individuals who presented with and without diabetic symptoms were also compared.\nFewer people with FPG in the lowest category had retinopathy, abnormal biothesiometer measurements, or reported erectile dysfunction. The rate of increase in FPG and HbA(1c) during the study was identical in all three groups, although absolute differences persisted. Individuals in the low FPG group had a significantly reduced risk for each predefined clinical outcome except stroke, whereas those in the intermediate group had significantly reduced risk for each outcome except stroke and myocardial infarction. The low and intermediate FPG groups had a significantly reduced risk for progression of retinopathy, reduction in vibration sensory threshold, or development of microalbuminuria.\nAre lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?",
        "answer": "yes",
        "answer_rationale": "People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether lower fasting plasma glucose (FPG) levels at diagnosis of type 2 diabetes are associated with improved outcomes. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study compared three groups based on FPG levels at diagnosis: low (<140 mg/dl), intermediate (140-180), and high (\u2265180). The outcomes looked at include things like retinopathy, nerve function (biothesiometer measurements), erectile dysfunction, HbA1c changes, and other clinical events like stroke or myocardial infarction.\n\nThe key findings mentioned are that those in the low FPG group had fewer cases of retinopathy, abnormal biothesiometer results, and erectile dysfunction. The rate of increase in FPG and HbA1c was the same across all groups, but the absolute levels differed. However, the low FPG group had a lower risk for most clinical outcomes except stroke. The intermediate group also had reduced risks except for stroke and MI. Both low and intermediate groups had lower risks for retinopathy progression, sensory issues, and microalbuminuria.\n\nSo the question is whether lower FPG at diagnosis is linked to better outcomes. The study shows that the lower the FPG at diagnosis, the better the outcomes in terms of complications. Even though the rate of increase in glucose levels was the same over time, starting at a lower level meant they had less complications. Therefore, the answer should be yes, lower FPG is associated with improved outcomes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 409,
            "completion_tokens": 352
        },
        "time_elapsed": 4.121922731399536
    },
    {
        "realidx": "12163782",
        "question": "Neutrophil infiltration of the lung is characteristic of early posttraumatic acute respiratory distress syndrome (ARDS). This study examines the ability of neutrophils isolated (over the first 24 hrs) from the peripheral blood of patients admitted after major trauma to migrate in response to interleukin-8. Interleukin-8 is elevated in the lung within 2 hrs of major trauma in patients who later develop ARDS, and thus it plays a central role in the recruitment of neutrophils to the lung and their subsequent activation. We hypothesized that enhanced interleukin-8-mediated neutrophil migratory activity in the early postinjury phase, before the development of ARDS, may be a crucial factor in the etiology of ARDS.\nProspective observational study.\nUniversity Hospital Wales, the Royal Gwent Hospital, and East Glamorgan General Hospital. Laboratory work was conducted at the Institute of Nephrology.\nAdult blunt trauma victims with Injury Severity Score>or = 18.\nNeutrophils were isolated from citrated blood from 17 adult blunt major trauma patients at admission (0 hrs) and 8 and 24 hrs later. Identical samples were obtained from normal laboratory volunteers (n = 9). The neutrophil count in each specimen was measured, and the number of neutrophils migrating across porous tissue culture inserts in response to defined concentrations of interleukin-8 (0, 10, 30, and 100 ng/mL) was quantitated by peroxidase assay. Neutrophil counts in the whole blood specimens obtained from those later developing ARDS were elevated significantly at admission and declined rapidly throughout the next 24 hrs. Significantly greater numbers of trauma patients' neutrophils migrated to concentrations of interleukin-8 (30 and 100 ng/mL) at each time point when compared with normal volunteers (Mann-Whitney U test, p<.05). Neutrophils isolated from major trauma patients exhibited an enhanced migratory response to high concentrations of interleukin-8 throughout the first 24 hrs of admission, in contrast to the normal physiologic attenuation of migration seen in neutrophils isolated from normal laboratory volunteers.\nIncreased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome?",
        "answer": "yes",
        "answer_rationale": "These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about neutrophil migration in trauma patients and its relation to ARDS. The hypothesis was that enhanced interleukin-8-mediated neutrophil migration early after injury might cause ARDS.\n\nThe results showed that trauma patients' neutrophils migrated more in response to higher IL-8 concentrations compared to normals. Also, those who developed ARDS had higher neutrophil counts initially which dropped. Since neutrophil infiltration is a feature of early ARDS, and their migration response was enhanced, the study supports the idea that this increased migration contributes to ARDS. The question asks if increased neutrophil migratory activity is a factor in ARDS etiology. The answer should be yes (A) because the study's findings align with the hypothesis.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 577,
            "completion_tokens": 168
        },
        "time_elapsed": 2.439467668533325
    },
    {
        "realidx": "12172698",
        "question": "Associations between several psychopathological alterations and lowered beta-endorphin(beta E) plasma levels have already been stated in former studies. However, whereas single measures during static conditions generally failed in linking beta E levels with psychopathology, dynamic changes of beta E in particular have been shown to be associated with spells of anxiety and depression. During alcohol withdrawal, a decreased secretion of beta E with a delayed normalization has been reported, but up to now only few data became available regarding the interaction of plasma beta E and psychopathological parameters.\nThe aim of our study was to test the hypothesis whether beta E during acute alcohol withdrawal is associated with anxiety, depression, and craving.\nWe observed self-rated anxiety, depression, and craving during alcohol withdrawal and assessed beta E levels (RIA) in a consecutive sample of 60 alcoholics on day 1 and day 14 after onset of withdrawal, and in 30 healthy volunteers. To control for mutual interactions of beta E and the pituitary-adrenocortical hormone secretion, plasma corticotropin (ACTH) and cortisol were also determined.\nIn accordance with prior studies, beta E was significantly lowered on day 1 and day 14 of alcohol withdrawal relative to controls. Plasma levels of ACTH correlated significantly with beta E in alcoholics at both time points and in controls, without differing significantly between the groups. Self-rated anxiety, depression, and alcohol craving decreased significantly between day 1 and day 14. Levels of beta E were inversely correlated with anxiety day 1 (r=-0.58) and day 14 (r=-0.71). Partial correlation coefficients controlling for ACTH plasma levels revealed that this correlation was largely independent from ACTH. In addition, a significant inverse relationship was found between beta E and craving on day 14 (r=-0.28). No association appeared between beta E and depression.\nIs withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?",
        "answer": "yes",
        "answer_rationale": "Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether withdrawal-induced anxiety in alcoholism is based on beta-endorphin deficiency. The study mentioned here looked at beta-endorphin (beta E) levels in alcoholics during withdrawal compared to healthy controls. \n\nFirst, the study found that beta E levels were significantly lower in alcoholics on both day 1 and day 14 of withdrawal compared to controls. That's a key point. Then, they looked at correlations between beta E and the psychological factors: anxiety, depression, and craving.\n\nThe results showed that beta E was inversely correlated with anxiety on both days. The correlation coefficients were pretty strong (r=-0.58 and r=-0.71), which means as beta E levels went down, anxiety went up. Also, when they controlled for ACTH (a hormone related to the stress response), the correlation still held, so it's not just because of ACTH levels. \n\nHowever, there's no association found between beta E and depression. And the craving only had a weaker inverse correlation on day 14. The question specifically asks about anxiety. Since the inverse correlation is strong and independent of ACTH, it suggests that lower beta-endorphin is linked to higher anxiety during withdrawal. \n\nThe options are yes, no, maybe. The study's data supports that the anxiety is associated with lower beta E. So the answer should be A) yes. Wait, but the question is phrased as \"based on beta-endorphin deficiency\". The study shows an association, but does that mean it's the cause? The study can't prove causation, only correlation. Hmm, but the question is whether the anxiety is \"based on\" the deficiency. Since the correlation is strong and independent of other factors like ACTH, maybe the answer is yes. The options don't have a \"maybe due to correlation but not causation\", but the options given are yes, no, maybe. The study's results support that there's an association, so the answer would be yes. The question is whether the hypothesis is supported. The hypothesis was that beta E is associated with anxiety, which the study confirmed. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 495,
            "completion_tokens": 457
        },
        "time_elapsed": 5.788998603820801
    },
    {
        "realidx": "12221908",
        "question": "The principal causes of morbidity and mortality during pregnancy in Mexico, are preeclampsia/eclampsia, obstetric hemorrhage and puerperium complications; this is, 62% of maternal deaths in last years. HELLP syndrome was observed between 5 to 25% of the mortality in pregnancies of 36 weeks or less.\nTo analyze patients with HELLP syndrome in ICU's (Intensive Care Unit) of a Gynecology and Obstetric Hospital, related to the abnormal hematological, hepatic and renal results with the obstetric case history and the clinical complications.\nA transversal study in patients with HELLP syndrome during 1998 and 1999 were carry out.\nPeripheral blood with Microangiopathic hemolysis, elevated liver enzymes: AST, ALT over 40 UI/L, even when were LDH lower than 600 UI/L. It was evaluated the hepatic and renal function, platelets count, microangiopathic hemolysis, arterial pressure, seizures, icteric skin color, blindness, visual disturbances, nausea, vomiting and upper quadrant right abdominal pain. In newborn we analyzed gestational age, sex, weight and APGAR. We studied for an association between maternal and biochemical variables with Correlation Pearson Test, and dependence between variables with lineal regression model.\n2878 patients with hypertensives disorders in pregnancy (11.64%). The 1.15% (n = 33) had HELLP syndrome with specific maternal mortality of 0.4 per 10,000 live birth, perinatal mortality of 1.62 per 10,000 live birth; and renal damage in 84.5%. Coefficient beta was higher between number of pregnancies to platelets count (-0.33) and creatinine clearance (-0.401).\nThe HELPP syndrome--evidence of a possible systemic inflammatory response in pre-eclampsia?",
        "answer": "yes",
        "answer_rationale": "We found an important renal damage, low platelets, elevated liver enzymes in women with two or more pregnancies. Then we propose there are similarities between HELLP syndrome and Systemic Inflammatory Response Syndrome (SIRS) because they could have the same pathophysiology.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether HELLP syndrome is evidence of a possible systemic inflammatory response in pre-eclampsia. The options are yes, no, or maybe.\n\nFirst, I need to recall what HELLP syndrome is. HELLP stands for Hemolysis, Elevated Liver enzymes, and Low Platelet count. It's a life-threatening complication related to pre-eclampsia and eclampsia, which are pregnancy-induced hypertensive disorders. \n\nThe question is linking HELLP to a systemic inflammatory response. From what I remember, pre-eclampsia is associated with inflammation. The pathophysiology involves endothelial dysfunction, which can lead to inflammation. HELLP syndrome is considered a severe form of pre-eclampsia. The systemic inflammatory response syndrome (SIRS) is characterized by systemic inflammation, often due to infection, but in the context of pre-eclampsia, the inflammation might be part of the underlying pathology.\n\nLooking at the study provided, they mention that in HELLP patients, there are abnormalities in hematological, hepatic, and renal functions. These could be indicative of systemic issues. The study also found associations between variables like number of pregnancies and platelets, creatinine clearance, which might relate to systemic effects. \n\nThe key point here is whether the features of HELLP (like liver enzyme elevations, hemolysis, thrombocytopenia) are part of a systemic inflammatory response. Since pre-eclampsia itself is linked to inflammation, and HELLP is a severe manifestation, it's plausible that the syndrome represents a systemic response. The study's findings of renal damage in 84.5% and other multi-organ involvement support this idea. \n\nTherefore, the answer should be \"yes\" because the systemic involvement in HELLP aligns with a systemic inflammatory response in the context of pre-eclampsia.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 507,
            "completion_tokens": 391
        },
        "time_elapsed": 4.460245847702026
    },
    {
        "realidx": "12377809",
        "question": "Dyschesia can be provoked by inappropriate defecation movements. The aim of this prospective study was to demonstrate dysfunction of the anal sphincter and/or the musculus (m.) puborectalis in patients with dyschesia using anorectal endosonography.\nTwenty consecutive patients with a medical history of dyschesia and a control group of 20 healthy subjects underwent linear anorectal endosonography (Toshiba models IUV 5060 and PVL-625 RT). In both groups, the dimensions of the anal sphincter and the m. puborectalis were measured at rest, and during voluntary squeezing and straining. Statistical analysis was performed within and between the two groups.\nThe anal sphincter became paradoxically shorter and/or thicker during straining (versus the resting state) in 85% of patients but in only 35% of control subjects. Changes in sphincter length were statistically significantly different (p<0.01, chi(2) test) in patients compared with control subjects. The m. puborectalis became paradoxically shorter and/or thicker during straining in 80% of patients but in only 30% of controls. Both the changes in length and thickness of the m. puborectalis were significantly different (p<0.01, chi(2) test) in patients versus control subjects.\nIs anorectal endosonography valuable in dyschesia?",
        "answer": "yes",
        "answer_rationale": "Linear anorectal endosonography demonstrated incomplete or even absent relaxation of the anal sphincter and the m. puborectalis during a defecation movement in the majority of our patients with dyschesia. This study highlights the value of this elegant ultrasonographic technique in the diagnosis of \"pelvic floor dyssynergia\" or \"anismus\".",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether anorectal endosonography is valuable in dyschesia based on the provided study.\n\nFirst, I need to understand what the study found. The study compared 20 patients with dyschesia to 20 healthy controls using anorectal endosonography. They measured the anal sphincter and puborectalis muscle during rest, squeezing, and straining. \n\nThe key results were that in patients, 85% had paradoxical shortening/thickening of the anal sphincter during straining, compared to 35% of controls. For the puborectalis, it was 80% vs 30%. Both differences were statistically significant (p<0.01). \n\nThe question is whether this makes the imaging technique valuable. Since the study shows a clear, significant difference between patients and controls, that suggests the test can help identify the muscle dysfunction associated with dyschesia. The high percentage of patients showing abnormal findings compared to controls indicates that the test is effective in detecting these issues. Therefore, the answer should be yes (A). The options are (A) yes, (B) no, (C) maybe. The study's results support the value, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 400,
            "completion_tokens": 274
        },
        "time_elapsed": 3.8269667625427246
    },
    {
        "realidx": "12380309",
        "question": "To evaluate prepuce development and retractibility in a group of boys. To point out the value of circumcision and prepucial forced dilation during childhood.\nPrepuce development and retractibility were evaluated in 400 boys ages between 0-16 year old.\nIn boys under 1 year prepuce retractibility (assessed only in children who did not undergo forced dilation previously) was type I (non retractile) in 71.5% whereas type V (completely retractile) was only 5.5%. In adolescent boys type I prepuce was observed in 1 boy only, 1.6%, whereas type V was observed in 82.3%. Furthermore, it was observed that at the time of examination for the study 106 boys who had undergone forced dilation at an earlier age had balano-prepucial adhesions again, which demonstrates that prepuce adheres again to glans penis in many boys after a forced dilation is performed. Only 11 boys were considered in need for circumcision, three of them for prepucial orifice stenosis, which prevented normal micturition, causing a prepucial sac, one case due to a constrictive ring below the prepucial edge that would have prevented ulterior retractability, two cases with repetitive balanopostitis, and five cases secondary to xerosol balanitis, accounting for 2.7% of all examined boys.\nShould circumcision be performed in childhood?",
        "answer": "no",
        "answer_rationale": "Incomplete separation between prepuce and glans penis is normal and common among new-borns, progressing until adolescence to spontaneous separation, at which time it is complete in the majority of boys. Accordingly to the criteria we have sustained for years and present study's findings, circumcision has few indications during childhood, as well as forced prepucial dilation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether circumcision should be performed in childhood based on the study provided. Let me read through the details again to make sure I understand the data.\n\nThe study looked at 400 boys aged 0-16 years. For boys under 1 year, most (71.5%) had non-retractile prepuce (type I), and only 5.5% were completely retractile (type V). In adolescents, almost the opposite: only 1.6% had type I, and 82.3% were type V. That shows that as boys get older, the prepuce naturally becomes retractile. \n\nThen there's a point about forced dilation: 106 boys who had it before had adhesions again. So forced dilation might not be effective because the adhesions come back. \n\nThe study also mentions that only 11 boys (2.7%) needed circumcision. The reasons included issues like stenosis, constrictive ring, recurrent infections, and xerosis. So in most cases, circumcision wasn't necessary. \n\nThe question is whether circumcision should be done in childhood. The options are yes, no, maybe. \n\nThe key points here are that most boys' prepuces become retractile by adolescence without intervention, and forced dilation can lead to recurrence of adhesions. The study shows that only a small percentage actually needed circumcision for specific medical issues. So routine circumcision isn't supported here. The answer would lean towards not performing it routinely, only in the specific cases where there's a clear medical need. So the answer should be B) no, unless there's a specific indication. The options don't have a \"only when necessary\" but since the question is general, the correct answer based on the data is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 404,
            "completion_tokens": 384
        },
        "time_elapsed": 4.962273597717285
    },
    {
        "realidx": "12407608",
        "question": "To investigate whether prepuncture ultrasound evaluation of vascular anatomy facilitates internal jugular vein cannulation compared with landmark-guided puncture.\nProspective randomized study.\nSingle community hospital.\nAdult patients undergoing general anesthesia (n = 240).\nThe right internal jugular vein was cannulated using either anatomic landmarks or prepuncture ultrasound (3.75/7.5 MHz) guidance. In the landmark group, respiratory jugular venodilation was used as the primary landmark for locating the vein. Results of cannulation and the incidence of complications were compared.\nPatients were randomly assigned to the ultrasound or landmark group. Respiratory jugular venodilation was identified in 188 patients (78.3%), in whom results of cannulation did not differ between the 2 techniques with respect to the venous access rate (cannulated at the first attempt: 83.5% in the landmark v 85.7% in the ultrasound group), the success rate (cannulated within 3 attempts: 96.9% v 95.6%), and the incidence of arterial puncture (1.0% v 3.3%). In the remaining 52 respiratory jugular venodilation-unidentified patients, the access rate (30.4% v 86.2%, p<0.001) and the success rate (78.3 v 100%, p<0.05) were significantly better in the ultrasound group, and no arterial puncture was recorded in the ultrasound group, whereas the incidence was 13.0% in the landmark group. The results were similar regardless of the ultrasound frequency used.\nDoes ultrasound imaging before puncture facilitate internal jugular vein cannulation?",
        "answer": "maybe",
        "answer_rationale": "Prepuncture ultrasound evaluation did not improve the result of right internal jugular vein cannulation compared with the respiratory jugular venodilation-guided approach. When the landmark was not observed, however, the prepuncture ultrasound guidance was helpful in facilitating the cannulation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing ultrasound guidance versus landmark-guided cannulation of the internal jugular vein. The key here is to see under what conditions ultrasound helps.\n\nFirst, the study split 240 patients into two groups. In the group where respiratory jugular venodilation was identified (188 patients), there wasn't a big difference between the two methods. The first-attempt success rates were similar (83.5% vs 85.7%), and overall success within three attempts was almost the same too. Arterial puncture rates were a bit higher in the landmark group but not statistically significant maybe? The p-values aren't given for those, except for the access rate and success in the other group.\n\nNow, the crucial part is the 52 patients where they couldn't identify the venodilation. Here, ultrasound really shone. The access rate at first attempt was way better (30.4% vs 86.2%), and the success rate within three attempts was 78.3% vs 100%. Also, no arterial punctures in the ultrasound group versus 13% in landmark. That's a big difference. \n\nThe question is asking if ultrasound facilitates cannulation. Well, in cases where the landmark method is tricky (when venodilation isn't visible), ultrasound is clearly better. Since the study shows that in a significant number of patients (52 out of 240, which is about 21.7%), ultrasound was better, the overall answer would be yes. The fact that in some cases (when landmarks are visible) there's no difference doesn't negate the benefit in the subgroup where landmarks aren't clear. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 452,
            "completion_tokens": 371
        },
        "time_elapsed": 5.131951808929443
    },
    {
        "realidx": "12419743",
        "question": "To determine whether patients with high-risk metastatic breast cancer draw benefit from combination chemotherapy as first-line treatment.\nA total of 260 women with measurable metastatic breast cancer fulfilling high-risk criteria, previously untreated with chemotherapy for their metastatic disease, were randomized to receive either mitoxantrone 12 mg/m(2) or the combination of fluorouracil 500 mg/m(2), epirubicin 50 mg/m(2) and cyclophosphamide 500 mg/m(2) (FEC) every 3 weeks. Treatment was continued until complete remission plus two cycles, or until disease progression. In the case of partial remission or stable disease, treatment was stopped after 12 cycles. Second-line treatment was vindesine, mitomycin and prednisolone. Gain from treatment was estimated using a modified Brunner's score composed of time to progression, patients' rating of the treatment benefit, alopecia, vomiting and performance status.\nAfter recruitment from 1992 to 1997 and observation from 1997 to 1999, the final evaluation showed that single-agent treatment with mitoxantrone does not differ significantly from combination treatment with FEC in terms of response, objective remission rate, remission duration, time to response, time to best response, time to progression or overall survival. There was, however, a significant difference in gain from treatment using a modified Brunner's score favoring the single-agent treatment arm. There was no evidence that any subgroup would fare better with combination treatment.\nIs first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy?",
        "answer": "yes",
        "answer_rationale": "No significant difference was detected between the treatment with mitoxantrone as a single agent and the combination of low-dose FEC in terms of response or survival; therefore, the imperative of the necessity of first-line combination chemotherapy for patients with high-risk metastatic breast cancer may be questioned. Since toxicity and quality of life score favored the single-agent mitoxantrone treatment arm, this treatment may be offered to patients preferring quality of life to a potential small prolongation of survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether single-agent mitoxantrone is as effective as combination chemotherapy (FEC) as first-line treatment for high-risk metastatic breast cancer. \n\nFirst, I need to look at the study details provided. The study randomized 260 women into two groups: mitoxantrone alone vs. FEC combination. The key outcomes measured were things like response rates, remission duration, time to progression, overall survival, and the modified Brunner's score which includes several factors.\n\nThe results stated that there was no significant difference between the two treatments in terms of response, remission rates, duration of remission, time to response, time to best response, time to progression, or overall survival. However, the modified Brunner's score showed a significant difference favoring the single-agent (mitoxantrone) arm. That score considers not just efficacy but also side effects like alopecia and vomiting, which might mean that while effectiveness was similar, the single agent had a better quality of life or less toxicity.\n\nThe question is specifically about effectiveness. Since all the efficacy endpoints (response rates, survival, etc.) didn't show a significant difference, that would mean they are equally effective. The Brunner's score's favorability towards mitoxantrone is about the gain from treatment, which includes side effects, not just efficacy. The question doesn't ask about side effects or quality of life, just effectiveness. So the answer should be that yes, single-agent is as effective as combination. \n\nThe options are (A) yes, (B) no, (C) maybe. The study's conclusion says there's no significant difference in the effectiveness measures, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 449,
            "completion_tokens": 362
        },
        "time_elapsed": 4.365120887756348
    },
    {
        "realidx": "12442934",
        "question": "To determine whether prior exposure of non-steroidal anti-inflammatory drugs increases perioperative blood loss associated with major orthopaedic surgery.\nFifty patients scheduled for total hip replacement were allocated to two groups (double blind, randomized manner). All patients were pretreated for 2 weeks before surgery: Group 1 with placebo drug, Group 2 with ibuprofen. All patients were injected intrathecally with bupivacaine 20mg plus morphine 0.1 mg, in a total volume of 4 mL, to provide surgical anaesthesia.\nThe presence of severe adverse effects caused eight patients in the ibuprofen group and six in the placebo group to terminate their participation in the trial. The perioperative blood loss increased by 45% in the ibuprofen group compared with placebo. The total (+/-SD) blood loss in the ibuprofen group was 1161 (+/-472) mL versus 796 (+/-337) mL in the placebo group.\nDoes ibuprofen increase perioperative blood loss during hip arthroplasty?",
        "answer": "yes",
        "answer_rationale": "Pretreatment with ibuprofen before elective total hip surgery increases the perioperative blood loss significantly. Early discontinuation of non-selective non-steroidal anti-inflammatory drugs is advised.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether ibuprofen increases perioperative blood loss during hip arthroplasty based on the given study.\n\nFirst, I need to recall what the question is about. The study is comparing two groups: one taking ibuprofen and the other a placebo before surgery. The key outcome here is the blood loss during surgery. \n\nLooking at the data provided, the ibuprofen group had an average blood loss of 1161 mL with a standard deviation of 472, while the placebo group had 796 mL with 337. The question states that the ibuprofen group's blood loss was 45% higher. That's a significant difference. \n\nBut wait, I should check if the study's design supports causation. It's a randomized, double-blind trial, which is good for minimizing bias. The groups were assigned randomly, so confounding variables should be balanced. The adverse effects led to some dropouts, but the question is about the effect in those who completed, right? The problem mentions that the increased blood loss was observed in the ibuprofen group compared to placebo. \n\nThe options are yes, no, maybe. The data shows a higher blood loss in the ibuprofen group. The study's results support the conclusion that prior ibuprofen use is associated with increased blood loss. Since it's a controlled trial, the conclusion would lean towards causation here. So the answer should be A) yes. \n\nBut wait, maybe I should consider statistical significance? The problem doesn't mention a p-value. Hmm. The question might be expecting that without statistical testing, we can't be certain. But the question says \"increased by 45%\", which might imply that the difference is statistically significant. Since the options don't have a \"maybe due to no stats\", and the question is phrased as \"does ibuprofen increase...\", based on the data given, the answer is yes. The study's results as presented show an increase. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 316,
            "completion_tokens": 431
        },
        "time_elapsed": 5.179394245147705
    },
    {
        "realidx": "12484580",
        "question": "To ascertain whether a written information sheet is acceptable to patients and improves recall of the consent interview.\nProspective randomised controlled study using questionnaires, comparing a group of patients given information in a written sheet with appropriate explanation to a group given verbal information alone.\nA specialist orthopaedic surgery unit.\nThe test group was 126 patients undergoing revision or primary total hip arthroplasty; 65 patients were given information verbally, 61 patients were given written information.\nPatients' recall of information given, tested with a questionnaire completed on admission (mean of 18 days later).\nThe patients receiving written information scored significantly higher (48% correct answers) than the patients receiving verbal information (38% correct answers).\nInformed consent for total hip arthroplasty: does a written information sheet improve recall by patients?",
        "answer": "yes",
        "answer_rationale": "Written information sheets contribute to the process of informed consent. As patients' recall of information is generally poor, the sheets may also be useful medicolegally, as a permanent record of what was discussed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether a written information sheet helps patients remember information better than just verbal explanation. The setup was a randomized controlled trial with two groups: one got written info plus explanation, the other just verbal. The test was done 18 days later using a questionnaire.\n\nThe results showed that the written group had 48% correct answers versus 38% for the verbal group, and that difference was statistically significant. The question is asking if the written sheet improves recall. Since the written group scored higher and the result is significant, the answer should be yes. The options are A, B, C. So A is correct.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 260,
            "completion_tokens": 143
        },
        "time_elapsed": 2.060103178024292
    },
    {
        "realidx": "12595848",
        "question": "Implementation of the complex treatment strategies that have been shown to improve survival of patients with congestive heart failure (CHF) may require certain expertise. We wanted to examine the association between pattern of outpatient care and survival of patients with CHF.\nIn a retrospective cohort study conducted with national Veterans Health Administration (VHA) databases, we examined the association between the pattern of outpatient care and survival in 11,661 patients discharged from VA hospitals between October 1, 1991, and September 30, 1992, with the primary diagnosis of CHF (cohort 1). Patients were divided into 4 groups, on the basis of their pattern of outpatient care over a 12-month period after discharge: 1) general medicine clinic visits only (GM-only); 2) cardiology clinic visits only (CARD-only); 3) general medicine and cardiology (MIXED) clinic visits; and 4) neither general medicine nor cardiology clinic visits (no-GM/CARD). We used the Cox proportional hazards model to evaluate 1-year survival, controlling for clinical and demographic factors. Consistency of our results was examined by performing identical analysis on a cohort of patients discharged from VHA hospitals between October 1, 1994, and September 30, 1995 (cohort 2, n = 10,141).\nThe overall 1-year mortality rate was 23% in the primary cohort. The unadjusted mortality rate was highest for patients in the no-GM/CARD follow up (29%) and lowest for patients in the MIXED group (19%). By use of the MIXED group as reference and adjusting for important clinical and demographic factors, the risk of death (risk ratio [95% CI]) was 1.12 (0.94-1.34) in the CARD-only group, 1.26 (1.15-1.38) in the GM-only group, and 1.48 (1.28-1.72) in the no-GM/CARD group. Cohort-2 results were consistent with cohort 1 for most covariates, and significant survival differences were again found between GM-only and the MIXED group (1.25 [1.14-1.37]).\nIs specialty care associated with improved survival of patients with congestive heart failure?",
        "answer": "yes",
        "answer_rationale": "We found an improved survival associated with cardiologist care and a mixture of general practitioner and cardiologist care compared with general practitioner care. The pattern of outpatient care may therefore be important for the survival of patients with CHF.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether specialty care is associated with improved survival in CHF patients based on the study described.\n\nFirst, I need to understand the study setup. They had two cohorts of patients with CHF, divided into four groups based on their outpatient care patterns: GM-only, CARD-only, MIXED (both general and cardiology), and no visits. The primary outcome is 1-year mortality.\n\nLooking at the results, the unadjusted mortality was highest in the no-GM/CARD group (29%) and lowest in the MIXED group (19%). When adjusted for other factors using Cox models, the risk ratios compared to the MIXED group are:\n\n- CARD-only: 1.12 (not statistically significant since the CI includes 1)\n- GM-only: 1.26 (significant)\n- no-GM/CARD: 1.48 (significant)\n\nThe MIXED group has the lowest mortality, and the GM-only group has a higher risk than MIXED. The CARD-only group's risk is slightly higher but not significant. The second cohort showed similar results, with GM-only still worse than MIXED.\n\nThe question is about specialty care (CARD) association. The CARD-only group's adjusted risk is only 1.12, which isn't significant. However, the MIXED group, which includes cardiology, has better survival. So maybe the combination (specialty plus general) is better. The study might suggest that having cardiology involvement (either alone or mixed) is better than general medicine alone. But the question is phrased as \"specialty care\" which would be the CARD groups. Since the MIXED group includes specialty, and their survival is best, but the CARD-only isn't significantly different from MIXED (since 1.12 is close to 1 and CI includes 1), maybe the key is that having some specialty care (either alone or mixed) is better than none or general only. \n\nThe options are yes, no, maybe. The study shows that MIXED (which includes specialty) has better survival than GM-only. The CARD-only isn't worse than MIXED, but not significantly. Since the question is whether specialty care (as opposed to non-specialty) is associated with improved survival, the answer would be yes because the groups with any cardiology (CARD-only or MIXED) have lower mortality than those without (GM-only and no-GM/CARD). Even though CARD",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 600,
            "completion_tokens": 512
        },
        "time_elapsed": 5.780012130737305
    },
    {
        "realidx": "12630042",
        "question": "The long-term survival of patients with gastric cancer is governed by various factors, such as the clinical stage of the cancer, the patient's nutritional state, and the treatment and may be governed by the volume of intraperitoneal adipose tissue. The aim of this study is to clarify the relationship between the degree of the patients' body mass index and their long-term survival.\nGastric cancer patients who had undergone a gastrectomy with D2-lymphadenectomy and with resection A and B according to the criteria of the Japanese Research Society for Gastric Cancer Rules were subgrouped into those patients with a body mass index<0.185 (the lower body mass index group) and those patients with a body mass index>0.210 (the higher body mass index group). The patient's morbidity and long-term survival rate was retrospectively compared between the 2 groups.\nA significantly longer mean survival rate was observed for the lower body mass index group in stage 2 (1667 vs. 1322 days, P = 0.0240). Also, a significantly longer mean survival rate was observed for the higher BMI group in stage 3a (1431 vs. 943, P = 0.0071).\nDoes body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy?",
        "answer": "maybe",
        "answer_rationale": "The body mass index is one of the prognostic factors of stage 2 and stage 3a gastric cancer. However, it does not appear to be useful for determining the prognosis of stage 1a, 1b, 3b, and 4a gastric cancers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether BMI influences morbidity and long-term survival in gastric cancer patients after gastrectomy. The study mentioned subgrouped patients into lower and higher BMI groups.\n\nLooking at the results: in stage 2, the lower BMI group had longer survival (1667 vs 1322 days, p=0.0240). In stage 3a, the higher BMI group had better survival (1431 vs 943, p=0.0071). So the effect of BMI depends on the cancer stage. The question is whether BMI has an influence. Since there are significant differences in survival based on BMI in different stages, the answer should be yes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 383,
            "completion_tokens": 175
        },
        "time_elapsed": 2.849843740463257
    },
    {
        "realidx": "12632437",
        "question": "To investigate the association between primary systemic vasculitis (PSV) and environmental risk factors.\nSeventy-five PSV cases and 273 controls (220 nonvasculitis, 19 secondary vasculitis, and 34 asthma controls) were interviewed using a structured questionnaire. Factors investigated were social class, occupational and residential history, smoking, pets, allergies, vaccinations, medications, hepatitis, tuberculosis, and farm exposure in the year before symptom onset (index year). The Standard Occupational Classification 2000 and job-exposure matrices were used to assess occupational silica, solvent, and metal exposure. Stepwise multiple logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (95% CI) adjusted for potential confounders. Total PSV, subgroups (47 Wegener's granulomatosis [WG], 12 microscopic polyangiitis, 16 Churg-Strauss syndrome [CSS]), and antineutrophil cytoplasmic antibody (ANCA)-positive cases were compared with control groups.\nFarming in the index year was significantly associated with PSV (OR 2.3 [95% CI 1.2-4.6]), with WG (2.7 [1.2-5.8]), with MPA (6.3 [1.9-21.6]), and with perinuclear ANCA (pANCA) (4.3 [1.5-12.7]). Farming during working lifetime was associated with PSV (2.2 [1.2-3.8]) and with WG (2.7 [1.3-5.7]). Significant associations were found for high occupational silica exposure in the index year (with PSV 3.0 [1.0-8.4], with CSS 5.6 [1.3-23.5], and with ANCA 4.9 [1.3-18.6]), high occupational solvent exposure in the index year (with PSV 3.4 [0.9-12.5], with WG 4.8 [1.2-19.8], and with classic ANCA [cANCA] 3.9 [1.6-9.5]), high occupational solvent exposure during working lifetime (with PSV 2.7 [1.1-6.6], with WG 3.4 [1.3-8.9], and with cANCA 3.3 [1.0-10.8]), drug allergy (with PSV 3.6 [1.8-7.0], with WG 4.0 [1.8-8.7], and with cANCA 4.7 [1.9-11.7]), and allergy overall (with PSV 2.2 [1.2-3.9], with WG 2.7 [1.4-5.7]). No other significant associations were found.\nAre environmental factors important in primary systemic vasculitis?",
        "answer": "yes",
        "answer_rationale": "A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether environmental factors are important in primary systemic vasculitis (PSV) based on the provided study.\n\nFirst, I need to recall what the study found. The study looked at 75 PSV cases and 273 controls, investigating various environmental factors like occupation, farming, silica, solvents, allergies, etc. The results showed several significant associations. \n\nThe key points from the study are:\n- Farming in the index year was associated with PSV (OR 2.3), WG (2.7), MPA (6.3), and pANCA (4.3). \n- Lifetime farming also linked to PSV and WG. \n- High occupational silica exposure in the index year was linked to PSV (OR 3.0), CSS (5.6), and ANCA (4.9). \n- Solvent exposure both in the index year and lifetime showed associations with PSV, WG, and ANCA subtypes. \n- Drug allergy and overall allergies also had significant ORs with PSV and its subtypes.\n\nThe question is whether environmental factors are important. Since the study found multiple significant associations (odds ratios above 1 with confidence intervals not including 1), this suggests that these environmental exposures (like farming, silica, solvents, allergies) do play a role. The options are yes, no, maybe. The correct answer should be \"yes\" because the study's results indicate that these factors are associated with increased odds of PSV. The other options don't fit because the data shows clear associations, so it's not a maybe or no.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 738,
            "completion_tokens": 346
        },
        "time_elapsed": 5.1145851612091064
    },
    {
        "realidx": "12765819",
        "question": "A case of spinal subdural hematoma (SSDH) following subarachnoid hemorrhage (SAH) because of a ruptured internal carotid aneurysm is described. Such a case has never been reported.\nA 52-year-old woman underwent a craniotomy for a ruptured internal carotid aneurysm. A computed tomography scan showed that SAH existed predominantly in the posterior fossa and subdural hematoma beneath the cerebellar tentorium. Intrathecal administration of urokinase, IV administration of fasudil hydrochloride, and continuous cerebrospinal fluid (CSF) evacuation via cisternal drainage were performed as prophylactic treatments for vasospasm. On the sixth postoperative day, the patient complained of severe lower back and buttock pain. Magnetic resonance imaging showed a subdural hematoma in the lumbosacral region. Although the mass effect was extensive, the patient showed no neurologic symptoms other than the sciatica. She was treated conservatively. The hematoma dissolved gradually and had diminished completely 15 weeks later. Her pain gradually subsided, and she was discharged 7 weeks later without any neurologic deficit.\nSpinal subdural hematoma: a sequela of a ruptured intracranial aneurysm?",
        "answer": "yes",
        "answer_rationale": "Although the exact mechanism of SSDH in this case is unclear, we speculate that this SSDH was a hematoma that migrated from the intracranial subdural space. Low CSF pressure because of continuous drainage and intrathecal thrombolytic therapy may have played an important role in the migration of the hematoma through the spinal canal. It is important to recognize the SSDH as a possible complication of the SAH accompanied with intracranial subdural hematoma.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The case is about a patient who had a ruptured internal carotid aneurysm treated with craniotomy. After surgery, she developed a subdural hematoma in the lumbosacral region, which is the spinal subdural hematoma (SSDH). The question is whether this SSDH is a sequela of the ruptured intracranial aneurysm.\n\nFirst, I need to recall what a sequela means. A sequela is a condition that is a consequence of a previous disease or injury. So, the question is asking if the SSDH here is a direct result of the aneurysm rupture and its treatment.\n\nThe case mentions that the patient had SAH (subarachnoid hemorrhage) from the ruptured aneurysm. Then, after surgery, they did some treatments like urokinase, fasudil, and CSF drainage to prevent vasospasm. On day 6, she developed lower back pain, and MRI showed SSDH. The hematoma resolved over time without neurological deficits except the pain.\n\nNow, the key point is whether the SSDH is a result of the SAH or the treatments. The options are yes, no, maybe. The question states that such a case (SSDH following SAH from an aneurysm) has never been reported before. Wait, the first sentence says \"Such a case has never been reported.\" So the scenario presented here is a case that hasn't been reported before. But the options are asking if spinal subdural hematoma is a sequela of the aneurysm rupture. \n\nWait, the question is phrased as \"Spinal subdural hematoma: a sequela of a ruptured intracranial aneurysm?\" The options are whether the answer is yes, no, maybe. The case here is describing a situation where after treating a ruptured aneurysm (which caused SAH), the patient developed SSDH. The fact that this case hasn't been reported before might suggest that it's an unusual occurrence, but the question is whether it can be considered a sequela here. \n\nSequela doesn't have to be common; it just needs to be a consequence. The fact that the SSDH occurred after the aneurysm treatment and the patient had procedures like CSF drainage and medications might be factors. But the question is whether the SSDH is a direct",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 368,
            "completion_tokens": 512
        },
        "time_elapsed": 6.209555387496948
    },
    {
        "realidx": "12769830",
        "question": "Most staging systems for soft tissue sarcoma are based on histologic malignancy-grade, tumor size and tumor depth. These factors are generally dichotomized, size at 5 cm. We believe it is unlikely that tumor depth per se should influence a tumor's metastatic capability. Therefore we hypothesized that the unfavourable prognostic importance of depth could be explained by the close association between size and depth, deep-seated tumors on average being larger than the superficial ones. When tumor size is dichotomized, this effect should be most pronounced in the large size (>5 cm) group in which the size span is larger.\nWe analyzed the associations between tumor size and depth and the prognostic importance of grade, size and depth in a population-based series of 490 adult patients with soft tissue sarcoma of the extremity or trunk wall with complete, 4.5 years minimum, follow-up.\nMultivariate analysis showed no major prognostic effect of tumor depth when grade and size were taken into account. The mean size of small tumors was the same whether superficial or deep but the mean size of large and deep-seated tumors were one third larger than that of large but superficial tumors. Tumor depth influenced the prognosis in the subset of high-grade and large tumors. In this subset deep-seated tumors had poorer survival rate than superficial tumors, which could be explained by the larger mean size of the deep-seated tumors.\nShould tumor depth be included in prognostication of soft tissue sarcoma?",
        "answer": "no",
        "answer_rationale": "Most of the prognostic value of tumor depth in soft tissue sarcomas of the extremity or trunk wall can be explained by the association between tumor size and depth.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether tumor depth should be included in the prognostication of soft tissue sarcoma based on the provided study.\n\nFirst, I need to recall the key points from the study described. The main hypothesis was that the unfavorable prognosis associated with tumor depth might actually be due to the association between size and depth. The study found that when considering grade and size in a multivariate analysis, tumor depth didn't have a major independent prognostic effect. However, in the subset of high-grade and large tumors, depth did influence prognosis, but this was explained by the larger mean size of deep-seated tumors in that group. \n\nSo the study's conclusion seems to suggest that once you account for tumor size (especially when it's over 5 cm) and grade, the depth itself doesn't add much predictive value. The effect seen in deeper tumors is because those tumors tend to be larger, and it's the size that's the real factor here. Therefore, the study's authors probably argue that depth isn't necessary to include if size and grade are already considered. \n\nLooking at the options: the question is whether to include depth. The study's results indicate that when grade and size are accounted for, depth doesn't add significant prognostic value. So the answer would be \"no\" (option B). But wait, the last part mentions that in the high-grade and large tumors, depth did have an effect, but that was because of the size difference. So maybe depth is a proxy for size in those cases. Since the study's multivariate analysis controlled for size, depth's effect was negated. Therefore, including depth might not be necessary because its effect is already captured by tumor size. Hence, the correct answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 370
        },
        "time_elapsed": 4.276539087295532
    },
    {
        "realidx": "12790890",
        "question": "Mesial temporal sclerosis (MTS) is characterized by neuronal loss in the hippocampus. Studies on experimental models and patients with intractable epilepsy suggest that apoptosis may be involved in neuronal death induced by recurrent seizures.\nWe searched evidence for apoptotic cell death in temporal lobes resected from drug-resistant epilepsy patients with MTS by using the terminal deoxynucleotidyl transferase (TdT) and digoxigenin-11-dUTP (TUNEL) method and immunohistochemistry for Bcl-2, Bax, and caspase-cleaved actin fragment, fractin. The temporal lobe specimens were obtained from 15 patients (six women and nine men; mean age, 29 +/- 8 years).\nUnlike that in normal adult brain, we observed Bcl-2 immunoreactivity in some of the remaining neurons dispersed throughout the hippocampus proper as well as in most of the reactive astroglia. Bax immunopositivity was increased in almost all neurons. Fractin immunostaining, an indicator of caspase activity, was detected in approximately 10% of these neurons. Despite increased Bax expression and activation of caspases, we could not find evidence for DNA fragmentation by TUNEL staining. We also could not detect typical apoptotic changes in nuclear morphology by Hoechst-33258 or hematoxylin counterstaining.\nIs the cell death in mesial temporal sclerosis apoptotic?",
        "answer": "maybe",
        "answer_rationale": "These data suggest that either apoptosis is not involved in cell loss in MTS, or a very slow rate of cell demise may have precluded detecting TUNEL-positive neurons dying through apoptosis. Increased Bax expression and activation of caspases support the latter possibility.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the cell death in mesial temporal sclerosis (MTS) is apoptotic based on the provided study.\n\nFirst, I need to recall what the study found. The study used several methods: TUNEL staining for DNA fragmentation, which is a classic marker of apoptosis. They also looked at Bcl-2, Bax, and fractin (a caspase-cleaved actin fragment). \n\nThe key points from the study are:\n- Bcl-2 was present in some neurons and reactive astroglia, which is interesting because Bcl-2 is usually anti-apoptotic. Its presence might suggest some cells are trying to resist apoptosis, but maybe not effective?\n- Bax immunopositivity was increased in almost all neurons. Bax is pro-apoptotic, so increased Bax typically indicates a push towards apoptosis.\n- Fractin, which indicates caspase activity, was present in about 10% of neurons. Caspases are enzymes central to the apoptotic process, so their activation is a strong sign of apoptosis.\n- However, TUNEL staining (which detects DNA fragmentation, a hallmark of apoptosis) didn't show evidence of DNA fragmentation. Also, they didn't see the typical nuclear changes like condensation or fragmentation with Hoechst or hematoxylin staining.\n\nSo, the confusion here is that some markers (Bax, caspase activation via fractin) suggest apoptosis, but the definitive markers (TUNEL, nuclear morphology) didn't show apoptosis. The question is whether this counts as apoptotic cell death.\n\nIn apoptosis, DNA fragmentation is a key step, and TUNEL is a standard method. If TUNEL is negative, that's a problem. The authors couldn't find DNA breaks or the nuclear changes. The presence of caspase activity might indicate that apoptotic pathways are being activated but maybe not completing the process. Alternatively, maybe the cell death is through another mechanism like necrosis or another form of regulated cell death that doesn't involve classic apoptosis.\n\nThe study's conclusion seems to be that despite some apoptotic markers (Bax, caspase), the lack of DNA fragmentation and nuclear changes means they didn't find evidence of apoptosis. So the answer would be \"no\" because the key apoptotic features aren't present. The options are (A) yes, (B) no, (C) maybe. The correct answer here is B.\n</think>",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 512
        },
        "time_elapsed": 5.990623712539673
    },
    {
        "realidx": "12805495",
        "question": "Warfarin increases both the likelihood and the mortality of intracerebral hemorrhage (ICH), particularly in patients with a history of prior ICH. In light of this consideration, should a patient with both a history of ICH and a clear indication for anticoagulation such as nonvalvular atrial fibrillation be anticoagulated? In the absence of data from a clinical trial, we used a decision-analysis model to compare the expected values of 2 treatment strategies-warfarin and no anticoagulation-for such patients.\nWe used a Markov state transition decision model stratified by location of hemorrhage (lobar or deep hemispheric). Effectiveness was measured in quality-adjusted life years (QALYs). Data sources included English language literature identified through MEDLINE searches and bibliographies from selected articles, along with empirical data from our own institution. The base case focused on a 69-year-old man with a history of ICH and newly diagnosed nonvalvular atrial fibrillation.\nFor patients with prior lobar ICH, withholding anticoagulation therapy was strongly preferred, improving quality-adjusted life expectancy by 1.9 QALYs. For patients with prior deep hemispheric ICH, withholding anticoagulation resulted in a smaller gain of 0.3 QALYs. In sensitivity analyses for patients with deep ICH, anticoagulation could be preferred if the risk of thromboembolic stroke is particularly high.\nCan patients be anticoagulated after intracerebral hemorrhage?",
        "answer": "maybe",
        "answer_rationale": "Survivors of lobar ICH with atrial fibrillation should not be offered long-term anticoagulation. Similarly, most patients with deep hemispheric ICH and atrial fibrillation should not receive anticoagulant therapy. However, patients with deep hemispheric ICH at particularly high risk for thromboembolic stroke or low risk of ICH recurrence might benefit from long-term anticoagulation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether patients can be anticoagulated after having an intracerebral hemorrhage (ICH). The options are yes, no, or maybe.\n\nFirst, I need to recall the information provided in the question. The study mentioned uses a decision-analysis model comparing warfarin and no anticoagulation in patients with a history of ICH and atrial fibrillation. The key points are that warfarin increases the risk and mortality of ICH, especially in those with prior ICH. \n\nThe results from the model show that for patients with prior lobar ICH, not using anticoagulation was better, giving a significant QALY gain. For deep hemispheric ICH, the gain was smaller (0.3 QALYs). However, in sensitivity analyses, if the risk of thromboembolic stroke is very high, anticoagulation might be preferred even in deep ICH cases.\n\nSo the answer depends on the type of ICH. Lobar ICH clearly suggests avoiding anticoagulation. But deep ICH might have a scenario where it's considered if the stroke risk is high. Since the options are yes, no, maybe, the correct answer would be \"maybe\" because it's not an absolute no, but depends on factors like the location of the hemorrhage and the individual's thromboembolic risk. The study's conclusion isn't a blanket recommendation but conditional based on these factors. Therefore, the answer is C) maybe.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 411,
            "completion_tokens": 320
        },
        "time_elapsed": 3.747262477874756
    },
    {
        "realidx": "12846929",
        "question": "As part of a prospective study on quality of life in newly diagnosed lung cancer patients an investigation was carried out to examine whether there were differences among patients' quality of life scores and their socioeconomic status.\nQuality of life was measured at two points in time (baseline and three months after initial treatment) using three standard instruments; the Nottingham Health Profile (NHP), the European Organization for Research and Cancer Treatment Quality of Life Questionnaire (EORTC QLQ-C30) and its lung cancer supplement (QLQ-LC13). Socioeconomic status for each individual patient was derived using Carstairs and Morris Deprivation Category ranging from 1 (least deprived) to 7 (most deprived) on the basis of the postcode sector of their address.\nIn all, 129 lung cancer patients entered into the study. Of these data for 82 patients were complete (at baseline and follow-up). 57% of patients were of lower socioeconomic status and they had more health problems, less functioning, and more symptoms as compared to affluent patients. Of these, physical mobility (P = 0.05), energy (P = 0.01), role functioning (P = 0.04), physical functioning (P = 0.03), and breathlessness (P = 0.02) were significant at baseline. However, at follow-up assessment there was no significant difference between patient groups nor did any consistent pattern emerge.\nQuality of life in lung cancer patients: does socioeconomic status matter?",
        "answer": "yes",
        "answer_rationale": "At baseline assessment patients of lower socioeconomic status showed lower health related quality of life. Since there was no clear trend at follow-up assessment this suggests that patients from different socioeconomic status responded to treatment similarly. In general, the findings suggest that quality of life is not only the outcome of the disease and its treatment, but is also highly dependent on each patients' socioeconomic characteristics.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether socioeconomic status (SES) affects the quality of life (QoL) in newly diagnosed lung cancer patients. They measured QoL at baseline and three months later using three different questionnaires. SES was categorized using the Carstairs and Morris Deprivation Index from 1 to 7, with 7 being the most deprived.\n\nOut of 129 patients, 82 had complete data. 57% were lower SES. At baseline, lower SES patients had worse scores in several areas like physical mobility, energy, role functioning, physical functioning, and breathlessness, with p-values all below 0.05, which is statistically significant. But at the follow-up three months later, there were no significant differences between the groups, and no consistent pattern emerged.\n\nThe question is asking if socioeconomic status matters regarding QoL in these patients. The options are yes, no, or maybe. \n\nHmm, so the key here is to interpret the results. At baseline, there were significant differences, meaning lower SES had worse QoL. But by follow-up, those differences weren't there anymore. The study's conclusion would probably say that while SES does matter initially, maybe the treatment or other factors over time negate that difference. But the question is phrased as \"does socioeconomic status matter?\" without specifying time. \n\nThe study shows that at the start, SES did have an impact, but later it didn't. However, the question is general. Since there was a significant effect at baseline, the answer might be \"yes\" because SES did matter at the initial stage. But the follow-up not showing differences could complicate that. The options are yes, no, maybe. The study's results indicate that SES was a factor initially, so the answer is probably yes. The fact that it didn't matter later might mean that over time it's not as important, but the question is whether it matters at all. Since there was a significant effect at baseline, the answer should be yes. Alternatively, if the question is about long-term, maybe the answer is no. But the question is general. The study's title is \"does socioeconomic status matter?\" and the results show that it did matter at baseline. So the answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 402,
            "completion_tokens": 478
        },
        "time_elapsed": 5.94774317741394
    },
    {
        "realidx": "12848629",
        "question": "Tuberculosis has increased in parallel with the acquired immunodeficiency syndrome epidemic and the use of immunosuppressive therapy, and the growing incidence of extra-pulmonary tuberculosis, especially with intestinal involvement, reflects this trend. However, the duration of anti-tuberculous therapy has not been clarified in intestinal tuberculosis.AIM: To compare the efficacy of different treatment durations in tuberculous enterocolitis in terms of response and recurrence rates.\nForty patients with tuberculous enterocolitis were randomized prospectively: 22 patients into a 9-month and 18 into a 15-month group. Diagnosis was made either by colonoscopic findings of discrete ulcers and histopathological findings of caseating granuloma and/or acid-fast bacilli, or by clinical improvement after therapeutic trial. Patients were followed up with colonoscopy every other month until complete response or treatment completion, and then every 6 months for 1 year and annually. Complete response was defined as a resolution of symptoms and active tuberculosis by colonoscopy.\nComplete response was obtained in all patients in both groups. Two patients in the 9-month group and one in the 15-month group underwent operation due to intestinal obstruction and perianal fistula, respectively. No recurrence of active intestinal tuberculosis occurred during the follow-up period in either group.\nIs a 9-month treatment sufficient in tuberculous enterocolitis?",
        "answer": "yes",
        "answer_rationale": "Tuberculous enterocolitis can be managed by 9-month chemotherapy without disease recurrence. Further investigations are needed in immunocompromised patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether a 9-month treatment is sufficient for tuberculous enterocolitis based on the study provided.\n\nFirst, I need to recall the details from the study described. The study randomized 40 patients into two groups: 22 received 9 months of treatment, and 18 got 15 months. The main outcomes were complete response and recurrence rates. \n\nThe key points from the results: Both groups had 100% complete response. That's interesting. The 9-month group had two patients who needed surgery for intestinal obstruction and perianal fistula, while the 15-month group had one. However, no recurrences were noted in either group during follow-up. \n\nThe question is whether 9 months is sufficient. The options are yes, no, or maybe. The study shows that the 9-month group achieved the same complete response rate as the longer treatment. Since recurrence didn't happen in either group, the shorter duration might be enough. But wait, the two surgeries in the 9-month group\u2014does that affect the answer? The question specifically asks about efficacy in terms of response and recurrence. Since both groups had no recurrences and full response, the 9 months seems sufficient. The surgeries might be due to complications but not failure of the treatment itself. So the answer would be A) yes. But I need to make sure I'm not missing something. The study's aim was to compare efficacy based on response and recurrence. Since both groups did equally well in those aspects, the 9-month duration is sufficient. The surgeries might be complications that aren't directly related to the treatment duration's effectiveness against TB. Therefore, the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 376,
            "completion_tokens": 363
        },
        "time_elapsed": 4.269659757614136
    },
    {
        "realidx": "12913878",
        "question": "Nd:YAG laser-induced thermo therapy (LITT) of rat brains is associated with blood-brain barrier (BBB) permeability changes. We address the question of whether LITT-induced locoregional disruption of the BBB could possibly allow a locoregional passage of chemotherapeutic agents into brain tissue to treat malignant glioma.STUDY DESIGN/\nCD Fischer rats were subject to LITT of the left forebrain. Disruption of the BBB was analyzed using Evans blue and immunohistochemistry (IH). Animals were perfused with paclitaxel, and high-pressure liquid chromatography (HPLC) was employed to analyze the content of paclitaxel in brain and plasma samples.\nLITT induces an opening of the BBB as demonstrated by locoregional extravasation of Evans blue, C3C, fibrinogen, and IgM. HPLC proved the passage of paclitaxel across the disrupted BBB.\nLocoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?",
        "answer": "yes",
        "answer_rationale": "LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about using LITT (Nd:YAG laser-induced thermo therapy) on rat brains to see if it can open the blood-brain barrier (BBB) locally, allowing chemotherapeutic agents like paclitaxel to enter the brain to treat glioma.\n\nFirst, the study design: They used rats, applied LITT to the left forebrain. They checked BBB disruption with Evans blue, which is a dye that doesn't normally cross the BBB. If it's found in the brain tissue, that means the BBB is compromised. They also used immunohistochemistry for C3C, fibrinogen, and IgM, which are other markers indicating BBB leakage. \n\nThen, they perfused the animals with paclitaxel and used HPLC to measure how much got into the brain versus the plasma. The results showed that LITT did cause BBB opening, as Evans blue and those other markers leaked. HPLC confirmed that paclitaxel passed into the brain where the BBB was disrupted.\n\nThe question is whether this method is a new concept for adjuvant glioma therapy. The options are yes, no, maybe. \n\nThe study's results support that LITT opens the BBB locally, allowing paclitaxel to pass into the brain. Since the goal is to treat malignant glioma, which is a brain tumor, getting chemo drugs past the BBB is a big deal because the BBB normally blocks most drugs. So if LITT can create a local opening, that could let more chemo into the tumor area. The study's findings seem to confirm that this is possible in rats. \n\nThe options are (A) yes, (B) no, (C) maybe. The study's results are positive, so the answer should be yes. The question is asking if this is a new concept, and since the study shows it works in their model, the answer would be A. Unless there's a reason to doubt applicability to humans or other factors, but the question is based on the study's results. The study's conclusion supports the concept, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 328,
            "completion_tokens": 449
        },
        "time_elapsed": 5.561213493347168
    },
    {
        "realidx": "12963175",
        "question": "It was the aim of the present study to elaborate criteria for the assessment of rapid hemodynamic progression of valvar aortic stenosis. These criteria are of special importance when cardiac surgery is indicated for other reasons but the established criteria for aortic valve replacement are not yet fulfilled. Such aspects of therapeutic planing were mostly disregarded in the past so that patients had to undergo cardiac reoperation within a few years.\nHemodynamic, echocardiographic, and clinical data of 169 men and 88 women with aortic stenosis, aged 55.2 +/- 15.7 years at their first and 63.4 +/- 15.6 years at their second cardiac catheterization, were analyzed.\nThe progression rate of aortic valve obstruction was found to be dependent on the degree of valvar calcification ([VC] scoring 0 to III) and to be exponentially correlated with the aortic valve opening area (AVA) at initial catheterization. Neither age nor sex of the patient nor etiology of the valvar obstruction significantly influence the progression of aortic stenosis. If AVA decreases below 0.75 cm(2) with a present degree of VC = 0, or AVA of 0.8 with VC of I, AVA of 0.9 with VC of II, or AVA of 1.0 with VC of III, it is probable that aortic stenosis will have to be operated upon in the following years.\nCan progression of valvar aortic stenosis be predicted accurately?",
        "answer": "yes",
        "answer_rationale": "The present data indicate that for clinical purposes and planning of valvar surgery the progression of asymptomatic aortic stenosis can be sufficiently predicted by the present aortic valve opening area and the degree of valvar calcification.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the progression of valvar aortic stenosis can be predicted accurately based on the study described.\n\nFirst, I need to look at the information provided in the passage. The study aimed to develop criteria for assessing rapid hemodynamic progression of aortic stenosis. The key points from the study are that the progression rate depends on the degree of valvar calcification (VC) and is exponentially correlated with the aortic valve opening area (AVA) at the initial catheterization. They also mention that age, sex, and etiology don't significantly influence progression. The criteria given are specific AVA thresholds based on VC scores (like AVA below 0.75 cm\u00b2 with VC 0, etc.) indicating probable need for surgery in the following years.\n\nThe question is whether progression can be predicted accurately. The options are yes, no, maybe. \n\nThe study's findings suggest that by using VC scoring and AVA measurements, they can predict when the stenosis will progress to the point where surgery is needed. Since they've established specific thresholds that correlate with the need for surgery, this implies that their criteria allow for accurate prediction. The fact that they mention these specific numbers (like 0.75 cm\u00b2 with VC 0) indicates that there's a clear method here. The study's purpose was to create these criteria, so the answer should be that yes, it can be predicted accurately based on these factors. The answer options are A, B, C. So the correct answer is A (yes).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 417,
            "completion_tokens": 329
        },
        "time_elapsed": 4.07100248336792
    },
    {
        "realidx": "12970636",
        "question": "To examine the impact of early discharge on newborn metabolic screening.\nMetabolic screening results were obtained from the Alabama State Lab for all infants born at our hospital between 8/1/97, and 1/31/99, and were matched with an existing database of early discharge infants. An early newborn discharge was defined as a discharge between 24 and 47 hours of age. Metabolic screening tests included phenylketonuria (PKU), hypothyroidism, and congenital adrenal hyperplasia (CAH). Early discharge and traditional stay infants were compared to determine the percentage of newborns screened and the timing of the first adequate specimen.\nThe state laboratory received specimens from 3860 infants; 1324 were on early discharge newborns and 2536 infants in the traditional stay group. At least one filter paper test (PKU, hypothyroidism, and CAH) was collected on 99.2% of early discharge infants and 96.0% of traditional stay infants (P<.0001). Early discharge infants had a higher rate of initial filter paper specimens being inadequate (22.9%) compared with traditional stay infants (14.3%, P<.0001) but had a higher rate of repeat specimens when the initial specimen was inadequate (85.0% early discharge vs 75.3% traditional stay, P=.002). The early discharge group was more likely to have an adequate specimen within the first 9 days of life (1001, 98.8% early discharge vs 2016, 96.7% traditional stay, P=.0005).\nDoes early discharge with nurse home visits affect adequacy of newborn metabolic screening?",
        "answer": "no",
        "answer_rationale": "In this well established early discharge program with nurse home visits, newborn metabolic screening is not compromised by early discharge.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether early discharge with nurse home visits affects the adequacy of newborn metabolic screening. The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided in the study. The study compared early discharge infants (24-47 hours) with traditional stay infants. The key points are:\n\n1. Screening rates: 99.2% of early discharge vs 96.0% traditional. So higher in early discharge.\n2. Initial inadequate specimens: 22.9% early vs 14.3% traditional. So more initial issues here.\n3. But when the first was inadequate, early discharge had a higher rate of getting a repeat (85% vs 75.3%). \n4. Ultimately, the early group had a higher percentage with adequate specimen within first 9 days (98.8% vs 96.7%, p=0.0005).\n\nThe question is about the effect of early discharge with nurse home visits. The study's results show that despite more initial inadequate samples, the early discharge group ended up with a higher rate of adequate specimens in the first 9 days. The higher repeat rate might be due to the nurse home visits ensuring that even if the first sample was bad, they followed up. \n\nThe answer would be \"yes\" because the study shows that early discharge (with the implied home visits) resulted in a higher adequacy rate overall. The P-values are significant, so the difference isn't by chance. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 335
        },
        "time_elapsed": 4.0194971561431885
    },
    {
        "realidx": "14551704",
        "question": "Communication with terminally ill patients is a main responsibility of physicians. However, many physicians feel insufficiently prepared for this task. Models of courses resulting in improvements of communicative skills of participants have been published mainly in the Anglo-American literature. This study describes the realization of a 2-day course model based on the experiences of the first three courses of this kind in Rhineland-Palatinate, and analyzes changes of participants' communication behavior.\nAfter each seminary, an evaluation form concerning participants' satisfaction with the course was filled in. Furthermore, all course participants received a questionnaire at the beginning and at the end of the course, as well as 3 months afterwards. The participants were asked to assess their own sense of security in seven different communication settings on a visual analog scale, and to specify perceived changes in their communication behavior 3 months after the course.\nThe first three courses were attended by 31 participants. Course evaluation revealed high satisfaction scores with methods as well as with clarity and relevance of the contents. Self-assessment of participants showed a growing sense of security in different communication settings. Important increases could be demonstrated for communicating a diagnosis of cancer with good or less good prognosis, recurrence of cancer or a far progressive cancer disease without curative approach. 3 months after the course, participants described multiple changes indicating increased sensibility and professionalism in communication behavior.\nCan communication with terminally ill patients be taught?",
        "answer": "yes",
        "answer_rationale": "The realized communication skills courses resulted in relevant changes in communication behaviour and self-confidence of participants. Communication with terminally ill patients can be taught.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether communication with terminally ill patients can be taught, based on the provided study.\n\nFirst, I need to understand the study's findings. The study describes a 2-day course model aimed at improving physicians' communication skills. They had three courses with 31 participants. The evaluation showed high satisfaction with the course methods and content. Participants also self-assessed their sense of security in various communication settings, which increased, especially in critical scenarios like delivering a cancer diagnosis. Additionally, three months later, participants reported changes showing more sensitivity and professionalism.\n\nThe key here is whether the course led to measurable improvements. The results indicate that after the course, participants felt more secure and changed their behavior positively. The question is whether this means communication can be taught. Since the study shows improvements in skills through the course, the answer would be yes. The options are A, B, C. The study's results support that the course was effective, so the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 374,
            "completion_tokens": 212
        },
        "time_elapsed": 3.2128121852874756
    },
    {
        "realidx": "14599616",
        "question": "Lymphedema may be identified by simpler circumference changes as compared with changes in limb volume.\nNinety breast cancer patients were prospectively enrolled in an academic trial, and seven upper extremity circumferences were measured quarterly for 3 years. A 10% volume increase or greater than 1 cm increase in arm circumference identified lymphedema with verification by a lymphedema specialist. Sensitivity and specificity of several different criteria for detecting lymphedema were compared using the academic trial as the standard.\nThirty-nine cases of lymphedema were identified by the academic trial. Using a 10% increase in circumference at two sites as the criterion, half the lymphedema cases were detected (sensitivity 37%). When using a 10% increase in circumference at any site, 74.4% of cases were detected (sensitivity 49%). Detection by a 5% increase in circumference at any site was 91% sensitive.\nCan a practicing surgeon detect early lymphedema reliably?",
        "answer": "maybe",
        "answer_rationale": "An increase of 5% in circumference measurements identified the most potential lymphedema cases compared with an academic trial.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a practicing surgeon can reliably detect early lymphedema based on the study described.\n\nFirst, I need to understand the study's findings. The study enrolled 99 breast cancer patients and measured their arm circumferences quarterly for three years. They used two main criteria to identify lymphedema: a 10% volume increase or a 1 cm or more increase in arm circumference. The gold standard here is the academic trial's identification of 39 cases.\n\nThe key data points are the sensitivity values for different criteria. Sensitivity refers to the test's ability to correctly identify those with the condition. \n\nWhen using a 10% increase in circumference at two sites, the sensitivity was 37%, meaning only 37% of actual cases were detected. That's pretty low. Then, using a 10% increase at any site, the sensitivity went up to 74.4%, which is better but still leaves about a quarter of cases undetected. The best sensitivity was 91% when using a 5% increase at any site. \n\nThe question is whether a surgeon can reliably detect early lymphedema. The options are yes, no, maybe. \n\nNow, considering the criteria. The 5% threshold has higher sensitivity, but the problem is that the study's standard is the academic trial, which might involve more comprehensive assessments by specialists. The surgeon might rely on simpler measurements like circumference changes. However, even with the 5% cutoff, there's still a 9% chance of missing cases. But the question is about reliability. \n\nThe options are tricky. The study shows that using a 5% increase at any site gives 91% sensitivity, which is high. But the question is about the surgeon's ability. The study's results suggest that using the 5% cutoff would detect most cases, but maybe in practice, other factors come into play. The options don't mention the 5% being the standard here. Wait, the question says \"Can a practicing surgeon detect early lymphedema reliably?\" based on the given data. \n\nThe study's results show that with the 5% increase at any site, sensitivity is 91%, which is quite high. However, the options might be considering the lower sensitivities when using higher thresholds (like 10% at two sites or even 10% at any site). The problem is that the surgeon might not be",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 299,
            "completion_tokens": 512
        },
        "time_elapsed": 6.1142942905426025
    },
    {
        "realidx": "14627582",
        "question": "The purpose of our study was to determine the effectiveness, clinical impact, and feasibility of double reading barium enemas.\nIndependent double readings of 1,003 consecutive barium enemas (822 double- and 181 single-contrast examinations) were prospectively performed. From this pool of 1,003 examinations, 994 were included in our study. Examinations showing at least one polyp or carcinoma 5 mm or larger were considered to have positive results. For combined readings, results were considered positive if either of the two interpreters reported finding a polyp or carcinoma. A McNemar test was used to compare the first reader's results with the combined results of the first and second readers. Results were retrospectively correlated with endoscopic or surgical results in 360 patients, and agreement between first and combined readings and endoscopic results was determined.\nAdding a second reader increased the number of positive results on examinations from 249 to 315 (p<0.0001) and resulted in potential alteration of clinical treatment in 98 patients (9.9%). Sensitivity of the first and combined readings for detection of all lesions was identical, 76.3% (95% CI, 65.4-87.1%). Specificity decreased from 91.0% (95% CI, 87.9-94.3%) for the first reading to 86.4% (95% CI, 82.2-90.0%) for the combined reading. The overall measurement of agreement decreased from a kappa value of 61.8 (95% CI, 51.2-72.4%) for the first reading to 52.9 (95% CI, 42.2-63.6%) for the combined reading. The second reading required an average of 3.3 min. Sensitivity for the detection of adenocarcinomas was 100%.\nDouble reading of barium enemas: is it necessary?",
        "answer": "no",
        "answer_rationale": "Although feasible, double reading of barium enemas does not improve sensitivity for detection of polyps and produces a higher false-positive rate.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether double reading barium enemas is necessary. The options are yes, no, or maybe. \n\nFirst, I need to look at the results provided. The key points are:\n\n- Adding a second reader increased positive results from 249 to 315, which is a significant increase (p<0.0001). That means more lesions were detected when two readers were used. \n\n- The clinical impact was that 98 patients (9.9%) might have had their treatment altered. That's a notable number, suggesting that double reading can lead to better patient outcomes by catching more issues.\n\n- Sensitivity for detecting all lesions was the same (76.3%) between the first reader and combined readings. Wait, that's interesting. If sensitivity is the same, maybe the second reader didn't miss anything the first one caught? Or perhaps the combined reading found the same number of true positives but with more false positives?\n\n- Specificity decreased from 91% to 86.4% when using combined readings. Lower specificity means more false positives. So while they found more actual positives (since sensitivity stayed the same?), they also had more false alarms. But the question is about necessity. \n\n- The kappa agreement (which measures inter-rater reliability) decreased from 61.8 to 52.9. Lower agreement between the first and combined readings might indicate that the second reader found different things, but since the sensitivity is the same, maybe they found the same true positives but added some false ones.\n\n- The time taken was only 3.3 minutes extra per exam. That's not too bad in terms of feasibility.\n\n- Importantly, the sensitivity for adenocarcinomas was 100% with combined readings. That's a critical point because catching cancers is vital. \n\nSo, even though specificity went down and there's a slight decrease in agreement, the increase in positive findings leading to altered treatment in nearly 10% of cases and 100% sensitivity for cancers suggests that double reading is beneficial. The main goal is to detect lesions, especially cancers, which the second reader helps with. The trade-off of lower specificity might be acceptable if missing a lesion is worse than a false positive leading to further tests. \n\nThe question is whether it's necessary. The study shows that double reading increases detection without missing cancers and only adds a few minutes. The clinical impact is significant",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 533,
            "completion_tokens": 512
        },
        "time_elapsed": 5.733741998672485
    },
    {
        "realidx": "14631523",
        "question": "The objectives were to identify prognostic factors for the survival of children with cerebellar astrocytoma, and to evaluate the reproducibility and prognostic value of histological sub-classification and grading.\nChildren aged 0-14 years treated in Denmark for a cerebellar astrocytoma in the period 1960-1984 were included and followed until January 2001 or until their death. The histological specimens from each patient were reviewed for revised grading and classification according to three different classification schemes: the WHO, the Kernohan and the Daumas-Duport grading systems.\nThe overall survival rate was 81% after a follow-up time of 15-40 years. The significant positive prognostic factors for survival were \"surgically gross-total removal\" of the tumour at surgery and location of the tumour in the cerebellum proper as opposed to location in the fourth ventricle. No difference in survival time was demonstrated when we compared pilocytic astrocytoma and fibrillary astrocytoma. Moreover, we found that the Kernohan and the WHO classification systems had no predictive value and that the Daumas-Duport system is unsuitable as a prognostic tool for low-grade posterior fossa astrocytomas.\nSub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful?",
        "answer": "no",
        "answer_rationale": "Discordant observations due to interobserver variability make histological sub-classification of low-grade cerebellar astrocytomas in children insufficient for predicting prognosis and biological behaviour. Similar survival rates in a population of paediatric low-grade cerebellar astrocytomas of grades I and II indicate that tumour grade has no prognostic significance within this group of patients. \"Surgically gross-total removal\", especially if the tumour is located in the fourth ventricle is of the highest importance for long-term survival. Histological sub-classification of the tumours has no predictive value.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether sub-classification of low-grade cerebellar astrocytoma is clinically meaningful based on the provided study.\n\nFirst, I need to recall the details from the study described. The main points are that they looked at children with cerebellar astrocytoma treated between 1960-1984 in Denmark. The key findings were that overall survival was 81% after a long follow-up. The significant prognostic factors were total surgical removal and tumor location (cerebellum vs. fourth ventricle). \n\nImportantly, the study compared different classification systems: WHO, Kernohan, and Daumas-Duport. The results stated that there was no difference in survival between pilocytic and fibrillary astrocytomas. Also, the Kernohan and WHO systems didn't have predictive value, and the Daumas-Duport system was unsuitable for low-grade posterior fossa tumors. \n\nThe question is whether sub-classification (like the different grades or types under these systems) is clinically meaningful. Since the study found that these classifications didn't add predictive value and the systems weren't useful for prognosis, the answer would lean towards \"no\". The study's conclusion suggests that sub-classification doesn't help in predicting survival, so it's not meaningful in that clinical context. The options are A (yes), B (no), C (maybe). The correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 381,
            "completion_tokens": 307
        },
        "time_elapsed": 4.045670032501221
    },
    {
        "realidx": "14652839",
        "question": "Embolisation of atherosclerotic debris during abdominal aortic aneurysm (AAA) repair is responsible for significant peri-operative morbidity. Reports have suggested that preferential clamping of the distal vessel(s) before the proximal aorta may decrease the number of emboli passing distally and hence reduce complications.\nForty patients undergoing AAA repair were randomised to have either first clamping of the proximal aorta or the iliac vessels. Emboli passing through the Superficial Femoral Arteries were detected with a Transcranial Doppler ultrasound system.\nThere was no difference between the two groups in the number of emboli detected (p=0.49) and no significant correlation between number of emboli and dissection time (r=0.0008). However, there was a significantly higher number of emboli in the patient sub-group that were current smokers (p=0.034).\nDoes the sequence of clamp application during open abdominal aortic aneurysm surgery influence distal embolisation?",
        "answer": "no",
        "answer_rationale": "There appears to be no difference in the numbers of emboli detected when the first vascular clamp is applied to the proximal aorta or iliacs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the sequence of clamp application during AAA surgery affects distal embolisation. The study mentioned randomized 40 patients into two groups: one where they clamped the proximal aorta first and the other the iliac vessels first. They used TCD to detect emboli in the superficial femoral arteries.\n\nThe results showed no difference in the number of emboli between the two groups (p=0.49). A p-value of 0.49 is way above the typical 0.05 threshold, meaning there's no statistically significant difference. Also, the correlation between emboli and dissection time was almost zero (r=0.0008), so time didn't matter. However, smokers had more emboli, but that's a different factor.\n\nThe question is specifically about the clamp sequence. Since the study found no significant difference between the two clamping orders, the answer should be \"no\". The options are A (yes), B (no), C (maybe). The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 308,
            "completion_tokens": 229
        },
        "time_elapsed": 3.544049024581909
    },
    {
        "realidx": "14692023",
        "question": "Despite advances in therapies for breast cancer, improvement in survival for patients with recurrent or metastatic breast cancer has been difficult to establish. The objective of the current study was to determine whether the survival of women with recurrent breast cancer has improved from 1974 to 2000.\nThe authors analyzed the survival experience of 834 women who developed recurrent breast cancer between November 1974 and December 2000. All patients had been treated previously with adjuvant anthracycline-based protocols. Patients were divided into five consecutive groups based on year of breast cancer recurrence, and survival was compared across the five groups. Because some prognostic variables were divided unevenly divided among the cohorts, a multivariate model was created to determine the association of year of recurrence and survival after accounting for other prognostic factors.\nIn the unadjusted analysis, there was a statistically significant improvement in survival across the five groups, and the more recent cohorts had longer survival (P<0.001). Other variables that predicted longer survival after breast cancer recurrence included smaller initial tumor size, lower stage of disease, fewer lymph nodes involved, longer disease-free interval, estrogen receptor-positive tumors, and nonvisceral dominant site of disease recurrence. In the multivariate analysis, which adjusted for these prognostic factors, year of recurrence was associated with a trend toward improved survival, with a 1% reduction in risk for each increasing year.\nIs breast cancer survival improving?",
        "answer": "yes",
        "answer_rationale": "For these cohorts of patients, the authors present data suggesting that the prognosis for patients with recurrent breast cancer improved between 1974 and 2000.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether breast cancer survival is improving based on the study described. The question is straightforward, but I need to make sure I understand the study's findings correctly.\n\nFirst, the study looked at women with recurrent breast cancer between 1974 and 2000. They were divided into five groups based on when their cancer recurred. The unadjusted analysis showed a significant improvement in survival over time, with more recent groups having longer survival (P<0.001). That's a strong statistical significance, so that's a big point.\n\nBut then there's the multivariate analysis. The question here is whether the improvement is still there after adjusting for other factors. The study mentions that other variables like tumor size, stage, lymph nodes, disease-free interval, estrogen receptor status, and recurrence site were also predictors. The multivariate analysis adjusted for these, and even then, there was a trend toward improved survival with each passing year\u2014a 1% reduction in risk per year. \n\nSo even after accounting for those other factors, there's still a trend. The key here is that the question is whether survival is improving. The unadjusted analysis clearly shows improvement, and the adjusted one still shows a trend. The options are yes, no, maybe. The answer should be yes because both analyses support improvement, even if the multivariate was a trend. The question is whether the answer is yes because the trend is still there. The study's objective was to see if survival improved, and the results, even adjusted, suggest that. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 392,
            "completion_tokens": 336
        },
        "time_elapsed": 7.324463844299316
    },
    {
        "realidx": "14697414",
        "question": "To analyze, retrospectively, the patterns and behavior of metastatic lesions in prostate cancer patients treated with external beam radiotherapy and to investigate whether patients with<or =5 lesions had an improved outcome relative to patients with>5 lesions.\nThe treatment and outcome of 369 eligible patients with Stage T1-T3aN0-NXM0 prostate cancer were analyzed during a minimal 10-year follow-up period. All patients were treated with curative intent to a mean dose of 65 Gy. The full history of any metastatic disease was documented for each subject, including the initial site of involvement, any progression over time, and patient survival.\nThe overall survival rate for the 369 patients was 75% at 5 years and 45% at 10 years. The overall survival rate of patients who never developed metastases was 90% and 81% at 5 and 10 years, respectively. However, among the 74 patients (20%) who developed metastases, the survival rate at both 5 and 10 years was significantly reduced (p<0.0001). The overall survival rate for patients who developed bone metastases was 58% and 27% at 5 and 10 years, respectively, and patients with bone metastases to the pelvis fared worse compared with those with vertebral metastases. With regard to the metastatic number, patients with<or =5 metastatic lesions had superior survival rates relative to those with>5 lesions (73% and 36% at 5 and 10 years vs. 45% and 18% at 5 and 10 years, respectively; p = 0.02). In addition, both the metastasis-free survival rate and the interval measured from the date of the initial diagnosis of prostate cancer to the development of bone metastasis were statistically superior for patients with<or =5 lesions compared with patients with>5 lesions (p = 0.01 and 0.02, respectively). However, the survival rate and the interval from the date of diagnosis of bone metastasis to the time of death for patients in both groups were not significantly different, statistically (p = 0.17 and 0.27, respectively).\nIs there a favorable subset of patients with prostate cancer who develop oligometastases?",
        "answer": "yes",
        "answer_rationale": "Patients with<or =5 metastatic sites had significantly better survival rates than patients with>5 lesions. Because existing sites of metastatic disease may be the primary sites of origin for additional metastases, our findings suggest that early detection and aggressive treatment of patients with a small number of metastatic lesions is worth testing as an approach to improving long-term survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a favorable subset of prostate cancer patients who develop oligometastases based on the provided study.\n\nFirst, I need to recall what oligometastases mean. Oligometastases refer to a small number of metastatic lesions, often considered as five or fewer. The study mentions that patients with \u22645 metastatic lesions had better survival rates compared to those with >5. Specifically, their 5-year survival was 73% vs. 45%, and 10-year was 36% vs. 18%. The p-values here are significant (p=0.02), which suggests the difference isn't by chance. \n\nThe question is whether this group (\u22645 lesions) constitutes a favorable subset. The study's results show that these patients do have improved outcomes in overall survival and metastasis-free survival. The answer options are yes, no, or maybe. Since the data clearly indicates better survival for those with \u22645 lesions, the answer should be yes. The other parts about the interval from diagnosis to metastasis and survival after metastasis diagnosis not being different might be distractors, but the key point is the improved survival before that. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 590,
            "completion_tokens": 266
        },
        "time_elapsed": 3.2722957134246826
    },
    {
        "realidx": "14872327",
        "question": "To study the prevalence of pain and risk factors for pain in psychiatric patients in a psychiatric hospital.\nUsing a questionnaire we investigated in a cross-sectional study the prevalence of pain, duration of pain, impairment and unfitness for work due to pain in 106 patients primarily diagnosed with a psychiatric disorder in the field of general adult psychiatry. Potential risk factors were explored.\nThe point prevalence of pain was about 50%, the 6-month prevalence 75.5% and the 12-month prevalence 76.5%. The patients' most frequent complaints were low back pain, headache and shoulder and neck pain. Patients with affective disorders most frequently had pain complaints, followed by those with neurotic, stress-related and somatoform disorders and those with psychotic disorders such as schizophrenia, schizotypic and delusional disorders. Almost 10% of all patients reported pain continuing at least 3 months in the past year. Impairment and unfitness for work were related to specific psychiatric diagnosis. Statistically significant risk factors for pain were depression (OR=6.05) and the number of past admissions to psychiatric hospitals (OR=3.609).\nIs pain a clinically relevant problem in general adult psychiatry?",
        "answer": "yes",
        "answer_rationale": "We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pain is a clinically relevant problem in general adult psychiatry based on the study provided.\n\nFirst, I need to recall what the study found. The prevalence rates are pretty high: 50% point prevalence, over 75% at six and twelve months. That's a lot. The most common types of pain mentioned are back, head, and neck/shoulder pain. Also, specific psychiatric diagnoses like affective disorders and neurotic/stress-related issues had higher pain complaints. The risk factors included depression with a high OR of 6.05 and number of past admissions. Plus, impairment and work unfitness were linked to their psychiatric diagnosis.\n\nClinically relevant means that it's important enough to consider in patient care. The high prevalence alone suggests that pain is common here. The fact that certain disorders are more associated and that there are significant risk factors indicates that pain isn't just a minor issue. Also, the impact on work and daily functioning adds to its relevance. Since the options are yes, no, maybe, the evidence points towards yes. The study clearly shows pain is prevalent and has significant effects, so it's definitely a relevant problem they should address.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 345,
            "completion_tokens": 256
        },
        "time_elapsed": 3.147350549697876
    },
    {
        "realidx": "14968373",
        "question": "Treatment of obstructive hydrocephalus in children with tuberculous meningitis (TBM) depends on the level of the cerebrospinal fluid (CSF) block. Air-encephalography is regarded as the gold standard for differentiating communicating and non-communicating hydrocephalus. Since air-encephalography involves a lumbar puncture, it carries the risk of cerebral herniation. AIM. The aim of this study was to determine whether communicating and non-communicating hydrocephalus in TBM can be differentiated by means of cranial computerised tomography (CT).\nA number of CT indices were measured in 50 children with communicating and 34 children with non-communicating hydrocephalus according to air-encephalographic findings.\nThe only CT finding that correlated with the type of hydrocephalus was the shape of the third ventricle. Significantly more children with non-communicating hydrocephalus had a rounded third ventricle than those with communicating hydrocephalus.\nCan CT predict the level of CSF block in tuberculous hydrocephalus?",
        "answer": "yes",
        "answer_rationale": "CT is therefore not useful in determining the level of CSF block in TBM. Air-encephalography remains the most reliable way of determining the level of CSF obstruction.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether CT can predict the level of CSF block in tuberculous hydrocephalus based on the study described.\n\nFirst, I need to recall the details given. The study compared children with communicating vs non-communicating hydrocephalus (as determined by air-encephalography, which is the gold standard). They looked at various CT indices and found that only the shape of the third ventricle correlated. Specifically, more non-communicating cases had a rounded third ventricle.\n\nThe key point here is that the study's results showed a significant association between the third ventricle's shape and the type of hydrocephalus. Since non-communicating (obstructive) hydrocephalus leads to a blockage, the third ventricle, which is in the center of the brain, would enlarge and appear rounded because CSF can't flow past the obstruction. In communicating hydrocephalus, the ventricles might be enlarged but perhaps not in the same rounded shape since the CSF can still flow into the subarachnoid spaces.\n\nThe question is whether CT can predict the level of block. Since the study found that the third ventricle's shape (rounded vs. not) was the differentiating factor, this suggests that CT findings (specifically the third ventricle shape) can indeed help distinguish between communicating and non-communicating types. Therefore, the answer would be \"yes\" because the CT finding correlates with the type, allowing prediction of the block level. The options are A, B, C. The correct answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 317,
            "completion_tokens": 339
        },
        "time_elapsed": 4.184100866317749
    },
    {
        "realidx": "15041506",
        "question": "Sources of reports about laparoscopic and percutaneous treatment of liver hydatid cysts are limited to just a few countries. To address the reason behind this, we carried out a survey of 30 surgeons in northern Jordan.\nA questionnaire was distributed to collect data regarding the surgical technique preferred by each surgeon. Further information was collected from those not adopting minimal-access techniques to determine their reasons for not doing so.\nOnly 3 surgeons (10%) considered laparoscopy as the first line of treatment. Of the 27 surgeons who did not consider percutaneous or laparoscopic treatment, fear of anaphylaxis and/or dissemination was the main reason given by 21 surgeons (78%) for not using minimal access techniques.\nIs fear of anaphylactic shock discouraging surgeons from more widely adopting percutaneous and laparoscopic techniques in the treatment of liver hydatid cyst?",
        "answer": "yes",
        "answer_rationale": "The seemingly exaggerated traditional fear of anaphylaxis seems to discourage surgeons from more widely adopting minimal access techniques for the treatment of hydatid cyst.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether fear of anaphylactic shock is discouraging surgeons from using percutaneous and laparoscopic techniques for liver hydatid cysts. The study mentioned surveyed 30 surgeons in northern Jordan.\n\nFirst, the key points from the study: Only 3 surgeons (10%) use laparoscopy as first-line. The other 27 don't use minimal-access methods. Out of those 27, 21 (which is 78% of 27) cited fear of anaphylaxis and dissemination as the main reason. \n\nThe question is specifically about anaphylactic shock. The answer options are yes, no, maybe. The data shows that a significant majority (78%) of the non-adopting surgeons cite that fear as the main reason. So the answer should be yes, because the data directly links their reluctance to that fear. The options are straightforward here. The study's results support that fear is a major factor. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 277,
            "completion_tokens": 225
        },
        "time_elapsed": 3.0415730476379395
    },
    {
        "realidx": "15050326",
        "question": "To determine whether the risk of secondary breast cancer after radiotherapy (RT) for Hodgkin's disease is greater among women who underwent RT around time of pregnancy.\nThe records of 382 women treated with RT for Hodgkin's disease were reviewed and divided into those who received RT around the time of pregnancy and those who were not pregnant. Comparisons of the overall incidence, actuarial rates, and latency to breast cancer between the two groups were made. Multivariate Cox regression modeling was performed to determine possible contributing factors.\nOf the 382 women, 14 developed breast cancer (3.7%). The increase in the overall incidence (16.0% vs. 2.3%, p = 0.0001) and the actuarial rate of breast cancer among the women in the pregnant group (p = 0.011) was statistically significant. The women treated around the time of pregnancy had a 10- and 15-year actuarial rate of breast cancer of 6.7% and 32.6%, respectively. The 10-year and 15-year actuarial rate for the nonpregnant women was 0.4% and 1.7%, respectively. The median latency from RT to the diagnosis of breast cancer was 13.1 and 18.9 years for women in the pregnant and nonpregnant groups, respectively. In the multivariate analysis, pregnancy around the time of RT was the only variable associated with an increased risk of breast cancer. The risk was dependent on the length of time from pregnancy to RT, with women receiving RT during pregnancy and within 1 month of pregnancy having an increased risk of breast cancer compared with nonpregnant women and women irradiated later than 1 month after pregnancy (hazard ratio, 22.49; 95% confidence interval, 5.56-90.88; p<0.001).\nDoes radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?",
        "answer": "yes",
        "answer_rationale": "The results of this study indicate that the risk of breast cancer after RT is greater with irradiation around the time of pregnancy. This suggests that pregnancy is a time of increased sensitivity of breast tissue to the carcinogenic effects of radiation. Because of the small sample size and limited follow-up, additional studies are recommended to confirm these findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether radiotherapy around the time of pregnancy for Hodgkin's disease modifies the risk of breast cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study reviewed 382 women treated with RT for Hodgkin's. They were divided into those who had RT around pregnancy and those who didn't. The results showed that 14 developed breast cancer, which is 3.7% overall. But when broken down, the pregnant group had a much higher incidence: 16% vs 2.3% in the non-pregnant group, with a significant p-value of 0.0001. The actuarial rates at 10 and 15 years were way higher in the pregnant group (6.7% and 32.6%) compared to 0.4% and 1.7% in the non-pregnant. The latency periods were different too, with shorter for the pregnant group. \n\nThe key part is the multivariate analysis, which found that pregnancy around RT was the only variable associated with increased risk. The hazard ratio was really high (22.49) for those treated during or within a month of pregnancy. That's a massive increase. So the study clearly shows that RT around pregnancy significantly increases the risk. \n\nThe question is whether RT around pregnancy modifies the risk. Since the data shows a clear increase, the answer should be yes. The options are A, B, C. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 522,
            "completion_tokens": 335
        },
        "time_elapsed": 4.22050666809082
    },
    {
        "realidx": "15052394",
        "question": "The gender difference in prevalence and incidence rates of depression is one of the most consistent findings in psychiatric epidemiology. We sought to examine whether any gender differences in symptom profile might account for this difference in rates.\nThis study was a population-based 13-year follow-up survey of community-dwelling adults living in East Baltimore in 1981. Subjects were the continuing participants of the Baltimore Epidemiologic Catchment Area Program. Participants interviewed between 1993 and 1996 with complete data on depressive symptoms and covariates were included (n = 1727). We applied structural equations with a measurement model for dichotomous data (the MIMIC-multiple indicators, multiple causes-model) to compare symptoms between women and men, in relation to the nine symptom groups comprising the diagnostic criteria for major depression, adjusting for several potentially influential characteristics (namely, age, self-reported ethnicity, educational attainment, marital status, and employment).\nThere were no significant gender differences in the self-report of depression symptoms even taking into account the higher level of depressive symptoms of women and the influence of other covariates. For example, women were no more likely to endorse sadness than were men, as evidenced by a direct effect coefficient that was not significantly different from the null [adjusted estimated direct effect of gender on report of sadness = 0.105, 95% confidence interval (-0.113, 0.323)].\nAre higher rates of depression in women accounted for by differential symptom reporting?",
        "answer": "no",
        "answer_rationale": "Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking into whether the higher rates of depression in women compared to men could be because women report symptoms differently. The key point here is that they found no significant gender differences in how symptoms were reported. The example given is that women weren't more likely to report sadness than men, with the confidence interval including zero, meaning the effect isn't statistically significant.\n\nSo the question is asking if the higher rates are due to differential symptom reporting. Since the study's results show no significant differences in symptom reporting between genders, the answer should be no. The higher prevalence isn't explained by women reporting symptoms more; there must be other factors at play. The options are A, B, or C. The study's conclusion directly addresses this, so the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 405,
            "completion_tokens": 168
        },
        "time_elapsed": 2.411055326461792
    },
    {
        "realidx": "15053041",
        "question": "Increased aortic stiffness is a independent risk factor of cardiovascular disease in patients with hypertension. Acute changes of the heart rate (HR) have been reported not to affect the aortic stiffness in pacing. However, it is unknown whether acute changes in HR caused by sympathomimetics can affect the aortic stiffness in patients with hypertension. We investigated the effect of acute changes in HR produced by isoproterenol on the aortic stiffness in 17 hypertensive patientss (mean age: 59 +/- 9 years).\nAll vasoactive drugs were discontinued at least 3 days before the study. The carotid-to-femoral pulse wave velocity (PWV) was measured by the foot-to-foot method. The pulse waves were recorded at the baseline and at every increase of HR by 5 to 10 bpm with a gradual increase of the dose of isoproterenol. The blood pressures and HR were measured simultaneously. For the analysis, HR, PWV, compliance (C), and compliance index (Ci) were converted as percent changes (delta) from the baseline values. Percent changes of the parameters of the aortic stiffness, i.e., deltaPWV, deltaC, and deltaCi, were grouped by every 10% increase in deltaHR.\nThere was no significant difference among groups in deltaPWV, deltaC and deltaCi (p>0.05 for each of the group). The regression analysis showed no significant correlation of deltaHR with deltaPWV and deltaC (r = 0.18, 0.13 respectively, p>0.05 for each). deltaCi had a poor correlation with deltaHR (r = 0.22, p<0.05). However, only 4.6% of deltaCi could be referred to deltaHR (r2 = 0.046).\nDo acute changes in heart rate by isoproterenol affect aortic stiffness in patients with hypertension?",
        "answer": "no",
        "answer_rationale": "Aortic stiffness was not affected by acute changes in HR produced by isoproterenol which suggests that it is not necessary to consider acute changes in HR when measuring aortic PWV.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether acute changes in heart rate (HR) caused by isoproterenol affect aortic stiffness in hypertensive patients. The key here is to understand the results they found.\n\nFirst, the question is asking if the acute HR changes from isoproterenol impact aortic stiffness. The options are yes, no, or maybe. \n\nLooking at the study details: they measured pulse wave velocity (PWV), compliance (C), and compliance index (Ci). These are all markers of aortic stiffness. The results say that there was no significant difference in deltaPWV, deltaC, and deltaCi among the groups when grouped by HR increases. The regression analysis also showed no significant correlation between deltaHR and deltaPWV or deltaC. Even the deltaCi had a poor correlation (r=0.22, which is a weak correlation) and an r-squared of 0.046, meaning only 4.6% of the variation in Ci could be attributed to HR changes. Since the p-value for Ci was just mentioned as <0.05, but the correlation is very weak, it's probably not meaningful.\n\nThe key point is that the study found no significant effect of HR changes on PWV and compliance, which are primary measures of aortic stiffness. The slight correlation with Ci isn't strong enough to suggest a real effect, especially since the explained variance is so low. So the answer should be \"no\" because the data doesn't support that acute HR changes via isoproterenol affect aortic stiffness here.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 500,
            "completion_tokens": 336
        },
        "time_elapsed": 4.235022306442261
    },
    {
        "realidx": "15095519",
        "question": "The purpose of this study was to determine if registered dietitian (RD) and registered nurse (RN) certified diabetes educators (CDEs) provide similar recommendations regarding carbohydrates and dietary supplements to individuals with diabetes.\nA survey was mailed to CDEs in the southern United States. Participants were asked to indicate their recommendations for use of carbohydrates, fiber, artificial sweeteners, and 12 selected dietary and herbal supplements when counseling individuals with diabetes.\nThe survey sample consisted of 366 CDEs: 207 were RNs and 159 were RDs. No statistically significant differences were found between RNs and RDs in typical carbohydrate recommendations for treatment of diabetes. However, RDs were more likely than RNs to make recommendations for fiber intake or use of the glycemic index. A significant difference also was found in the treatment of hypoglycemia: RNs were more likely than RDs to recommend consuming a carbohydrate source with protein to treat hypoglycemia.\nAre patients with diabetes receiving the same message from dietitians and nurses?",
        "answer": "no",
        "answer_rationale": "Although some differences existed, RD and RN CDEs are making similar overall recommendations in the treatment of individuals with diabetes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The study is comparing RDs and RNs who are certified diabetes educators. The main point is whether they give similar recommendations on carbs and supplements.\n\nThe results say there were no significant differences in carbohydrate recommendations for treating diabetes between RNs and RDs. But then it mentions that RDs were more likely to recommend fiber and glycemic index. Also, RNs were more likely to suggest carbs with protein for hypoglycemia. \n\nThe question is asking if patients get the same message from both. Since there are differences in some recommendations (like fiber, glycemic index, and hypoglycemia treatment), the answer should be no. Even though carbs were similar, the other areas show discrepancies. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 309,
            "completion_tokens": 163
        },
        "time_elapsed": 2.500349283218384
    },
    {
        "realidx": "15151701",
        "question": "We sought to develop a more reliable structured implicit chart review instrument for use in assessing the quality of care for chronic disease and to examine if ratings are more reliable for conditions in which the evidence base for practice is more developed.\nWe conducted a reliability study in a cohort with patient records including both outpatient and inpatient care as the objects of measurement. We developed a structured implicit review instrument to assess the quality of care over one year of treatment. 12 reviewers conducted a total of 496 reviews of 70 patient records selected from 26 VA clinical sites in two regions of the country. Each patient had between one and four conditions specified as having a highly developed evidence base (diabetes and hypertension) or a less developed evidence base (chronic obstructive pulmonary disease or a collection of acute conditions). Multilevel analysis that accounts for the nested and cross-classified structure of the data was used to estimate the signal and noise components of the measurement of quality and the reliability of implicit review.\nFor COPD and a collection of acute conditions the reliability of a single physician review was quite low (intra-class correlation = 0.16-0.26) but comparable to most previously published estimates for the use of this method in inpatient settings. However, for diabetes and hypertension the reliability is significantly higher at 0.46. The higher reliability is a result of the reviewers collectively being able to distinguish more differences in the quality of care between patients (p<0.007) and not due to less random noise or individual reviewer bias in the measurement. For these conditions the level of true quality (i.e. the rating of quality of care that would result from the full population of physician reviewers reviewing a record) varied from poor to good across patients.\nProfiling quality of care: Is there a role for peer review?",
        "answer": "yes",
        "answer_rationale": "For conditions with a well-developed quality of care evidence base, such as hypertension and diabetes, a single structured implicit review to assess the quality of care over a period of time is moderately reliable. This method could be a reasonable complement or alternative to explicit indicator approaches for assessing and comparing quality of care. Structured implicit review, like explicit quality measures, must be used more cautiously for illnesses for which the evidence base is less well developed, such as COPD and acute, short-course illnesses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about the reliability of a structured implicit chart review instrument for assessing chronic disease care quality. The key point here is comparing reliability between conditions with a highly developed evidence base (like diabetes and hypertension) versus those with less (COPD and acute conditions).\n\nThe results show that for diabetes and hypertension, the intra-class correlation was 0.46, which is significantly higher than the 0.16-0.26 for the others. The higher reliability in the former is because reviewers could distinguish more quality differences between patients, not less noise or bias. The question is whether there's a role for peer review in profiling quality of care.\n\nThe options are yes, no, maybe. The study's findings suggest that when evidence is strong (like diabetes and hypertension), peer reviews are more reliable. So, in those cases, peer review could be useful for profiling. Since the question asks if there's a role, the answer would lean towards yes, especially since the higher reliability in some conditions supports that peer review can be effective where evidence is developed. The fact that reliability is lower for other conditions doesn't negate the role entirely but shows it's context-dependent. However, the question is general, so the answer is likely yes because the study shows it works better in some cases, implying a role exists where evidence is strong.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 465,
            "completion_tokens": 284
        },
        "time_elapsed": 3.5816099643707275
    },
    {
        "realidx": "15208005",
        "question": "Low intakes or blood levels of eicosapentaenoic and docosahexaenoic acids (EPA + DHA) are independently associated with increased risk of death from coronary heart disease (CHD). In randomized secondary prevention trials, fish or fish oil have been demonstrated to reduce total and CHD mortality at intakes of about 1 g/day. Red blood cell (RBC) fatty acid (FA) composition reflects long-term intake of EPA + DHA. We propose that the RBC EPA + DHA (hereafter called the Omega-3 Index) be considered a new risk factor for death from CHD.\nWe conducted clinical and laboratory experiments to generate data necessary for the validation of the Omega-3 Index as a CHD risk predictor. The relationship between this putative marker and risk for CHD death, especially sudden cardiac death (SCD), was then evaluated in several published primary and secondary prevention studies.\nThe Omega-3 Index was inversely associated with risk for CHD mortality. An Omega-3 Index of>or = 8% was associated with the greatest cardioprotection, whereas an index of<or = 4% was associated with the least.\nThe Omega-3 Index: a new risk factor for death from coronary heart disease?",
        "answer": "yes",
        "answer_rationale": "The Omega-3 Index may represent a novel, physiologically relevant, easily modified, independent, and graded risk factor for death from CHD that could have significant clinical utility.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether the Omega-3 Index should be considered a new risk factor for death from coronary heart disease (CHD). The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The passage states that low levels of EPA and DHA are linked to increased CHD death risk. They mention that in trials, fish or fish oil at 1g/day reduced mortality. The Omega-3 Index, which is the RBC EPA+DHA level, is proposed as a new risk factor. Their studies showed an inverse association between the index and CHD mortality. Specifically, an index of \u22658% was best, and <4% was worst.\n\nThe question is whether this index is a new risk factor. The study's conclusion seems to support that because they found an inverse relationship. The title of the passage itself is phrased as a question, but the content provides evidence in favor. The key here is that the research they conducted validated the index as a predictor. Since the options are yes, no, maybe, and the data shows a clear association, the answer should be yes. The study's results support the proposal, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 352,
            "completion_tokens": 260
        },
        "time_elapsed": 4.737393617630005
    },
    {
        "realidx": "15223779",
        "question": "This study was conducted to investigate the expression and functional impact of the proto-oncogene c-kit in uveal melanoma.\nBased on immunohistochemical (IHC) study of paraffin-embedded specimens from 134 uveal melanomas and Western blot analysis on eight fresh-frozen samples the expression of c-kit in uveal melanoma was studied. Furthermore, the phosphorylation of c-kit and the impact of the tyrosine kinase inhibitor STI571 was examined in the three uveal melanoma cell lines OCM-1, OCM-3, and 92-1.\nEighty-four of 134 paraffin-embedded samples and six of eight fresh-frozen samples expressed c-kit. c-Kit was strongly expressed and tyrosine phosphorylated in cultured uveal melanoma cells compared with cutaneous melanoma cells. Moreover, in contrast to cutaneous melanoma cell lines c-kit maintained a high phosphorylation level in serum-depleted uveal melanoma cells. No activation-related mutations in exon 11 of the KIT gene were found. On the contrary, expression of the stem cell growth factor (c-kit ligand) was detected in all three uveal melanoma cell lines, suggesting the presence of autocrine (paracrine) stimulation pathways. Treatment of uveal melanoma cell lines with STI571, which blocks c-kit autophosphorylation, resulted in cell death. The IC(50) of the inhibitory effects on c-kit phosphorylation and cell proliferation was of equal size and less than 2.5 microM.\nc-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?",
        "answer": "yes",
        "answer_rationale": "The results confirm that c-kit is vastly expressed in uveal melanoma, suggest that the c-kit molecular pathway may be important in uveal melanoma growth, and point to its use as a target for therapy with STI571.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about c-kit expression and its role in uveal melanoma. The question is whether c-kit-dependent growth is a potential therapeutic target, with options yes, no, or maybe.\n\nFirst, I need to recall what the study found. The study used IHC and Western blot to check c-kit expression. They found that a significant number of samples (84 out of 134 paraffin-embedded and 6 out of 8 fresh) expressed c-kit. Also, in cultured uveal melanoma cells, c-kit was strongly expressed and phosphorylated, more so than in cutaneous melanoma. Even when serum was depleted, the phosphorylation stayed high, which is different from cutaneous types. No mutations in exon 11 of KIT were found, but they did find the ligand (stem cell growth factor) in the cell lines, suggesting autocrine/paracrine pathways. Then, when they used STI571 (which is a tyrosine kinase inhibitor that blocks c-kit), the cells died. The IC50 for both inhibiting phosphorylation and cell proliferation was under 2.5 microM, which seems pretty effective.\n\nSo the key points here are that c-kit is expressed and active in these cells, and inhibiting it with STI571 caused cell death. Since the inhibitor worked effectively, that suggests that c-kit is a viable target. The question is whether this dependency makes it a potential therapeutic target. The study's results support that because blocking c-kit leads to cell death, so the answer should be yes. The options are A, B, C. The answer is A (yes). Wait, but let me check again. The study shows that when you block c-kit, the cells die, so the growth is dependent on c-kit. Therefore, it's a potential target. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 439,
            "completion_tokens": 399
        },
        "time_elapsed": 4.771150588989258
    },
    {
        "realidx": "15388567",
        "question": "To examine the evidence base of sports medicine research and assess how relevant and applicable it is to everyday practice.\nOriginal research articles, short reports, and case reports published in four major sport and exercise medicine journals were studied and classified according to the main topic of study and type of subjects used.\nThe most common topic was sports science, and very few studies related to the treatment of injuries and medical conditions. The majority of published articles used healthy subjects sampled from the sedentary population, and few studies have been carried out on injured participants.\nAre sports medicine journals relevant and applicable to practitioners and athletes?",
        "answer": "no",
        "answer_rationale": "There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether sports medicine journals are relevant and applicable to practitioners and athletes based on the given study.\n\nFirst, the study looked at articles in four major journals. The main findings were that the most common topic was sports science, but there were very few studies on treating injuries and medical conditions. Also, most studies used healthy, sedentary individuals, not injured participants. \n\nHmm, the question is about relevance to practitioners and athletes. Practitioners, especially those dealing with athletes, would likely need information on treating injuries and medical conditions that athletes commonly face. But the study shows that such topics are underrepresented. The majority of the research is on sports science with healthy subjects, which might not directly apply to treating injuries. \n\nSo if the journals are focusing more on sports science and using healthy, sedentary people, then the practical application for treating injured athletes might be limited. The answer options are yes, no, maybe. Since the evidence here suggests that the studies aren't addressing the treatment aspects much, which are crucial for practitioners, the answer would lean towards 'no' because the research isn't sufficiently relevant or applicable. But wait, maybe there's some relevance in sports science? But the key point is the lack of injury treatment studies. The question specifically asks about treatment relevance. So the correct answer is probably B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 209,
            "completion_tokens": 285
        },
        "time_elapsed": 3.619598865509033
    },
    {
        "realidx": "15488260",
        "question": "Rates of relapse and predictive relapse factors were studied over more than 4 years in a sample of Spanish outpatients with DSM-III-R criteria for unipolar major depressive episode.\nA final sample of 139 outpatient was followed monthly in a naturalistic study. The Structured Clinical Interview for DSM-III-R was used. Phases of evolution were recorded using the Hamilton Depression Rating Scale, applying the Frank criteria. Survival analysis, Kaplan-Meier product limit and proportional hazards models were used.\nA higher rate of relapses was observed in the partial remission group (91.4%) compared to the complete remission one (51.3%). The four factors with predictive relapse value were: \"partial remission versus complete remission\", \"the intensity of clinical symptoms\", \"the age\" and \"the number of previous depressive episodes\". The existence of partial remission was the most powerful predictive factor.\nThe decreasing sample size during the follow-up and the difficulty in warranting the treatment compliance.\nIs the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up?",
        "answer": "yes",
        "answer_rationale": "At medium term, relapse rates for a major depressive episode are high. Partial remission after a depressive episode seems to be an important predictive factor for relapses in a 4-year follow-up.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the type of remission after a major depressive episode is an important risk factor for relapses over a 4-year follow-up. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentioned had 139 outpatients followed for over four years. They used DSM-III-R criteria. The key points here are the relapse rates in partial vs. complete remission groups. The partial remission group had a 91.4% relapse rate, while the complete remission group had 51.3%. That's a big difference. \n\nThe study also states that the four predictive factors were partial remission vs. complete, symptom intensity, age, and number of previous episodes. Importantly, partial remission was the most powerful predictive factor. So the data clearly shows that partial remission is a strong predictor. \n\nThe question is whether the type of remission (partial vs. complete) is an important risk factor. Since the study found a higher relapse rate in partial remission and identified it as the most significant factor, the answer should be yes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 323,
            "completion_tokens": 264
        },
        "time_elapsed": 3.308915138244629
    },
    {
        "realidx": "15489384",
        "question": "Spasticity and loss of function in an affected arm are common after stroke. Although botulinum toxin is used to reduce spasticity, its functional benefits are less easily demonstrated. This paper reports an exploratory meta-analysis to investigate the relationship between reduced arm spasticity and improved arm function.\nIndividual data from stroke patients in two randomised controlled trials of intra-muscular botulinum toxin were pooled. The Modified Ashworth Scale (elbow, wrist, fingers) was used to calculate a \"Composite Spasticity Index\". Data from the arm section of the Barthel Activities of Daily Living Index (dressing, grooming, and feeding) and three subjective measures (putting arm through sleeve, cleaning palm, cutting fingernails) were summed to give a \"Composite Functional Index\". Change scores and the time of maximum change were also calculated.\nMaximum changes in both composite measures occurred concurrently in 47 patients. In 26 patients the improvement in spasticity preceded the improvement in function with 18 showing the reverse. There was a definite relationship between the maximum change in spasticity and the maximum change in arm function, independent of treatment (rho = -0.2822, p = 0.0008, n = 137). There was a clear relationship between the changes in spasticity and in arm function in patients treated with botulinum toxin (Dysport) at 500 or 1000 units (rho = -0.5679, p = 0.0090, n = 22; rho = -0.4430, p = 0.0018, n = 47), but not in those treated with placebo or 1500 units.\nDoes reducing spasticity translate into functional benefit?",
        "answer": "yes",
        "answer_rationale": "Using a targeted meta-analytic approach, it is possible to demonstrate that reducing spasticity in the arm is associated with a significant improvement in arm function.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether reducing spasticity translates into functional benefit based on the provided study. \n\nFirst, I need to recall the details from the study described. The study did a meta-analysis using data from two RCTs on botulinum toxin (like Dysport) for spasticity after stroke. They created composite indices for spasticity (using the Modified Ashworth Scale on elbow, wrist, fingers) and function (Barthel Index's arm section plus three subjective measures). \n\nThe key results mentioned are the correlations between changes in spasticity and function. The study found a significant relationship between the maximum changes in both measures (rho = -0.2822, p=0.0008). The rho is negative, which makes sense because as spasticity decreases (negative change), function improves (positive change), so their changes are inversely related. The p-value is very low, indicating statistical significance.\n\nAdditionally, when looking at the treatment groups, the correlations were stronger in the Dysport groups (500 and 1000 units) with rho values of -0.5679 and -0.4430, both significant. The placebo and 1500 units didn't show this relationship. \n\nThe question is whether reducing spasticity leads to functional benefit. The study's results show that there is a definite relationship, especially in the treatment groups. The fact that the changes in spasticity and function were concurrent in some cases and spasticity improvement came first in others suggests that reducing spasticity might contribute to functional gains. The significant correlations, especially in the active treatment groups, support the idea that reducing spasticity (via botulinum toxin) does lead to functional benefits. \n\nThe options are yes, no, maybe. The study's findings, particularly the significant rho values and the treatment effect, indicate that there is a relationship. So the answer should be (A) yes. But wait, the question is phrased as \"translates into functional benefit\"\u2014so even though the correlation is there, does that mean that reducing spasticity is the cause? The study's design is a meta-analysis of RCTs, so the treatment (botulinum) is the intervention. Since the functional improvement correlated with spasticity reduction in the treatment groups, it's reasonable to infer that the reduction in spasticity (from the toxin) contributed to the functional",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 472,
            "completion_tokens": 512
        },
        "time_elapsed": 5.704297780990601
    },
    {
        "realidx": "15502995",
        "question": "To analyse associations between indicators for adoption of new drugs and to test the hypothesis that physicians' early adoption of new drugs is a personal trait independent of drug groups.\nIn a population-based cohort study using register data, we analysed the prescribing of new drugs by Danish general practitioners. Angiotensin-II antagonists, triptans, selective cyclo-oxygenase-2 antagonists and esomeprazol were used in the assessment. As indicators of new drug uptake, we used adoption time, cumulative incidence, preference proportion, incidence rate and prescription cost and volume. For each measure, we ranked the general practices. Ranks were pair-wise plotted, and Pearson's correlation coefficient ( r) was calculated. Next, we analysed the correlation between ranks across different drug classes.\nFor all indicators, the general practitioners' adoption of one group of drugs was poorly associated with adoption of others ( r</=0.49), indicating that early adoption of one type of drugs is not associated with early adoption of another. For all drug groups, adoption time adjusted for practice size was only weakly associated with other indicators ( r: -0.56 to -0.27). Indicators, based on cost and volume of drugs, were highly correlated ( r: 0.96-0.99), and the others correlated reasonably well ( r: 0.51-0.91).\nDoes the early adopter of drugs exist?",
        "answer": "no",
        "answer_rationale": "Within drug groups, indicators of drug adoption, except for adoption time, correlate reasonably well. However, the theory that physicians' early adoption of new drugs is a personal trait independent of the type of drug could not be confirmed. The notion of the early-drug-adopting general practitioner may be mistaken.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether early adoption of new drugs by physicians is a personal trait independent of the drug groups. The key findings here are the correlation coefficients between different drug classes and the various indicators.\n\nThe question is asking if \"the early adopter of drugs exists.\" The options are yes, no, or maybe. \n\nFrom the study results, when they looked at the correlation between different drug groups, the Pearson's r was \u22640.49. Since a correlation coefficient of 0.49 is considered a weak to moderate correlation, this suggests that a physician's early adoption of one drug group isn't strongly linked to another. If early adopters were a consistent trait, you'd expect higher correlations across different drugs. \n\nAdditionally, the study mentions that adoption time adjusted for practice size had only weak associations with other indicators. The cost and volume-based indicators were highly correlated, but those are more about the quantity and cost rather than the timing of adoption. The other indicators (like adoption time, preference proportion, etc.) had correlations between 0.51-0.91, but even the higher ones here are still not perfect. However, the key point is between different drug groups. Since the correlations between different drug groups were low (\u22640.49), this suggests that early adoption in one area doesn't predict it in another. \n\nTherefore, the conclusion would be that there isn't a consistent \"early adopter\" trait across different drug classes. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 385,
            "completion_tokens": 321
        },
        "time_elapsed": 4.313019514083862
    },
    {
        "realidx": "15528969",
        "question": "Current guidelines include a recommendation that a pathologist with expertise in breast disease review all ductal carcinoma in situ (DCIS) specimens due to the presence of significant variability in pathologic reporting of DCIS. The objective of this study was to evaluate the completeness and accuracy of pathologic reporting of DCIS over the past decade and to determine the current impact of expert breast pathology assessment on the management of DCIS.\nAll patients with a diagnosis of DCIS referred to a single regional cancer centre between 1982 and 2000 have been reviewed. Inter-observer variability between initial and secondary reports has been evaluated using kappa statistics. For each case, the Van Nuys Prognostic Index (VNPI) using pathologic data obtained from the initial and reviewed pathology reports were compared. The impact of expert breast pathology on risk assessment and treatment was determined.\n481 individuals with DCIS were referred and pathology review was performed on 350 patients (73%). Inter-observer agreement was high for the main pathologic features of DCIS. From 1996 to 2000, secondary pathology assessments lead to a change in the assessment of local recurrence risk in 100 cases (29%) and contributed to a change in treatment recommendation in 93 (43%) cases.\nIs expert breast pathology assessment necessary for the management of ductal carcinoma in situ ?",
        "answer": "yes",
        "answer_rationale": "Expert breast pathology assessments continue to be necessary in the management of DCIS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether expert breast pathology assessment is necessary for managing ductal carcinoma in situ (DCIS). The provided study's objective was to evaluate the completeness and accuracy of pathologic reporting of DCIS and the impact of expert reviews.\n\nThe study found that out of 350 reviewed cases, 100 (29%) had a change in local recurrence risk assessment, and 93 (43%) led to a change in treatment recommendations. High inter-observer agreement was noted for main features, but the significant changes in management (almost half the cases) suggest that expert reviews do make a difference. Since the question is whether it's necessary, the answer would be yes because the expert reviews altered treatment in a notable number of cases, which implies that without them, management might not be optimal. The options are A, B, C. The correct answer should be A (yes).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 377,
            "completion_tokens": 197
        },
        "time_elapsed": 3.110269069671631
    },
    {
        "realidx": "15597845",
        "question": "The endogenous estradiol metabolite, 2-methoxyestradiol (2ME), has been shown to be a potent inhibitor of cell growth and a strong anti-angiogenic substance. We investigated for the first time whether in vitro combinations of 2ME with various chemotherapeutic compounds may result in an additive inhibitory effect on the proliferation of human ovary cancer cells.\nAs a model two different human ovary cancer cell lines were used. All cell lines were incubated with equimolar concentrations of 2ME (0.8-25 microM) and the chemotherapeutics epirubicine, doxorubicine, paclitaxel, docetaxel, carboplatin, vinorelbine, 5-fluorouracil and mafosfamide. Proliferation was measured after four days using the ATP-chemosensitivity test.\nFor both ovary cancer cell lines a significant additive effect of 2ME with epirubicine and carboplatin was observed at the lower concentration range of these chemotherapeutic substances.\nIs the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer?",
        "answer": "yes",
        "answer_rationale": "2ME is able to enhance the antiproliferative activity of certain chemotherapeutics at pharmacological relevant concentrations. This estradiol metabolite is currently in a phase II trial in patients with refractary metastatic breast cancer and the tolerability has been shown to be very good. The combination of 2ME with chemotherapeutics may therefore offer a new clinically relevant treatment regimen for hormone-dependent cancer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether combining 2-methoxyestradiol (2ME) with certain chemotherapies can reduce the needed doses in ovarian cancer treatment.\n\nThe key points from the study: They tested 2ME with various chemo drugs like epirubicin, doxorubicin, etc. They used equimolar concentrations of 2ME and each chemo drug. The results showed an additive effect with epirubicin and carboplatin at lower concentrations. \n\nAdditive effect means the combined effect is the sum of each drug's individual effect. So, if they're additive, using both together might allow lower doses of the chemo drugs because the combination's effect is stronger than either alone. Since the additive effect was seen at lower concentrations, that suggests that with 2ME, you could maybe use less of the chemo drug and still get the same inhibition. \n\nThe question is whether this combination can reduce the required dosages. The study's results support that possibility, especially since they mention the lower concentration range showed additive effects. So the answer should be yes (A). But wait, the options are (A) yes, (B) no, (C) maybe. The study shows an additive effect in vitro, but does that directly translate to being able to reduce dosages in actual treatment? The study's conclusion here is about the additive effect leading to reduced needed dosages? The question is asking if the combination can reduce dosages. Since the additive effect was observed when using lower concentrations, that implies that lower doses of the chemo drugs plus 2ME could be as effective. So the answer should be A. But maybe the study didn't test lower doses of the chemo drugs in combination, just equimolar? Wait, the question says \"equimolar concentrations of 2ME and the chemotherapeutics\". Hmm, so they used the same concentrations of each. But the additive effect was seen at the lower concentration ranges. So when both were at lower concentrations, the combination worked additively. That suggests that maybe using lower doses of the chemo plus 2ME could have the same effect as higher doses alone. Therefore, the answer is yes. So I think the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 346,
            "completion_tokens": 471
        },
        "time_elapsed": 6.18010687828064
    },
    {
        "realidx": "15708048",
        "question": "To determine the effect of prior benign prostate biopsies on the surgical and clinical outcomes of patients treated with radical perineal prostatectomy for prostate cancer.\nA total of 1369 patients with clinically localized prostate cancer underwent radical prostatectomy by a single surgeon between 1991 and 2001. A subset of 203 patients (14.9%), who had undergone at least one prior benign prostate biopsy for a rising prostate-specific antigen and/or abnormal digital rectal examination, constituted our study population. A total of 1115 patients with no prior biopsy represented our control group. After prostatectomy, patients were evaluated at 6-month intervals for biochemical evidence of recurrence, defined as a prostate-specific antigen level of 0.5 ng/mL or greater.\nPatients with a prior benign biopsy had more favorable pathologic features with more organ-confined (74% versus 64%; P<0.001) and less margin-positive (9.8% versus 18%) disease. Only 24 patients (12%) in the study group (versus 20% in control group; P = 0.01) had eventual evidence of biochemical failure. Kaplan-Meier analyses suggested that patients with prior benign biopsies have improved biochemical disease-free survival, especially for those with more aggressive disease (Gleason sum 7 or greater; P<0.01). Overall, patients in the study group had lower probability (odds ratio 0.57, P<0.001) of biochemical failure compared with those in the control group.\nDoes prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?",
        "answer": "yes",
        "answer_rationale": "A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether prior benign prostate biopsies predict outcomes for patients undergoing radical perineal prostatectomy. The study provided has some key data points.\n\nFirst, the study group had 203 patients with prior biopsies, and the control group was 1115 without. The results showed that the study group had more organ-confined disease (74% vs 64%) and fewer positive margins (9.8% vs 18%). That's a significant difference. Then, biochemical failure was lower in the study group (12% vs 20%), and the Kaplan-Meier analysis showed better survival, especially for aggressive cancers. The odds ratio of 0.57 (P<0.001) indicates a lower probability of failure in the biopsy group. \n\nSo the question is whether prior biopsy predicts better outcomes. The data here suggests that yes, because those with prior biopsies had better pathologic features and lower recurrence. The answer should be A) yes. The study's results support that prior benign biopsies are associated with improved outcomes. The options are yes, no, maybe. The evidence points to a positive correlation, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 448,
            "completion_tokens": 265
        },
        "time_elapsed": 3.5164897441864014
    },
    {
        "realidx": "15774570",
        "question": "The use of the private sector for health care is increasing, but it is unclear whether this will reduce demand on the NHS. The aim of this study was to examine the relationship between private and NHS outpatient referral rates accounting for their association with deprivation.\nThis is a prospective survey of general practitioner referrals to private and NHS consultant-led services between 1 January and 31 December 2001 from 10 general practices in the Trent Focus Collaborative Research Network, United Kingdom. Patient referrals were aggregated to give private and NHS referral rates for each electoral ward in each practice.\nOf 17,137 referrals, 90.4 percent (15,495) were to the NHS and 9.6 percent (1642) to the private sector. Private referral rates were lower in patients from the most deprived fifth of wards compared with the least deprived fifth (rate ratio 0.25, 95 percent CI 0.15 to 0.41, p<0.001), whereas NHS referral rates were slightly higher in patients in the most deprived fifth of wards (rate ratio 1.18, 95 percent CI 0.98 to 1.42, p = 0.08) both after age standardisation and adjustment for practice. The NHS referral rate was significantly higher (rate ratio 1.40, 95 percent CI 1.15 to 1.71, p = 0.001) in wards with private referral rates in the top fifth compared with the bottom fifth after adjustment for deprivation and practice.\nDoes increased use of private health care reduce the demand for NHS care?",
        "answer": "no",
        "answer_rationale": "Increased private health care activity does not reduce the demand for NHS care: NHS and private referral rates were positively associated with each other after adjusting for age, deprivation and practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether increased use of private healthcare reduces demand on the NHS based on the study provided.\n\nFirst, I need to understand the study's findings. The study looked at referrals from general practitioners to both private and NHS services. They found that 90.4% of referrals were to the NHS and 9.6% to the private sector. \n\nLooking at the data broken down by deprivation: in the most deprived areas, private referrals were much lower (rate ratio 0.25 compared to the least deprived). Meanwhile, NHS referrals were slightly higher in the most deprived areas (rate ratio 1.18, but the p-value was 0.08, which is not statistically significant at the 0.05 level). However, when they looked at wards with higher private referral rates (top fifth), the NHS referral rate was significantly higher (rate ratio 1.40) compared to those with lower private rates, even after adjusting for deprivation and practice.\n\nHmm, so the key point here is that in areas where more people use private healthcare (top fifth), the NHS referrals are actually higher. That seems counterintuitive. If private use was reducing NHS demand, you'd expect the NHS referrals to be lower where private is higher. But the opposite is found here. The study's results suggest that higher private use is associated with higher NHS use, not lower. \n\nThe question is whether increased private use reduces NHS demand. The study's data shows a positive association between private and NHS referrals. So the answer would be no, it doesn't reduce demand. The correct answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 444,
            "completion_tokens": 346
        },
        "time_elapsed": 4.326890468597412
    },
    {
        "realidx": "15841770",
        "question": "Annual data on children aged under 16 y treated for asthma, including consumption of regular medication for asthma, numbers of hospital periods, lengths of hospitalizations and annual proportions of readmissions, were collected using patient-specific medical records from 1995 to 1999. In the Kuopio province, on average, 35.6-36.7/1000 children were on maintenance for asthma, of which 23% were receiving cromones, 51% were taking inhaled steroids and 26% were treated with cromones plus intermittent steroids. In the Oulu province, the respective prevalence was 32.7-34.9/1000, and the respective proportions were 5%, 93% and 2%.\nTotal and first admissions, as well as hospital days were clearly less in the Oulu province. In the children aged>or = 6y, the average annual total admissions were 0.3/1000 (Oulu) vs 1.2/1000 (Kuopio) (p<0.001). Similarly, the first admissions were 0.2/1000 vs 1.0/1000 (p<0.001), proportions of readmissions 6.3% vs 19.3% (p<0.05), and numbers of hospital days 0.7/1000 vs 3.8/1000 (p<0.001). The differences were in the same direction, though less prominent, also among children 2-5 y of age.\nDo inhaled steroids differ from cromones in terms of hospital admission rates for asthma in children?",
        "answer": "yes",
        "answer_rationale": "Our results suggest that inhaled steroids are better than cromones in preventing admissions for asthma when two provinces with different practices for maintenance medication of steady-state asthma were compared.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether inhaled steroids differ from cromones in terms of hospital admission rates for asthma in children, based on the provided data from Kuopio and Oulu provinces.\n\nFirst, I need to look at the data given. In Kuopio, 23% of children were on cromones, 51% on inhaled steroids, and 26% a combination. Oulu had 5% cromones, 93% inhaled steroids, and 2% combination. \n\nThe key outcomes are the hospital admissions. The Oulu province, which uses more inhaled steroids (93% vs 51% in Kuopio), has lower admission rates. For kids over 6, Oulu had 0.3 vs 1.2 total admissions per 1000. First admissions were 0.2 vs 1.0, readmissions 6.3% vs 19.3%, and hospital days 0.7 vs 3.8. These differences are statistically significant (p<0.001 or p<0.05). \n\nThe question is whether the difference in medication (steroids vs cromones) affects hospital rates. Since Oulu uses more steroids and has lower admissions, it suggests that steroids might be more effective in reducing admissions compared to cromones. The data shows a correlation between higher steroid use and lower admissions. The answer would be yes, they do differ, with steroids leading to lower rates. The options are A, B, C. So the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 468,
            "completion_tokens": 343
        },
        "time_elapsed": 4.4004597663879395
    },
    {
        "realidx": "15918864",
        "question": "Little is known about how information needs change over time in the early postpartum period or about how these needs might differ given socioeconomic circumstances. This study's aim was to examine women's concerns at the time of hospital discharge and unmet learning needs as self-identified at 4 weeks after discharge.\nData were collected as part of a cross-sectional survey of postpartum health outcomes, service use, and costs of care in the first 4 weeks after postpartum hospital discharge. Recruitment of 250 women was conducted from each of 5 hospitals in Ontario, Canada (n = 1,250). Women who had given vaginal birth to a single live infant, and who were being discharged at the same time as their infant, assuming care of their infant, competent to give consent, and able to communicate in one of the study languages were eligible. Participants completed a self-report questionnaire in hospital; 890 (71.2%) took part in a structured telephone interview 4 weeks after hospital discharge.\nApproximately 17 percent of participants were of low socioeconomic status. Breastfeeding and signs of infant illness were the most frequently identified concerns by women, regardless of their socioeconomic status. Signs of infant illness and infant care/behavior were the main unmet learning needs. Although few differences in identified concerns were evident, women of low socioeconomic status were significantly more likely to report unmet learning needs related to 9 of 10 topics compared with women of higher socioeconomic status. For most topics, significantly more women of both groups identified learning needs 4 weeks after discharge compared with the number who identified corresponding concerns while in hospital.\nLearning needs of postpartum women: does socioeconomic status matter?",
        "answer": "yes",
        "answer_rationale": "It is important to ensure that new mothers are adequately informed about topics important to them while in hospital. The findings highlight the need for accessible and appropriate community-based information resources for women in the postpartum period, especially for those of low socioeconomic status.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether socioeconomic status matters regarding the learning needs of postpartum women based on the provided study.\n\nFirst, I need to recall the key points from the study summary. The study aimed to examine women's concerns at hospital discharge and their unmet learning needs at 4 weeks. They had a sample of 1,250 women from Ontario. About 17% were of low socioeconomic status. \n\nThe results mentioned that breastfeeding and signs of infant illness were the top concerns for all women, regardless of their SES. However, when looking at unmet learning needs, the low SES group was significantly more likely to report unmet needs in 9 out of 10 topics compared to higher SES women. Also, both groups had more learning needs identified at 4 weeks than during hospital stay, but the disparity between SES groups was notable.\n\nThe question is whether SES matters. The key here is the difference in unmet needs between the two groups. Since the low SES group had more unmet needs across most topics, that suggests that SES does play a role. The answer options are yes, no, maybe. The study's findings clearly indicate a significant difference, so the answer should be (A) yes. The \"maybe\" might be a distractor if someone thinks there's uncertainty, but the study's results are stated as significant, so it's a clear yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 436,
            "completion_tokens": 296
        },
        "time_elapsed": 3.886991262435913
    },
    {
        "realidx": "15919266",
        "question": "The criteria for administration of adjuvant radiation therapy after thymoma resection remains controversial, and it is unclear whether patients with Masaoka stage III thymoma benefit from adjuvant radiation. The goal of this report was to determine whether or not this group benefits from radiation therapy in disease-specific survival and disease-free survival.\nCase records of the Massachusetts General Hospital were retrospectively reviewed from 1972 to 2004. One hundred and seventy-nine patients underwent resection for thymoma, of which 45 had stage III disease.\nForty-five stage III patients underwent resection and in 36 it was complete. Thirty-eight stage III patients received radiation therapy. Baseline prognostic factors between radiated and nonradiated groups were similar. The addition of adjuvant radiotherapy did not alter local or distant recurrence rates in patients with stage III thymoma. Disease-specific survival at 10 years in stage III patients who did not receive radiation was 75% (95% confidence interval, 32% to 100%) and in patients who did receive radiation therapy it was 79% (95% confidence interval, 64% to 94%) (p = 0.21). The most common site of relapse was the pleura.\nAdjuvant radiation of stage III thymoma: is it necessary?",
        "answer": "no",
        "answer_rationale": "Most patients who have stage III thymoma undergo complete resection. Some patients enjoy prolonged disease-free survival without adjuvant radiation after resection of stage III thymoma. Radiation does not seem to prevent pleural recurrences when given after resection of stage III thymomas. The use of routine adjuvant radiation after a complete resection of stage III thymoma needs to be re-addressed. There may be a role for the use of chemotherapy to reduce pleural recurrences.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether adjuvant radiation therapy is necessary for stage III thymoma after surgery. The provided study's results need to be analyzed to determine the correct answer.\n\nFirst, the study looked at 45 stage III patients. Out of these, 38 received radiation. The key point here is that the baseline factors between the groups were similar, so the comparison should be fair. The main outcomes are disease-specific survival and disease-free survival. \n\nThe results show that the 10-year disease-specific survival was 75% without radiation and 79% with radiation. The p-value is 0.21, which is not statistically significant. That means there's no significant difference between the two groups. Also, the addition of radiation didn't change local or distant recurrence rates. The most common relapse site was the pleura, but that doesn't indicate radiation's effectiveness here.\n\nSince the survival rates are almost the same and the p-value is high, the study suggests that radiation doesn't provide a significant benefit. Therefore, the conclusion would be that adjuvant radiation isn't necessary. The options are (A) yes, (B) no, (C) maybe. The answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 265
        },
        "time_elapsed": 3.400952100753784
    },
    {
        "realidx": "15943725",
        "question": "Serum pancreatic lipase may improve the diagnosis of pancreatitis compared to serum amylase. Both enzymes have been measured simultaneously at our hospital allowing for a comparison of their diagnostic accuracy.\nSeventeen thousand five hundred and thirty-one measurements of either serum amylase and or serum pancreatic lipase were made on 10 931 patients treated at a metropolitan teaching hospital between January 2001 and May 2003. Of these, 8937 were initially treated in the Emergency Department. These results were collected in a database, which was linked by the patients' medical record number to the radiology and medical records. Patients with either an elevated lipase value or a discharge diagnosis of acute pancreatitis had their radiological diagnosis reviewed along with their biochemistry and histology record. The diagnosis of acute pancreatitis was made if there was radiological evidence of peripancreatic inflammation.\nOne thousand eight hundred and twenty-five patients had either elevated serum amylase and or serum pancreatic lipase. The medical records coded for pancreatitis in a further 55 whose enzymes were not elevated. Three hundred and twenty of these had radiological evidence of acute pancreatitis. Receiver operator characteristic analysis of the initial sample from patients received in the Emergency Department showed improved diagnostic accuracy for serum pancreatic lipase (area under the curve (AUC) 0.948) compared with serum amylase (AUC, 0.906, P<0.05). A clinically useful cut-off point would be at the diagnostic threshold; 208 U/L (normal<190 U/L) for serum pancreatic lipase and 114 U/L (normal 27-100 U/L) for serum amylase where the sensitivity was 90.3 cf., 76.8% and the specificity was 93 cf., 92.6%. 18.8% of the acute pancreatitis patients did not have elevated serum amylase while only 2.9% did not have elevated serum pancreatic lipase on the first emergency department measurement.\nShould serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis?",
        "answer": "yes",
        "answer_rationale": "It is concluded that serum pancreatic lipase is a more accurate biomarker of acute pancreatitis than serum amylase.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether serum pancreatic lipase should replace serum amylase as a biomarker for acute pancreatitis based on the provided study.\n\nFirst, I need to recall what the key points in the study are. The study compared the diagnostic accuracy of lipase and amylase. The main findings mentioned are the AUC values: lipase had an AUC of 0.948 versus amylase's 0.906, which is statistically significant (P<0.05). A higher AUC means better accuracy, so lipase is better here. \n\nThen, looking at sensitivity and specificity. The sensitivity for lipase is 90.3% vs 76.8% for amylase. Sensitivity is the ability to correctly identify those with the disease. So lipase is better at catching actual cases. Specificity is almost the same (93% vs 92.6%), meaning both are good at ruling out false positives, but lipase is slightly better. \n\nThe study also mentions that 18.8% of pancreatitis patients didn't have elevated amylase, but only 2.9% had normal lipase. That's a big difference. Since lipase is less likely to give a false negative, it's more reliable. \n\nThe question is whether to replace amylase with lipase. The data clearly shows lipase is more accurate, especially in sensitivity. The study's conclusion supports using lipase because it's better at detecting the condition without a significant trade-off in specificity. So the answer should be yes, option A. \n\nWait, but maybe there's a reason not to? The options are yes, no, maybe. The study's data seems pretty conclusive. The AUC difference is significant, and the lower false negatives with lipase are a strong point. Unless there's some other factor like cost or availability, but the question doesn't mention that. The study's results are from a teaching hospital, but the sample size is large (over 10k patients). So I think the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 548,
            "completion_tokens": 445
        },
        "time_elapsed": 5.430714845657349
    },
    {
        "realidx": "15995461",
        "question": "This article examines the hypothesis that the six U.S. states with the highest rates of road traffic deaths (group 1 states) also had above-average rates of other forms of injury such as falling, poisoning, drowning, fire, suffocation, homicide, and suicide, and also for the retail trade and construction industries. The converse, second hypothesis, for the six states with the lowest rates of road traffic deaths (group 2 states) is also examined.\nData for these 12 states for the period 1983 to 1995 included nine categories of unintentional and four categories of intentional injury. Seventy-four percent of the group 1 states conformed to the first hypothesis, and 85% of the group 2 states conformed to the second hypothesis.\nDo some U.S. states have higher/lower injury mortality rates than others?",
        "answer": "yes",
        "answer_rationale": "Group 1 states are likely to exhibit above-average rates for most other categories of injury death, whereas group 2 states are even more likely to exhibit below-average rates for most other categories of injury death.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether some U.S. states have higher or lower injury mortality rates than others based on the provided article summary.\n\nFirst, I need to understand the study's setup. The article looks at two groups of states: group 1 with the highest road traffic death rates and group 2 with the lowest. They checked if group 1 also had higher rates in other injury categories, and group 2 had lower rates. The results showed 74% of group 1 states supported the first hypothesis, and 85% of group 2 supported the second. \n\nThe question is essentially asking if there's a variation in injury mortality rates among states. The study's findings indicate that states with high road traffic deaths also tend to have higher rates in other injuries, and those with low road deaths have lower rates in others. The percentages (74% and 85%) suggest a significant correlation. \n\nSo, the answer should be yes because the data shows that group 1 and 2 states conform to their respective hypotheses most of the time, implying that some states do have higher or lower overall injury mortality rates compared to others. The options are yes (A), no (B), maybe (C). Since the study supports the hypothesis, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 268,
            "completion_tokens": 274
        },
        "time_elapsed": 3.468116044998169
    },
    {
        "realidx": "16046584",
        "question": "Irregular bleeding affects many users of combined menopausal hormone therapy (HT) and commonly leads to invasive and expensive investigations to exclude underlying malignancy. In most cases no abnormality is found.\nThe main objective of this study was to explore the role of uterine natural killer (uNK) cells and their regulatory cytokine IL-15 in irregular bleeding in HT users.\nThis was a prospective observational study conducted between 2002 and 2004.\nThe study was conducted in a tertiary referral menopause clinic at King Edward Memorial Hospital, Western Australia.\nPatients included 117 postmenopausal women taking combined HT.\nOutpatient endometrial biopsies were taken during and outside bleeding episodes.\nThe relationship between endometrial uNK cells (CD56+) and bleeding patterns was measured. We also addressed the impact of HT exposure on uNK cell populations, the relationship between endometrial IL-15 expression and uNK cell populations, and killer Ig like receptor genotype in subjects with irregular bleeding.\nEndometrial CD56+ uNK cells were significantly increased in biopsies obtained during bleeding episodes (P<0.001), compared with HT users with no bleeding. The highest level of IL-15 expression was also seen in biopsies taken during bleeding. No clear relationship between killer Ig like receptor genotype and bleeding on HT was observed.\nMenopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?",
        "answer": "yes",
        "answer_rationale": "Little is known about the mechanisms underlying irregular bleeding in HT users. This is the first report of uNK cells and their association with regulating cytokines in postmenopausal endometrium and demonstrates a possible mechanism by which HT may induce irregular bleeding.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether menopausal hormone therapy and irregular endometrial bleeding have a potential role for uterine natural killer cells. The options are yes, no, maybe.\n\nFirst, I need to look at the study details provided. The main objective was to explore the role of uNK cells and IL-15 in irregular bleeding among HT users. The study found that during bleeding episodes, the CD56+ uNK cells were significantly increased (P<0.001) compared to when there was no bleeding. Also, IL-15 expression was highest during bleeding. The killer Ig like receptor genotype didn't show a clear link. \n\nSo the study's results show a strong association between the presence of uNK cells and bleeding episodes. Since the question is asking if there's a potential role, the answer would be yes because the data supports that uNK cells are involved. The title of the study even poses it as a question, but the results answer it affirmatively. The options are (A) yes, so that's the answer. The other options don't fit because the study found significant correlations.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 399,
            "completion_tokens": 244
        },
        "time_elapsed": 3.7990634441375732
    },
    {
        "realidx": "16147837",
        "question": "To compare maternal and neonatal outcomes among grandmultiparous women to those of multiparous women 30 years or older.\nA database of the vast majority of maternal and newborn hospital discharge records linked to birth/death certificates was queried to obtain information on all multiparous women with a singleton delivery in the state of California from January 1, 1997 through December 31, 1998. Maternal and neonatal pregnancy outcomes of grandmultiparous women were compared to multiparous women who were 30 years or older at the time of their last birth.\nThe study population included 25,512 grandmultiparous and 265,060 multiparous women 30 years or older as controls. Grandmultiparous women were predominantly Hispanic (56%). After controlling for potential confounding factors, grandmultiparous women were at significantly higher risk for abruptio placentae (odds ratio OR: 1.3; 95% confidence intervals CI: 1.2-1.5), preterm delivery (OR: 1.3; 95% CI: 1.2-1.4), fetal macrosomia (OR: 1.5; 95% CI: 1.4-1.6), neonatal death (OR: 1.5; 95% CI: 1.3-1.8), postpartum hemorrhage (OR: 1.2; 95% CI: 1.1-1.3) and blood transfusion (OR: 1.5; 95% CI: 1.3-1.8).\nIs grandmultiparity an independent risk factor for adverse perinatal outcomes?",
        "answer": "yes",
        "answer_rationale": "Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether grandmultiparity is an independent risk factor for adverse perinatal outcomes based on the provided study.\n\nFirst, I need to recall what grandmultiparity means. Grandmultiparous women are those who have had five or more pregnancies. The study compared them to multiparous women aged 30 or older. The key here is understanding if the increased risks found are independent of other factors.\n\nThe study mentions that they controlled for potential confounding factors. That's important because it suggests they accounted for variables like age, ethnicity, or other health issues that might influence the outcomes. The results showed higher odds ratios for several adverse outcomes in grandmultiparous women: abruptio placentae, preterm delivery, fetal macrosomia, neonatal death, postpartum hemorrhage, and blood transfusion. All these ORs are above 1, and the confidence intervals don't include 1, which means the results are statistically significant.\n\nSince the question is about whether grandmultiparity is an independent risk factor, the fact that they controlled for confounders and still found significant associations indicates that grandmultiparity itself contributes to these risks. The answer should be yes. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 465,
            "completion_tokens": 271
        },
        "time_elapsed": 3.6455469131469727
    },
    {
        "realidx": "16266387",
        "question": "Lifestyle changes over the last 30 years are the most likely explanation for the increase in allergic disease over this period.AIM: This study tests the hypothesis that the consumption of fast food is related to the prevalence of asthma and allergy.\nAs part of the International Study of Asthma and Allergies in Childhood (ISAAC) a cross-sectional prevalence study of 1321 children (mean age = 11.4 years, range: 10.1-12.5) was conducted in Hastings, New Zealand. Using standard questions we collected data on the prevalence of asthma and asthma symptoms, as well as food frequency data. Skin prick tests were performed to common environmental allergens and exercise-induced bronchial hyperresponsiveness (BHR) was assessed according to a standard protocol. Body mass index (BMI) was calculated as weight/height2 (kg/m2) and classified into overweight and obese according to a standard international definition.\nAfter adjusting for lifestyle factors, including other diet and BMI variables, compared with children who never ate hamburgers, we found an independent risk of hamburger consumption on having a history of wheeze [consumption less than once a week (OR = 1.44, 95% CI: 1.06-1.96) and 1+ times a week (OR = 1.65, 95% CI: 1.07-2.52)] and on current wheeze [consumption less than once a week (OR = 1.17, 95% CI: 0.80-1.70) and 1+ times a week (OR = 1.81, 95% CI: 1.10-2.98)]. Takeaway consumption 1+ times a week was marginally significantly related to BHR (OR = 2.41, 95% CI: 0.99-5.91). There was no effect on atopy.\nFast foods - are they a risk factor for asthma?",
        "answer": "yes",
        "answer_rationale": "Frequent consumption of hamburgers showed a dose-dependent association with asthma symptoms, and frequent takeaway consumption showed a similar association with BHR.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether fast foods are a risk factor for asthma based on the provided study.\n\nFirst, I need to recall the study's findings. The study was part of ISAAC, involving over 1300 children. They looked at the relationship between fast food consumption (like hamburgers and takeaway) and asthma symptoms, allergies, etc. \n\nThe key results mentioned are the odds ratios (OR) for wheeze. For hamburger consumption, even after adjusting for other factors, kids who ate hamburgers less than once a week had an OR of 1.44 for having a history of wheeze. Those eating once or more had an even higher OR of 1.65. For current wheeze, the OR was 1.81 for the higher consumption group. The takeaway once a week had a marginal link to BHR, but the confidence interval included 1 (since 0.99 is almost 1), so that's not statistically significant. Also, no effect on atopy (allergies) was found.\n\nThe question is whether fast food is a risk factor. The study shows a positive association between hamburgers (a fast food) and wheeze, which is a symptom of asthma. The ORs are above 1 and the confidence intervals don't include 1 for some categories, indicating statistical significance. Since the study adjusted for other factors, the link seems independent. \n\nTakeaway's effect on BHR was only marginally significant, but the main point is the hamburger results. Since wheeze is a key asthma symptom, and the study found increased risk, the answer would lean towards \"yes\". The options are A, B, C. The study supports the hypothesis that fast food (hamburgers here) is a risk factor. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 526,
            "completion_tokens": 391
        },
        "time_elapsed": 4.479596138000488
    },
    {
        "realidx": "16296668",
        "question": "To investigate the ability of a bedside swallowing assessment to reliably exclude aspiration following acute stroke.\nConsecutive patients admitted within 24 h of stroke onset to two hospitals.\nA prospective study. Where possible, all patients had their ability to swallow assessed on the day of admission by both a doctor and a speech and language therapist using a standardized proforma. A videofluoroscopy examination was conducted within 3 days of admission.\n94 patients underwent videofluoroscopy; 20 (21%) were seen to be aspirating, although this was not detected at the bedside in 10. In 18 (22%) of the patients the speech and language therapist considered the swallow to be unsafe. In the medical assessment, 39 patients (41%) had an unsafe swallow. Bedside assessment by a speech and language therapist gave a sensitivity of 47%, a specificity of 86%, positive predictive value (PPV) of 50% and a negative predictive value (NPV) of 85% for the presence of aspiration. Multiple logistic regression was used to identify the optimum elements of the bedside assessments for predicting the presence of aspiration. A weak voluntary cough and any alteration in conscious level gave a sensitivity of 75%, specificity of 72%, PPV of 41% and NPV of 91% for aspiration.\nCan bedside assessment reliably exclude aspiration following acute stroke?",
        "answer": "no",
        "answer_rationale": "Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether bedside assessment can reliably exclude aspiration following an acute stroke. The options are yes, no, or maybe. \n\nFirst, I need to look at the data provided. The study involved 94 patients who had videofluoroscopy, which is the gold standard for detecting aspiration. Out of these, 20 (21%) were found to be aspirating. However, the bedside assessment by the speech and language therapist missed 10 of those cases. That means the sensitivity of the bedside assessment was 47%, which is the ability to correctly identify those with the condition. A lower sensitivity means more false negatives, so some aspirating patients aren't detected.\n\nThe negative predictive value (NPV) was 85%, which is the probability that a patient doesn't have the condition if the test is negative. An NPV of 85% isn't perfect, but it's not terrible. However, the question is about reliably excluding aspiration. The NPV tells us that if the bedside test is negative, there's an 85% chance they don't aspirate, but 15% chance they might still have it. That's a significant risk, especially in a critical situation like post-stroke where aspiration can lead to pneumonia.\n\nThen, the study mentions that using a combination of a weak voluntary cough and altered consciousness improved the sensitivity to 75% and NPV to 91%. The NPV here is better, but still not 100%. A 9% chance of missing aspiration might still be too high for reliable exclusion. \n\nIn clinical practice, if the goal is to exclude aspiration reliably, you want a very high NPV. Since even the best combination here only gets to 91%, there's still a 9% false negative rate. That might not be sufficient to confidently say it can reliably exclude aspiration. The question is whether \"reliably\" here means high enough to be trusted, and given that there's still a non-negligible chance of missing cases, the answer might be no. \n\nThe options are yes, no, maybe. The study's results show that while the bedside assessment has some predictive value, it's not perfect. The NPV isn't high enough to be considered reliable for exclusion in all cases. Therefore, the answer is probably B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 385,
            "completion_tokens": 498
        },
        "time_elapsed": 6.60068416595459
    },
    {
        "realidx": "16392897",
        "question": "Quantitative real-time PCR has become the predominant molecular technique to monitor BCRABL levels in response to treatment in Ph(+) leukemia patients. However, without some form of standardized methodology between laboratories, the correlation of results is difficult.\nUsing TaqMan-based assays, parallel quantitative real-time PCR analysis was performed on 70 clinical specimens at Vanderbilt University Medical Center and Virginia Commonwealth University. While the same positive control cell line (K562) and quality control gene (BCR) were used, the RNA isolation technique, cDNA synthesis, BCR control cell line, and PCR primer and probe sequences were different.\nThe detection of BCRABL-positive results spanned a dynamic range from 10(0) to 10(5)/100,000 cells. Forty-three samples were negative at both facilities. A Spearman rank correlation analysis was performed for the 22 BCRABL-positive paired results. The correlation coefficient, r(s), was 0.9435 (p<0.00001), suggesting a strong correlation of the results. One discordant result was obtained for consecutive samples from one patient with a low BCRABL copy number as a result of a minimal RNA yield at one laboratory.\nBCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays?",
        "answer": "maybe",
        "answer_rationale": "These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for patients who are monitored at different facilities, but also for larger investigative studies in which hematologic, cytogenetic and molecular responses are to be compared.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether correlated results are possible from homebrew assays when detecting BCR-ABL transcripts using quantitative real-time PCR. The question is based on a study described where two labs used different methodologies but some common elements like the same positive control and quality control gene.\n\nFirst, I need to recall what the study found. The key points are that even though the labs had differences in RNA isolation, cDNA synthesis, and primer/probe sequences, they still found a strong correlation (Spearman r(s) of 0.9435 with p<0.00001) in 22 positive samples. Only one discordant result came up, probably due to low RNA yield in one lab. \n\nThe options are yes, no, maybe. The high correlation coefficient (close to 1) indicates a strong positive relationship between the two labs' results. The p-value being very low suggests this correlation is statistically significant. The fact that most results correlated well, except for one case with technical issues (low RNA), implies that despite methodological differences, the assays can still produce correlated results. The question is whether \"correlated results are possible,\" and the study's outcome supports that they are, except in cases with technical problems. So the answer should be yes (A). The presence of one discordant result might make someone think \"maybe,\" but the strong overall correlation and the reason for the discrepancy (technical issue, not the assay design) points towards \"yes\" being correct.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 367,
            "completion_tokens": 319
        },
        "time_elapsed": 4.482458114624023
    },
    {
        "realidx": "16403186",
        "question": "To examine family-based transmission of the number of 5' flanking arginine vasopressin V1a receptor (AVPR1A) microsatellites, which include [(GATA)(14)] and complex [(CT)(4)-TT-(CT)(8)-(GT)(24)]repeats, in probands with a prepubertal and early adolescent bipolar disorder phenotype (PEA-BP). Preferential transmission of the number of AVPR1A microsatellite repeats to hypersexual and uninhibited people-seeking probands was hypothesized, based on reports from preclinical work in the literature.\nProbands were 83 participants in an ongoing controlled study of PEA-BP. The PEA-BP phenotype was defined by DSM-IV mania with at least one of the cardinal symptoms of mania (elation and/or grandiosity) to avoid diagnosing mania only by symptoms that overlapped with those for attention-deficit hyperactivity disorder (ADHD). Comprehensive assessment of the probands included separate Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) interviews of parents about their children and of children about themselves. Hypersexuality and uninhibited people-seeking were assessed from the corresponding WASH-U-KSADS items. Microsatellite genotyping of the AVPR1A repeats was conducted using fluorescently labeled primers and detected by laser-induced fluorescence. Alleles were determined with the assistance of semi-automated allele-calling software. There were 32 complete, biological trios (28 informative families) for the GATA repeat and 34 complete, biological trios (30 informative families) for the complex repeat. Data were analyzed using case-control and family-based association methods.\nPreferential transmission of AVPR1A GATA or complex repeats was not significant for hypersexuality or uninhibited people-seeking, using the transmission disequilibrium test. Similarly, case-control analyses found no significant associations between hypersexuality or uninhibited people-seeking and the number of AVPR1A GATA or complex repeats. For p<0.05, there was about 80% power to detect odds ratios of 5.0 and 4.0 (in the family-based analyses) and 3.5 and 2.6 (in the case-control analyses), for allele frequencies of 0.1 and 0.5, respectively.\nAre the arginine vasopressin V1a receptor microsatellites related to hypersexuality in children with a prepubertal and early adolescent bipolar disorder phenotype?",
        "answer": "no",
        "answer_rationale": "Preferential transmission of AVPR1A to hypersexual or uninhibited people-seeking probands was not supported.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the arginine vasopressin V1a receptor (AVPR1A) microsatellites are related to hypersexuality in children with a prepubertal and early adolescent bipolar disorder phenotype (PEA-BP). \n\nFirst, I need to look at the study described. The question mentions that the researchers were examining family-based transmission of these microsatellites in probands with PEA-BP. They hypothesized that there would be preferential transmission of the repeats to those with hypersexuality and uninhibited people-seeking traits, based on preclinical reports.\n\nThe study involved 83 participants, with specific criteria for diagnosing PEA-BP to avoid overlap with ADHD. They used the WASH-U-KSADS interviews to assess symptoms. The genotyping was done using fluorescent primers and analyzed with software. They had a decent number of trios (parent and child) for both the GATA and complex repeats.\n\nThe key results here are that the transmission disequilibrium test (a family-based association method) didn't show significant preferential transmission for either the GATA or complex repeats regarding hypersexuality or the other trait. Also, case-control analyses didn't find any significant associations either. The study had 80% power to detect certain odds ratios, which suggests that if there were an effect of that magnitude, they likely would have found it. Since they didn't find significance, the conclusion is that there's no evidence supporting the hypothesis.\n\nThe options are yes, no, maybe. The study's results are negative, so the answer should be B) no. The \"maybe\" might be tempting if there was some trend or underpowered study, but the power here was adequate for the effect sizes they mention. Since the p-value wasn't below 0.05 and they state no significant associations, the correct answer is no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 627,
            "completion_tokens": 396
        },
        "time_elapsed": 4.9206929206848145
    },
    {
        "realidx": "16418930",
        "question": "Assessment of visual acuity depends on the optotypes used for measurement. The ability to recognize different optotypes differs even if their critical details appear under the same visual angle. Since optotypes are evaluated on individuals with good visual acuity and without eye disorders, differences in the lower visual acuity range cannot be excluded. In this study, visual acuity measured with the Snellen E was compared to the Landolt C acuity.\n100 patients (age 8 - 90 years, median 60.5 years) with various eye disorders, among them 39 with amblyopia due to strabismus, and 13 healthy volunteers were tested. Charts with the Snellen E and the Landolt C (Precision Vision) which mimic the ETDRS charts were used to assess visual acuity. Three out of 5 optotypes per line had to be correctly identified, while wrong answers were monitored. In the group of patients, the eyes with the lower visual acuity, and the right eyes of the healthy subjects, were evaluated.\nDifferences between Landolt C acuity (LR) and Snellen E acuity (SE) were small. The mean decimal values for LR and SE were 0.25 and 0.29 in the entire group and 0.14 and 0.16 for the eyes with strabismus amblyopia. The mean difference between LR and SE was 0.55 lines in the entire group and 0.55 lines for the eyes with strabismus amblyopia, with higher values of SE in both groups. The results of the other groups were similar with only small differences between LR and SE.\nLandolt C and snellen e acuity: differences in strabismus amblyopia?",
        "answer": "no",
        "answer_rationale": "Using the charts described, there was only a slight overestimation of visual acuity by the Snellen E compared to the Landolt C, even in strabismus amblyopia. Small differences in the lower visual acuity range have to be considered.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there are differences in Landolt C and Snellen E acuity in strabismus amblyopia. The study mentioned compared these two optotypes in various groups, including 39 patients with amblyopia due to strabismus.\n\nLooking at the results: For the entire group, the mean decimal values were 0.25 (Landolt C) and 0.29 (Snellen E). For the strabismus amblyopia group specifically, the values were 0.14 and 0.16 respectively. The mean difference between the two tests was 0.55 lines in both the entire group and the amblyopia subgroup. The Snellen E scores were higher in both cases. \n\nThe question is whether there's a difference. The study states that even in the amblyopia group, the difference was 0.55 lines, which is the same as the overall group. The text also mentions that \"the results of the other groups were similar with only small differences between LR and SE.\" So even in strabismus amblyopia, the difference exists but is small. The options are yes, no, maybe. Since the study found a consistent difference (even if small), the answer would be yes. But wait, the options might be tricky. The question is phrased as \"differences in strabismus amblyopia?\" The study says that in that group, the difference was the same as others. So the answer is yes, there are differences. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 462,
            "completion_tokens": 340
        },
        "time_elapsed": 3.9299333095550537
    },
    {
        "realidx": "16465002",
        "question": "To study the correlation and agreement between end-tidal carbon dioxide (EtCO2) and arterial carbon dioxide (PaCO(2)) in ventilated extremely low birth weight (ELBW) infants in the first week of life.\nRetrospective chart review of all ELBW (<1,000 g) infants admitted to a level III NICU from January 2003 to December 2003. Data collected included demographic details and simultaneous EtCO(2) (mainstream capnography) and arterial blood gas values (pH, PaCO(2), PaO(2)).\nThe correlation coefficient, degree of bias with 95% confidence interval between the EtCO(2) and PaCO(2).\nThere were 754 end-tidal and arterial CO(2) pairs from 31 ELBW infants (21 male and 10 female). The overall EtCO(2) values were significantly lower than PaCO(2) value. In only 89/754(11.8%) pairs, the EtCO(2) was higher than the PaCO(2). The overall bias was 5.6 +/- 6.9 mmHg (95% C.I. 5.11-6.09). The intraclass correlation coefficient was 0.81. Using EtCO2 ranges of 30 to 50 mmHg, the capnographic method was able to identify 84% of instances where PaCO(2) was between 35 (<35 = hypocarbia) and 55 mmHg (>55= hypercapnia).\nDose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life?",
        "answer": "yes",
        "answer_rationale": "There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether end-tidal CO2 (EtCO2) correlates with arterial CO2 (PaCO2) in extremely low birth weight (ELBW) infants during their first week of life. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided study details. The study was a retrospective chart review of 31 ELBW infants, with 754 pairs of EtCO2 and PaCO2 measurements. The key findings mentioned are the correlation coefficient and the intraclass correlation coefficient. The overall bias was 5.6 mmHg, but the important part here is the correlation. \n\nThe intraclass correlation coefficient (ICC) was 0.81. I remember that correlation coefficients range from -1 to 1, where 1 is a perfect positive correlation. An ICC of 0.81 is quite high, indicating a strong correlation. The question is about correlation, so this value directly answers that. Additionally, the study states that using EtCO2 ranges could identify 84% of instances where PaCO2 was within the target range. Even though EtCO2 was often lower than PaCO2, the correlation coefficient suggests a strong relationship. \n\nThe options are yes, no, maybe. Since the ICC is 0.81, which is a strong positive correlation, the answer should be yes. The bias and the fact that sometimes EtCO2 was lower might make someone think maybe, but the question specifically asks about correlation, not agreement. Correlation refers to the relationship between the two variables, not whether they are exactly the same. So a high ICC means they do correlate well. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 464,
            "completion_tokens": 362
        },
        "time_elapsed": 4.443258762359619
    },
    {
        "realidx": "16538201",
        "question": "To determine whether the use of hydrophilic guidewires has increased the technical success rate of peripheral percutaneous transluminal angioplasty (PTA).MATERIAL/\nWe performed 125 procedures and analyzed the technical success rates of PTA using the conventional guidewire first and then if needed, the hydrophilic guidewire for iliac and SFA stenoses or occlusions. Angioplasty was performed on 25 stenosed, 25 occluded iliac arteries and 25 stenosed, 50 occluded femoral arteries. The result was defined as technical success when the lesion was crossed by a guidewire and balloon, then it was dilated with restoration of vessel lumen and less than 30% residual stenosis and the rise in ABI values was at least 0.15 after 24 hours.\nThe technical success rate after PTA of stenosed iliac arteries was achieved in 96% (24/25) using conventional wires and 100% using hydrophilic guidewire; in iliac occlusions, the rates were 60% (15/25) and 96%, respectively; in femoral stenosis - 84% (21/25) and 100%; in occlusions in the first group: lesions<10 cm -64% (16/25) and 96%, in the second group: lesions>10 cm -48% (12/25) and 88%. In the iliac group, there was no significant difference in the success of iliac stenosis PTA. However, there were significant changes in the success rates of PTA performed for SFA stenosis and iliac and SFA occlusions.\nDoes use of hydrophilic guidewires significantly improve technical success rates of peripheral PTA?",
        "answer": "maybe",
        "answer_rationale": "In summary, we report an overall improvement and high technical success rate for peripherial PTA. The use of hydrophilic guidewires made significant difference to the technical success rate of PTA, especially in occlusion and more complicated lesions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether hydrophilic guidewires significantly improve the technical success rates of peripheral PTA based on the provided study data.\n\nFirst, I need to understand the data given. The study compared conventional and hydrophilic guidewires in different types of lesions: stenosed vs. occluded in iliac and femoral arteries. The technical success is defined by crossing the lesion, restoring the lumen with less than 30% residual stenosis, and an ABI increase of at least 0.15 after 24 hours.\n\nLooking at the numbers:\n\nFor iliac stenosis:\n- Conventional: 96% (24/25)\n- Hydrophilic: 100%\nThe difference here is small (4%), and the text mentions there was no significant difference in iliac stenosis. So hydrophilic didn't make a significant improvement here.\n\nIliac occlusions:\n- Conventional: 60% (15/25)\n- Hydrophilic: 96%\nThat's a big jump. 60% to 96% is a 36% increase. The question is whether this is significant. The study states there were significant changes in success rates for iliac occlusions and SFA (superficial femoral artery) cases.\n\nFor femoral (SFA?) stenosis:\n- Conventional: 84% to 100% with hydrophilic. That's a 16% increase. The text says there were significant changes here too.\n\nIn femoral occlusions, they split into <10cm and >10cm:\n- <10cm occlusions: conventional 64% vs hydrophilic 96% (32% improvement)\n- >10cm occlusions: conventional 48% vs hydrophilic 88% (40% improvement)\nAgain, those are substantial increases. The study mentions significant changes in SFA occlusions as well.\n\nThe key point is that while in iliac stenosis there was no significant difference, the other categories (occlusions in iliac, SFA stenosis, and SFA occlusions) all showed significant improvements with hydrophilic wires. The question is whether overall, the use of hydrophilic guidewires \"significantly improve technical success rates of peripheral PTA\". Since the study states there were significant",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 494,
            "completion_tokens": 512
        },
        "time_elapsed": 6.866511583328247
    },
    {
        "realidx": "16678696",
        "question": "It is widely accepted that exemplary surgical care involves a surgeon's involvement in the preoperative, perioperative, and postoperative periods. In an era of ever-expanding therapeutic modalities available to the vascular surgeon, it is important that trainees gain experience in preoperative decision-making and how this affects a patient's operative and postoperative course. The purpose of this study was to define the current experience of residents on a vascular surgery service regarding the continuity of care they are able to provide for patients and the factors affecting this experience.\nThis prospective cohort study was approved by the Institutional Review Board and conducted at the University of British Columbia during January 2005. All patients who underwent a vascular procedure at either of the two teaching hospitals were included. In addition to type of case (emergent, outpatient, inpatient), resident demographic data and involvement in each patient's care (preoperative assessment, postoperative daily assessment, and follow-up clinic assessment) were recorded. Categoric data were analyzed with the chi2 test.\nThe study included 159 cases, of which 65% were elective same-day admission patients, 20% were elective previously admitted patients; and 15% were emergent. The overall rate of preoperative assessment was 67%, involvement in the decision to operate, 17%; postoperative assessment on the ward, 79%; and patient follow-up in clinic, 3%. The rate of complete in-hospital continuity of care (assessing patient pre-op and post-op) was 57%. Emergent cases were associated with a significantly higher rate of preoperative assessment (92% vs 63%, P<.05). For elective cases admitted before the day of surgery compared with same-day admission patients, the rates of preoperative assessment (78% vs 58%, P<.05) and involvement in the decision to operate (16% vs 4%, P<.05) were significantly higher.\nContinuity of care experience of residents in an academic vascular department: are trainees learning complete surgical care?",
        "answer": "no",
        "answer_rationale": "The continuity-of-care experiences of vascular trainees are suboptimal. This is especially true for postoperative clinic assessment. Same-day admission surgery accounted for most of the cases and was associated with the poorest continuity of care. To provide complete surgical training in an era of changing therapeutic modalities and same-day admission surgery, vascular programs must be creative in structuring training to include adequate ambulatory experience.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether vascular surgery residents are getting complete continuity of care experience. The options are yes, no, maybe.\n\nFirst, I need to look at the data provided. The study says the overall rate of preoperative assessment was 67%, involvement in the decision to operate was only 17%, postoperative ward assessment was 79%, and follow-up in clinic was a mere 3%. The complete in-hospital continuity (both pre-op and post-op) was 57%. \n\nHmm, so complete in-hospital continuity is 57%, which is less than half. But the question is about \"complete surgical care,\" which probably includes pre-op, peri-op, and post-op. The follow-up in clinic is really low, 3%, which is a big red flag. That's part of the postoperative follow-up, right? So even if they did pre and post in the hospital, the outpatient follow-up is almost non-existent. \n\nThe study's purpose was to see if trainees are gaining experience in continuity. The results show that most of them aren't following patients through all phases. The emergent cases had higher pre-op involvement, but elective same-day admissions had lower pre-op assessment and decision involvement. Since follow-up is so low, the residents aren't seeing patients through the entire continuum. \n\nThe question is whether they are learning complete surgical care. The answer would be no because the rates, especially follow-up, are too low. The 57% in-hospital continuity doesn't account for the clinic follow-up, which is part of the postoperative phase. So overall, they aren't getting complete experience. The correct answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 520,
            "completion_tokens": 360
        },
        "time_elapsed": 4.342073440551758
    },
    {
        "realidx": "16713745",
        "question": "Cytokine concentration in pancreatic juice of patients with pancreatic disease is unknown. Secretin stimulation allows endoscopic collection of pancreatic juice secreted into the duodenum. We aimed to evaluate the cytokine concentrations in pancreatic juice of patients with abdominal pain to discriminate presence from absence of pancreatic disease.\nFrom January 2003-December 2004, consecutive patients with abdominal pain compatible with pancreatic origin were enrolled. Patients underwent upper endoscopy. Intravenous secretin (0.2 mug/kg) was given immediately before scope intubation. Pancreatic juice collected from the duodenum was immediately snap-frozen in liquid nitrogen until assays were performed. Pancreatic juice levels of interleukin-8, interleukin-6, intercellular adhesion molecule 1, and transforming growth factor-beta 1 were measured by modified enzyme-linked immunosorbent assays. The final diagnosis was made by the primary gastroenterologist on the basis of medical history; laboratory, endoscopic, and imaging studies; and clinical follow-up. Fisher exact test and Kruskal-Wallis rank sum test were used for statistical analysis.\nOf 130 patients screened, 118 met the inclusion criteria. Multivariate analysis revealed that only interleukin-8 was able to discriminate between normal pancreas and chronic pancreatitis (P = .011), pancreatic cancer (P = .044), and the presence of pancreatic diseases (P = .007). Individual cytokine concentrations were not significantly different in chronic pancreatitis compared with pancreatic cancer.\nDo cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases?",
        "answer": "yes",
        "answer_rationale": "Cytokine levels can be measured in pancreatic juice obtained from the duodenum without direct cannulation of the pancreatic duct. Interleukin-8 concentration in pancreatic juice can be used to discriminate between normal pancreas and patients with pancreatic disease. This is a relatively simple and noninvasive method to aid in the diagnosis of pancreatic diseases.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether cytokine concentrations in pancreatic juice can predict the presence of pancreatic diseases. The study mentioned looked at several cytokines like interleukin-8, interleukin-6, intercellular adhesion molecule 1, and transforming growth factor-beta 1.\n\nThe key part here is the results from the multivariate analysis. It says that only interleukin-8 was able to discriminate between normal pancreas and chronic pancreatitis (P = .011), pancreatic cancer (P = .044), and the presence of pancreatic diseases overall (P = .007). The other cytokines didn't show significant differences between chronic pancreatitis and cancer. \n\nSo the question is whether cytokines (in general) predict pancreatic diseases. Since interleukin-8, which is a cytokine, was found to have significant differences, the answer would be yes. The fact that other cytokines didn't make a difference doesn't negate the fact that at least one cytokine (IL-8) was predictive. The options are yes, no, maybe. The study's results support that at least one cytokine can predict, so the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 426,
            "completion_tokens": 256
        },
        "time_elapsed": 3.7242743968963623
    },
    {
        "realidx": "16735905",
        "question": "To investigate polysomnographic and anthropomorphic factors predicting need of high optimal continuous positive airway pressure (CPAP).\nRetrospective data analysis.\nThree hundred fifty-three consecutive obstructive sleep apnea (OSA) patients who had a successful manual CPAP titration in our sleep disorders unit.\nThe mean optimal CPAP was 9.5 +/- 2.4 cm H2O. The optimal CPAP pressure increases with an increase in OSA severity from 7.79 +/- 2.2 in the mild, to 8.7 +/- 1.8 in the moderate, and to 10.1 +/- 2.3 cm H2O in the severe OSA group. A high CPAP was defined as the mean + 1 standard deviation (SD;>or =12 cm H2O). The predictor variables included apnea-hypopnea index (AHI), age, sex, body mass index (BMI), Epworth Sleepiness Scale (ESS), and the Multiple Sleep Latency Test (MSLT). High CPAP was required in 2 (6.9%), 6 (5.8%), and 63 (28.6%) patients with mild, moderate, and severe OSA, respectively. On univariate analysis, AHI, BMI, ESS score, and the proportion of males were significantly higher in those needing high CPAP. They also have a lower MSLT mean. On logistic regression, the use of high CPAP was 5.90 times more frequent (95% confidence interval 2.67-13.1) in severe OSA patients after adjustment for the other variables. The area under the receiver operator curve was 72.4%, showing that the model was adequate.\nDoes the severity of obstructive sleep apnea predict patients requiring high continuous positive airway pressure?",
        "answer": "maybe",
        "answer_rationale": "Severe OSA patients are much more likely to need high CPAP levels. However, because of the low positive predictive value (only 28.6%), the clinical value of such information is limited. ESS and MSLT did not increase the predictive value for the need for high CPAP.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the severity of obstructive sleep apnea (OSA) predicts patients requiring high continuous positive airway pressure (CPAP). The options are yes, no, or maybe.\n\nFirst, I need to look at the provided study details. The study analyzed 353 OSA patients who had successful CPAP titration. The mean optimal CPAP was 9.5 cm H2O. They noted that the optimal CPAP increased with OSA severity: mild (7.79), moderate (8.7), and severe (10.1). High CPAP was defined as above 12 cm H2O (mean + 1 SD). \n\nThe results showed that only 2% of mild, 6% of moderate, and 28.6% of severe OSA patients needed high CPAP. Univariate analysis found that AHI, BMI, ESS, and male proportion were higher in those needing high CPAP. The logistic regression showed that severe OSA patients were 5.9 times more likely to require high CPAP after adjusting for other variables. The model's ROC was 72.4%, which is considered adequate.\n\nThe key point here is the logistic regression result. Even after adjusting for other variables like BMI and AHI, severe OSA was a significant predictor. The odds ratio of 5.9 suggests a strong association. Since the question is whether severity predicts high CPAP need, the answer should be yes. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 477,
            "completion_tokens": 335
        },
        "time_elapsed": 4.63467001914978
    },
    {
        "realidx": "16769333",
        "question": "Despite surgical refinements, perioperative use of tracheobronchoscopy (TBS) as part of surgical approach to esophageal atresia (EA) is still controversial. The purpose of this study was to evaluate the influence of preoperative TBS in newborns with EA in preventing complications and improving diagnosis and surgical treatment.\nIn the period ranging from 1997 to 2003, 62 patients with EA underwent preoperative TBS. The procedure was carried out with flexible bronchoscope maintaining spontaneous breathing. When a wide carinal fistula was found, this was mechanically occluded by Fogarty catheter and cannulated with rigid bronchoscopy. Type of EA, surgical procedure variations caused by TBS, and associated anomalies not easily detectable were recorded.\nBefore TBS, the Gross classification of the 62 patients was as follows: type A, 9 patients; type B, none; type C, 51 patients. At TBS, however, 3 of 9 type A patients had an unsuspected proximal fistula (type B). These 3 patients, plus the 2 with H-type fistula, were repaired through a cervical approach. In 4 patients, previously undetected malformations of the respiratory tree (2 aberrant right upper bronchus and 2 hypoplastic bronchi) were found at TBS. Carinal fistulas in 14 type C patients were occluded by Fogarty catheter to improve ventilation during repair. No complications were observed. Overall, TBS was clinically useful in 28 (45.2%) of 62 patients, including 15 (24.2%) of 62 infants in whom it was crucial in modifying the surgical approach.\nPreoperative tracheobronchoscopy in newborns with esophageal atresia: does it matter?",
        "answer": "yes",
        "answer_rationale": "Tracheobronchoscopy is a useful and safe procedure and should be recommended in tertiary centers for babies with EA before surgical repair.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether preoperative tracheobronchoscopy (TBS) in newborns with esophageal atresia (EA) matters based on the provided study.\n\nFirst, I need to understand the study's findings. The study included 62 patients with EA who underwent preoperative TBS from 1997 to 2003. The main points from the study are:\n\n1. Before TBS, the Gross classification was: 9 Type A, 0 Type B, 51 Type C.\n2. After TBS, 3 of the 9 Type A patients were found to have an unsuspected proximal fistula, changing their classification to Type B. Additionally, 2 had H-type fistulas.\n3. These 3 + 2 patients were managed with a cervical approach, which is different from what was planned initially. So the TBS changed the surgical approach here.\n4. They found 4 undetected respiratory tree malformations (aberrant bronchi and hypoplastic bronchi) via TBS. This info would be important for surgery.\n5. In 14 Type C patients with carinal fistulas, the TBS allowed occlusion with a Fogarty catheter to improve ventilation during repair. That's a direct benefit during surgery.\n6. The study states that TBS was clinically useful in 28 (45.2%) patients, and crucial in modifying the surgical approach in 15 (24.2%) of them. No complications from TBS were noted.\n\nThe question is whether TBS matters. The options are yes, no, maybe. The study's results show that TBS led to changes in surgical approach in a significant number of cases (almost a quarter), detected previously unknown anomalies, and allowed for better management during surgery without complications. The fact that it was crucial in modifying surgery in 15 out of 62 suggests it does have a meaningful impact. The answer should be (A) yes because the study's data supports the utility of TBS in improving diagnosis and surgical planning, leading to better outcomes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 480,
            "completion_tokens": 449
        },
        "time_elapsed": 6.561834812164307
    },
    {
        "realidx": "16772913",
        "question": "This study provides the first large-volume (1000 implant) comparison of the deflation rates of Poly Implant Prosthesis prefilled textured saline breast implants versus a control group of Mentor Siltex textured saline implants.\nA consecutive series of 500 Poly Implant Prosthesis prefilled textured saline breast implants was compared with a consecutive series of 500 Mentor Siltex breast implants. Each breast implant was evaluated for a 4-year period, and the annual deflation rate (number of deflations during a given year divided by the total number of implants) and cumulative deflation rate (cumulative total of deflations through a given year divided by the total number of implants) were recorded. Statistical significance was calculated using the Fisher's exact test at year 1 and the chi-square analysis at years 2 through 4.\nThe cumulative deflation rates of the Poly Implant Prosthesis implants was as follows: year 1, 1.2 percent; year 2, 5.6 percent; year 3, 11.4 percent; and year 4, 15.4 percent. The cumulative deflation rates of the Mentor implants was: year 1, 0.2 percent; year 2, 0.6 percent; year 3, 1.6 percent; and year 4, 4.4 percent. At year 1, the difference between deflation rates was not statistically significant (Fisher's exact test, p>0.05). However, at year 2 (chi-square, 13.29; p<0.001), year 3 (chi-square, 37.91; p<0.001), and year 4 (chi-square, 32.69; p<0.001), the difference was statistically significant.\nA comparison of 500 prefilled textured saline breast implants versus 500 standard textured saline breast implants: is there a difference in deflation rates?",
        "answer": "yes",
        "answer_rationale": "There was a statistically significant difference between the overall deflation rates of Poly Implant Prosthesis prefilled textured saline breast implants and Mentor Siltex breast implants at year 2, year 3, and year 4. After 4 years, the 15.56 percent cumulative deflation rate of Poly Implant Prosthesis implants was over 3.5 times higher than the 4.31 percent deflation rate of the Mentor Siltex implants. There may be several factors contributing to the higher deflation rate seen in Poly Implant Prosthesis implants, including possible in vitro deflation before implantation and silicone shell curing technique. Nevertheless, this statistically significant deflation difference must be taken into account when balancing the risks and benefits of Poly Implant Prosthesis breast implants.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. So, the study is comparing two types of breast implants: Poly Implant Prosthesis (PIP) prefilled textured saline ones and Mentor Siltex textured saline implants. They had 500 each, followed for 4 years. The question is whether there's a difference in deflation rates between them.\n\nLooking at the data provided, the cumulative deflation rates for PIP are 1.2%, 5.6%, 11.4%, and 15.4% over the four years. For Mentor, they're much lower: 0.2%, 0.6%, 1.6%, and 4.4%. \n\nThe key part here is the statistical significance. At year 1, the difference wasn't significant (p>0.05). But starting from year 2 onwards, the p-values are all less than 0.001, which is highly significant. The chi-square tests show that after the first year, the difference in deflation rates between the two groups is statistically significant. \n\nSo even though the first year didn't show a significant difference, by years 2, 3, and 4, the rates diverge a lot. The question is asking if there's a difference in deflation rates overall. Since the later years show a significant difference, the answer should be yes. The options are (A) yes, (B) no, (C) maybe. The correct answer is A because the study clearly shows a significant difference in later years, indicating that there is a difference.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 515,
            "completion_tokens": 335
        },
        "time_elapsed": 3.9767372608184814
    },
    {
        "realidx": "16776337",
        "question": "A retrospective analysis of a contemporary series of patients with pituitary apoplexy was performed to ascertain whether the histopathological features influence the clinical presentation or the outcome.\nA retrospective analysis was performed in 59 patients treated for pituitary apoplexy at the University of Virginia Health System, Charlottesville, Virginia, or Groote Schuur Hospital, University of Cape Town, South Africa. The patients were divided into two groups according to the histological features of their disease: one group with infarction alone, comprising 22 patients; and the other with hemorrhagic infarction and/or frank hemorrhage, comprising 37 patients. The presenting symptoms, clinical features, endocrinological status, and outcome were compared between the two groups.\nPituitary apoplexy: do histological features influence the clinical presentation and outcome?",
        "answer": "yes",
        "answer_rationale": "The patients who presented with histological features of pituitary tumor infarction alone had less severe clinical features on presentation, a longer course prior to presentation, and a better outcome than those presenting with hemorrhagic infarction or frank hemorrhage. The endocrine replacement requirements were similar in both groups.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the histological features of pituitary apoplexy influence the clinical presentation or outcome based on the provided study.\n\nFirst, I need to recall what pituitary apoplexy is. It's a clinical syndrome due to hemorrhage or infarction of the pituitary gland, often in the context of an adenoma. The study mentioned here divided patients into two groups: those with infarction alone (22 patients) and those with hemorrhagic infarction or frank hemorrhage (37 patients). They compared symptoms, clinical features, endocrine status, and outcomes between these groups.\n\nThe question is whether the histological features (so the type of tissue changes, like just infarction vs. hemorrhage) affect how the patients present clinically or their outcomes. The options are yes, no, maybe.\n\nThe key here is to determine if the study found differences between the two groups. The problem is that the user hasn't provided the actual results of the study, only the methodology. Wait, but the question is phrased as a setup for the study's conclusion. The user is probably testing knowledge of whether histopathological features (like presence of hemorrhage vs. infarction alone) are known to influence presentation or outcome. \n\nAlternatively, maybe the question is expecting me to know from existing medical knowledge whether histological features matter here. Let me think. From what I remember, pituitary apoplexy's clinical presentation can vary, but the presence of hemorrhage might lead to more acute symptoms like severe headache, visual disturbances, etc., compared to infarction alone. However, I need to be careful here. The study's purpose was to see if histology affects these factors. Since the question is based on the study described, but the study's results aren't given here. Wait, the user's question is phrased as if the study's conclusion is the answer. Wait, the question says \"Given the following question and options, select the correct answer...\" but the user provided the study's setup but not the results. Wait, maybe I'm misunderstanding. Let me re-read the question.\n\nThe question is: \"Pituitary apoplexy: do histological features influence the clinical presentation and outcome?\" The options are yes, no, maybe. The study was done to ascertain this. The user is probably expecting the answer based on the study's findings, but since the user hasn't provided the results",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 262,
            "completion_tokens": 512
        },
        "time_elapsed": 6.264777421951294
    },
    {
        "realidx": "16778275",
        "question": "Pneumothorax following flexible bronchoscopy (FB) with transbronchial biopsy (TBB) occurs in 1 to 6% of cases. Routine chest radiography (CXR) following TBB is therefore requested by most pulmonologists in an attempt to detect complications, particularly pneumothorax. The objective of this study was to determine if routine CXR after bronchoscopy and TBB is necessary.\nThe study group included 350 consecutive patients who underwent FB with TBB at our institution between December 2001 and January 2004. Routine CXR was performed up to 2 h after the procedure in all cases. Additionally, the following information was recorded in all patients: sex, age, immune status, indication for bronchoscopy, total number of biopsies done, segment sampled, pulse oxygen saturation, and development of symptoms suggestive of pneumothorax.\nPneumothorax was diagnosed radiologically in 10 patients (2.9%). Seven patients had symptoms strongly suggestive of pneumothorax prior to CXR, including four patients with large (>10%) pneumothorax. The other three patients were asymptomatic, with only minimal pneumothorax (</= 10%), which resolved completely 24 to 48 h later.\nIs routine chest radiography after transbronchial biopsy necessary?",
        "answer": "no",
        "answer_rationale": "We conclude that routine CXR after bronchoscopy with TBB is necessary only in patients with symptoms suggestive of pneumothorax. In asymptomatic patients, pneumothorax is rare and usually small, so routine CXR is not necessary in this category of patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether routine chest X-rays (CXR) after transbronchial biopsy (TBB) are necessary. The options are yes, no, or maybe.\n\nFirst, the background says that pneumothorax occurs in 1-6% of cases. The study included 350 patients. They found 10 cases (2.9%), which is within that range. Out of those 10, 7 were symptomatic before the CXR. The other 3 were asymptomatic but had minimal pneumothorax (\u226410%) that resolved on its own. \n\nThe key point here is whether the routine CXR adds value. The symptomatic patients were already showing signs, so the CXR confirmed it, but maybe their symptoms were enough to warrant a CXR only when needed. The asymptomatic cases had small pneumothoraces that didn't require intervention. So, if the asymptomatic ones are mild and resolve, maybe routine CXR isn't necessary because they don't need treatment. The argument against routine CXR would be that you can just check CXR when symptoms occur, saving resources and radiation for others. The study's results suggest that most pneumothoraxes are symptomatic, so maybe routine isn't needed. The question is whether the asymptomatic cases justify the routine. Since the asymptomatic ones were minor and self-resolving, perhaps the risk isn't high enough to warrant routine imaging. So the answer might be B) no. But I need to make sure I'm not missing anything. The study's objective was to see if routine is necessary. Since the majority of cases that needed detection were already symptomatic, and the others were minor, maybe routine isn't needed. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 379,
            "completion_tokens": 373
        },
        "time_elapsed": 5.263995409011841
    },
    {
        "realidx": "16809243",
        "question": "To investigate if fetal gender (1) affects the risk of having an emergency department (ED) visit for asthma; and (2) is associated with adverse pregnancy outcomes among women who had at least one visit to the ED for asthma during pregnancy.\nWe linked two provincial administrative databases containing records on in-patient deliveries and ED visits. The study sample included women who delivered a live singleton baby between April 2003 and March 2004. Pregnant women who made at least one ED visit for asthma were counted as cases and the rest of the women as control subjects. We performed a multivariable analysis using logistic regression to model the risk of having an ED visit for asthma, with fetal gender being one of the predictors. In addition, a series of multivariable logistic regressions were also constructed separately for cases and controls for the following adverse delivery outcomes: low birth weight baby, preterm delivery, and delivery via Caesarian section.\nAmong 109,173 live singleton deliveries, 530 women had visited ED due to asthma during pregnancy. While having an ED visit for asthma was positively associated with teenage pregnancy, low income, and presence of pregnancy-induced hypertension, it was not associated with fetal gender (OR 1.01, 95% CI 0.85-1.19). Fetal gender was not a significant predictor of adverse pregnancy outcomes among women who had an asthma ED visit during pregnancy.\nIs fetal gender associated with emergency department visits for asthma during pregnancy?",
        "answer": "no",
        "answer_rationale": "Fetal gender does not affect the risk of having an ED visit for asthma during pregnancy, and it is not associated with adverse pregnancy outcomes among women who had an asthma-related ED during pregnancy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether fetal gender is associated with emergency department visits for asthma during pregnancy based on the provided study.\n\nFirst, I need to look at the key points from the study description. The study had two main objectives: first, to see if fetal gender affects the risk of ED visits for asthma, and second, to check if fetal gender is linked to adverse pregnancy outcomes among those who had asthma ED visits. \n\nThe study included over 100,000 deliveries, with 530 cases (women who went to the ED for asthma). They used logistic regression, and the results showed that having an ED visit for asthma was associated with factors like teenage pregnancy, low income, and hypertension, but not with fetal gender. The odds ratio given is 1.01 with a 95% confidence interval of 0.85 to 1.19. Since the confidence interval includes 1 (the OR is 1.01, and the interval spans below and above 1 but very close), this indicates that there's no statistically significant association between fetal gender and ED visits for asthma. \n\nAdditionally, the text explicitly states, \"fetal gender was not a significant predictor of adverse pregnancy outcomes among women who had an asthma ED visit during pregnancy.\" But the question specifically asks about the ED visits themselves, not the outcomes. The OR and CI provided for the first part (ED visits) confirm that fetal gender isn't a significant factor here. \n\nThe options are yes, no, maybe. Since the study found no significant association (OR 1.01, CI includes 1), the correct answer should be B) no. The \"maybe\" might be a distractor if someone misinterprets the confidence interval, but since it includes 1, we can't say there's an association. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 402,
            "completion_tokens": 393
        },
        "time_elapsed": 4.919878721237183
    },
    {
        "realidx": "16816043",
        "question": "To determine under what conditions lay people and health professionals find it acceptable for a physician to breach confidentiality to protect the wife of a patient with a sexually transmitted disease (STD).\nIn a study in France, breaching confidentiality in 48 scenarios were accepted by 144 lay people, 10 psychologists and 7 physicians. The scenarios were all possible combinations of five factors: severity of the disease (severe, lethal); time taken to discuss this with (little time, much time); intent to inform the spouse about the disease (none, one of these days, immediately); intent to adopt protective behaviours (no intent, intent); and decision to consult an expert in STDs (yes, no), 2 x 2 x 3 x 2 x 2. The importance and interactions of each factor were determined, at the group level, by performing analyses of variance and constructing graphs.\nThe concept of breaching confidentiality to protect a wife from her husband's STD was favoured much more by lay people and psychologists than by physicians (mean ratings 11.76, 9.28 and 2.90, respectively, on a scale of 0-22). The patient's stated intentions to protect his wife and to inform her of the disease had the greatest impact on acceptability. A cluster analysis showed groups of lay participants who found breaching confidentiality \"always acceptable\" (n = 14), \"depending on the many circumstances\" (n = 87), requiring \"consultation with an expert\" (n = 30) and \"never acceptable (n = 13)\".\nDo French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease?",
        "answer": "maybe",
        "answer_rationale": "Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from an STD. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study involved 144 lay people, 10 psychologists, and 7 physicians. The key results mentioned are the mean ratings: lay people had 11.76, psychologists 9.28, and physicians 2.90 on a 0-22 scale. The higher the score, the more acceptable they found breaching confidentiality. \n\nThe question is asking if they \"find it acceptable,\" so we need to see if the ratings are high enough to indicate acceptance. The scale goes up to 22, so 11.76 for lay people is over halfway, which suggests they do find it acceptable. Psychologists are also above 50% (9.28 is about 42% but wait, 9.28 out of 22 is actually around 42%, which is less than half. Wait, maybe I should think again. Wait, 11.76 is over half of 22? Let me calculate: 22 divided by 2 is 11. So 11.76 is just over 11, so just over halfway. So that's a positive rating. The psychologists at 9.28 are below halfway, but still, maybe they still consider it acceptable to some extent. The physicians are at 2.9, which is much lower. \n\nBut the question is about whether they \"find it acceptable.\" The options are yes, no, maybe. The study says that lay people and psychologists favored it much more than physicians. The mean for lay people is 11.76, which is above the midpoint, so that's a yes. Psychologists are 9.28, which is still above 0, but the question groups both lay and health professionals. Wait, the options are for both groups together. The question is whether \"French lay people and health professionals\" as a combined group find it acceptable. But the health professionals here are psychologists and physicians. The psychologists' mean is 9.28, which is still higher than the physicians' 2.9. But the problem is that the answer options are for the combination. \n\nWait, the",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 448,
            "completion_tokens": 512
        },
        "time_elapsed": 6.022699594497681
    },
    {
        "realidx": "16827975",
        "question": "Few studies have assessed whether the advantage chemotherapy has been shown to have in treating advanced non-small lung carcinoma in clinical trials is transferrable to normal health care activity. This could explain the skepticism of a large number of pneumologists towards this treatment. The objective of our study was to analyze prognostic factors related to survival and to see whether cytostatic treatment was an independent predictor.\nPatients enrolled in the study had been diagnosed with non-small cell carcinoma in stages IV or IIIB with pleural or N2-N3 involvement and with a performance status of 2 or below according to the Eastern Cooperative Oncology Group (ECOG). Survival was analyzed with regard to the following variables: age, sex, comorbidity, weight loss, laboratory test results, histological type, ECOG score, TNM staging, and treatment. The Student t test, the chi(2) test, the Kaplan-Meier method, the log-rank test, and Cox regression analysis were used in the statistical analysis.\nWe enrolled 190 patients (157 men and 33 women) with a mean (SD) age of 61.75 (10.85) years (range, 33-85 years). Of these patients, 144 received cytostatic treatment and 46 palliative treatment. The median survival was 31 weeks and was related to absence of weight loss (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.26-2.39; P=.001), cytostatic treatment (HR, 1.85; 95% CI, 1.25-2.76; P=.002), and ECOG score of 0 to 1 (HR, 2.84; 95% CI, 1.62-5.00; P=.0001). In patients with ECOG scores of 0 to 1, weight loss and treatment were significant prognostic factors. Survival in the ECOG 2 group was 15 weeks for patients undergoing cytostatic treatment and 11 weeks for patients with symptomatic treatment.\nChemotherapy and survival in advanced non-small cell lung carcinoma: is pneumologists' skepticism justified?",
        "answer": "no",
        "answer_rationale": "In normal clinical practice, chemotherapy significantly prolongs survival in patients with performance status of less than 2, more time being gained if there is no associated weight loss. We conclude that the reluctance shown by many pneumologists toward using this treatment is not entirely justified.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether the benefits of chemotherapy seen in clinical trials for advanced non-small cell lung carcinoma (NSCLC) translate to real-world healthcare settings. The main point here is addressing the skepticism of pneumologists towards chemotherapy for this condition.\n\nThe study enrolled 190 patients with stage IV or IIIB NSCLC. They looked at various prognostic factors, including whether they received cytostatic (chemo) treatment versus palliative. The statistical analysis included Kaplan-Meier and Cox regression. The key results were that cytostatic treatment had a hazard ratio (HR) of 1.85, which is significant (p=0.002). A higher HR here means that patients on chemo had better survival. The ECOG score was also important; those with ECOG 0-1 had even better outcomes with chemo. Even in the ECOG 2 group, chemo gave a median survival of 15 weeks vs 11 for palliative.\n\nThe question is whether the skepticism is justified. Since the study shows that chemo is an independent predictor of better survival (HR 1.85, p=0.002), that suggests that the advantage from trials does apply in real settings. So the skepticism might not be justified because the study supports chemo's benefit. The answer should be B (no), because the study's results counter the skepticism.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 579,
            "completion_tokens": 307
        },
        "time_elapsed": 3.7108559608459473
    },
    {
        "realidx": "16872243",
        "question": "In this study, an expert panel assessed causality of adverse reports by using the WHO global introspection (GI) method. The same reports were independently assessed using 15 published algorithms. The causality assessment level 'possible' was considered the lower limit for a report to be considered to be drug related. For a given algorithm, sensitivity was determined by the proportion of reports simultaneously classified as drug related by the algorithm and the GI method. Specificity was measured as the proportion of reports simultaneously considered non-drug related. The analysis was performed for the total sample and within serious or unexpected events.\nFive hundred adverse reports were studied. Algorithms presented high rates of sensitivity (average of 93%, positive predictive value of 89%) and low rates of specificity (average of 7%, negative predictive value of 31%).\nCan decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?",
        "answer": "no",
        "answer_rationale": "Decisional algorithms are sensitive methods for the detection of ADRs, but they present poor specificity. A reference method was not identified. Algorithms do not replace GI and are not definite alternatives in the individual causality assessment of suspected ADRs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. So, the main point is whether decisional algorithms can replace the WHO's global introspection (GI) method for assessing causality in adverse drug reactions (ADRs). The study compared both methods.\n\nFirst, the question gives some data: 500 adverse reports were analyzed. The algorithms had high sensitivity (average 93%) which means they correctly identified most cases that the GI method deemed drug-related. But specificity was low (average 7%), meaning they didn't do well in correctly identifying non-drug-related cases. Specificity is about true negatives, so a low rate here suggests many false positives\u2014cases where the algorithm thought it was drug-related, but GI didn't.\n\nThe question asks if algorithms can replace GI. The key here is understanding what sensitivity and specificity mean in this context. High sensitivity is good for not missing cases (so they catch most true drug-related ADRs), but low specificity means they have a lot of false positives. That could lead to over-reporting, which might not be desirable because it could result in unnecessary investigations or incorrect conclusions about drug safety.\n\nThe study also mentions that 'possible' was the lower limit for considering a report drug-related. Since algorithms have low specificity, they might classify many cases as possible or higher even when GI says it's not. The positive predictive value (PPV) is 89%, which is the probability that if the algorithm says it's drug-related, it actually is. But PPV depends on prevalence, and with low specificity, even a high PPV might not be sufficient if the goal is high accuracy in individual assessments.\n\nThe problem with replacing GI would be the high number of false positives. While they catch most true cases (high sensitivity), the low specificity means they can't reliably rule out non-drug-related cases. So for individual assessments, where you need both high sensitivity and specificity, the algorithms might not be sufficient on their own. The GI method is more comprehensive, considering all factors, which algorithms might not capture. Therefore, the answer is probably no (B), because the algorithms aren't as specific, leading to too many false positives to replace the expert method.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 279,
            "completion_tokens": 450
        },
        "time_elapsed": 6.1188085079193115
    },
    {
        "realidx": "16962519",
        "question": "To estimate changes in uterine myoma volume during pregnancy.\nReview of departmental electronic perinatal database and medical records. Canadian Task Force Classification II-3.\nObstetrical ultrasound unit in an academic tertiary care center.\nOne hundred-seven patients diagnosed with uterine myomas during pregnancy and who had two or more obstetrical ultrasounds in different periods of pregnancy.\nWe analyzed the change in volume of uterine myomas between the first half of pregnancy (up until 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). The volume of largest uterine myoma was calculated using the formula Volume (mm3)=Pi/6x(length mm)x(width mm)x(height mm).\nThe mean age of the population was 31+/-6 years. Between the first and the second study periods, the percentage of uterine myomas that decreased in size was 55.1% (95% CI: 43-66), with a mean decrease in volume of 35%+/-4%; while the percentage of uterine myomas that enlarged was 44.9% (95% CI: 34-56), with a mean increase in volume of 69%+/-11%. Between the second and the third study periods, 75% (95% CI: 56-87) became smaller, with a mean decrease in volume of 30%+/-3%; while 25% (95% CI: 13-43) enlarged, with a mean increase in volume of 102%+/-62%.\nVolume change of uterine myomas during pregnancy: do myomas really grow?",
        "answer": "no",
        "answer_rationale": "Contrary to common belief, we found that uterine myomas commonly decrease in volume over the course of pregnancy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether uterine myomas really grow during pregnancy based on the provided study. The options are yes, no, or maybe.\n\nFirst, I need to look at the data given. The study tracked changes in myoma volume in 107 pregnant patients with multiple ultrasounds. They divided the pregnancy into three periods: first half (up to 19 weeks), third quarter (20-30 weeks), and last quarter (31 weeks to term). \n\nLooking at the first interval between the first and second periods (which I assume are the first half and then the third quarter?), the results show that 55.1% of myomas decreased in size with a mean decrease of 35%, while 44.9% increased by an average of 69%. So here, some grew significantly, but most shrank. \n\nThen between the second and third periods (third quarter to last quarter), 75% decreased by 30% on average, and 25% increased by 102%. Again, a portion grew a lot, but the majority shrank. \n\nThe question is whether myomas \"really grow\" during pregnancy. The answer hinges on whether there's any growth observed. Since in both intervals, a significant percentage (over 40% initially, then 25% later) did grow, even if the majority didn't, the answer would be yes, some do grow. However, the options are yes, no, maybe. The study shows that a subset of myomas do grow, so the answer should be yes. But wait, the question is phrased as \"do myomas really grow?\" which might be interpreted as whether they generally tend to grow. The majority actually shrink, but the fact that some do grow means the answer is yes. The options don't have a \"sometimes\" but \"maybe\" is an option. Wait, the options are (A) yes (B) no (C) maybe. The study clearly shows that some myomas do grow during pregnancy, so the answer is yes. The fact that the majority don't doesn't negate that some do. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 464,
            "completion_tokens": 468
        },
        "time_elapsed": 5.610668182373047
    },
    {
        "realidx": "16968876",
        "question": "The aim of this prognostic factor analysis was to investigate if a patient's self-reported health-related quality of life (HRQOL) provided independent prognostic information for survival in non-small cell lung cancer (NSCLC) patients.\nPretreatment HRQOL was measured in 391 advanced NSCLC patients using the EORTC QLQ-C30 and the EORTC Lung Cancer module (QLQ-LC13). The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. In addition, a bootstrap validation technique was used to assess the stability of the outcomes.\nThe final multivariate Cox regression model retained four parameters as independent prognostic factors for survival: male gender with a hazard ratio (HR) = 1.32 (95% CI 1.03-1.69; P = 0.03); performance status (0 to 1 versus 2) with HR = 1.63 (95% CI 1.04-2.54; P = 0.032); patient's self-reported score of pain with HR= 1.11 (95% CI 1.07-1.16; P<0.001) and dysphagia with HR = 1.12 (95% CI 1.04-1.21; P = 0.003). A 10-point shift worse in the scale measuring pain and dysphagia translated into an 11% and 12% increased in the likelihood of death respectively. A risk group categorization was also developed.\nIs a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients?",
        "answer": "maybe",
        "answer_rationale": "The results suggest that patients' self-reported HRQOL provide independent prognostic information for survival. This finding supports the collection of such data in routine clinical practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a patient's self-reported health-related quality of life (HRQOL) is a prognostic factor for survival in non-small cell lung cancer (NSCLC) patients. The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided in the question. The study mentioned used the EORTC QLQ-C30 and QLQ-LC13 to measure HRQOL. The key part here is the results from the multivariate Cox regression model. The final model included four independent prognostic factors: male gender, performance status, pain score, and dysphagia. \n\nThe question specifically asks about self-reported HRQOL. The pain and dysphagia scores are part of the HRQOL assessments. The hazard ratios for pain and dysphagia are both significant (p < 0.05), with a 10-point worse score increasing the hazard by 11% and 12% respectively. Since these are components of the HRQOL questionnaires, this suggests that self-reported symptoms (part of HRQOL) are indeed independent prognostic factors. \n\nThe options are straightforward. Since the analysis shows that pain and dysphagia (as parts of HRQOL) are significant, the answer should be yes. The study's conclusion supports that HRQOL provides independent prognostic information. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 472,
            "completion_tokens": 312
        },
        "time_elapsed": 4.05519700050354
    },
    {
        "realidx": "16971978",
        "question": "Coronary atherosclerotic burden is excessive in diabetic patients. Diabetes mellitus (DM) is an independent predictor for both death and myocardial infarction. It is not known whether the prevalence of complex coronary lesions, such as bifurcation and ostial lesions, is different in diabetics from nondiabetics.\nThe aim of present study was to investigate the prevalence of these lesions in patients with DM.\nOne thousand fourteen consecutive patients (mean age 61.3+/-10.7 years) were investigated. Coronary angiograms were examined for bifurcation and ostial lesions using a digital quantitative system. Patients were classified as diabetic (n=281) or nondiabetic (n=733).\nPatient mean age, and rates of hypertension and hyperlipidemia were significantly higher in the diabetic group than in the nondiabetic group (P<0.0001), although smoking was significantly lower (P=0.001). Reasons for coronary angiography and treatment were comparable between the two groups. The prevalence of bifurcation lesions and ostial lesions was significantly greater in the diabetic group than in the nondiabetic group (9.8% versus 4.3% [P=0.001] and 38.4% versus 29.2% [P=0.003]in the diabetic group versus the nondiabetic group). The presence of DM and greater age were found to be independent predictors for bifurcation lesions (OR=2.27 [P=0.004] and OR=1.03 [P=0.01], for DM and age, respectively) and ostial lesions (OR=1.40 [P=0.027] and OR=1.02 [P=0.001], for DM and age, respectively) in multivariate analysis.\nAre complex coronary lesions more frequent in patients with diabetes mellitus?",
        "answer": "yes",
        "answer_rationale": "Complex coronary lesions such as bifurcation and ostial lesions were significantly more common in diabetic patients than in nondiabetic patients. Greater age and the presence of DM were independent predictors for these complex lesions. These results may help to explain the poor prognosis of coronary artery disease among diabetic patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether complex coronary lesions are more frequent in patients with diabetes mellitus based on the provided study.\n\nFirst, I need to recall the details from the study description. The study compared 281 diabetic patients with 733 non-diabetic patients. The key findings mentioned were that the prevalence of bifurcation lesions (9.8% vs 4.3%, p=0.001) and ostial lesions (38.4% vs 29.2%, p=0.003) were significantly higher in the diabetic group. The p-values are both less than 0.05, which indicates statistical significance. Additionally, in the multivariate analysis, diabetes was an independent predictor for both types of lesions with odds ratios of 2.27 for bifurcation and 1.40 for ostial lesions. \n\nThe question is straightforward: are these complex lesions more frequent in diabetics? The data clearly shows higher percentages in the diabetic group for both lesion types, and the study's conclusion supports that DM is an independent predictor. So the answer should be \"yes,\" which corresponds to option A. I need to make sure there's no trick here, like maybe the question is about something else, but the options are just yes, no, maybe. The study's results directly answer the question affirmatively. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 506,
            "completion_tokens": 302
        },
        "time_elapsed": 3.722940444946289
    },
    {
        "realidx": "17032327",
        "question": "The quality of surgical excision is held to be a major determinant of outcome following surgery for rectal cancer. Macroscopic examination of the excised mesorectum allows for reproducible assessment of the quality of surgery. We aimed to determine whether quality of excision undertaken by colorectal trainees under supervision was comparable with that performed by consultants, as measured using mesorectal grades.\nA total of 130 consecutive patients undergoing potentially curative resection for primary adenocarcinoma of the rectum in our centre from 2001 to 2003 were included in the study. The pathologists graded the excised mesorectum according to staged classification proposed by Quirke. The outcome (quality of mesorectal excision and secondary outcomes including local recurrence and overall recurrence) of operations performed by consultants was compared with that of trainees. Statistical significance was tested using Pearson chi(2) test.\nEighty-nine operations were performed by consultants and 41 by senior colorectal trainees with consultant supervision. Forty-four patients (49%) had good mesorectum when operated by consultants in comparison with 17 (41.5%) by the trainees. There was no statistically significant difference (P = 0.717) between the two groups in terms of quality of mesorectum excised after potentially curative resection. Furthermore, there were seven local recurrences in patients operated by consultants (7.8%) when compared with four in the trainee group (9.5%) and once again there was no statistical significance between the two groups (P = 0.719).\nDo supervised colorectal trainees differ from consultants in terms of quality of TME surgery?",
        "answer": "no",
        "answer_rationale": "We conclude that the quality of rectal cancer excision, as defined by mesorectal grades, achieved by supervised colorectal trainees is comparable with that achieved by consultants.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether supervised colorectal trainees differ from consultants in terms of the quality of TME (Total Mesorectal Excision) surgery. The study provided gives some data to answer this.\n\nFirst, I need to recall what the study found. The question mentions that they compared the outcomes between consultants and trainees. The key results are that 49% of consultants' cases had a good mesorectum grade versus 41.5% for trainees. But the p-value for that comparison was 0.717, which is not statistically significant. Also, local recurrence rates were 7.8% vs 9.5%, with a p-value of 0.719, again not significant. \n\nThe options are (A) yes, (B) no, (C) maybe. The question is whether there's a difference. Since both p-values are above 0.05 (assuming that's the threshold here), the study didn't find a statistically significant difference. So the answer should be B) no. The study's conclusion supports that there's no significant difference in the quality between the two groups. The \"maybe\" option might be a distractor if someone thinks about other factors, but based on the data given, the answer is no difference.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 447,
            "completion_tokens": 281
        },
        "time_elapsed": 3.6245601177215576
    },
    {
        "realidx": "17051586",
        "question": "Several studies have suggested a protective effect of folic acid (FA) on congenital heart anomalies. Down syndrome (DS) infants are known to have a high frequency of heart anomalies. Not all children with DS suffer from heart anomalies, which raises the question whether maternal factors might affect the risk of these anomalies. Our objectives were to investigate whether first-trimester FA use protects against heart anomalies among DS children.\nWomen with liveborn DS children participating in the Slone Epidemiology Center Birth Defects Study between 1976 and 1997 were included. We performed case-control analyses using DS, with heart anomalies as cases and DS, without heart anomalies as controls. Subanalyses were performed for defects that have been associated with FA in non-DS populations (conotruncal, ventricular septal [VSD]) and for those that are associated with DS (ostium secundum type atrial septal defects [ASD]and endocardial cushion defects [ECD]). Exposure was defined as the use of any FA-containing product for an average of at least 4 days per week during the first 12 weeks of pregnancy, whereas no exposure was defined as no use of FA in these 12 weeks.\nOf the 223 cases, 110 (49%) were exposed versus 84 (46%) of the 184 controls. After adjustment for possible confounders, no protective effect of FA was found on heart anomalies overall (OR 0.95, 95% CI: 0.61-1.47) nor separately for conotruncal defects, VSDs, ASDs, or ECDs.\nCan folic acid protect against congenital heart defects in Down syndrome?",
        "answer": "no",
        "answer_rationale": "Our study does not show a protective effect of FA on heart anomalies among infants with DS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether folic acid can protect against congenital heart defects in Down syndrome based on the provided study.\n\nFirst, I need to recall the study's findings. The study included women who had liveborn DS children. They compared those with heart anomalies (cases) to those without (controls). The key point here is that they looked at whether the mothers took folic acid in the first trimester.\n\nThe results showed that 49% of cases vs. 46% of controls were exposed to folic acid. The odds ratio (OR) after adjustment was 0.95 with a 95% confidence interval from 0.61 to 1.47. Since the OR is around 1 and the CI includes 1, this suggests no statistically significant protective effect. The study also broke it down into different types of defects (conotruncal, VSD, ASD, ECD) and found no protection in any of them.\n\nThe question is whether folic acid helps. The options are yes, no, maybe. The study's conclusion clearly states there's no protective effect. So the answer should be B) no. The \"maybe\" might be tempting if the results were inconclusive, but the CI includes 1, so it's not significant. Therefore, the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 457,
            "completion_tokens": 287
        },
        "time_elapsed": 3.8159878253936768
    },
    {
        "realidx": "17054994",
        "question": "Frozen section (FS) evaluation during thyroid surgery is often used to guide intraoperative management. We sought to determine the utility of FS in patients undergoing thyroidectomy for multinodular thyroid disease.\nFrom May 1994 through November 2004, 236 patients with multinodular goiter underwent thyroidectomy at our institution. Patient data were retrospectively analyzed to see if a frozen section was performed during the procedure and whether it changed the patient's outcome.\nOf the 236 patients, 135 (57%) had intra-operative FS. There were no differences between patients who had FS analysis and those who did not with regard to age, gender, and the incidence of malignancy. Of the patients who had FS, 4/135 (3%) were subsequently diagnosed with thyroid cancer on permanent histology. Three of these FS were misread as benign. Therefore, the sensitivity of FS for the diagnosis of thyroid cancer was only 25%. Importantly, in none of the 135 patients did FS alter the intraoperative management.\nDoes frozen section alter surgical management of multinodular thyroid disease?",
        "answer": "no",
        "answer_rationale": "While FS was commonly used in patients undergoing thyroidectomy at our institution, in no patient over the last decade did FS correctly alter the intraoperative management. Given the time required to perform FS and the cost associated with it, we believe that routine FS should not be performed in these patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether frozen section (FS) alters the surgical management of multinodular thyroid disease based on the provided study.\n\nFirst, I need to recall the key points from the study described. The study included 236 patients who had thyroidectomy for multinodular goiter. Out of these, 135 had FS during surgery. The results showed that 4 out of 135 patients were later found to have cancer on permanent histology, but three of those were misread as benign on FS. That gives a sensitivity of 25%, which is pretty low. But the crucial point here is the last sentence: \"in none of the 135 patients did FS alter the intraoperative management.\" \n\nSo the question is whether FS changes how the surgery is managed. The options are yes, no, or maybe. The study's conclusion here is clear\u2014FS didn't change management in any of the cases. Even though there were some cancers detected, the FS results didn't lead to different surgical decisions. The low sensitivity might mean it's not reliable enough to influence decisions, or perhaps the standard approach for multinodular goiter doesn't change based on FS results. The answer should be 'no' because the study explicitly states there was no alteration in management. The options are A, B, C corresponding to yes, no, maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 326,
            "completion_tokens": 301
        },
        "time_elapsed": 4.169539928436279
    },
    {
        "realidx": "17062234",
        "question": "Occlusion of the atherosclerotic ascending aorta by an endoaortic inflatable balloon has been proposed as an alternative to conventional cross-clamping to prevent injury to the vessel and distal embolization of debris. The safety and the effectiveness of endoaortic occlusion have not been documented in this setting.\nEndoaortic occlusion was employed in 52 of 2,172 consecutive patients. Surgeon's choice was based on preoperative identification of aortic calcifications or intraoperative epiaortic ultrasonographic scanning. Deaths and strokes were analyzed casewise and in aggregate.\nIn 10 patients (19.2%), the endoaortic balloon had to be replaced by the ordinary cross-clamp because of incomplete occlusion (n = 5), hindered exposure (n = 2), or balloon rupture (n = 3). In-hospital death occurred in 13 patients (25%), and stroke on awakening from anesthesia in 2 (3.8%). The death rate of patients treated by endoaortic occlusion was significantly higher compared with all other patients (4.2%, p<0.0001) and with the expected estimate by European System for Cardiac Operative Risk Evaluation (10.5%, p = 0.05). By multivariable analysis, use of endoaortic occlusion was independently associated with in-hospital death (odds ratio = 5.609, 95% confidence interval: 2.684 to 11.719). Although the stroke rate was higher in the endoaortic occlusion group compared with all other patients, the difference was only possibly significant (3.8% versus 0.8%, p = 0.067).\nSurgical management of the atherosclerotic ascending aorta: is endoaortic balloon occlusion safe?",
        "answer": "no",
        "answer_rationale": "In this series, the endoaortic occlusion was frequently ineffective, and was associated with a significantly higher risk of in-hospital death and a numerically higher risk of stroke.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether endoaortic balloon occlusion is safe for managing the atherosclerotic ascending aorta based on the provided study.\n\nFirst, I need to understand the key points from the passage. The study compared endoaortic occlusion with conventional cross-clamping. They used the balloon in 52 out of 2,172 patients. The main issues they found were that in 10 patients (almost 20%), the balloon didn't work properly and they had to switch to the cross-clamp. Reasons included incomplete occlusion, exposure problems, or balloon rupture. \n\nThen looking at outcomes: the in-hospital death rate was 25% for the balloon group versus 4.2% in others. That's a big difference, and the p-value was less than 0.0001, which is highly significant. The stroke rate was also higher (3.8% vs 0.8%), but the p-value was 0.067, which is not statistically significant. The multivariable analysis showed that using the balloon was associated with a 5.6 times higher odds of death. \n\nThe question is about safety. Even though the study mentions that safety and effectiveness aren't well-documented, the results here show higher mortality and some technical issues. The higher death rate being significant and the association in the analysis points towards the balloon being less safe. So the answer should be no, it's not safe based on these results. The options are A (yes), B (no), C (maybe). The data clearly indicates negative outcomes, so B is correct.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 484,
            "completion_tokens": 348
        },
        "time_elapsed": 4.268904209136963
    },
    {
        "realidx": "17076091",
        "question": "We sought to determine whether patients with obstructive sleep apnea (OSA) had an objective change in aerobic fitness during cycle ergometry compared to a normal population. The most accurate test of aerobic fitness is measurement of maximum oxygen consumption (VO2max) with cycle ergometry.\nWe performed a retrospective cohort analysis (247 patients with OSA) of VO2max from annual cycle ergometry tests compared to a large control group (normative data from 1.4 million US Air Force tests) in a tertiary care setting.\nOverall, individuals with OSA had increased VO2max when compared to the normalized US Air Force data (p<.001). Patients with an apnea-hypopnea index of greater than 20 demonstrated a decreased VO2max as compared to normalized values (p<.001). No differences in VO2max were observed after either medical or surgical therapy for OSA.\nDoes obstructive sleep apnea affect aerobic fitness?",
        "answer": "maybe",
        "answer_rationale": "Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with OSA severity and treatment is needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether obstructive sleep apnea (OSA) affects aerobic fitness. The options are yes, no, or maybe. \n\nFirst, I need to look at the provided information. The study compared VO2max (the gold standard for aerobic fitness) in OSA patients versus a large control group. The results showed that overall, OSA patients had higher VO2max than the normative data (p<0.001). Wait, that's interesting because I would expect OSA to lower aerobic capacity. But then there's a nuance: when they looked at patients with an apnea-hypopnea index (AHI) over 20 (which indicates severe OSA), those patients had a decreased VO2max compared to the controls (also p<0.001). \n\nSo the answer might depend on the severity. The question is general, though. The first part says \"patients with OSA\" in general had increased VO2max, but the subgroup with severe OSA (AHI>20) had decreased. The study's conclusion here is a bit conflicting. However, the question is whether OSA affects aerobic fitness. The fact that in severe cases it does lower VO2max suggests that OSA can affect it. The overall increase might be due to other factors, maybe the population studied? Like maybe the OSA patients were younger or more active? But the key point is that in the subgroup with more severe OSA, there's a decrease. \n\nThe options are yes, no, maybe. The study shows that in some cases (severe OSA), there is a decrease. So the answer would be yes, OSA can affect aerobic fitness. The overall result might be confounded, but the presence of a significant effect in the severe group indicates that OSA does have an impact. The question is whether OSA affects it, not whether all patients are affected. Since some do, the answer is yes. The \"no differences after treatment\" part might be a distractor, but the main point is the effect exists in certain cases. So the correct answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 290,
            "completion_tokens": 452
        },
        "time_elapsed": 5.547402381896973
    },
    {
        "realidx": "17192736",
        "question": "The aim of this study was to assess the efficacy of ureteroscopy for lower ureteric stones without the use of fluoroscopy.\nBetween June 2001 and January 2005, a total of 110 patients with a mean age of 33.5 years (range 12-65) suffering from of lower ureteral calculi (below the upper margin of the sacroiliac joint) prospectively underwent ureteroscopic removal. Retrograde pyelography was avoided, and no safety guidewire was placed. Whenever required, the ureteric meatus was dilated with a ureteric balloon under direct vision. Double-J stent placement was done with the aid of ureteroscopy. A fluoroscope was kept standby. The patients had a postoperative X-ray of the kidney-ureter-bladder region to document the stone clearance.\nThe mean stone size was 8.7 mm (range 6-15). Complete clearance without the use of fluoroscopy was achieved in 99 patients (94.2%). Fluoroscopy was required in 6 patients (4%) for calcified stricture (n = 1), duplex system (n = 1), narrow and tortuous meatus causing difficulty in passing the 5-Fr balloon dilator (n = 3), and confirmation of spontaneous passage of the stone (n = 1). Of the 13 patients who required balloon dilatation it was successfully achieved without fluoroscopy. Double-J stenting was done due to mucosal ulceration (n = 3), polypoid reaction (n = 2), and perforation (n = 1). All these patients had correct placement of the stent, as confirmed by X-ray of the kidney-ureter-bladder region postoperatively.\nIs fluoroscopy essential for retrieval of lower ureteric stones?",
        "answer": "no",
        "answer_rationale": "To uphold the notion for radiation exposure to be as low as reasonably achievable, ureteroscopic stone retrieval can safely be done without the use of fluoroscopy in a significant number of patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether fluoroscopy is essential for retrieving lower ureteric stones during ureteroscopy. The key points from the study are that out of 110 patients, 99 (94.2%) had complete clearance without using fluoroscopy. Only 6 patients (4%) needed fluoroscopy, and the reasons included things like calcified strictures, duplex systems, or difficult meatus. The rest managed without it. The question is asking if fluoroscopy is essential. Essential would mean it's necessary in most cases or can't be done without it. But since the majority didn't need it, and only a small percentage required it for specific complications, it seems like it's not essential. The answer should be B) no. Wait, but maybe the fact that they had fluoroscopy on standby and used it in some cases means it's still considered essential? Hmm. The study's aim was to see if they could do it without, and they succeeded in most cases. So the conclusion would be that it's not essential because they achieved high success without it, even though in some complex cases it was needed. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 488,
            "completion_tokens": 256
        },
        "time_elapsed": 3.533027172088623
    },
    {
        "realidx": "17208539",
        "question": "The transanal endorectal pull-through (TERPT) is becoming the most popular procedure in the treatment of Hirschsprung disease (HD), but overstretching of the anal sphincters remains a critical issue that may impact the continence. This study examined the long-term outcome of TERPT versus conventional transabdominal (ABD) pull-through for HD.\nRecords of 41 patients more than 3 years old who underwent a pull-through for HD (TERPT, n = 20; ABD, n = 21) were reviewed, and their families were thoroughly interviewed and scored via a 15-item post-pull-through long-term outcome questionnaire. Patients were operated on between the years 1995 and 2003. During this time, our group transitioned from the ABD to the TERPT technique. Total scoring ranged from 0 to 40: 0 to 10, excellent; 11 to 20 good; 21 to 30 fair; 31 to 40 poor. A 2-tailed Student t test, analysis of covariance, as well as logistic and linear regression were used to analyze the collected data with confidence interval higher than 95%.\nOverall scores were similar. However, continence score was significantly better in the ABD group, and the stool pattern score was better in the TERPT group. A significant difference in age at interview between the 2 groups was noted; we therefore reanalyzed the data controlling for age, and this showed that age did not significantly affect the long-term scoring outcome between groups.\nAre the long-term results of the transanal pull-through equal to those of the transabdominal pull-through?",
        "answer": "no",
        "answer_rationale": "Our long-term study showed significantly better (2-fold) results regarding the continence score for the abdominal approach compared with the transanal pull-through. The stool pattern and enterocolitis scores were somewhat better for the TERPT group. These findings raise an important issue about the current surgical management of HD; however, more cases will need to be studied before a definitive conclusion can be drawn.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the long-term results of the transanal pull-through (TERPT) are equal to those of the transabdominal (ABD) pull-through for Hirschsprung disease based on the provided study.\n\nFirst, I need to look at the study's findings. The question states that overall scores were similar between the two groups. But then it mentions that continence scores were significantly better in the ABD group, while stool pattern scores were better in the TERPT group. However, after controlling for age, which was a confounding variable, the analysis showed that age didn't significantly affect the outcomes between the groups. \n\nThe key here is understanding what \"equal long-term results\" means. The overall scores being similar might suggest equivalence, but the breakdown shows differences in specific aspects. Since continence and stool pattern are both important outcomes, the fact that each method has a significant advantage in one area means that the overall results aren't exactly equal. The study's conclusion probably points out that while total scores are comparable, there are trade-offs between the two procedures. Therefore, the answer would be that they aren't equal because specific outcomes differ significantly. So the correct answer should be (B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 450,
            "completion_tokens": 261
        },
        "time_elapsed": 3.6447768211364746
    },
    {
        "realidx": "17274051",
        "question": "The aim of the study was to evaluate the outcomes and patterns of failure in patients with metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary origin, who were treated curatively with radiotherapy, with or without neck dissection.\nThe study included 61 patients referred to the McGill University Hospital Centers from 1987 to 2002. The median age was 57 years, with male to female ratio of 4:1. Distribution of patients by N status was as follows: N1, 16 patients (26%); N2a, 18 (30%); N2b, 13 (22%); N2c, 7 (11%); and N3, 7 (11%). Twenty patients underwent neck dissection (11 radical, 9 functional) and 41 patients had biopsy (9 fine-needle aspiration and 32 excisional biopsy). All patients received radiotherapy. The median dose to the involved node(s) was 64 Gy, and 60 Gy to the rest of the neck. Treatment of the neck was bilateral in 50 patients (82%) and ipsilateral in 11 (18%). The minimum duration of the follow-up was 12 months, with the median of 32 months.\nThe 5- and 8-year overall survival for the whole population was 79% and 67%, respectively. There was no statistically significant difference in the 8-year actuarial overall survival (64.8% and 67.6%, respectively, p = .64) and local relapse-free survival (75% vs 74.5%, respectively, p = .57), among patients who had biopsy versus those who had neck dissection.\nMetastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?",
        "answer": "no",
        "answer_rationale": "In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether neck dissection is necessary for patients with metastatic carcinoma to cervical lymph nodes when the primary head and neck cancer isn't known. The key here is the outcomes they measured.\n\nThe study included 61 patients treated with radiotherapy, some also had neck dissection. The results showed that the overall survival at 8 years was similar between those who had a biopsy versus neck dissection (64.8% vs 67.6%), and the p-value was 0.64, which isn't statistically significant. Also, the local relapse-free survival was almost the same (75% vs 74.5%, p=0.57). \n\nSince there's no significant difference in survival or local recurrence between the two groups, that suggests that adding neck dissection didn't provide a benefit over just biopsy and radiotherapy. So the answer would lean towards not needing neck dissection. The options are (A) yes, (B) no, (C) maybe. The data supports that neck dissection isn't necessary, so the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 499,
            "completion_tokens": 241
        },
        "time_elapsed": 3.2029364109039307
    },
    {
        "realidx": "17276182",
        "question": "This study sought to evaluate mutations in genes encoding the slow component of the cardiac delayed rectifier K+ current (I(Ks)) channel in familial atrial fibrillation (AF).\nAlthough AF can have a genetic etiology, links between inherited gene defects and acquired factors such as atrial stretch have not been explored.\nMutation screening of the KCNQ1, KCNE1, KCNE2, and KCNE3 genes was performed in 50 families with AF. The effects of mutant protein on cardiac I(Ks) activation were evaluated using electrophysiological studies and human atrial action potential modeling.\nOne missense KCNQ1 mutation, R14C, was identified in 1 family with a high prevalence of hypertension. Atrial fibrillation was present only in older individuals who had developed atrial dilation and who were genotype positive. Patch-clamp studies of wild-type or R14C KCNQ1 expressed with KCNE1 in CHO cells showed no statistically significant differences between wild-type and mutant channel kinetics at baseline, or after activation of adenylate cyclase with forskolin. After exposure to hypotonic solution to elicit cell swelling/stretch, mutant channels showed a marked increase in current, a leftward shift in the voltage dependence of activation, altered channel kinetics, and shortening of the modeled atrial action potential duration.\nStretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?",
        "answer": "yes",
        "answer_rationale": "These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about familial atrial fibrillation (AF) and mutations in genes related to the cardiac potassium current I(Ks). The main point here is whether there's a link between a genetic mutation and an environmental or acquired factor like atrial stretch.\n\nThe question is asking if the study found a link between a stretch-sensitive KCNQ1 mutation and AF's pathogenesis involving both genetic and environmental factors. The options are yes, no, maybe.\n\nLooking at the details: They found a mutation (R14C in KCNQ1) in a family with hypertension. AF occurred only in older members with atrial dilation (which is stretching of the atria) and who had the mutation. The electrophysiological studies showed that under normal conditions, the mutant channels didn't behave differently. But when they exposed the cells to hypotonic solution (causing swelling/stretch), the mutant channels had increased current and changes in activation voltage, leading to shorter action potential duration. \n\nSo the mutation alone might not cause AF, but when combined with atrial stretch (from dilation due to hypertension or aging), it triggers the AF. That means the genetic mutation interacts with an environmental factor (atrial stretch) to cause the condition. Therefore, the answer should be yes, there's a link between genetic and environmental factors here.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 389,
            "completion_tokens": 282
        },
        "time_elapsed": 3.626697301864624
    },
    {
        "realidx": "17306983",
        "question": "Enlargement of the ascending aorta is often combined with valvular, coronary, or other cardiac diseases. Reduction aortoplasty can be an optional therapy; however, indications regarding the diameter of aorta, the history of dilatation (poststenosis, bicuspid aortic valve), or the intraoperative management (wall excision, reduction suture, external reinforcement) are not established.\nIn a retrospective study between 1997 and 2005, we investigated 531 patients operated for aneurysm or ectasia of the ascending aorta (diameter: 45-76mm). Of these, in 50 patients, size-reducing ascending aortoplasty was performed. External reinforcement with a non-coated dacron prosthesis was added in order to stabilize the aortic wall.\nAortoplasty was associated with aortic valve replacement in 47 cases (35 mechanical vs 12 biological), subvalvular myectomy in 29 cases, and CABG in 13 cases. The procedure was performed with low hospital mortality (2%) and a low postoperative morbidity. Computertomographic and echocardiographic diameters were significantly smaller after reduction (55.8+/-9mm down to 40.51+/-6.2mm (CT), p<0.002; 54.1+/-6.7mm preoperatively down to 38.7+/-7.1mm (echocardiography), p<0.002), with stable performance in long-term follow-up (mean follow-up time: 70 months).\nIs size-reducing ascending aortoplasty with external reinforcement an option in modern aortic surgery?",
        "answer": "yes",
        "answer_rationale": "As demonstrated in this study, size reduction of the ascending aorta using aortoplasty with external reinforcement is a safe procedure with excellent long-term results. It is a therapeutic option in modern aortic surgery in patients with poststenotic dilatation of the aorta without impairment of the sinotubular junction of the aortic valve and root.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether size-reducing ascending aortoplasty with external reinforcement is an option in modern aortic surgery. The provided information is from a study between 1997 and 2005 involving 531 patients, with 50 undergoing the aortoplasty procedure. The study mentions that the procedure had low hospital mortality (2%) and morbidity, and the aortic diameters decreased significantly post-op, with stable results over a 70-month follow-up.\n\nFirst, I need to recall what aortoplasty entails. Aortoplasty is a surgical procedure to reduce the size of an enlarged aorta, often used when there's an aneurysm or ectasia. The question is whether this method, especially with external reinforcement (like a Dacron prosthesis), is considered viable now.\n\nThe study's results show positive outcomes: reduced diameter, low mortality, and long-term stability. The fact that it was associated with other procedures (like aortic valve replacement, myectomy, CABG) suggests it can be part of a multi-faceted approach. The key here is whether the evidence from the study supports its use as an option. Since the outcomes are favorable and the study is retrospective but shows effectiveness, the answer would lean towards \"yes.\" However, I should check if there are any caveats. The question mentions that indications aren't well-established, but the study's results might support its use in certain cases. The options are yes, no, maybe. Since the study's results are positive and the question is whether it's an \"option,\" the answer is likely A) yes. The fact that it's used alongside other procedures and has good outcomes suggests it's a valid option in modern practice, even if guidelines aren't fully established.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 465,
            "completion_tokens": 383
        },
        "time_elapsed": 5.1987597942352295
    },
    {
        "realidx": "17342562",
        "question": "Some patients with suspected common bile duct (CBD) stones are found to have sludge and no stones. Although sludge in the gallbladder is a precursor of gallbladder stones, the significance of bile duct sludge (BDS) is poorly defined. This study aimed to compare BDS with bile duct stones in terms of frequency, associated risk factors, and clinical outcome after endoscopic therapy.\nThe study enrolled 228 patients who underwent therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for suspected choledocholithiasis. The patients were divided into two groups: patients with BDS but no stones on ERCP and patients with CBD stones. The presence of risk factors for bile duct stones (age, periampullary diverticulum, ductal dilation or angulation, previous open cholecystectomy) were assessed at ERCP. Follow-up data (36 +/- 19 months) were obtained from medical records and by patient questioning.\nBile duct sludge occurred in 14% (31/228) of patients and was more common in females. After endoscopic clearance, CBD stones recurred in 17% (33/197) of the patients with CBD stones, and in 16% (5/31) of the patients with BDS (p = 0.99). Common bile duct dilation was less common in the sludge group. The other known risk factors for recurrent CBD stones (age, previous open cholecystectomy, bile duct angulation, and the presence of a peripampullary diverticulum) were not statistically different between the two groups.\nThe clinical significance of bile duct sludge: is it different from bile duct stones?",
        "answer": "no",
        "answer_rationale": "The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the clinical significance of bile duct sludge (BDS) is different from bile duct stones based on the provided study.\n\nFirst, I need to recall the key points from the study summary. The study compared patients with BDS and those with CBD stones. The main outcomes looked at recurrence rates after ERCP, presence of risk factors, and other clinical outcomes.\n\nThe results mentioned that recurrence of CBD stones after endoscopic clearance was 17% in the stone group and 16% in the sludge group. The p-value was 0.99, which is way above the significance level (usually 0.05), meaning there's no statistically significant difference in recurrence rates between the two groups. \n\nAlso, the other risk factors like age, previous surgery, ductal angulation, and periampullary diverticulum didn't differ between groups except for bile duct dilation being less common in the sludge group. However, the question is about overall clinical significance. Since recurrence rates are similar and other risk factors aren't different (except dilation, which might not be a functional difference in terms of clinical management), the study suggests that BDS isn't significantly different in terms of recurrence or associated risks compared to stones. \n\nThe question is whether their clinical significance is different. Since the outcomes (recurrence) are similar, the answer would be that there's no significant difference. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 451,
            "completion_tokens": 307
        },
        "time_elapsed": 3.7415051460266113
    },
    {
        "realidx": "17355582",
        "question": "The validity of quality of care measurement has important implications for practicing clinicians, their patients, and all involved with health care delivery. We used empirical data from managed care patients enrolled in west coast physician organizations to test the hypothesis that observed changes in health-related quality of life across a 2.5-year window reflecting process of care.DATA SOURCES/\nPatient self-report data as well as clinically detailed medical record review regarding 963 patients with chronic disease associated with managed care from three west coast states.\nProspective cohort study of change in health-related quality of life scores across 30 months as measured by change in SF-12 physical component scores.DATA COLLECTION/\nPatient self-report and medical record abstraction.\nWe found a positive relationship between better process scores and higher burden of illness (p<.05). After adjustment for burden of illness, using an instrumental variables approach revealed better process is associated with smaller declines in SF-12 scores across a 30-month observation window (p=.014). The application of the best quartile of process of care to patients currently receiving poor process is associated with a 4.24 increment in delta SF-12-physical component summary scores.\nDoes ambulatory process of care predict health-related quality of life outcomes for patients with chronic disease?",
        "answer": "yes",
        "answer_rationale": "The use of instrumental variables allowed us to demonstrate a significant relationship between better ambulatory process of care and better health-related quality of life. This finding underscores the importance of efforts to improve the process of care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether ambulatory process of care predicts health-related quality of life outcomes for patients with chronic disease. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentioned used data from managed care patients over 2.5 years. They measured changes in health-related quality of life using the SF-12 physical component scores. The key findings were that better process scores were related to higher burden of illness, but after adjusting for that burden using instrumental variables, better process was linked to smaller declines in SF-12 scores (p=0.014). Also, applying the best quartile of process care to those with poor process led to a 4.24 increase in the SF-12 scores.\n\nSo the study's results show a statistically significant association between better process of care and better quality of life outcomes (since smaller decline is positive, and the intervention effect is a 4.24 increment). The p-value is less than 0.05, which typically indicates statistical significance. The question is whether process of care predicts these outcomes. The study's conclusion seems to support that better processes do predict better outcomes. Therefore, the answer should be yes, which is option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 351,
            "completion_tokens": 271
        },
        "time_elapsed": 3.6053643226623535
    },
    {
        "realidx": "17445978",
        "question": "To evaluate renal damage and impairment of renal function 1 yr after laparoscopic partial nephrectomy (LPN) with warm ischemia>30 min.\nFrom July 2004 to June 2005, 18 patients underwent LPN with warm ischemia time>30 min. Kidney damage markers (daily proteinuria and tubular enzymes) and renal function (serum creatinine, cystatin C, and creatinine clearances) were assessed on postoperative days 1 and 5 and at 12 mo. Glomerular filtration rate (GFR) was evaluated before surgery and at 3 mo. Renal scintigraphy was performed before the procedure, at 5 d and at 3 and 12 mo postoperatively. Statistical analysis was performed using the Student t test and logistic regression analysis.\nIn terms of kidney damage and renal function markers, the statistical analysis demonstrated that at 1 yr there was complete return to the normal range and no statistical difference between the values at the various time points. The GFR was not significantly different before and 3 mo after surgery. In terms of scintigraphy of the operated kidney, the values were 48.35+/-3.82% (40-50%) before the procedure, 36.88+/-8.42 (16-50%) on postoperative day 5 (p=0.0001), 40.56+/-8.96 (20-50%) at 3 mo (p=0.003), and 42.8+/-7.2% (20-50%) 1 yr after surgery (p=0.001).\nIs renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible?",
        "answer": "no",
        "answer_rationale": "Our results demonstrate that kidney damage occurs during LPN when warm ischemia is>30 min. This damage is only partially reversible and efforts should be made to keep warm ischemia within 30 min.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy is possible, based on the provided study.\n\nFirst, I need to understand the context. The study followed 18 patients who had LPN with warm ischemia times exceeding 30 minutes. They measured various kidney function markers and GFR at different time points. The results showed that by 1 year, all the kidney damage markers and renal function tests returned to normal, with no statistical differences from baseline except in the scintigraphy. The scintigraphy values did decrease post-op but started to recover over time, though still lower than pre-op at 1 year. However, the key point here is whether having warm ischemia over 30 minutes is possible without causing permanent damage, as the question is about the possibility, not the outcome.\n\nThe options are yes, no, maybe. The study's results indicate that even with ischemia over 30 minutes, the patients' kidney function markers returned to normal at 1 year. The scintigraphy showed some reduction but maybe that's acceptable. The question isn't about whether it's safe, but whether it's possible. Since the study included patients who underwent the procedure with ischemia over 30 minutes and they survived with function\u6062\u590d, the answer would be yes, it's possible. The fact that the study was done on these patients shows that it can be done, even if there were temporary issues. The statistical analysis showed no difference in markers at 1 year, so the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 480,
            "completion_tokens": 336
        },
        "time_elapsed": 4.226131916046143
    },
    {
        "realidx": "17565137",
        "question": "To evaluate the effect of an antismoking advertisement on young people's perceptions of smoking in movies and their intention to smoke.SUBJECTS/\n3091 cinema patrons aged 12-24 years in three Australian states; 18.6% of the sample (n = 575) were current smokers.DESIGN/\nQuasi-experimental study of patrons, surveyed after having viewed a movie. The control group was surveyed in week 1, and the intervention group in weeks 2 and 3. Before seeing the movie in weeks 2 and 3, a 30 s antismoking advertisement was shown, shot in the style of a movie trailer that warned patrons not to be sucked in by the smoking in the movie they were about to see.\nAttitude of current smokers and non-smokers to smoking in the movies; intention of current smokers and non-smokers to smoke in 12 months.\nAmong non-smokers, 47.8% of the intervention subjects thought that the smoking in the viewed movie was not OK compared with 43.8% of the control subjects (p = 0.04). However, there was no significant difference among smokers in the intervention (16.5%) and control (14.5%) groups (p = 0.4). A higher percentage of smokers in the intervention group indicated that they were likely to be smoking in 12 months time (38.6%) than smokers in the control group (25.6%; p<0.001). For non-smokers, there was no significant difference in smoking intentions between groups, with 1.2% of intervention subjects and 1.6% of controls saying that they would probably be smoking in 12 months time (p = 0.54).\nOut of the smokescreen II: will an advertisement targeting the tobacco industry affect young people's perception of smoking in movies and their intention to smoke?",
        "answer": "yes",
        "answer_rationale": "This real-world study suggests that placing an antismoking advertisement before movies containing smoking scenes can help to immunise non-smokers against the influences of film stars' smoking. Caution must be exercised in the type of advertisement screened as some types of advertising may reinforce smokers' intentions to smoke.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about evaluating the effect of an antismoking ad on young people's perceptions and intentions to smoke. The key points here are the results they found.\n\nFirst, looking at non-smokers: the intervention group had 47.8% thinking smoking in the movie wasn't OK versus 43.8% in the control. That's a statistically significant difference (p=0.04). So the ad did affect their perception positively. But for smokers, there was no significant difference in their perception (16.5% vs 14.5%, p=0.4). \n\nNow, the intention to smoke in a year. For non-smokers, there was no significant difference between groups (1.2% vs 1.6%, p=0.54). But here's the kicker: among current smokers in the intervention group, 38.6% said they might smoke in a year, compared to 25.6% in the control. That's a big jump and statistically significant (p<0.001). Wait, that's the opposite of what you'd expect. The ad was supposed to deter smoking, but among smokers, their intention to continue smoking increased? That's concerning.\n\nThe question is asking if the advertisement targeting the tobacco industry affected their perceptions and intentions. The answer has to consider both aspects. The ad did improve non-smokers' perceptions, but it had a negative effect on smokers' intentions. The options are yes, no, maybe. The question is phrased as \"will an advertisement... affect...\" so technically, yes, it did have an effect. But maybe the intended effect was positive. The question doesn't specify direction, just if it had an effect. Since there were significant changes (both positive and negative), the answer would be yes. But wait, the options are (A) yes, (B) no, (C) maybe. The study shows that there were effects, so the answer is A. But wait, the question is about the effect on both perceptions and intentions. The ad affected perceptions in non-smokers and intentions in smokers (but in a negative way). So the ad did have an effect, so the answer is yes. But maybe the question is implying a positive effect? The title mentions \"smokescreen II\" which might imply that the ad was a smokescreen, so maybe the answer is no? Wait, the options are",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 498,
            "completion_tokens": 512
        },
        "time_elapsed": 6.250935316085815
    },
    {
        "realidx": "17598882",
        "question": "A genetic component is well established in the etiology of breast cancer. It is not well known, however, whether genetic traits also influence prognostic features of the malignant phenotype.\nWe carried out a population-based cohort study in Sweden based on the nationwide Multi-Generation Register. Among all women with breast cancer diagnosed from 1961 to 2001, 2,787 mother-daughter pairs and 831 sister pairs with breast cancer were identified; we achieved complete follow-up and classified 5-year breast cancer-specific prognosis among proband (mother or oldest sister) into tertiles as poor, intermediary, or good. We used Kaplan-Meier estimates of survival proportions and Cox models to calculate relative risks of dying from breast cancer within 5 years depending on the proband's outcome.\nThe 5-year survival proportion among daughters whose mothers died within 5 years was 87% compared to 91% if the mother was alive (p = 0.03). Among sisters, the corresponding proportions were 70% and 88%, respectively (p = 0.001). After adjustment for potential confounders, daughters and sisters of a proband with poor prognosis had a 60% higher 5-year breast cancer mortality compared to those of a proband with good prognosis (hazard ratio [HR], 1.6; 95% confidence interval [CI], 1.2 to 2.2; p for trend 0.002). This association was slightly stronger among sisters (HR, 1.8; 95% CI, 1.0 to 3.4) than among daughters (HR, 1.6; 95% CI, 1.1 to 2.3).\nIs breast cancer prognosis inherited?",
        "answer": "yes",
        "answer_rationale": "Breast cancer prognosis of a woman predicts the survival in her first-degree relatives with breast cancer. Our novel findings suggest that breast cancer prognosis might be inherited.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether breast cancer prognosis is inherited based on the provided study. The options are yes, no, or maybe.\n\nFirst, I need to understand the study's findings. The study looked at mother-daughter and sister pairs with breast cancer. They classified the proband's (mother or older sister) 5-year prognosis into poor, intermediary, or good. Then they compared the survival rates of the daughters and sisters based on the proband's outcome.\n\nThe results showed that daughters whose mothers had a poor prognosis (died within 5 years) had an 87% survival rate, compared to 91% if the mother survived. For sisters, the numbers were 70% vs 88%, which was statistically significant (p=0.001). After adjusting for confounders, the hazard ratio was 1.6 overall, meaning a 60% higher mortality in those with a proband of poor prognosis. The HR was higher for sisters (1.8) than daughters (1.6), but both are significant.\n\nThe key point here is whether the prognosis is inherited. The study shows that family members (daughters and sisters) of someone with a poor prognosis have a higher risk of dying within 5 years. This suggests that there's a genetic component influencing the prognosis. The hazard ratios are above 1 and the confidence intervals don't include 1, indicating a statistically significant association. \n\nThe question is whether this implies that prognosis is inherited. Since the study found that the daughters and sisters (who share genetic material) have worse outcomes when their relative did, it supports the idea that genetic factors contribute to the prognosis. The answer options are yes, no, maybe. The study's results point towards a positive association, so the answer should be (A) yes. The study's data shows a heritable component affecting prognosis, so the answer is yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 470,
            "completion_tokens": 403
        },
        "time_elapsed": 4.964736461639404
    },
    {
        "realidx": "17621202",
        "question": "A prospective randomized clinical study.\nTo determine whether shaving the incision site before spinal surgery causes postsurgical infection.\nSpine surgeons usually shave the skin of the incision site immediately before surgery is performed. However, evidence from some surgical series suggests that presurgical shaving may increase the postsurgical infection rate. To our knowledge, no previously published studies have addressed this issue.\nA total of 789 patients scheduled to undergo spinal surgery were randomly allocated into 2 groups: those in whom the site of operation was shaved immediately before surgery (shaved group; 371 patients) and the patients in whom presurgical shaving was not performed (unshaved group; 418 patients). The mean duration of anesthesia and the infection rates in both groups were recorded and compared.\nThe duration of anesthesia did not differ in the 2 groups (P>0.05). A postoperative infection developed in 4 patients in the shaved group and in 1 patient in the nonshaved group (P<0.01).\nDoes shaving the incision site increase the infection rate after spinal surgery?",
        "answer": "maybe",
        "answer_rationale": "The shaving of the incision site immediately before spinal surgery may increase the rate of postoperative infection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether shaving before spinal surgery increases the infection rate. The options are yes, no, or maybe.\n\nFirst, the study design: it's a randomized controlled trial with 789 patients split into two groups. One group got shaved before surgery, the other didn't. The key results are the infection rates. The shaved group had 4 infections out of 371, and the unshaved had 1 out of 418. The p-value for the infection rate difference is less than 0.01, which is statistically significant. \n\nThe question is asking if shaving increases the infection rate. Since the shaved group had a higher infection rate and the result is statistically significant, the answer should be yes. The p-value for anesthesia duration was not significant, so that's a confounder they controlled for. The study's conclusion would support that shaving does increase the risk. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 314,
            "completion_tokens": 206
        },
        "time_elapsed": 3.4919018745422363
    },
    {
        "realidx": "17682349",
        "question": "To identify gender differences in delay time and the reasons why African Americans delay in seeking medical care for symptoms of acute myocardial infarction (AMI).\nCross-sectional.\nFive hospitals in the San Francisco and East Bay areas.\nSixty-one African American men and women diagnosed with an AMI.\nPrehospital delay time.\nMedian delay time was longer for women compared to men (4.4 hours vs 3.5 hours), although the difference was not significant. Single women delayed longer than single men (P = .03), and women who were alone when symptoms began delayed longer than women with someone (P = .03). Women who received advice to seek help or call 911 upon symptom onset had shorter delays compared to women who were not advised to call 911 (P = .01). Men at home delayed longer than men who experienced their symptoms outside the home (P = .01). Men with emergency room insurance delayed longer than men without emergency room insurance (P = .03), and men who took an ambulance to the hospital had shorter delay times than men who took other means of transportation (P = .04).\nAre there gender differences in the reasons why African Americans delay in seeking medical help for symptoms of an acute myocardial infarction?",
        "answer": "yes",
        "answer_rationale": "Women compared to men often delay seeking treatment for an AMI, which further increases their risks. Our findings suggest specific characteristics that can serve as a profile to those African Americans most likely to delay seeking treatment for AMI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there are gender differences in the reasons why African Americans delay seeking medical help for AMI based on the provided study.\n\nFirst, I need to look at the study's findings. The question is about gender differences in the reasons for delay. The results mention several comparisons between men and women. \n\nThe median delay time was longer for women (4.4 vs 3.5 hours), but it's noted that the difference wasn't significant. However, the question isn't just about the delay time itself but the reasons behind the delays. \n\nLooking further, the study found that single women delayed longer than single men (P=0.03), which is statistically significant. Also, women who were alone when symptoms started had longer delays compared to women with someone present (P=0.03). For women, getting advice to call 911 led to shorter delays, which is another significant factor (P=0.01). \n\nOn the men's side, those at home delayed longer than those whose symptoms started outside the home (P=0.01). Men with ER insurance had longer delays than those without (P=0.03), and men taking an ambulance had shorter delays than other transport (P=0.04). \n\nSo, the study shows different factors influencing delay times between genders. Women's delays were linked to being single or alone, while men's delays were related to location, insurance type, and transportation. These are distinct reasons based on gender, so the answer should be \"yes\" there are gender differences in the reasons. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 352,
            "completion_tokens": 354
        },
        "time_elapsed": 4.84089732170105
    },
    {
        "realidx": "17691856",
        "question": "Rising health care costs and the need to consolidate expertise in tertiary services have led to the centralisation of services. In the UK, the result has been that many rural maternity units have become midwife-led. A key consideration is that midwives have the skills to competently and confidently provide maternity services in rural areas, which may be geographically isolated and where the midwife may only see a small number of pregnant women each year. Our objective was to compare the views of midwives in rural and urban settings, regarding their competence and confidence with respect to 'competencies' identified as being those which all professionals should have in order to provide effective and safe care for low-risk women.\nThis was a comparative questionnaire survey involving a stratified sample of remote and rural maternity units and an ad hoc comparison group of three urban maternity units in Scotland. Questionnaires were sent to 82 midwives working in remote and rural areas and 107 midwives working in urban hospitals with midwife-led units.\nThe response rate from midwives in rural settings was considerably higher (85%) than from midwives in the urban areas (60%). Although the proportion of midwives who reported that they were competent was broadly similar in the two groups, there were some significant differences regarding specific competencies. Midwives in the rural group were more likely to report competence for breech delivery (p = 0.001), while more urban midwives reported competence in skills such as intravenous fluid replacement (p<0.001) and initial and discharge examination of the newborn (p<0.001). Both groups reported facing barriers to continuing professional development; however, more of the rural group had attended an educational event within the last month (p<0.001). Lack of time was a greater barrier for urban midwives (p = 0.02), whereas distance to training was greater for rural midwives (p = 0.009). Lack of motivation or interest was significantly higher in urban units (p = 0.006).\nMidwives' competence: is it affected by working in a rural location?",
        "answer": "maybe",
        "answer_rationale": "It is often assumed that midwives in rural areas where there are fewer deliveries, will be less competent and confident in their practice. Our exploratory study suggests that the issue of competence is far more complex and deserves further attention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether midwives' competence is affected by working in a rural location based on the study described.\n\nFirst, I need to recall the details from the provided text. The study compared rural and urban midwives' competence and confidence. The key points are:\n\n- Both groups had similar overall competence proportions.\n- However, there were specific differences: rural midwives were more competent in breech delivery, while urban midwives were better in IV fluids and newborn exams.\n- Both faced barriers to continuing education, but rural ones attended more events recently. Barriers differed: time for urban, distance for rural, and motivation more in urban.\n\nThe question is whether location affects competence. The answer hinges on whether the differences in specific competencies count as an overall effect. Since the study found that competence varied by location for certain skills, that suggests that rural vs. urban does influence their competence in those areas. The overall proportion was similar, but specific competencies differed. So competence is affected in terms of the specific skills they're competent in, depending on their setting. Therefore, the answer should be \"yes\" (A), because the location does impact their competence in certain areas, even if general competence is comparable.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 528,
            "completion_tokens": 258
        },
        "time_elapsed": 3.546966314315796
    },
    {
        "realidx": "17894828",
        "question": "An association has been described between elevated serum angiotensin-converting enzyme (ACE) and an increased risk of severe hypoglycaemia (SH). To ascertain whether this reported association could be replicated in a different country, it was re-examined in 300 individuals with Type 1 diabetes.\nPeople with Type 1 diabetes, none of whom was taking renin-angiotensin system blocking drugs, were recruited. Participants recorded the frequency with which they had experienced SH. Glycated haemoglobin (HbA(1c)) and serum ACE were measured. The difference in the incidence of SH between different quartiles of ACE activity and the relationship between serum ACE and SH were examined using non-parametric statistical tests and a negative binomial model.\nData were obtained from 300 patients [158 male; HbA(1c) median (range) 8.2% (5.2-12.8%), median age 36 years (16-88); duration of diabetes 14.5 years (2-49)]. The incidence of SH was 0.93 episodes per patient year. The mean incidence of SH in the top and bottom quartiles of ACE activity was 0.5 and 1.7 episodes per patient year, respectively, but this difference was not statistically significant (P = 0.075). Spearman's test showed a very weak, although statistically significant, association between serum ACE level and SH incidence (r = 0.115, P = 0.047). The binomial model also showed a statistically significant (P = 0.002), but clinically weak, relationship between serum ACE and SH.\nSerum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist?",
        "answer": "yes",
        "answer_rationale": "The present survey showed a weak relationship between serum ACE and the frequency of SH, the clinical relevance of which is unclear. This limits the proposed role for serum ACE as an index of risk for SH.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a relationship between serum angiotensin-converting enzyme (ACE) and the frequency of severe hypoglycaemia (SH) in Type 1 diabetes based on the provided study.\n\nFirst, I need to parse the study details. The study involved 300 individuals with Type 1 diabetes not on renin-angiotensin system blockers. They measured ACE levels, HbA1c, and recorded SH episodes. The key results are:\n\n1. The difference in SH incidence between the top and bottom ACE quartiles (0.5 vs 1.7 episodes per patient year) had a p-value of 0.075, which is not statistically significant (since typically p <0.05 is considered significant).\n\n2. Spearman's test showed a weak but statistically significant correlation (r=0.115, p=0.047). Here, the p-value is just under 0.05, so technically significant, but the correlation is weak (r=0.115 is a small effect size).\n\n3. The negative binomial model also found a statistically significant relationship (p=0.002), but again described as clinically weak.\n\nThe question is whether a relationship exists. The options are yes, no, maybe. \n\nThe study's results are conflicting in terms of statistical significance and clinical significance. The quartile comparison wasn't significant, but the other two tests were statistically significant but with weak associations. The authors mention that the relationship is \"statistically significant but clinically weak.\" \n\nIn research, statistical significance doesn't always mean clinical relevance. The question is whether the association exists. Since some tests showed a statistically significant (even if weak) link, but others didn't, the answer might depend on how the question is framed. The options are yes/no/maybe. The study's conclusion probably states that there's a weak association, so the answer would be yes, but the options might hinge on the interpretation. However, the first comparison (quartiles) wasn't significant, but the other two were. The question is whether the association exists. Since there is some statistical evidence, albeit weak, the answer might be yes. Alternatively, if the question is about a strong or clinically meaningful relationship, then no. But the options are yes/no/maybe. The study's abstract says \"a statistically significant... but clinically weak relationship.\" So the answer would",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 481,
            "completion_tokens": 512
        },
        "time_elapsed": 7.187384128570557
    },
    {
        "realidx": "17910536",
        "question": "Adults with a mild intellectual disability (ID) often show poor decoding and reading comprehension skills. The goal of this study was to investigate the effects of teaching text comprehension strategies to these adults. Specific research goals were to determine (1) the effects of two instruction conditions, i.e. strategy instruction to individuals and strategy instruction in small groups in a reciprocal teaching context; (2) intervention programme effects on specific strategy tests (so-called direct effects), and possible differences between strategies; (3) (long-term) transfer effects of the programme on general reading comprehension ability; and (4) the regression of general text comprehension by the variables of technical reading, IQ, reading comprehension of sentences (RCS), and pretest and posttest scores on the strategies taught.\nIn total, 38 adults (age range 20-72 years; mean age of 36 years) with ID participated in the study. IQs ranged from 45 to 69 with a mean IQ of 58. The intervention programme involved 15 weekly lessons of 1 h each, taught during 3 months. Blocks of lessons included each of Brown and Palincsar's strategies of summarizing, questioning, clarifying and predicting, as participants read and studied narrative and expository texts.\nResults indicated no significant difference between group and individual instruction conditions. Second, direct programme effects - as determined by posttest-pretest contrasts for strategy tests - were substantial, except for the questioning strategy. Third, even more substantial was the transfer effect to general text comprehension. Moreover, the results on this test were well maintained at a follow-up test. Finally, the variance of general reading comprehension ability was best explained by the test of RCS, and only moderately by the strategies trained.\nAdults with mild intellectual disabilities: can their reading comprehension ability be improved?",
        "answer": "yes",
        "answer_rationale": "The presently used intervention programme provides a good starting point for adults with ID to become better readers.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether adults with mild intellectual disabilities can improve their reading comprehension based on the study described.\n\nFirst, I need to recall the key points from the study. The study had two main conditions: strategy instruction individually and in small groups. The results showed no significant difference between the two conditions, so the method of delivery (group vs individual) didn't matter much. \n\nNext, the direct effects of the program on the specific strategies were substantial except for questioning. That means the strategies like summarizing, clarifying, and predicting improved, but questioning didn't. However, the most important part here is the transfer effect. The study mentions that the transfer effect to general text comprehension was even more substantial. So not only did they get better at the specific strategies, but their overall reading comprehension improved. Plus, the follow-up test showed that these gains were maintained over time. \n\nThe last point is about the variables explaining general reading comprehension. RCS (reading comprehension of sentences) was the best predictor, followed by the strategies. But the key takeaway is that the intervention led to improvement. The question is whether their reading comprehension can be improved. The study's results clearly show that the transfer effect was substantial and maintained, so the answer should be yes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 462,
            "completion_tokens": 279
        },
        "time_elapsed": 3.5645668506622314
    },
    {
        "realidx": "17940352",
        "question": "To evaluate the impact of HER2 immunoreactivity on clinical outcome in locally advanced urothelial carcinoma patients who received surgery alone, or methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC) as adjuvant chemotherapy.\nWe studied 114 formalin-fixed paraffin-embedded specimens obtained from locally advanced urothelial carcinoma patients receiving surgery alone or adjuvant M-VEC. The authors evaluated HER2 immunoreactivity using immunohistochemical staining and explored the influence of pathological parameters and HER2 immunoreactivity on progression-free survival (PFS) and disease-specific overall survival (OS) using univariate and multivariate Cox's analyses.\nUrothelial carcinoma of the bladder had a significantly higher frequency of HER2 immunoreactivity than that of the upper urinary tract (60.7 vs. 20.7%, p<0.0001). Overall, nodal status was a strong and independent prognostic indicator for clinical outcome. The HER2 immunoreactivity was significantly associated with PFS (p = 0.02) and disease-specific OS (p = 0.005) in advanced urothelial carcinoma patients. As for patients with adjuvant M-VEC, HER2 immunoreactivity was a significant prognostic factor for PFS (p = 0.03) and disease-specific OS (p = 0.02) using univariate analysis, but not multivariate analysis, and not for patients receiving watchful waiting.\nDoes HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?",
        "answer": "maybe",
        "answer_rationale": "HER2 immunoreactivity might have a limited prognostic value for advanced urothelial carcinoma patients with adjuvant M-VEC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether HER2 immunoreactivity provides prognostic information in locally advanced urothelial carcinoma patients who received adjuvant M-VEC chemotherapy. The options are yes, no, or maybe.\n\nFirst, I need to look back at the provided information. The study included 114 patients who had surgery alone or adjuvant M-VEC. They used immunohistochemistry for HER2 and analyzed survival outcomes with Cox's models. \n\nThe key points from the study results: \n\n- Overall, HER2 was significantly associated with both PFS (p=0.02) and OS (p=0.005) in advanced patients. \n- For the subgroup that received M-VEC, HER2 was significant in univariate analysis for PFS (p=0.03) and OS (p=0.02), but not in multivariate analysis. \n- It wasn't significant for those who had watchful waiting instead of chemo.\n\nThe question specifically asks about patients receiving adjuvant M-VEC. The univariate analysis showed significance, but multivariate didn't. The problem is whether that's enough to say it provides prognostic info. \n\nIn medical studies, multivariate analysis adjusts for other variables, so if it's not significant there, maybe other factors are confounding. But the question is about whether HER2 provides any prognostic info. Since it was significant in univariate, even if not in multivariate, some might argue it still has some prognostic value, but the answer might hinge on the context of the question's phrasing. \n\nThe options are yes, no, maybe. The study says that in the M-VEC group, HER2 was a significant prognostic factor in univariate but not multivariate. The question is whether it \"provides prognostic information\". Since univariate shows an association, but multivariate doesn't, the answer might be that it's not an independent prognostic factor, but the question isn't asking about independence. \n\nWait, the options are yes/no/maybe. The study's own conclusion here would be that in the M-VEC group, HER2 was significant in univariate but not multivariate. So as a prognostic factor, if it's not independent (multivariate), then maybe the answer is no. But the question is phrased as \"provide prognostic information\"\u2014so even if it",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 444,
            "completion_tokens": 512
        },
        "time_elapsed": 7.071132183074951
    },
    {
        "realidx": "17971187",
        "question": "The study was carried on 2096 school children (1043 male, 1053 female) in Ankara. Their mean age was 9.03 years. Demographic properties of the study group and their families were determined and the serum lipid levels of the subjects were obtained. The relation between these demographic properties and lipid levels were investigated.\nIn 135 of the subjects' serum cholesterol level was>or=200 mg/dL and in 83 subjects serum LDL-cholesterol level was>or=130 mg/dL. Despite 64.4% of the subjects reported a family history of hyperlipidemia, no relations between family history and serum lipid levels were found.\nCholesterol screening in school children: is family history reliable to choose the ones to screen?",
        "answer": "no",
        "answer_rationale": "We suggest that regardless of family history, all children over 5 years should be screened for hyperlipidemia. Education about hyperlipidemia and precautions for its complications should be given to both children and families. The best and easiest way to reach children is to screen them at schools. School is also a good place for education of children about hyperlipidemia and risk factors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study involved 2096 school children in Ankara. They looked at their demographic info and lipid levels. The key point here is that even though 64.4% of the kids had a family history of hyperlipidemia, there was no found relationship between that family history and their actual serum lipid levels. The question is asking whether family history is reliable for choosing which children to screen for cholesterol.\n\nHmm, so the options are yes, no, or maybe. The study's results show that despite a high percentage reporting a family history, there's no correlation. That would suggest that family history isn't a reliable indicator here. If there's no statistical relationship found, then using family history to select kids for screening might not be effective. So the answer should be B, no. Because if there's no relation, then family history doesn't predict lipid levels, so it's not reliable for screening purposes.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 262,
            "completion_tokens": 200
        },
        "time_elapsed": 2.6868693828582764
    },
    {
        "realidx": "18019905",
        "question": "To illustrate how maternal mortality audit identifies different causes of and contributing factors to maternal deaths in different settings in low- and high-income countries and how this can lead to local solutions in reducing maternal deaths.\nDescriptive study of maternal mortality from different settings and review of data on the history of reducing maternal mortality in what are now high-income countries.\nKalabo district in Zambia, Farafenni division in The Gambia, Onandjokwe district in Namibia, and the Netherlands.\nPopulation of rural areas in Zambia and The Gambia, peri-urban population in Namibia and nationwide data from The Netherlands.\nData from facility-based maternal mortality audits from three African hospitals and data from the latest confidential enquiry in The Netherlands.\nMaternal mortality ratio (MMR), causes (direct and indirect) and characteristics.\nMMR ranged from 10 per 100,000 (the Netherlands) to 1540 per 100,000 (The Gambia). Differences in causes of deaths were characterized by HIV/AIDS in Namibia, sepsis and HIV/AIDS in Zambia, (pre-)eclampsia in the Netherlands and obstructed labour in The Gambia.\nThe use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor?",
        "answer": "no",
        "answer_rationale": "Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to be promoted through audit, both national and local.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether the use of audit to identify maternal mortality in different settings is just a difference between the rich and the poor. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study compares maternal mortality ratios (MMR) in different regions: the Netherlands (high-income) with an MMR of 10 per 100,000, and three African countries (Zambia, The Gambia, Namibia) with much higher MMRs, like 1540 in The Gambia. The causes of death vary: HIV/AIDS in Namibia, sepsis and HIV in Zambia, pre-eclampsia in the Netherlands, and obstructed labor in The Gambia.\n\nThe question is whether the audit differences are simply about rich vs. poor. The data shows that high-income countries like the Netherlands have lower MMR and different causes (like pre-eclampsia) compared to low-income countries with issues like HIV/AIDS and obstructed labor. But the answer might not be just about wealth. For instance, the Netherlands has pre-eclampsia as a cause, which can occur anywhere but might be managed better there. The other countries have issues related to access to healthcare, like obstructed labor needing timely C-sections, which might be more about healthcare infrastructure than just income. Also, HIV/AIDS in Namibia could relate to specific epidemics in the region, not just poverty. So the factors are more complex than just rich vs. poor. The audit helps identify local specific issues, which might vary beyond just economic status. Therefore, the answer is probably no, because it's not just a simple rich-poor divide but involves other factors like healthcare systems, disease prevalence, and specific local challenges. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 358,
            "completion_tokens": 386
        },
        "time_elapsed": 4.571177005767822
    },
    {
        "realidx": "18041059",
        "question": "Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada-Common Toxicity Criteria [version 2.0] was demonstrated.\nPhase 3 randomized clinical trials (RCTs) comparing AI with tamoxifen in early breast cancer were considered eligible for this review. The event-based risk ratios (RRs) with 95% confidence intervals (95% CIs) were derived, and a test of heterogeneity was applied. Finally, absolute differences (ADs) in event rates and the number of patients needed to harm 1 patient (NNH) were determined.\nSeven eligible RCTs (19,818 patients) reported CVAE results. When considering all RCTs, the AD of the primary endpoint (CVAE) between the 2 arms (0.52%), tamoxifen versus AI, was statistically significant (RR, 1.31; 95% CI, 1.07-1.60; P= .007). This translated into an NNH value of 189 patients; when only third-generation AIs were considered, the difference (0.57%) remained significant (RR, 1.34; 95% CI, 1.09-1.63; P= .0038). Thromboembolic events were significantly more frequent in the tamoxifen arm, regardless of the strategy adopted (RR, 0.53; 95% CI, 0.42-0.65; P<.0001), without significant heterogeneity (P= .21). An AD of 1.17% and an NNH value of 85 patients were observed.\nDo adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer?",
        "answer": "yes",
        "answer_rationale": "According to the results from this meta-analysis, the risk of grade 3 and 4 CVAEs in patients who were receiving AIs was higher compared with the risk in patients who were receiving tamoxifen, and the difference reached statistical significance. However, the AD was relatively low, and from 160 to 180 patients had to be treated to produce 1 event.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether adjuvant aromatase inhibitors (AIs) increase cardiovascular risk in postmenopausal women with early breast cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The question references a meta-analysis of seven phase 3 RCTs involving 19,818 patients. The key findings are that when comparing AI to tamoxifen, there was a statistically significant increased risk of grade 3 and 4 cardiovascular events (CVAE). The risk ratio (RR) was 1.31, which means that the AI group had a 31% higher risk compared to tamoxifen. The absolute difference was 0.52%, leading to an NNH of 189. Even when considering only third-generation AIs, the RR was 1.34, still significant. \n\nAdditionally, the thromboembolic events were more frequent in the tamoxifen arm, but that's the opposite of what's being asked here. The main point here is the CVAE. Since the RR is greater than 1 and the confidence intervals don't include 1 (since the 95% CI is 1.07-1.60 for all AIs and 1.09-1.63 for third-gen), this suggests that AIs are associated with a higher risk of these cardiovascular events compared to tamoxifen. \n\nThe question is whether AIs increase the risk. The data shows that compared to tamoxifen, the risk is higher. So the answer should be yes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 517,
            "completion_tokens": 362
        },
        "time_elapsed": 5.000351190567017
    },
    {
        "realidx": "18065862",
        "question": "We searched for factors present preoperatively which could be used to predict the intensity of postoperative pain.\nWe undertook a prospective study among all patients aged over 18 years who underwent shoulder surgery from January to September 2004 in our unit. The study included 86 patients for which the following data were noted preoperatively: past history of pain, intensity and duration of prior pain, triggering factors, localization, psychological context. The intensity of the postoperative pain was measured on a visual analog scale (VAS); measurements were noted up to 24 hours postop then at one month. Data processing was performed with Statview5.5.\nSignificant postoperative pain was correlated with a prior history of surgical pain, with duration of prior pain, with intensity of preoperative pain, and with depression.\nSignificant sustained preoperative pain can favor memory of pain leading to postoperative sensitivization of nociception neurons. Intense postoperative pain can favor the development of refractory chronic pain.\nCan the postoperative pain level be predicted preoperatively?",
        "answer": "yes",
        "answer_rationale": "Significant postoperative pain can be expected in the following situations: pain after prior surgery, presence of chronic pain sustained for more than six months, intense preoperative pain, state of depression.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the postoperative pain level can be predicted preoperatively based on the study described.\n\nFirst, I need to recall the details from the provided information. The study was prospective, involving 86 patients over 18 who had shoulder surgery. They collected preoperative data like past pain history, pain intensity and duration, triggers, location, and psychological factors (like depression). Then they measured postoperative pain with a VAS scale up to 24 hours and at one month.\n\nThe results mentioned that significant postoperative pain was correlated with prior surgical pain history, duration of prior pain, intensity of preoperative pain, and depression. The explanation given is that sustained preoperative pain might lead to memory of pain and sensitization of nociception neurons, which could result in more postoperative pain. Also, intense postop pain might lead to chronic pain.\n\nThe question is whether preoperative prediction is possible. The options are yes, no, maybe. \n\nThe key here is the word \"correlated.\" The study found that certain preoperative factors (like prior pain history, its duration and intensity, and depression) were significantly linked with postoperative pain. If these factors are present preoperatively, they can be used as predictors. Since the study shows a correlation, that implies that by assessing these factors before surgery, one can predict the likelihood of higher postoperative pain. \n\nSo the answer should be (A) yes. The study's findings support that these preoperative factors are predictive. The explanation about sensitization and memory of pain also provides a mechanism, reinforcing that prediction is feasible.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 309,
            "completion_tokens": 339
        },
        "time_elapsed": 3.9399375915527344
    },
    {
        "realidx": "18158048",
        "question": "There is controversy surrounding the optimal management of the testicular remnant associated with the vanishing testes syndrome. Some urologists advocate the need for surgical exploration, whereas others believe this is unnecessary. These differing opinions are based on the variable reports of viable germ cell elements found within the testicular remnants. To better understand the pathology associated with this syndrome and the need for surgical management, we reviewed our experience regarding the incidence of viable germ cell elements within the testicular remnant.\nAn institutional review board-approved, retrospective review was performed of all consecutive patients undergoing exploration for a nonpalpable testis at Eastern Virginia Medical School and Geisinger Medical Center between 1994 and 2006. Patients who were found to have spermatic vessels and a vas deferens exiting a closed internal inguinal ring were included in this analysis.\nFifty-six patients underwent removal of the testicular remnant. Patient age ranged from 11 to 216 months. In 8 of the specimens (14%), we identified viable germ cell elements. In an additional 4 patients (7%), we identified seminiferous tubules without germ cell elements.\nHistologic evaluation of the testicular remnant associated with the vanishing testes syndrome: is surgical management necessary?",
        "answer": "yes",
        "answer_rationale": "In our review, we identified that a significant number of testicular remnants associated with the vanishing testes syndrome can harbor viable germ cell elements or seminiferous tubules. The exact fate of these residual elements remains unknown; however, there may exist the potential for malignant transformation. Given the potential for malignant degeneration, we believe that these remnants should be removed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether surgical management is necessary for testicular remnants in vanishing testes syndrome based on the study described.\n\nFirst, I need to recall what vanishing testes syndrome is. From what I remember, it's when a testicle fails to descend and over time, it degenerates. The controversy here is whether to surgically remove the remaining tissue (the remnant) because some think there might still be viable germ cells, which could lead to cancer or other issues, while others say it's not necessary.\n\nThe study mentioned looked at 56 patients who had surgery. They found viable germ cells in 14% (8 out of 56) and seminiferous tubules without germ cells in another 7% (4 patients). The key point here is the presence of viable germ cells. If there's a chance that some tissue is still viable, even if it's a minority, then some might argue that surgery is needed to prevent future problems like germ cell tumors. \n\nThe options are yes, no, or maybe. The study shows that in some cases, there are viable cells. So the argument for surgery would be to remove those remnants that have viable tissue to prevent malignancy. However, since not all cases have viable cells, some might say it's not always necessary. But the question is whether the answer is yes, no, or maybe based on the study's findings. \n\nThe study's purpose was to see the incidence of viable germ cells. Since 14% had viable elements, that's a non-negligible percentage. Therefore, the authors might argue that because there's a possibility, surgery is necessary to remove the remnant. Hence, the answer would be (A) yes. But wait, maybe the answer is (C) maybe, because it's variable. However, the question is phrased as \"is surgical management necessary?\" based on their findings. Since they found viable cells in some cases, the conclusion would support the need for surgery to remove the remnant when present, hence advocating for surgical exploration. The study's results support that there is a significant enough incidence (14%) to warrant surgery. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 353,
            "completion_tokens": 465
        },
        "time_elapsed": 5.419198751449585
    },
    {
        "realidx": "18179827",
        "question": "To determine whether post-operative administration of topical ropivacaine hydrochloride decreases morbidity following adenotonsillectomy.\nProspective, randomized, double-blind clinical trial.\nUniversity referral center; ENT Department.\nFourty one children, aged 4-16 years, undergoing tonsillectomy.\nPatients received 1.0% ropivacaine hydrochloride soaked swabs packed in their tonsillar fossae while the control group received saline-soaked swabs. Mc Grath's face scale was used to compare the two groups in respect of pain control. Chi-square and two-tailed unpaired Student's t-tests or Mann-Whitney-U-tests were used to compare the two independent groups. As 10 we made 11 comparison between groups, for Bonferroni correction, p<0.005 was accepted as statistically significant.\nOnly first hour there was no significant pain-relieving effect seen in the ropivacaine group (p>0.05). The other hours and days there were statistically significance between the two groups (p<0.001). Also, the other post-operative parameters such as nausea, fever, vomiting, odor, bleeding, otalgia and trismus were not statistically different between the two groups. There were no complications associated with ropivacaine hydrochloride. No patients in this study suffered systemic side effects related to the use of this medication.\nDoes topical ropivacaine reduce the post-tonsillectomy morbidity in pediatric patients?",
        "answer": "yes",
        "answer_rationale": "Locally 1.0% ropivacaine administration significantly relieves the pain of pediatric tonsillectomy and, it is a safe and effective method. High concentrations of ropivaciane may produce clinically significant pain relief. It is more effective to reduce of post-operative analgesic requirement after first hour.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether topical ropivacaine reduces post-tonsillectomy morbidity in pediatric patients based on the provided study.\n\nFirst, I need to recall what morbidity means here. Morbidity refers to the presence or development of a disease or\u4e0d\u826f condition. In this context, it's about the negative outcomes or complications after surgery like pain, nausea, fever, etc.\n\nLooking at the study details: it's a randomized, double-blind trial with 41 children. The intervention group got ropivacaine-soaked swabs, and the control got saline. They measured pain using Mc Grath's face scale. The statistical tests used were appropriate, and they applied Bonferroni correction, setting significance at p<0.005.\n\nThe results say that in the first hour, there was no significant pain relief (p>0.05). But from other hours and days, the differences were statistically significant (p<0.001). However, other parameters like nausea, fever, vomiting, etc., didn't differ between groups. Also, no complications from ropivacaine were noted.\n\nThe key here is understanding what the question means by \"morbidity.\" If morbidity includes pain, then since ropivacaine reduced pain significantly after the first hour, that would mean it does reduce morbidity related to pain. But the other parameters (nausea, fever, etc.) didn't show a difference. However, the question is specifically about whether it \"decreases morbidity.\" Since pain is a significant part of postoperative morbidity, and the study shows that pain was significantly reduced in the ropivacaine group except the first hour, the answer would lean towards yes. The other parameters not being different might not negate the pain aspect. The study's conclusion states there were no complications from the drug, so it's safe. Therefore, the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 405,
            "completion_tokens": 409
        },
        "time_elapsed": 5.799066781997681
    },
    {
        "realidx": "18182265",
        "question": "In this study, the authors discussed the feasibility and value of diffusion-weighted (DW) MR imaging in the detection of uterine endometrial cancer in addition to conventional nonenhanced MR images.\nDW images of endometrial cancer in 23 patients were examined by using a 1.5-T MR scanner. This study investigated whether or not DW images offer additional incremental value to conventional nonenhanced MR imaging in comparison with histopathological results. Moreover, the apparent diffusion coefficient (ADC) values were measured in the regions of interest within the endometrial cancer and compared with those of normal endometrium and myometrium in 31 volunteers, leiomyoma in 14 patients and adenomyosis in 10 patients. The Wilcoxon rank sum test was used, with a p<0.05 considered statistically significant.\nIn 19 of 23 patients, endometrial cancers were detected only on T2-weighted images. In the remaining 4 patients, of whom two had coexisting leiomyoma, no cancer was detected on T2-weighted images. This corresponds to an 83% detection sensitivity for the carcinomas. When DW images and fused DW images/T2-weighted images were used in addition to the T2-weighted images, cancers were identified in 3 of the remaining 4 patients in addition to the 19 patients (overall detection sensitivity of 96%). The mean ADC value of endometrial cancer (n=22) was (0.97+/-0.19)x10(-3)mm(2)/s, which was significantly lower than those of the normal endometrium, myometrium, leiomyoma and adenomyosis (p<0.05).\nBody diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?",
        "answer": "yes",
        "answer_rationale": "DW imaging can be helpful in the detection of uterine endometrial cancer in nonenhanced MR imaging.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether diffusion-weighted (DW) MR imaging adds value to conventional nonenhanced MR in detecting endometrial cancer. The key points from the study are:\n\nFirst, using just T2-weighted images, they detected cancer in 19 out of 23 patients, which is 83% sensitivity. Then, when they added DW images and fused images, they found 3 more out of the remaining 4 patients, bringing the total to 22 out of 23, which is 96% sensitivity. That's a significant improvement. \n\nThe ADC values for cancer were lower than normal tissues, which is a known thing because cancer cells have less diffusion. The p-values were significant, so the difference is real. The question is asking if DW imaging is helpful in detection when added to nonenhanced MR. Since adding DW increased detection from 83% to 96%, that's a clear incremental value. So the answer should be yes, which is option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 487,
            "completion_tokens": 222
        },
        "time_elapsed": 3.259183406829834
    },
    {
        "realidx": "18222909",
        "question": "The hypothesis was tested that pectin content and methylation degree participate in regulation of cell wall mechanical properties and in this way may affect tissue growth and freezing resistance over the course of plant cold acclimation and de-acclimation.\nExperiments were carried on the leaves of two double-haploid lines of winter oil-seed rape (Brassica napus subsp. oleifera), differing in winter survival and resistance to blackleg fungus (Leptosphaeria maculans).\nPlant acclimation in the cold (2 degrees C) brought about retardation of leaf expansion, concomitant with development of freezing resistance. These effects were associated with the increases in leaf tensile stiffness, cell wall and pectin contents, pectin methylesterase (EC 3.1.1.11) activity and the low-methylated pectin content, independently of the genotype studied. However, the cold-induced modifications in the cell wall properties were more pronounced in the leaves of the more pathogen-resistant genotype. De-acclimation promoted leaf expansion and reversed most of the cold-induced effects, with the exception of pectin methylesterase activity.\nAre pectins involved in cold acclimation and de-acclimation of winter oil-seed rape plants?",
        "answer": "yes",
        "answer_rationale": "The results show that the temperature-dependent modifications in pectin content and their methyl esterification degree correlate with changes in tensile strength of a leaf tissue, and in this way affect leaf expansion ability and its resistance to freezing and to fungus pathogens.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pectins are involved in the cold acclimation and de-acclimation of winter oil-seed rape plants based on the provided experiments.\n\nFirst, I need to recall what the study found. The hypothesis was that pectin content and methylation degree affect cell wall mechanics, which in turn influence tissue growth and freezing resistance during cold acclimation and de-acclimation. The experiments were done on two genotypes of winter oil-seed rape. \n\nThe key results mentioned are that during cold acclimation (at 2\u00b0C), there was an increase in leaf tensile stiffness, cell wall content, pectin content, pectin methylesterase activity, and low-methylated pectin. These changes happened in both genotypes but were more pronounced in the more pathogen-resistant one. When de-acclimation occurred (presumably moving back to warmer conditions), most of the cold-induced effects were reversed except for the pectin methylesterase activity. \n\nThe question is whether pectins are involved. The study shows that pectin content increased during acclimation and decreased during de-acclimation (since most effects were reversed). The methylesterase activity, which affects pectin methylation, stayed higher even after de-acclimation. Since pectin's structure (like methylation state) is linked to cell wall properties and freezing resistance, the changes in pectin content and its methylation clearly correlate with the plant's response to cold. \n\nThe options are yes, no, maybe. The study's results directly support that pectins are involved because their levels and modifications (methylation) changed in response to cold treatment and de-acclimation. Even though some aspects like methylesterase activity didn't reverse, the overall pattern shows involvement. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 355,
            "completion_tokens": 397
        },
        "time_elapsed": 4.8266823291778564
    },
    {
        "realidx": "18235194",
        "question": "In a prospective study 218 preschool children were enrolled (stratified in 2 training programs, one specialized for phonologic awareness in order to prevent dyslexia, the other consisting in training of general perception) during the last year of kindergarten. After finishing the first grade 131 children were compared in their reading and writing abilities.\nIn the whole group only a slight difference was found between both training modalities concerning their writing abilities. However, children with a history of hearing loss, actual hearing loss or pathologic middle ear findings profited most from the specialized training program compared to the control in their reading abilities.\nIs a specialised training of phonological awareness indicated in every preschool child?",
        "answer": "maybe",
        "answer_rationale": "A specialized training program to improve phonologic awareness as a basis for reading and writing in every kindergarten and preschool child seems to be unnecessary. However, children with temporary hearing deficits benefit from such a program. For all other children general perception training may be sufficient.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study involved 218 preschool kids split into two training programs: one focused on phonological awareness to prevent dyslexia and the other on general perception. After first grade, they compared 131 kids' reading and writing. The overall group didn't show much difference in writing between the two trainings. But the key point is that children with a history of hearing loss, current hearing loss, or middle ear issues benefited more from the specialized phonological training in their reading abilities.\n\nThe question is whether specialized phonological training is indicated for EVERY preschool child. The options are yes, no, or maybe. \n\nHmm, the study's results show that the general group didn't have a big difference, but a specific subgroup (those with hearing issues) did benefit. So the answer probably isn't \"yes\" for everyone. Since the benefit was only significant in that subgroup, the recommendation would be that it's not necessary for all kids, but maybe for those with hearing problems. The question is asking if it's indicated for EVERY child. Since the study found that only certain kids had better outcomes, the answer should be no. Unless there's some other consideration, but the data here points to not everyone needing it. So the correct answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 232,
            "completion_tokens": 271
        },
        "time_elapsed": 3.6254124641418457
    },
    {
        "realidx": "18239988",
        "question": "Specific markers for differentiation of nonalcoholic (NASH) from alcoholic steatohepatitis (ASH) are lacking. We investigated the role of routine laboratory parameters in distinguishing NASH from ASH.\nLiver biopsies performed at our hospital over a 10-year period were reviewed, 95 patients with steatohepatitis identified and their data prior to biopsy reevaluated. The diagnosis NASH or ASH was assigned (other liver diseases excluded) on the basis of the biopsy and history of alcohol consumption (<140 g/week). Logistic regression models were used for analysis.\nNASH was diagnosed in 58 patients (61%; 30 f) and ASH in 37 (39%; 9 f). High-grade fibrosis (59% vs. 19%, P<0.0001) and an AST/ALT ratio>1 (54.1% vs 20.7%, P = 0.0008) were more common in ASH. The MCV was elevated in 53% of ASH patients and normal in all NASH patients (P<0.0001). Multivariate analysis identified the MCV (P = 0.0013), the AST/ALT ratio (P = 0.011) and sex (P = 0.0029) as relevant regressors (aROC = 0.92). The AST/ALT ratio (P<0.0001) and age (P = 0.00049) were independent predictors of high-grade fibrosis. Differences in MCV were more marked in high-grade fibrosis.\nDifferentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?",
        "answer": "yes",
        "answer_rationale": "Higher MCVs and AST/ALT ratios in ASH reflect the severity of underlying liver disease and do not differentiate NASH from ASH. Instead, these biomarkers might prove useful in guiding selection of patients for liver biopsy and in targeting therapy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether routine laboratory markers are useful in differentiating NASH from ASH based on the provided study.\n\nFirst, I need to recall the key findings from the study summary. The study compared 58 NASH and 37 ASH patients. They looked at various lab parameters. The results mentioned that MCV was elevated in 53% of ASH patients but normal in all NASH patients, which is a big difference (p<0.0001). Also, the AST/ALT ratio >1 was more common in ASH (54% vs 20.7%, p=0.0008). Multivariate analysis showed MCV, AST/ALT ratio, and sex were significant predictors, with an aROC of 0.92, which is pretty high. Additionally, AST/ALT and age predicted high-grade fibrosis, and MCV differences were more pronounced in those with high fibrosis.\n\nThe question is whether routine labs are useful here. The options are yes, no, maybe. The study clearly found that MCV and AST/ALT ratio, which are routine tests, were significant in distinguishing the two conditions. Since MCV is a standard part of a CBC and AST/ALT are routine liver function tests, these are indeed routine markers. The high aROC suggests good accuracy. So the answer should be yes (A). The study's conclusion supports that these markers are useful, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 469,
            "completion_tokens": 317
        },
        "time_elapsed": 4.380135774612427
    },
    {
        "realidx": "18243752",
        "question": "This study aims to evaluate local failure patterns in node negative breast cancer patients treated with post-mastectomy radiotherapy including internal mammary chain only.\nRetrospective analysis of 92 internal or central-breast node-negative tumours with mastectomy and external irradiation of the internal mammary chain at the dose of 50 Gy, from 1994 to 1998.\nLocal recurrence rate was 5 % (five cases). Recurrence sites were the operative scare and chest wall. Factors associated with increased risk of local failure were age<or = 40 years and tumour size greater than 20mm, without statistical significance.\nShould chest wall irradiation be included after mastectomy and negative node breast cancer?",
        "answer": "maybe",
        "answer_rationale": "Post-mastectomy radiotherapy should be discussed for a sub-group of node-negative patients with predictors factors of local failure such as age<or = 40 years and larger tumour size.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The study is about evaluating local failure patterns in node-negative breast cancer patients who had post-mastectomy radiotherapy that included the internal mammary chain. The key points here are that the patients had negative nodes, underwent mastectomy, and received radiation to the internal mammary area at 50 Gy. The local recurrence rate was 5%, and the recurrences were in the scar or chest wall. The factors like age \u226440 and tumor size >20mm were mentioned but not statistically significant.\n\nThe question is whether chest wall irradiation should be included after mastectomy in these cases. The options are yes, no, maybe.\n\nFirst, I need to recall standard practices. Typically, after mastectomy, if the nodes are negative, the standard radiation fields might not include the chest wall unless certain high-risk factors are present. But the study here included internal mammary chain radiation but not the chest wall? Wait, the question says the radiotherapy included the internal mammary chain only. The local recurrences were in the chest wall and scar. So even with IMN radiation, the failures were in the chest wall area. The study's local recurrence rate was 5%, which might be considered low, but the question is whether adding chest wall irradiation is needed.\n\nThe study's results show that even with IMN radiation, there were chest wall recurrences. The factors like age and tumor size were not statistically significant, so maybe those aren't strong indicators here. The question is whether the chest wall should be irradiated in addition to the internal mammary chain. Since the current treatment in the study didn't include chest wall irradiation (they only did IMN), and there were still chest wall recurrences, perhaps adding chest wall RT would help reduce that 5% rate. But the answer options are yes, no, maybe.\n\nWait, but the study's conclusion might suggest that since the local recurrence was in the chest wall, maybe the current treatment (IMN only) isn't sufficient, so adding chest wall irradiation would be better. However, the question is asking based on the study's findings. The study's recurrence sites were chest wall and scar, which are areas not covered by IMN radiation. So perhaps the answer is that yes, chest wall irradiation should be included because the current approach (IMN only) still had chest wall failures. Alternatively, maybe the answer is no because the recurrence rate was low (5%) even without chest wall RT. But",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 242,
            "completion_tokens": 512
        },
        "time_elapsed": 5.771027326583862
    },
    {
        "realidx": "18274917",
        "question": "To investigate whether low-tone SD was a precursor of Meniere's disease and whether patients with low-tone SD suffered from endolymphatic hydrops.\nThis was a retrospective case review in the university hospital. A total of 184 patients with low-tone SD were divided into two groups with single and recurrent episodes. The progress, follow-up audiograms, and ECochG results of the patients were reviewed and compared with those of patients with high-tone SD and Meniere's disease.\nIn all, 83 of 177 patients with low-tone SD unaccompanied by vertigo had recurrent hearing loss; 15 of the 83 developed vertiginous attacks. The remaining 94 patients had a single episode. Three of the seven patients with low-tone SD accompanied by vertigo had recurrent hearing loss; two of the three were subsequently confirmed to have Meniere's disease. The other four had a single episode. No difference in rate of progress from SD to Meniere's disease was observed among the low-tone and the high-tone SD groups. The average -SP/AP of each group with a single episode is smaller than that of other groups with recurrent episodes and Meniere's disease.\nPrognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?",
        "answer": "no",
        "answer_rationale": "We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether low-tone sudden deafness (SD) inevitably progresses to Meniere's disease based on the provided study.\n\nFirst, I need to parse the study details. The study looked at 184 patients with low-tone SD divided into single or recurrent episodes. They compared them with high-tone SD and Meniere's patients. \n\nThe key points from the results: 83 out of 177 low-tone SD patients without vertigo had recurrent hearing loss, and 15 of those 83 developed vertigo. But only 2 out of the 3 who had both low-tone SD and vertigo ended up with Meniere's. Also, the study mentions there's no difference in the progression rate from SD to Meniere's between low-tone and high-tone groups. The SP/AP ratio in single episode groups was lower than those with recurrent episodes or Meniere's.\n\nThe question is whether low-tone SD inevitably leads to Meniere's. The options are yes, no, maybe. \n\nThe study shows that some patients developed vertigo, but only a small number (2 out of 3 in the group with vertigo) were confirmed to have Meniere's. Also, the progression rate wasn't higher than in high-tone SD. The word \"inevitably\" implies it always happens, but the data shows that most didn't progress. The majority had single episodes and didn't develop Meniere's. So the answer should be no, it's not inevitable. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 355,
            "completion_tokens": 324
        },
        "time_elapsed": 3.785672903060913
    },
    {
        "realidx": "18284441",
        "question": "Paraffin-embedded tissues in Cukurova University Faculty of Medicine Department of Pathology between January 2002 and February 2006 were searched restrospectively to investigate this issue. We performed immunohistochemistry on biopsies of 125 patients with HBV infection, grouped as: mild, moderate and severe hepatitis, cirrhosis and HCC, 25 patients in each of them, using anti c-kit monoclonal antibody. The severity of parenchymal inflammation and of interface hepatitis was semiquantitatively graded on a haematoxylin and eosin stained paraffin sections. Additionally, 50 more HCC, formed on HBV basis, were studied to determine the prevalence of c-kit overexpression.\nIn cirrhotic liver, lower intensity of staining and rarely c-kit positivity were present. The greatest number of the c-kit positivity and higher intensity of staining was found in the livers of patients with severe hepatitis and HCC. In chronic hepatitis B infection, the staining intensity was parallel with the grade and stage of the disease. In the areas where fibrosis was seen, c-kit positivity was rare or absent. In the HCC specimens, c-kit positivity appeared both inside and around the cancerous nodes. C-kit expression was observed in 62 of 75 HCC tissue specimens (82%) (p<0.001).\nExpression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?",
        "answer": "maybe",
        "answer_rationale": "C-kit positivity was observed in the mitotic, proliferating and also dysplastic hepatic cells. These results suggest that c-kit expression may be used as an early diagnostic indicator for HBV induced HCC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about c-kit expression in HBV-related liver diseases. The options are whether this expression has a diagnostic role, with yes, no, or maybe.\n\nFirst, I need to recall what the study found. The abstract mentions that in cirrhosis, c-kit positivity was lower and less intense. But in severe hepatitis and HCC, there was higher positivity and staining. Also, in HCC, 82% showed c-kit expression, which is statistically significant (p<0.001). The staining correlated with the severity (grade and stage) of the disease. In fibrotic areas, it was rare. So, the expression seems to increase with disease severity, especially in HCC.\n\nThe question is whether this has a diagnostic role. Since c-kit is more expressed in HCC compared to earlier stages like cirrhosis, maybe it can help distinguish HCC from other conditions. The high prevalence in HCC (82%) suggests it could be a marker. However, the study might not have compared with other non-HBV HCC or other liver diseases, so maybe there's a possibility. But the question is based on the given data. Since the expression is significantly higher in HCC and correlates with disease severity, it might be useful diagnostically. The answer options are yes, no, maybe. The study's results support that it could have a role, so the answer is probably A) yes. Wait, but the question is about diagnostic role. The study shows association, but does that mean it's diagnostic? Maybe they need to see if it's specific enough. The abstract doesn't mention controls or specificity. For example, if c-kit is also expressed in other cancers or conditions, but the question is about HBV-induced cases. Since in HCC it's 82%, and lower in cirrhosis, perhaps it can help diagnose HCC in HBV patients. The study's conclusion might suggest a possible diagnostic role, so the answer is A. But maybe the answer is C) maybe, because more studies are needed. However, the question is based on the given information. The abstract states that the expression is significantly higher in HCC and correlates with severity, so the authors might argue it has a role. The options are yes, no, maybe. The correct answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 417,
            "completion_tokens": 491
        },
        "time_elapsed": 5.76967978477478
    },
    {
        "realidx": "18307476",
        "question": "The robust relationship between socioeconomic factors and health suggests that social and economic policies might substantially affect health, while other evidence suggests that medical care, the main focus of current health policy, may not be the primary determinant of population health. Income support policies are one promising avenue to improve population health. This study examines whether the federal cash transfer program to poor elderly, the Supplemental Security Income (SSI) program, affects old-age disability.\nThis study uses the 1990 and 2000 censuses, employing state and year fixed-effect models, to test whether within-state changes in maximum SSI benefits over time lead to changes in disability among people aged sixty-five and older.\nHigher benefits are linked to lower disability rates. Among all single elderly individuals, 30 percent have mobility limitations, and an increase of $100 per month in the maximum SSI benefit caused the rate of mobility limitations to fall by 0.46 percentage points. The findings were robust to sensitivity analyses. First, analyses limited to those most likely to receive SSI produced larger effects, but analyses limited to those least likely to receive SSI produced no measurable effect. Second, varying the disability measure did not meaningfully alter the findings. Third, excluding the institutionalized, immigrants, individuals living in states with exceptionally large benefit changes, and individuals living in states with no SSI supplements did not change the substantive conclusions. Fourth, Medicaid did not confound the effects. Finally, these results were robust for married individuals.\nUpstream solutions: does the supplemental security income program reduce disability in the elderly?",
        "answer": "yes",
        "answer_rationale": "Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether the Supplemental Security Income (SSI) program reduces disability in the elderly. The key points from the passage are that higher SSI benefits are linked to lower disability rates. Specifically, a $100 increase in the maximum SSI benefit led to a 0.46 percentage point drop in mobility limitations among single elderly individuals. The study also mentions that the findings were robust even after various sensitivity analyses, like looking at different groups and excluding certain populations. They also checked if Medicaid had an effect, but it didn't confound the results. Since the effect was consistent across these tests, especially with the most likely recipients showing larger effects and others not, it seems the answer is yes. The options are A, B, C. The question is whether SSI reduces disability, and the study's results support that. So the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 411,
            "completion_tokens": 191
        },
        "time_elapsed": 2.525092601776123
    },
    {
        "realidx": "18319270",
        "question": "IVF singletons have poorer perinatal outcomes than singletons from spontaneous conceptions. This may be due to the influence of ovarian stimulation on the chromosomal constitution of the embryos which could be translated into localized chromosomal anomalies in the placenta. The aim of this study was to compare the incidence of confined placental mosaicism (CPM) in IVF/ICSI pregnancies and spontaneous conceptions.\nWe conducted a multi-centre retrospective analysis of karyotype results obtained by chorionic villus sampling (CVS), performed due to advanced maternal age (>or=36 years at 18 weeks of gestation), in the Netherlands between 1995 and 2005.\nFrom a total of 322 246 pregnancies, 20 885 CVS results were analysed: 235 in the IVF/ICSI group and 20 650 in the control group. The mean age of women in both groups was 38.4 years (mean difference -0.08, 95% CI -0.35 to 0.18). Data relating to the fetal karyotype were missing in 143 cases in the control group. When taking into account missing data, the incidence of CPM was lower in the IVF-ICSI group than in the control group, 1.3% versus 2.2% (odds ratio 0.59, 95% CI 0.19-1.85), whereas the incidence of fetal chromosomal anomalies was increased 4.3% versus 2.4% (odds ratio 1.81, 95% CI 0.95-3.42). Neither differences were statistically significant.\nDoes confined placental mosaicism account for adverse perinatal outcomes in IVF pregnancies?",
        "answer": "no",
        "answer_rationale": "The incidence of CPM is not increased in IVF/ICSI pregnancies compared with spontaneous conceptions. CPM probably does not account for the adverse perinatal outcomes following IVF/ICSI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether confined placental mosaicism (CPM) accounts for the adverse perinatal outcomes in IVF pregnancies. The study provided compared IVF/ICSI pregnancies with spontaneous conceptions.\n\nFirst, the study's main findings: They looked at CVS results from over 20,000 cases. The IVF group had a lower incidence of CPM (1.3% vs 2.2% in controls), but the difference wasn't statistically significant (OR 0.59, CI includes 1). Also, fetal chromosomal anomalies were higher in IVF (4.3% vs 2.4%), but again, not significant. \n\nThe question is whether CPM explains the poorer outcomes. Since the incidence of CPM was actually lower in IVF, and the study found no significant difference, it suggests that CPM isn't the main factor. The options are yes, no, maybe. The answer should be B (no) because the data doesn't support that CPM is responsible. The study's results don't show a higher CPM in IVF, which would be needed to link it to worse outcomes. The lack of statistical significance also weakens the connection. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 485,
            "completion_tokens": 270
        },
        "time_elapsed": 3.3098864555358887
    },
    {
        "realidx": "18322741",
        "question": "Atrial fibrillation, which occurs in 12% of all major foregut surgeries, can prolong hospital stay and increase morbidity. Minimally invasive techniques in foregut surgery have been suggested to cause less tissue trauma. We examined the factors associated with new-onset atrial fibrillation after foregut surgery at our institution.\nWe retrospectively examined the records of 154 adult patients who underwent major foregut surgery which included esophagectomy, partial or total gastrectomy, redo Heller myotomy, redo or transthoracic fundoplications. Univariate and multivariate logistic regression analysis with standard modeling techniques were performed to determine risk factors for new-onset atrial fibrillation.\nOf the 154 patients, 14 patients developed new-onset atrial fibrillation with a higher mean age of 67.1 years (+/-8.8 years) versus 56.4 years (+/-14.1 years) (p = 0.006). Laparoscopic (p = 0.004) and nonthoracic surgeries (p = 0.01) were associated with lower risk of atrial fibrillation. Patients with atrial fibrillation had received more fluid (6.5 +/- 2.8 liters versus 5.3 +/- 2.0 liters) and had longer operations (370 +/- 103 min versus 362 +/- 142 min), none of which were statistically significant. The average intensive care length of stay of patients was longer: 7.5 +/- 6.8 days versus 4.0 +/- 7.1 days (p = 0.004). Multivariate analysis revealed an association of atrial fibrillation with age (OR 1.08, 95% CI 1.02-1.14, p = 0.01), and laparoscopic surgery (OR 0.09, 95% CI 0.01-0.95, p = 0.04) after adjusting for surgery type.\nDoes laparoscopic surgery decrease the risk of atrial fibrillation after foregut surgery?",
        "answer": "yes",
        "answer_rationale": "Laparoscopic surgery is associated with lower risk of atrial fibrillation in foregut surgery. Development of atrial fibrillation is associated with increased length of intensive care stay. We recommend a prospective trial to confirm our findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether laparoscopic surgery decreases the risk of atrial fibrillation after foregut surgery based on the provided study.\n\nFirst, I need to look at the data given. The study says that in the univariate analysis, laparoscopic (p = 0.004) and nonthoracic surgeries were associated with lower risk. Then, in the multivariate analysis, which adjusts for surgery type, laparoscopic surgery had an OR of 0.09 with a 95% CI of 0.01-0.95 and a p-value of 0.04. \n\nThe OR is less than 1, which means that laparoscopic surgery is associated with a lower odds of atrial fibrillation. The confidence interval doesn't include 1, which suggests the result is statistically significant. The p-value is also below 0.05. So, according to the multivariate analysis, which controls for other variables like surgery type, laparoscopic surgery is indeed a protective factor. \n\nThe question is whether this means laparoscopic surgery decreases the risk. Since the OR is 0.09, that's a strong association. The answer should be yes. The options are A, B, C. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 555,
            "completion_tokens": 282
        },
        "time_elapsed": 4.248415946960449
    },
    {
        "realidx": "18359123",
        "question": "Swedish hospital mergers seem to stem from a conviction among policy makers that bigger hospitals lead to lower average costs and improved clinical outcomes. The effects of mergers in the form of multisited hospitals have not been systematically evaluated. The purpose of this article is to contribute to this area of knowledge by exploring responses to the merger of Blekinge Hospital.\nThe evaluation was guided by the philosophy of triangulation. A questionnaire was sent to 597 randomly selected employees, that is 24% of the health care staff. Four hundred ninety-eight employees answered the questionnaire, giving a response rate of 83%. Furthermore, interviews of different groups of stakeholders were conducted.\nA moderate increase of quality was assessed, which, a low proportion of the employees perceived had decisively or largely to do with the merger. The majority perceives economical incentives as the drivers of change, but, at the same time, only 10% of this group believes this target was reached completely or to a large extent.\nIs it better to be big?",
        "answer": "no",
        "answer_rationale": "The employees believe the merger has neither generated economy of scale advantages nor substantial quality improvement. Instead, it seems more rewarding to promote cross-functional collaboration together with clinical specialisation. Needs for both integration and differentiation could thereby be fulfilled.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether it's better to be big, based on the information provided about the Swedish hospital mergers.\n\nFirst, I need to recall the details from the passage. The article discusses the merger of Blekinge Hospital and evaluates its effects. The key points are:\n\n- The merger was based on the belief that larger hospitals lead to lower costs and better outcomes.\n- The evaluation used triangulation, with a questionnaire and interviews.\n- The results showed a moderate increase in quality, but only a low proportion of employees thought the merger was the main reason.\n- Most employees saw economic incentives as the driver of change, but only 10% felt that the economic goals were largely achieved.\n\nThe question is whether being big (i.e., merging into a larger hospital) is better. The options are yes, no, maybe.\n\nLooking at the results: the quality increase was moderate, but not strongly linked to the merger. The economic goals, which were a key reason for the merger, weren't met by most people's perceptions. So the evidence here suggests that the merger didn't achieve its intended benefits as much as hoped. \n\nThe title \"Is it better to be big?\" is probably answered negatively based on the study's findings. The correct answer would be (B) no. But wait, the study found a moderate increase in quality. However, the employees didn't attribute that much to the merger. The main drivers (economic incentives) didn't pan out. So the conclusion is that the merger didn't lead to the expected benefits. Therefore, the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 300,
            "completion_tokens": 336
        },
        "time_elapsed": 4.192802429199219
    },
    {
        "realidx": "18378554",
        "question": "The authors examined equivalence of wandering and physically nonaggressive agitation (PNA) as concepts.\nA cross-sectional correlational design was used.\nParticipants were recruited from 22 nursing homes and 6 assisted living facilities in two states.\nAmbulatory residents meeting DSM-IV criteria for dementia (N = 181) were studied.\nVideo-tapes for up to twelve 20-minute observations per participant were coded for wandering using an empirically derived taxonomy of ambulation patterns. Separate raters coded the same tapes for six PNA behaviors on the agitation behavior mapping instrument.\nMost participants (73.5%) wandered; all showed PNA behaviors. Factor analyses yielded an one-factor solution for wandering (explained variance = 43.66%) and a two-factor solution for PNA (explained variance = 53.45%). Overall wandering correlated significantly with PNA Factor 1 (df =179, r = 0.68, p<0.001) and Factor 2, but at a lower value (df = 179, r = 0.26, p<0.01).\nAre wandering and physically nonaggressive agitation equivalent?",
        "answer": "no",
        "answer_rationale": "Findings depict wandering and PNA as overlapping, but nonequivalent phenomena. Evidence supporting construct validity of wandering was more robust than that for PNA. Results have implications for accuracy in scientific and clinical detection and labeling of wandering and agitation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether wandering and physically nonaggressive agitation (PNA) are equivalent based on the study described.\n\nFirst, I need to understand the study's findings. The authors did a cross-sectional study with dementia patients in nursing homes and assisted living. They used video observations to code wandering and PNA behaviors. \n\nThe key results here are the factor analyses. Wandering had a one-factor solution explaining 43.66% of variance. PNA had a two-factor solution with 53.45% variance. That suggests wandering is a single construct, while PNA is made up of two different factors. \n\nThen, the correlation between wandering and PNA Factor 1 was strong (r=0.68, p<0.001), but with Factor 2 it was weaker (r=0.26, p<0.01). A significant correlation doesn't necessarily mean equivalence. Since PNA breaks down into two factors, and only one of them is strongly related to wandering, they might not be the same. The two-factor structure for PNA implies it's a broader or different construct. \n\nThe question is about equivalence. If they were equivalent, you'd expect a single factor or the factors to align more closely. Since PNA has two factors and wandering is one factor, and only one of PNA's factors is strongly correlated, they aren't the same. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 338,
            "completion_tokens": 313
        },
        "time_elapsed": 3.8564836978912354
    },
    {
        "realidx": "18399830",
        "question": "To evaluate whether robotically assisted laparoscopic prostatectomy (RALP) is less invasive than radical retropubic prostatectomy (RRP), as experimental studies suggest that the acute phase reaction is proportional to surgery-induced tissue damage.\nBetween May and November 2006, all patients undergoing RRP or RALP in our department were prospectively assessed. Blood samples were collected 24 h before (T0), during surgery (T1), at the end of anaesthesia (T2), and 12 (T3) and 24 h after surgery (T4), and assayed for interleukin(IL)-6 and IL-1 alpha, C-reactive protein (CRP), and lactate. The Mann-Whitney U-, Student's t- and Friedman tests were used to compare continuous variables, and the Pearson chi-square and Fisher test for categorical variables, with a two-sided P<0.05 considered to indicate significance.\nIn all, 35 and 26 patients were assessed for RALP and RRP, respectively; the median (interquartile range) age was 62 (56-68) and 68.5 (59.2-71.2) years, respectively (P<0.009). Baseline levels (T0) of IL-1, IL-6, CRP and lactate were comparable in both arms. IL-6, CRP and lactates levels increased during both kinds of surgery. The mean IL-6 and CPR values were higher for RRP at T1 (P = 0.01 and 0.001), T2 (P = 0.001 and<0.001), T3 (P = 0.002 and<0.001) and T4 (P<0.001 and 0.02), respectively. Lactate was higher for RRP at T2 (P = 0.001), T3 (P = 0.001) and T4 (P = 0.004), although remaining within the normal ranges. IL-1 alpha did not change at the different sample times.\nIs robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy?",
        "answer": "yes",
        "answer_rationale": "This study showed for the first time that RALP induces lower tissue trauma than RRP.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether robotically assisted laparoscopic prostatectomy (RALP) is less invasive than radical retropubic prostatectomy (RRP) based on the study provided.\n\nFirst, I need to recall what the question is about. The key point here is the comparison between RALP and RRP in terms of invasiveness. The study uses markers like IL-6, CRP, and lactate to assess the acute phase reaction, which is proportional to tissue damage from surgery. So, higher levels of these markers would indicate more tissue damage, implying a more invasive procedure.\n\nLooking at the data given: the study had 35 RALP and 26 RRP patients. The baseline levels (T0) of the markers were the same for both groups. Then, during surgery (T1) and after (T2, T3, T4), the RRP group had significantly higher levels of IL-6, CRP, and lactate compared to RALP. The p-values are all below 0.05, which is the threshold for significance. \n\nIL-1 alpha didn't change, so that's not a factor here. The fact that RRP had higher levels of the other markers at multiple time points suggests that RRP causes a more pronounced acute phase reaction. Since the acute phase reaction is linked to tissue damage, this would mean RRP is more invasive. Therefore, RALP being associated with lower levels of these markers would be less invasive. \n\nThe options are (A) yes, (B) no, (C) maybe. The study's results support that RALP is less invasive, so the answer should be A. Wait, but I need to make sure I didn't misinterpret the direction. The question is whether RALP is less invasive than RRP. Since RRP has higher markers, that means RALP is indeed less invasive. So yes, the answer is A. The age difference between groups was significant (P<0.009), but the question is about invasiveness based on the markers. The study controlled for baseline levels, so the differences post-surgery are likely due to the surgery type. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 586,
            "completion_tokens": 475
        },
        "time_elapsed": 5.622637987136841
    },
    {
        "realidx": "18435678",
        "question": "Kell haemolytic disease in pregnancies has been suggested to be associated with decreased fetal platelet counts. The aim of this study was to evaluate the incidence and clinical significance of fetal thrombocytopenia in pregnancies complicated by Kell alloimmunization.\nIn this retrospective cohort study, fetal platelet counts were performed in 42 pregnancies with severe Kell alloimmunization prior to the first intrauterine blood transfusion. Platelet counts from 318 first intrauterine transfusions in RhD alloimmunized pregnancies were used as controls.\nFetal thrombocytopenia (platelet count<150 x 10(9)/l) was found in 4/42 (10%) in the Kell group and in 84/318 (26%) in the RhD group. None of the fetuses in the Kell alloimmunized pregnancies, including 15 with severe hydrops, had a clinically significant thrombocytopenia defined as a platelet count<50 x 10(9)/l. In the RhD alloimmunized pregnancies, 2/230 (1%) of the non-hydropic fetuses and 7/30 (23%) of the severely hydropic fetuses had a clinically significant thrombocytopenia.\nKell alloimmunization in pregnancy: associated with fetal thrombocytopenia?",
        "answer": "no",
        "answer_rationale": "In contrast to fetuses with severe anaemia and hydrops due to RhD alloimmunization, fetuses with severe anaemia due to Kell alloimmunization are generally not at risk for substantial thrombocytopenia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Kell alloimmunization in pregnancy is associated with fetal thrombocytopenia. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study compared Kell and RhD alloimmunized pregnancies. The key points are:\n\n- In the Kell group (42 pregnancies), 4 out of 42 (10%) had fetal thrombocytopenia (platelets <150). \n- The RhD group (318 cases) had 26% with thrombocytopenia. \n- Importantly, none of the Kell cases had platelets below 50 (the clinically significant threshold), even among those with hydrops. \n- In RhD, some hydropic fetuses did have very low platelets.\n\nThe question is whether Kell is associated. The study shows that while there was some thrombocytopenia (10%), it didn't reach the clinically significant level (<50) in any case. But the question is about association, not necessarily clinical significance. The presence of any thrombocytopenia (even if not severe) would suggest an association. However, the options are yes/no/maybe. The answer might hinge on whether the 10% counts as \"associated.\" Since the study found it occurred more in Kell than not, but less than RhD, but still present, the answer is yes. But wait, the options are (A) yes, (B) no, (C) maybe. The study does show that Kell is associated with some thrombocytopenia (10% had <150), so the answer should be yes. The fact that none had severe thrombocytopenia might be a point, but the question is about any association. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 397,
            "completion_tokens": 409
        },
        "time_elapsed": 5.43337345123291
    },
    {
        "realidx": "18472368",
        "question": "The protraction of external beam radiotherapy (RT) time is detrimental in several disease sites. In prostate cancer, the overall treatment time can be considerable, as can the potential for treatment breaks. We evaluated the effect of elapsed treatment time on outcome after RT for prostate cancer.\nBetween April 1989 and November 2004, 1,796 men with prostate cancer were treated with RT alone. The nontreatment day ratio (NTDR) was defined as the number of nontreatment days divided by the total elapsed days of RT. This ratio was used to account for the relationship between treatment duration and total RT dose. Men were stratified into low risk (n = 789), intermediate risk (n = 798), and high risk (n = 209) using a single-factor model.\nThe 10-year freedom from biochemical failure (FFBF) rate was 68% for a NTDR<33% vs. 58% for NTDR>/=33% (p = 0.02; BF was defined as a prostate-specific antigen nadir + 2 ng/mL). In the low-risk group, the 10-year FFBF rate was 82% for NTDR<33% vs. 57% for NTDR>/=33% (p = 0.0019). The NTDR was independently predictive for FFBF (p = 0.03), in addition to T stage (p = 0.005) and initial prostate-specific antigen level (p<0.0001) on multivariate analysis, including Gleason score and radiation dose. The NTDR was not a significant predictor of FFBF when examined in the intermediate-risk group, high-risk group, or all risk groups combined.\nDoes treatment duration affect outcome after radiotherapy for prostate cancer?",
        "answer": "yes",
        "answer_rationale": "A proportionally longer treatment duration was identified as an adverse factor in low-risk patients. Treatment breaks resulting in a NTDR of>/=33% (e.g., four or more breaks during a 40-fraction treatment, 5 d/wk) should be avoided.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether treatment duration affects the outcome after radiotherapy for prostate cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study involved 1,796 men treated with RT alone. They used the NTDR (nontreatment days divided by total elapsed days) to assess treatment breaks. The key results are the FFBF (Freedom from Biochemical Failure) rates. \n\nThe 10-year FFBF was 68% for NTDR <33% versus 58% for NTDR \u226533%, which is a statistically significant difference (p=0.02). In the low-risk group, the difference was even more pronounced: 82% vs 57% (p=0.0019). The NTDR was an independent predictor of FFBF on multivariate analysis, along with T stage and initial PSA. However, in intermediate and high-risk groups, NTDR wasn't significant. \n\nThe question is general\u2014does treatment duration affect outcome? The study shows that in the overall cohort and especially in low-risk patients, a higher NTDR (longer treatment time) was linked to worse outcomes. Even though it wasn't significant in higher risk groups, the overall answer would still be yes because the NTDR was a significant predictor in the multivariate analysis and in the low-risk group. The fact that it's not significant in all subgroups might mean the effect is more pronounced in certain groups, but the question isn't restricted to those. The main conclusion from the study's results is that treatment duration (as measured by NTDR) does affect outcome, so the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 488,
            "completion_tokens": 367
        },
        "time_elapsed": 5.1531805992126465
    },
    {
        "realidx": "18496363",
        "question": "To characterize the gender dimorphism after injury with specific reference to the reproductive age of the women (young,<48 yrs of age, vs. old,>52 yrs of age) in a cohort of severely injured trauma patients for which significant variation in postinjury care is minimized.\nSecondary data analysis of an ongoing prospective multicenter cohort study.\nAcademic, level I trauma and intensive care unit centers.\nBlunt-injured adults with hemorrhagic shock.\nNone.\nSeparate Cox proportional hazard regression models were formulated based on all patients to evaluate the effects of gender on mortality, multiple organ failure, and nosocomial infection, after controlling for all important confounders. These models were then used to characterize the effect of gender in young and old age groups. Overall mortality, multiple organ failure, and nosocomial infection rates for the entire cohort (n = 1,036) were 20%, 40%, and 45%, respectively. Mean Injury Severity Score was 32 +/- 14 (mean +/- SD). Men (n = 680) and women (n = 356) were clinically similar except that men required higher crystalloid volumes, more often had a history of alcoholism and liver disease, and had greater ventilatory and intensive care unit requirements. Female gender was independently associated with a 43% and 23% lower risk of multiple organ failure and nosocomial infection, respectively. Gender remained an independent risk factor in young and old subgroup analysis, with the protection afforded by female gender remaining unchanged.\nCharacterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible?",
        "answer": "no",
        "answer_rationale": "The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than sex hormones may be responsible for gender-based differences after injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether hormonal differences are responsible for the gender dimorphism observed after injury and hemorrhagic shock based on the provided study.\n\nFirst, I need to recall the study's findings. The study found that female gender was associated with lower risks of multiple organ failure and nosocomial infections compared to males. This protective effect was consistent in both younger and older women (divided at ages 48 and 52). The analysis controlled for confounders, so factors like crystalloid volume or medical history (like alcoholism) which differed between genders were accounted for. \n\nThe key here is that the question is about whether hormonal differences are the cause. The study's results show a consistent protective effect in women regardless of their age group (which spans pre and post-menopausal, since the cutoff is around 48-52, typical menopause age). If hormonal factors like estrogen were the main reason, one might expect a difference between younger (with more estrogen) and older (potentially post-menopausal, lower estrogen) women. However, the study states that the protection remained unchanged in both subgroups. That suggests that the hormonal differences (like estrogen levels) might not be the primary factor because the effect is the same across different hormonal states. \n\nTherefore, the answer would be \"no\" because the study's results don't support hormonal differences as the cause since the protective effect is consistent across age groups with varying hormone levels. The options are (A) yes, (B) no, (C) maybe. So the correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 430,
            "completion_tokens": 333
        },
        "time_elapsed": 3.989802837371826
    },
    {
        "realidx": "18507507",
        "question": "Specialty pharmaceuticals have evolved beyond their status as niche drugs designed to treat rare conditions and are now poised to become the standard of care in a wide variety of common chronic illnesses. Due in part to the cost of these therapies, payers are increasingly demanding evidence of their value. Determining the value of these medications is hampered by a lack of robust pharmacoeconomic data.\nTo outline emerging strategies and case study examples for the medical and pharmacy benefits management of specialty pharmaceuticals.\nThe promise of specialty pharmaceuticals: increased life expectancy, improved quality of life, enhanced workplace productivity, decreased burden of disease, and reduced health care spending comes at a significant cost. These agents require special handling, administration, patient education, clinical support, and risk mitigation. Additionally, specialty drugs require distribution systems that ensure appropriate patient selection and data collection. With the specialty pharmaceutical pipeline overflowing with new medicines and an aging population increasingly relying on these novel treatments to treat common diseases, the challenge of managing the costs associated with these agents can be daunting. Aided by sophisticated pharmacoeconomic models to assess value, the cost impacts of these specialty drugs can be appropriately controlled.\nThe promise of specialty pharmaceuticals: are they worth the price?",
        "answer": "yes",
        "answer_rationale": "Current evidence suggests that when used in targeted patient populations, specialty pharmaceuticals may represent a good health care value.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the promise of specialty pharmaceuticals is worth the price. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The passage mentions that specialty drugs have moved beyond treating rare conditions and are now becoming standard for common chronic illnesses. However, their high cost means payers want evidence of value. The problem is a lack of robust pharmacoeconomic data to determine their value. \n\nThe benefits listed include increased life expectancy, better quality of life, improved workplace productivity, reduced disease burden, and lower healthcare spending. But there's a significant cost, plus they require special handling, administration, education, and distribution. The challenge is managing costs with new medicines and an aging population. The passage also says that using pharmacoeconomic models can help control costs.\n\nThe question is whether the promise is worth the price. The passage doesn't outright say yes or no. It presents both the benefits and the challenges. The conclusion seems to suggest that with proper management and models, the costs can be controlled, implying that they might be worth it, but there's uncertainty because of the lack of data. The answer options are yes, no, maybe. Since the passage discusses both sides and mentions the need for strategies and models, the answer is probably \"maybe\" because it's not a clear yes or no. The author is highlighting that while there's potential, the cost and data issues mean it's not yet definitively worth it. So the correct answer is C.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 332,
            "completion_tokens": 318
        },
        "time_elapsed": 3.7655510902404785
    },
    {
        "realidx": "18537964",
        "question": "To determine the impact of a physician's specialty on the frequency and depth of medication history documented in patient medical records.\nA cross-sectional assessment of the frequency and depth of medication history information documented by 123 physicians for 900 randomly selected patients stratified across Cardiology, Chest, Dermatology, Endocrine, Gastroenterology, Haematology, Neurology, Psychiatry and Renal specialties was carried out at a 900-bed teaching hospital located in Ibadan, Nigeria.\nFour hundred and forty-three (49.2%) of the cohort were males and 457 (50.8%) were females; with mean ages 43.2 +/- 18.6 and 43.1 +/- 17.9 years respectively. Physicians' specialties significantly influenced the depth of documentation of the medication history information across the nine specialties (P<0.0001). Post hoc pair-wise comparisons with Tukey's HSD test showed that the mean scores for adverse drug reactions and adherence to medicines was highest in the Cardiology specialty; while the Chest specialty had the highest mean scores for allergy to drugs, food, chemicals and cigarette smoking. Mean scores for the use of alcohol; illicit drugs; dietary restrictions was highest for Gastroenterology, Psychiatry and Endocrine specialties respectively. Physicians' specialties also significantly influenced the frequency of documentation of the medication history across the nine specialties (P<0.0001).\nDoes a physician's specialty influence the recording of medication history in patients' case notes?",
        "answer": "yes",
        "answer_rationale": "Physicians appear to document more frequently and in greater depth medication history information that may aid the diagnostic tasks in their specific specialty. Researchers and other users of medication history data documented in patients' medical records by physicians may want to take special cognizance of this phenomenon.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a physician's specialty influences the recording of medication history in patients' case notes. The provided information is from a study done in a hospital in Ibadan, Nigeria.\n\nFirst, I need to look at the key points from the study. The question mentions a cross-sectional assessment of 123 physicians across nine specialties. The results state that physicians' specialties significantly influenced both the depth and frequency of medication history documentation. The p-value is less than 0.0001, which is a strong indicator of statistical significance. \n\nThe post hoc tests with Tukey's HSD further break down where the differences lie. For example, Cardiology had the highest scores for adverse reactions and adherence, Chest for allergies and smoking, and others for alcohol, drugs, and dietary restrictions. Since the p-value is so low, this means the differences observed are not due to chance. \n\nThe options are (A) yes, (B) no, (C) maybe. The study clearly states that specialty significantly influenced both depth and frequency. So the answer should be (A) yes. The \"maybe\" option might be a distractor, but the statistical significance here is clear. There's no ambiguity in the results presented. The answer is definitely yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 407,
            "completion_tokens": 272
        },
        "time_elapsed": 3.566058397293091
    },
    {
        "realidx": "18540901",
        "question": "DNA was collected for genotyping from 73 term newborns suffering from TTN and 55 healthy controls from a Caucasian cohort.\nTTN infants were more likely to be male (70% vs. 49%; p<0.05), had a lower mean birthweight (3120 +/- 450 vs. 3396 +/- 504 g; p<0.001) and gestational age (GA) (38.4 +/- 1.2 vs. 39.4 +/- 1.3 weeks; p<0.001) and were more often delivered by caesarean section (CS) (71% vs. 26%; p<0.001). The beta1Ser49Gly polymorphism differed significantly between cases and controls. Multivariate analysis provided beta1Gly49 homozygotes with higher risk for TTN (OR 18.5; 95%CI 1.5-229; p = 0.023) than beta1Ser49 allele carrier. Further analysis showed significant association of T-47C, A46G, C79G and C491T (TACC) haplotype in ADRB2 gene with TTN (p = 0.048).\nTransient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes?",
        "answer": "yes",
        "answer_rationale": "We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a role for polymorphisms in the beta-adrenergic receptor (ADRB) genes in Transient Tachypnea of the Newborn (TTN) based on the provided study.\n\nFirst, I need to understand the study's findings. The study compared 73 TTN newborns with 55 controls. They found several differences: more males in TTN group, lower birthweight, lower gestational age, and more cesarean sections. But the key part here is the genetic analysis.\n\nThe beta1Ser49Gly polymorphism showed a significant difference. The multivariate analysis indicated that homozygotes for beta1Gly49 had an OR of 18.5 for TTN, which is a strong risk factor. Also, the TACC haplotype in the ADRB2 gene was associated with TTN at p=0.048. \n\nSince the question is about ADRB genes, the beta1 is part of the beta-adrenergic receptors (ADRB1). The ADRB2 is also mentioned directly with the haplotype. The significant associations (p-values less than 0.05) suggest that these genetic variants are linked to TTN. The OR of 18.5 is very high, indicating a strong association. The haplotype's p-value is just under 0.05, which is considered statistically significant. \n\nSo the study's results support the idea that polymorphisms in these genes play a role. The answer should be \"yes\" which is option A. I need to make sure there's no conflicting data. The question is whether the study suggests a role, and the findings do point towards that. The other options, like maybe or no, don't fit because the data shows significant associations. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 417,
            "completion_tokens": 402
        },
        "time_elapsed": 4.980283260345459
    },
    {
        "realidx": "18565233",
        "question": "Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a central role in lipid and glucose metabolism, had been hypothesized as being involved in colon cancerogenesis. In animal studies the lipid-lowering PPAR ligand bezafibrate suppressed colonic tumors. However, the effect of bezafibrate on colon cancer development in humans is unknown. Therefore, we proposed to investigate a possible preventive effect of bezafibrate on the development of colon cancer in patients with coronary artery disease during a 6-year follow-up.\nOur population included 3011 patients without any cancer diagnosis who were enrolled in the randomized, double blind Bezafibrate Infarction Prevention (BIP) Study. The patients received either 400 mg of bezafibrate retard (1506 patients) or placebo (1505 patients) once a day. Cancer incidence data were obtained by matching a subject's identification numbers with the National Cancer Registry. Each matched record was checked for correct identification.\nDevelopment of new cancer (all types) was recorded in 177 patients: in 79 (5.25%) patients from the bezafibrate group vs. 98 (6.51%) from the placebo group. Development of colon cancer was recorded in 25 patients: in 8 (0.53%) patients from the bezafibrate group vs. 17 (1.13%) from the placebo group, (Fisher's exact test: one side p = 0.05; two side p = 0.07). A difference in the incidence of cancer was only detectable after a 4 year lag and progressively increased with continued follow-up. On multivariable analysis the colon cancer risk in patients who received bezafibrate tended to be lower with a hazard ratio of 0.47 and 95% confidence interval 0.2-1.1.\nDoes the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?",
        "answer": "yes",
        "answer_rationale": "Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether bezafibrate, a PPAR ligand used to lower lipids, can prevent colon cancer in patients with coronary artery disease. The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided. The study had 3011 patients split into bezafibrate and placebo groups. After 6 years, colon cancer developed in 8 out of 1506 (0.53%) in the bezafibrate group versus 17 out of 1505 (1.13%) in the placebo group. The p-values from Fisher's exact test are one-sided 0.05 and two-sided 0.07. The hazard ratio from multivariable analysis was 0.47 with a 95% CI of 0.2 to 1.1.\n\nHmm, the key here is interpreting the statistical significance. The two-sided p-value is 0.07, which is above the common threshold of 0.05 for significance. That suggests the difference might not be statistically significant. The confidence interval for the hazard ratio includes 1 (since the upper limit is 1.1), meaning the effect could be neutral or even slightly positive, but also the lower end is 0.2, which is a big reduction. However, because the interval crosses 1, it's not statistically significant. \n\nThe question is whether bezafibrate \"prevents\" colon cancer. Since the results are on the border of significance (one-sided p=0.05 vs two-sided 0.07), and the confidence interval includes 1, the conclusion might be that there's a trend but not a definitive proof. The hazard ratio is 0.47, which is a 53% reduction, but the CI's upper limit being over 1 means we can't rule out no effect or even increased risk, though the point estimate is favorable. \n\nThe options are yes, no, maybe. The study's results are inconclusive because the p-value is not below 0.05 (two-tailed is more stringent), and the CI includes 1. So the answer is probably \"maybe\" because the data suggest a possible benefit but it's not statistically significant. Alternatively, if the question considers the one-sided p-value, which is exactly 0.05, maybe some might argue significance, but typically two-sided",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 541,
            "completion_tokens": 512
        },
        "time_elapsed": 5.680516481399536
    },
    {
        "realidx": "18568239",
        "question": "To evaluate the influence of the urologist's experience on the surgical results and complications of transurethral resection of the prostate (TURP).\nSixty-seven patients undergoing transurethral resection of the prostate without the use of a video camera were randomly allocated into three groups according to the urologist's experience: a urologist having done 25 transurethral resections of the prostate (Group I - 24 patients); a urologist having done 50 transurethral resections of the prostate (Group II - 24 patients); a senior urologist with vast transurethral resection of the prostate experience (Group III - 19 patients). The following were recorded: the weight of resected tissue, the duration of the resection procedure, the volume of irrigation used, the amount of irrigation absorbed and the hemoglobin and sodium levels in the serum during the procedure.\nThere were no differences between the groups in the amount of irrigation fluid used per operation, the amount of irrigation fluid absorbed or hematocrit and hemoglobin variation during the procedure. The weight of resected tissue per minute was approximately four times higher in group III than in groups I and II. The mean absorbed irrigation fluid was similar between the groups, with no statistical difference between them (p=0.24). Four patients (6%) presented with TUR syndrome, without a significant difference between the groups.\nIs the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience?",
        "answer": "yes",
        "answer_rationale": "The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the surgeon's experience affects their ability to perform TURP based on the study described.\n\nFirst, I need to look at the data provided. The study divided patients into three groups based on the urologist's experience: Group I (25 procedures), Group II (50), and Group III (senior with lots of experience). The outcomes measured include resected tissue weight, procedure duration, irrigation used, absorbed fluid, and hemoglobin/sodium levels.\n\nThe key findings were that Groups I and II had about a quarter of the tissue resected per minute compared to Group III. That's a big difference. However, the amount of irrigation used and absorbed was similar across all groups, and TUR syndrome occurred in 6% without group differences. The p-value for absorbed fluid was 0.24, which isn't statistically significant. \n\nThe question is about the surgeon's ability being influenced by experience. The higher tissue resection per minute in the more experienced group suggests that experience does make a difference in efficiency. The other factors like irrigation and complications didn't differ, but the main outcome here is the procedure's effectiveness (tissue removed per time). So the answer should be \"yes\" because the senior surgeon's group performed better in that key metric. The options are A, B, C. So A is correct.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 415,
            "completion_tokens": 293
        },
        "time_elapsed": 3.6001827716827393
    },
    {
        "realidx": "18568290",
        "question": "The etiology of hemodialysis (HD)-induced hypotension and hypertension remains speculative. There is mounting evidence that endothelin-1 (ET-1) may play a vital role in these hemodynamic changes. We examined the possible role of intradialytic changes of ET-1 in the pathogenesis of hypotension and rebound hypertension during HD.\nThe present study included 45 patients with end-stage renal disease (ESRD) on regular HD. They were divided according to their hemodynamic status during HD into three groups (group I had stable intradialytic hemodynamics, group II had dialysis-induced hypotension, and group III had rebound hypertension during HD). In addition, 15 healthy volunteers were included as a control group. Pulse and blood pressure were monitored before, during (every half hour), and after HD session. ET-1 level was measured at the beginning, middle, and end of HD. ET-1 was measured in the control group for comparison.\nPre-dialysis levels of ET-1 were significantly higher in dialysis patients compared to the controls (P<0.001); however, they were comparable in the three HD groups. The post-dialysis ET-1 level was not changed significantly in group I compared with predialysis values (14.49 +/- 2.04 vs. 14.33 +/- 2.23 pg/ml; P = NS), while the ET-1 concentration decreased significantly in group II and increased in group III in comparison to predialysis values (8.56 +/- 1.44 vs. 11.75 +/- 2.51; 16.39 +/- 3.12 vs. 11.93 +/- 2.11 pg/ml, respectively; P<0.001).\nIs there a role for endothelin-1 in the hemodynamic changes during hemodialysis?",
        "answer": "maybe",
        "answer_rationale": "Altered ET-1 levels may be involved in the pathogenesis of rebound hypertension and hypotension during HD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether endothelin-1 (ET-1) plays a role in the hemodynamic changes during hemodialysis, specifically hypotension and rebound hypertension.\n\nFirst, the study divided 45 ESRD patients into three groups: those with stable hemodynamics (group I), those with dialysis-induced hypotension (group II), and those with rebound hypertension (group III). They also had a control group of healthy volunteers. They measured ET-1 levels before, during, and after dialysis.\n\nThe key findings were that pre-dialysis ET-1 levels in all dialysis patients were higher than controls, but similar among the three groups. Post-dialysis, group I's ET-1 didn't change much. But group II (hypotension) had a significant decrease in ET-1, while group III (rebound hypertension) had a significant increase. \n\nSo, the question is whether ET-1 has a role here. The data shows that in hypotension cases, ET-1 goes down, which might contribute to the drop in blood pressure. Conversely, in rebound hypertension, ET-1 increases, which could lead to higher BP post-dialysis. Since ET-1 is a potent vasoconstrictor, lower levels would relax blood vessels, possibly causing hypotension, and higher levels would constrict, causing hypertension. This suggests that ET-1 fluctuations are linked to these hemodynamic changes. Therefore, the answer should be yes (A).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 496,
            "completion_tokens": 321
        },
        "time_elapsed": 4.128069639205933
    },
    {
        "realidx": "18570208",
        "question": "To determine the association between fetal biometry in the first or early second trimester and severe macrosomia at delivery.\nThis case-control study included 30 term severely macrosomic neonates; 90 appropriate-for-gestational age (AGA) neonates served as controls. All pregnancies underwent nuchal translucency (NT) screening at 11-14 weeks' gestation. Pregnancies were dated by accurate last menstrual period consistent with crown-rump length (CRL) measurements at the time of screening, early pregnancy CRL or date of fertilization. The association between birth weight and the difference between the measured and the expected CRL at the time of NT screening was analyzed.\nThe difference between measured and expected CRL, expressed both in mm and in days of gestation, was statistically greater in the severely macrosomic neonates compared with controls (mean, 6.66 +/- 4.78 mm vs. 1.17 +/- 4.6 mm, P<0.0001 and 3 +/- 2.2 days vs. 0.5 +/- 2.3 days, P<0.0001, respectively). Furthermore, there were significant correlations between the extent of macrosomia and the discrepancy between expected and measured fetal size at the time of NT screening (r = 0.47, P<0.01 and r = 0.48, P<0.01, respectively).\nIs severe macrosomia manifested at 11-14 weeks of gestation?",
        "answer": "yes",
        "answer_rationale": "Severe macrosomia apparently manifests as early as 11-14 weeks' gestation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether severe macrosomia is manifested at 11-14 weeks of gestation based on the provided study.\n\nFirst, I need to understand the study's setup. It's a case-control study with 30 severely macrosomic neonates and 90 controls. All had NT screening at 11-14 weeks. They used accurate dating methods like LMP and CRL. The key point is the comparison between measured CRL and expected CRL at NT screening.\n\nThe results show that the difference between measured and expected CRL was significantly greater in the macrosomic group. Both in mm and days, the means were higher (6.66 vs 1.17 mm, p<0.0001; 3 vs 0.5 days, p<0.0001). Also, there was a correlation between the extent of macrosomia and the discrepancy at NT screening (r=0.47 and 0.48, both p<0.01). \n\nSo, the study's findings suggest that even at 11-14 weeks, there's a measurable difference in CRL between those who later became macrosomic and controls. The discrepancy in CRL indicates that the fetuses who became macrosomic were already larger than expected early on. Since CRL is a biometric measure, this implies that the macrosomia's roots might be present early. The question is whether this means it's \"manifested\" at that stage. \n\nManifested here would mean that the condition is already detectable or present. Since the study shows a significant difference in CRL at 11-14 weeks, that suggests that the fetal size was already larger than expected, which could be an early sign. The correlations also support that the degree of macrosomia relates to the early discrepancy. Therefore, the answer should be yes (A). The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 417,
            "completion_tokens": 424
        },
        "time_elapsed": 4.868677616119385
    },
    {
        "realidx": "18594195",
        "question": "Refusal of patients to participate in intervention programs is an important problem in clinical trials but, in general, researchers devote relatively little attention to it. In this article, a comparison is made between patients who, after having been invited, agreed to participate in a self-management intervention (participants) and those who refused (refusers). Compared with other studies of refusers, relatively more information could be gathered with regard to both their characteristics and reasons for refusing, because all potential participants were invited personally.\nOlder patients from a Dutch outpatient clinic were invited to participate in a self-management intervention, and their characteristics were assessed. Demographic data were collected, as well as data on physical functioning and lack of emotional support. People who refused to participate were asked to give their reasons for refusing.\nOf the 361 patients invited, 267 (74%) refused participation. These refusers were more restricted in their mobility, lived further away from the location of the intervention, and had a partner more often than did the participants. No differences were found in level of education, age or gender. The main reasons given by respondents for refusing to participate were lack of time, travel distance, and transport problems.\nDo older patients who refuse to participate in a self-management intervention in the Netherlands differ from older patients who agree to participate?",
        "answer": "yes",
        "answer_rationale": "As in many studies, the refusal rate in this study is high, and seems to be related to physical mobility restrictions, travel distance and, partly, to availability of emotional support. These findings may be used to make the recruitment process more effective - for example, by offering transport to the location of the intervention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether older patients who refuse to participate in a self-management intervention in the Netherlands differ from those who agree. The options are yes, no, or maybe.\n\nFirst, I need to look back at the provided information. The study invited 361 patients, and 267 (74%) refused. The key point here is the comparison between refusers and participants. The passage states that refusers were more restricted in mobility, lived further away, and had a partner more often than participants. However, there were no differences in education, age, or gender. \n\nThe question is asking if they differ. The answer hinges on whether any significant differences were found. Since the study found differences in mobility, distance, and partnership, the answer should be yes. The fact that some factors (education, age, gender) didn't differ doesn't negate the other differences mentioned. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 356,
            "completion_tokens": 202
        },
        "time_elapsed": 4.534977197647095
    },
    {
        "realidx": "18616781",
        "question": "Pigmentary dilution is observed in patients with homocystinuria. Therefore, it is possible that an increase of local homocysteine (Hcy) interferes with normal melanogenesis and plays a role in the pathogenesis of vitiligo. Vitamin B12 and folic acid, levels of which are decreased in vitiligo, are important cofactors in the metabolism of Hcy. Consequently, a nutritional deficiency in either of these two vitamins will result in an increase in homocysteine in the circulation, a finding that we expect to find in vitiligo.\nTo determine the level of Hcy in the blood of patients with vitiligo as a first step in revealing if it has any relationship with the pathogenesis of vitiligo and consequently if this will have an impact on the treatment of vitiligo.\nTwenty-six patients of both sexes with vitiligo (age range 20-50 years, mean 31.4 +/- 8.09) and 26 age-matched healthy controls were included in the study. After excluding factors that may affect serum Hcy levels, blood samples from patients and controls were obtained for homocysteine determination by enzyme immunoassay.\nThe mean serum level of Hcy was significantly higher in patients with vitiligo than in controls (21.61 +/- 13.28 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). The Hcy level was significantly higher in male patients than in female patients (28.67 +/- 15.95 vs. 15.56 +/- 6.2 micromol L(-1); P<0.001) and in male controls compared with female controls (15.07 +/- 4.61 vs. 12.05 +/- 4.82 micromol L(-1); P<0.001). The homocysteine level was related to the activity of vitiligo and was significantly higher in patients with progressive disease than in controls (25.4 +/- 14.99 vs. 13.1 +/- 4.88 micromol L(-1); P<0.001). No significant difference in Hcy levels was found between either untreated vitiligo patients (22.77 +/- 13.36 micromol L(-1)) or patients receiving ultraviolet therapy (20.45 +/- 13.73 micromol L(-1)) and the total patient group (21.62 +/- 13.28 micromol L(-1)).\nIs there a relationship between homocysteine and vitiligo?",
        "answer": "yes",
        "answer_rationale": "An elevated homocysteine level may be a precipitating factor for vitiligo in predisposed individuals. In view of the biological role of vitamin B(12) and folic acid in Hcy metabolism, we present our recommendations regarding the investigation and treatment of this common disease.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a relationship between homocysteine and vitiligo based on the provided study.\n\nFirst, I need to recall the details from the study description. The study included 26 vitiligo patients and 26 controls. The key findings were that the mean serum Hcy level was significantly higher in patients with vitiligo compared to controls (21.61 vs 13.1, p<0.001). That's a statistically significant difference, which suggests a possible link. \n\nAdditionally, the study noted that Hcy levels were higher in males than females in both groups, but the main point here is the comparison between vitiligo patients and controls. Also, the Hcy level was related to disease activity\u2014higher in those with progressive vitiligo. The fact that even untreated patients had higher Hcy than controls, and that treatment (UV) didn't make a significant difference, supports that the elevation is inherent to the condition, not the treatment.\n\nThe question is whether this indicates a relationship. Since the study shows higher Hcy in vitiligo patients, especially when active, and considering the background info about B12 and folate being cofactors in Hcy metabolism (which are low in vitiligo), it all points towards a connection. The study's results directly answer the question by showing a significant association. So the answer should be \"yes\" which is option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 681,
            "completion_tokens": 310
        },
        "time_elapsed": 3.816599130630493
    },
    {
        "realidx": "18667100",
        "question": "Suicide is a leading cause of death and has been strongly associated with affective disorders. The influence of affective disorder polarity on subsequent suicide attempts or completions and any differential effect of suicide risk factors by polarity were assessed in a prospective cohort.\nParticipants with major affective disorders in the National Institute of Mental Health (NIMH) Collaborative Depression Study (CDS) were followed prospectively for up to 25 years. A total of 909 participants meeting prospective diagnostic criteria for major depressive and bipolar disorders were followed through 4204 mood cycles. Suicidal behavior was defined as suicide attempts or completions. Mixed-effects, grouped-time survival analysis assessed risk of suicidal behavior and differential effects of risk factors for suicidal behavior by polarity. In addition to polarity, the main effects of age, gender, hopelessness, married status, prior suicide attempts and active substance abuse were modeled, with mood cycle as the unit of analysis.\nAfter controlling for age of onset, there were no differences in prior suicide attempts by polarity although bipolar participants had more prior severe attempts. During follow-up, 40 cycles ended in suicide and 384 cycles contained at least one suicide attempt. Age, hopelessness and active substance abuse but not polarity predicted suicidal behavior. The effects of risk factors did not differ by polarity.\nDo risk factors for suicidal behavior differ by affective disorder polarity?",
        "answer": "no",
        "answer_rationale": "Bipolarity does not independently influence risk of suicidal behavior or alter the influence of well-established suicide risk factors within affective disorders. Suicide risk assessment strategies may continue to appraise these common risk factors without regard to mood polarity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the risk factors for suicidal behavior differ based on the polarity of affective disorders, which in this context would be major depressive versus bipolar disorders.\n\nFirst, I need to look back at the provided study details. The study followed participants with major depressive and bipolar disorders over a long period. They used a mixed-effects survival analysis to assess the risk of suicidal behavior and how different factors might influence that risk depending on the disorder's polarity.\n\nThe key results mentioned here are important. The study states that after controlling for age of onset, there were no differences in prior suicide attempts by polarity. Although bipolar participants had more severe prior attempts, the main point is about the risk factors. The results say that age, hopelessness, and active substance abuse predicted suicidal behavior, but polarity itself did not. Additionally, the effects of these risk factors did not differ by polarity. \n\nSo the question is whether the risk factors differ by polarity. The study's conclusion here is clear: the effects of the risk factors (like age, hopelessness, substance abuse) were the same regardless of whether the disorder was depressive or bipolar. Therefore, the answer should be that no, the risk factors do not differ by polarity. The correct option is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 371,
            "completion_tokens": 263
        },
        "time_elapsed": 3.246392011642456
    },
    {
        "realidx": "18693227",
        "question": "This study was performed to describe the treatment plan modifications after a geriatric oncology clinic. Assessment of health and functional status and cancer assessment was performed in older cancer patients referred to a cancer center.\nBetween June 2004 and May 2005, 105 patients 70 years old or older referred to a geriatric oncology consultation at the Institut Curie cancer center were included. Functional status, nutritional status, mood, mobility, comorbidity, medication, social support, and place of residence were assessed. Oncology data and treatment decisions were recorded before and after this consultation. Data were analyzed for a possible correlation between one domain of the assessment and modification of the treatment plan.\nPatient characteristics included a median age of 79 years and a predominance of women with breast cancer. About one half of patients had an independent functional status. Nearly 15% presented severe undernourishment. Depression was suspected in 53.1% of cases. One third of these patients had>2 chronic diseases, and 74% of patients took>or =3 medications. Of the 93 patients with an initial treatment decision, the treatment plan was modified for 38.7% of cases after this assessment. Only body mass index and the absence of depressive symptoms were associated with a modification of the treatment plan.\nDoes a geriatric oncology consultation modify the cancer treatment plan for elderly patients?",
        "answer": "yes",
        "answer_rationale": "The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a geriatric oncology consultation modifies the cancer treatment plan for elderly patients. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided study details. The study included 105 patients over 70 referred to the geriatric oncology clinic. They assessed various factors like functional status, nutrition, mood, etc. Before and after the consultation, they recorded treatment decisions. \n\nThe key result here is that out of 93 patients with an initial treatment decision, 38.7% had their treatment plan modified after the consultation. That's almost 40%, which is a significant number. The question is whether this means the consultation modifies the plan. The answer seems straightforward because the study directly states that the plan was modified in nearly 39% of cases. \n\nThe options are yes, no, maybe. The study clearly shows a modification occurred in a notable percentage, so the answer should be yes. The other details about BMI and depressive symptoms being associated factors might be distractors, but the main point is the modification happened in a significant number of cases. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 383,
            "completion_tokens": 251
        },
        "time_elapsed": 3.369656801223755
    },
    {
        "realidx": "18708308",
        "question": "Despite evidence against its utility, many surgeons continue to employ prophylactic nasogastric decompression in elective colonic resection. This study aimed to establish whether an easy and practical intervention, mailing out a summary of current evidence to surgeons, can change surgeons practice to bring it more in line with current evidence.\nThe use of prophylactic nasogastric (NG) decompression in elective colonic resections was documented for the 2 consecutive months of October and November, 2004 at the Royal Alexandra Hospital (RAH). A one page summary of recent evidence concerning this practice was then mailed to all general surgeons at that institution. A similar second review was carried out for the months of January and February, 2005. The two periods were compared with regards to prophylactic NG use.\nTwenty two patients underwent elective colonic resections during the months of October and November, 2004. Twenty one patients underwent such procedures in January and February, 2005. Seven out of the 22 cases in the first group (the pre-intervention block) received prophylactic NG decompression. Five out of the 21 cases in the second group (the post-intervention block) received prophylactic NG decompression. The difference in prophylactic NG use between the two groups was not statistically significant.\nCan surgeon familiarization with current evidence lead to a change in practice?",
        "answer": "no",
        "answer_rationale": "This study has shown that mailing out a summary of current evidence to surgeons concerning a certain issue is not sufficient to lead to a change in practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. So the study is about whether sending surgeons a summary of current evidence would change their practice regarding prophylactic nasogastric (NG) decompression in elective colonic resections. The setup is that they looked at two time periods: before the intervention (October-November 2004) and after sending the summary (January-February 2005). \n\nIn the first period, 22 patients had surgery, and 7 out of 22 got NG decompression. After the intervention, 21 patients, with 5 out of 21 getting it. The key point here is that the difference between 7/22 (about 32%) and 5/21 (about 24%) wasn't statistically significant. \n\nThe question is asking if familiarizing surgeons with the evidence led to a change in practice. The options are yes, no, maybe. \n\nHmm, the study's result says the difference wasn't statistically significant. That means there's not enough evidence to conclude that the intervention caused a real change. Even though the percentage went down a bit, it's possible that's just random variation. So the answer would be that it didn't lead to a significant change, so the answer would be B (no) or maybe C (maybe). Wait, but the options are (A) yes, (B) no, (C) maybe. \n\nThe study's conclusion is that the difference wasn't statistically significant. So the correct answer would be B, no, because the data doesn't show a significant change. But wait, maybe \"maybe\" because the sample size was small? The numbers are 22 and 21 patients. Maybe the study wasn't powered enough. The question is whether the intervention can lead to a change. The study didn't find a significant effect, so the answer would be B (no) because the evidence from this study doesn't support that it worked. Alternatively, maybe the answer is C (maybe) because the trend is downward but not significant. But the question is phrased as \"Can surgeon familiarization...\" based on this study's results. Since the study found no significant difference, the answer would be B (no), because the study didn't show that the intervention worked. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 383,
            "completion_tokens": 486
        },
        "time_elapsed": 5.637925386428833
    },
    {
        "realidx": "18714572",
        "question": "Vaginal intraepithelial neoplasia is a little known disease which could be related to risk factors different from simple HPV infections.\nTo ascertain wheter vaginal lesions have a natural history similar to cervical lesions.MATERIALS &\nA retrospective study to identify patients with vaginal lesions and synchronous cervical lesions through biopsy. The rate of mild cervical lesions (koilocytosis, warts, CIN I with and without koilocytosis) was compared with the rate of severe cervical lesions (CIN II and III, cervical carcinoma) in patients with mild vaginal lesions (warts and koilocytosis, and low-grade VAIN) and in patients with severe vaginal lesions (high-grade VAIN). Using koilocytosis as a marker, the rate of \"active\" cervical lesions was compared with the rate of \"non active\" cervical lesions in patients with \"active\" versus \"non active\" vaginal lesions. Finally, the rates of mild and severe cervical lesions were compared among each group of VAIN (low-grade, high-grade, with or without koilocytosis).\nIn patients with mild vaginal lesions, mild cervical lesions were significantly more frequent than severe cervical lesions. In patients with \"active\" vaginal lesions the rate of \"active\" cervical lesions was significantly higher than \"non active\" cervical lesions. The differences in rates of mild cervical lesions and severe cervical lesions among patients with high-grade VAIN and low-grade VAIN (with and without koilocytosis) were not significant.\nDoes vaginal intraepithelial neoplasia have the same evolution as cervical intraepithelial neoplasia?",
        "answer": "maybe",
        "answer_rationale": "These data suggest that CIN and VAIN may have some common features in certain cases, i.e., if an HPV infection is proved.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether vaginal intraepithelial neoplasia (VAIN) has the same evolution as cervical intraepithelial neoplasia (CIN). The options are yes, no, or maybe.\n\nFirst, I need to recall what the study found. The question provided a summary of a retrospective study comparing vaginal and cervical lesions. The key points from the study's results are:\n\n1. In patients with mild vaginal lesions (like warts, koilocytosis, low-grade VAIN), mild cervical lesions (like CIN I) were more common than severe ones (CIN II/III or cancer).\n2. When looking at \"active\" vaginal lesions (those with koilocytosis), there was a higher rate of \"active\" cervical lesions compared to non-active ones. \n3. However, the rates of mild vs. severe cervical lesions didn't differ significantly between high-grade VAIN and low-grade VAIN groups, regardless of koilocytosis.\n\nNow, the question is about the natural history (evolution) of VAIN compared to CIN. CIN is known to have a progression where low-grade lesions (like CIN1) can progress to high-grade (CIN2/3) and possibly cancer, though many regress. The study here shows that in VAIN, mild vaginal lesions are associated with more mild cervical lesions, and active vaginal lesions correlate with active cervical ones. But when comparing high vs low-grade VAIN, the cervical lesion severity didn't differ much. That suggests that maybe high-grade VAIN doesn't necessarily lead to more severe cervical lesions as much as high-grade CIN might. Or perhaps the progression isn't as direct. Since the study found that the rates of cervical lesions' severity weren't significantly different between the VAIN groups, this might indicate that the natural history isn't the same. If they were the same, you'd expect high-grade VAIN to correlate more with severe cervical lesions, but the study says that difference wasn't significant. So the answer would be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 416,
            "completion_tokens": 432
        },
        "time_elapsed": 5.316967964172363
    },
    {
        "realidx": "18719011",
        "question": "To compare growth curves of body mass index from children to adolescents, and then to young adults, in Japanese girls and women in birth cohorts born from 1930 to 1999.\nRetrospective repeated cross sectional annual nationwide surveys (national nutrition survey, Japan) carried out from 1948 to 2005.\nJapan.\n76,635 females from 1 to 25 years of age.\nBody mass index.\nGenerally, body mass index decreased in preschool children (2-5 years), increased in children (6-12 years) and adolescents (13-18 years), and slightly decreased in young adults (19-25 years) in these Japanese females. However, the curves differed among birth cohorts. More recent cohorts were more overweight as children but thinner as young women. The increments in body mass index in early childhood were larger in more recent cohorts than in older cohorts. However, the increments in body mass index in adolescents were smaller and the decrease in body mass index in young adults started earlier, with lower peak values in more recent cohorts than in older cohorts. The decrements in body mass index in young adults were similar in all birth cohorts.\nDo overweight children necessarily make overweight adults?",
        "answer": "no",
        "answer_rationale": "An overweight birth cohort in childhood does not necessarily continue to be overweight in young adulthood. Not only secular trends in body mass index at fixed ages but also growth curves for wide age ranges by birth cohorts should be considered to study obesity and thinness. Growth curves by birth cohorts were produced by a repeated cross sectional annual survey over nearly six decades.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether overweight children necessarily become overweight adults, based on the provided study.\n\nFirst, I need to recall the study's findings. The study compared BMI growth curves across different birth cohorts in Japanese females. The key points are that more recent cohorts were more overweight as children but thinner as young women. So, even though the children in recent cohorts had higher BMIs, when they became young adults, their BMIs were lower compared to older cohorts. The study also mentions that the decrease in BMI started earlier and had lower peak values in recent cohorts. \n\nThe question is whether being an overweight child leads to being an overweight adult. The study's data shows that even though recent cohorts had higher BMIs as kids, they ended up being thinner as young adults. That suggests that just because a child is overweight doesn't mean they will definitely be overweight as adults. The answer would be \"no\" because the study indicates that the trend can change. The options are (A) yes, (B) no, (C) maybe. The correct answer here is B. But wait, maybe there's a nuance. The study says \"more overweight as children but thinner as young women.\" So the answer is no, they don't necessarily become overweight adults. So the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 347,
            "completion_tokens": 275
        },
        "time_elapsed": 3.6395528316497803
    },
    {
        "realidx": "18783922",
        "question": "We analyzed cytokines levels in patients with epilepsy and new onset seizure and correlated it with various parameters.\nAfter obtaining consent, serum samples from 100 patients with epilepsy or new onset seizure were prospectively collected in the immediate post-ictal phase. In 16 patients, a second sample was collected during the seizure-free period. The serum cytokine levels [TNF-alpha, IFN-gamma, IL-1beta, IL-2, IL-4, and IL-6] were assessed (ELISA) in these patients and 100 matched healthy controls. CSF analysis was carried out in 9 patients of this cohort, when clinically indicated.\nThe type of seizures (n=100) was major (45), partial (41) and status epilepticus (SE=14), while the epilepsy syndromes were idiopathic generalized (53) and localization related (47). The detectable serum cytokines in the patient group (n=100) were: IL-6 (42), TNF-alpha (36), IL-2 (22), IL-4 (22), IFN-gamma (20) and IL-1 (11) compared to the controls. CSF IL-6 and IL-1 was detectable in 4/9 and 2/9 patients, respectively while, IL-2, IL-4, IFN-gamma was detectable 1 in each patient. Correlations were noted between male gender and IL-1beta (p=0.04), positive family history and IL-1beta (p=0.001), \"no alcohol use\" and TNF-alpha (p=0.05), more than one year history of epilepsy and IL-1beta (p=0.02), status epilepticus (SE) and IL-6 (p=0.04). There was no difference between the new onset seizures vs. epilepsy group. Serial analysis during the seizure-free period revealed a decrease in cytokine levels: TNF-alpha (25% to 12.5%), IFN-gamma (12.5% to 0%), IL-1 (25% to 0) and IL-2 (6.2% to 6.2%), IL-4 (18.8% to 0%) and IL-6 (18.8% to 6.2%).\nDo cytokines have any role in epilepsy?",
        "answer": "yes",
        "answer_rationale": "We found increased post-ictal serum cytokine levels in patients with several epilepsy syndromes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether cytokines have any role in epilepsy based on the provided study. \n\nFirst, I need to recall what the study found. The study measured various cytokines in patients with epilepsy or new onset seizures compared to healthy controls. The results showed that several cytokines like IL-6, TNF-alpha, IL-1beta, etc., were detectable more in the patient group than in controls. For example, IL-6 was present in 42 out of 100 patients versus controls, which is higher. Also, there were correlations between certain cytokines and factors like male gender, family history, duration of epilepsy, and type of seizure (like status epilepticus correlating with IL-6). \n\nAdditionally, when they took follow-up samples during the seizure-free period, the cytokine levels decreased. This suggests that cytokine levels might be elevated during or right after seizures and drop when the seizures are controlled. The fact that there are statistical significances (like p-values less than 0.05) in these correlations indicates that these associations are not random.\n\nThe question is whether cytokines have a role in epilepsy. The study's findings show that certain cytokines are associated with various aspects of epilepsy, such as specific seizure types, demographics, and disease duration. The decrease in cytokines during the seizure-free period also implies a possible link between cytokine activity and seizure activity. \n\nThe options are yes, no, maybe. Since the study found significant correlations and differences between patients and controls, the answer should be \"yes\" because the data supports a role for cytokines in epilepsy. The study's results aren't just neutral; they show specific associations which suggest a role. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 613,
            "completion_tokens": 368
        },
        "time_elapsed": 4.486192226409912
    },
    {
        "realidx": "18802997",
        "question": "Assessing the clinical course of inflammatory bowel disease (IBD) patients consists of periodical clinical evaluations and laboratory tests. We aimed to assess the role of calprotectin tests in predicting clinical relapse in IBD patients.\nNinety-seven patients with ulcerative colitis (UC) and 65 with Crohn's disease (CD) in clinical remission were prospectively included in the study. A 10-g stool sample was collected for calprotectin assay. The cutoff level was set at 130 mg/kg of feces. Patients were followed up for 1 yr after the test or until relapse. The cumulative proportion of relapses was estimated by the Kaplan-Meier analysis. Statistics for equality of survival distribution were tested using the log-rank test.\nThe calprotectin test was positive in 44 UC patients and 26 of them relapsed within a year, while 11 of 53 UC patients with a negative calprotectin test relapsed within the same time frame. Thirty CD patients had a positive calprotectin test and 13 of them relapsed within a year, as did 7 of the 35 with a negative test result. A significant correlation emerged between a positive calprotectin test and the probability of relapse in UC patients (P= 0.000). In CD patients, only cases of colonic CD showed a significant correlation between a positive calprotectin test and the probability of relapse, i.e., 6 colonic CD patients were positive for the calprotectin test and 4 relapsed (P= 0.02).\nCan calprotectin predict relapse risk in inflammatory bowel disease?",
        "answer": "maybe",
        "answer_rationale": "Measuring calprotectin may help to identify UC and colonic CD patients at higher risk of clinical relapse.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether calprotectin can predict relapse risk in inflammatory bowel disease (IBD). The options are yes, no, or maybe. \n\nFirst, I need to look at the study details provided. The study included both UC and CD patients in remission. They measured calprotectin in stool samples with a cutoff of 130 mg/kg. Then they followed them for a year to see who relapsed.\n\nFor UC patients: 44 had a positive test, and 26 of those relapsed. Out of 53 with negative tests, 11 relapsed. That seems like a higher relapse rate in the positive group. The log-rank test showed a significant P=0.000, so definitely a correlation here.\n\nFor CD patients overall: 30 positive, 13 relapsed; 35 negative, 7 relapsed. The P-value isn't mentioned for all CD, but when they looked at colonic CD specifically, 6 positive with 4 relapses, which had P=0.02, so that's significant too. But maybe the overall CD group wasn't significant? The question is about IBD as a whole, which includes both UC and CD.\n\nWait, the question is whether calprotectin can predict relapse in IBD. The study shows that in UC, yes, it's significant. In CD, only colonic CD had a significant link. But the options are general. The answer might be yes because it works for UC and a subset of CD. The question doesn't specify which type, so overall, the test does have predictive value in some cases. The answer should be A (yes) because the study found significant correlations in UC and colonic CD, so calprotectin can predict relapse in those subsets. The options don't have a \"sometimes\" but \"maybe\" is an option. Wait, the options are (A) yes, (B) no, (C) maybe. \n\nHmm, the question is phrased generally. The study shows that in UC, it's predictive, and in some CD (colonic), but not all CD. Since the question is about IBD as a whole, maybe the answer is yes because it's valid for parts of the population. The study's conclusion would support that calprotectin can predict relapse in certain IBD patients, so the answer is yes. The options don't",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 441,
            "completion_tokens": 512
        },
        "time_elapsed": 7.2012200355529785
    },
    {
        "realidx": "18926458",
        "question": "Several prospective randomized trials have proved carotid endarterectomy to be safe and effective for both symptomatic and asymptomatic patients younger than 80 years of age. Recently, carotid artery stenting (CAS) has been approved for use in selected high-risk patients. It has been proposed that being an octogenarian places patients in this high-risk category.\nAll patients between the ages of 80 to 89 years undergoing carotid endarterectomy during a 12-year period were included in the study. Information included indications for carotid endarterectomy, associated risk factors, length of stay, and hospital course. Perioperative morbidity and mortality, including neurologic events and myocardial infarction, were recorded.\nA total of 103 carotid endarterectomies were performed in 95 octogenarians. Procedures were performed on 59 men and 36 women. Indications for operation included symptomatic carotid stenosis in 44 patients (43%) and asymptomatic carotid stenosis in 59 (57%). Associated risk factors included diabetes mellitus (17%), hypertension (76%), coronary artery disease (28%), hyperlipidemia (39%), and history of smoking (42%). There were 4 perioperative neurologic complications, which included 1 transient ischemic attack (0.97%), 2 minor strokes (1.94%), and 1 major stroke (0.97%). There were no deaths.\nAre octogenarians at high risk for carotid endarterectomy?",
        "answer": "no",
        "answer_rationale": "Combined end points for adverse events are acceptable in the octogenarian. Carotid endarterectomy remains the gold standard for treatment of extracranial carotid disease in all age groups. Age alone should not place patients in the high-risk category for carotid endarterectomy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether octogenarians (people aged 80-89) are at high risk for carotid endarterectomy based on the provided study data.\n\nFirst, I need to recall what the study found. The study included 103 procedures in 95 patients aged 80-89. The key outcomes here are the perioperative morbidity and mortality. The question is whether these outcomes indicate high risk.\n\nLooking at the numbers: there were 4 neuro complications. Breaking that down, 1 TIA (0.97%), 2 minor strokes (1.94%), and 1 major stroke (0.97%). Also, no deaths. The total complications here are under 3% for strokes/TIA, which seems low. \n\nNow, comparing this to general risk data. I remember that carotid endarterectomy (CEA) is considered a standard treatment for symptomatic and asymptomatic patients under 80. The question is about those over 80. The study's results show that even in this older group, the complication rates are low. The mortality was zero, which is important because high-risk categories often have higher mortality. \n\nThe options are yes, no, maybe. The study's results suggest that the risk might not be as high as previously thought. The morbidity rates here are within acceptable ranges compared to younger patients. Since there were no deaths and the stroke rates are low, the data from the study would indicate that octogenarians might not be at high risk, at least based on this dataset. \n\nThe proposal mentioned in the question was that being an octogenarian places them in high-risk, but the study's outcomes contradict that. The answer should be 'no' because the study's results show acceptable outcomes, suggesting they aren't high risk. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 427,
            "completion_tokens": 396
        },
        "time_elapsed": 5.101071357727051
    },
    {
        "realidx": "18928979",
        "question": "The objective of the study was to determine whether myometrial electrical activity can differentiate false from true preterm labor.\nElectrical uterine myography (EUM) was measured prospectively on 87 women, gestational age less than 35 weeks. The period between contractions, power of contraction peaks and movement of center of electrical activity (RMS), was used to develop an index score (1-5) for prediction of preterm delivery (PTD) within 14 days of the test. The score was compared with fetal fibronectin (fFN) and cervical length (CL).\nPatients delivering within 14 days from testing showed a higher index and mean RMS (P = .000). No patients with EUM index scores of 1-2 delivered in this time frame. Combining EUM with CL or fFN increased predictability. Logistic regression revealed that history of PTD and EUM index had 4- to 5-fold increased risk for PTD. Gestational age at testing, body mass index, fFN, and CL were nonsignificant contributors to PTD risk.\nCan myometrial electrical activity identify patients in preterm labor?",
        "answer": "yes",
        "answer_rationale": "Measuring myometrial electrical activity may enhance identification of patients in true premature labor.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether myometrial electrical activity can identify patients in preterm labor based on the study described.\n\nFirst, I need to recall the details from the provided study. The objective was to see if myometrial electrical activity (measured via EUM) can differentiate between false and true preterm labor. The study included 87 women with gestational age under 35 weeks. They used an index score (1-5) based on EUM parameters like the period between contractions, power of peaks, and RMS movement. The results showed that those who delivered within 14 days had higher index scores and mean RMS, with a significant p-value of 0.000. Importantly, no one with scores 1-2 delivered in that timeframe. Combining EUM with other factors like cervical length or fFN improved predictability. Logistic regression found that EUM index and history of PTD were strong predictors (4-5x risk), while other factors weren't significant.\n\nThe question is whether the myometrial electrical activity can identify preterm labor. The study's results indicate that higher EUM scores correlated with higher risk of PTD within 14 days. Since those with lower scores (1-2) didn't deliver, it suggests the EUM index can distinguish between those likely to have true preterm labor versus false. The fact that it was a significant predictor in logistic regression also supports this. The options are yes, no, maybe. The study's findings seem to support that it can identify, so the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 336,
            "completion_tokens": 338
        },
        "time_elapsed": 4.502113580703735
    },
    {
        "realidx": "19027440",
        "question": "The objectives of this study were to investigate longitudinal predictors of fear of recurrence in survivors of head and neck cancer (HNC) using Leventhal's Common Sense Model (CSM) as a framework. The research questions were as follows: (a) to what extent do HNC patients report fear of cancer recurrence? (b) To what extent are fears of recurrence manifestations of illness-related anxiety? (c) Are fears of recurrence closely related to current symptoms, disease, and treatment-related factors, or psychological/socio-demographic factors? (d) What factors are predictive of long-term fears of recurrence?\nA prospective repeat measures design was employed whereby a sample of 82 newly diagnosed HNC patients (54 males, 28 females, mean age 60 years) completed measures of fears of recurrence, illness perceptions, coping, and anxiety and depression, prior to treatment and 6-8 months after treatment (fears of recurrence only).\nA third of HNC patients at diagnosis reported relatively high levels of fears of recurrence, with 12% still reporting similar levels of fear 6-8 months after treatment. Fears of recurrence were not related to any socio-demographic factor (age, gender, ethnicity, marital status, and educational attainment) or disease, treatment, or symptom-related factors. Path analyses demonstrated that fears of cancer recurrence after treatment were directly predicted by pre-treatment fears and optimism.\nCan we predict which head and neck cancer survivors develop fears of recurrence?",
        "answer": "yes",
        "answer_rationale": "Although components of the CSM (cognitive and emotional representations, coping strategies) were associated with fears of recurrence, optimism was found to be the strongest predictor of fear, independent of anxiety and level of fear reported prior to treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether we can predict which head and neck cancer survivors develop fears of recurrence based on the study described.\n\nFirst, I need to look at the study's findings. The question refers to the research's fourth objective: identifying predictive factors for long-term fears. The key part here is the path analysis result mentioned. It says that post-treatment fears were directly predicted by pre-treatment fears and optimism. \n\nSo, the study found that if a patient had higher fears before treatment, they were more likely to have fears later. Also, optimism levels before treatment played a role. Since these are factors measured before treatment, they can be used to predict who might develop ongoing fears. \n\nThe options are yes, no, or maybe. The study clearly identifies pre-treatment fears and optimism as predictors. Therefore, the answer should be (A) yes. The other options don't fit because the study does provide predictive factors, so it's not uncertain (maybe) or impossible (no). Even though some factors like symptoms or demographics weren't related, the presence of pre-treatment variables means prediction is possible.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 392,
            "completion_tokens": 238
        },
        "time_elapsed": 2.9461441040039062
    },
    {
        "realidx": "19100463",
        "question": "Tacrolimus is a potent immunosuppressive drug used in organ transplantation. Because of its substantial toxic effects, narrow therapeutic index, and interindividual pharmacokinetic variability, therapeutic drug monitoring of whole-blood tacrolimus concentrations has been recommended. We investigated the comparability of the results of 2 immunoassay systems, affinity column-mediated immunoassay (ACMIA) and microparticle enzyme immunoassay (MEIA), comparing differences in the tacrolimus concentrations measured by the 2 methods in relation to the hematologic and biochemical values of hepatic and renal functions.\nA total of 154 samples from kidney or liver transplant recipients were subjected to Dimension RxL HM with a tacrolimus Flex reagent cartilage for the ACMIA method and IMx tacrolimus II for the MEIA method.\nTacrolimus concentrations measured by the ACMIA method (n = 154) closely correlated with those measured by the MEIA method (r = 0.84). The Bland-Altman plot using concentration differences between the 2 methods and the average of the 2 methods showed no specific trends. The tacrolimus levels determined by both the MEIA method and the ACMIA method were not influenced by hematocrit levels, but the difference between the 2 methods (ACMIA - MEIA) tended to be larger in low hematocrit samples (P<.001).\nIs the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?",
        "answer": "yes",
        "answer_rationale": "The ACMIA method used for a tacrolimus assay is precise and has advantages, including the lack of a required pretreatment procedure. Furthermore, it is only slightly influenced by the hematologic or biochemical status of the samples.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the ACMIA method can be used as an alternative to the MEIA method for measuring tacrolimus in blood. \n\nFirst, I need to recall what the study found. The question mentions that the two methods were compared using 154 samples. The correlation coefficient was 0.84, which is a strong positive correlation. That's a good sign because it means the two methods generally agree with each other.\n\nThen there's the Bland-Altman plot. The question states that there were no specific trends in the differences between the two methods. A Bland-Altman plot is used to assess agreement between two measurement techniques. If there's no systematic bias (like the differences not increasing or decreasing with the average concentration), that's a good thing. The plot here didn't show such trends, so that's another point in favor of the ACMIA being a suitable alternative.\n\nHowever, the difference between the two methods (ACMIA - MEIA) was larger in low hematocrit samples, and this was statistically significant (P<0.001). The question also mentions that both methods weren't influenced by hematocrit levels themselves, but the difference between them was larger when hematocrit was low. \n\nWait, so even though the methods aren't affected by hematocrit individually, their difference is more pronounced in low hematocrit. That could be a problem because if the difference is larger in certain conditions (like low hematocrit), then in those cases, the ACMIA might not be as reliable as MEIA. But the question is about whether ACMIA is suitable as an alternative. \n\nThe study's main findings are a strong correlation and no systematic bias in the Bland-Altman plot. The only issue is that in low hematocrit, the difference is larger. But the question is whether that's enough to make ACMIA unsuitable. \n\nThe options are yes, no, maybe. The study shows that overall, the methods agree well, but there's a caveat with low hematocrit. However, the problem states that the tacrolimus levels from both methods weren't influenced by hematocrit. The difference between them being larger in low hematocrit might mean that in those cases, the two methods don't agree as well. But the question is about suitability as an alternative. \n\nIn clinical practice, if the difference is significant in some samples, especially those with low hematocrit,",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 419,
            "completion_tokens": 512
        },
        "time_elapsed": 6.615679740905762
    },
    {
        "realidx": "19103915",
        "question": "There is an urgent need to increase opportunistic screening for sexually transmitted infections (STIs) in community settings, particularly for those who are at increased risk including men who have sex with men (MSM). The aim of this qualitative study was to explore whether home sampling kits (HSK) for multiple bacterial STIs are potentially acceptable among MSM and to identify any concerns regarding their use. This study was developed as part of a formative evaluation of HSKs.\nFocus groups and one-to-one semi-structured interviews with MSM were conducted. Focus group participants (n = 20) were shown a variety of self-sampling materials and asked to discuss them. Individual interviewees (n = 24) had experience of the self-sampling techniques as part of a pilot clinical study. All data were digitally recorded and transcribed verbatim. Data were analysed using a framework analysis approach.\nThe concept of a HSK was generally viewed as positive, with many benefits identified relating to increased access to testing, enhanced personal comfort and empowerment. Concerns about the accuracy of the test, delays in receiving the results, the possible lack of support and potential negative impact on 'others' were raised.\nAre home sampling kits for sexually transmitted infections acceptable among men who have sex with men?",
        "answer": "maybe",
        "answer_rationale": "The widespread acceptability of using HSKs for the diagnosis of STIs could have important public health impacts in terms of earlier diagnosis of asymptomatic infections and thus a decrease in the rate of onward transmission. In addition, HSKs could potentially optimize the use of genitourinary medicine services and facilitate patient choice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether home sampling kits (HSK) for STIs are acceptable among men who have sex with men (MSM) based on the provided study.\n\nFirst, I need to recall the details from the study description. The study used focus groups and interviews with MSM. The participants were either shown the self-sampling materials or had actually used them in a pilot. The analysis was done through framework analysis.\n\nThe key findings mentioned are that the concept of HSK was generally viewed positively. The benefits included increased access to testing, which is important because some people might not go to clinics due to stigma or inconvenience. Enhanced personal comfort suggests that doing it at home is less stressful than a clinic visit. Empowerment probably refers to the control they have over their own testing process.\n\nHowever, there were some concerns: accuracy of the test, delays in results, lack of support, and potential negative impact on others. But the question is about acceptability. Even if there are concerns, the overall view was positive. The question isn't asking if there are no issues, just whether they are acceptable. Since the majority saw benefits and the general view was positive, the answer would lean towards yes. The options are A (yes), B (no), C (maybe). The study's conclusion states the concept was \"generally viewed as positive,\" so the answer should be A. The concerns exist but don't negate the overall acceptability. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 347,
            "completion_tokens": 311
        },
        "time_elapsed": 4.796894788742065
    },
    {
        "realidx": "19106867",
        "question": "Recent suicide bombings pose the novel problem for Trauma Centers of the massive simultaneous arrival of many gravely wounded patients.\nWe report the experience of the French-German Military Trauma Group, a Level 2 Trauma Center, in Afghanistan during the wave of suicide bombings in February 2007.\nFourteen casualties were received. A first triage was carried out by the U S Army Level I group prior to evacuation. A second surgical triage was carried out with systematic ultrasound exam. Four cases (ISS>25) were re-categorized and underwent emergency surgical procedures.\nThe Main Gate Syndrome: a new format in mass-casualty victim \"surge\" management?",
        "answer": "yes",
        "answer_rationale": "Suicide bombing in crowded locations near an evacuation hospital may overwhelm the medical resources of the receiving center. It has been referred to as \"The Main Gate Syndrome.\" We introduced the novel concept of a semi-evacuation hospital or receiving center where a second surgical triage was carried out. These exceptional circumstances require open-minded flexibility, a tailored approach, and close cooperation between surgeons and anesthetists to share experience, opinions, and ideas. In the setting of mass casualties, emergency ultrasound exam was shown to be a valuable and effective tool by virtue of its mobility, reproducibility, and immediate results.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the Main Gate Syndrome is a new format in managing mass-casualty victim surges, based on the provided case study.\n\nFirst, I need to understand the context. The scenario describes a situation where a French-German Military Trauma Center (Level 2) dealt with 14 casualties from suicide bombings. They mention that the U.S. Army Level I group did an initial triage before evacuation. Then, the trauma center did a second surgical triage using ultrasound exams. Four patients with an ISS (Injury Severity Score) over 25 were re-categorized and got emergency surgery.\n\nThe question is whether the Main Gate Syndrome represents a new approach here. The options are yes, no, maybe. \n\nThe term \"Main Gate Syndrome\" isn't familiar to me off the top of my head. But from the context, it's probably referring to a specific triage or management strategy they implemented. The key points here are the two-step triage process: first by the Level I group, then another surgical triage with ultrasound. The re-categorization based on ultrasound and ISS suggests a more refined approach to prioritize patients effectively during a mass casualty event.\n\nThe question is whether this is a \"new format.\" The study is reporting their experience, and the title poses it as a question, implying they might be introducing or evaluating a new method. Since the answer options are about whether it's a new format, the fact that they're presenting this as their experience in the context of the question suggests that the answer is affirmative. The article's title ends with a question mark, but the content shows they implemented a two-tier triage with ultrasound, which might be their novel approach. Therefore, the answer is likely (A) yes. But wait, maybe the question is tricky. The options are about whether the Main Gate Syndrome is the new format. If the article is presenting their method as the Main Gate Syndrome and discussing its effectiveness, then the answer would be yes. Since the question is phrased as \"a new format in mass-casualty victim 'surge' management?\" and the study's experience involved a structured approach with two triage steps, including ultrasound, which might be a new method, the answer is probably A. However, without knowing exactly what Main Gate Syndrome refers to, but given the context, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 229,
            "completion_tokens": 498
        },
        "time_elapsed": 7.168388605117798
    },
    {
        "realidx": "19108857",
        "question": "Tuberculosis continues to be a public health problem in emerging countries with a recent evidence of increased incidence of extrapulmonary localization in developed countries probably linked to HIV. To our knowledge the occurrence of cerebro-mediastinal tuberculosis in an immuno-competent child has not been previously described; moreover the child we describe has a probable Say-Barber-Miller syndrome. We discuss a putative causative link between this syndrome and the occurrence of tuberculosis.\nA seven-year-old girl presented to our department with a history of infantile encephalopathy since birth characterized by a facial dysmorphy (evocative of a bird face), microcephaly, and mental retardation, and with recurrent infections. The child had complained of back pain for several months; the parents reported anorexia, loss of weight. Spinal and cerebral MRI showed a mediastinal mass involving the spine and cerebral lesions evocative of tuberculomas. The tuberculin interdermal reaction was positive. Culture of a vertebral biopsy was positive for Koch bacillus. Anti-tuberculosis treatment improved general and local status. An extensive immunological work-up was normal.\nCerebromediastinal tuberculosis in a child with a probable Say-Barber-Miller syndrome: a causative link?",
        "answer": "yes",
        "answer_rationale": "[corrected] This observation is exceptional in many aspects: very early age of onset of extrapulmonary tuberculosis, no immune deficit, association with a rare congenital neurological syndrome. We discuss the possible link between this entity and the occurrence of tuberculosis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The case is about a 7-year-old girl with Say-Barber-Miller syndrome who developed cerebro-mediastinal tuberculosis. The question is whether there's a causative link between the syndrome and the tuberculosis.\n\nFirst, I need to recall what Say-Barber-Miller syndrome is. From what I remember, it's a rare genetic disorder characterized by facial dysmorphism (like the \"bird face\" mentioned), microcephaly, mental retardation, and recurrent infections. The key here is the recurrent infections, which might suggest an immunodeficiency. But the case says the immunological work-up was normal. That's a bit confusing because if the syndrome is associated with immune issues, but her tests were normal, maybe the connection isn't straightforward.\n\nThe child had a positive tuberculin skin test and cultures positive for TB. The treatment worked, so the diagnosis seems solid. The question is whether the syndrome caused the TB. Since the syndrome includes recurrent infections, maybe her immune system was compromised despite normal tests. But the article mentions she's immunocompetent. Wait, the case states \"immuno-competent child\" but with the syndrome. The syndrome might predispose her to infections even if standard immune tests are normal. \n\nThe article's authors are discussing a \"putative causative link,\" so they're suggesting a possible connection. The options are yes, no, maybe. The answer probably leans towards \"maybe\" because the case is the first described, and the link isn't proven yet. The fact that they're discussing it as a possibility and not confirming it would mean the answer isn't a definite yes. Also, the immunological work-up was normal, so maybe the syndrome's effect isn't captured by standard tests. Therefore, the answer is C) maybe.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 352,
            "completion_tokens": 377
        },
        "time_elapsed": 4.426203012466431
    },
    {
        "realidx": "19130332",
        "question": "Uncontrolled hemorrhage is the leading cause of fatality. The aim of this study was to evaluate the effect of zeolite mineral (QuikClot - Advanced Clotting Sponge [QC-ACS]) on blood loss and physiological variables in a swine extremity arterial injury model.\nSixteen swine were used. Oblique groin incision was created and a 5 mm incision was made. The animals were allocated to: control group (n: 6): Pressure dressing was applied with manual pressure over gauze sponge; or QC group (n: 10): QC was directly applied over lacerated femoral artery. Mean arterial pressure, blood loss and physiological parameters were measured during the study period.\nApplication of QC led to a slower drop in blood pressure. The control group had a significantly higher increase in lactate within 60 minutes. The mean prothrombin time in the control group was significantly increased at 60 minutes. The application of QC led to decreased total blood loss. The QC group had significantly higher hematocrit levels. QC application generated a significant heat production. There were mild edematous and vacuolar changes in nerve samples.\nIs the zeolite hemostatic agent beneficial in reducing blood loss during arterial injury?",
        "answer": "yes",
        "answer_rationale": "According to the physiological parameters, we observed that zeolite tends to reduce blood loss, however could not stop bleeding completely. We believe that further clinical trials are needed to conclude that zeolite could be used in the routine practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether QuikClot Advanced Clotting Sponge (QC-ACS) is beneficial in reducing blood loss during arterial injuries in swine. The options are yes, no, or maybe.\n\nFirst, I need to look at the results provided. The question is specifically about reducing blood loss. The key points from the study are:\n\n- QC group had a slower drop in blood pressure. That might indicate better clotting because if bleeding is controlled, blood pressure wouldn't drop as quickly.\n- Control group had higher lactate increase. Lactate goes up with shock or hypoperfusion, so maybe the QC group's better blood pressure meant better perfusion.\n- Prothrombin time increased in control group. Longer prothrombin time suggests clotting issues, which makes sense if they're losing more blood and maybe developing coagulopathy.\n- QC led to decreased total blood loss. That's a direct measure, so that's a strong point in favor.\n- QC group had higher hematocrit, which would make sense if they lost less blood, so their hematocrit (concentration of red blood cells) stays higher.\n- There were some side effects like heat production and mild tissue changes, but the question is about benefit in reducing blood loss, not about side effects.\n\nThe question is whether the zeolite is beneficial for reducing blood loss. The study's results clearly state that QC application decreased total blood loss. Even though there are some adverse effects mentioned, the question is specifically about the benefit regarding blood loss. So the answer should be yes. The options are A, B, C. So A is correct.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 351,
            "completion_tokens": 348
        },
        "time_elapsed": 4.24025297164917
    },
    {
        "realidx": "19142546",
        "question": "We compared left ventricular regional wall motion, the global left ventricular ejection fraction, and the New York Heart Association functional class pre- and postoperatively.\nEndomyocardial fibrosis is characterized by fibrous tissue deposition in the endomyocardium of the apex and/or inflow tract of one or both ventricles. Although left ventricular global systolic function is preserved, patients exhibit wall motion abnormalities in the apical and inferoapical regions. Fibrous tissue resection in New York Heart Association FC III and IV endomyocardial fibrosis patients has been shown to decrease morbidity and mortality.\nWe prospectively studied 30 patients (20 female, 30+/-10 years) before and 5+/-8 months after surgery. The left ventricular ejection fraction was determined using the area-length method. Regional left ventricular motion was measured by the centerline method. Five left ventricular segments were analyzed pre- and postoperatively. Abnormality was expressed in units of standard deviation from the mean motion in a normal reference population.\nLeft ventricular wall motion in the five regions did not differ between pre- and postoperative measurements. Additionally, the left ventricular ejection fraction did not change after surgery (0.45+/-0.13% x 0.43+/-0.12% pre- and postoperatively, respectively). The New York Heart Association functional class improved to class I in 40% and class II in 43% of patients postoperatively (p<0.05).\nDoes quantitative left ventricular regional wall motion change after fibrous tissue resection in endomyocardial fibrosis?",
        "answer": "no",
        "answer_rationale": "Although endomyocardial fibrosis patients have improved clinical symptoms after surgery, the global left ventricular ejection fraction and regional wall motion in these patients do not change. This finding suggests that other explanations, such as improvements in diastolic function, may be operational.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether quantitative left ventricular regional wall motion changes after fibrous tissue resection in endomyocardial fibrosis. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study compared several factors before and after surgery: regional wall motion, global ejection fraction, and NYHA functional class. The key points here are the results regarding the wall motion and ejection fraction.\n\nThe passage states that the left ventricular wall motion in the five regions didn't differ between pre- and postoperative measurements. Also, the ejection fraction didn't change significantly (0.45 vs 0.43, which is a small difference and the standard deviations are similar). However, the NYHA class improved a lot, with most patients moving to class I or II from presumably higher classes before.\n\nThe question is specifically about regional wall motion. Since the study found no difference in the regional motion between the two time points, the answer should be \"no\" (option B). Even though the functional class improved, the actual quantitative measurements of the wall motion didn't change. The improvement in functional class might be due to other factors like reduced fibrosis allowing better hemodynamics without changing the wall motion abnormalities. The question is about whether the motion itself changed quantitatively, and the data says it didn't. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 440,
            "completion_tokens": 296
        },
        "time_elapsed": 3.6603407859802246
    },
    {
        "realidx": "19237087",
        "question": "An unknown number of colorectal cancers could be due to missed adenomas during previous endoscopy. Data in the literature are sparse. A large cross-sectional study was done in a prospective database of all patients diagnosed with colorectal cancer.\nAll consecutive endoscopies over a period of 15 years, in which colorectal cancer was diagnosed were included. All patients who underwent more than one endoscopy and in whom ultimately cancer was diagnosed were studied separately.\nColorectal cancer was diagnosed in 835 patients. Twenty-five patients underwent a previous endoscopy without a cancer diagnosis. These 25 patients were divided into three groups according to the time between the endoscopy in which the cancer was detected and the previous endoscopy. Five out of these 25 patients underwent regular surveillance. Only 11 patients had no argument for regular follow-up. Assuming that these cancers developed from an adenoma than only 11 out of 835 (1.3%) cancers were missed in the adenoma phase. There was no difference in the size of the tumour between the three groups of patients.\nAre many colorectal cancers due to missed adenomas?",
        "answer": "no",
        "answer_rationale": "In normal daily practice, only a small number of clinically important adenomas are missed. The problem of missed adenomas probably is being exaggerated.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether many colorectal cancers are due to missed adenomas based on the provided study.\n\nFirst, I need to understand the study's setup. The study looked at 835 patients diagnosed with colorectal cancer. Out of these, 25 had a previous endoscopy where cancer wasn't detected. These 25 were split into three groups based on the time between their previous endoscopy and the cancer diagnosis. \n\nThe key point here is that only 11 of those 25 didn't have a reason for regular follow-up. The argument is that if the cancers developed from adenomas, then only 11 out of 835 (which is about 1.3%) could be attributed to missed adenomas during prior endoscopies. The other 14 might have had reasons for surveillance, like known risk factors, so their adenomas might have been expected or they weren't following recommended screenings.\n\nThe question is whether \"many\" cancers are due to missed adenomas. The study's data shows that only 1.3% are from missed adenomas in the general group. Since 1.3% is a small percentage, \"many\" would imply a higher number. The options are yes, no, or maybe. The study's conclusion here suggests that it's not a large number, so the answer is probably no. The tumor size didn't differ either, which might indicate that missing adenomas didn't lead to larger tumors, supporting that missed adenomas aren't a major cause here. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 330,
            "completion_tokens": 339
        },
        "time_elapsed": 4.277081727981567
    },
    {
        "realidx": "19302863",
        "question": "The present study aims to compare strength, healing, and operation time of experimental intestinal anastomoses performed by polyglactin 910 (Vicryl; Ethicon, Edinburgh, United Kingdom) sutures with ethyl-2-cyanoacrylate glue (Pattex; Henkel, Dusseldorf, Germany).\nNinety-six Sprague-Dawley rats were divided into 2 (groups E and L). Each group was further subdivided into 6 subgroups (EA1, EA2, EA3, EB1, EB2, EB3, LA1, LA2, LA3, LB1, LB2, LB3), each containing 8 rats. Intestinal anastomosis was performed by polyglactin 910 sutures in A subgroups and with ethyl-2-cyanoacrylate in B subgroups. The anastomosis was end to end in A1 and B1, side to side in A2 and B2, and end to side in A3 and B3. Time for anastomosis performance (AT) was recorded. In group E, bursting pressures and hydroxyproline levels were determined on the second postoperative day, whereas in group L, the same measurements were made on the sixth postoperative day. One-way analysis of variance was used for analyses of variance in the groups. Quantitative data were analyzed with Student's t test. P value was considered significant at less than .05.\nThere was no significant difference between bursting pressures of subgroup pairs on both postoperative days 2 and 6. Hydroxyproline levels and AT were significantly better in B subgroups.\nIs the use of cyanoacrylate in intestinal anastomosis a good and reliable alternative?",
        "answer": "yes",
        "answer_rationale": "Better healing, shorter AT, and equal strength were achieved with ethyl-2-cyanoacrylate compared with polyglactin 910 sutures in intestinal anastomosis in the experimental setting.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing Vicryl sutures and cyanoacrylate glue (Pattex) for intestinal anastomosis in rats. The main outcomes are strength (bursting pressure and hydroxyproline levels), healing (hydroxyproline is a marker for collagen, so higher levels might indicate better healing), and operation time (AT).\n\nThe results say there was no significant difference in bursting pressures between the subgroups using glue vs sutures on days 2 and 6. That's important because bursting pressure is a measure of anastomotic strength. If there's no difference, that's a good sign for the glue. \n\nThen, hydroxyproline levels and AT (operation time) were significantly better in the B subgroups (which used glue). Better hydroxyproline might mean better healing, and shorter operation time is a plus. \n\nThe question is whether cyanoacrylate is a good and reliable alternative. Since the glue didn't show worse bursting pressure (same as sutures) and had better hydroxyproline and faster time, the answer should be yes. The options are A, B, C. The study's results support the glue as a viable alternative. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 462,
            "completion_tokens": 266
        },
        "time_elapsed": 4.168400526046753
    },
    {
        "realidx": "19351635",
        "question": "National guidelines and government directives have adopted policies for urgent assessment of patients with a transient ischaemic attack or minor stroke not admitted to hospital. The risk of recurrent stroke increases substantially with age, as does the potential benefit of secondary prevention. In order to develop effective strategies for older patients, it is important to identify how stroke care is currently provided for this patient group.\nBetween 2004 and 2006, older patients (>75 years) referred to a neurovascular clinic were compared with younger patients (<or =75 years). Sociodemographic details, clinical features, resource use and secondary prevention in a neurovascular clinic were collected.\nOf 379 patients referred to the clinic, 129 (34%) were given a non-stroke diagnosis. Of the remaining 250 patients, 149 (60%) were<or =75 years. Median time from symptom onset to clinic appointment was similar for the two groups (24 (IQR 15-42) vs 24 (IQR 14-43) days; p = 0.58). Older patients were more likely to be in atrial fibrillation (10.1% vs 22.8%, p<0.001) and have lacunar stroke (34.7% vs 22.1%; p = 0.04). CT rates were similar in the two groups (27.8% vs 80.0%, p = 0.75). Scans were performed more quickly in younger patients (p<0.01). MRI scan rates were higher in younger patients (26% vs 4%, p<0.01), as was carotid Doppler imaging (92% vs 77%, p<0.01). There were no differences in prescribed secondary preventive treatments. Older patients experienced less delay for carotid endarterectomy (49 vs 90 days, p<0.01). Younger patients were more likely to be given advice on weight reduction (30.2% vs 12.9%, p<0.01) and diet (46.3% vs 31.7%, p = 0.02) than older patients.\nDo older patients receive adequate stroke care?",
        "answer": "maybe",
        "answer_rationale": "Older patients were less likely to receive diagnostic investigations and lifestyle modification advice than younger patients. Guidelines need to be adopted to ensure prompt evidence-based stroke care in the outpatient setting.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether older patients receive adequate stroke care based on the provided study data. The options are yes, no, or maybe.\n\nFirst, I need to go through the information given. The study compared patients over 75 and those 75 or younger. The key points are:\n\n- Both groups had similar median time to clinic appointment (24 days each), so no major delay there.\n- Older patients had more atrial fibrillation and lacunar strokes, which are important factors but maybe not directly about care adequacy.\n- CT scan rates were similar (27.8% vs 80%? Wait, that can't be right. Wait, maybe a typo? Wait, the numbers say 27.8% vs 80.0%, but that seems like a big difference. Wait, maybe I misread. Let me check again. The text says \"CT rates were similar in the two groups (27.8% vs 80.0%, p = 0.75).\" Wait, 27.8 vs 80? That's a huge difference, but the p-value is 0.75, meaning no statistical difference. That must be a mistake in the numbers. Wait, maybe it's a typo. Alternatively, maybe the older group had 27.8% and younger 80%? But that would be a big discrepancy. Alternatively, maybe it's the other way around. Wait, the way it's written: \"CT rates were similar in the two groups (27.8% vs 80.0%, p = 0.75).\" Hmm, that's confusing. Maybe it's a mistake in the question's data. But moving on.\n\nScans (maybe MRI?) were done more quickly in younger patients (p<0.01). MRI scan rates were higher in younger (26% vs 4%, p<0.01). So older patients got fewer MRIs. Carotid Doppler was also less in older (77% vs 92%). So they had less imaging done, which might indicate inadequate care if those tests are needed.\n\nPrescribed secondary prevention treatments were the same between groups. So medications like anticoagulants, antiplatelets, etc., were equally prescribed. But maybe the imaging part is a problem.\n\nOlder patients had less delay for carotid endarterectomy (4",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 584,
            "completion_tokens": 512
        },
        "time_elapsed": 6.868942737579346
    },
    {
        "realidx": "19394934",
        "question": "The incidence of large-scale urban attacks on civilian populations has significantly increased across the globe over the past decade. These incidents often result in Hospital Multiple Casualty Incidents (HMCI), which are very challenging to hospital teams. 15 years ago the Emergency and Disaster Medicine Division in the Israeli Ministry of Health defined a key of 20 percent of each hospital's bed capacity as its readiness for multiple casualties. Half of those casualties are expected to require immediate medical treatment. This study was performed to evaluate the efficacy of the current readiness guidelines based on the epidemiology of encountered HMCIs.\nA retrospective study of HMCIs was recorded in the Israeli Defense Force (IDF) home front command and the Israeli National Trauma Registry (ITR) between November 2000 and June 2003. An HMCI is defined by the Emergency and Disaster Medicine Division in the Israeli Ministry of Health as>or=10 casualties or>or=4 suffering from injuries with an ISS>or=16 arriving to a single hospital.\nThe study includes a total of 32 attacks, resulting in 62 HMCIs and 1292 casualties. The mean number of arriving casualties to a single hospital was 20.8+/-13.3 (range 4-56, median 16.5). In 95% of the HMCIs the casualty load was<or=52. Based on severity scores and ED discharges 1022 (79.2%) casualties did not necessitate immediate medical treatment.\nIsraeli hospital preparedness for terrorism-related multiple casualty incidents: can the surge capacity and injury severity distribution be better predicted?",
        "answer": "yes",
        "answer_rationale": "Hospital preparedness can be better defined by a fixed number of casualties rather than a percentile of its bed capacity. Only 20% of the arriving casualties will require immediate medical treatment. Implementation of this concept may improve the utilisation of national emergency health resources both in the preparation phase and on real time.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the surge capacity and injury severity distribution can be better predicted based on the study described.\n\nFirst, I need to understand the study's findings. The study looked at HMCIs (Hospital Multiple Casualty Incidents) in Israel between 2000 and 2003. They found that out of 1292 casualties, 1022 (79.2%) didn't need immediate treatment. The current guideline is that 20% of a hospital's beds should be ready for MCIs, with half needing immediate care. But the study shows that actually, most casualties (79%) didn't require immediate treatment. That suggests the current guidelines might overestimate the need for immediate care, since only about 20.8% actually needed it (since 79.2% didn't). \n\nThe question is whether the current guidelines can be improved. The study's data shows a discrepancy between the expected 50% needing immediate treatment versus the actual 20.8%. This implies that the injury severity distribution in real incidents is different from what the guidelines assumed. Therefore, using the new data, hospitals might adjust their preparedness. The study's purpose was to evaluate the current guidelines' efficacy, and since the results differ, it suggests that better prediction is possible with the new data. \n\nSo the answer should be (A) yes, because the study's findings provide better data to predict surge capacity and injury severity, indicating the current guidelines may not be optimal and can be improved.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 438,
            "completion_tokens": 330
        },
        "time_elapsed": 3.9889438152313232
    },
    {
        "realidx": "19398929",
        "question": "Cholecystectomy for GB polyps that are larger than 10 mm is generally recommended because of the high probability of neoplasm. In contrast, a follow-up strategy is preferred for GB polyps smaller than 10 mm. However, there are no treatment guidelines for polyps that grow in size during the follow-up period.STUDY: We retrospectively investigated 145 patients with GB polyps who underwent at least 1 ultrasonographic follow-up examination over an interval greater than 6 months, before cholecystectomy at Samsung medical center, South Korea, from 1994 to 2007. The growth rate was determined based on the change in size per time interval between 2 ultrasonographic examinations (mm/mo).\nThe median age of the patients was 48 years (range: 25 to 75). One hundred twenty-five non-neoplastic polyps and 20 neoplastic polyps were found. Neoplastic polyps were more frequently found in patients older than 60 years, those with hypertension, a polyp size greater than 10 mm, and a rapid growth rate greater than 0.6 mm/mo. On multivariate analysis, however, the growth rate was not related to the neoplastic nature of a polyp, but older age (>60 y) and large size (>10 mm) were significantly associated with neoplastic polyps.\nCan the growth rate of a gallbladder polyp predict a neoplastic polyp?",
        "answer": "no",
        "answer_rationale": "Patient's age (>60 y) and large polyp size (>10 mm) were significant predictive factors for neoplastic GB polyps. GB polyps less than 10 mm in diameter do not require surgical intervention simply because they grow.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the growth rate of a gallbladder (GB) polyp can predict if it's neoplastic. The study provided gives some details.\n\nFirst, the background mentions that polyps over 10mm usually get cholecystectomy because of higher neoplasm risk, while smaller ones are followed up. The study looked at 145 patients who had follow-ups before surgery. They found 125 non-neoplastic and 20 neoplastic polyps. \n\nIn the results, it says that neoplastic polyps were more common in older patients (over 60), those with hypertension, larger size (>10mm), and a growth rate over 0.6 mm/month. But then the key part is the multivariate analysis: growth rate wasn't related to neoplastic nature, but age and size were. \n\nSo the question is whether growth rate predicts neoplastic. The study's multivariate analysis shows that even though there was an initial association, when adjusting for other factors, growth rate itself wasn't significant. Therefore, the answer should be no, growth rate isn't a predictor. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 410,
            "completion_tokens": 257
        },
        "time_elapsed": 3.3151798248291016
    },
    {
        "realidx": "19419587",
        "question": "Sternal instability with mediastinitis is a very serious complication after median sternotomy. Biomechanical studies have suggested superiority of rigid plate fixation over wire cerclage for sternal fixation. This study tests the hypothesis that sternal closure stability can be improved by adding plate fixation in a human cadaver model.\nMidline sternotomy was performed in 18 human cadavers. Four sternal closure techniques were tested: (1) approximation with six interrupted steel wires; (2) approximation with six interrupted cables; (3) closure 1 (wires) or 2 (cables) reinforced with a transverse sternal plate at the sixth rib; (4) Closure using 4 sternal plates alone. Intrathoracic pressure was increased in all techniques while sternal separation was measured by three pairs of sonomicrometry crystals fixed at the upper, middle and lower parts of the sternum until 2.0 mm separation was detected. Differences in displacement pressures were analyzed using repeated measures ANOVA and Regression Coefficients.\nIntrathoracic pressure required to cause 2.0 mm separation increased significantly from 183.3 +/- 123.9 to 301.4 +/- 204.5 in wires/cables alone vs. wires/cables plus one plate respectively, and to 355.0 +/- 210.4 in the 4 plates group (p<0.05). Regression Coefficients (95% CI) were 120 (47-194) and 142 (66-219) respectively for the plate groups.\nSternal plating for primary and secondary sternal closure; can it improve sternal stability?",
        "answer": "yes",
        "answer_rationale": "Transverse sternal plating with 1 or 4 plates significantly improves sternal stability closure in human cadaver model. Adding a single sternal plate to primary closure improves the strength of sternal closure with traditional wiring potentially reducing the risk of sternal dehiscence and could be considered in high risk patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about sternal closure techniques after median sternotomy. The main point is comparing different methods to see which provides better stability. The options are whether sternal plating improves stability.\n\nThe question gives details of the study with 18 cadavers and four techniques. The key results are the intrathoracic pressure needed to cause 2mm separation. For wires or cables alone, the pressure was around 183.3. When they added a plate (either with wires or cables), it went up to 301.4. Then, using four plates alone, it was even higher at 355.0. The p-values are less than 0.05, which means the differences are statistically significant. The regression coefficients also show positive values, indicating that adding plates increases the required pressure, thus improving stability.\n\nSo the hypothesis was that adding plates would improve stability, and the results support that. The question asks if sternal plating can improve stability. The answer should be yes (A). The options are A, B, C. The study clearly shows that plates, especially four of them, significantly increased the pressure needed to separate the sternum, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 454,
            "completion_tokens": 262
        },
        "time_elapsed": 3.840488910675049
    },
    {
        "realidx": "19430778",
        "question": "To correlate magnetic resonance (MR) image findings with pain response by provocation discography in patients with discogenic low back pain, with an emphasis on the combination analysis of a high intensity zone (HIZ) and disc contour abnormalities.\nSixty-two patients (aged 17-68 years) with axial low back pain that was likely to be disc related underwent lumbar discography (178 discs tested). The MR images were evaluated for disc degeneration, disc contour abnormalities, HIZ, and endplate abnormalities. Based on the combination of an HIZ and disc contour abnormalities, four classes were determined: (1) normal or bulging disc without HIZ; (2) normal or bulging disc with HIZ; (3) disc protrusion without HIZ; (4) disc protrusion with HIZ. These MR image findings and a new combined MR classification were analyzed in the base of concordant pain determined by discography.\nDisc protrusion with HIZ [sensitivity 45.5%; specificity 97.8%; positive predictive value (PPV), 87.0%] correlated significantly with concordant pain provocation (P<0.01). A normal or bulging disc with HIZ was not associated with reproduction of pain. Disc degeneration (sensitivity 95.4%; specificity 38.8%; PPV 33.9%), disc protrusion (sensitivity 68.2%; specificity 80.6%; PPV 53.6%), and HIZ (sensitivity 56.8%; specificity 83.6%; PPV 53.2%) were not helpful in the identification of a disc with concordant pain.\nCan magnetic resonance imaging accurately predict concordant pain provocation during provocative disc injection?",
        "answer": "yes",
        "answer_rationale": "The proposed MR classification is useful to predict a disc with concordant pain. Disc protrusion with HIZ on MR imaging predicted positive discography in patients with discogenic low back pain.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether MRI can accurately predict concordant pain provocation during provocative disc injection based on the provided study.\n\nFirst, I need to understand the study's findings. The study looked at 62 patients with discogenic low back pain and used discography as the gold standard. They classified discs into four groups based on MRI findings of HIZ and disc contour abnormalities. \n\nThe key results mentioned are the sensitivity, specificity, and PPV for each classification. The question is about accuracy, so I should focus on these metrics. \n\nThe study states that disc protrusion with HIZ had a sensitivity of 45.5% and specificity of 97.8%. High specificity means that if the test is positive (i.e., protrusion with HIZ), it's likely to correctly predict concordant pain. However, sensitivity is lower, meaning it misses some cases. The PPV here is 87%, which is good, but the sensitivity being under 50% might mean it's not great at overall prediction.\n\nLooking at the other options: normal/bulging with HIZ didn't correlate. The other\u5355\u72ec factors like disc degeneration, protrusion, or HIZ alone had lower specificity and PPV. The study concludes that only the combination of protrusion and HIZ was significant (p<0.01). \n\nBut the question is whether MRI can \"accurately\" predict. Accuracy would require both high sensitivity and specificity. The protrusion with HIZ has high specificity but low sensitivity. So while it's good at ruling in (high PPV), it's not so good at ruling out (low sensitivity). The other options (like degeneration) have higher sensitivity but low specificity, so they aren't helpful either. \n\nThe options are yes, no, maybe. The study shows that only one combination (protrusion + HIZ) has significant correlation, but even that has low sensitivity. Since the question is general about MRI's ability, the answer might be \"no\" because overall, the individual factors aren't helpful except in that specific combination, but even that combination isn't perfect. The conclusion in the study says that the combination analysis was done, but the other parameters (like degeneration alone) weren't helpful. The question is whether MRI can accurately predict. Since the best case (protrusion + HIZ) has 45% sensitivity, which is not very high, maybe the answer is no.",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 468,
            "completion_tokens": 512
        },
        "time_elapsed": 6.022967100143433
    },
    {
        "realidx": "19468282",
        "question": "Prospective multicenter longitudinal cohort study.\nTo validate the prognostic value of the acute phase sacral sparing measurements with regard to chronic phase-independent ambulation in patients with traumatic spinal cord injury (SCI).\nEuropean Multicenter Study of Human Spinal Cord Injury (EM-SCI).\nIn 432 patients, acute phase (0-15 days) American Spinal Injury Association (ASIA)/International Spinal Cord Society neurological standard scale (AIS) grades, ASIA sacral sparing measurements, which are S4-5 light touch (LT), S4-5 pin prick (PP), anal sensation and voluntary anal contraction; and chronic phase (6 or 12 months) indoor mobility Spinal Cord Independence Measure (SCIM) measurements were analyzed. Calculations of positive and negative predictive values (PPV/NPV) as well as univariate and multivariate logistic regressions were performed in all four sacral sparing criteria. The area under the receiver-operating characteristic curve (AUC) ratios of all regression equations was calculated.\nTo achieve independent ambulation 1-year post injury, a normal S4-5 PP score showed the best PPV (96.5%, P<0.001, 95% confidence interval (95% CI): 87.9-99.6). Best NPV was reported in the S4-5 LT score (91.7%, P<0.001, 95% CI: 81.6-97.2). The use of the combination of only voluntary anal contraction and the S4-5 LT and PP sensory scores (AUC: 0.906, P<0.001, 95% CI: 0.871-0.941) showed significantly better (P<0.001, 95% CI: 0.038-0.128) discriminating results in prognosticating 1-year independent ambulation than with the use of currently used distinction between complete and incomplete SCI (AUC: 0.823, P<0.001, 95% CI: 0.781-0.864).\nIs determination between complete and incomplete traumatic spinal cord injury clinically relevant?",
        "answer": "maybe",
        "answer_rationale": "Out of the four sacral sparing criteria, the acute phase anal sensory score measurements do not contribute significantly to the prognosis of independent ambulation. The combination of the acute phase voluntary anal contraction and the S4-5 LT and PP scores, predicts significantly better chronic phase-independent ambulation outcomes than the currently used distinction between complete and incomplete SCI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether determining between complete and incomplete traumatic spinal cord injury (SCI) is clinically relevant based on the provided study.\n\nFirst, I need to understand the study's findings. The study compared the prognostic value of sacral sparing measurements versus the traditional complete vs. incomplete SCI classification. The key results mentioned are the AUC values. The combination of voluntary anal contraction and S4-5 LT and PP scores had an AUC of 0.906, which is higher than the AUC of 0.823 for the complete/incomplete distinction. A higher AUC means better ability to discriminate between groups. The study also states that the combination was significantly better (P<0.001) than the current method. \n\nThe question is whether the traditional complete vs. incomplete classification is still clinically relevant. Since the study shows that the sacral sparing measures are a better predictor of independent ambulation at 1 year, this suggests that the current method (complete/incomplete) may not be as useful. The answer options are yes, no, maybe. The study's conclusion implies that the traditional distinction isn't as good, so the answer would lean towards \"no\" because the combination of sacral measures is more effective, making the traditional determination less relevant. But I need to be careful here. The question is about whether the determination is clinically relevant at all, not whether it's the best. However, the study's point is that the new method is significantly better, so maybe the traditional method isn't as relevant anymore. The options are (A) yes, (B) no, (C) maybe. The study's conclusion says the combination was \"significantly better,\" which suggests that the current distinction (complete/incomplete) isn't as good, so perhaps it's not as clinically relevant. Therefore, the answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 576,
            "completion_tokens": 395
        },
        "time_elapsed": 4.656590461730957
    },
    {
        "realidx": "19481382",
        "question": "Androgen serum levels significantly decrease in older men, causing quality of life impairment and increasing the risk of chronic disease. This disorder is defined as PADAM (Partial Androgen Deficiency of Aging Men).\nTo evaluate a PADAM screening tool and determine the prevalence of this disorder in healthy adult men.\nThis was a cross-sectional study in which 96 men aged 40 or more of the South Metropolitan Region of Santiago de Chile were surveyed with the Androgen Deficiency of Aging Men (ADAM) questionnaire of the Saint Louis University and sampled for the serum determination of total testosterone, sexual hormone binding globulin (SHBG) and albumin. Also free and bioavailable testosterone were calculated. PADAM was considered present if items 1 or 7 or any 3 other questions of the ADAM questionnaire were positive. An available testosterone of<198.4 ng/dL was used as a gold standard for the diagnosis of PADAM.\nA total of 78 men (81.3%) were identified as possible PADAM according to the ADAM questionnaire. Total testosterone levels fell from 503.6+/-180.1 ng/dL in men aged 40 to 54 years to 382.1+/-247.3 in those>70 years; however this was not statistically significant (ANOVA, p=0.06). In the same age groups, SHBG significantly increased (31.0+/-15.0 to 47.5+/-15.0 nmol/L, p<0.001) whereas free and available testosterone significantly decreased (10.6+/-3.2 to 6.4+/-3.6 ng/dL and 266.6+/-81.2 to 152.2+/-97.6 ng/dL, respectively, p<0.0001). Overall (n=96), available testosterone confirmed PADAM diagnosis in 27 cases (28.1%). The ADAM tool rendered a 83.3% sensitivity and 19.7% specificity in the detection of PADAM. Item 1 (decreased sexual desire) was a better predictor of hypogonadism than the complete questionnaire (63.3% sensitivity and 66.7% specificity).\nIs the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?",
        "answer": "no",
        "answer_rationale": "In this series, in accordance to available testosterone, the prevalence of PADAM was determined to be high, in which the ADAM questionnaire rendered a low diagnostic efficiency. PADAM diagnosis could be clinically suspected when symptoms of sexual dysfunction are present.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the ADAM questionnaire is useful for screening PADAM based on the study provided.\n\nFirst, I need to recall the study details. The study was cross-sectional with 96 men. They used the ADAM questionnaire and measured testosterone levels. The criteria for PADAM via the questionnaire was having item 1 or 7 positive or any 3 other questions. The gold standard was available testosterone <198.4 ng/dL. \n\nThe results showed that 78 men (81.3%) were identified as possible PADAM by the questionnaire. However, when looking at the actual testosterone levels, only 27 (28.1%) met the gold standard. The ADAM tool had 83.3% sensitivity but only 19.7% specificity. Sensitivity is good at catching true positives, but low specificity means a lot of false positives. The question is about the questionnaire's usefulness. \n\nThe options are yes, no, maybe. High sensitivity is good for screening because you want to catch most cases, but low specificity means many false positives, which could lead to overdiagnosis. The study also mentions that item 1 alone had better specificity (66.7%) and decent sensitivity (63.3%). The ADAM questionnaire's low specificity might make it not very useful because it's not good at ruling out false positives. The question is whether it's considered useful despite the low specificity. \n\nIn screening tools, sometimes higher sensitivity is prioritized even if specificity is lower, but the low specificity here (under 20%) is quite poor. The fact that a single item performed better suggests the full questionnaire isn't effective. The answer might be \"no\" because the specificity is too low, making it not reliable. Alternatively, \"maybe\" if considering the sensitivity. But the question is whether it's \"useful\"\u2014given the low specificity, it might not be considered useful overall. The correct answer is probably B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 614,
            "completion_tokens": 421
        },
        "time_elapsed": 4.755711793899536
    },
    {
        "realidx": "19482903",
        "question": "Earlier studies have demonstrated low peak oxygen uptake ((.)Vo(2)peak) in children with spina bifida. Low peak heart rate and low peak respiratory exchange ratio in these studies raised questions regarding the true maximal character of (.)Vo(2)peak values obtained with treadmill testing.\nThe aim of this study was to determine whether the Vo(2)peak measured during an incremental treadmill test is a true reflection of the maximum oxygen uptake ((.)Vo(2)max) in children who have spina bifida and are ambulatory.\nA cross-sectional design was used for this study.\nTwenty children who had spina bifida and were ambulatory participated. The (.)Vo(2)peak was measured during a graded treadmill exercise test. The validity of (.)Vo(2)peak measurements was evaluated by use of previously described guidelines for maximum exercise testing in children who are healthy, as well as differences between Vo(2)peak and (.)Vo(2) during a supramaximal protocol ((.)Vo(2)supramaximal).\nThe average values for (.)Vo(2)peak and normalized (.)Vo(2)peak were, respectively, 1.23 L/min (SD=0.6) and 34.1 mL/kg/min (SD=8.3). Fifteen children met at least 2 of the 3 previously described criteria; one child failed to meet any criteria. Although there were no significant differences between (.)Vo(2)peak and Vo(2)supramaximal, 5 children did show improvement during supramaximal testing.\nThese results apply to children who have spina bifida and are at least community ambulatory.\nTreadmill testing of children who have spina bifida and are ambulatory: does peak oxygen uptake reflect maximum oxygen uptake?",
        "answer": "yes",
        "answer_rationale": "The (.)Vo(2)peak measured during an incremental treadmill test seems to reflect the true (.)Vo(2)max in children who have spina bifida and are ambulatory, validating the use of a treadmill test for these children. When confirmation of maximal effort is needed, the addition of supramaximal testing of children with disability is an easy and well-tolerated method.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the peak oxygen uptake (Vo2peak) measured during a treadmill test in ambulatory children with spina bifida truly reflects their maximum oxygen uptake (Vo2max). The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study's aim was to determine if Vo2peak from the treadmill test is a true reflection of Vo2max. They used a cross-sectional design with 20 participants. They measured Vo2peak and compared it to Vo2supramaximal, which is a test designed to push beyond maximum to see if there's an increase, indicating that the previous peak wasn't actually max.\n\nThe results mentioned that 15 out of 20 kids met at least 2 of the 3 criteria for maximum testing (like peak heart rate, respiratory exchange ratio, etc.), but one didn't meet any. Also, even though there were no significant differences between Vo2peak and Vo2supramaximal overall, 5 children did show improvement during the supramaximal test. That suggests that for those 5, their initial Vo2peak wasn't their true max because they could go higher in the supramax test.\n\nSo the question is whether the peak measured is a true max. The study's results are mixed. Most met some criteria, but some didn't, and 5 improved in the supramax test. Since the answer options are yes, no, maybe, the key here is that the study found that in some cases (the 5 children), the Vo2peak wasn't the true max. Therefore, the answer can't be a definitive yes. But it's also not a clear no because most met the criteria. However, the fact that some didn't and that there was improvement in the supramax test suggests that the peak might not always be the true max. The conclusion would be that it's not a definitive yes, so the answer is probably \"maybe\" (option C). Wait, but the options are (A) yes, (B) no, (C) maybe. The study's conclusion says that the results apply to ambulatory children with spina bifida. The abstract states that 15 met at least 2 criteria, but one didn't. Also, 5 showed improvement in supramax. Since the question is whether the peak reflects the maximum, the answer would be that it's not always,",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 465,
            "completion_tokens": 512
        },
        "time_elapsed": 6.2738237380981445
    },
    {
        "realidx": "19520213",
        "question": "A list of telephone numbers of UK hospitals with a radiology department was obtained from the Royal College of Radiologists. One hundred hospitals were then randomly selected for inclusion in the survey. An 18-item questionnaire was successfully administered to consultant radiologists from 84 departments.\nSixty-one percent of departments had a named radiologist to report their skeletal surveys, 16% assigned surveys to a random radiologist, and 23% referred them elsewhere. Only 52% of departments had a dedicated paediatric radiologist, thus in a significant proportion of departments (25%) initial reports on skeletal surveys for physical abuse were provided by non-paediatric radiologists. Fifteen percent did not have ready access to a paediatric radiology opinion. Sixty-one percent thought that the service could be improved. Expert evidence was provided by 5% of respondents. Seventy-three percent would never consider providing expert evidence, even if given adequate radiology and/or legal training.\nAre UK radiologists satisfied with the training and support received in suspected child abuse?",
        "answer": "no",
        "answer_rationale": "The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether UK radiologists are satisfied with the training and support they received regarding suspected child abuse. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentions that 61% of departments had a named radiologist for skeletal surveys, but 16% used a random radiologist and 23% referred elsewhere. That might indicate some inconsistency in handling these cases. Then, only 52% had a dedicated paediatric radiologist, meaning in 25% of departments, initial reports were done by non-paediatric radiologists. That could be a problem because paediatric cases require specific knowledge. \n\nNext, 15% didn't have easy access to a paediatric radiology opinion. That's another potential gap. The key point here is that 61% thought the service could be improved. If they think it can be better, that suggests they aren't fully satisfied. Also, 73% wouldn't provide expert evidence even with training, which might imply they feel unprepared or lack confidence. Only 5% provided expert evidence already. \n\nPutting this together, the majority (61%) believe the service needs improvement, and a large portion (73%) are hesitant to give expert testimony even with training. This points towards dissatisfaction with their current training and support. So the answer should be no, which is option B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 305,
            "completion_tokens": 305
        },
        "time_elapsed": 3.628772020339966
    },
    {
        "realidx": "19546588",
        "question": "Although the mechanism of muscle wasting in end-stage renal disease is not fully understood, there is increasing evidence that acidosis induces muscle protein degradation and could therefore contribute to the loss of muscle protein stores of patients on hemodialysis, a prototypical state of chronic metabolic acidosis (CMA). Because body protein mass is controlled by the balance between synthesis and degradation, protein loss can occur as result of either increased breakdown, impaired synthesis, or both. Correction of acidosis may therefore help to maintain muscle mass and improve the health of patients with CMA. We evaluated whether alkalizing patients on hemodialysis might have a positive effect on protein synthesis and on nutritional parameters.\nEight chronic hemodialysis patients were treated daily with oral sodium bicarbonate (NaHCO(3)) supplementation for 10-14 days, yielding a pre-dialytic plasma bicarbonate concentration of 28.6 +/-1.6 mmol/l. The fractional synthesis rates (FSR) of muscle protein and albumin were obtained by the L-[(2)H(5)ring]phenylalanine flooding technique.\nOral NaHCO(3 )supplementation induced a significant increase in serum bicarbonate (21.5 +/- 3.4 vs. 28.6 +/- 1.6 mmol/l; p = 0.018) and blood pH (7.41 vs. 7.46; p = 0.041). The FSR of muscle protein and the FSR of albumin did not change significantly (muscle protein: 2.1 +/- 0.2 vs. 2.0 +/- 0.5% per day, p = 0.39; albumin: 8.3 +/- 2.2 vs. 8.6 +/- 2.5% per day, p = 0.31). Plasma concentrations of insulin-like growth factor 1 decreased significantly (33.4 +/- 21.3 vs. 25.4 +/- 12.3 nmol/l; p = 0.028), whereas thyroid-stimulating hormone, free thyroxin and free triiodothyronine did not change significantly and nutritional parameters showed no improvement.\nDoes increasing blood pH stimulate protein synthesis in dialysis patients?",
        "answer": "no",
        "answer_rationale": "In contrast to other findings, raising the blood pH of dialysis patients was not associated with a positive effect on albumin and muscle protein synthesis, or nutritional and endocrinal parameters.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether increasing blood pH stimulates protein synthesis in dialysis patients, based on the provided study.\n\nFirst, I need to recall the study's findings. The study gave hemodialysis patients sodium bicarbonate to correct acidosis. They measured the fractional synthesis rates (FSR) of muscle protein and albumin. The key results here are that the FSR for both muscle protein and albumin didn't change significantly after treatment. The muscle protein FSR was 2.1% vs. 2.0%, and albumin was 8.3% vs. 8.6%, with p-values above 0.05, meaning no statistical significance. \n\nThe question is whether increasing pH (which they did by raising bicarbonate and pH) led to increased protein synthesis. Since the FSR didn't go up, the answer would be no. The study's conclusion here is that even though they corrected acidosis, protein synthesis rates didn't improve. The insulin-like growth factor 1 actually decreased, but that's another point. The main thing is the FSR didn't change. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 571,
            "completion_tokens": 247
        },
        "time_elapsed": 3.551337242126465
    },
    {
        "realidx": "19575104",
        "question": "Fixation of foreign bodies (FB), in the mucosa, can favor its migration, giving origin to the popular saying: 'FB walk to the heart'.AIM: Describe the mechanisms involved in FB migration and how to diagnose them.\nFrom a sample of 3,000 foreign bodies, during 40 years, we analyzed four which had extra-lumen migration. We analyzed clinical, radiologic, endoscopic and ultrasound data collected at the medical documentation service.\nThree clinical histories are presented, describing two fish bones and one piece of fish cartilage. FB shifting was analyzed in all of them. Migration started in the esophagus in two, one going to the aorta and the other to the neck area. In the other two, migration started in the pharynx, and the FB moved towards the prevertebral fascia and the other externalized in the submandibular region. The mechanisms and the risks posed to the patient, by FB migration, and the way to diagnose them are hereby discussed.\nDo foreign bodies migrate through the body towards the heart?",
        "answer": "no",
        "answer_rationale": "The study allows us to determine that FB can move through the body but not towards the heart. The study also serves as a warning sign: in cases of prolonged histories of FB ingestion, imaging studies are mandatory before endoscopic examination.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether foreign bodies (FB) migrate through the body towards the heart. The options are yes, no, or maybe.\n\nFirst, I need to recall the information provided in the question. The study mentioned here looked at 3,000 cases over 40 years and found four instances where the FB migrated outside the lumen. The examples given include fish bones and cartilage moving from the esophagus to the aorta, neck, prevertebral fascia, and even externalizing in the submandibular area. The key point here is that migration can occur, but the question is specifically about moving towards the heart. \n\nThe popular saying mentioned is \"FB walk to the heart,\" which the question is referencing. The study's cases include one moving to the aorta, which is part of the heart's vicinity, but others moved to the neck or other areas. However, the answer needs to be based on the given data. The study shows that migration can happen, but does it specifically towards the heart? The aorta is near the heart, but the other migrations weren't towards the heart. The saying might be a generalization. The options are yes, no, maybe. The study's cases include at least one moving towards the aorta (near heart), but others not. However, the question is whether they \"migrate towards the heart\" in general. The answer options are about whether they do, based on the study. Since the study found cases where they did migrate (including towards the aorta), the answer would be yes. But wait, the options are (A) yes, (B) no, (C) maybe. The study's data shows that in some cases, they do migrate, so the answer would be yes. But maybe the question is a trick because the saying is popular but the actual migration isn't always towards the heart. Wait, the question is \"Do foreign bodies migrate through the body towards the heart?\" The study's examples include one going to the aorta (which is part of the heart's vicinity) and others to other areas. So in some cases, yes, but not always. However, the options are yes, no, maybe. The question is whether they do migrate towards the heart. Since the study shows that in some cases they do (like the aorta case), the answer would be yes. But maybe the correct answer is no because the migration isn't a directed movement towards",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 309,
            "completion_tokens": 512
        },
        "time_elapsed": 6.205519914627075
    },
    {
        "realidx": "19578820",
        "question": "Opioid-dependent patients often have co-occurring chronic illnesses requiring medications that interact with methadone. Methadone maintenance treatment (MMT) is typically provided separately from medical care. Hence, coordination of medical care and substance use treatment is important to preserve patient safety.\nTo identify potential safety risks among MMT patients engaged in medical care by evaluating the frequency that opioid dependence and MMT documentation are missing in medical records and characterizing potential medication-methadone interactions.\nAmong patients from a methadone clinic who received primary care from an affiliated, but separate, medical center, we reviewed electronic medical records for documentation of methadone, opioid dependence, and potential drug-methadone interactions. The proportions of medical records without opioid dependence and methadone documentation were estimated and potential medication-methadone interactions were identified.\nAmong the study subjects (n = 84), opioid dependence documentation was missing from the medical record in 30% (95% CI, 20%-41%) and MMT documentation was missing from either the last primary care note or the last hospital discharge summary in 11% (95% CI, 5%-19%). Sixty-nine percent of the study subjects had at least 1 medication that potentially interacted with methadone; 19% had 3 or more potentially interacting medications.\nAre opioid dependence and methadone maintenance treatment (MMT) documented in the medical record?",
        "answer": "maybe",
        "answer_rationale": "Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether opioid dependence and methadone maintenance treatment (MMT) are documented in the medical records based on the provided study.\n\nFirst, I need to look back at the information given. The study states that among 84 patients, 30% were missing documentation of opioid dependence. That means 70% had it documented. For MMT, the documentation was missing in 11% of cases, so 89% were documented. The question is asking if they are documented, so the answer would be that they are documented in most cases, but the options are yes, no, or maybe. \n\nWait, the options are (A) yes, (B) no, (C) maybe. The question is phrased as a general question: \"Are opioid dependence and MMT documented?\" The study shows that a significant portion (30% and 11%) were missing, but the majority were documented. However, the options are not about the percentage but whether they are documented. Since the question is a yes/no/maybe, the correct answer would be \"maybe\" because there's a chance they might not be documented, but the options might expect \"no\" because they are often missing. Wait, but the question is whether they are documented. The study shows that in some cases they are missing, but in others they are present. So the answer can't be a definitive yes or no. The options are (A) yes, (B) no, (C) maybe. The correct answer would be (C) maybe, because sometimes they are documented and sometimes not. But wait, the question is phrased as a general statement. The options are answer choices for the question, so maybe the answer is (B) no, because the documentation is missing in a significant number of cases. Wait, but the question is not asking if they are often missing, but whether they are documented. The answer would be that they are not always documented, so the answer is (B) no? Or is the question asking if they are documented in the records, and since in some cases they are, but in others not, the answer is maybe. Hmm. The options are a bit ambiguous. Let me re-read the question again.\n\nThe question is: \"Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record?\" The study found that 30% of the records lacked opioid dependence",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 388,
            "completion_tokens": 512
        },
        "time_elapsed": 6.314255475997925
    },
    {
        "realidx": "19593710",
        "question": "ESC (Electronic Stability Control) is a crash avoidance technology that reduces the likelihood of collisions involving loss of control. Although past and emerging research indicates that ESC is effective in reducing collision rates and saving lives, and its inclusion in all vehicle platforms is encouraged, drivers may demonstrate behavioral adaptation or an overreliance on ESC that could offset or reduce its overall effectiveness. The main objective of the present study was to determine whether behavioral adaptation to ESC is likely to occur upon the widespread introduction of ESC into the Canadian vehicle fleet. Secondary objectives were to confirm the results of a previous ESC public survey and to generate a baseline measure for the future assessment of planned and ongoing ESC promotional activities in Canada.\nTwo separate telephone surveys evaluated drivers' perceptions and awareness of ESC. The first surveyed 500 randomly selected owners/drivers of passenger vehicles. The second surveyed 1017 owners/drivers of 2006-2008 ESC-equipped passenger vehicles from the provinces of Quebec and British Columbia, Canada.\nThough ESC drivers were much more likely than drivers of other vehicles to be aware of ESC (77% vs. 39%) and that their own vehicle was equipped with it (63% vs. 8%), 23 percent had never heard of it. Ninety percent of drivers who knew that their vehicle was equipped with ESC believed that ESC had made it safer to drive and reported being confident that ESC would work in an emergency. Twenty-three percent of ESC owners who knew their vehicle had ESC reported noticing long-lasting changes in their driving behavior since they began driving the vehicle.\nCould ESC (Electronic Stability Control) change the way we drive?",
        "answer": "yes",
        "answer_rationale": "Collectively, results suggest that behavioral adaptation to ESC is likely in certain drivers; however, its proven effectiveness in reducing the likelihood of being involved in a serious crash probably outweighs any potential increases in unsafe driving. To fully benefit from ESC, vehicle manufacturers are encouraged to market ESC-equipped vehicles in a realistic, safe manner. Driver training and safety organizations are also encouraged to provide balanced educational information about ESC to their members.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether ESC (Electronic Stability Control) can change the way we drive, with options yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentioned two surveys. The first surveyed 500 drivers of regular vehicles, and the second 1017 drivers with ESC-equipped vehicles from specific provinces. \n\nKey points from the data: \n\n- ESC drivers were more aware of ESC (77% vs 39% in others). But 23% of ESC owners had never heard of it. \n- 90% of those who knew their car had ESC believed it made driving safer and were confident in its effectiveness. \n- Importantly, 23% of ESC owners who knew about their car's ESC reported noticing long-lasting changes in their driving behavior since driving the vehicle. \n\nThe question is whether ESC changes driving behavior. The 23% figure here is crucial. If almost a quarter of those aware of ESC in their cars changed their behavior, that suggests that yes, ESC can influence driving habits. The study's main objective was to see if behavioral adaptation occurs, and the results here indicate that a significant minority did adapt their behavior. \n\nThe options are yes, no, maybe. Since the data shows a portion of drivers did change their behavior, the answer should be \"yes\" (A). The \"maybe\" might be tempting if there was uncertainty, but the study's results provide evidence of actual changes in some drivers. The 23% is a notable percentage, so it's not just possible but demonstrated. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 422,
            "completion_tokens": 348
        },
        "time_elapsed": 4.41594934463501
    },
    {
        "realidx": "19640728",
        "question": "Bias against operating on patients with prosthetic valve endocarditis (PVE) who have multiple prostheses may preclude the use of life-saving valve replacement. We investigated the accuracy of the preoperative diagnosis of PVE in patients with both mitral and aortic prosthesis and the safety of single-valve replacement when only one valve seemed infected.\nPatients with a diagnosis of active PVE who had mitral and aortic prosthesis in place were assessed. We looked at the methods for diagnosis, causative agents, indication for valve replacement, operative findings and outcome.\nTwenty patients, who had both mitral and aortic prostheses and a diagnosis of PVE, were assessed. Streptococci and staphylococci caused 70% of cases. By means of echocardiography, the valves involved were: mitral (11 patients), aortic (six patients), and in three cases both prosthetic valves seemed infected. Surgery was undertaken in 17 patients (85%). The positive predictive value of transesophageal echocardiogram (TEE) for the preoperative diagnosis of the site of infection was 100%. In 13 patients, only the prosthetic valve that seemed infected was replaced. Four of these patients died within a week after the procedure. Nine patients survived the surgical procedure, completed a course of antimicrobial therapy and were followed up for 15.78 months (95% CI: 12.83-18.72). All were considered cured and relapses were not observed.\nSurgical treatment of prosthetic valve endocarditis in patients with double prostheses: is single-valve replacement safe?",
        "answer": "yes",
        "answer_rationale": "TEE allowed a diagnosis of site involvement that did correlate with the anatomic diagnosis obtained during the operation. This fact contributed to the management of patients and was of great help in guiding the surgical intervention. Echo-oriented single-valve replacement may be a safe strategy for patients with PVE and double prostheses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether single-valve replacement is safe in patients with prosthetic valve endocarditis (PVE) who have both mitral and aortic prostheses. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study included 20 patients with both mitral and aortic prostheses diagnosed with PVE. The main points from the study are:\n\n- Echocardiography (specifically TEE) had a 100% positive predictive value for identifying the infected valve preoperatively. That means when the TEE showed a valve was infected, it was definitely infected. \n- Out of 17 patients who underwent surgery, 13 had only the infected valve replaced (single-valve). \n- Of those 13, 4 died within a week, but 9 survived, completed antibiotics, and were followed for about 15 months without relapse. \n\nThe key here is to determine if single-valve replacement is considered safe based on the outcomes. The mortality rate here is high (4 out of 13), but the question is about safety in terms of effectiveness and avoiding relapse. The study mentions that all 9 survivors were considered cured with no relapses. The deaths might be due to the severity of their condition rather than the single-valve approach failing. Since the positive predictive value of TEE was 100%, the surgery accurately targeted the infected valve, and those who survived didn't have relapses, it suggests that when TEE correctly identifies the infected valve, replacing just that valve is safe. The high mortality might be a factor in the overall risk but doesn't negate the effectiveness of the procedure when it's successful. The study's conclusion seems to support that single-valve replacement can be safe when the diagnosis is accurate, so the answer would be yes (A). But wait, the question is phrased as \"is single-valve replacement safe?\" Given that 4 died, but the ones who survived didn't have relapses, the safety might be in terms of not leading to recurrence. The answer options are yes, no, maybe. The study's results show that when done correctly (with accurate TEE), it works without relapse, so the answer is A. The deaths might be due to other factors like severity, but the procedure itself was effective where it was possible. The question is about the safety regarding",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 443,
            "completion_tokens": 512
        },
        "time_elapsed": 7.172069549560547
    },
    {
        "realidx": "19694846",
        "question": "Although there is evidence for the influential role of transformational leadership on health outcomes, researchers have used either attitude outcomes (e.g. job satisfaction) or softer health measures, such as general well-being. Specific measures of well-being such as sleep quality have not been used, despite its association with working conditions.\nA longitudinal design was used to collect data from Danish healthcare workers at time 1 in 2005 (n = 447) and 18 months later at time 2 in 2007 (n = 274). Structural equation modelling was used to investigate the relationships between transformational leadership, self-efficacy and sleep quality at both time points independently (cross-sectionally) and longitudinally.\nFor all constructs, time 2 measures were influenced by the baseline level. Direct relationships between transformational leadership and sleep quality were found. This relationship was negative cross-sectionally at both time points, but positive between baseline and follow-up. The relationship between leadership and employees' sleep quality was not mediated by employees' self-efficacy.\nDoes self-efficacy mediate the relationship between transformational leadership behaviours and healthcare workers' sleep quality?",
        "answer": "maybe",
        "answer_rationale": "Our results indicate that training managers in transformational leadership behaviours may have a positive impact on healthcare workers' health over time. However, more research is needed to examine the mechanisms by which transformational leadership brings about improved sleep quality; self-efficacy was not found to be the explanation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether self-efficacy mediates the relationship between transformational leadership and healthcare workers' sleep quality based on the study described.\n\nFirst, I need to recall what mediation means. Mediation occurs when a third variable (here, self-efficacy) explains the relationship between an independent variable (leadership) and a dependent variable (sleep quality). So if self-efficacy mediates, then leadership would affect sleep quality through self-efficacy.\n\nLooking at the study details provided: The results state that \"The relationship between leadership and employees' sleep quality was not mediated by employees' self-efficacy.\" That's a direct statement from the research findings. \n\nThe options are (A) yes, (B) no, (C) maybe. Since the study explicitly says there's no mediation, the answer should be B. \n\nWait, but let me double-check. The question is phrased exactly as in the study's conclusion. The key sentence is clear\u2014no mediation. So the correct answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 329,
            "completion_tokens": 226
        },
        "time_elapsed": 2.9614477157592773
    },
    {
        "realidx": "19836806",
        "question": "Obesity may be associated with lower prostate specific antigen through hemodilution. We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index.\nThe study population included 994 men (4,937 observations) without prostate cancer in the Baltimore Longitudinal Study of Aging. Mixed effects models were used to examine the relationship between prostate specific antigen and body mass index in kg/m(2) by age. Separate models were explored in men with prostate cancer censored at diagnosis, for percent body fat measurements, for weight changes with time and adjusting for initial prostate size in 483 men (2,523 observations) with pelvic magnetic resonance imaging measurements.\nIn men without prostate cancer body mass index was not significantly associated with prostate specific antigen after adjusting for age (p = 0.06). A 10-point body mass index increase was associated with a prostate specific antigen difference of -0.03 ng/ml (95% CI -0.40-0.49). Results were similar when men with prostate cancer were included, when percent body fat was substituted for body mass index, and after adjusting for prostate volume. Longitudinal weight changes also had no significant association with prostate specific antigen.\nShould prostate specific antigen be adjusted for body mass index?",
        "answer": "no",
        "answer_rationale": "Consistent with prior studies, we found an inverse relationship between obesity and serum prostate specific antigen. However, the magnitude of the difference was small. Thus, adjusting prostate specific antigen for body mass index does not appear warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether prostate-specific antigen (PSA) should be adjusted for body mass index (BMI) based on the study described.\n\nFirst, I need to recall what the study found. The study included 994 men without prostate cancer and looked at the relationship between BMI and PSA levels. They used mixed effects models. The key result here is that after adjusting for age, BMI wasn't significantly associated with PSA. The p-value was 0.06, which is just above the common threshold of 0.05 for statistical significance. The actual difference in PSA for a 10-point BMI increase was -0.03 ng/ml, with a 95% confidence interval from -0.40 to 0.49. That interval includes zero, meaning the effect isn't statistically significant. \n\nThey also checked other factors like substituting BMI with percent body fat and adjusting for prostate volume, but the results were similar\u2014no significant association. Even when considering men with prostate cancer (censored at diagnosis) and longitudinal weight changes, there was no significant link between BMI and PSA.\n\nThe question is whether PSA should be adjusted for BMI. Since the study's results show no significant association after adjusting for age, and even when other variables were considered, the conclusion would be that adjusting for BMI isn't necessary. The answer options are (A) yes, (B) no, (C) maybe. The study's findings support that BMI doesn't have a significant impact on PSA levels, so the correct answer should be (B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 378,
            "completion_tokens": 333
        },
        "time_elapsed": 3.936119318008423
    },
    {
        "realidx": "19854401",
        "question": "The purpose of this survey was to ascertain the most common surgical practices for attaining negative (tumor-free) surgical margins in patients desiring breast-conservation treatment for breast cancer to see if a consensus exists for optimal treatment of patients.\nWe sent a survey to 1,000 surgeons interested in the treatment of breast cancer. Three hundred eighty-one surgeons responded to this survey and 351 were used for the analysis (response rate of 38%).\nAnswers showed a large variety in clinical practices among breast surgeons across the country. There was little intraoperative margin analysis; only 48% of surgeons examine the margins grossly with a pathologist and even fewer used frozen sections or imprint cytology. Decisions to reexcise specific margins varied greatly. For example, 57% of surgeons would never reexcise for a positive deep margin, but 53% would always reexcise for a positive anterior margin. Most importantly, there was a large range in answers about acceptable margins with ductal carcinoma in situ and invasive carcinoma. Fifteen percent of surgeons would accept any negative margin, 28% would accept a 1-mm negative margin, 50% would accept a 2-mm negative margin, 12% would accept a 5-mm negative margin, and 3% would accept a 10-mm negative margin.\nAttaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?",
        "answer": "no",
        "answer_rationale": "Results of this survey highlight the wide variety of practice patterns in the US for handling surgical margins in breast-conservation treatment. This issue remains controversial, with no prevailing standard of care. Consequently, additional study is needed in the modern era of multimodality treatment to examine the minimal amount of surgical treatment necessary, in conjunction with chemotherapy and radiation, to attain adequate local control rates in breast-conservation treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a consensus among breast surgeons on attaining negative margins in breast-conservation surgeries based on the survey described.\n\nFirst, I need to recall the details from the provided information. The survey had 351 responses analyzed. The key points mentioned are the variety in practices: only 48% do gross margin examination with a pathologist, and even fewer use other methods like frozen sections. Then, decisions to reexcise margins vary a lot. For example, 57% never reexcise a positive deep margin, but 53% always do for a positive anterior margin. Also, there's a big range in acceptable margins: 15% accept any negative margin, 28% 1mm, 50% 2mm, 12% 5mm, 3% 10mm. \n\nThe question is whether there's a consensus. A consensus would mean agreement among the surgeons. But the results show a lot of variation. The answer options are yes, no, maybe. The correct answer should be no because the survey found large variations in practices. The text even states \"a large variety in clinical practices\" and \"decisions to reexcise varied greatly.\" The margins accepted also differ a lot. So, no consensus exists. The answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 388,
            "completion_tokens": 287
        },
        "time_elapsed": 3.7466447353363037
    },
    {
        "realidx": "19913785",
        "question": "Little is known about whether a routinely inserted endoscopic nasobiliary drainage (ENBD) tube improves the clinical course in patients with choledocholithiasis-induced acute cholangitis after clearance of choledocholithiasis.\nThe aim of this study was to investigate the need for ENBD on the clinical outcomes of patients with acute cholangitis undergoing endoscopic clearance of common bile duct (CBD) stones.\nProspective, randomized study.\nTertiary referral center.\nA total of 104 patients with choledocholithiasis-induced acute cholangitis who underwent primary endoscopic treatment were compared according to insertion of an ENBD tube (51 in the ENBD group and 53 in the no-ENBD group).\nInsertion of an ENBD tube after clearance of CBD stones.\nRecurrence of cholangitis and length of hospital stay after clearance of CBD stones.\nBaseline clinical characteristics were similar between both groups. There were no significant differences in the recurrence rate of cholangitis at 24 weeks (3.9% for the ENBD group vs 3.8% for the no-ENBD group at 24 weeks; P = .99) and length of hospital stay (7.9 days [standard error = 1.2] for the ENBD group vs 7.9 days [standard error = 0.7]for the no-ENBD group; P = .98). However, procedure time was longer (26.2 [SE = 1.8] minutes vs 22.7 [SE = 1.0]minutes, respectively; P = .01) and the discomfort score was higher (4.9 [SE = 0.4] vs 2.8 [SE = 0.3], respectively; P = .02) in the ENBD group than in the no-ENBD group.\nSingle-center study.\nIs it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis?",
        "answer": "no",
        "answer_rationale": "A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether inserting an ENBD tube after endoscopic clearance of CBD stones in patients with acute cholangitis is necessary. The key points from the study are that they did a randomized trial with 104 patients split into ENBD and no-ENBD groups.\n\nThe main outcomes they looked at were recurrence of cholangitis and hospital stay length. The results showed no significant difference between the two groups in recurrence rates (both around 4%) and hospital stay (both about 8 days). However, the ENBD group had longer procedure times and higher discomfort scores.\n\nSo the question is asking if it's necessary to routinely insert the ENBD. Since the study found no benefit in the primary outcomes (recurrence and length of stay) but did find downsides (longer time, more discomfort), the conclusion would be that routine insertion isn't necessary. The answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 523,
            "completion_tokens": 198
        },
        "time_elapsed": 3.0209617614746094
    },
    {
        "realidx": "19923859",
        "question": "The present studywas designed to investigate the possible role of T cells in spatial learning ability in mouse after toluene exposure.\nEight-week-old male wild-type (WT) and nude mice of BALB/c strain were exposed to toluene (0, 9 and 90 ppm) in a nose-only exposure chamber for 30 min per day for 3 consecutive days and then once per week for 4 weeks. Twenty-four hours after the completion of exposure, we examined the spatial learning ability in each mouse using the Morris water maze apparatus.\nIn the acquisition phase, a longer escape latency was observed in nude mice exposed to 90 ppm toluene on days 3 and 4 when compared with corresponding WT mice. However, the effect of toluene on the escape latency was not significant in nude mice. In the probe trial, WT mice exposed to 90 ppm toluene showed poor retention memory compared with the control group. In the reversal phase, we did not find any significant difference between groups.\nCan T-cell deficiency affect spatial learning ability following toluene exposure?",
        "answer": "yes",
        "answer_rationale": "These results indicate that T-cell deficiency may affect spatial learning performance following toluene exposure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether T cells play a role in spatial learning after toluene exposure. They used wild-type (WT) and nude mice. Nude mice lack T cells, right? So the key here is comparing the two groups.\n\nIn the acquisition phase, nude mice exposed to 90 ppm toluene had longer escape latencies on days 3 and 4 compared to WT mice under the same conditions. But the effect of toluene wasn't significant in the nude mice themselves. Wait, that's a bit confusing. So maybe the T-cell deficient mice (nude) are more affected in some way?\n\nThen in the probe trial, the WT mice exposed to 90 ppm had worse retention memory than controls. But the nude mice's results here aren't mentioned directly. The reversal phase showed no differences. \n\nThe question is whether T-cell deficiency affects spatial learning after toluene. Since the nude mice (no T cells) had longer latencies when exposed to high toluene compared to WT mice, that suggests that without T cells, the spatial learning impairment is more pronounced. So T-cell deficiency might be making the effect of toluene worse. Therefore, the answer should be yes, T-cell deficiency does affect spatial learning in this context. The fact that the effect wasn't significant in the nude group's toluene exposure might be because their baseline is already different, but the comparison between WT and nude at the same exposure shows a difference. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 314,
            "completion_tokens": 320
        },
        "time_elapsed": 3.923041820526123
    },
    {
        "realidx": "20064872",
        "question": "To identify the features of PMR that may predict the duration of steroid therapy, the occurrence of relapses and the late development of GCA.\nProspective cohort study of 176 patients with PMR, followed up for 5 years. Baseline factors associated with the duration of steroids therapy were identified using Cox regression. Predictors of relapse and the late development of GCA were identified using binary logistic regression.\nA total of 176 patients with PMR were included, of whom 124 stopped steroids within 5 years. The probability of stopping steroids within 5 years was independently reduced by an elevated plasma viscosity (PV) [hazard ratio (HR) = 0.49; 95% CI 0.29, 0.82 for a PV>or = 2.00 mPa s compared with a PV<or = 1.80 mPa s; overall P = 0.024] and by starting treatment at>15 mg prednisolone (HR = 0.63; 95% CI 0.41, 0.97; P = 0.036). Either of these independently reduced the chances of stopping steroids within a given time interval between 27 and 51%. No significant predictors of relapse were identified. Predictors of late GCA on univariable analysis were female sex [odds ratio (OR) = 8.16; 95% CI 1.06, 63.13; P = 0.044], HLA-DRB1*0101 or -*0401 alleles (OR = 4.95; 95% CI 1.05, 23.34; P = 0.043), PV>or = 2.00 mPa s compared with PV<or = 1.80 mPa s (OR = 10.64; 95% CI 1.28, 88.38; P = 0.029) and initial prednisolone dose>15 mg (OR = 4.53; 95% CI 1.61, 12.79; P = 0.004).\nCan the prognosis of polymyalgia rheumatica be predicted at disease onset?",
        "answer": "yes",
        "answer_rationale": "A higher PV in PMR increases the risk of prolonged steroid therapy and late GCA. Female sex and particular HLA alleles may increase the risk of late GCA. Starting patients on>15 mg prednisolone is associated with a prolonged steroid duration.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the prognosis of polymyalgia rheumatica (PMR) can be predicted at disease onset based on the provided study.\n\nFirst, I need to recall what the study found. The study was a prospective cohort of 176 PMR patients followed for 5 years. They used Cox regression to find baseline factors associated with steroid duration and logistic regression for relapses and late GCA.\n\nThe key findings mentioned are that elevated plasma viscosity (PV \u22652.00 vs \u22641.80 mPa s) and starting prednisolone at >15 mg were independent predictors of longer steroid use (since lower hazard ratios mean lower chance of stopping, so longer duration). Also, for late GCA, factors like female sex, certain HLA alleles, high PV, and higher initial steroid dose were predictors. \n\nThe question is whether prognosis (which includes duration of therapy, relapses, late GCA) can be predicted at onset. The study shows that certain baseline factors (PV, initial dose) do predict the duration of steroids and the risk of developing GCA later. However, they didn't find predictors for relapses. But since some factors are predictive, the answer would lean towards \"yes\" because at least some aspects of prognosis (steroid duration and GCA development) can be predicted. The options are A (yes), B (no), C (maybe). The study provides evidence that some predictors exist, so the answer should be A. Even though not all outcomes (like relapses) have predictors, the question is general about prognosis, so the presence of some predictors would support \"yes\".\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 609,
            "completion_tokens": 347
        },
        "time_elapsed": 4.5458807945251465
    },
    {
        "realidx": "20084845",
        "question": "Accurate and updated information on airborne pollen in specific areas can help allergic patients. Current monitoring systems are based on a morphologic identification approach, a time-consuming method that may represent a limiting factor for sampling network enhancement.\nTo verify the feasibility of developing a real-time polymerase chain reaction (PCR) approach, an alternative to optical analysis, as a rapid, accurate, and automated tool for the detection and quantification of airborne allergenic pollen taxa.\nThe traditional cetyl trimethyl ammonium bromide-based method was modified for DNA isolation from pollen. Taxon-specific DNA sequences were identified via bioinformatics or literature searches and were PCR amplified from the matching allergenic taxa; based on the sequences of PCR products, complementary or degenerate TaqMan probes were developed. The accuracy of the quantitative real-time PCR assay was tested on 3 plant species.\nThe setup of a modified DNA extraction protocol allowed us to achieve good-quality pollen DNA. Taxon-specific nuclear gene fragments were identified and sequenced. Designed primer pairs and probes identified selected pollen taxa, mostly at the required classification level. Pollen was properly identified even when collected on routine aerobiological tape. Preliminary quantification assays on pollen grains were successfully performed on test species and in mixes.\nBiomolecular identification of allergenic pollen: a new perspective for aerobiological monitoring?",
        "answer": "yes",
        "answer_rationale": "The real-time PCR approach revealed promising results in pollen identification and quantification, even when analyzing pollen mixes. Future perspectives could concern the development of multiplex real-time PCR for the simultaneous detection of different taxa in the same reaction tube and the application of high-throughput molecular methods.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether biomolecular identification of allergenic pollen is a new perspective for aerobiological monitoring. The options are yes, no, maybe.\n\nFirst, I need to look at the provided information. The question is based on a study that tested a real-time PCR method as an alternative to the traditional morphologic identification. The traditional method is time-consuming, which limits expanding monitoring networks. The study modified a DNA extraction method, found specific DNA sequences, designed primers and probes, and tested them. They were able to identify pollen even from tapes used in aerobiological sampling and did quantification successfully on test species and mixes.\n\nThe key points here are that the study's results showed that their PCR method worked for identification and quantification. The setup allowed good DNA quality, the primers and probes worked, and they could identify pollen even in mixes. The question is whether this suggests a new perspective (i.e., a viable method) for monitoring. Since the study's results were successful in their tests, the answer would lean towards yes. The options are (A) yes, (B) no, (C) maybe. The conclusion of the study seems positive, so the answer is likely A. The title of the study itself is phrased as a question, but the results support the feasibility, so the answer should be yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 357,
            "completion_tokens": 286
        },
        "time_elapsed": 3.510498523712158
    },
    {
        "realidx": "20121683",
        "question": "Community-based medical education is growing to meet the increased demand for quality clinical education in expanded settings, and its sustainability relies on patient participation. This study investigated patients' views on being used as an educational resource for teaching medical students.\nQuestionnaire-based survey.\nPatients attending six rural and 11 regional general practices in New South Wales over 18 teaching sessions in November 2008, who consented to student involvement in their consultation.\nPatient perceptions, expectations and acceptance of medical student involvement in consultations, assessed by surveys before and after their consultations.\n118 of 122 patients consented to medical student involvement; of these, 117 (99%) completed a survey before the consultation, and 100 (85%) after the consultation. Patients were overwhelmingly positive about their doctor and practice being involved in student teaching and felt they themselves played an important role. Pre-consultation, patients expressed reluctance to allow students to conduct some or all aspects of the consultation independently. However, after the consultation, they reported they would have accepted higher levels of involvement than actually occurred.\nAre patients willing participants in the new wave of community-based medical education in regional and rural Australia?",
        "answer": "yes",
        "answer_rationale": "Patients in regional and rural settings were willing partners in developing skills of junior medical students, who had greater involvement in patient consultations than previously reported for urban students. Our study extends the findings from urban general practice that patients are underutilised partners in community-based medical training. The support of patients from regional and rural settings could facilitate the expansion of primary care-based medical education in these areas of workforce need.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether patients are willing participants in community-based medical education in regional and rural Australia, based on the provided study.\n\nFirst, I need to recall the details from the study summary. The study involved patients in rural and regional practices who consented to having medical students involved in their consultations. Out of 122 patients, 118 consented, which is a high number. Then, almost all of them completed the pre-survey, and 85% did the post-survey. \n\nThe key findings mentioned are that patients were \"overwhelmingly positive\" about their doctors and practices being involved in teaching. They felt they had an important role. Before the consultation, they were reluctant to let students do some parts independently, but after, they reported they would have accepted more involvement than actually happened. \n\nThe question is whether patients are willing participants. The options are yes, no, maybe. The study's results show high consent rates and positive feedback, especially after the fact. Even though they were initially reluctant about students doing more, after experiencing it, they were more open. The overall sentiment is positive, so the answer should be yes. The options given are A, B, C. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 333,
            "completion_tokens": 267
        },
        "time_elapsed": 3.33496356010437
    },
    {
        "realidx": "20187289",
        "question": "Stock et al. (Eur Respir J 25:47-53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data.\nWe replicated the selection procedure of Stock et al. using data on 290,919 children aged 0-17 years insured in the Gm\u00fcnder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0-17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006.\nIn children aged 0-4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0-4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children>4 years, prevalences were found to increase with increasing age.\nPrescriptions as a proxy for asthma in children: a good choice?",
        "answer": "no",
        "answer_rationale": "When additional validation studies were taken into account, asthma medications were found to be prescribed not only for asthma but also for other respiratory diseases. In addition, not all children with current asthma had prescriptions. We therefore conclude that asthma medications are therefore not a good proxy for the disease.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether prescriptions are a good choice as a proxy for asthma in children, based on the study described.\n\nFirst, I need to understand the key points from the provided information. The study by Stock et al. used claims data (prescriptions and hospital diagnoses) and found high asthma prevalence peaks in infants. The current study replicated their methods using GEK data and compared it with KiGGS data. \n\nIn the GEK data for 0-4 year olds, the asthma prevalence was much higher (11.7-17.7% for boys, 7.2-11.1% for girls) compared to the KiGGS data, which showed 0-2.6% for boys and 0-1.0% for girls in the same age group. Also, in older children, GEK showed a decline while KiGGS showed an increase with age. \n\nThe discrepancy here is significant. The high prevalence in infants using prescription data might be overestimating asthma because prescriptions for asthma medications (like bronchodilators or corticosteroids) could be given for other respiratory issues in young children, such as RSV bronchiolitis or recurrent wheezing that isn't actual asthma. KiGGS, which is a more clinical survey, likely has better diagnostic criteria, leading to lower numbers. \n\nSince the question is whether prescriptions are a good proxy, the answer would be no. The high rates in the claims data don't align with the clinical survey, suggesting that using prescriptions alone might not accurately capture asthma cases, especially in younger children. Overprescription or misdiagnosis could be factors here. The different age trends also indicate that prescriptions might not be reliable across all age groups. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 425,
            "completion_tokens": 376
        },
        "time_elapsed": 4.773717641830444
    },
    {
        "realidx": "20197761",
        "question": "Guidelines emphasize that irritable bowel syndrome (IBS) is not a diagnosis of exclusion and encourage clinicians to make a positive diagnosis using the Rome criteria alone. Yet many clinicians are concerned about overlooking alternative diagnoses. We measured beliefs about whether IBS is a diagnosis of exclusion, and measured testing proclivity between IBS experts and community providers.\nWe developed a survey to measure decision-making in two standardized patients with Rome III-positive IBS, including IBS with diarrhea (D-IBS) and IBS with constipation (C-IBS). The survey elicited provider knowledge and beliefs about IBS, including testing proclivity and beliefs regarding IBS as a diagnosis of exclusion. We surveyed nurse practitioners, primary care physicians, community gastroenterologists, and IBS experts.\nExperts were less likely than nonexperts to endorse IBS as a diagnosis of exclusion (8 vs. 72%; P<0.0001). In the D-IBS vignette, experts were more likely to make a positive diagnosis of IBS (67 vs. 38%; P<0.001), to perform fewer tests (2.0 vs. 4.1; P<0.01), and to expend less money on testing (US$297 vs. $658; P<0.01). Providers who believed IBS is a diagnosis of exclusion ordered 1.6 more tests and consumed $364 more than others (P<0.0001). Experts only rated celiac sprue screening and complete blood count as appropriate in D-IBS; nonexperts rated most tests as appropriate. Parallel results were found in the C-IBS vignette.\nIs irritable bowel syndrome a diagnosis of exclusion?",
        "answer": "maybe",
        "answer_rationale": "Most community providers believe IBS is a diagnosis of exclusion; this belief is associated with increased resource use. Experts comply more closely with guidelines to diagnose IBS with minimal testing. This disconnect suggests that better implementation of guidelines is warranted to minimize variation and improve cost-effectiveness of care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether irritable bowel syndrome (IBS) is a diagnosis of exclusion. The options are yes, no, or maybe.\n\nFirst, I need to recall what a diagnosis of exclusion means. A diagnosis of exclusion is when a doctor only arrives at a diagnosis after ruling out all other possible conditions through tests. So, for example, if someone has symptoms that could be due to several diseases, you have to do tests to exclude those other diseases before settling on the diagnosis.\n\nNow, the question is specifically about IBS. The provided information from the study says that guidelines emphasize IBS is NOT a diagnosis of exclusion and encourage using Rome criteria alone for a positive diagnosis. The study compared experts vs. non-experts. The experts were less likely to think IBS is a diagnosis of exclusion (only 8% vs. 72% of non-experts). The experts also did fewer tests, which aligns with not needing to exclude other conditions because they rely on the Rome criteria.\n\nThe key point here is the guidelines' stance. The study's results support that experts follow the guidelines, not considering IBS a diagnosis of exclusion. The question is asking whether IBS is a diagnosis of exclusion, and according to the study's premise, the correct answer should be \"no\" because the guidelines say it's not, and experts agree. The fact that many clinicians (non-experts) still think it is shows a discrepancy, but the question is about what's correct per the guidelines. \n\nSo the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 458,
            "completion_tokens": 327
        },
        "time_elapsed": 4.045049428939819
    },
    {
        "realidx": "20297950",
        "question": "To investigate the effect of fenofibrate on sleep apnoea indices.\nProof-of-concept study comprising a placebo run-in period (1 week, 5 weeks if fibrate washout was required) and a 4-week randomized, double-blind treatment period. Thirty-four subjects (mean age 55 years, body mass index 34 kg/m 2 , fasting triglycerides 3.5 mmol/L) with diagnosed sleep apnoea syndrome not treated with continuous positive airways pressure were enrolled and randomized to once daily treatment with fenofibrate (145 mg NanoCrystal(R) tablet) or placebo. Overnight polysomnography, computerized attention/vigilance tests and blood sampling for measurement of lipids, insulin, fasting plasma glucose and fibrinogen were performed at the end of each study period.\nNCT00816829.\nAs this was an exploratory study, a range of sleep variables were evaluated. The apnoea/hypopnoea index (AHI) and percentage of time spent with arterial oxygen saturation (SpO(2))<90% were relevant as they have been evaluated in other clinical trials. Other variables included total apnoeas, hypopnoeas and oxygen desaturations, and non-cortical micro-awakenings related to respiratory events per hour.\nFenofibrate treatment significantly reduced the percentage of time with SpO(2)<90% (from 9.0% to 3.5% vs. 10.0% to 11.5% with placebo, p = 0.007), although there was no significant change in the AHI (reduction vs. control 14% (95%CI -47 to 40%, p = 0.533). Treatment reduced obstructive apnoeas (by 44%, from 18.5 at baseline to 15.0 at end of treatment vs. 29.0 to 30.5 on placebo, p = 0.048), and non-cortical micro-awakenings per hour (from 23.5 to 18.0 vs. 24.0 to 25.0 with placebo, p = 0.004). Other sleep variables were not significantly influenced by fenofibrate.\nExploratory study in patients with mild to moderate sleep apnoea, limited treatment duration; concomitant hypnotic treatment (35%); lack of correction for multiplicity of testing.\nProof of concept study: does fenofibrate have a role in sleep apnoea syndrome?",
        "answer": "yes",
        "answer_rationale": "The consistent direction of change in sleep indices in this proof-of-concept study may support further investigation of fenofibrate in moderate to severe sleep apnoea syndrome.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether fenofibrate has a role in sleep apnoea syndrome based on the provided study.\n\nFirst, I need to recall the study details. The study was a proof-of-concept with a placebo-controlled design. They looked at several outcomes: AHI (apnoea/hypopnoea index), time with SpO2 <90%, obstructive apnoeas, and micro-awakenings. \n\nThe key results mentioned are that fenofibrate significantly reduced the percentage of time with SpO2 <90% (from 9% to 3.5% vs placebo's increase from 10% to 11.5%, p=0.007). That's a notable improvement. Also, it reduced obstructive apnoeas by 44% (from 18.5 to 15 vs placebo's increase from 29 to 30.5, p=0.048). Additionally, non-cortical micro-awakenings per hour went down significantly (23.5 to 18 vs placebo's 24 to 25, p=0.004). \n\nHowever, the AHI didn't show a significant change (14% reduction vs placebo, but p=0.533). The study mentions it was exploratory, had a short duration, some patients on hypnotics, and no correction for multiple testing. \n\nThe question is whether fenofibrate has a role. The significant improvements in SpO2 time, apnoeas, and micro-awakenings suggest some positive effect, even if AHI wasn't significant. Since it's a proof-of-concept, the results are promising but not definitive. The options are yes, no, maybe. The study shows some benefits, so \"maybe\" (C) might be the answer. But wait, the question is about \"a role\"\u2014since there were significant improvements in some key variables, even if not all, maybe the answer is yes (A). But the study's limitations (small sample, short duration, etc.) mean it's not conclusive. The options are (A) yes, (B) no, (C) maybe. The study's results are positive in some aspects, so the answer is probably (C) maybe, as it's an exploratory study and not definitive. But the question is phrased as",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 649,
            "completion_tokens": 512
        },
        "time_elapsed": 7.048969745635986
    },
    {
        "realidx": "20306735",
        "question": "To ascertain the perspectives of Trainee Ophthalmologist Diplomats (TOD) on the Ophthalmic Diploma Training (ODT) in West Africa with a view to improving the programme.\nA survey of set 2005 TOD on ODT was carried out in Ghana, 2006.\nThe trainees included 10 (83.35%) males and two (16.7%) females whose ages ranged between thirty-two and fifty-one years. The sponsors of the trainees included Sight Savers International, five (41.7%); Christian Blind Mission International, three (25.0%); Eye Foundation, Lagos, Nigeria two (16.7%); Ministry of Defence Nigeria, one (8.3%); and Health Authority Ghana, one (8.3%). Nine trainees (75.0%) felt the programme was well structured, training allowances were adequate eight (66.7%) and inadequate four (33.3%). Eleven (91.7%) trainees would work wherever they were posted; ten (83.3%) trainees had sense of fulfillment and three (25%) would like to proceed for residency training. All trainees were at least good in chalazion surgery and treatment of common medical eye conditions. Majority were at least good in eye surgery like cataract, eleven (91.7%); trabeculectomy nine (75.0%); pterygium 10 (83.3%); eyelid, eight (66.7%); destructive 11 (91.6%) and refraction 9 (75.0%). Some trainees' perceived problems included inadequate sponsorship (33.3%), short duration of the course four (33.3%) and poor accommodation facility two (16.7%). However, trainees' suggested increase in training posts, four (33.3); training allowance three (25.0%); and incentives for trainers/training hospitals two (16.7%).\nFulfilling human resources development goal in West Africa: can the training of ophthalmologist diplomates be improved?",
        "answer": "yes",
        "answer_rationale": "The ODT programme ensures ophthalmic manpower for secondary eye care level despite challenges. The stakeholders should look into problems facing the programme in order to improve it.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the training of Ophthalmologist Diplomates (TOD) in West Africa can be improved based on the survey results provided.\n\nFirst, I need to look at the data given. The survey included 12 trainees (since 10 males and 2 females make 12 total). The key points from the survey are:\n\n- 75% felt the program was well-structured.\n- 66.7% found allowances adequate, but 33.3% didn't.\n- 91.7% would work where posted, and 83.3% had a sense of fulfillment.\n- Most were skilled in various surgeries, which is positive.\n- Problems mentioned: inadequate sponsorship (33.3%), short course duration (33.3%), and poor accommodation (16.7%).\n- Suggestions: increase training posts (33.3%), more allowance (25%), and incentives for trainers (16.7%).\n\nThe question is whether the program can be improved. The data shows that while there are positive aspects (majority like the structure, feel fulfilled, and are competent), there are also areas needing improvement like sponsorship, allowance, course duration, and facilities. The trainees themselves suggested improvements, which indicates that addressing these issues could enhance the program. Since the survey highlights specific problems and suggestions, it's clear that there are actionable items to make the program better. Therefore, the answer should be \"yes\" because the issues identified can be addressed to improve the training program.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 543,
            "completion_tokens": 331
        },
        "time_elapsed": 4.403124094009399
    },
    {
        "realidx": "20337202",
        "question": "To determine the duration of continuing pregnancy after antenatal corticosteroid (AC) administration and to evaluate the potential opportunity for rescue AC.\nRetrospective analysis of women at 24-32 weeks' gestation who received AC at one institution.\nSix hundred ninety-two women received AC. Two hundred forty-seven (35.7%) delivered at>or = 34 weeks' gestation. Three hundred twenty-one (46.4%) delivered within 1 week of AC; 92 of those women (13.3%) delivered within 24 hours. Only 124 (17.9%) remained pregnant 1 week after AC and delivered at<34 weeks. The latter were compared to women delivering>2 week after AC but>or = 34 weeks. More likely to deliver at<34 weeks were those women who received AC for premature preterm rupture of membranes (OR 3.83, 95% CI 2.06-7.17), twins (OR 2.90, 95% CI 1.42-5.95) or before 28 weeks (OR 2.21, 95% CI 1.38-3.52).\nContinuation of pregnancy after antenatal corticosteroid administration: opportunity for rescue?",
        "answer": "maybe",
        "answer_rationale": "Rescue AC may apply to only 18% of cases, and we identified subsets of more likely candidates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's an opportunity for rescue antenatal corticosteroids (AC) after the initial administration. The study provided gives some data on delivery times after AC.\n\nFirst, the study says that 35.7% of women delivered at \u226534 weeks, which is a good outcome. But the key part here is looking at the timing. 46.4% delivered within a week of getting AC, and 13.3% within 24 hours. That's pretty quick. However, 17.9% were still pregnant a week after AC but ended up delivering before 34 weeks. The question is about the possibility of a rescue dose. \n\nRescue AC usually refers to a second course given if the first doesn't delay delivery enough, allowing the steroids to have their full effect. The study mentions that if women delivered within a week, especially within 24 hours, they might not have had enough time for the steroids to work. But those who remained pregnant a week after the first AC might be candidates for another dose. The study also notes that certain factors like PPROM, twins, or earlier gestational age (before 28 weeks) increased the chance of delivering before 34 weeks. \n\nThe options are yes, no, maybe. The study's data shows that a significant portion (17.9%) were still pregnant a week later but delivered preterm. Since rescue AC is recommended when delivery is not imminent (like within 7 days), this group might have had the opportunity for a second dose. The fact that some women stayed pregnant beyond a week suggests that in those cases, a rescue dose could be possible. Therefore, the answer should be yes (A) because there's an opportunity for rescue in those who don't deliver quickly after the first dose.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 378,
            "completion_tokens": 389
        },
        "time_elapsed": 4.488277196884155
    },
    {
        "realidx": "20354380",
        "question": "To assess gender differences among residents regarding their plans to have children during residency and determine the most influential reasons for these differences.\nUsing the Health Belief Model as a framework, the authors created an instrument to survey 424 residents from 11 residency programs at three academic medical institutions about their intentions to have children during residency. The authors developed a scale to assess the perceived career threats of having children during residency, evaluated its psychometric properties, and calculated the effect of the mediators.\nThe response rate was 77% (328/424). Forty-one percent of men versus 27% of women planned to have children during residency (P = .01). The instrument measured four career threats-extended training, loss of fellowship positions, pregnancy complications, and interference with career plans-on a five-point Likert scale. The scale had a Cronbach alpha of 0.84 and an eigenvalue of 2.2. Compared with men, women had higher scores for each item and a higher mean score (2.9 versus 2.1, P = .001), signifying greater belief in the potential of pregnancy to threaten careers. After adjusting for age, institution, postgraduate year, and knowledge of parental leave policies, women were less likely to plan to have children during residency (odds ratio 0.46 [95% confidence interval 0.25-0.84]). In mediation analysis, threats to career explained 67% of the gender variance.\nDo women residents delay childbearing due to perceived career threats?",
        "answer": "yes",
        "answer_rationale": "Women residents intentionally postpone pregnancy because of perceived threats to their careers. Medical educators should be aware of these findings when counseling female trainees.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether women residents delay childbearing due to perceived career threats based on the provided study.\n\nFirst, I need to recall the key points from the study summary. The study compared men and women residents' plans to have children during residency. The results showed that 41% of men versus 27% of women planned to have children during residency, which was statistically significant (P = .01). The instrument they used measured four career threats, and women had higher scores on each of these, meaning they perceived more threats. The mediation analysis found that threats to career explained 67% of the gender variance in their plans. Also, after adjusting for other factors, women were less likely to plan to have children during residency (OR 0.46). \n\nThe question is whether the delay is due to perceived career threats. The study's mediation analysis shows that the perceived career threats account for a major portion (67%) of the gender difference. Since women perceived more threats and were less likely to have children during residency, this suggests that their perception of career threats is a significant factor in their decision to delay. The high Cronbach's alpha indicates the scale was reliable, so the results are credible. Therefore, the answer should be yes, women do delay because of these perceived threats. The options are A, B, C. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 415,
            "completion_tokens": 294
        },
        "time_elapsed": 3.9629008769989014
    },
    {
        "realidx": "20537205",
        "question": "Halofantrine is a newly developed antimalarial drug used for the treatment of Plasmodium falciparum malaria. The introduction of this drug has been delayed because of its possible side effects, and due to insufficient studies on adverse reactions in humans. There have been no studies investigating its effect on hearing.\nThirty guinea pigs were divided into three groups: a control group, a halofantrine therapeutic dose group and a halofantrine double therapeutic dose group. One cochlea specimen from each animal was stained with haematoxylin and eosin and the other with toluidine blue.\nNo changes were detected in the control group. The halofantrine therapeutic dose group showed loss and distortion of inner hair cells and inner phalangeal cells, and loss of spiral ganglia cells. In the halofantrine double therapeutic dose group, the inner and outer hair cells were distorted and there was loss of spiral ganglia cells.\nIs halofantrine ototoxic?",
        "answer": "yes",
        "answer_rationale": "Halofantrine has mild to moderate pathological effects on cochlea histology, and can be considered an ototoxic drug.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether halofantrine is ototoxic based on the study described. First, I need to recall what ototoxicity means. Ototoxicity refers to drugs that can damage the ear, particularly the cochlea or the vestibular system, leading to hearing loss or balance issues.\n\nThe study involved guinea pigs divided into three groups: control, therapeutic dose, and double dose. The control group showed no changes. The therapeutic dose group had inner hair cell loss and distortion, plus loss of spiral ganglia cells. The double dose group had worse effects, affecting both inner and outer hair cells and more spiral ganglia loss.\n\nHair cells in the cochlea are crucial for hearing. Damage to them typically leads to hearing problems. Spiral ganglia cells are the neurons that transmit sound signals to the brain. Their loss would also impair hearing. Since both the therapeutic and higher doses caused these issues, it suggests that halofantrine can damage parts of the ear critical for hearing. \n\nThe question is whether this constitutes ototoxicity. Since the drug caused structural damage to the cochlea's components, the answer should be yes. The fact that even the therapeutic dose caused issues is important. The study didn't mention hearing tests, but histological changes like these are indicators of ototoxicity. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 300,
            "completion_tokens": 284
        },
        "time_elapsed": 3.4492952823638916
    },
    {
        "realidx": "20538207",
        "question": "It is generally considered that kidney grafts should be preserved at 4 degrees C during cold storage. However, actual temperature conditions are not known. We decided to study the temperature levels during preservation with the Biotainer storage can and Vitalpack transport pack.\nTemperature was monitored using the Thermobouton probe during preservation of pig kidneys, in the same conditions used with human grafts. The probe recorded the temperature level every 10 minutes during four days. We compared the results found with the new storage can with results obtained in the same conditions with the storage can formerly used by our team. We also studied the best position of the probe for temperature monitoring and the influence of the amount of ice within the transport pack on the temperature level. We then monitored the temperature during the conservation of actual human kidney grafts harvested at our institution from August 2007 to May 2008.\nThe temperature levels were the same regardless of the position of the probe within the transport pack. The lowest temperature was maintained during 15 hours, and the temperature level stayed below 5 degrees C for 57 hours with the new storage can. The former storage can maintained the lowest temperature level for 80 minutes, and temperature reached 5 degrees C after 10 hours 40 minutes. Temperature levels were similar when 2 or 4 kg of crushed ice were used. We observed similar results when monitoring the conservation of human grafts.\nShould temperature be monitorized during kidney allograft preservation?",
        "answer": "no",
        "answer_rationale": "The new storage can affords more stable temperature levels when compared to the formerly used can. Since temperature is stable during conservation, continuous monitoring in everyday practice does not seem warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether temperature should be monitored during kidney allograft preservation based on the study described.\n\nFirst, I need to recall the key points from the provided information. The study compared two storage containers (the new Biotainer and the former one) using pig kidneys and later human grafts. They used temperature probes to monitor every 10 minutes over four days. The results showed that the new storage can maintained lower temperatures much longer (15 hours at lowest, under 5\u00b0C for 57 hours) compared to the old one (80 minutes lowest, reached 5\u00b0C after ~10.7 hours). Also, the probe position didn't affect the readings, and the amount of ice (2kg vs 4kg) didn't make a difference. The human grafts had similar results.\n\nThe question is whether temperature monitoring is necessary. The study's findings indicate that the storage method significantly affects temperature maintenance. Since the new container is better, but the old one was less effective, monitoring would help ensure that the kidneys are kept at the correct temperature. The fact that they found variations between the containers and confirmed the new one's effectiveness suggests that monitoring is important to verify the preservation conditions. Also, even though probe position didn't matter in this setup, knowing the actual temps is crucial. The study itself was possible because they monitored, so in practice, doing so would allow teams to confirm their preservation methods are working. Therefore, the answer should be yes (A).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 396,
            "completion_tokens": 316
        },
        "time_elapsed": 3.9286718368530273
    },
    {
        "realidx": "20549895",
        "question": "There has never been a nationally representative survey of medical students' personal health-related practices, although they are inherently of interest and may affect patient-counseling practices. This study evaluated the health practices and the vaccination status of first year residents working at the academic hospital H\u00f4tel-Dieu de France.\nThe medical files of all medicine and surgery residents in their first year of specialization between the years 2005 and 2008 were reviewed. These residents were required to go through a preventive medical visit at the University Center of Family and Community Health.\nOne hundred and nine residents (109) were included in the study; 68 (6239%) were male and 41 (37.61%) were female with a mean age of 26 years. Only 6 residents (5.50%) practiced physical activity according to international guidelines (more than three times a week for more than 30 minutes each time). Most residents (n = 76 ; 69.73%) used to skip one or two meals especially breakfast and as a consequence 30 male (44.11%) and 4 female (9.75%) students were overweight, with a statistical difference between the two sexes (Fisher test, p-value = 0.001). Twenty-eight residents (25.69%) were smokers with a male predominance. Fourteen residents of both genders (12.84%) drank alcohol regularly (>3 times a week) and 71 (65.14%) had a drink occasionally (once a month or less). Only 25 residents (23%) of the cohort had a complete and up-to-date immunization status. The immunization gap was basically against measles, mumps, rubella (MMR) and diphtheria, tetanus, poliomyelitis (dT Polio). Ninety-nine residents (90.83%) had full immunization against hepatitis B with an adequate response in 78 residents (71.56%).\nHealth habits and vaccination status of Lebanese residents: are future doctors applying the rules of prevention?",
        "answer": "no",
        "answer_rationale": "This study showed that our residents did not always have a healthy lifestyle especially when it comes to physical activity and eating habits. They also lacked an adequate vaccination. Interventions should take place in order to promote healthy life style and to improve their vaccination status.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user provided a study about the health practices and vaccination status of first-year residents at a hospital. The question is asking whether these future doctors are applying the rules of prevention, with options yes, no, or maybe.\n\nFirst, I need to look at the data presented. The study found that only 5.5% of the residents met the physical activity guidelines. That's really low\u2014most don't exercise enough. Then, a majority (69.73%) skip meals, leading to a significant number being overweight, especially males. Smoking was at 25.69%, which is high for medical professionals. Alcohol use: 12.84% drink regularly, which might not be great either. \n\nVaccination status: Only 23% had complete and up-to-date immunizations. Even though 90% were immunized against Hepatitis B, only 71.56% had an adequate response. The gaps were in MMR and dT Polio, which are important. \n\nThe question is whether they're applying preventive health rules. Since the numbers for good habits and vaccinations are very low compared to recommended standards, the answer should be \"no.\" The options are A (yes), B (no), C (maybe). The data clearly shows poor adherence, so B is correct.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 538,
            "completion_tokens": 286
        },
        "time_elapsed": 3.466545820236206
    },
    {
        "realidx": "20571467",
        "question": "Kidneys from elderly donors tend to be implanted in recipients who are also elderly. We present the results obtained after 10 years of evolution on transplanting elderly kidneys into young recipients.\nNinety-one consecutive transplants are studied, carried out in our center with kidneys from cadaver donors older than 60 years implanted in recipients younger than 60 years. The control group is made up of 91 transplants, matched with those from the study group, whose donor and recipient were younger than 60 years.\nThere were no differences between groups with regard to recipient age, sex, cause of death and renal function of the donor, hepatitis C and cytomegalovirus serologies, cold ischemia time, tubular necrosis, immediate diuresis, need for dialysis, human leukocyte antigen incompatibilities, hypersensitized patients, acute rejection, waiting time on dialysis, and days of admission. Survival in both groups at 1, 5, and 10 years was 97.6%, 87.2%, and 76.6% vs. 98.8%, 87.5%, and 69.5% for the patient (P=0.642), 92.9%, 81.3%, and 64.2% vs. 93.9%, 76.4%, and 69.5% for the graft (P=0.980), and 94.4%, 92.6%, and 77.4% vs. 94.3%, 86.7%, and 84.4% for the graft with death censured (P=0.747), respectively. Creatininaemias at 1, 5, and 10 years were 172, 175, and 210 vs. 139, 134, and 155 (P<0.05).\nIs it appropriate to implant kidneys from elderly donors in young recipients?",
        "answer": "yes",
        "answer_rationale": "We conclude that patient and graft survival on transplanting kidneys from elderly donors to young recipients is superimposable on that obtained with young donors. However, renal function is better in the group of young donors.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing kidney transplants from elderly donors (over 60) into young recipients (under 60) versus a control group where both donor and recipient are young. The key here is to look at the outcomes provided.\n\nFirst, the survival rates for patients at 1, 5, and 10 years are very similar between the two groups. The p-values for these comparisons are 0.642 and 0.980, which are both above 0.05, meaning there's no statistically significant difference in patient or graft survival. That's a good sign because it suggests that using older kidneys doesn't harm survival rates.\n\nHowever, the creatinine levels (a measure of kidney function) are higher in the elderly donor group. At 10 years, their creatinine is 210 vs 155 in the control. The p-value here is less than 0.05, indicating a significant difference. Higher creatinine means worse kidney function, so the grafts from elderly donors aren't functioning as well long-term.\n\nBut the question is whether it's appropriate to implant these kidneys. The survival rates are comparable, which is crucial because the main goal is keeping the patient alive. The reduced kidney function might mean the recipient's quality of life could be affected, but since survival isn't compromised, and given that organs are a scarce resource, using older donors might be acceptable. The study's results don't show a significant downside in survival, so the answer would lean towards yes. The options are (A) yes, (B) no, (C) maybe. The data supports that it's appropriate, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 532,
            "completion_tokens": 360
        },
        "time_elapsed": 4.362375497817993
    },
    {
        "realidx": "20577124",
        "question": "Hyperleptinemia and oxidative stress play a major role in the development of cardiovascular diseases in obesity. This study aimed to investigate whether there is a relationship between plasma levels of leptin and phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and its potential relevance in the vascular remodeling in obese patients.\nThe study was performed in 164 obese and 94 normal-weight individuals (controls). NADPH oxidase activity was evaluated by luminescence in phagocytic cells. Levels of leptin were quantified by ELISA in plasma samples. Carotid intima-media thickness (cIMT) was measured by ultrasonography. In addition, we performed in-vitro experiments in human peripheral blood mononuclear cells and murine macrophages.\nPhagocytic NADPH oxidase activity and leptin levels were enhanced (P<0.05) in obese patients compared with controls. NADPH oxidase activity positively correlated with leptin in obese patients. This association remained significant in a multivariate analysis. cIMT was higher (P<0.05) in obese patients compared with controls. In addition, cIMT also correlated positively with leptin and NADPH oxidase activity in obese patients. In-vitro studies showed that leptin induced NADPH oxidase activation. Inhibition of the leptin-induced NADPH oxidase activity by wortmannin and bisindolyl maleimide suggested a direct involvement of the phosphatidylinositol 3-kinase and protein kinase C pathways, respectively. Finally, leptin-induced NADPH oxidase activation promoted macrophage proliferation.\nIs leptin involved in phagocytic NADPH oxidase overactivity in obesity?",
        "answer": "yes",
        "answer_rationale": "These findings show that phagocytic NADPH oxidase activity is increased in obesity and is related to preclinical atherosclerosis in this condition. We also suggest that hyperleptinemia may contribute to phagocytic NADPH oxidase overactivity in obesity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether leptin is involved in the overactivity of phagocytic NADPH oxidase in obesity. The question is straightforward, but I need to make sure I understand the results presented.\n\nFirst, the study found that both NADPH oxidase activity and leptin levels were higher in obese patients compared to controls (P<0.05). That's a correlation, but does it show causation? The next part says there's a positive correlation between NADPH and leptin in the obese group, and this remained significant even after multivariate analysis. That strengthens the link, but still, correlation doesn't equal causation. However, the in-vitro experiments are key here. They mention that leptin induced NADPH oxidase activation. They also tested inhibitors: wortmannin (PI3K inhibitor) and bisindolyl maleimide (PKC inhibitor) blocked the effect. So this suggests that leptin directly causes the NADPH activation through those pathways. Additionally, the leptin-induced NADPH activation led to macrophage proliferation, which ties into vascular remodeling mentioned in the study. \n\nThe question is whether leptin is involved. Since the in-vitro experiments show that adding leptin causes the NADPH activity, and blocking the pathways specific to leptin's action stops it, that's a direct causal relationship. So the answer should be yes. The options are A, B, C. The study's results support that leptin is involved. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 464,
            "completion_tokens": 331
        },
        "time_elapsed": 4.281906843185425
    },
    {
        "realidx": "20602101",
        "question": "Studies have indicated that hypoalbuminemia is associated with decreased survival of patients with gastric cancer. However, the prognostic value of albumin may be secondary to an ongoing systemic inflammatory response. The aim of the study was to assess the relation between hypoalbuminemia, the systemic inflammatory response, and survival in patients with gastric cancer.\nPatients diagnosed with gastric carcinoma attending the upper gastrointestinal surgical unit in the Royal Infirmary, Glasgow between April 1997 and December 2005 and who had a pretreatment measurement of albumin and C-reactive protein (CRP) were studied.\nMost of the patients had stage III/IV disease and received palliative treatment. The minimum follow-up was 15 months. During follow-up, 157 (72%) patients died of their cancer. On univariate analysis, stage (p<0.001), treatment (p<0.001), albumin level (p<0.001), and CRP level (p<0.001) were significant predictors of survival. On multivariate analysis, stage (p<0.001), treatment (p<0.001), and CRP level (p<0.001) remained significant predictors of survival. Albumin was no longer an independent predictor of survival.\nIs hypoalbuminemia an independent prognostic factor in patients with gastric cancer?",
        "answer": "no",
        "answer_rationale": "Low albumin concentrations are associated with poorer survival in patients with gastric cancer. However, the strength of this relation with survival is dependent on the presence of a systemic inflammatory response, as evidenced by an elevated CRP level. Therefore, it appears that the relation between hypoalbuminemia and poor survival is secondary to that of the systemic inflammatory response.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether hypoalbuminemia is an independent prognostic factor in gastric cancer patients based on the study described.\n\nFirst, I need to recall what an independent prognostic factor means. It's a variable that still predicts outcome even when other variables are accounted for in the analysis. So, if albumin remains significant in multivariate analysis, it's independent. If not, then it's not.\n\nLooking at the study details: On univariate analysis, albumin was a significant predictor. But in the multivariate analysis, which adjusts for other factors like stage, treatment, and CRP, albumin didn't remain significant. The key point here is that after considering other variables (like CRP, which is part of the inflammatory response), albumin's effect was no longer independent. The study's aim was to see if albumin's prognostic value was due to the inflammatory response, which CRP measures. Since CRP stayed significant and albumin didn't, it suggests that the inflammation (CRP) is the real independent factor, and albumin's effect was confounded by that. \n\nSo the answer should be no, because in the multivariate model, albumin wasn't an independent predictor anymore. The correct option is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 386,
            "completion_tokens": 270
        },
        "time_elapsed": 3.274259328842163
    },
    {
        "realidx": "20602784",
        "question": "This paper investigates the impact of geographic scale (census tract, zip code, and county) on the detection of disparities in breast cancer mortality among three ethnic groups in Texas (period 1995-2005). Racial disparities were quantified using both relative (RR) and absolute (RD) statistics that account for the population size and correct for unreliable rates typically observed for minority groups and smaller geographic units. Results were then correlated with socio-economic status measured by the percentage of habitants living below the poverty level.\nAfrican-American and Hispanic women generally experience higher mortality than White non-Hispanics, and these differences are especially significant in the southeast metropolitan areas and southwest border of Texas. The proportion and location of significant racial disparities however changed depending on the type of statistic (RR versus RD) and the geographic level. The largest proportion of significant results was observed for the RD statistic and census tract data. Geographic regions with significant racial disparities for African-Americans and Hispanics frequently had a poverty rate above 10.00%.\nIdentification of racial disparities in breast cancer mortality: does scale matter?",
        "answer": "yes",
        "answer_rationale": "This study investigates both relative and absolute racial disparities in breast cancer mortality between White non-Hispanic and African-American/Hispanic women at the census tract, zip code and county levels. Analysis at the census tract level generally led to a larger proportion of geographical units experiencing significantly higher mortality rates for minority groups, although results varied depending on the use of the relative versus absolute statistics. Additional research is needed before general conclusions can be formulated regarding the choice of optimal geographic regions for the detection of racial disparities.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The main point here is whether the scale (like census tract, zip code, or county) affects the identification of racial disparities in breast cancer mortality. The study found that the proportion and location of these disparities changed based on the statistic used (relative risk vs. absolute difference) and the geographic scale. The largest significant results were with RD and census tracts. Also, areas with higher poverty had more disparities.\n\nThe question is asking if scale matters. Since the results changed depending on the geographic level, that implies that scale does matter. The answer should be A) yes. The study's findings show that different scales lead to different observations of disparities, so scale is a significant factor here.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 314,
            "completion_tokens": 152
        },
        "time_elapsed": 2.1892364025115967
    },
    {
        "realidx": "20605051",
        "question": "Reimbursement based on the total care of a patient during an acute episode of illness is believed to stimulate management and clinicians to reduce quality problems like waiting times and poor coordination of care delivery. Although many studies already show that this kind of case-mix based reimbursement leads to more efficiency, it remains unclear whether care coordination improved as well. This study aims to explore whether case-mix based reimbursement stimulates development of care coordination by the use of care programmes, and a process-oriented way of working.\nData for this study were gathered during the winter of 2007/2008 in a survey involving all Dutch hospitals. Descriptive and structural equation modelling (SEM) analyses were conducted.\nSEM reveals that adoption of the case-mix reimbursement within hospitals' budgeting processes stimulates hospitals to establish care programmes by the use of process-oriented performance measures. However, the implementation of care programmes is not (yet) accompanied by a change in focus from function (the delivery of independent care activities) to process (the delivery of care activities as being connected to a chain of interdependent care activities).\nDoes case-mix based reimbursement stimulate the development of process-oriented care delivery?",
        "answer": "yes",
        "answer_rationale": "This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether case-mix based reimbursement stimulates the development of process-oriented care delivery based on the provided study.\n\nFirst, I need to recall the details from the passage. The study's aim was to see if case-mix reimbursement leads to better care coordination through care programmes and process-oriented work. The methods included a survey in Dutch hospitals with SEM analysis.\n\nThe key findings from the study, as mentioned, are that adopting case-mix reimbursement in budgeting does encourage hospitals to set up care programmes using process-oriented measures. However, the implementation of these programmes hasn't yet led to a shift from focusing on individual functions (like separate care activities) to a process-oriented approach where activities are seen as interconnected in a chain. \n\nSo the question is whether the reimbursement stimulates process-oriented care. The answer hinges on the study's conclusion. Even though they started care programmes with some process measures, the focus hasn't shifted to the interconnected processes. The SEM shows that while there's a stimulation to establish programmes, the actual process-oriented delivery (the chain of interdependent activities) hasn't changed. \n\nThe options are yes, no, maybe. The study says that the implementation isn't accompanied by the change in focus. So the answer would be no, because even though there's some movement, the key aspect of process-oriented care (the interconnected chain) hasn't been achieved. The question is whether it \"stimulates the development\"\u2014since the study found that the development (implementation of programmes) is there, but the actual process focus isn't. Wait, maybe I need to parse the wording again.\n\nThe question is specifically about process-oriented care delivery. The study says that the adoption stimulates establishing care programmes using process-oriented measures, but the implementation isn't accompanied by a shift from function to process. So the process-oriented measures are used, but the focus remains on functions rather than the process as a chain. \n\nHmm. The answer options are about whether it stimulates the development. The first part of the finding says that adoption does stimulate establishing care programmes with process measures. But the second part says that the implementation isn't leading to the process focus. The question is about whether the reimbursement stimulates the development. The study's SEM shows that it does stimulate the establishment of care programmes via process measures. However, the process-oriented delivery (the actual shift in focus) hasn't happened yet. \n\nThe question is a bit ambiguous. The options are yes, no, maybe. The study's conclusion is that while there",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 324,
            "completion_tokens": 512
        },
        "time_elapsed": 7.188732147216797
    },
    {
        "realidx": "20608141",
        "question": "Prostate-specific antigen (PSA) levels can show wide fluctuations when repeatedly measured. Here we investigatewd if: (a) biopsy timing influences the prostate cancer (PC) detection rate in patients with fluctuating PSA (flu-PSA) in comparison with patients with steadily increasing PSA (si-PSA); (b) PSA slope estimated in patients with flu-PSA predicts a different risk of cancer detection; (c) flu-PSA and si-PSA patients develop PC in topographically different sites; (d) the behaviour of pre-operative PSA is an expression of a disease with defferent characteristics to the following radical prostatectomy.\nThe study involved 211 patients who underwent at least a second biopsy after a first negative prostate biopsy. PSA Slope, PSA velocity (PSAV) and PSA doubling time (PSADT) were estimated. Flu-PSA level was defined as a PSA series with at least one PSA value lower than the one immediately preceding it.\n82 patients had flu-PSA levels and 129 si-PSA levels. There were no significant differences between the two groups in terms of cancer detection, clinical or pathological stage, but the si-PSA group with cancer had a higher Gleason score. No difference was found for PSA Slope between flu-PSA patients with cancer and those without.\nPSA repeatedly fluctuating levels are reassuring enough to avoid biopsy?",
        "answer": "no",
        "answer_rationale": "Our study demonstrates no difference in PC detection rate at repeat biopsy between patients with flu or si-PSA levels. PSA Slope, PSAV and PSADT were not found helpful tools in cancer detection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether fluctuating PSA levels are reassuring enough to avoid a biopsy. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study included 211 patients who had a second biopsy after an initial negative one. They divided them into flu-PSA (fluctuating) and si-PSA (steadily increasing). The key findings were that there were no significant differences in cancer detection rates between the two groups. However, the si-PSA group with cancer had higher Gleason scores. Also, the PSA slope didn't differ between cancer and non-cancer in the flu-PSA group.\n\nThe question is whether fluctuating PSA means you can skip a biopsy. The study shows that even with fluctuating PSA, cancer was still detected at similar rates as the steadily increasing group. So, even though the PSA fluctuates, you can't be sure there's no cancer. The fact that the cancer detection rate was the same suggests that not doing a biopsy based on fluctuating PSA might miss cancers. The higher Gleason in the si-PSA group might indicate more aggressive tumors there, but the main point is that both groups had cancers detected. Therefore, the answer should be \"no\" because fluctuating PSA isn't a reason to avoid biopsy since cancer can still be present. The study's results don't support skipping biopsies even with fluctuations.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 382,
            "completion_tokens": 305
        },
        "time_elapsed": 3.8476972579956055
    },
    {
        "realidx": "20629769",
        "question": "The National Infarct Angioplasty Project assessed the feasibility of establishing a comprehensive primary angioplasty service. We aimed to compare satisfaction at intervention hospitals offering angioplasty-based care and control hospitals offering thrombolysis-based care.\nMixed methods, with postal survey of patients and their carers, supported by semi-structured interviews.\nSurvey of 682 patients and 486 carers, and interviews with 33 patients and carers, in eight English hospitals.\nPrimary angioplasty or thrombolysis.\nSatisfaction with treatment.\nResponses were received from 595/682 patients (87%) and 418/486 carers (86%). Satisfaction with overall care was high at both intervention and control sites (78% vs. 71% patients rated their care as 'excellent', P = 0.074). Patient satisfaction was higher at intervention sites for some aspects of care such as speed of treatment (80% vs. 67%'excellent', P = 0.001). Convenience of visiting was rated lower at intervention sites by carers (12% vs. 1%'poor', P = 0.001). During interviews, carers reported that they accepted the added inconvenience of visiting primary angioplasty sites in the context of this life-saving treatment. Patient satisfaction with discharge and aftercare was lower in both treatment groups than for other aspects of care.\nIs primary angioplasty an acceptable alternative to thrombolysis?",
        "answer": "yes",
        "answer_rationale": "Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether primary angioplasty is an acceptable alternative to thrombolysis based on the study described.\n\nFirst, I need to look at the study's findings. The main points from the data are that patient satisfaction with overall care was high at both intervention (angioplasty) and control (thrombolysis) sites. The percentages were 78% vs. 71% for patients rating their care as 'excellent', but the p-value is 0.074, which is not statistically significant (since it's above 0.05). However, there were some areas where intervention sites did better, like speed of treatment (80% vs 67%, p=0.001 which is significant). \n\nOn the flip side, carers rated convenience of visiting lower at intervention sites (12% vs 1% said 'poor', which is significant). But the interviews mentioned that carers accepted this inconvenience because the treatment is life-saving. Also, patient satisfaction with discharge and aftercare was lower in both groups compared to other aspects. \n\nThe question is about acceptability. Even though there's a trend towards higher satisfaction in some areas with angioplasty and the life-saving aspect is a big plus, the overall care satisfaction wasn't statistically different. However, since the study's aim was to assess feasibility and acceptability, and the higher satisfaction in key areas like speed, plus the carers accepting the inconvenience for the treatment's benefits, it seems like the answer would lean towards yes. The study didn't find a significant difference in overall satisfaction, but the aspects that matter (like effectiveness and speed) are better, so it's acceptable. The options are yes, no, maybe. The answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 408,
            "completion_tokens": 377
        },
        "time_elapsed": 4.73984694480896
    },
    {
        "realidx": "20736672",
        "question": "To assess whether perspective-taking, which researchers in other fields have shown to induce empathy, improves patient satisfaction in encounters between student-clinicians and standardized patients (SPs).\nIn three studies, randomly assigned students (N = 608) received either a perspective-taking instruction or a neutral instruction prior to a clinical skills examination in 2006-2007. SP satisfaction was the main outcome in all three studies. Study 1 involved 245 third-year medical students from two universities. Studies 2 and 3 extended Study 1 to examine generalizability across student and SP subpopulations. Study 2 (105 physician assistant students, one university) explored the effect of perspective-taking on African American SPs' satisfaction. Study 3 (258 third-year medical students, two universities) examined the intervention's effect on students with high and low baseline perspective-taking tendencies.\nIntervention students outscored controls in patient satisfaction in all studies: Study 1: P = .01, standardized effect size = 0.16; Study 2: P = .001, standardized effect size = 0.31; Study 3: P = .009, standardized effect size = 0.13. In Study 2, perspective-taking improved African American SPs' satisfaction. In Study 3, intervention students with high baseline perspective-taking tendencies outscored controls (P = .0004, standardized effect size = 0.25), whereas those with low perspective-taking tendencies did not (P = .72, standardized effect size = 0.00).\nDoes perspective-taking increase patient satisfaction in medical encounters?",
        "answer": "maybe",
        "answer_rationale": "Perspective-taking increased patient satisfaction in all three studies, across medical schools, clinical disciplines, and racially diverse students and SPs. Perspective-taking as a means for improving patient satisfaction deserves further exploration in clinical training and practice.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether perspective-taking increases patient satisfaction in medical encounters based on the provided studies.\n\nFirst, I need to recall the details from the study description. The main outcome was SP satisfaction, and they had three studies with different groups. The key results are that in all three studies, the intervention group (those given perspective-taking instructions) scored higher than the control groups. The p-values were significant in all cases (like 0.01, 0.001, etc.), which means the results are statistically significant. The effect sizes varied but were all positive. \n\nIn Study 2, specifically with African American SPs, it worked. Study 3 showed that students with higher baseline tendencies benefited more, but even those with lower didn't show a negative effect, just no significant difference. The question is whether perspective-taking increases satisfaction. Since all studies showed improvement in the intervention group compared to control, the answer should be yes. The options are A, B, C. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 440,
            "completion_tokens": 219
        },
        "time_elapsed": 3.289562225341797
    },
    {
        "realidx": "20736887",
        "question": "A retrospective multicenter study of series of 12 patients with spinal cord sarcoidosis who underwent surgery.\nTo evaluate the postoperative outcomes of patients with cervical spinal cord sarcoidosis accompanied with compressive myelopathy and effect of decompressive surgery on the prognosis of sarcoidosis.\nSarcoidosis is a chronic, multisystem noncaseating granulomatous disease. It is difficult to differentiate spinal cord sarcoidosis from cervical compressive myelopathy. There are no studies regarding the coexistence of compressive cervical myelopathy with cervical spinal cord sarcoidosis and the effect of decompressive surgery.\nNagoya Spine Group database included 1560 cases with cervical myelopathy treated with cervical laminectomy or laminoplasty from 2001 to 2005. A total of 12 patients (0.08% of cervical myelopathy) were identified spinal cord sarcoidosis treated with decompressive surgery. As a control subject, 8 patients with spinal cord sarcoidosis without compressive lesion who underwent high-dose steroid therapy without surgery were recruited.\nIn the surgery group, enhancing lesions on magnetic resonance imaging (MRI) were mostly seen at C5-C6, coincident with the maximum compression level in all cases. Postoperative recovery rates in the surgery group at 1 week and 4 weeks were -7.4% and -1.1%, respectively. Only 5 cases had showed clinical improvement, and the condition of these 5 patients had worsened again at averaged 7.4 weeks after surgery. Postoperative oral steroid therapy was initiated at an average of 6.4 weeks and the average initial dose was 54.0 mg in the surgery group, while 51.3 mg in the nonsurgery group. The recovery rate of the Japanese Orthopedic Association score, which increased after steroid therapy, was better in the nonsurgery group (62.5%) than in the surgery group (18.6%) with significant difference (P<0.01).\nIs decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy?",
        "answer": "no",
        "answer_rationale": "The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether decompressive surgery is effective for spinal cord sarcoidosis with compressive cervical myelopathy. The study provided has some key points.\n\nFirst, the study looked at 12 patients who had surgery and 8 who didn't. The surgery group's recovery rates at 1 week and 4 weeks were negative (-7.4% and -1.1%), which suggests they got worse initially. Only 5 improved, but their condition worsened again around 7.4 weeks post-op. Then, when they started steroids, the recovery in the surgery group was only 18.6% compared to 62.5% in the non-surgery group, and that difference was statistically significant (P<0.01). \n\nSo the data here shows that the surgery group didn't do as well as the ones who just had steroids. The question is whether surgery is effective. Since the outcomes were worse in the surgery group, especially after considering steroid therapy's impact, the answer would lean towards no. The study's conclusion seems to indicate that surgery isn't effective here because the non-surgery group had better recovery rates once steroids were applied. The key point is that even after surgery, they needed steroids, and the surgery didn't add benefit. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 533,
            "completion_tokens": 284
        },
        "time_elapsed": 4.108873605728149
    },
    {
        "realidx": "20850631",
        "question": "We investigated the efficacy of ultrasound in determining megarectum and fecal load and the response to treatment in constipation and tried to specify objective criteria in this study.\nA total of 66 cases were queried and divided into 2 groups as constipated (n = 35; mean age, 6.8 \u00b1 2.9 years) and control (n = 31; mean age, 8.4 \u00b1 3.8 years) according to Rome III criteria. After the clinical evaluation, pelvic ultrasonography (US) was performed by 2 separate radiologists. The bladder capacity and the transverse rectal diameter were measured with a full bladder. Then the rectal diameter and rectal anterior wall thickness were measured, and the presence of fecal load in the rectum and sigmoid colon was recorded with an empty bladder. The examination and ultrasound were repeated after treatment for a month in these patients.\nComparison of the US measurements of the 2 radiologists performing the US tests did not show any interobserver difference (r = 0.981; P<.001). We therefore believe our results are objective and reproducible. We found a positive correlation between the rectal diameters and the age, height, weight, and bladder capacity. The posturination mean rectal diameter was thicker in the constipated group (3.02 \u00b1 1.04 cm) than in the control group (1.98 \u00b1 0.64 cm) (P<.001). The cutoff point of rectal diameter for a diagnosis of constipation was determined as 2.44 cm (71% sensitive; 76% specific; area under curve, 0.825; P<.001). The rectal anterior wall thickness and fecal load were higher in the constipated patients (P<.001). There was a significant decrease in the constipation score and fecal load after treatment for a month (P<.001), but the rectal diameter had not reached normal limits yet despite the decrease (2.71 \u00b1 0.77 cm) (P>.05).\nDiagnosis and follow-up in constipated children: should we use ultrasound?",
        "answer": "yes",
        "answer_rationale": "The use of US helps in making a correct diagnosis and in the follow-up with objective criteria and also convinces the patient and the family that the treatment needs to be continued.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about using ultrasound to determine megarectum and fecal load in children with constipation and how they respond to treatment. The main question is whether we should use ultrasound for diagnosis and follow-up in constipated children.\n\nFirst, looking at the study details: they had 66 participants split into constipated and control groups. The ultrasound measurements were done by two radiologists with high interobserver agreement (r=0.981), which suggests the measurements are reliable. That's a good point in favor of using ultrasound.\n\nThe study found that the rectal diameter was significantly larger in the constipated group compared to controls (3.02 vs 1.98 cm, p<0.001). They also determined a cutoff of 2.44 cm with decent sensitivity and specificity (71% and 76%), and an AUC of 0.825. That's a pretty good AUC, indicating the ultrasound is a useful diagnostic tool. \n\nAdditionally, after treatment, there was a significant decrease in symptoms and fecal load, but the rectal diameter didn't normalize. However, the fact that the rectal diameter decreased (from 3.02 to 2.71) but wasn't yet normal might still be useful for follow-up to monitor improvement, even if it's not back to control levels. The study's results show that ultrasound can objectively measure these parameters, which supports its use in both diagnosis and follow-up.\n\nThe options are yes, no, maybe. The study's results seem to support using ultrasound because it provides objective, reproducible measurements and helps in assessing treatment response. Even though the rectal diameter didn't reach normal after treatment, the decrease is measurable, so it's still useful. The high interobserver reliability and the established cutoff add to its validity. So the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 560,
            "completion_tokens": 401
        },
        "time_elapsed": 5.26512598991394
    },
    {
        "realidx": "20971618",
        "question": "Cutaneous infections such as impetigo contagiosum (IC), molluscum contagiosum (MC) and herpes virus infection (HI) appear to be associated with atopic dermatitis (AD), but there are no reports of concrete epidemiological evidence.\nWe evaluated the association of childhood AD with these infections by conducting a population-based cross-sectional study.\nEnrolled in this study were 1117 children aged 0-6 years old attending nursery schools in Ishigaki City, Okinawa Prefecture, Japan. Physical examination was performed by dermatologists, and a questionnaire was completed on each child's history of allergic diseases including AD, asthma, allergic rhinitis and egg allergy, and that of skin infections including IC, MC and HI, as well as familial history of AD.\nIn 913 children (AD; 132), a history of IC, MC or HI was observed in 45.1%, 19.7%, and 2.5%, respectively. Multiple logistic regression analysis revealed that the odds of having a history of IC were 1.8 times higher in AD children than in non-AD children. Meanwhile, a history of MC was significantly correlated to the male gender, but not to a personal history of AD. As for HI, we found no correlated factors in this study.\nAre lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?",
        "answer": "maybe",
        "answer_rationale": "The lifetime prevalence of IC was indeed higher in young children with a history of AD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the lifetime prevalence of impetigo, molluscum, and herpes infections is really increased in children with atopic dermatitis (AD) based on the provided study.\n\nFirst, I need to look at the study details given. The study was a population-based cross-sectional study with 1117 children. They found that among 913 children, 45.1% had a history of impetigo contagiosum (IC), 19.7% molluscum contagiosum (MC), and 2.5% herpes virus infection (HI). \n\nThe key part here is the multiple logistic regression analysis. It says that the odds of having a history of IC were 1.8 times higher in AD children compared to non-AD children. That's a significant increase, so for impetigo, the answer would lean towards yes. \n\nBut what about the other infections? For molluscum contagiosum (MC), the study found that it was significantly correlated with male gender but not with AD. So MC's prevalence isn't higher in AD kids. Then, for herpes infection (HI), no correlated factors were found in the study. \n\nThe question asks about all three infections. The options are (A) yes, (B) no, (C) maybe. The question is whether the prevalence of all three are increased, or just some. The study shows that IC is increased in AD, but MC and HI are not. Since the question is phrased as \"really increased in children having AD\" for all three, the answer would be no because not all three are increased. The correct answer would be B (no) because while impetigo is higher, the other two aren't. The question is asking if all three have increased prevalence, so the answer is no. But wait, the options are (A) yes, (B) no, (C) maybe. The question is whether the lifetime prevalence of these three infections are increased in AD children. Since only IC is higher, the answer is no because the others aren't. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 389,
            "completion_tokens": 452
        },
        "time_elapsed": 5.106355667114258
    },
    {
        "realidx": "21074975",
        "question": "The ultra high risk (UHR) for psychosis criteria have been validated in a number of studies. However, it is not known whether particular UHR criteria (Attenuated Psychotic Symptoms (APS), Brief Limited Intermittent Psychotic Symptoms (BLIPS) or Trait vulnerability criteria), or combination of criteria, is associated with a higher risk of transition to psychosis. The current study investigated this issue over a 6-month follow-up period. We hypothesised that the risk of transition would increase in the following order: Trait alone<APS alone<APS+Trait<BLIPS.\nData on UHR intake criteria and transition to psychosis status at 6 months were analysed for UHR patients seen at the PACE clinic, Orygen Youth Health between January 2000 and November 2008.\nA total of 928 new referrals were accepted into the PACE clinic over this period of whom 817 (88%) had baseline information available for analysis. The percentage of subjects who presented with APS, Trait and BLIPS were 83%, 27% and 4%, respectively. When the two intermediate groups (APS alone and APS+Trait) were combined, there was evidence that the risk of transition increased in the order of Trait alone<APS<BLIPS (p=0.024, adjusted analysis).\nUltra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?",
        "answer": "yes",
        "answer_rationale": "Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the UHR criteria for psychosis have different levels of risk for transitioning to psychosis. The study mentioned looked at three criteria: APS, BLIPS, and Trait vulnerability. The hypothesis was that the risk increases in the order Trait alone < APS alone < APS+Trait < BLIPS. \n\nThe results from the study combined the APS alone and APS+Trait groups. They found that the risk increased as Trait alone < APS (which includes both APS alone and APS+Trait) < BLIPS, and this was statistically significant (p=0.024). \n\nSo the question is whether there are different levels of risk. Since the study shows a clear increasing order of risk among the groups, the answer should be yes. The options are A, B, C. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 392,
            "completion_tokens": 179
        },
        "time_elapsed": 2.6602158546447754
    },
    {
        "realidx": "21123461",
        "question": "Weight scales as height squared, which is an observation that forms the basis of body mass index (weight/height(2)). If, and how, circumferences, including waist circumference (WC) and hip circumference (HC), scale to height remains unclear, but this is an important consideration when developing normative ranges or applying WC/height and HC/height as risk indexes.\nThe study aim was to examine the scaling of weight, WC, and HC to height in NHANES (National Health and Nutrition Examination Survey) III participants.\nSubjects were adult non-Hispanic white, non-Hispanic black, and Mexican American men (n = 7422) and nonpregnant women (n = 7999) who had complete demographic and anthropometric data. In addition to height, allometric models were developed for each measure that controlled for age, race, and self-reported health status.\nAfter adjustment for age and race, weight scaled to height in men and women with mean (\u00b1SEE) powers of 2.29 \u00b1 0.11 and 1.80 \u00b1 0.07, respectively (both P<0.001). Although univariate circumference-height models were weak or nonsignificant, when adjusted for age and race WC and HC scaled to height with powers of 0.76 \u00b1 0.08 and 0.45 \u00b1 0.05, respectively, in men and 0.80 \u00b1 0.05 and 0.53 \u00b1 0.04, respectively, in women (all P<0.001). Age- and race-adjusted incremental increases in circumferences ranged from 0.2 to 0.5 cm per centimeter increase in height. Both WC/height and HC/height scaled negatively to height in men and women, and WC/HC scaled negatively to height in women only (all P<0.001). Health status-adjusted models were similar.\nAre adult body circumferences associated with height?",
        "answer": "yes",
        "answer_rationale": "Circumferences and related ratios scale significantly to height, notably after adjustment for age and race, across subjects who are representative of the US population. These observations have implications for the clinical and epidemiologic use of these anthropometric measures and indexes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether adult body circumferences are associated with height based on the provided study.\n\nFirst, I need to recall the key points from the study summary. The study looked at weight, waist circumference (WC), and hip circumference (HC) in relation to height among adults. They used allometric models adjusted for age, race, and health status. \n\nThe results mentioned that after adjusting for age and race, weight scaled to height with exponents 2.29 for men and 1.80 for women. Then, for circumferences: WC and HC scaled to height with powers of 0.76 and 0.45 in men, and 0.80 and 0.53 in women, all with significant p-values. The study also noted that the incremental increases in circumferences were between 0.2 to 0.5 cm per cm of height. Additionally, WC/height and HC/height scaled negatively with height in both sexes, and WC/HC did so in women only. \n\nThe question is whether circumferences are associated with height. The study's adjusted models showed that WC and HC do scale with height, as the exponents (like 0.76, 0.80 etc.) indicate a relationship. Even though the univariate models were weak, after adjusting for confounders, the associations became significant. The fact that the scaling exponents are not zero and the p-values are significant (P<0.001) suggests a clear association. \n\nThe options are yes, no, maybe. Since the study found significant associations after adjustments, the answer should be yes. The \"maybe\" might be a trap if someone focuses on the univariate results, but the question probably refers to the adjusted models which are the main analysis here. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 513,
            "completion_tokens": 392
        },
        "time_elapsed": 4.8259172439575195
    },
    {
        "realidx": "21164063",
        "question": "A possible role for fondaparinux as a bridging agent in the perioperative setting is explored.\nAnticoagulation guidelines provide minimal direction on the perioperative use of fondaparinux. Fondaparinux's extended half-life of 17-21 hours complicates its use as a perioperative bridging therapy. The ideal time for discontinuation before surgery is an issue, particularly in surgeries with a high bleeding risk or in which neuraxial anesthesia is used. Guidance for perioperative bridging with fondaparinux must be derived from pharmacokinetic data, surgical prophylaxis trials, case reports, and anesthesia guidelines. Published trials used fondaparinux sodium 2.5 mg daily for venous thromboembolism prophylaxis in surgical patients, and the majority avoided its use before surgery in patients receiving neuraxial anesthesia. Three case reports cited the use of fondaparinux sodium as perioperative bridge therapy; one used a 2.5-mg dose, and the other two used a full treatment dose of 7.5 mg. Furthermore, professional anesthesia guidelines conflict in their recommendations regarding the timing of drug administration with neuraxial catheter use. For these reasons, it may be optimal to avoid fondaparinux use before surgery. In some instances, the use of low-molecular-weight heparin or inpatient use of i.v. unfractionated heparin is not possible, is contraindicated, or has limited efficacy, such as a patient with history of heparin-induced thrombocytopenia or antithrombin III deficiency. Fondaparinux may have a role in bridge therapy for these patients.\nIs there a role for fondaparinux in perioperative bridging?",
        "answer": "no",
        "answer_rationale": "The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a role for fondaparinux in perioperative bridging. The provided text gives a lot of details.\n\nFirst, the question is about bridging therapy around surgery. The passage mentions that anticoagulation guidelines don't give much direction here. Fondaparinux has a long half-life (17-21 hours), which complicates its use because you need to know when to stop it before surgery, especially for high-bleeding-risk surgeries or neuraxial anesthesia. \n\nThe text says that some trials used 2.5 mg daily for prophylaxis, but most avoided it before surgery with neuraxial anesthesia. There are three case reports where it was used as a bridge, with doses of 2.5 or 7.5 mg. However, anesthesia guidelines are conflicting about timing with neuraxial catheters. \n\nThe conclusion in the passage suggests that maybe it's best to avoid fondaparinux before surgery. But then it mentions exceptions: when other options like LMWH or UFH can't be used (like in heparin-induced thrombocytopenia or antithrombin III deficiency). So in those specific cases, fondaparinux might have a role. \n\nThe options are yes, no, maybe. The answer can't be a straightforward yes or no because the text says \"may have a role in bridge therapy for these patients\" under certain conditions. So the answer is probably \"maybe\" (C). The key here is that while generally it's advised to avoid it, there are specific scenarios where it's considered. So the correct answer is C.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 451,
            "completion_tokens": 349
        },
        "time_elapsed": 4.365076780319214
    },
    {
        "realidx": "21194998",
        "question": "Minimal access surgery (MAS) in adults is associated with less postoperative pain in comparison to conventional 'open' surgery. It is not known whether this holds true for neonates as well. Less pain would imply that opioid consumption can be reduced, which has a beneficial effect on morbidity.AIM: To evaluate potential differences in' opioid consumption between neonates undergoing thoracoscopic minimal access surgery or conventional surgery of esophageal atresia (EA) and congenital diaphragmatic hernia (CDH).\nIn this retrospective cohort study we included two controls for each MAS patient, matched on diagnosis, sex and age at surgery. Opioid dose titration was based on validated pain scores (VAS and COMFORT behaviour), applied by protocol. Cumulative opioid doses at 12, 24, 48 h and 7 days postoperatively were compared between groups with the Mann-Whitney test.\nThe study group consisted of 24 MAS patients (14 EA; 10 CDH). These were matched to 48 control patients (28 EA; 20 CDH). At none of the time points cumulative opioid (median in mg/kg (IQR)) doses significantly differed between MAS patients and controls, both with CDH and EA. For example at 24 h postoperative for CDH patients cumulative opioid doses were [0.84(0.61-1.83) MAS vs. 1.06(0.60-1.36) p=1.0] controls, For EApatients at 24 h the cumulative opioid doses were [0.48(0.30-0.75) MAS vs. 0.49(0.35-0.79) p=0.83] controls. This held true for the postoperative pain scores as well.\nDoes minimal access major surgery in the newborn hurt less?",
        "answer": "no",
        "answer_rationale": "Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether minimal access surgery (MAS) in newborns results in less pain compared to conventional open surgery. The study provided here is a retrospective cohort study comparing opioid consumption between the two groups.\n\nFirst, I need to look at the results presented. The study included 24 MAS patients matched with 48 controls. They measured cumulative opioid doses at several time points: 12, 24, 48 hours, and 7 days post-op. The key point here is that at none of these time points were there significant differences in opioid use between MAS and the control group. For example, in CDH patients at 24 hours, the median opioid doses were almost the same (0.84 vs 1.06, p=1.0), and for EA patients, the doses were 0.48 vs 0.49 with a p-value of 0.83. The p-values here are way above the typical threshold of 0.05, meaning no statistical significance. Also, the pain scores didn't differ either.\n\nThe question is whether MAS hurts less. Since the study found no significant difference in opioid use or pain scores, the answer would be that there's no evidence that MAS causes less pain in neonates. The options are (A) yes, (B) no, (C) maybe. The correct answer should be B) no, because the study's results don't support the idea of reduced pain leading to lower opioid use in MAS compared to open surgery for these conditions in newborns.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 493,
            "completion_tokens": 336
        },
        "time_elapsed": 3.978670597076416
    },
    {
        "realidx": "21214884",
        "question": "Using polymerase chain reaction techniques, we evaluated the presence of HPV infection in human breast milk collected from 21 HPV-positive and 11 HPV-negative mothers.\nOf the 32 studied human milk specimens, no 'high-risk' HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 or 58 DNA was detected.\nCan 'high-risk' human papillomaviruses (HPVs) be detected in human breast milk?",
        "answer": "no",
        "answer_rationale": "This preliminary case-control study indicates the absence of mucosal 'high-risk' HPV types in human breast milk.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. So the user is asking whether high-risk HPV can be detected in human breast milk based on a study they mentioned. The study looked at 21 HPV-positive and 11 HPV-negative mothers, making a total of 32 samples. They used PCR, which is a pretty sensitive method for detecting DNA.\n\nThe key point here is that the study found no high-risk HPV types like 16, 18, etc., in any of the breast milk specimens. The options are yes, no, or maybe. Since the study specifically states that none were detected, the answer should be B) no. But wait, I need to make sure there's no nuance. The mothers were HPV-positive, but maybe their breast milk didn't have the high-risk types. The study's result is negative, so the answer is B. The options are straightforward here. The study's conclusion directly answers the question, so there's no maybe involved. The answer must be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 214,
            "completion_tokens": 212
        },
        "time_elapsed": 2.901503801345825
    },
    {
        "realidx": "21228436",
        "question": "The purpose of this study was to evaluate the impact of a patient-safety curriculum administered during a paediatric clerkship on medical students' attitudes towards patient safety.\nMedical students viewed an online video introducing them to systems-based analyses of medical errors. Faculty presented an example of a medication administration error and demonstrated use of the Learning From Defects tool to investigate the defect. Student groups identified and then analysed medication errors during their clinical rotation using the Learning From Defects framework to organise and present their findings. Outcomes included patient safety attitudinal changes, as measured by questions derived from the Safety Attitudes Questionnaire.\n108 students completed the curriculum between July 2008 and July 2009. All student groups (25 total) identified, analysed and presented patient safety concerns. Curriculum effectiveness was demonstrated by significant changes on questionnaire items related to patient safety attitudes. The majority of students felt that the curriculum was relevant to their clinical rotation and should remain part of the clerkship.\nCan teaching medical students to investigate medication errors change their attitudes towards patient safety?",
        "answer": "yes",
        "answer_rationale": "An active learning curriculum integrated into a clinical clerkship can change learners' attitudes towards patient safety. Students found the curriculum relevant and recommended its continuation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study in question is about whether teaching medical students to investigate medication errors changes their attitudes towards patient safety. The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided. The study's purpose was to evaluate the impact of a patient-safety curriculum during a pediatric clerkship. The methods included an online video on systems-based analysis of medical errors, a faculty example of a medication error, and using the Learning From Defects tool. Students then analyzed errors during their rotations using that framework.\n\nThe outcomes measured were changes in patient safety attitudes using the Safety Attitudes Questionnaire. The results state that 108 students completed the curriculum, all 25 groups identified and presented safety concerns. The curriculum effectiveness was shown by significant changes in questionnaire items related to patient safety attitudes. Also, most students found it relevant and thought it should stay in the clerkship.\n\nThe question is whether teaching this curriculum changes their attitudes. The key points here are the significant changes in the questionnaire results and the students' positive feedback. Since the study found significant changes, that would indicate a positive effect. The answer should be yes, so option A. The other options: B is no, which contradicts the results. C is maybe, but the study's results are stated as significant, so it's more definitive. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 307,
            "completion_tokens": 291
        },
        "time_elapsed": 3.791121482849121
    },
    {
        "realidx": "21252642",
        "question": "Oncology literature cites that only 2% to 4% of patients participate in research. Up to 85% of patients are unaware that clinical trials research is being conducted at their treatment facility or that they might be eligible to participate.\nIt was hypothesized that patients' satisfaction with information regarding clinical trials would improve after targeted educational interventions, and accruals to clinical trials would increase in the year following those interventions.\nAll new patients referred to the cancer center over a 4-month period were mailed a baseline survey to assess their knowledge of clinical research. Subsequently, educational interventions were provided, including an orientation session highlighting clinical trials, a pamphlet, and a reference to a clinical trials Web site. A postintervention survey was sent to the responders of the initial survey 3 months after the initial mailing.\nPatient satisfaction with information significantly increased after the interventions. There was no increase in subsequent enrollment in clinical trials. Patients who indicated an inclination to participate in clinical trials tended to have greater satisfaction with the information they received.\nDoes increased patient awareness improve accrual into cancer-related clinical trials?",
        "answer": "no",
        "answer_rationale": "A set of educational interventions designed for cancer patients significantly improved their satisfaction with information on clinical research, but did not improve clinical trial enrollment of these participants as of 1 year after the study.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether increased patient awareness improves accrual into cancer-related clinical trials based on the study described.\n\nFirst, I need to recall the details from the scenario. The study had two main parts: a baseline survey and a post-intervention survey. The interventions included an orientation, pamphlets, and a website reference. The results showed that patient satisfaction with the information increased significantly after the interventions. However, there was no increase in actual enrollment in the trials. But it's noted that those who were inclined to participate had higher satisfaction.\n\nThe key point here is the difference between awareness/satisfaction and actual enrollment. The question is whether awareness (which leads to better satisfaction) translates to more people joining trials. The study's result was that even though satisfaction went up, enrollment didn't. So even though aware patients were more satisfied, their actions (enrollment) didn't change. \n\nThe options are yes, no, maybe. The study's conclusion here is that despite improved awareness (as indicated by satisfaction), accrual didn't increase. So the answer would be no, because the data shows no increase. But wait, the last sentence says that those inclined to participate had higher satisfaction. Maybe there's a correlation but not causation leading to enrollment. The study's hypothesis was that accrual would increase, but it didn't. Therefore, the answer should be B) no. Because the result didn't show an increase in enrollment despite the awareness interventions. The question is whether increased awareness (from the interventions) leads to more accrual. Since the answer is no, the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 311,
            "completion_tokens": 336
        },
        "time_elapsed": 4.2419044971466064
    },
    {
        "realidx": "21256734",
        "question": "A secondary analysis of one-hundred-sixty-seven patients referred for treatment of cancer-related pain was conducted. Pain intensity at admission was recorded and patients were divided in three categories of pain intensity: mild, moderate and severe. Patients were offered a treatment with opioid dose titration, according to department policy. Data regarding opioid doses and pain intensity were collected after dose titration was completed. Four levels of opioid response were considered: (a) good pain control, with minimal opioid escalation and without relevant adverse effects; (b) good pain control requiring more aggressive opioid escalation, for example doubling the doses in four days; (c) adequate pain control associated with the occurrence of adverse effects; (d) poor pain control with adverse effects.\nSeventy-six, forty-four, forty-one and six patients showed a response a, b, c, and d, respectively. No correlation between baseline pain intensity categories and opioid response was found. Patients with response 'b' and 'd' showed higher values of OEImg.\nDoes pain intensity predict a poor opioid response in cancer patients?",
        "answer": "no",
        "answer_rationale": "Baseline pain intensity does not predict the outcome after an appropriate opioid titration. It is likely that non-homogeneous pain treatment would have biased the outcome of a previous work.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pain intensity predicts a poor opioid response in cancer patients based on the study described.\n\nFirst, I need to recall the details from the question. The study had 167 patients divided into three pain intensity categories: mild, moderate, and severe. They were given opioid treatment, and their responses were categorized into four levels (a to d). The key point here is that the analysis found no correlation between baseline pain intensity categories and opioid response. \n\nThe question is specifically asking if pain intensity predicts a poor response. The options are yes, no, or maybe. The study's results state there was no correlation between the initial pain levels and how they responded to opioids. Even though the patients with responses b and d (which include more aggressive escalation and poor control with adverse effects) had higher OEImg values, the baseline pain intensity wasn't linked to these outcomes. \n\nSo since there's no correlation found between pain intensity at admission and the opioid response categories, the answer should be no. The fact that they checked the three categories against the four responses and found no connection means pain intensity isn't a predictor here. The OEImg part might be a distractor, but since the question is about prediction based on pain intensity, the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 306,
            "completion_tokens": 269
        },
        "time_elapsed": 3.2368736267089844
    },
    {
        "realidx": "21342862",
        "question": "To evaluate the construct validity of the Turkish version of the EQ-5D in patients with acute coronary syndrome.\nThe study was conducted as a cross-sectional study at the Trakya University Hospital between February and May 2008. All patients completed the Turkish version of the EQ-5D and MacNew heart-related quality of life scale. Construct validity of the EQ-5D was assessed according to relationships with MacNew subscales by using Spearman rank correlation and multiple linear regression analyses.\nOne hundred and twenty-two patients responded to the instruments. Mean age was 62.9\u00b19.3 years and male gender (88 or 72.1%) was dominant. Mean score of the EQ-5D index was 0.79\u00b10.32, while the global score of MacNew was 5.01\u00b11.16. The correlation coefficients of the EQ-5D index score with the MacNew subscales ranged from 0.557 to 0.721, with EQ-5D VAS score ranging from 0.297 to 0.484 (p<0.001 for all of them). According to the stepwise regression model MacNew global score was found to be significantly effective factor on EQ-5D index score (\u03b2 =0.188; 95% CI: 0.152-0.224; p<0.001).\nIs EQ-5D a valid quality of life instrument in patients with acute coronary syndrome?",
        "answer": "yes",
        "answer_rationale": "The Turkish version of the EQ-5D-based utility score seems to be a valid instrument in the assessment of quality of life studies in patients with acute coronary syndrome.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the EQ-5D is a valid quality of life instrument for patients with acute coronary syndrome based on the provided study.\n\nFirst, I need to recall what construct validity means. Construct validity refers to whether a test measures the theoretical construct it's intended to measure. In this case, the EQ-5D's construct validity is being evaluated by its correlation with the MacNew scale, which is another measure of heart-related quality of life.\n\nThe study used Spearman rank correlation and multiple linear regression. The correlation coefficients between EQ-5D index and MacNew subscales were between 0.557 and 0.721, which are moderate to strong positive correlations. The p-values were all less than 0.001, indicating statistical significance. Also, in the regression model, the MacNew global score was a significant predictor of the EQ-5D index (\u03b2=0.188, p<0.001). \n\nHigh correlation coefficients suggest that as one scale's scores increase, the other does too, which is good for validity. The fact that the MacNew score significantly affects the EQ-5D index in regression supports that they are measuring related constructs. Since the correlations are strong and statistically significant, this would indicate that the EQ-5D is indeed capturing the same underlying construct as the MacNew, which is heart-related quality of life. \n\nTherefore, the answer should be \"yes\" because the study's results support the construct validity of the EQ-5D in this population. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 419,
            "completion_tokens": 346
        },
        "time_elapsed": 4.334107875823975
    },
    {
        "realidx": "21346501",
        "question": "This study was designed to determine whether preclerkship performance examinations could accurately identify medical students at risk for failing a senior clinical performance examination (CPE).\nThis study used a retrospective case-control, multiyear design, with contingency table analyses, to examine the performance of 412 students in the classes of 2005 to 2010 at a midwestern medical school. During their second year, these students took four CPEs that each used three standardized patient (SP) cases, for a total of 12 cases. The authors correlated each student's average year 2 case score with the student's average case score on a senior (year 4) CPE. Contingency table analysis was carried out using performance on the year 2 CPEs and passing/failing the senior CPE. Similar analyses using each student's United States Medical Licensing Examination (USMLE) Step 1 scores were also performed. Sensitivity, specificity, odds ratio, and relative risk were calculated for two year 2 performance standards.\nStudents' low performances relative to their class on the year 2 CPEs were a strong predictor that they would fail the senior CPE. Their USMLE Step 1 scores also correlated with their performance on the senior CPE, although the predictive values for these scores were considerably weaker.\nCan students' scores on preclerkship clinical performance examinations predict that they will fail a senior clinical performance examination?",
        "answer": "yes",
        "answer_rationale": "Under the conditions of this study, preclerkship (year 2) CPEs strongly predicted medical students at risk for failing a senior CPE. This finding opens the opportunity for remediation of deficits prior to or during clerkships.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether preclerkship exams can predict if a student will fail their senior CPE. The question is asking if the scores on these preclerkship exams can predict failure in the senior exam.\n\nLooking at the study details: They used data from 412 students over several years. The students took four CPEs in their second year with standardized patients, totaling 12 cases. They compared the average scores from year 2 with their senior year CPE scores. They also looked at USMLE Step 1 scores. \n\nThe key result mentioned is that low performance in year 2 CPEs was a strong predictor of failing the senior CPE. The USMLE Step 1 scores correlated but were weaker. The question is specifically about the preclerkship (which would be the year 2 exams here) predicting failure. \n\nThe options are yes, no, maybe. Since the study states that the year 2 performance was a strong predictor, the answer should be yes. The USMLE part is additional but the main point here is the preclerkship exams. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 385,
            "completion_tokens": 246
        },
        "time_elapsed": 3.2594852447509766
    },
    {
        "realidx": "21361755",
        "question": "Two common causes of cervical myelopathy include degenerative stenosis and ossification of the posterior longitudinal ligament (OPLL). It has been postulated that patients with OPLL have more complications and worse outcomes than those with degenerative stenosis. The authors sought to compare the surgical results of laminoplasty in the treatment of cervical stenosis with myelopathy due to either degenerative changes or segmental OPLL.\nThe authors conducted a retrospective review of 40 instrumented laminoplasty cases performed at a single institution over a 4-year period to treat cervical myelopathy without kyphosis. Twelve of these patients had degenerative cervical stenotic myelopathy ([CSM]; degenerative group), and the remaining 28 had segmental OPLL (OPLL group). The 2 groups had statistically similar demographic characteristics and number of treated levels (mean 3.9 surgically treated levels; p>0.05). The authors collected perioperative and follow-up data, including radiographic results.\nThe overall clinical follow-up rate was 88%, and the mean clinical follow-up duration was 16.4 months. The mean radiographic follow-up rate was 83%, and the mean length of radiographic follow-up was 9.3 months. There were no significant differences in the estimated blood loss (EBL) or length of hospital stay (LOS) between the groups (p>0.05). The mean EBL and LOS for the degenerative group were 206 ml and 3.7 days, respectively. The mean EBL and LOS for the OPLL group were 155 ml and 4 days, respectively. There was a statistically significant improvement of more than one grade in the Nurick score for both groups following surgery (p<0.05). The Nurick score improvement was not statistically different between the groups (p>0.05). The visual analog scale (VAS) neck pain scores were similar between groups pre- and postoperatively (p>0.05). The complication rates were not statistically different between groups either (p>0.05). Radiographically, both groups lost extension range of motion (ROM) following laminoplasty, but this change was not statistically significant (p>0.05).\nLaminoplasty outcomes: is there a difference between patients with degenerative stenosis and those with ossification of the posterior longitudinal ligament?",
        "answer": "no",
        "answer_rationale": "Patients with CSM due to either degenerative disease or segmental OPLL have similar perioperative results and neurological outcomes with laminoplasty. The VAS neck pain scores did not improve significantly with laminoplasty for either group. Laminoplasty may limit extension ROM.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a difference in laminoplasty outcomes between patients with degenerative stenosis and those with OPLL. The study compared these two groups.\n\nFirst, I need to look at the key results from the study provided. The question mentions that the authors found no significant differences in several factors. The EBL (estimated blood loss) and LOS (length of stay) were similar between groups, though the numbers are slightly different, the p-values are above 0.05, so not statistically significant. \n\nThe Nurick score improvement was significant in both groups, but the improvement wasn't different between the two. So both groups improved similarly. The VAS scores for neck pain were also similar before and after surgery in both groups. Complication rates didn't differ either. Even the radiographic outcomes like extension ROM loss weren't statistically different.\n\nThe options are (A) yes, (B) no, (C) maybe. The study's conclusion based on the data here shows that in terms of clinical outcomes (Nurick score improvement), complications, blood loss, hospital stay, and radiographic measures, there were no statistically significant differences between the two groups. Therefore, the answer should be B) no, there's no difference.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 597,
            "completion_tokens": 269
        },
        "time_elapsed": 3.355419874191284
    },
    {
        "realidx": "21394762",
        "question": "To investigate the significance of pelvic pain and its association with defecatory symptoms in women with pelvic organ prolapse (POP).\nThis is a cross sectional study of 248 women with stage II POP or greater. Women were stratified into \"pain\" and \"no-pain\" groups based on their response to a question on the Pelvic Floor Distress Inventory short form. Associations between patient demographics, exam findings and responses to validated questionnaires were evaluated.\nIn women with POP, defecatory symptoms are significantly more common in women with pelvic pain including straining with bowel movement (OR 2.4, 95% CI 1.3, 4.6), sense of incomplete emptying (OR 4.4, 95% CI 2.3, 8.2), pain with bowel movement (OR 5.3, 95% CI 1.2, 23.0) and splinting with bowel movement (OR 3.8, 95% CI 2.0, 7.5).\nIs pelvic pain associated with defecatory symptoms in women with pelvic organ prolapse?",
        "answer": "yes",
        "answer_rationale": "In women with POP, the symptom of pelvic pain is associated with the presence of defecatory symptoms.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pelvic pain is associated with defecatory symptoms in women with pelvic organ prolapse (POP). The provided information is from a study involving 248 women with stage II POP or worse. They were divided into \"pain\" and \"no-pain\" groups using a questionnaire.\n\nThe key part here is the results section. It states that defecatory symptoms are significantly more common in women with pelvic pain. The specific symptoms listed have odds ratios (OR) with confidence intervals that don't include 1, which means the associations are statistically significant. For example, straining has an OR of 2.4, and the 95% CI is 1.3 to 4.6. Since the CI doesn't include 1, this indicates a significant association. The same applies to the other symptoms like incomplete emptying (OR 4.4), pain during bowel movement (OR 5.3), and splinting (OR 3.8). All these ORs are greater than 1, suggesting that having pelvic pain increases the odds of these defecatory issues.\n\nThe question is straightforward: does pelvic pain correlate with these symptoms? The study's results clearly show a significant association. The options are yes, no, maybe. Since the study found statistically significant higher occurrences in the pain group, the answer should be \"yes\". The \"maybe\" might be a trap if there were inconclusive results, but here the data supports a clear link. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 330,
            "completion_tokens": 325
        },
        "time_elapsed": 4.102588415145874
    },
    {
        "realidx": "21420186",
        "question": "Sporadic data present in literature report how preterm birth and low birth weight are risk factors for the development of cardiovascular diseases in later life. High levels of asymmetric dimethylarginine (ADMA), a strong inhibitor of nitric oxide synthesis, are associated with the future development of adverse cardiovascular events and cardiac death.\n1) to verify the presence of a statistically significant difference between ADMA levels in young adults born preterm at extremely low birth weight (<1000 g; ex-ELBW) and those of a control group of healthy adults born at term (C) and 2) to seek correlations between ADMA levels in ex-ELBW and anthropometric and clinical parameters (gender, chronological age, gestational age, birth weight, and duration of stay in Neonatal Intensive Care Unit).\nThirty-two ex-ELBW subjects (11 males [M] and 21 females [F], aged 17-29years, mean age 22.2 \u00b1 2.3 years) were compared with 25 C (7 M and 18F). ADMA levels were assessed by high-performance liquid chromatography with highly sensitive laser fluorescent detection.\nADMA levels were reduced in ex-ELBW subjects compared to C (0.606+0.095 vs 0.562+0.101 \u03bcmol/L, p<0.05), and significantly correlated inversely with gestational age (r=-0.61, p<0.00001) and birth weight (r=-0.57, p<0.0002).\nCould ADMA levels in young adults born preterm predict an early endothelial dysfunction?",
        "answer": "yes",
        "answer_rationale": "Our findings reveal a significant decrease in ADMA levels of ex-ELBW subjects compared to C, underlining a probable correlation with preterm birth and low birth weight. Taken together, these results may underlie the onset of early circulatory dysfunction predictive of increased cardiovascular risk.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether ADMA levels in young adults born preterm can predict early endothelial dysfunction. The study mentioned found that ex-ELBW individuals had lower ADMA levels compared to the control group. Also, ADMA was inversely correlated with gestational age and birth weight.\n\nHmm, the question is about prediction. Since ADMA is an inhibitor of nitric oxide, lower levels might mean less inhibition, which could be protective. But wait, the literature says high ADMA is linked to cardiovascular issues. So lower ADMA here might seem better, but the study's results are the opposite of what's typically expected. \n\nThe study's results show that preterm individuals have lower ADMA. But the original premise states that high ADMA is a risk factor. So maybe lower ADMA here isn't predicting endothelial dysfunction? But the question is whether it can predict it. The study found correlations with gestational age and birth weight. Since endothelial dysfunction is related to cardiovascular risks, and ADMA levels are associated with those, even if lower here, maybe the inverse correlation suggests that those with lower birth weight (more preterm) have lower ADMA. But how does that link to endothelial dysfunction?\n\nWait, the study's conclusion might be that lower ADMA in preterm individuals could indicate something different. Since ADMA is a marker, even if lower, maybe other factors are at play. The question is whether ADMA levels can predict early endothelial dysfunction. The study found a correlation between ADMA and gestational age/birth weight. Since endothelial dysfunction is a precursor to cardiovascular issues, and ADMA is a known marker, even if the direction is opposite, the presence of a correlation might still suggest that ADMA levels are a predictive factor. \n\nThe options are yes, no, maybe. The study shows a significant difference and correlations. So even though the direction is unexpected, the answer might be yes because there's a correlation. Alternatively, since lower ADMA is associated with preterm (and lower ADMA is not the high-risk factor), maybe it's not predictive. But the question is whether it can predict, not whether it's higher. The study's data shows that ADMA levels are associated with those parameters, so they could be used as a predictor. Therefore, the answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 448,
            "completion_tokens": 487
        },
        "time_elapsed": 6.402403831481934
    },
    {
        "realidx": "21431987",
        "question": "This study was designed to determine prospectively whether the systematic use of PET/CT associated with conventional techniques could improve the accuracy of staging in patients with liver metastases of colorectal carcinoma. We also assessed the impact on the therapeutic strategy.\nBetween 2006 and 2008, 97 patients who were evaluated for resection of LMCRC were prospectively enrolled. Preoperative workup included multidetector-CT (MDCT) and PET/CT. In 11 patients with liver steatosis or iodinated contrast allergy, MR also was performed. Sixty-eight patients underwent laparotomy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive values for hepatic and extrahepatic staging of MDCT and PET-CT were calculated.\nIn a lesion-by-lesion analysis of the hepatic staging, the sensitivity of MDCT/RM was superior to PET/CT (89.2 vs. 55%, p\u00a0<\u00a00.001). On the extrahepatic staging, PET/CT was superior to MDCT/MR only for the detection of locoregional recurrence (p\u00a0=\u00a00.03) and recurrence in uncommon sites (p\u00a0=\u00a00.016). New findings in PET/CT resulted in a change in therapeutic strategy in 17 patients. However, additional information was correct only in eight cases and wrong in nine patients.\nPreoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?",
        "answer": "no",
        "answer_rationale": "PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing PET/CT and MDCT (with MR in some cases) for staging liver metastases from colorectal cancer. The main question is whether PET/CT adds value to MDCT.\n\nFirst, looking at the results. For hepatic staging, MDCT/MR had higher sensitivity (89.2% vs 55% for PET/CT), which is a big difference. That means MDCT is better at detecting lesions in the liver. So PET/CT isn't better here. \n\nFor extrahepatic staging, PET/CT was only better in detecting locoregional recurrence and uncommon sites. But those are specific areas. The study mentions that PET/CT led to a change in therapy in 17 patients, but only 8 were correct and 9 were wrong. So more harm than help in some cases. \n\nThe question is whether PET/CT adds something. The key points are that MDCT is better for liver lesions, and while PET/CT has some advantages in certain extrahepatic areas, the overall impact on therapy was mixed. Since the study shows that in many cases the PET/CT changes were incorrect, it might not be adding significant benefit. The answer would lean towards 'no' because the main staging (hepatic) is better with MDCT, and the added info from PET/CT isn't consistently beneficial. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 418,
            "completion_tokens": 303
        },
        "time_elapsed": 3.616081953048706
    },
    {
        "realidx": "21459725",
        "question": "Xanthogranulomatous cholecystitis (XGC) is an uncommon variant of chronic cholecystitis, characterized by marked thickening of the gallbladder wall and dense local adhesions. It often mimics a gallbladder carcinoma (GBC), and may coexist with GBC, leading to a diagnostic dilemma. Furthermore, the premalignant nature of this entity is not known. This study was undertaken to assess the p53, PCNA and beta-catenin expression in XGC in comparison to GBC and chronic inflammation.\nSections from paraffin-embedded blocks of surgically resected specimens of GBC (69 cases), XGC (65), chronic cholecystitis (18) and control gallbladder (10) were stained with the monoclonal antibodies to p53 and PCNA, and a polyclonal antibody to beta-catenin. p53 expression was scored as the percentage of nuclei stained. PCNA expression was scored as the product of the percentage of nuclei stained and the intensity of the staining (1-3). A cut-off value of 80 for this score was taken as a positive result. Beta-catenin expression was scored as type of expression-membranous, cytoplasmic or nuclear staining.\np53 mutation was positive in 52% of GBC cases and 3% of XGC, but was not expressed in chronic cholecystitis and control gallbladders. p53 expression was lower in XGC than in GBC (P<0.0001). PCNA expression was seen in 65% of GBC cases and 11% of XGC, but not in chronic cholecystitis and control gallbladders. PCNA expression was higher in GBC than XGC (P=0.0001), but there was no significant difference between the XGC, chronic cholecystitis and control gallbladder groups. Beta-catenin expression was positive in the GBC, XGC, chronic cholecystitis and control gallbladder groups. But the expression pattern in XGC, chronic cholecystitis and control gallbladders was homogenously membranous, whereas in GBC the membranous expression pattern was altered to cytoplasmic and nuclear.\nXanthogranulomatous cholecystitis: a premalignant condition?",
        "answer": "no",
        "answer_rationale": "The expression of p53, PCNA and beta-catenin in XGC was significantly different from GBC and similar to chronic cholecystitis, thus indicating the inflammatory nature of XGC and may not support a premalignant nature of the lesion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether xanthogranulomatous cholecystitis (XGC) is a premalignant condition. The options are yes, no, or maybe. \n\nFirst, I need to recall what premalignant means. Premalignant conditions are those that have a higher risk of progressing to cancer. So, the question is whether XGC has such a risk based on the study provided.\n\nLooking at the study details: They compared XGC with gallbladder carcinoma (GBC), chronic cholecystitis, and controls. They looked at p53, PCNA, and beta-catenin expressions. \n\nThe results show that p53 mutation was positive in 52% of GBC but only 3% in XGC. PCNA was higher in GBC (65%) versus XGC (11%). Both XGC and chronic cholecystitis had low PCNA similar to controls. Beta-catenin was present in all groups, but the pattern differed: in GBC, it was cytoplasmic/nuclear, while in XGC and others, it was membranous. \n\nThe key here is whether XGC shows any signs that suggest it's on the path to cancer. Since p53 and PCNA, which are markers associated with cell proliferation and cancer, are much lower in XGC compared to GBC, that suggests XGC isn't showing the same malignant features. Also, the beta-catenin pattern in XGC is normal (membranous) like in non-cancerous tissues, unlike GBC. \n\nThe study mentions that the premalignant nature isn't known, but the data here shows that XGC's markers are more similar to chronic inflammation and controls than to GBC. So, there's no strong evidence here that XGC is progressing to cancer. Therefore, the answer would be \"no\" because the study's results don't support it being premalignant. The fact that it can coexist with GBC might be coincidental or due to similar presentation, but the molecular markers don't indicate a premalignant state.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 596,
            "completion_tokens": 449
        },
        "time_elapsed": 5.768265724182129
    },
    {
        "realidx": "21481154",
        "question": "Our hypothesis is that the adoption of Department of Health (DH) guidance has led to an improvement in outcome in gynaecological cancer survival.\nIn 1999 the DH in England introduced the Improving Outcomes in Gynaecological Cancer guidance, advising case management by multidisciplinary teams with surgical concentration in specialist hospitals. This guidance was rapidly adopted in the East of England, with a population of 2.5 million.\nThe population of the Anglia Cancer Network was approximately 2.3 million.\nFrom 1996 to 2003, details of 3406 cases of gynaecological cancer were identified in the Anglia region of England. Survival analysis was performed by Cox proportional hazards regression, relative to cases diagnosed in 1996.\nPrimary endpoint was survival.\nThe survival rates for cases diagnosed between 1996 and 1999 were broadly the same across the time period, with a marked improvement taking place in 2000, and continuing to 2003 (HR 0.71, 95% CI 0.64-0.79, comparing 2000-03 with 1996-99 diagnoses), for all gynaecological sites combined. Adjustment for treatments or method of case follow-up did not attenuate these improvements. There was a concurrent change towards major surgery being performed in specialist centres from 2000.\nImprovements in survival of gynaecological cancer in the Anglia region of England: are these an effect of centralisation of care and use of multidisciplinary management?",
        "answer": "yes",
        "answer_rationale": "The adoption of the 1999 guidance on gynaecological cancer, which included multidisciplinary case management and centralisation of surgery, resulted in a marked step-change improvement in survival of gynaecological cancer in an area of eastern England in 2000.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the improvement in survival rates for gynaecological cancers in the Anglia region is due to centralizing care and using multidisciplinary teams as per the DH guidance.\n\nFirst, the background info says that the DH introduced the guidance in 1999, which was quickly adopted in the East of England. The study looked at data from 1996 to 2003. The key points here are the timing: the guidance was implemented in 1999, and the survival improvements started in 2000 and continued until 2003. The hazard ratio (HR) of 0.71 with a significant confidence interval suggests a statistically significant improvement. \n\nThe study also mentions that adjusting for treatments or follow-up methods didn't change the results, which implies that the effect is likely due to the intervention (centralization and multidisciplinary care) rather than other factors. Additionally, there was a shift towards major surgeries being done in specialist centers from 2000, aligning with the guidance's recommendations. \n\nThe question is whether this improvement is an effect of those changes. Since the timing matches (implementation in '99, effect starts in 2000), and the study controlled for other variables, it's reasonable to infer causation here. The options are yes, no, maybe. The data supports a positive answer, so the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 431,
            "completion_tokens": 309
        },
        "time_elapsed": 4.063985347747803
    },
    {
        "realidx": "21645374",
        "question": "Programmed cell death (PCD) is the regulated death of cells within an organism. The lace plant (Aponogeton madagascariensis) produces perforations in its leaves through PCD. The leaves of the plant consist of a latticework of longitudinal and transverse veins enclosing areoles. PCD occurs in the cells at the center of these areoles and progresses outwards, stopping approximately five cells from the vasculature. The role of mitochondria during PCD has been recognized in animals; however, it has been less studied during PCD in plants.\nThe following paper elucidates the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis. A single areole within a window stage leaf (PCD is occurring) was divided into three areas based on the progression of PCD; cells that will not undergo PCD (NPCD), cells in early stages of PCD (EPCD), and cells in late stages of PCD (LPCD). Window stage leaves were stained with the mitochondrial dye MitoTracker Red CMXRos and examined. Mitochondrial dynamics were delineated into four categories (M1-M4) based on characteristics including distribution, motility, and membrane potential (\u0394\u03a8m). A TUNEL assay showed fragmented nDNA in a gradient over these mitochondrial stages. Chloroplasts and transvacuolar strands were also examined using live cell imaging. The possible importance of mitochondrial permeability transition pore (PTP) formation during PCD was indirectly examined via in vivo cyclosporine A (CsA) treatment. This treatment resulted in lace plant leaves with a significantly lower number of perforations compared to controls, and that displayed mitochondrial dynamics similar to that of non-PCD cells.\nDo mitochondria play a role in remodelling lace plant leaves during programmed cell death?",
        "answer": "yes",
        "answer_rationale": "Results depicted mitochondrial dynamics in vivo as PCD progresses within the lace plant, and highlight the correlation of this organelle with other organelles during developmental PCD. To the best of our knowledge, this is the first report of mitochondria and chloroplasts moving on transvacuolar strands to form a ring structure surrounding the nucleus during developmental PCD. Also, for the first time, we have shown the feasibility for the use of CsA in a whole plant system. Overall, our findings implicate the mitochondria as playing a critical and early role in developmentally regulated PCD in the lace plant.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether mitochondria play a role in remodelling lace plant leaves during programmed cell death (PCD). The question is based on the provided passage, so I need to go through the details given there.\n\nFirst, the passage explains that PCD in the lace plant creates perforations in the leaves. The study divided cells into three areas: NPCD (no PCD), EPCD (early), and LPCD (late). They looked at mitochondrial dynamics using MitoTracker staining and categorized them into M1-M4. The TUNEL assay showed fragmented nuclear DNA in a gradient across these stages, which suggests that as PCD progresses, DNA fragmentation increases, possibly linked to mitochondrial changes.\n\nThen, they mention that chloroplasts and transvacuolar strands were examined, but the key part here is the cyclosporine A (CsA) treatment. CsA is known to inhibit the mitochondrial permeability transition pore (PTP). The result was that treated leaves had fewer perforations and mitochondria similar to non-PCD cells. Since PTP inhibition led to reduced perforations, this implies that PTP (and thus mitochondria) are involved in the PCD process. If blocking PTP stops or reduces PCD, then mitochondria must play a role. \n\nThe options are yes, no, maybe. The study's results with CsA suggest that mitochondria are indeed involved because interfering with their function (via PTP) altered the outcome. The answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 475,
            "completion_tokens": 324
        },
        "time_elapsed": 4.040913343429565
    },
    {
        "realidx": "21658267",
        "question": "There are three main service delivery channels: clinical services, outreach, and family and community. To determine which delivery channels are associated with the greatest reductions in under-5 mortality rates (U5MR), we used data from sequential population-based surveys to examine the correlation between changes in coverage of clinical, outreach, and family and community services and in U5MR for 27 high-burden countries.\nHousehold survey data were abstracted from serial surveys in 27 countries. Average annual changes (AAC) between the most recent and penultimate survey were calculated for under-five mortality rates and for 22 variables in the domains of clinical, outreach, and family- and community-based services. For all 27 countries and a subset of 19 African countries, we conducted principal component analysis to reduce the variables into a few components in each domain and applied linear regression to assess the correlation between changes in the principal components and changes in under-five mortality rates after controlling for multiple potential confounding factors.\nAAC in under 5-mortality varied from 6.6% in Nepal to -0.9% in Kenya, with six of the 19 African countries all experiencing less than a 1% decline in mortality. The strongest correlation with reductions in U5MR was observed for access to clinical services (all countries: p = 0.02, r\u00b2 = 0.58; 19 African countries p<0.001, r\u00b2 = 0.67). For outreach activities, AAC U5MR was significantly correlated with antenatal care and family planning services, while AAC in immunization services showed no association. In the family- and community services domain, improvements in breastfeeding were associated with significant changes in mortality in the 30 countries but not in the African subset; while in the African countries, nutritional status improvements were associated with a significant decline in mortality.\nDo improvements in outreach, clinical, and family and community-based services predict improvements in child survival?",
        "answer": "yes",
        "answer_rationale": "Our findings support the importance of increasing access to clinical services, certain outreach services and breastfeeding and, in Africa, of improving nutritional status. Integrated programs that emphasize these services may lead to substantial mortality declines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether improvements in outreach, clinical, and family and community-based services predict improvements in child survival. The options are yes, no, maybe.\n\nFirst, I need to look back at the provided study details. The study examined three service delivery channels: clinical, outreach, and family/community. They analyzed data from 27 countries, including a subset of 19 African countries. The key findings were that access to clinical services had the strongest correlation with reductions in under-5 mortality. The p-values and r-squared values indicate statistical significance. \n\nFor outreach, the study mentions that antenatal care and family planning were correlated, but immunizations weren't. So some outreach aspects help. The family/community domain showed breastfeeding improvements linked to mortality in all countries but not just the African subset, and in Africa, nutrition improvements were significant. \n\nThe question is whether all three services predict improvements. Since clinical had the strongest link, and some parts of outreach and family/community also showed positive correlations in certain regions, the answer would be yes. The study's results support that improvements in these areas do correlate with lower mortality, even if some services within the categories didn't. The options are yes, no, maybe. The correct answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 498,
            "completion_tokens": 268
        },
        "time_elapsed": 3.5059850215911865
    },
    {
        "realidx": "21689015",
        "question": "Canine-assisted therapy has been receiving growing attention as a means of aiding children with autism spectrum disorder (ASD). Yet, only limited studies have been done and a great deal of literature related to this intervention is anecdotal. The present study aims at providing additional quantitative evidence on the potential of dogs to positively modulate the behavior of children with ASD.SETTINGS/\nA 12-year-old boy diagnosed with ASD was exposed, at his usual treatment location (the Portuguese Association for Developmental Disorders and Autism at Vila Nova de Gaia, Portugal), to the following treatment conditions: (1) one-to-one structured activities with a therapist assisted by a certified therapy dog, and (2) one-to-one structured activities with the same therapist alone (as a control). To accurately assess differences in the behavior of the participant between these treatment conditions, the therapist followed a strict research protocol. The behavior of the participant was continuously video-recorded during both treatment conditions for further analysis and comparison. Treatment outcomes: In the presence of the dog, the participant exhibited more frequent and longer durations of positive behaviors (such as smiling and positive physical contacting) as well as less frequent and shorter durations of negative behaviors (such as aggressive manifestations).\nCan dogs prime autistic children for therapy?",
        "answer": "yes",
        "answer_rationale": "These findings are in accordance with previous experimental work and provide additional support for the assertion that dogs can prime autistic children for therapy. Ultimately, this study may contribute toward a change for full acceptance of canine-assisted therapy programs within the medical milieu. Additional studies using a similar research protocol on more autistic children will certainly help professionals to work on the most effective methods to individually serve this population through canine-assisted interventions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether dogs can prime autistic children for therapy based on the provided study. The options are yes, no, or maybe.\n\nFirst, I need to understand what the study found. The study involved a 12-year-old boy with ASD. They compared two conditions: therapy with a dog present and therapy without the dog. The results showed that when the dog was there, the child had more positive behaviors (like smiling and physical contact) and fewer negative ones (like aggression). \n\nThe question is whether this means dogs \"prime\" the children for therapy. Priming here likely means the dog helps make the therapy more effective or easier. The study's results are positive for the presence of the dog. The child's behavior improved in the sessions with the dog. \n\nBut wait, the options are yes, no, maybe. The study is a single case, right? It's just one participant. The user mentioned that previous literature is limited and anecdotal. The study adds quantitative data but only on one child. So, while the results are positive here, can we generalize? The question is asking if dogs can prime, so based on this study, the answer would be yes for this case, but since it's a single case, maybe the answer is \"maybe\" because more studies are needed. However, the options don't have a \"maybe\" as a definitive answer. Wait, the options are (A) yes, (B) no, (C) maybe. The study's results support that in this case, the dog did help. The question is phrased as \"Can dogs prime...\" which is a general question. The study provides evidence that in this instance, it worked. But since it's a single case, the answer might be \"maybe\" because it's not conclusive. However, the options might expect \"yes\" because the study's outcome is positive. The question is from the study's perspective. The study's conclusion would suggest that dogs can have a positive effect, so the answer would be yes. But the user also mentioned that the literature is limited and anecdotal, so the correct answer might be \"maybe\" because the study is just one example. Hmm. The options are (A) yes, (B) no, (C) maybe. The study's results are positive, so the answer is A. But maybe the question is tricky because it's only one child. However, the question is asking based on the given information",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 343,
            "completion_tokens": 512
        },
        "time_elapsed": 6.253441572189331
    },
    {
        "realidx": "21712147",
        "question": "Combining various antiretroviral agents into one single dosage form has been a strategy to reduce pill burden and enhance medication adherence among human immunodeficiency virus /AIDS (HIV/AIDS) patients.\nThis is a cost-utility study from a health care system's perspective comparing coformulated fixed dose (FXD) strategy versus multiple free dose combination (FRC) in antiretroviral therapy.\nThe Medical Expenditure Panel Survey (MEPS) was used to identify HIV/AIDS patients with \u22652 active antiretroviral medications. Patients on FXD were matched in 1:1 ratio with the FRC group using propensity scores. All medical costs excluding those paid by patients and families were included. Utility was measured using SF-6D scores from the SF-12 questionnaire. Incremental cost-utility ratios (ICURs) were calculated using the mean annual estimates. A cost-effectiveness acceptability curve was determined using a Monte Carlo probabilistic simulation technique.\nNine FXD antiretroviral formulations approved by the U.S. Food and Drug Administration by 2005 was included in this study. One hundred seventy HIV/AIDS patients with \u22652 antiretroviral agents were identified from the MEPS database, of which 53% (n=92) were on FXD formulation. On matching, 70 patients from FXD had a match from the FRC group. No differences in sociodemographic and health status variables were observed between the matched groups. The mean annual cost was $15,766.15 for FXD patients and $11,875.21 for FRC patients. The mean utility gained by using FXD over FRC was 0.085; however, this difference was not statistically significant. The ICUR for the FXD treatment over FRC treatment was $45,540.49/quality-adjusted life years (QALYs). Probabilistic sensitivity analysis showed FXD to dominate FRC (>50% probability of being cost-effective) above the $40,000 threshold.\nDoes combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients?",
        "answer": "no",
        "answer_rationale": "Although the cost-effectiveness of a single-pill strategy was within the acceptable willingness-to-pay threshold, the QALY difference were minimal. Further research is recommended to explore the long-term impact of the strategy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether combining antiretroviral agents into a single dosage form (FXD) enhances the quality of life for HIV/AIDS patients compared to multiple free dose combinations (FRC). The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided in the study. The key points here are the results regarding utility and the incremental cost-utility ratio (ICUR). The utility measure used was the SF-6D derived from the SF-12, which is a quality of life assessment. The study states that the mean utility gained by FXD over FRC was 0.085, but this difference wasn't statistically significant. \n\nHmm, so even though there's a numerical difference in utility (which would translate to QALYs), the lack of statistical significance suggests that this difference might not be real and could be due to random variation. The ICUR is $45,540 per QALY gained. The cost-effectiveness acceptability curve showed that FXD is more likely to be cost-effective above a $40,000 threshold, meaning that at that willingness-to-pay threshold, FXD has over 50% probability of being cost-effective. But the question isn't about cost-effectiveness; it's specifically about enhancing quality of life.\n\nThe utility gain was 0.085 QALYs, but since it's not statistically significant, we can't be sure that the FXD actually improves quality of life more than FRC. The study's primary outcome here for quality of life doesn't show a significant difference. The cost part is about cost-effectiveness, which is a different consideration. The question is strictly about quality of life enhancement. Since the utility difference isn't significant, the answer would lean towards no, but maybe there's a nuance. Wait, the question is whether combining the drugs enhances quality of life. The study's utility measure didn't find a significant improvement. So the answer would be B (no) because the difference wasn't statistically significant. Alternatively, maybe the answer is C (maybe) because there was a trend but not significant. But the options are yes, no, maybe. The question is phrased as \"does it enhance\"\u2014since the study didn't find a significant effect, the answer would be no. But wait, the utility was higher in FXD, but not significant. The question is whether it \"enhances",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 553,
            "completion_tokens": 512
        },
        "time_elapsed": 6.661690711975098
    },
    {
        "realidx": "21726930",
        "question": "Endometrial polyp is a common cause of abnormal uterine bleeding, but the etiology and pathogenesis remain unclear. Vascular endothelial growth factor (VEGF) is angiogenic, related to thick walled vessels and transforming growth factor-beta1 (TGF-\u03b21) is related to fibrotic tissue, which are characteristics of endometrial polyps. The primary objective of this study was to find out if endometrial polyp formation is associated with increased expression of VEGF or TGF-\u03b21, or both. A secondary objective is to determine if the changes are related to steroid receptor expression.\nThis prospective study compared VEGF and TGF-\u03b21 expression of endometrial polyps and adjacent endometrial tissue in 70 premenopausal women. The comparison of results was separately made for endometrium specimens obtained in the proliferative and secretory phases. The results were correlated with the steroid receptors (estrogen receptor and progesterone receptor) expression.\nThe score of VEGF in glandular cells of endometrial polyps was significantly higher than the score in adjacent endometrium, both in the proliferative phase (P<0.001) and the secretory phase (P=0.03); the score of VEGF in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium only in proliferative phase (P=0.006). The score of TGF-\u03b21 in glandular cells of endometrial polyps was significantly higher than the score in adjacent endometrium in proliferative phase (P=0.02); whereas the score of TGF-\u03b21 in stromal cells of endometrial polyps was significantly higher than the score in adjacent endometrium, both in the proliferative phase (P=0.006) and the secretory phase (P=0.008). There was a significant correlation between the expression of steroid receptors and VEGF and TGF-\u03b21 (Spearman's correlation P<0.001 and P<0.05, respectively).\nIs endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?",
        "answer": "yes",
        "answer_rationale": "There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether endometrial polyp formation is associated with increased expression of VEGF and TGF-\u03b21. The options are yes, no, or maybe.\n\nFirst, I need to look back at the provided study details. The study compared VEGF and TGF-\u03b21 in endometrial polyps versus adjacent tissue in 70 premenopausal women, during both proliferative and secretory phases. \n\nThe results mentioned that VEGF in glandular cells of polyps had higher scores than adjacent endometrium in both phases (p<0.001 and p=0.03). For stromal cells, VEGF was higher only in the proliferative phase (p=0.006). \n\nThen, TGF-\u03b21 in glandular cells was higher in polyps during the proliferative phase (p=0.02), and in stromal cells, it was higher in both phases (p=0.006 and 0.008). Also, there was a correlation with steroid receptors. \n\nThe question is whether polyps are associated with increased expression of both factors. Since both VEGF and TGF-\u03b21 showed significant increases in various cell types and phases, the answer should be yes. The study's results support that both are involved. The options are A, B, C. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 566,
            "completion_tokens": 310
        },
        "time_elapsed": 4.084847450256348
    },
    {
        "realidx": "21789019",
        "question": "The increasingly older population confronts oncologists with an imposing challenge: older cancer patients have specific healthcare needs both independent of and associated with the diagnosis of cancer. The aim of the present study is to examine whether elderly versus younger cancer patients have different needs with respect to attendance, treatment and information.\nThis is an observational and cross-sectional study. Cancer patients aged 35 to 82 years were consecutively interviewed. The group was divided into two subgroups aged \u226465 and \u226566 years old. The Needs Evaluation Questionnaire (NEQ) was used to assess patients' needs and demographic variables were collected. Data analysis was carried out by means of cross-tabulation analyses and the chi-square test.\nThe requests most frequently expressed by the older group concerned financial-insurance information (73.9%), the need to talk to people with the same illness (71.7%), the need to receive more comprehensible information from doctors and nurses (71.7%), and the need for a better dialogue with clinicians (69.6%). Few significant differences between the two age subgroups were found, with the exception of issues such as the need for intimacy and support.\nDo elderly cancer patients have different care needs compared with younger ones?",
        "answer": "no",
        "answer_rationale": "Elderly patients have informational and relational needs similar to those of younger patients. In fact, most of the whole sample flagged up the need for higher levels of satisfaction especially concerning a better dialogue with health staff, along with a new factor: the need to talk to people with the same illness.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether elderly cancer patients have different care needs compared to younger ones based on the provided study.\n\nFirst, I need to look at the study details. The study is observational and cross-sectional, involving patients aged 35-82, split into \u226465 and \u226566. They used the NEQ to assess needs. The results mentioned that the older group had higher requests in areas like financial-insurance info (73.9%), talking to others with the same illness (71.7%), more comprehensible info from clinicians (71.7%), and better dialogue with clinicians (69.6%). However, the study states that few significant differences were found between the two age groups except for intimacy and support.\n\nWait, the question is whether there are different care needs. The options are yes, no, maybe. The study says \"few significant differences\" except for some specific issues like intimacy and support. The older group had higher needs in those four areas mentioned. So even though most weren't different, the presence of some differences (like the ones listed and the intimacy/support) would mean that there are some differences. The answer should be yes because the study found differences in some aspects. The key here is that the question is general\u2014do they have different needs? The study found that in some areas they do, so the answer is yes. The options are A, B, C. The correct answer is A (yes).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 342,
            "completion_tokens": 310
        },
        "time_elapsed": 4.251774072647095
    },
    {
        "realidx": "21823940",
        "question": "Research on stroke survivors' driving safety has typically used either self-reports or government records, but the extent to which the 2 may differ is not known. We compared government records and self-reports of motor vehicle collisions and driving convictions in a sample of stroke survivors.\nThe 56 participants were originally recruited for a prospective study on driving and community re-integration post-stroke; the study population consisted of moderately impaired stroke survivors without severe communication disorders who had been referred for a driving assessment. The driving records of the 56 participants for the 5 years before study entry and the 1-year study period were acquired with written consent from the Ministry of Transportation of Ontario (MTO), Canada. Self-reports of collisions and convictions were acquired via a semistructured interview and then compared with the MTO records.\nForty-three participants completed the study. For 7 (13.5%) the MTO records did not match the self-reports regarding collision involvement, and for 9 (17.3%) the MTO records did not match self-reports regarding driving convictions. The kappa coefficient for the correlation between MTO records and self-reports was 0.52 for collisions and 0.47 for convictions (both in the moderate range of agreement). When both sources of data were consulted, up to 56 percent more accidents and up to 46 percent more convictions were identified in the study population in the 5 years before study entry compared to when either source was used alone.\nDepartment of Transportation vs self-reported data on motor vehicle collisions and driving convictions for stroke survivors: do they agree?",
        "answer": "no",
        "answer_rationale": "In our population of stroke survivors, self-reports of motor vehicle collisions and driving convictions differed from government records. In future studies, the use of both government and self-reported data would ensure a more accurate picture of driving safety post-stroke.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Department of Transportation data and self-reported data on motor vehicle collisions and convictions for stroke survivors agree. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study compared government records (MTO) with self-reports from 56 stroke survivors. They found that for collisions, 7 out of 43 participants (13.5%) had discrepancies. For convictions, 9 out of 43 (17.3%) didn't match. The kappa coefficients were 0.52 and 0.47, which are considered moderate agreement. However, when both sources were used together, they found significantly more accidents and convictions than either alone. \n\nThe question is about whether the two data sources agree. The kappa values indicate moderate agreement, which isn't perfect but isn't terrible either. However, the fact that there were notable discrepancies (over 10% for collisions and nearly 17% for convictions) suggests that they don't fully agree. The answer options are yes, no, maybe. Since the agreement is only moderate and there are significant mismatches, the correct answer would be \"no\" because they don't fully agree. The kappa in the moderate range (which is often considered 0.41-0.60) means there's room for disagreement. The study's conclusion that using both sources found more incidents also implies that relying on one alone might miss things, hence they aren't in full agreement. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 422,
            "completion_tokens": 334
        },
        "time_elapsed": 4.00904655456543
    },
    {
        "realidx": "21845457",
        "question": "Trauma centers are designated to provide systematized multidisciplinary care to injured patients. Effective trauma systems reduce patient mortality by facilitating the treatment of injured patients at appropriately resourced hospitals. Several U.S. studies report reduced mortality among patients admitted directly to a level I trauma center compared with those admitted to hospitals with less resources. It has yet to be shown whether there is an outcome benefit associated with the \"level of hospital\" initially treating severely injured trauma patients in Australia. This study was designed to determine whether the level of trauma center providing treatment impacts mortality and/or hospital length of stay.\nOutcomes were evaluated for severely injured trauma patients with an Injury Severity Score (ISS)>15 using NSW Institute of Trauma and Injury Management data from 2002-2007 for our regional health service. To assess the association between trauma centers and binary outcomes, a logistic regression model was used. To assess the association between trauma centers and continuous outcomes, a multivariable linear regression model was used. Sex, age, and ISS were included as covariates in all models.\nThere were 1,986 trauma presentations during the 6-year period. Patients presenting to a level III trauma center had a significantly higher risk of death than those presenting to the level I center, regardless of age, sex, ISS, or prehospital time. Peer review of deaths at the level III center identified problems in care delivery in 15 cases associated with technical errors, delay in decision making, or errors of judgement.\nOutcomes of severely injured adult trauma patients in an Australian health service: does trauma center level make a difference?",
        "answer": "yes",
        "answer_rationale": "Severely injured patients treated at a level III center had a higher mortality rate than those treated at a level I center. Most problems identified occurred in the emergency department and were related to delays in care provision. This research highlights the importance of efficient prehospital, in-hospital, and regional trauma systems, performance monitoring, peer review, and adherence to protocols and guidelines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether the level of trauma center affects mortality and hospital stay for severely injured patients in Australia. The user provided the study details, so I need to focus on the results mentioned.\n\nThe key points from the study: They looked at patients with ISS >15 over six years. They used logistic regression for binary outcomes (like death) and linear regression for continuous ones (like length of stay). The results showed that patients at level III had a significantly higher risk of death compared to level I, even after adjusting for age, sex, ISS, and prehospital time. Also, peer reviews found issues in care delivery in 15 cases at the level III center.\n\nThe question is asking if trauma center level makes a difference in outcomes. The answer should be yes because the study found higher mortality at level III. The options are A (yes), B (no), C (maybe). The correct answer is A. The study's results support that level I centers have better outcomes, so the answer is yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 419,
            "completion_tokens": 220
        },
        "time_elapsed": 2.725987195968628
    },
    {
        "realidx": "21848798",
        "question": "In recent clinical trials (RCT) of bowel preparation, Golytely was more efficacious than MiraLAX. We hypothesised that there is a difference in adenoma detection between Golytely and MiraLAX.\nTo compare the adenoma detection rate (ADR) between these bowel preparations, and to identify independent predictors of bowel preparation quality and adenoma detection.\nThis was a post hoc analysis of an RCT that assessed efficacy and patient tolerability of Golytely vs. MiraLAX/Gatorade in average risk screening colonoscopy patients. Bowel preparation quality was measured with the Boston Bowel Preparation Scale (BBPS). An excellent/good equivalent BBPS score was defined as \u2265 7. Polyp pathology review was performed. ADR was defined as the proportion of colonoscopies with an adenoma. Univariate and multivariate analyses were conducted.\nOne hundred and ninety patients were prospectively enrolled (87 MiraLAX, 103 Golytely). Golytely had a higher rate of a BBPS score \u2265 7 (82.5% vs. MiraLAX 67.8%, P=0.02). The ADR in the Golytely cohort was 26.2% (27/103), and was 16.1% (14/87) for MiraLAX (P = 0.091). On multivariate analyses, Golytely was 2.13 \u00d7 more likely to be associated with a BBPS \u2265 7 (95% CI 1.05-4.32, P = 0.04) and 2.28 \u00d7 more likely to be associated with adenoma detection (95% CI 1.05-4.98, P = 0.04) than MiraLAX.\nMiraLAX vs. Golytely: is there a significant difference in the adenoma detection rate?",
        "answer": "yes",
        "answer_rationale": "Golytely was more efficacious than MiraLAX in bowel cleansing, and was independently associated with both bowel prep quality (BBPS \u2265 7) and higher adenoma detection. Golytely should be used as first line for bowel prep for colonoscopy. Studies with larger populations are needed to confirm these results.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a significant difference in the adenoma detection rate (ADR) between MiraLAX and Golytely. The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided in the study. The question mentions that in the RCT, Golytely was more efficacious than MiraLAX. The study's results show that the ADR for Golytely was 26.2% (27/103) versus 16.1% (14/87) for MiraLAX. The p-value given for the ADR comparison is 0.091. \n\nWait, a p-value of 0.091 is greater than 0.05, which is the typical threshold for statistical significance. So that would suggest that the difference in ADR between the two isn't statistically significant based on that p-value. But then the multivariate analysis part says that Golytely was 2.28 times more likely to be associated with adenoma detection with a 95% CI of 1.05-4.98 and a p-value of 0.04. \n\nHmm, so the univariate analysis (the raw comparison) had a p=0.091, which isn't significant, but the multivariate analysis adjusted for other variables and found a significant association (p=0.04). The question is asking if there's a significant difference. The options are yes, no, maybe. \n\nThe key here is understanding whether the question is referring to the raw data or the adjusted analysis. The way the question is phrased: \"is there a significant difference in the adenoma detection rate?\" The study's conclusion, based on the multivariate analysis, shows a significant association. The multivariate analysis controls for other variables, so that's probably the more reliable result. Since the multivariate p-value is 0.04, which is below 0.05, that would indicate a significant difference. \n\nTherefore, the answer should be (A) yes. But wait, the options are (A) yes, (B) no, (C) maybe. The user is probably testing if I notice that the raw p-value was 0.091 (not significant) but the adjusted was 0.04 (significant). The question",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 516,
            "completion_tokens": 512
        },
        "time_elapsed": 6.855332851409912
    },
    {
        "realidx": "21849531",
        "question": "Adults with GH deficiency (GHD) have a decreased life expectancy. The effect of GH treatment on mortality remains to be established.\nThis nationwide cohort study investigates the effect of GH treatment on all-cause and cause-specific mortality and analyzes patient characteristics influencing mortality in GHD adults.\nPatients in the Dutch National Registry of Growth Hormone Treatment in Adults were retrospectively monitored (1985-2009) and subdivided into treatment (n = 2229), primary (untreated, n = 109), and secondary control (partly treated, n = 356) groups.\nStandardized mortality ratios (SMR) were calculated for all-cause, malignancy, and cardiovascular disease (CVD) mortality. Expected mortality was obtained from cause, sex, calendar year, and age-specific death rates from national death and population counts.\nIn the treatment group, 95 patients died compared to 74.6 expected [SMR 1.27 (95% confidence interval, 1.04-1.56)]. Mortality was higher in women than in men. After exclusion of high-risk patients, the SMR for CVD mortality remained increased in women. Mortality due to malignancies was not elevated. In the control groups mortality was not different from the background population. Univariate analyses demonstrated sex, GHD onset, age, and underlying diagnosis as influencing factors.\nDoes growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency?",
        "answer": "no",
        "answer_rationale": "GHD men receiving GH treatment have a mortality rate not different from the background population. In women, after exclusion of high-risk patients, mortality was not different from the background population except for CVD. Mortality due to malignancies was not elevated in adults receiving GH treatment. Next to gender, the heterogeneous etiology is of influence on mortality in GHD adults with GH treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether growth hormone replacement therapy reduces mortality in adults with GHD. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study is a nationwide cohort from the Dutch registry, tracking patients from 1985 to 2009. They divided them into treatment, primary control (untreated), and secondary control (partly treated). \n\nThe key results mentioned are the standardized mortality ratios (SMR). For the treatment group, the SMR was 1.27, which is higher than 1. That means their mortality was 27% higher than expected. The confidence interval was 1.04-1.56, which just crosses over 1 but still mostly above. The study also noted that women had higher mortality than men. Even after excluding high-risk patients, the CVD mortality in women remained increased. However, malignancy mortality wasn't elevated. The control groups (untreated or partly treated) didn't have different mortality from the general population.\n\nSo the question is whether GH treatment reduces mortality. The SMR in the treatment group is higher than expected, which suggests that the treatment group had worse outcomes. But wait, the controls didn't have higher SMR. So maybe the treatment isn't helping, or perhaps there's another factor. The study's conclusion here is that the SMR for the treated group is higher, which would imply that the treatment isn't reducing mortality. The fact that the control groups (who aren't on treatment) have mortality similar to the general population might mean that the treatment group's higher SMR is due to the treatment itself or other factors associated with being on treatment. \n\nThe options are yes, no, maybe. The study's data shows that the treated group had higher mortality than expected. So the answer would be no, the therapy doesn't reduce mortality. The SMR being over 1 indicates higher mortality, so the therapy isn't helping in that aspect. The \"maybe\" might be if there was uncertainty, but the SMR is statistically significant (since the CI doesn't include 1 much). The answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 460
        },
        "time_elapsed": 5.488199472427368
    },
    {
        "realidx": "21850494",
        "question": "Hepatorenal syndrome (HRS) is the functional renal failure associated with advanced cirrhosis and has also been described in fulminant hepatic failure. Without liver transplantation its prognosis is dismal. Our study included patients with type 1 HRS associated with cirrhosis, who were not liver transplant candidates.AIM: To identify variables associated with improved survival.\nSixty-eight patients fulfilled the revised Ascites Club Criteria for type 1 HRS. None of them was suitable for liver transplantation. All the patients were treated with combinations of: albumin, midodrine and octreotide, pressors, and hemodialysis.\nMedian survival was 13 days for the whole group. Survival varied with the end-stage liver disease (ESLD) etiology: autoimmune, 49 days, cardiac cirrhosis, 22 days, idiopathic, 15.5 days, viral, 15 days, hepatitis C and alcohol, 14.5 days, alcohol 8 days, and neoplasia 4 days (p = 0.048). Survival of HRS associated with alcoholic liver disease versus other etiologies was not statistically significant (p = 0.1). Increased serum creatinine (p = 0.02) and urinary sodium 6-10 mEq/l (p = 0.027) at the initiation of therapy were prognostic factors for mortality. HRS treatment modalities (p = 0.73), use of dialysis (p = 0.56), dialysis modality (p = 0.35), use of vasopressors (p = 0.26), pre-existing renal disease (p = 0.49), gender (p = 0.90), and age (p = 0.57) were not associated with survival.\nHepatorenal syndrome: are we missing some prognostic factors?",
        "answer": "yes",
        "answer_rationale": "We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether we are missing some prognostic factors for Hepatorenal Syndrome (HRS) based on the study described. The options are yes, no, or maybe.\n\nFirst, I need to understand the study's findings. The study looked at 68 patients with type 1 HRS who weren't candidates for liver transplants. They were treated with various combinations of medications and dialysis. The median survival was 13 days overall. \n\nThe study found that survival varied depending on the etiology of the end-stage liver disease (ESLD). For example, autoimmune had the longest at 49 days, while neoplasia was the shortest at 4 days. However, when they compared alcoholic liver disease versus others, there wasn't a statistically significant difference (p=0.1). \n\nThey also noted that higher serum creatinine and urinary sodium (6-10 mEq/l) at the start of treatment were linked to worse outcomes. But other factors like treatment modalities, dialysis use, vasopressors, pre-existing kidney disease, gender, and age didn't affect survival. \n\nThe question is whether the study suggests that there are missing prognostic factors. The authors mention that even though some factors were significant (like ESLD etiology and certain lab values), others like alcohol vs. other causes weren't. Also, the treatments didn't show an effect. The title of the study itself is \"Hepatorenal syndrome: are we missing some prognostic factors?\" which implies that the authors are suggesting that there might be other factors not considered here that could influence survival. \n\nThe options are (A) yes, (B) no, (C) maybe. The study's results show that some variables were associated, but others weren't. The fact that the authors pose the question in their title suggests they think there might be more factors to consider. The answer would be \"yes\" because the study's findings indicate that current known factors don't fully explain the survival differences, so there could be other variables not accounted for. The p-values for some etiologies were significant, but others weren't, which might mean that more detailed subcategories or other variables (like specific comorbidities, genetic factors, or treatment specifics not measured here) could be important. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 501,
            "completion_tokens": 497
        },
        "time_elapsed": 6.520995140075684
    },
    {
        "realidx": "21864397",
        "question": "Nasopharyngeal carcinoma (NPC) with lung metastasis alone has been reported as a relatively favorable prognostic group, and combined modality treatment might be indicated for selected cases. However, the prognostic factors determining survival of this group and the indication of combined therapy have not been thoroughly studied.\nWe retrospectively reviewed 246 patients of NPC with lung metastasis(es) alone presented at diagnosis or as the first failure after primary treatment from 1993 to 2008 in an academic tertiary hospital. Univariate and multivariate survival analyses of post-metastasis survival (PMS) and overall survival (OS) were carried out to determine the prognostic factors.\nThe 3-year, 5-year, and 10-year of PMS and OS for the whole cohort were 34.3%, 17.0%, 8.6% and 67.8%, 45.4%, 18.5%, respectively. The median PMS (45.6 months vs. 23.7 months) and OS (73.7 months vs. 46.2 months) of patients treated with combined therapy was significantly longer than that of those treated with chemotherapy alone (P<0.001). Age, disease-free interval (DFI) and treatment modality were evaluated as independent prognostic factors of OS, while only age and treatment modality retain their independent significance in PMS analysis. In stratified survival analysis, compared to chemotherapy alone, combined therapy could benefit the patients with DFI>1 year, but not those with DFI \u2264 1 year.\nFactors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?",
        "answer": "yes",
        "answer_rationale": "Age \u2264 45 years, DFI>1 year, and the combined therapy were good prognostic factors for NPC patients with lung metastasis(es) alone. The combination of local therapy and the basic chemotherapy should be considered for these patients with DFI>1 year.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether combined modality treatment benefits patients with nasopharyngeal carcinoma (NPC) that has metastasized to the lungs. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study reviewed 246 patients with NPC and lung metastasis. The key findings from the study are mentioned: the median post-metastasis survival (PMS) and overall survival (OS) were significantly longer for those who received combined therapy compared to chemotherapy alone (p<0.001). That's a strong statistical significance. \n\nThe multivariate analysis showed that treatment modality was an independent prognostic factor for both OS and PMS (except DFI in PMS). Also, the stratified analysis indicated that combined therapy benefits patients with a disease-free interval (DFI) over 1 year, but not those with DFI \u22641 year. \n\nThe question is whether combined modality treatment is beneficial. The answer seems to be yes, but with a caveat based on DFI. However, the options don't have a conditional answer. The question is general, so the study's main conclusion is that combined therapy does provide benefit, especially in certain subgroups. Since the question is whether it \"benefit[s]\" in general, the answer would be yes (A), because the study shows a significant benefit in the group as a whole and specifically in those with DFI>1 year. The \"maybe\" might come from the DFI consideration, but the question doesn't specify DFI. The options are yes, no, maybe. The study's conclusion supports that combined therapy does benefit, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 459,
            "completion_tokens": 360
        },
        "time_elapsed": 4.655823469161987
    },
    {
        "realidx": "21889895",
        "question": "The aim of this study was to determine if educating residents about the potential effects of radiation exposure from computed tomographic (CT) imaging alters ordering patterns. This study also explored whether referring physicians are interested in radiation education and was an initial effort to address their CT ordering behavior.\nTwo to four months after a radiologist's lecture on the potential effects of radiation exposure related to CT scans, urology and orthopedic residents were surveyed regarding the number and types of CT scans they ordered, the use of alternative imaging modalities, and whether they used the lecture information to educate patients.\nTwenty-one resident lecture attendants completed the survey. The number of CT scans ordered after the lecture stayed constant for 90% (19 of 21) and decreased for 10% (two of 21). The types of CT scans ordered changed after the lecture for 14% (three of 21). Thirty-three percent (seven of 21) reported increases in alternative imaging after the lecture, including 24% (five of 21) reporting increases in magnetic resonance imaging and 19% (four of 21) reporting increases in ultrasound. Patients directed questions about radiation exposure to 57% (12 of 21); 38% (eight of 21) used the lecture information to educate patients. Referring physicians were interested in the topic, and afterward, other physician groups requested radiation education lectures.\nWill CT ordering practices change if we educate residents about the potential effects of radiation exposure?",
        "answer": "no",
        "answer_rationale": "Most clinicians did not change their CT scan ordering after receiving education about radiation from a radiologist. Radiation education allowed clinicians to discuss CT benefits and risks with their patients and to choose appropriate CT protocols. Referring physician groups are interested in this topic, and radiologists should be encouraged to give radiation lectures to them.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study's aim was to see if educating residents about radiation from CT scans changes their ordering habits. The options are yes, no, maybe.\n\nLooking at the results: after the lecture, 90% kept the same number of CT orders, 10% decreased. So most didn't change, but some did reduce. Then, 14% changed the types of CTs ordered. Also, 33% increased alternative imaging like MRI or ultrasound. That suggests some substitution, which might mean less CT use indirectly. Also, some residents used the info to educate patients, and other docs wanted the lectures. \n\nThe question is whether CT ordering practices will change. The study shows that while most kept the same, some decreased or changed types, and more used alternatives. So there was some change, but not a majority. However, the fact that some did change and others are interested in more education might indicate that overall, there's a possibility. The answer might be \"maybe\" because it's not a clear majority, but there's some effect. Wait, but the options are yes, no, maybe. The question is phrased as \"will CT ordering practices change if we educate residents\". The study's results show that in their case, some did change. So the answer could be yes, because there was a change in some cases. Alternatively, since most didn't change, maybe the answer is no. Hmm. The question is whether the education leads to changes. The study found that 10% decreased, 14% changed types, and 33% used alternatives. So overall, there were changes in ordering practices, even if not all. The answer might be yes because the study shows that some changes occurred. The fact that other physicians also wanted the lectures suggests that education can lead to changes. So the correct answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 406,
            "completion_tokens": 395
        },
        "time_elapsed": 4.663579702377319
    },
    {
        "realidx": "21946341",
        "question": "Ablation of persistent atrial fibrillation (AF) may require adjunctive methods of substrate modification. Both ablation-targeting complex fractionated atrial electrograms (CFAEs) recorded during AF and fractionated electrograms recorded during sinus rhythm (sinus rhythm fractionation [SRF]) have been described. However, the relationship of CFAEs with SRF is unclear.\nTwenty patients (age 62 \u00b1 9 years, 13 males) with persistent AF and 9 control subjects without organic heart disease or AF (age 36 \u00b1 6 years, 4 males) underwent detailed CFAE and SRF left atrial electroanatomic maps. The overlap in left atrial regions with CFAEs and SRF was compared in the AF population, and the distribution of SRF was compared among patients with AF and normal controls. Propagation maps were analyzed to identify the activation patterns associated with SR fractionation.\nSRF (338 \u00b1 150 points) and CFAE (418 \u00b1 135 points) regions comprised 29% \u00b1 14% and 25% \u00b1 15% of the left atrial surface area, respectively. There was no significant correlation between SRF and CFAE maps (r = .2; P = NS). On comparing patients with AF and controls, no significant difference was found in the distribution of SRF between groups (P = .74). Regions of SRF overlapped areas of wave-front collision 75% \u00b1 13% of the time.\nIs there a relationship between complex fractionated atrial electrograms recorded during atrial fibrillation and sinus rhythm fractionation?",
        "answer": "no",
        "answer_rationale": "(1) There is little overlap between regions of CFAEs during AF and regions of SRF measured in the time domain or the frequency domain, (2) the majority of SRF appears to occur in regions with wave-front collision, (3) the distribution of SRF is similar in patients with AF and normal controls, suggesting that this may not have an important role in AF maintenance and may not be a suitable ablation target.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a relationship between complex fractionated atrial electrograms (CFAEs) recorded during atrial fibrillation (AF) and sinus rhythm fractionation (SRF). \n\nFirst, I need to recall the study details provided. The study involved 20 patients with persistent AF and 9 controls. They mapped both CFAEs and SRF in the left atrium. The key findings were that the areas with CFAEs and SRF each covered around 25-29% of the left atrial surface, but there was no significant correlation between their maps (r = 0.2, which isn't statistically significant as P = NS). Also, the distribution of SRF didn't differ between AF patients and controls (P = 0.74). Additionally, SRF overlapped with wave-front collisions 75% of the time, but that's about SRF's mechanism, not the relationship between CFAEs and SRF.\n\nThe question is specifically about the relationship between CFAEs and SRF. Since the correlation coefficient (r) was 0.2 and not significant (P = NS), that suggests there's little to no linear relationship. Also, since the SRF distribution was similar in AF patients and controls, it implies that the presence of AF doesn't enhance SRF in those areas where CFAEs are found. The overlap with wave-front collisions might explain why SRF occurs but doesn't link it to CFAEs. \n\nSo the answer should be \"no\" because the study found no significant correlation between CFAE and SRF regions. The options are A (yes), B (no), C (maybe). The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 441,
            "completion_tokens": 366
        },
        "time_elapsed": 4.573770761489868
    },
    {
        "realidx": "21952349",
        "question": "Myocardial damage that is associated with percutaneous coronary intervention (PCI) partially affects the results of the procedure, and is related to medium-term cardiovascular death. Remote postischemic conditioning might reduce the myocardial lesions that are associated with PCI, but perhaps less so in diabetics. The aim of this study was to evaluate the protective effect of remote postischemic conditioning in patients undergoing elective PCI for stable angina or non-ST elevation acute coronary syndrome with troponin<1 ng/ml at the time of randomization.\nThis randomized single-blinded single-center clinical trial involved 320 patients undergoing elective PCI who were randomized to either receive three 5-min cycles of ischemia by inflation of a cuff on the non-dominant arm to 200 mm Hg (remote postischemic conditioning) or to placebo (uninflated cuff). The primary outcome variable was the maximum increase in troponin in the first 24 h. The secondary outcome variable was readmission due to heart failure or cardiovascular mortality after 1 year of follow-up. In addition, a diabetic population was studied.\nRemote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization?",
        "answer": "yes",
        "answer_rationale": "This clinical trial evaluated the possible reduction in intervention-related myocardial damage that was attributable to remote postischemic conditioning.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether remote ischemic postconditioning protects against ischemic damage during PCI. The study mentioned here is a randomized, single-blinded, single-center trial with 320 patients. They were split into two groups: one got the remote postconditioning with a cuff inflated to 200 mmHg in three cycles, and the other had a placebo (uninflated cuff). The primary outcome was the maximum troponin increase in 24 hours, and secondary was readmission or mortality at one year, especially looking at diabetics.\n\nThe question is whether the remote ischemic postconditioning works. The options are yes, no, maybe. The study's aim was to evaluate the protective effect. The background mentions that remote postconditioning might reduce myocardial lesions but maybe less so in diabetics. \n\nWait, the key here is the study's results. But the user hasn't provided the actual results of the study. The question is phrased as a scenario where the user is probably expecting the answer based on the information given. Wait, but the options are (A) yes, (B) no, (C) maybe. The problem is that the user hasn't given the results of the study's findings. The question is presented as if the study's results are known, but in the provided text, the study's aim is stated, but the actual outcomes (like whether the primary or secondary endpoints were met) aren't detailed here. \n\nHmm, maybe I need to look again. The user's question is phrased as a test question where the options are based on the information given. Wait, perhaps the user expects me to know that in real studies, remote ischemic conditioning has mixed results. For example, some studies suggest it might have a protective effect, but maybe in this particular study's setup, the answer is maybe because the study's results aren't presented here. Wait, but the user's question is about the study described here. Since the user hasn't provided the actual results of the study (like whether the primary outcome was lower in the treatment group), how can I answer? \n\nWait, maybe I misread. Let me check again. The user's question is: \"Remote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization?\" The options are based on the study described. The problem is that the study's results aren't given",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 344,
            "completion_tokens": 512
        },
        "time_elapsed": 5.892330884933472
    },
    {
        "realidx": "22011946",
        "question": "Many insurance payors mandate that bariatric surgery candidates undergo a medically supervised weight management (MSWM) program as a prerequisite for surgery. However, there is little evidence to support this requirement. We evaluated in a randomized controlled trial the hypothesis that participation in a MSWM program does not predict outcomes after laparoscopic adjustable gastric banding (LAGB) in a publicly insured population.\nThis pilot randomized trial was conducted in a large academic urban public hospital. Patients who met NIH consensus criteria for bariatric surgery and whose insurance did not require a mandatory 6-month MSWM program were randomized to a MSWM program with monthly visits over 6 months (individual or group) or usual care for 6 months and then followed for bariatric surgery outcomes postoperatively. Demographics, weight, and patient behavior scores, including patient adherence, eating behavior, patient activation, and physical activity, were collected at baseline and at 6 months (immediately preoperatively and postoperatively).\nA total of 55 patients were enrolled in the study with complete follow-up on 23 patients. Participants randomized to a MSWM program attended an average of 2 sessions preoperatively. The majority of participants were female and non-Caucasian, mean age was 46 years, average income was less than $20,000/year, and most had Medicaid as their primary insurer, consistent with the demographics of the hospital's bariatric surgery program. Data analysis included both intention-to-treat and completers' analyses. No significant differences in weight loss and most patient behaviors were found between the two groups postoperatively, suggesting that participation in a MSWM program did not improve weight loss outcomes for LAGB. Participation in a MSWM program did appear to have a positive effect on physical activity postoperatively.\nDoes a preoperative medically supervised weight loss program improve bariatric surgery outcomes?",
        "answer": "no",
        "answer_rationale": "MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a preoperative medically supervised weight loss program improves bariatric surgery outcomes based on the provided study.\n\nFirst, I need to recall the details from the study description. The study was a randomized controlled trial comparing a MSWM program group with usual care. The key findings mentioned were that there were no significant differences in weight loss and most patient behaviors between the two groups postoperatively. However, the MSWM did have a positive effect on physical activity. \n\nThe question is specifically about improving \"bariatric surgery outcomes.\" The primary outcome here, weight loss, didn't show a significant difference. Even though physical activity was better in the MSWM group, the main focus of bariatric surgery outcomes, especially in the context of the study's hypothesis, is likely weight loss. The study's conclusion states that participation didn't improve weight loss outcomes, which is the main outcome. The answer options are yes, no, maybe. Since the study found no significant difference in the main outcome (weight loss), the answer should be no. The positive effect on physical activity is a secondary finding but doesn't override the primary conclusion regarding the main outcomes. So the correct answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 477,
            "completion_tokens": 256
        },
        "time_elapsed": 3.400817394256592
    },
    {
        "realidx": "22012962",
        "question": "Men appear to benefit more from being married than women with respect to mortality in middle age. However, there is some uncertainty about gender differences in mortality risks in older individuals, widowed, divorced and single individuals and about the impact of living arrangements.\nLongitudinal data with 1990 census records being linked to mortality data up to 2005 were used (Swiss National Cohort). The sample comprised all residents over age 44 years in Switzerland (n=2,440,242). All-cause mortality HRs for marital status and living arrangements were estimated by Cox regression for men and women and different age groups with adjustment for education and socio-professional category.\nThe benefit of being married was stronger for men than for women; however, mortality patterns were similar, with higher mortality in divorced and single individuals compared with widowed individuals (<80 years). After adjustment for living arrangements, the gender difference by marital status disappeared. Stratification by living arrangement revealed that mortality risks were highest for 45-64-year-old divorced (HR 1.72 (95% CI 1.67 to 1.76)) and single men (HR 1.67 (95% CI 1.63 to 1.71)) who lived alone. In women of the same age, the highest mortality risk was observed for those who were single and living with a partner (HR 1.70 (95% CI 1.58 to 1.82)). In older age groups, the impact of marital status decreased.\nMarital status, living arrangement and mortality: does the association vary by gender?",
        "answer": "yes",
        "answer_rationale": "Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the association between marital status, living arrangement, and mortality varies by gender. The study mentioned in the question looked at data from Switzerland, analyzing over 2 million people over 44 years old.\n\nFirst, the key points from the study: The benefit of being married was stronger for men than women. However, after adjusting for living arrangements, the gender difference in mortality related to marital status went away. That's interesting. So when they controlled for where people live, the difference between men and women's mortality risks due to marital status disappeared. \n\nThen, when they looked at different living arrangements, the highest risks for men aged 45-64 were those who were divorced or single and living alone. For women of the same age, the highest risk was being single but living with a partner. In older groups, marital status had less impact. \n\nThe question is whether the association varies by gender. The study shows that before adjusting for living arrangements, there was a gender difference (men had more benefit from marriage). But after considering living arrangements, that difference disappeared. However, the mortality risks based on living arrangements themselves still showed different patterns between genders. For example, in the 45-64 age group, the risky living situations differed between men and women. \n\nSo the association's effect might depend on both marital status and living arrangements, and how those interact with gender. Since the study found that when you account for living arrangements, the gender difference in marital status impact goes away, but the living arrangements themselves have different effects by gender, this suggests that the overall association does vary by gender. The answer options are yes, no, maybe. The study's results support that there is a variation because the factors influencing mortality differ between genders when considering both marital status and living arrangements. Therefore, the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 437,
            "completion_tokens": 391
        },
        "time_elapsed": 4.493215799331665
    },
    {
        "realidx": "22023714",
        "question": "To explore the impact of delivery mode on women's postpartum quality of life in rural China and probe factors influencing postnatal quality of life.\nChildbirth significantly affects puerpera's physical, psychological and social domains of quality of life. Under the circumstance of increasing high caesarean section rate in rural China, the impact of delivery mode on postnatal quality of life remains unclear.\nCross-sectional study design.\nWomen residing in rural areas and in their 0-12 months after childbirth from 30 rural townships participated in a household survey. A structured questionnaire was used to evaluate women's socio-demographic characteristics, previous pregnant experiences, foetal characteristics and use of maternal health services. The scale for rural postnatal quality of life was adopted to assess postnatal quality of life from six dimensions: physical complaints and pain, sleep and energy, sex satisfaction, interpersonal communication, self-evaluated living stress and perceived life satisfaction.\nThe overall caeserean section rate was 70\u00b70% (962/1375), and most of them (59\u00b77%) were selected by maternal request. None of six dimensions and total score of quality of life displayed significant difference between women with normal delivery and cesaerean section. It was found that postnatal home visit related to good postnatal quality of life and lower husband education level, male gender of infant were associated with poor quality of life.\nDoes delivery mode affect women's postpartum quality of life in rural China?",
        "answer": "no",
        "answer_rationale": "Delivery mode did not affect postpartum quality of life in rural China. Socio-cultural determinants may contribute more in influencing postnatal quality of life.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether delivery mode affects women's postpartum quality of life in rural China based on the provided study.\n\nFirst, I need to look at the study's findings. The key point here is that the study found \"None of six dimensions and total score of quality of life displayed significant difference between women with normal delivery and cesarean section.\" That's a crucial statement. The six dimensions they measured\u2014like physical complaints, sleep, sex satisfaction, etc.\u2014didn't show any significant differences between those who had natural births and C-sections. \n\nThe question is asking if delivery mode (which refers to the method of birth, either normal or C-section) has an impact. Since the study's results say there's no significant difference, the answer would be that it doesn't affect. \n\nBut wait, the options are (A) yes, (B) no, (C) maybe. The study's conclusion directly states no significant difference, so the answer should be B. \n\nHowever, I should check if there's any other factor mentioned that might influence the answer. The study also mentions that postnatal home visits and lower husband education, along with the infant's gender, were associated with quality of life. But those are other factors, not the delivery mode. The question specifically asks about delivery mode, so those other factors don't change the answer here. \n\nSo the correct answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 397,
            "completion_tokens": 301
        },
        "time_elapsed": 4.074319362640381
    },
    {
        "realidx": "22042121",
        "question": "Demonstrate that the rabbit may be used in the training of surgery, in addition to present its perioperative care.\nThirty two animals, with age and weight, respectively, from 3 to 5.5 months old and 3000 to 4200 grams, were undergone different periods of pre-operative fasting, exclusive intramuscular anesthesia (ketamine+xylazine), laparotomy with total gastrectomy and total splenectomy. It was dosed the pre-operative (initial) and post-surgical (end) serum blood glucose, in addition to quantify the gastric content after the resection of the part.\nThe anesthetical-surgical procedure presented a mortality rate of 3.125% (1:32) and a morbidity rate of 6.25% (2:32). It was evidenced an initial mean blood glucose = 199.4 mg/dl and the end = 326.1 mg/dl. In spite of extended fasting (minimum of 2 hours for the absolute fasting and maximum of 8.5 hours for liquids, and 20.5 hours for solids) all animals presented at the end of the surgical procedure any gastric content and a blood glucose increase. Those with fasting for liquids and solids when compared to the quantity of solid gastric content, presented a moderate negative degree of correlation.\nPerioperative care in an animal model for training in abdominal surgery: is it necessary a preoperative fasting?",
        "answer": "no",
        "answer_rationale": "The rabbit is a good model to be used in training of surgery, with a low morbi-mortality, able to be anesthetized intramuscularly, with no need of pre-operative fasting and does not present hypoglycemia even with the extended fasting period.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether preoperative fasting is necessary in a rabbit model for surgical training, based on the study described.\n\nFirst, I need to understand the study details. The rabbits were fasted for varying periods: some had absolute fasting (no food or water) for at least 2 hours, others had up to 8.5 hours with liquids and 20.5 hours for solids. Despite this extended fasting, all animals had no gastric content at the end of surgery. Also, their blood glucose levels increased from an average of 199.4 mg/dl pre-op to 326.1 mg/dl post-op. The mortality and morbidity rates were low (3.125% and 6.25% respectively).\n\nThe key points here are the absence of gastric content despite fasting and the rise in blood glucose. Preoperative fasting is typically done to prevent aspiration pneumonia by reducing stomach contents. However, in this study, even with fasting, there was an increase in blood glucose, which might indicate stress or the effects of anesthesia. But the main finding is that all animals had no gastric content post-surgery. That suggests that maybe the fasting wasn't necessary because they didn't have residual food, but the study also mentions a moderate negative correlation between fasting duration and solid gastric content. Wait, a negative correlation here would mean that longer fasting led to less content, but since all had no content, maybe the correlation is in the amount before surgery? Hmm, the wording says \"moderate negative degree of correlation\" between fasting for liquids and solids compared to solid content. Maybe those with longer fasting had less, but even so, all ended up with none. \n\nThe question is whether preoperative fasting is necessary. The study's results show that even with extended fasting, there was no gastric content found. So maybe the fasting wasn't needed because even without it, they might not have had content? But the study's fasting periods varied, but all had some fasting. Wait, the minimum fasting was 2 hours for absolute fasting. The problem is that the study's design might not have a control group without fasting. Since all animals had some fasting, we can't tell if fasting was the reason for no content. However, the question is whether it's necessary. The study's results indicate that even with the fasting, blood glucose went up, which is a downside of fasting (since hyperglycemia can be a stress response). The morb",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 512
        },
        "time_elapsed": 6.341435670852661
    },
    {
        "realidx": "22075911",
        "question": "Figures from the British Defence Dental Services reveal that serving personnel in the British Army have a persistently lower level of dental fitness than those in the Royal Navy or the Royal Air Force. No research had been undertaken to ascertain if this reflects the oral health of recruits joining each Service. This study aimed to pilot a process for collecting dental and sociodemographic data from new recruits to each Service and examine the null hypothesis that no differences in dental health existed.\nDiagnostic criteria were developed, a sample size calculated and data collected at the initial training establishments of each Service.\nData for 432 participants were entered into the analysis. Recruits in the Army sample had a significantly greater prevalence of dental decay and greater treatment resource need than either of the other two Services. Army recruits had a mean number of 2.59 (2.08, 3.09) decayed teeth per recruit, compared to 1.93 (1.49, 2.39 p<0.01) in Royal Navy recruits and 1.26 (0.98, 1.53 p<0.001) in Royal Air Force recruits. Among Army recruits 62.7% were from the two most deprived quintiles of the Index of Multiple Deprivation compared to 42.5% of Royal Naval recruits and 36.6% of Royal Air Force recruits.\nIs there a differential in the dental health of new recruits to the British Armed Forces?",
        "answer": "yes",
        "answer_rationale": "A significant difference in dental health between recruits to each Service does exist and is a likely to be a reflection of the sociodemographic background from which they are drawn.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a differential in the dental health of new recruits to the British Armed Forces. The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided. The study compared dental health among new recruits in the Army, Royal Navy, and Royal Air Force. The key findings were that Army recruits had a significantly higher prevalence of dental decay and more treatment needs. The mean number of decayed teeth was 2.59 for the Army, which is higher than the Navy's 1.93 and the Air Force's 1.26. The p-values here are less than 0.01 and 0.001, which are statistically significant. Also, a higher percentage of Army recruits came from the most deprived areas, which might correlate with dental health.\n\nThe question is about whether there's a differential. Since the data shows statistically significant differences in decayed teeth and treatment needs between the Army and the other two services, the answer should be yes. The null hypothesis was that there's no difference, but the results reject that. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 246
        },
        "time_elapsed": 3.747227907180786
    },
    {
        "realidx": "22117569",
        "question": "An effective advance care planning programme involves an organizational wide commitment and preparedness for health service reform to embed advance care planning into routine practice. Internationally, such programmes have been implemented predominantly in aged and acute care with more recent work in primary care.\nA multi-site action research was conducted over a 16-month period in 2007-2009 with three Victorian community palliative care services. Using mixed method data collection strategies to assess feasibility, we conducted a baseline audit of staff and clients; analysed relevant documents (client records, policies, procedures and quality improvement strategies) pre-implementation and post-implementation and conducted key informant interviews (n\u2003=\u20039).\nThree community palliative care services: one regional and two metropolitan services in Victoria, Australia.\nThe services demonstrated that it was feasible to embed the Model into their organizational structures. Advance care planning conversations and involvement of family was an important outcome measure rather than completion rate of advance care planning documents in community settings. Services adapted and applied their own concept of community, which widened the impact of the model. Changes to quality audit processes were essential to consolidate the model into routine palliative care practice.\nIs an advance care planning model feasible in community palliative care?",
        "answer": "yes",
        "answer_rationale": "An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether an advance care planning model is feasible in community palliative care based on the provided study.\n\nFirst, I need to recall the details from the passage. The study was a multi-site action research over 16 months in Victorian community palliative care services. They used mixed methods: audits, document analysis, and interviews. The key findings mentioned that the services demonstrated it was feasible to embed the Model into their organizational structures. They also noted that advance care planning conversations and family involvement were important, and that adapting the concept of community helped widen the model's impact. Plus, changing quality audit processes was essential for consolidating the model into routine practice.\n\nThe question is straightforward: is the model feasible? The passage clearly states that feasibility was demonstrated. The answer should be yes. The options are A, B, C. So A is the correct choice. I don't see any hesitation in the conclusion, so \"maybe\" isn't right. The study's results support feasibility, so B is out. Definitely A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 339,
            "completion_tokens": 222
        },
        "time_elapsed": 3.16874098777771
    },
    {
        "realidx": "22154448",
        "question": "To study the risks of haemodynamic instability, and the possible occurrence of spinal haematoma, meningitis and epidural abscess when epidural analgesia is performed for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).\nWe retrospectively analyzed the data of 35 patients treated by HIPEC with oxaliplatin or cisplatin. An epidural catheter was inserted before induction of general anaesthesia. Postoperatively, a continuous epidural infusion of ropivacain, then a patient-controlled epidural analgesia were started.\nThe epidural catheter was used peroperatively before HIPEC in 12 subjects (34%), and after HIPEC in 23 subjects (66%). The median dose of ropivacain given peroperatively in the epidural catheter was 40 mg (30-75). Norepinephrin was used in two subjects (6%) peroperatively (median infusion rate 0.325 \u03bcg/kg per minute [0.32-0.33]), and in four subjects (11%) in the postoperative 24 hours. No spinal haematoma, meningitis or epidural abscess were noted. Five subjects (14%) had a thrombopenia or a prothrombin time less than 60% before catheter removal. Two subjects (6%) had a leukopenia before catheter removal. No thrombopenia or blood coagulation disorders were recorded the day of catheter removal.\nEpidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky technique?",
        "answer": "no",
        "answer_rationale": "In this series of 35 patients, the use of epidural analgesia for HIPEC does not seem to be associated with a worse risk of haemodynamic instability, spinal haematoma, meningitis or epidural abscess. HIPEC with platinum salt is not incompatible with the safety of epidural analgesia, with an optimized fluid management peroperatively and the following of perimedullary anesthesia practice guidelines.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether epidural analgesia is a risky technique for the surgical treatment of peritoneal carcinomatosis, based on the provided study.\n\nFirst, I need to understand the study's findings. The study looked at 35 patients who underwent HIPEC with either oxaliplatin or cisplatin. They used epidural catheters before general anesthesia, and post-op they used continuous infusion of ropivacaine and patient-controlled epidural analgesia. The catheters were placed either before or after HIPEC. \n\nThe key outcomes they were checking for were haemodynamic instability, spinal hematoma, meningitis, and epidural abscess. The results showed that no cases of spinal hematoma, meningitis, or epidural abscess were noted. That's a big point because those are serious complications. \n\nThey did mention that 5 patients (14%) had thrombocytopenia or prothrombin time below 60% before catheter removal, and 2 had leukopenia. However, after removal, there were no thrombocytopenia or coagulation issues on the day of removal. The use of norepinephrine was in a small number (6% perioperative and 11% post-op), which relates to hemodynamic issues, but the question is whether that's considered a major risk. \n\nThe question is whether the technique is \"risky.\" The options are yes, no, maybe. The study's results show that the specific complications they were looking for (spinal hematoma, meningitis, abscess) didn't occur. The other issues like low platelets or coagulation problems before removal didn't lead to actual complications post-removal. The norepinephrine use suggests some hemodynamic instability, but it was managed and maybe not severe enough to be a major risk. Since the main risks they were concerned about didn't materialize, the answer would lean towards \"no\" it's not a risky technique based on this data. The study's conclusion here seems to support that the risks might be manageable or lower than expected. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 436,
            "completion_tokens": 459
        },
        "time_elapsed": 5.206531286239624
    },
    {
        "realidx": "22188074",
        "question": "To investigate whether problems in instrumental activities of daily living (IADL) can add to conventionally used clinical measurements in helping to predict a diagnosis of dementia at 1- and 2-year follow-up.\nMulticenter prospective cohort study.\nMemory clinics in Europe.\nIndividuals aged 55 and older without dementia.\nIADLs were measured using pooled activities from five informant-based questionnaires. Structural equation modeling (SEM) was used to investigate the relation between IADLs and dementia. Age, sex, education, depression, and cognitive measures (Mini-Mental State Examination and verbal memory) were included in the model.\nFive hundred thirty-one participants had baseline and 1-year follow-up assessments; 69 (13.0%) of these had developed dementia at 1-year follow-up. At 2-year follow-up, 481 participants were seen, of whom 100 (20.8%) had developed dementia. Participants with IADL disabilities at baseline had a higher conversion rate (24.4%) than participants without IADL disabilities (16.7%) (chi-square\u00a0=\u00a04.28, degrees of freedom\u00a0=\u00a01, P\u00a0=\u00a0.04). SEM showed that IADL disability could help predict dementia in addition to the measured variables at 1-year follow-up (odds ratio (OR)\u00a0=\u00a02.20, 95% confidence interval (CI)\u00a0= 1.51-3.13) and 2-year follow-up (OR\u00a0=\u00a02.11, 95% CI\u00a0=\u00a01.33-3.33).\nDo instrumental activities of daily living predict dementia at 1- and 2-year follow-up?",
        "answer": "yes",
        "answer_rationale": "IADL disability is a useful addition to the diagnostic process in a memory clinic setting, indicating who is at higher risk of developing dementia at 1- and 2-year follow-up.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether instrumental activities of daily living (IADL) predict dementia at 1- and 2-year follow-ups based on the provided study.\n\nFirst, I need to recall what the study found. The question mentions that the study used a multicenter prospective cohort design. The key results are in the last few sentences. \n\nThe study states that participants with IADL disabilities at baseline had a higher conversion rate to dementia (24.4% vs 16.7%), which was statistically significant (p=0.04). Then, the structural equation modeling (SEM) results show that IADL disability added predictive value beyond other variables. The odds ratios are 2.20 at 1 year and 2.11 at 2 years, both with confidence intervals that don't include 1, indicating statistical significance. \n\nThe options are yes, no, maybe. Since the study clearly found that IADLs were significant predictors at both time points, the answer should be (A) yes. The ORs being over 2 and the p-values under 0.05 support this. The question is whether IADLs \"can add to\" conventional measures, which the SEM analysis confirms. So the answer is definitely yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 458,
            "completion_tokens": 275
        },
        "time_elapsed": 3.573800802230835
    },
    {
        "realidx": "22227642",
        "question": "The aim of this work is to assess a previously described slit-lamp biomicroscopy-based method (SLBM) for measuring pupil diameter and compare it to Colvard infrared pupillometry (CIP).\nTwo examiners performed three repeated measurements with each instrument in 40 healthy eyes. We determined the agreement of SLBM and CIP, intraobserver and interobserver repeatabilities, and interobserver concordance (kappa) and SLBM ability for detecting pupil sizes over 6.0\u00a0mm.\nThe mean (\u00b1standard deviation [SD]) pupil diameter was 5.81 \u00b1 0.70\u00a0mm with SLBM and 6.26 \u00b1 0.68\u00a0mm with CIP (p\u2009=\u20090.01) averaging both examiner's results. Mean differences between the SLBM and CIP were -0.60\u00a0mm and -0.30\u00a0mm for each examiner using the average of the three readings (p\u2009=\u20090.02), and they were very similar using the first reading. Intraobserver reproducibility: the width of the 95% LoA ranged from 1.79 to 2.30\u00a0mm. The ICCs were 0.97 and 0.92 for SLBM, and 0.96 and 0.90 for CIP. Interobserver reproducibility: the width of the LoA ranged from 1.82 to 2.09\u00a0mm. Kappa statistics were 0.39 and 0.49 for the first and mean SLBM readings, respectively, and 0.45 for both the first and mean CIP readings. Sensitivity and specificity of SLBM for detection of pupils larger than 6\u00a0mm ranged from 55.56% to 73.68% and from 76.19% to 95.45%, respectively. The best trade-off between sensitivity and specificity ranged from 5.4\u00a0mm to 6.2\u00a0mm.\nCan we measure mesopic pupil size with the cobalt blue light slit-lamp biomicroscopy method?",
        "answer": "no",
        "answer_rationale": "Although the SLBM is quite repeatable, it underestimates mesopic pupil size and shows a too wide range of agreement with CIP. SLBM shows low sensitivity in detecting pupils larger than 6\u00a0mm, which may be misleading when planning anterior segment surgery. Previous grading-consensus training strategies may increase interrater reproducibility, and compensation for the systematic underestimation could improve accuracy of the SLBM.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether mesopic pupil size can be measured using the cobalt blue light slit-lamp biomicroscopy method (SLBM) based on the provided study.\n\nFirst, I need to recall what mesopic conditions are. Mesopic vision refers to the intermediate level of light between scotopic (low light) and photopic (bright light). Pupil size is typically measured under specific lighting conditions, like in a dark room (mesopic) because pupils are larger then, which is common in eye exams.\n\nThe study compares SLBM with Colvard infrared pupillometry (CIP). The key here is understanding what each method uses. The SLBM uses a slit-lamp with cobalt blue light. The question is whether this setup allows measurement under mesopic conditions. \n\nIn mesopic measurements, the lighting should be dim to allow the pupils to dilate. However, the slit-lamp's cobalt blue light might introduce some illumination, possibly affecting pupil size. The study mentions that the SLBM had a mean pupil diameter of 5.81 mm versus CIP's 6.26 mm. The difference is statistically significant (p=0.01), suggesting that the SLBM might not be as accurate. \n\nThe study's results also show that SLBM's sensitivity and specificity for detecting pupils over 6mm aren't perfect. The kappa values indicate moderate agreement between observers, but not high. The main point is whether the method can measure mesopic pupils. Since the SLBM uses a slit-lamp with its own light, it might not be in true mesopic conditions because the light from the instrument could constrict the pupil. However, the study's aim was to assess SLBM's ability, and they did measure pupil sizes, even if there's a discrepancy with CIP. The question isn't about accuracy but whether it's possible. The study's very existence suggests that they did measure it, so the answer would be yes. But wait, maybe the cobalt blue light isn't in a mesopic setting. Mesopic requires low light, so if the slit-lamp's light is too bright, it might not be mesopic. The study might have controlled the lighting, but the method's use of active illumination might not be suitable for mesopic measurements. The answer could be no. Hmm, the options are yes, no, maybe. The study's abstract says they used SLBM to measure, so they must have done it",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 551,
            "completion_tokens": 512
        },
        "time_elapsed": 6.005621910095215
    },
    {
        "realidx": "22233470",
        "question": "The 58th World Health Assembly called for all health systems to move towards universal coverage where everyone has access to key promotive, preventive, curative and rehabilitative health interventions at an affordable cost. Universal coverage involves ensuring that health care benefits are distributed on the basis of need for care and not on ability to pay. The distribution of health care benefits is therefore an important policy question, which health systems should address. The aim of this study is to assess the distribution of health care benefits in the Kenyan health system, compare changes over two time periods and demonstrate the extent to which the distribution meets the principles of universal coverage.\nTwo nationally representative cross-sectional households surveys conducted in 2003 and 2007 were the main sources of data. A comprehensive analysis of the entire health system is conducted including the public sector, private-not-for-profit and private-for-profit sectors. Standard benefit incidence analysis techniques were applied and adopted to allow application to private sector services.\nThe three sectors recorded similar levels of pro-rich distribution in 2003, but in 2007, the private-not-for-profit sector was pro-poor, public sector benefits showed an equal distribution, while the private-for-profit sector remained pro-rich. Larger pro-rich disparities were recorded for inpatient compared to outpatient benefits at the hospital level, but primary health care services were pro-poor. Benefits were distributed on the basis of ability to pay and not on need for care.\nDoes the distribution of health care benefits in Kenya meet the principles of universal coverage?",
        "answer": "no",
        "answer_rationale": "The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the distribution of healthcare benefits in Kenya meets the principles of universal coverage based on the provided study.\n\nFirst, I need to recall what universal coverage entails. The question's introduction mentions that universal coverage should distribute benefits based on need, not ability to pay. So the key points here are: pro-poor vs pro-rich distribution and whether it's based on need or ability to pay.\n\nLooking at the study's findings: In 2003, all three sectors (public, private-not-for-profit, private-for-profit) were pro-rich. By 2007, the private-not-for-profit became pro-poor, public was equal, and private-for-profit stayed pro-rich. Also, inpatient services at hospitals had larger pro-rich disparities, while primary care was pro-poor. However, the critical point is that benefits were distributed based on ability to pay, not need.\n\nThe principles of universal coverage require distribution based on need, not payment ability. The study's conclusion states that the distribution was based on ability to pay, which contradicts the universal coverage principle. Even though some sectors shifted (like private-not-for-profit being pro-poor and public equal), the overall distribution didn't align because it wasn't need-based. The fact that in 2007, parts were more equitable but still not based on need, and some sectors remained pro-rich, means the answer should be no. The answer options are A, B, C. The correct answer is B (no).\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 401,
            "completion_tokens": 320
        },
        "time_elapsed": 4.304758310317993
    },
    {
        "realidx": "22236315",
        "question": "Distance to provider might be an important barrier to timely diagnosis and treatment for cancer patients who qualify for Medicaid coverage. Whether driving time or driving distance is a better indicator of travel burden is also of interest.\nDriving distances and times from patient residence to primary care provider were calculated for 3,917 breast, colorectal (CRC) and lung cancer Medicaid patients in Washington State from 1997 to 2003 using MapQuest.com. We fitted regression models of stage at diagnosis and time-to-treatment (number of days between diagnosis and surgery) to test the hypothesis that travel burden is associated with timely diagnosis and treatment of cancer.\nLater stage at diagnosis for breast cancer Medicaid patients is associated with travel burden (OR = 1.488 per 100 driving miles, P= .037 and OR = 1.270 per driving hour, P= .016). Time-to-treatment after diagnosis of CRC is also associated with travel burden (14.57 days per 100 driving miles, P= .002 and 5.86 days per driving hour, P= .018).\nIs distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer?",
        "answer": "no",
        "answer_rationale": "Although travel burden is associated with timely diagnosis and treatment for some types of cancer, we did not find evidence that driving time was, in general, better at predicting timeliness of cancer diagnosis and treatment than driving distance. More intensive efforts at early detection of breast cancer and early treatment of CRC for Medicaid patients who live in remote areas may be needed.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether distance to provider is a barrier to care for Medicaid patients with breast, colorectal, or lung cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study included 3,917 patients with those cancers on Medicaid. They looked at driving distance and time, and how that relates to stage at diagnosis and time to treatment.\n\nThe results mention that for breast cancer patients, later stage at diagnosis is associated with both driving miles and hours. The odds ratios are significant (p-values under 0.05). For colorectal cancer, the time-to-treatment increased with both distance and driving time. The p-values here are also significant. However, the question includes lung cancer as well. Wait, the results only mention breast and colorectal. The study's abstract might not have data on lung cancer outcomes? The question includes all three cancers, but the results provided only discuss breast and CRC. Hmm, that's a point to note. \n\nThe question is whether distance is a barrier for any of the three. Since the study shows that for breast and CRC, there is an association between travel burden (distance/time) and later stage or delayed treatment, that suggests distance is a barrier for those two. The lung cancer part isn't addressed in the results given here. But the options are yes, no, maybe. The question is phrased generally for all three. Since at least two of the three cancers (breast and CRC) show an association, the answer would still be yes, because the question is whether distance is a barrier for these patients. The lung cancer data might not be present here, but the question is about whether distance is a barrier in general for these patients. Since two of the three show a significant association, the answer would be yes. The options don't require all three to be affected, just whether it's a barrier. So the correct answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 354,
            "completion_tokens": 415
        },
        "time_elapsed": 5.420706033706665
    },
    {
        "realidx": "22237146",
        "question": "Epidermal growth factor receptor (EGFR) mutations as prognostic or predictive marker in patients with non-small cell lung cancer (NSCLC) have been used widely. However, it may be difficult to get tumor tissue for analyzing the status of EGFR mutation status in large proportion of patients with advanced disease.\nWe obtained pairs of tumor and serum samples from 57 patients with advanced NSCLC, between March 2006 and January 2009. EGFR mutation status from tumor samples was analyzed by genomic polymerase chain reaction and direct sequence and EGFR mutation status from serum samples was determined by the peptide nucleic acid locked nucleic acid polymerase chain reaction clamp.\nEGFR mutations were detected in the serum samples of 11 patients and in the tumor samples of 12 patients. EGFR mutation status in the serum and tumor samples was consistent in 50 of the 57 pairs (87.7%). There was a high correlation between the mutations detected in serum sample and the mutations detected in the matched tumor sample (correlation index 0.62; P<0.001). Twenty-two of 57 patients (38.5%) received EGFR-tyrosine kinase inhibitors as any line therapy. The response for EGFR-tyrosine kinase inhibitors was significantly associated with EGFR mutations in both tumor samples and serum samples (P<0.05). There was no significant differences in overall survival according to the status of EGFR mutations in both serum and tumor samples (P>0.05).\nCan serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?",
        "answer": "yes",
        "answer_rationale": "Serum sample might be alternatively used in the difficult time of getting tumor tissue for analyzing the status of EGFR mutation status in patients with advanced NSCLC.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether serum can be used to analyze EGFR mutation status in advanced NSCLC patients based on the provided study.\n\nFirst, I need to recall what the study found. The study had 57 patients with both tumor and serum samples. They checked EGFR mutations in both. The results showed that in 50 out of 57 pairs (87.7%), the mutation status was consistent between serum and tumor. The correlation index was 0.62, which is statistically significant (P<0.001). Also, response to EGFR-TKIs was linked to mutations in both serum and tumor samples. However, there was no difference in overall survival based on mutation status in either sample.\n\nThe key here is whether serum is a viable alternative when tumor tissue isn't available. The high concordance rate (87.7%) suggests that serum can often reflect the tumor's EGFR status. The correlation being significant also supports this. Since the question is about using serum as an analysis method, the answer would lean towards yes, especially since the study shows a strong association. The fact that response to treatment was associated with mutations in both samples adds credibility. Even though survival didn't differ, the predictive aspect (response to TKIs) is still valid. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 436,
            "completion_tokens": 287
        },
        "time_elapsed": 3.4594926834106445
    },
    {
        "realidx": "22251324",
        "question": "This study investigated associations between the performance of dental students in each of the three components of the selection procedure [academic average, Undergraduate Medicine and Health Sciences Admission Test (UMAT) and structured interview], socio-demographic characteristics and their academic success in an undergraduate dental surgery programme.\nLongitudinal review of admissions data relating to students entering dental education at the University of Otago, New Zealand, between 2004 and 2009 was compared with academic performance throughout the dental programme.\nAfter controlling for variables, pre-admission academic average, UMAT scores and interview performance did not predict performance as a dental student. Class place in second year, however, was a strong predictor of class place in final year. Multivariate analysis demonstrated that the best predictors of higher class placement in the final year were New Zealand European ethnicity and domestic (rather than international) student status. Other socio-demographic characteristics were not associated with performance. These interim findings provide a sound base for the ongoing study.\nDoes performance in selection processes predict performance as a dental student?",
        "answer": "no",
        "answer_rationale": "The study found important socio-demographic differences in pre-admission test scores, but those scores did not predict performance in the dental programme, whether measured in second year or in final year.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether performance in selection processes predicts performance as a dental student based on the provided study.\n\nFirst, I need to look at the study's findings. The abstract mentions that they looked at three components: academic average, UMAT scores, and structured interview performance. After controlling for variables, these three didn't predict dental student performance. However, class place in the second year was a strong predictor for the final year. \n\nThe key part here is that the selection procedures' components (academic average, UMAT, interview) didn't predict success. The question is specifically about the selection processes predicting performance. The study says those pre-admission factors didn't work. The other predictors mentioned are ethnicity and student status (domestic vs international), which are socio-demographic but not part of the selection processes themselves. \n\nSo the answer should be no because the selection components didn't predict performance. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 303,
            "completion_tokens": 200
        },
        "time_elapsed": 2.8724541664123535
    },
    {
        "realidx": "22266735",
        "question": "The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recently recommended new criteria for diagnosing gestational diabetes mellitus (GDM). This study was undertaken to determine whether adopting the IADPSG criteria would be cost-effective, compared with the current standard of care.\nWe developed a decision analysis model comparing the cost-utility of three strategies to identify GDM: 1) no screening, 2) current screening practice (1-h 50-g glucose challenge test between 24 and 28 weeks followed by 3-h 100-g glucose tolerance test when indicated), or 3) screening practice proposed by the IADPSG. Assumptions included that 1) women diagnosed with GDM received additional prenatal monitoring, mitigating the risks of preeclampsia, shoulder dystocia, and birth injury; and 2) GDM women had opportunity for intensive postdelivery counseling and behavior modification to reduce future diabetes risks. The primary outcome measure was the incremental cost-effectiveness ratio (ICER).\nOur model demonstrates that the IADPSG recommendations are cost-effective only when postdelivery care reduces diabetes incidence. For every 100,000 women screened, 6,178 quality-adjusted life-years (QALYs) are gained, at a cost of $125,633,826. The ICER for the IADPSG strategy compared with the current standard was $20,336 per QALY gained. When postdelivery care was not accomplished, the IADPSG strategy was no longer cost-effective. These results were robust in sensitivity analyses.\nScreening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective?",
        "answer": "yes",
        "answer_rationale": "The IADPSG recommendation for glucose screening in pregnancy is cost-effective. The model is most sensitive to the likelihood of preventing future diabetes in patients identified with GDM using postdelivery counseling and intervention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the IADPSG criteria for diagnosing gestational diabetes are cost-effective based on the provided study.\n\nFirst, I need to recall the key points from the study summary. The study used a decision analysis model comparing three strategies: no screening, current screening (which is the 50g GCT followed by 100g GTT), and the IADPSG's proposed method. The main outcome was the incremental cost-effectiveness ratio (ICER). \n\nThe results mentioned that the IADPSG strategy is cost-effective only if postdelivery care reduces diabetes incidence. The numbers given are 6,178 QALYs gained at a cost of around $125 million, leading to an ICER of $20,336 per QALY. The article also states that when postdelivery care isn't done, the IADPSG approach isn't cost-effective. The sensitivity analyses confirmed these results were robust.\n\nNow, the options are yes, no, maybe. The question is whether the criteria are cost-effective. The study's conclusion hinges on the condition of postdelivery care. Since the question is general, but the study says it is cost-effective \"only when\" postdelivery care is effective. However, the options don't have a conditional answer. The options are yes, no, maybe. The study's main conclusion is that under the assumption that postdelivery care works (as per their model's assumptions), the IADPSG is cost-effective. The answer would be yes, but only if that condition holds. However, the question is phrased as \"are the criteria... cost-effective?\" without specifying conditions. But according to the study's own conclusion, when the postdelivery care is in place, it is cost-effective. Since the assumptions included that women have the opportunity for postdelivery counseling, the model's answer under those assumptions is yes. The study's answer is that it is cost-effective under those conditions, so the correct answer would be (A) yes. But wait, the options are (A) yes, (B) no, (C) maybe. The study says that when postdelivery care is done, it is cost-effective, but if not, then no. Since the question is whether the criteria are cost-effective, the answer depends on whether the postdelivery care is implemented. The question doesn't specify, but the study's model assumes that the postdelivery care is part",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 462,
            "completion_tokens": 512
        },
        "time_elapsed": 5.755145788192749
    },
    {
        "realidx": "22302761",
        "question": "It has been shown in vitro that pretreatment of skin with fractional lasers enhances transdermal delivery of drugs. The aim of this study is to demonstrate in vivo firstly that laser enhances transdermal drug absorption and secondly that this can be manipulated by altering laser settings.STUDY DESIGN/\nFour pigs were used in the IACUC approved animal study. On day 0, 5 g of 4% topical lidocaine was applied under occlusion for 60 minutes to a 400 cm(2) area on the abdomen. Blood was drawn at 0, 60, 90, 120, 180, and 240 minutes. On day 7, the Er:YAG laser was used at 500, 250, 50, and 25 \u00b5m ablative depth, respectively, over a 400 cm(2) area on the abdomen. Five grams of 4% topical lidocaine was applied immediately with occlusion for 60 minutes, and then removed. Blood was drawn at 0, 60, 90, 120, 180, and 240 minutes. The serum was extracted and analyzed for lidocaine and its metabolite monoethylglycinexylidide (MEGX).\nSerum levels of lidocaine and MEGX were undetectable in untreated skin. Following laser treatment both lidocaine and MEGX were detectable. Peak levels of lidocaine were significantly higher (P = 0.0002) at 250 \u00b5m (0.62 mg/L), compared to 500 \u00b5m (0.45 mg/L), 50 \u00b5m (0.48 mg/L), and 25 \u00b5m (0.3 mg/L). Peak levels of MEGX were significantly higher (P \u2264 0.0001) at 250 \u00b5m (0.048 mg/L), compared to 500 \u00b5m (0.018 mg/L), 50 \u00b5m (0.036 mg/L), and 25 \u00b5m (0.0144 mg/L).\nCan fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model?",
        "answer": "yes",
        "answer_rationale": "This study demonstrates that laser pretreatment significantly increases absorption of topical lidocaine so that it is detectable in the blood and that manipulating laser settings can affect drug absorption. Future work will look at translating this effect into clinical benefit.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether fractional lasers can enhance the transdermal absorption of lidocaine in pigs. The question is straightforward: can they?\n\nFirst, looking at the study design. They used four pigs. On day 0, they applied lidocaine without any laser, and the serum levels of lidocaine and its metabolite MEGX were undetectable. That's the control. Then, on day 7, after using the Er:YAG laser with different settings (500, 250, 50, 25 \u00b5m depths), they applied the same lidocaine. Now, after the laser treatments, both lidocaine and MEGX were detectable in the serum. That's a key point\u2014without laser, nothing was detected, but with laser, they found the drugs. \n\nThe peak levels varied with the laser settings. The highest peak for lidocaine was at 250 \u00b5m, but even the lower settings like 50 \u00b5m still had higher levels than the control (since control was undetectable). The same goes for MEGX. The p-values are really low, indicating statistical significance. \n\nThe question is asking if fractional lasers can enhance absorption. The study shows that when the laser was used, the drugs were absorbed, whereas without it, they weren't. Even the lowest laser setting (25 \u00b5m) had some detectable levels, which is more than nothing. So the answer should be yes. The options are A, B, C. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 588,
            "completion_tokens": 337
        },
        "time_elapsed": 4.411660194396973
    },
    {
        "realidx": "22348433",
        "question": "The optimum protocol for expander volume adjustment with respect to the timing and application of radiotherapy remains controversial.\nEighteen New Zealand rabbits were divided into three groups. Metallic port integrated anatomic breast expanders of 250 cc were implanted on the back of each animal and controlled expansion was performed. Group I underwent radiotherapy with full expanders while in Group II, expanders were partially deflated immediately prior to radiotherapy. Control group did not receive radiotherapy.The changes in blood flow at different volume adjustments were investigated in Group II by laser Doppler flowmetry. Variations in the histopathologic properties of the irradiated tissues including the skin, capsule and the pocket floor, were compared in the biopsy specimens taken from different locations in each group.\nA significant increase in skin blood flow was detected in Group II with partial expander deflation. Overall, histopathologic exam revealed aggravated findings of chronic radiodermatitis (epidermal atrophy, dermal inflammation and fibrosis, neovascularisation and vascular changes as well as increased capsule thickness) especially around the lower expander pole, in Group II.\nDoes partial expander deflation exacerbate the adverse effects of radiotherapy in two-stage breast reconstruction?",
        "answer": "yes",
        "answer_rationale": "Expander deflation immediately prior to radiotherapy, may augment the adverse effects, especially in the lower expander pole, possibly via enhanced radiosensitization due to a relative increase in the blood flow and tissue oxygenation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether partial deflation of breast expanders before radiotherapy worsens the adverse effects in breast reconstruction. The groups are set up with Group I getting radiotherapy with full expanders, Group II deflating before radiotherapy, and a control without radiotherapy.\n\nThe key findings were that Group II (partial deflation) had a significant increase in skin blood flow. But histopathology showed worse chronic radiodermatitis, like more inflammation, fibrosis, and thicker capsules, especially around the lower pole. The question is if partial deflation exacerbates radiotherapy's adverse effects.\n\nHmm, the histopath results in Group II were worse. Even though blood flow was higher, which might seem like a good thing, the actual tissue damage was more severe. So the answer would be that partial deflation does make the adverse effects worse. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 336,
            "completion_tokens": 195
        },
        "time_elapsed": 2.7648961544036865
    },
    {
        "realidx": "22350859",
        "question": "The objective of this study was to determine the most effective content of pictorial health warning labels (HWLs) and whether educational attainment moderates these effects.\nField experiments were conducted with 529 adult smokers and 530 young adults (258 nonsmokers; 271 smokers). Participants reported responses to different pictorial HWLs printed on cigarette packages. One experiment involved manipulating textual form (testimonial narrative vs. didactic) and the other involved manipulating image type (diseased organs vs. human suffering).\nTests of mean ratings and rankings indicated that pictorial HWLs with didactic textual forms had equivalent or significantly higher credibility, relevance, and impact than pictorial HWLs with testimonial forms. Results from mixed-effects models confirmed these results. However, responses differed by participant educational attainment: didactic forms were consistently rated higher than testimonials among participants with higher education, whereas the difference between didactic and testimonial narrative forms was weaker or not statistically significant among participants with lower education. In the second experiment, with textual content held constant, greater credibility, relevance, and impact was found for graphic imagery of diseased organs than imagery of human suffering.\nCan pictorial warning labels on cigarette packages address smoking-related health disparities?",
        "answer": "yes",
        "answer_rationale": "Pictorial HWLs with didactic textual forms seem to work better than those with testimonial narratives. Future research should determine which pictorial HWL content has the greatest real-world impact among consumers from disadvantaged groups, including assessment of how HWL content should change to maintain its impact as tobacco control environments strengthen and consumer awareness of smoking-related risks increases.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether pictorial warning labels on cigarette packages can address smoking-related health disparities. The options are yes, no, or maybe.\n\nFirst, I need to recall the information given in the study. The study's objective was to find the most effective content for these warnings and see if educational attainment affects their effectiveness. They tested different textual forms (testimonial vs. didactic) and image types (diseased organs vs. human suffering).\n\nFrom the results, didactic text (which is more factual and direct) was rated higher in credibility, relevance, and impact compared to testimonial narratives, especially among higher-educated participants. For those with lower education, the difference wasn't as significant. Also, when the text was constant, images of diseased organs were more effective than human suffering images.\n\nNow, the question is about addressing health disparities. Health disparities often relate to differences in health outcomes among different groups, which could include education levels. The study shows that didactic labels work better for higher-educated individuals, but maybe not as much for lower-educated. However, the diseased organs imagery was more effective overall. \n\nWait, but the key point here is whether the labels can address disparities. Since the effectiveness varies by education, maybe the labels aren't equally effective across all groups. But the study found that even in lower education groups, didactic might still be somewhat effective, just not as much as in higher education. Alternatively, maybe using the more effective images (diseased organs) combined with didactic text could help. The study's results suggest that using the best combinations (didactic and diseased organs) might be more effective overall, but since lower education groups don't show as strong a preference for didactic over testimonial, perhaps a mixed approach could be better. \n\nThe question is whether the labels can address disparities. Since the study shows that certain types of labels work better for different education levels, it implies that by choosing the most effective combinations (like didactic and diseased organs), the warnings could be more effective across the board, potentially reducing disparities. Alternatively, if lower education groups don't respond as well to didactic, maybe the disparity remains. But the fact that the study found that even in lower education, the didactic was not worse by much, and diseased organs were better, suggests that using these labels could help. The answer might be yes because the study shows that certain labels are effective, and by using the most effective ones, disparities could be",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 344,
            "completion_tokens": 512
        },
        "time_elapsed": 5.575213670730591
    },
    {
        "realidx": "22365295",
        "question": "To determine the rate of early infection for totally implantable venous access devices (TIVADs) placed without antibiotic prophylaxis.\nA list of patients who underwent TIVAD placement in 2009 was obtained from the patient archiving and communication system (PACS). This list was cross-referenced to all patients who underwent TIVAD removal from January 1, 2009, through January 30, 2010, to identify TIVADs that were removed within 30 days of placement. Retrospective chart review was performed to record patient demographics, including age, sex, cancer diagnosis, and indication for removal. Concurrent antibiotic therapy, chemotherapy, and laboratory data before and within 30 days of placement were recorded. Central line-associated bloodstream infections (CLABSIs) were identified using U.S. Centers for Disease Control and Prevention (CDC) criteria.\nThere were 1,183 ports placed and 13 removed. CLABSIs occurred in seven (0.6%) patients within 30 days of placement. At the time of TIVAD placement, 81 (7%) patients were receiving antibiotics incidental to the procedure. One patient who received an antibiotic the day of implantation developed a CLABSI. Chemotherapy was administered to 148 (13%) patients on the day of placement.\nTotally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?",
        "answer": "no",
        "answer_rationale": "The rate of early infection without antibiotic prophylaxis before TIVAD placement in the interventional radiology suite is<1%. Based on these data, use of prophylactic antibiotics for TIVAD placement is not recommended.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The main point is to determine whether prophylactic antibiotics are necessary for TIVAD placements based on the study's findings.\n\nFirst, the study looked at TIVADs placed without antibiotic prophylaxis. They had 1,183 devices placed, and only 13 were removed within 30 days. Out of those, seven patients (0.6%) had CLABSIs. That's a pretty low rate. \n\nThe question is asking if prophylactic antibiotics are needed. The key here is that even without antibiotics, the infection rate is low. Also, they mention that 81 patients were on antibiotics for other reasons, and one of those still got an infection. But since the overall rate is only 0.6%, which is under 1%, that suggests that maybe antibiotics aren't necessary. The study's results show that even without prophylaxis, infections are rare. So the answer would lean towards 'no' because the data doesn't support a high enough infection rate to warrant routine antibiotics. The options are A (yes), B (no), C (maybe). The correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 397,
            "completion_tokens": 246
        },
        "time_elapsed": 3.1574039459228516
    },
    {
        "realidx": "22382608",
        "question": "The differential diagnosis between essential tremor (ET) and Parkinson's disease (PD) may be, in some cases, very difficult on clinical grounds alone. In addition, it is accepted that a small percentage of ET patients presenting symptoms and signs of possible PD may progress finally to a typical pattern of parkinsonism. Ioflupane, N-u-fluoropropyl-2a-carbomethoxy-3a-(4-iodophenyl) nortropane, also called FP-CIT, labelled with (123)I (commercially known as DaTSCAN) has been proven to be useful in the differential diagnosis between PD and ET and to confirm dopaminergic degeneration in patients with parkinsonism. The aim of this study is to identify dopaminergic degeneration in patients with PD and distinguish them from others with ET using semi-quantitative SPECT (123)I-Ioflupane (DaTSCAN) data in comparison with normal volunteers (NV), in addition with the respective ones of patients referred as suffering from ET, as well as, of patients with a PD diagnosis at an initial stage with a unilateral presentation of motor signs.\nTwenty-eight patients suffering from ET (10 males plus 18 females) and 28 NV (12 males and 16 females) were enroled in this study. In addition, 33 patients (11 males and 22 females) with an established diagnosis of PD with unilateral limb involvement (12 left hemi-body and 21 right hemi-body) were included for comparison with ET. We used DaTSCAN to obtain SPECT images and measure the radiopharmaceutical uptake in the striatum (S), as well as the caudate nucleus (CN) and putamen (P) in all individuals.\nQualitative (Visual) interpretation of the SPECT data did not find any difference in the uptake of the radiopharmaceutical at the level of the S, CN and P between NV and ET patients. Reduced accumulation of the radiopharmaceutical uptake was found in the P of all PD patients. Semiquantitative analysis revealed significant differences between NV and ET patients in the striatum, reduced in the latter. There was also a significant reduction in the tracer accumulation in the left putamen of patients with right hemi-parkinsonism compared to ET and NV. Patients with left hemi-parkinsonism, demonstrated reduced radioligand uptake in the right putamen in comparison with ET and NV. Clinical follow-up of 20 patients with ET at (so many months afterwards) revealed no significant change in clinical presentation, particularly no signs of PD. Follow-up DaTSCAN performed in 10 of them (so many months afterwards) was negative in all but one. This one had an equivocal baseline study which deteriorated 12\u00a0months later.\nSPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?",
        "answer": "no",
        "answer_rationale": "Our results do not support the hypothesis of a link between essential tremor and Parkinson's disease. However, it appears that ET patients have a small degree of striatal dopaminergic degeneration. If this is due to alterations in the nigrostriatl pathway or of other origin it is not clear. Follow-up studies of essential tremor patients are warranted to assess progression of disease and to understand better the possible cause for striatal dopaminergic degeneration.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a correlation between essential tremor (ET) and Parkinson's disease (PD) based on the SPECT study using I-123-Ioflupane (DaTSCAN). The options are yes, no, or maybe.\n\nFirst, I need to recall what the study found. The study compared ET patients, normal volunteers (NV), and PD patients. The key points from the study are:\n\n1. Qualitative analysis showed no difference between NV and ET in striatum, caudate, and putamen uptake. So ET patients had normal DaTSCAN results visually.\n2. PD patients had reduced uptake in the putamen. That's expected because PD involves dopamine degeneration, which DaTSCAN can detect.\n3. Semiquantitative analysis found that ET patients had reduced striatal uptake compared to NV. Wait, that's interesting. Wait, the summary says \"significant differences between NV and ET patients in the striatum, reduced in the latter.\" So ET patients had lower uptake than normals? But that contradicts the visual which said no difference. Hmm, maybe the semiquantitative is more sensitive? Or maybe a mistake in reading?\n\nWait, the question is about correlation between ET and PD. The study's aim was to see if ET patients might have PD features. The follow-up of 20 ET patients showed no PD signs, and follow-up DaTSCAN in 10 showed no change except one with equivocal baseline that got worse. That one might have been a PD case initially misdiagnosed as ET. \n\nThe main point is that in the initial study, ET patients didn't show the same pattern as PD. PD patients had reduced putamen uptake, but ET didn't. The semiquantitative finding that ET had reduced striatal uptake compared to NV is confusing. Wait, maybe I misread. Let me check again.\n\nThe study says: \"Qualitative (Visual) interpretation... no difference in uptake between NV and ET patients.\" So visually, they looked the same. But semiquantitative analysis found significant differences, with ET having reduced uptake in striatum. That's conflicting. Maybe the semiquantitative is more sensitive but not clinically significant? Or perhaps a typo? Alternatively, maybe the semiquantitative analysis compared ET to NV and found a reduction, but that's unexpected. Wait, but PD patients had reduced putamen uptake. So maybe the ET group's striatal",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 723,
            "completion_tokens": 512
        },
        "time_elapsed": 6.541773557662964
    },
    {
        "realidx": "22453060",
        "question": "Bystander resuscitation plays an important role in lifesaving cardiopulmonary resuscitation (CPR). A significant reduction in the \"no-flow-time\", quantitatively better chest compressions and an improved quality of ventilation can be demonstrated during CPR using supraglottic airway devices (SADs). Previous studies have demonstrated the ability of inexperienced persons to operate SADs after brief instruction. The aim of this pilot study was to determine whether an instruction manual consisting of four diagrams enables laypersons to operate a Laryngeal Mask Supreme\u00ae (LMAS) in the manikin.\nAn instruction manual of four illustrations with speech bubbles displaying the correct use of the LMAS was designed. Laypersons were handed a bag containing a LMAS, a bag mask valve device (BMV), a syringe prefilled with air and the instruction sheet, and were asked to perform and ventilate the manikin as displayed. Time to ventilation was recorded and degree of success evaluated.\nA total of 150 laypersons took part. Overall 145 participants (96.7%) inserted the LMAS in the manikin in the right direction. The device was inserted inverted or twisted in 13 (8.7%) attempts. Eight (5.3%) individuals recognized this and corrected the position. Within the first 2 minutes 119 (79.3%) applicants were able to insert the LMAS and provide tidal volumes greater than 150 ml (estimated dead space). Time to insertion and first ventilation was 83.2 \u00b1 29 s. No significant difference related to previous BLS training (P = 0.85), technical education (P = 0.07) or gender could be demonstrated (P = 0.25).\nDoes a 4 diagram manual enable laypersons to operate the Laryngeal Mask Supreme\u00ae?",
        "answer": "yes",
        "answer_rationale": "In manikin laypersons could insert LMAS in the correct direction after onsite instruction by a simple manual with a high success rate. This indicates some basic procedural understanding and intellectual transfer in principle. Operating errors (n = 91) were frequently not recognized and corrected (n = 77). Improvements in labeling and the quality of instructional photographs may reduce individual error and may optimize understanding.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether a 4-diagram manual helps laypersons use the Laryngeal Mask Supreme (LMAS). The key points from the study are that 150 participants took part. 145 (96.7%) inserted the LMAS correctly. Even though some had it inverted or twisted, a few corrected it. The majority (79.3%) could insert and ventilate properly within 2 minutes. The time to insertion was around 83 seconds. Also, there was no significant difference based on prior training, education, or gender.\n\nThe question is asking if the 4-diagram manual enables them. The results show a high success rate in correct insertion and effective ventilation. Even though some made errors, the overall success is very high. The study's aim was to see if the manual works, and the results support that it does. So the answer should be yes, which is option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 484,
            "completion_tokens": 206
        },
        "time_elapsed": 2.8560330867767334
    },
    {
        "realidx": "22491528",
        "question": "To determine if composite measures based on process indicators are consistent with short-term outcome indicators in surgical colorectal cancer care.\nLongitudinal analysis of consistency between composite measures based on process indicators and outcome indicators for 85 Dutch hospitals.\nThe Dutch Surgical Colorectal Audit database, the Netherlands.\n4732 elective patients with colon carcinoma and 2239 with rectum carcinoma treated in 85 hospitals were included in the analyses.\nAll available process indicators were aggregated into five different composite measures. The association of the different composite measures with risk-adjusted postoperative mortality and morbidity was analysed at the patient and hospital level.\nAt the patient level, only one of the composite measures was negatively associated with morbidity for rectum carcinoma. At the hospital level, a strong negative association was found between composite measures and hospital mortality and morbidity rates for rectum carcinoma (p<0.05), and hospital morbidity rates for colon carcinoma.\nCombining process indicators to evaluate quality of care for surgical patients with colorectal cancer: are scores consistent with short-term outcome?",
        "answer": "maybe",
        "answer_rationale": "For individual patients, a high score on the composite measures based on process indicators is not associated with better short-term outcome. However, at the hospital level, a good score on the composite measures based on process indicators was consistent with more favourable risk-adjusted short-term outcome rates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether composite measures based on process indicators are consistent with short-term outcome indicators in surgical colorectal cancer care. The study they mentioned looked at 85 Dutch hospitals and analyzed data from over 4,000 colon and 2,000 rectum carcinoma patients.\n\nThe key points from the study are that at the patient level, only one composite measure was negatively associated with morbidity for rectum carcinoma. But at the hospital level, there was a strong negative association between the composite measures and both mortality and morbidity for rectum carcinoma, and morbidity for colon carcinoma, with p-values less than 0.05. \n\nThe question is whether combining process indicators to evaluate quality of care shows consistency with outcomes. The options are yes, no, maybe. \n\nHmm, the study found that at the hospital level, there was a significant association, which suggests that the composite measures (process indicators) do align with the outcomes (mortality and morbidity). However, at the patient level, it was only one measure for rectum cancer. But the question is about the consistency in general. Since the hospital-level results showed a strong association, which is a common way to assess hospital performance, the answer would lean towards yes. The study's conclusion probably supports that the composite measures are consistent with outcomes, especially at the hospital level which is the focus for quality evaluation. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 307,
            "completion_tokens": 305
        },
        "time_elapsed": 4.153823614120483
    },
    {
        "realidx": "22497340",
        "question": "To clarify whether horizontal canal ocular reflex is influenced by otolith organs input.\nThe subjects were seven healthy humans. The right ear was stimulated using ice-water. Each subject was kept in a left-ear-down position for 20 s and then repositioned to a prone position, a right-ear-down position and a supine position with 20 s intervals. Nystagmus was analysed using three-dimensional video-oculography.\nEye movements in the supine position and the prone position were not in a symmetric fashion. Nystagmus in the left-ear-down position and the right-ear-down position were not symmetric either. These phenomena indicate that the axis of the eyeball rotation was affected by the shift of the direction of gravity exerted on the head.\nIs horizontal semicircular canal ocular reflex influenced by otolith organs input?",
        "answer": "yes",
        "answer_rationale": "Otolith organs input influences the axis of horizontal semicircular canal ocular reflex; therefore, the plane of compensatory eye movements induced by the horizontal canal stimulation is not always parallel to the canal.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the horizontal semicircular canal ocular reflex is influenced by otolith organ input. The study described involved seven healthy subjects whose right ears were stimulated with ice water. They were positioned in different orientations\u2014left-ear-down, prone, right-ear-down, and supine, each for 20 seconds with intervals. They measured nystagmus using video-oculography.\n\nThe key findings were that the eye movements weren't symmetric between supine and prone positions, and also between left and right ear-down positions. The conclusion given is that the axis of eyeball rotation was affected by gravity's direction on the head. \n\nNow, the question is whether this means the horizontal canal reflex is influenced by otolith input. The otolith organs (utricle and saccule) detect linear acceleration and gravity, which influence the vestibular system's input related to head position. The horizontal semicircular canals primarily detect horizontal angular acceleration. However, the otolith organs might modulate the response of the semicircular canals. \n\nIn the experiment, changing the head position relative to gravity (different positions like left-ear-down vs. right) altered the nystagmus symmetry. Since the otoliths sense gravity's direction, their input could be modifying the horizontal canal's response. The asymmetric nystagmus in different positions suggests that the otolith input is influencing the horizontal canal's ocular reflex. Therefore, the answer should be yes, the horizontal canal reflex is influenced by otolith input. The options are A, B, C. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 266,
            "completion_tokens": 341
        },
        "time_elapsed": 4.2606940269470215
    },
    {
        "realidx": "22504515",
        "question": "The study was performed to evaluate the clinical and technical efficacy of endovenous laser ablation (EVLA) of small saphenous varicosities, particularly in relation to the site of endovenous access.\nTotally 59 patients with unilateral saphenopopliteal junction incompetence and small saphenous vein reflux underwent EVLA (810 nm, 14 W diode laser) with ambulatory phlebectomies. Small saphenous vein access was gained at the lowest site of truncal reflux. Patients were divided into 2 groups: access gained above mid-calf (AMC, n = 33) and below mid-calf (BMC, n = 26) levels. Outcomes included Venous Clinical Severity Scores (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), patient satisfaction, complications, and recurrence rates.\nBoth groups demonstrated significant improvement in VCSS, AVVQ, generic quality of life Short Form 36, and EuroQol scores (P<.05) up to 1 year. No differences were seen between AMC and BMC groups for complications (phlebitis: 2 [6%] and 1 [3.8%], P>.05; paresthesia: 2 [6%] and 5 [19%], P = .223) and recurrence (3 [9%] and 1 [3.8%], P = .623), respectively.\nEndovenous laser ablation in the treatment of small saphenous varicose veins: does site of access influence early outcomes?",
        "answer": "no",
        "answer_rationale": "The site of access in our study does not appear to influence complications specifically neural injury or recurrence rates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about endovenous laser ablation (EVLA) for small saphenous varicosities, specifically looking at whether the site of access (above or below mid-calf) affects early outcomes. The key here is to see if there were differences between the two groups (AMC and BMC) in terms of the outcomes measured.\n\nThe question asks if the site of access influences early outcomes. The outcomes mentioned include VCSS, AVVQ, quality of life scores, complications, and recurrence rates. According to the provided data, both groups showed significant improvements in all those outcome measures up to a year. The important part is that there were no statistically significant differences between the two groups. For example, complications like phlebitis and paresthesia had similar rates (P values above 0.05), and recurrence rates were also not different (P = 0.623). Since the p-values are greater than 0.05, that means the differences observed aren't statistically significant. \n\nSo the answer should be that the site of access does not influence the early outcomes, which corresponds to option B (no). The study's results show that regardless of whether the access was above or below the mid-calf, the outcomes were similar. Therefore, the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 438,
            "completion_tokens": 282
        },
        "time_elapsed": 3.597851276397705
    },
    {
        "realidx": "22513023",
        "question": "To assess whether Indigenous Australians age prematurely compared with other Australians, as implied by Australian Government aged care policy, which uses age 50 years and over for population-based planning for Indigenous people compared with 70 years for non-indigenous people.\nCross-sectional analysis of aged care assessment, hospital and health survey data comparing Indigenous and non-indigenous age-specific prevalence of health conditions. Analysis of life tables for Indigenous and non-indigenous populations comparing life expectancy at different ages.\nAt age 63 for women and age 65 for men, Indigenous people had the same life expectancy as non-indigenous people at age 70. There is no consistent pattern of a 20-year lead in age-specific prevalence of age-associated conditions for Indigenous compared with other Australians. There is high prevalence from middle-age onwards of some conditions, particularly diabetes (type unspecified), but there is little or no lead for others.\nDo Indigenous Australians age prematurely?",
        "answer": "no",
        "answer_rationale": "The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Indigenous Australians age prematurely compared to other Australians based on the provided study results.\n\nFirst, I need to understand the key points from the information given. The Australian Government's aged care policy uses age 50 for Indigenous people versus 70 for non-Indigenous for planning. The study compared life expectancies and prevalence of health conditions. \n\nThe results say that at age 63 for Indigenous women and 65 for men, their life expectancy matches that of non-Indigenous people at 70. That suggests that, in terms of life expectancy, Indigenous Australians' remaining years at those ages are the same as non-Indigenous people a decade older. But the question is about premature aging, which would mean their biological age is higher than their chronological age.\n\nHowever, the study also mentions there's no consistent 20-year lead in age-specific conditions. While some conditions like diabetes are more prevalent from middle age, others don't show this lead. The key here is that the life expectancy part shows a difference (Indigenous at 63/65 have the same life expectancy as non-Indigenous at 70), which might imply they age faster. But the conditions part isn't a consistent 20 years ahead. The question is whether this meets the criteria for premature aging.\n\nThe options are yes, no, maybe. The study's conclusion seems to say that the 20-year lead isn't consistent. The life expectancy part does show an equivalent at 63/65 vs 70, which is a 7-8 year difference, not 20. The question mentions the policy's 20-year difference (age 50 vs 70), but the study found no consistent 20-year lead in conditions. So maybe the answer is no, because the study didn't find the 20-year lead as implied by the policy. The life expectancy difference is there but not exactly 20 years, and the conditions aren't consistently 20 years ahead. The answer would be B) no, because the study's findings don't support the idea of a consistent 20-year premature aging. The policy's use of age 50 might be a guideline, but the data shows it's not a 20-year difference in all aspects. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 278,
            "completion_tokens": 498
        },
        "time_elapsed": 6.018435716629028
    },
    {
        "realidx": "22522271",
        "question": "Forty obese patients with T2DM without clinical features of Cushing's syndrome were recruited. Plasma, urinary and salivary cortisol were measured directly by an enzyme-linked immunosorbent assay using monoclonal antibodies. The specificities of the three tests using various cutoffs were calculated and compared, employing the assumption that none of the patients had hypercortisolism.\nThe patients had a mean age and BMI of 56 years (range 31-75) and 37 kg/m\u00b2 (31-56) respectively. All 40 provided late-night salivary cortisol samples. Thirty-eight patients completed all three tests. Two patients only completed two screening tests. The specificities of late-night salivary cortisol (cutoff 10 nmol/L), 24hr UFC (400 nmol) and 1mg DST (50 nmol/L) were 70% (95% CI 53-83%), 90% (76-97%) and 72% (55-85%) respectively. The specificity of late-night salivary cortisol was significantly less than 24 hr UFC (P=0.039) but not 1mg DST (P>0.99).\nIs late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes?",
        "answer": "no",
        "answer_rationale": "Late-night salivary cortisol has a poor specificity for cortisol excess in obese patients with T2DM with 24 hr UFC showing significantly better specificity in our population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether late-night salivary cortisol is a better screening test for cortisol excess in obese T2DM patients compared to standard tests. The options are yes, no, maybe.\n\nFirst, I need to recall what specificity means. Specificity is the ability of a test to correctly identify those without the condition (true negatives). A higher specificity means fewer false positives. The question is about whether the late-night salivary cortisol is better, so I need to compare its specificity to the other tests mentioned.\n\nLooking at the data provided: the specificities were 70% for late-night salivary (cutoff 10), 90% for 24hr UFC (400), and 72% for 1mg DST (50). The study says that the specificity of salivary cortisol was significantly less than 24hr UFC (p=0.039), but not different from the 1mg DST (p>0.99). \n\nSince the question is about being a \"better\" screening test, and assuming that better here refers to higher specificity (since they're comparing specificities), the salivary cortisol has lower specificity than the 24hr UFC. The 24hr UFC had 90% specificity, which is higher. The 1mg DST was similar. So compared to the standard tests (which would include both the 24hr UFC and the 1mg DST?), the salivary cortisol isn't better because it's worse than one and similar to the other. \n\nThe options are (A) yes, (B) no, (C) maybe. Since the specificity is lower than one of the standard tests (24hr UFC) and not better than the other (1mg DST), it's not a better test overall. Therefore, the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 389,
            "completion_tokens": 401
        },
        "time_elapsed": 5.243112325668335
    },
    {
        "realidx": "22532370",
        "question": "To provide insight into the factors by which obesity in itself may directly lead to early arterial damage, we aimed to determine early sonographic markers of obesity-related vascular dysfunction in young obese males.\nThirty-five young obese males and 23 age-matched healthy male volunteers were recruited into the study. Common carotid artery pulsatility index and resistance index were calculated from blood flow velocities curves obtained by pulsed Doppler ultrasonography.\nThe mean pulsatility index, resistance index, body mass index, waist circumference, systolic and diastolic blood pressure, homeostasis model assessment for insulin resistance, plasma fasting glucose, insulin, C-peptide, triglycerides, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were statistically higher in obese subjects than in healthy controls.\nAre increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males?",
        "answer": "yes",
        "answer_rationale": "Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether obesity directly leads to early arterial damage in young males by checking specific ultrasound markers. The main focus here is on the pulsatility index (PI) and resistance index (RI) of the carotid artery.\n\nThe study compared 35 obese males with 23 healthy controls. The results showed that the mean PI and RI were statistically higher in the obese group. The question is asking if these increased indexes are early signs of vascular abnormalities in this population.\n\nHmm, so the key points here are that higher PI and RI typically indicate increased resistance in the blood vessels. In healthy individuals, lower resistance would mean better vascular function. Since the obese group had higher values, that suggests their arteries are stiffer or have more resistance, which could be an early sign of vascular issues like atherosclerosis or endothelial dysfunction. The study's results support that these indices are higher in the obese group compared to controls, so the answer should be yes. The options are A, B, C. The question is whether the increased indexes are early signs. Since the study found a statistical difference, the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 272,
            "completion_tokens": 242
        },
        "time_elapsed": 3.777787208557129
    },
    {
        "realidx": "22534881",
        "question": "The correlation between radiographic transition zone on contrast enema in Hirschsprung's disease and the total length of aganglionosis is known to be inaccurate. The aim of our study was to analyse this correlation more precisely to improve preoperative planning of the corrective surgery.\nFrom 1998 to 2009, 79 patients were operated on for Hirschsprung's disease. All available preoperative contrast enemas (n = 61) had been single blind reviewed by the same radiologist who defined the radiographic transition zone when present in vertebral level. Four groups were determined (rectal, rectosigmoid, long segment, and absence of transition zone) and by Kappa coefficient of agreement correlated to the length of aganglionosis in the pathological report.\nRadiological findings were concordant with the specimen in pathology in 8 cases of 19 in rectal form (42 %), in 20 cases of 35 in rectosigmoid form (57 %), in all 6 cases of long-segment form (100 %), in the 2 cases of total colonic form (100 %) with a global agreement of 58.1 %, \u03ba = 0.39 CI [0.24; 0.57].\nDoes the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease?",
        "answer": "no",
        "answer_rationale": "Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the radiographic transition zone on a contrast enema correlates with the level of aganglionosis found in the surgical specimen for Hirschsprung's disease. The options are yes, no, or maybe.\n\nFirst, I need to look at the study's results provided. The study included 79 patients, but they analyzed 61 contrast enemas. They divided the cases into four groups based on the radiographic findings: rectal, rectosigmoid, long segment, and absence of transition zone. Then they compared these to the pathology reports to see how well they matched.\n\nThe results show that in the rectal form group, only 42% (8 out of 19) were concordant. For rectosigmoid, it was 57% (20/35). The long-segment and total colonic forms had 100% agreement, but there were only 6 and 2 cases respectively. The overall agreement was 58.1% with a Kappa coefficient of 0.39. \n\nNow, the Kappa coefficient is a measure of inter-rater reliability, but here it's between the radiographic findings and the pathology. A Kappa of 0.39 is considered fair agreement, according to Landis and Koch's benchmarks (where 0.21-0.40 is fair, 0.41-0.60 moderate, etc.). Since the question is about correlation, the key points are the percentage agreement and the Kappa value. \n\nThe overall agreement is just over 50%, which isn't very high. The Kappa being 0.39 suggests that while there's some agreement beyond chance, it's not strong. The question is whether this is considered a \"correlation.\" Since the agreement isn't high (less than 60% overall, and even lower in the more common groups like rectal and rectosigmoid), the answer would lean towards \"no\" because the correlation isn't accurate enough. The study's own statement mentions that the correlation is known to be inaccurate, and their results support that. So the correct answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 392,
            "completion_tokens": 466
        },
        "time_elapsed": 5.489257574081421
    },
    {
        "realidx": "22537902",
        "question": "Synchronous liver metastases (SLM) occur in 20% of colorectal cancers (CRC). Resection of SLM and CLC can be undertaken at different centres (separate management, SM) or at the same centre (global management, GM).\nRetrospective study of SLM and CRC resections carried out during 01/2000 - 12/2006 by SM or GM, using a combined or delayed strategy.\nMorphologic characteristics and type of CRC and SLM resection were similar for the GM (n = 45) or SM (n = 66) groups. In patients with delayed liver resection (62 SM, 17 GM), chemotherapy prior to liver surgery was used in 92% and 38% of SM and GM patients (P<0.0001) and the median delay between procedures was 212 and 182 days, respectively (P = 0.04). First step of liver resection was more often performed during colorectal surgery in the GM group (62 vs. 6% for SM, P<0.0001) and the mean number of procedures (CRC+SLM) was lower (1.6 vs. 2.3, P = 0.003). Three-month mortality was 3% for GM and 0% for SM (n.s.). Overall survival rates were 67% and 51% for SM and GM at 3 years (n.s.), and 35 and 31% at 5 years (n.s.). Disease-free survival to 5 years was higher in SM patients (14% vs. 11%, P = 0.009).\nColorectal cancer with synchronous liver metastases: does global management at the same centre improve results?",
        "answer": "no",
        "answer_rationale": "GM of CRC and SLM was associated with fewer procedures but did not influence overall survival. SM was associated with a longer delay and increased use of chemotherapy between procedures, suggesting that more rigorous selection of SM patients for surgery may explain the higher disease-free survival after SLM resection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether global management (GM) at the same center improves results compared to separate management (SM) for colorectal cancer with synchronous liver metastases.\n\nFirst, I need to look at the data provided in the question. The study compared GM (n=45) and SM (n=66) groups. The key outcomes mentioned are three-month mortality, overall survival rates at 3 and 5 years, and disease-free survival at 5 years.\n\nLooking at three-month mortality: GM had 3% vs. 0% in SM, but it's noted as not significant (n.s.). So no difference there.\n\nOverall survival at 3 years: SM is 67% vs. GM's 51%. Wait, that's actually higher in SM. But the p-value is not significant (n.s.), meaning the difference might be due to chance. At 5 years, both are around 35% and 31%, still not significant. \n\nDisease-free survival at 5 years is where the difference is significant (P=0.009). SM has 14% vs. GM's 11%. So SM is better here. \n\nThe question is whether GM improves results. The options are yes, no, maybe. The study's results don't show better outcomes for GM. In fact, SM had better disease-free survival, which is a significant point. The other survival rates didn't reach significance, but the trend isn't in favor of GM. The mortality was similar. \n\nSo the answer should be (B) no, because the data doesn't support that GM improves results. The significant disease-free survival is worse in GM, and other measures didn't show improvement. The study's non-significant results for overall survival might mean no difference, but since the question is about improvement, GM doesn't seem better. \n\nWait, but maybe I need to check if the question is about any improvement. The options are yes/no/maybe. Since the study didn't find significant better results for GM, the answer would be no. The higher disease-free in SM is a point against GM. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 485,
            "completion_tokens": 461
        },
        "time_elapsed": 5.295362710952759
    },
    {
        "realidx": "22540518",
        "question": "To analyze the reliability of micro-computed tomography (micro-CT) to assess bone density and the microstructure of the maxillary bones at the alveolar process in human clinics by direct comparison with conventional stereologic-based histomorphometry.\nAnalysis of osseous microstructural variables including bone volumetric density (BV/TV) of 39 biopsies from the maxillary alveolar bone was performed by micro-CT. Conventional stereologic-based histomorphometry of 10 bone biopsies was performed by optic microscopy (OM) and low-vacuum surface electronic microscopy (SEM). Percentages of bone between micro-CT and conventional stereologic-based histomorphometry were compared.\nSignificant positive correlations were observed between BV/TV and the percentage of bone (%Bone) analyzed by SEM (r\u00a0=\u00a00.933, P\u00a0<\u00a00.001), by toluidine blue staining OM (r\u00a0=\u00a00.950, P\u00a0<\u00a00.001) and by dark field OM (r\u00a0=\u00a00.667, P\u00a0=\u00a00.05). The high positive correlation coefficient between BV/TV and trabecular thickness illustrates that a value of BV/TV upper than 50% squares with a bone presenting most of their trabecules thicker than 0.2\u00a0mm. The high negative correlation between BV/TV and trabecular separation shows that values of BV/TV upper than 50% squares with a bone presenting most of their trabecules separated less than 0.3\u00a0mm each other.\nIs micro-computed tomography reliable to determine the microstructure of the maxillary alveolar bone?",
        "answer": "yes",
        "answer_rationale": "BV/TV assessed by micro-CT correlates with the percentage of bone assessed by conventional stereologic-based histomorphometry. Micro-CT is a reliable technique to determine the bone density and the microstructure of the maxillary alveolar bone at the site of dental implant insertion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether micro-CT is reliable for determining the microstructure of the maxillary alveolar bone based on the provided study.\n\nFirst, I need to look at the study's findings. The analysis compared micro-CT with conventional methods like OM and SEM. The key points are the correlation coefficients between BV/TV from micro-CT and the histomorphometry results. \n\nThe correlations were significant and positive for SEM (r=0.933), toluidine blue OM (r=0.950), and dark field OM (r=0.667). High r values like 0.93 and above indicate strong positive correlations. Even the lower 0.667 is still a moderate to strong correlation, especially since it's statistically significant (P=0.05). \n\nThe text also mentions that high BV/TV values (over 50%) correlate with thicker trabeculae and closer spacing, which suggests that micro-CT can accurately capture these structural features. Since the correlations are strong and significant, this implies that micro-CT measurements align well with the gold standard histomorphometric methods. \n\nTherefore, the study's results support the reliability of micro-CT. The answer should be \"yes,\" which is option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 450,
            "completion_tokens": 279
        },
        "time_elapsed": 3.5655291080474854
    },
    {
        "realidx": "22617083",
        "question": "To examine age-related differences in the relationship between personality and coping strategies in an Australian population of psychiatric inpatients.\nConsenting eligible adults (N=238) from 18-100 years of age consecutively admitted to inpatient psychiatry units were assessed using the SCID I and II, the Coping Orientations to Problems Experienced Scale (COPE), the Brief Psychiatric Rating Scale (BPRS), the Global Assessment of Functioning Scale (GAF), the Social and Occupational Functioning Assessment Scale (SOFAS), the 12 Item Short-Form Heath Survey (SF12), the Sarason Social Support Questionnaire, and the NEO Five Factor Inventory (NEO-FFI) (cognitively impaired, and non-English speaking patients were excluded).\nOlder adults reported less symptomatology than younger patients and younger patients described more personality dysfunction than older patients. As assessed by the COPE, older adults reported lower levels of dysfunctional coping strategies than younger adults. Personality traits, social supports, gender, and age predicted coping strategies, while Axis I diagnosis, education, personality disorder, and symptom severity were not significant predictors of coping strategies.\nDoes age moderate the effect of personality disorder on coping style in psychiatric inpatients?",
        "answer": "yes",
        "answer_rationale": "This study found that influences on coping were multifactorial and moderated by age. These factors have implications for interventions designed to enhance coping strategies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether age moderates the effect of personality disorder on coping style in psychiatric inpatients based on the study described.\n\nFirst, I need to recall what the study found. The key points from the study are:\n\n- Older adults had less symptomatology compared to younger patients.\n- Younger patients had more personality dysfunction than older ones.\n- Older adults used fewer dysfunctional coping strategies according to the COPE.\n- The predictors of coping strategies included personality traits, social supports, gender, and age. \n- Notably, Axis I diagnosis, education, personality disorder, and symptom severity were not significant predictors.\n\nThe question is about moderation. A moderating effect would mean that the relationship between personality disorder and coping style depends on age. In other words, the effect of personality disorder on coping style is different for different age groups.\n\nLooking at the results, the study states that personality disorder was NOT a significant predictor of coping strategies. Since personality disorder itself isn't a significant predictor, even if age interacts with it, the main effect isn't there. If the main effect isn't significant, the interaction (moderation) might not be present either. The study's results don't mention an interaction term between age and personality disorder. They only mention that age, along with other variables, predicted coping strategies. The absence of personality disorder as a predictor suggests that even when considering age, personality disorder doesn't influence coping style. Therefore, age doesn't moderate an effect that isn't there in the first place. \n\nSo the answer should be B) no, because the study found that personality disorder wasn't a significant predictor, so age can't moderate that non-existent effect.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 345,
            "completion_tokens": 349
        },
        "time_elapsed": 4.44489598274231
    },
    {
        "realidx": "22644412",
        "question": "To evaluate retrospectively whether technical factors of hepatic arterial embolization affect the prognosis of patients with hepatocellular carcinoma (HCC).\nInclusion criteria of this study were the following: (1) patients received embolization as the initial treatment during 2003-2004, (2) Child A or B liver profile, (3) five or fewer HCCs with maximum diameter of 7 cm or smaller, and (4) no extrahepatic metastasis. Patient data were gathered from 43 centers. Prognostic factors were evaluated using univariate and multivariate analyses.\nEight hundred fifteen patients were enrolled. The 1-, 3-, 5-, and 7-year overall survival rates were 92.0 % (95 % CI 90.1-93.9), 62.9 % (95 % CI 59.3-66.6), 39.0 % (95 % CI 35.1-43.0), and 26.7 % (95 % CI 22.6-30.8) in all patients. Univariate analysis showed a Child-Pugh class-A, alpha-fetoprotein level lower than 100 ng/ml, tumor size of 3 cm or smaller, tumor number of 3 or fewer, one-lobe tumor distribution, nodular tumor type, within the Milan criteria, stage I or II, no portal venous invasion, use of iodized oil, and selective embolization were significantly better prognostic factors. In the multivariate Cox model, the benefit to survival of selective embolization remained significant (hazard ratio 0.68; 95 % CI 0.48-0.97; p = 0.033).\nHepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?",
        "answer": "yes",
        "answer_rationale": "Selective embolization contributes to survival in patients with HCCs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether technical factors in hepatic arterial embolization affect the prognosis of HCC patients based on the provided study.\n\nFirst, I need to recall what the study found. The question mentions that the study evaluated technical factors retrospectively. The inclusion criteria are given, and the methods include univariate and multivariate analyses. \n\nLooking at the results: the univariate analysis listed several factors, including \"selective embolization\" as a significant prognostic factor. Then, in the multivariate Cox model, selective embolization still showed a significant benefit (hazard ratio 0.68, p=0.033). \n\nThe key point here is that even after adjusting for other variables in the multivariate analysis, selective embolization remained a significant factor. That means the technical aspect of using selective embolization (as opposed to non-selective) does have an impact on survival. \n\nThe options are yes, no, maybe. Since the study's multivariate analysis confirmed that selective embolization is a significant factor, the answer should be \"yes\". The other factors might also be technical, but the question specifically asks if technical factors (like embolization type) affect prognosis. The study's conclusion supports that at least one technical factor (selective embolization) does matter. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 502,
            "completion_tokens": 290
        },
        "time_elapsed": 3.6941702365875244
    },
    {
        "realidx": "22656647",
        "question": "Preventive home visits are offered to community dwelling older people in Denmark aimed at maintaining their functional ability for as long as possible, but only two thirds of older people accept the offer from the municipalities. The purpose of this study is to investigate 1) whether socioeconomic status was associated with acceptance of preventive home visits among older people and 2) whether municipality invitational procedures for the preventive home visits modified the association.\nThe study population included 1,023 community dwelling 80-year-old individuals from the Danish intervention study on preventive home visits. Information on preventive home visit acceptance rates was obtained from questionnaires. Socioeconomic status was measured by financial assets obtained from national registry data, and invitational procedures were identified through the municipalities. Logistic regression analyses were used, adjusted by gender.\nOlder persons with high financial assets accepted preventive home visits more frequently than persons with low assets (adjusted OR = 1.5 (CI95%: 1.1-2.0)). However, the association was attenuated when adjusted by the invitational procedures. The odds ratio for accepting preventive home visits was larger among persons with low financial assets invited by a letter with a proposed date than among persons with high financial assets invited by other procedures, though these estimates had wide confidence intervals.\nAre acceptance rates of a national preventive home visit programme for older people socially imbalanced?",
        "answer": "yes",
        "answer_rationale": "High socioeconomic status was associated with a higher acceptance rate of preventive home visits, but the association was attenuated by invitational procedures. The results indicate that the social inequality in acceptance of publicly offered preventive services might decrease if municipalities adopt more proactive invitational procedures.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the acceptance rates of the preventive home visit program in Denmark are socially imbalanced. The options are yes, no, or maybe.\n\nFirst, I need to look at the study's findings. The study found that older people with high financial assets were more likely to accept the home visits (adjusted OR 1.5, 95% CI 1.1-2.0). That suggests that those with higher socioeconomic status (as measured by financial assets) are more accepting, which would indicate a social imbalance because the acceptance isn't equal across different socioeconomic groups.\n\nBut then the study mentions that when they adjusted for invitational procedures, the association was attenuated. That means the effect of socioeconomic status was reduced when considering how the municipalities invited people. So maybe the way they invited people (like using a letter with a proposed date) affected the results. Specifically, the odds ratio was larger for low financial asset individuals when invited by a letter with a date, but the confidence intervals were wide, so that might not be statistically significant.\n\nThe key point here is whether the initial association (before adjusting for invitational procedures) shows a social imbalance. Since the adjusted OR was 1.5, which is statistically significant (since the CI doesn't include 1), that indicates that even after adjusting for gender, higher financial assets were associated with higher acceptance. The fact that adjusting for invitational procedures weakened this association suggests that the invitation method might be a mediator or a factor that influences the relationship. However, the question is about whether the acceptance rates are socially imbalanced. The study's first part shows that socioeconomic status (financial assets) is associated with acceptance, so that would mean there is a social imbalance. The invitational procedures might modify that association, but the existence of the association before adjustment implies that without considering the invitation method, there is an imbalance. \n\nThe options are yes, no, maybe. The study's main finding is that there is an association between higher assets and higher acceptance, so the answer would be yes, there is a social imbalance. The fact that invitational procedures modify it might complicate things, but the question is whether the rates are imbalanced, not whether the procedures eliminate the imbalance. Since the adjusted OR (even if attenuated by procedures) still shows an association, the answer is yes. The confidence intervals for the interaction term were wide, but the original association is present. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 367,
            "completion_tokens": 511
        },
        "time_elapsed": 5.938173770904541
    },
    {
        "realidx": "22668712",
        "question": "The aim of this study was to assess the diagnostic value of articular sounds, standardized clinical examination, and standardized articular ultrasound in the detection of internal derangements of the temporomandibular joint.\nForty patients and 20 asymptomatic volunteers underwent a standardized interview, physical examination, and static and dynamic articular ultrasound. Sensitivity, specificity, and predictive values were calculated using magnetic resonance as the reference test.\nA total of 120 temporomandibular joints were examined. Based on our findings, the presence of articular sounds and physical signs are often insufficient to detect disk displacement. Imaging by static and dynamic high-resolution ultrasound demonstrates considerably lower sensitivity when compared with magnetic resonance. Some of the technical difficulties resulted from a limited access because of the presence of surrounding bone structures.\nInternal derangement of the temporomandibular joint: is there still a place for ultrasound?",
        "answer": "no",
        "answer_rationale": "The present study does not support the recommendation of ultrasound as a conclusive diagnostic tool for internal derangements of the temporomandibular joint.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about assessing the diagnostic value of articular sounds, clinical exam, and ultrasound in detecting temporomandibular joint (TMJ) internal derangements. The reference test is MRI.\n\nThe key points from the study: they found that articular sounds and physical signs aren't enough to detect disk displacement. Also, the ultrasound (both static and dynamic) had lower sensitivity compared to MRI. Technical issues like bone structures limiting access were mentioned. The question is asking if there's still a place for ultrasound in diagnosing internal derangement of the TMJ.\n\nHmm, the options are yes, no, maybe. The study says ultrasound has lower sensitivity than MRI. Lower sensitivity means it's less likely to detect the condition when it's present. So maybe it's not as good as MRI. But the question is whether there's still a place for it. Even if it's not as good, maybe it's still used because it's cheaper, more accessible, or doesn't require MRI's resources. The study mentions technical difficulties, but maybe in some cases it's still useful. The conclusion might be that since it's less sensitive, perhaps it's not the best, but the answer options are about whether there's still a place. The abstract says \"considerably lower sensitivity\" so maybe the answer is no? Or maybe the authors are suggesting that despite lower sensitivity, it might still have a role? Wait, the title is a question: \"is there still a place for ultrasound?\" The study's findings might suggest that since ultrasound isn't as good as MRI, maybe it's not the preferred method. But the options are yes/no/maybe. The study's conclusion probably says that because of lower sensitivity and technical issues, maybe ultrasound isn't as effective, so the answer would be B) no. But I need to check the exact wording. The study states that ultrasound has lower sensitivity compared to MRI, so perhaps it's not as good. The question is whether there's still a place. If MRI is the reference and ultrasound is worse, maybe the answer is no. Alternatively, maybe in some contexts ultrasound is still used because it's non-invasive, cheaper, or real-time. The abstract mentions technical difficulties, so maybe the answer is no. The study's conclusion might be that ultrasound isn't sufficient, so the answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 272,
            "completion_tokens": 491
        },
        "time_elapsed": 5.901566028594971
    },
    {
        "realidx": "22668852",
        "question": "The high prevalence of obesity in African American (AA) women may result, in part, from a lower resting metabolic rate (RMR) than non-AA women. If true, AA women should require fewer calories than non-AA women to maintain weight. Our objective was to determine in the setting of a controlled feeding study, if AA women required fewer calories than non-AA women to maintain weight.\nThis analysis includes 206 women (73% AA), aged 22-75 years, who participated in the Dietary Approaches to Stop Hypertension (DASH) trial-a multicenter, randomized, controlled, feeding study comparing the effects of 3 dietary patterns on blood pressure in individuals with prehypertension or stage 1 hypertension. After a 3-week run-in, participants were randomized to 1 of 3 dietary patterns for 8 weeks. Calorie intake was adjusted during feeding to maintain stable weight. The primary outcome of this analysis was average daily calorie (kcal) intake during feeding.\nAA women had higher baseline weight and body mass index than non-AA women (78.4 vs 72.4 kg, P<.01; 29.0 vs 27.6 kg/m(2), P<.05, respectively). During intervention feeding, mean (SD) kcal was 2168 (293) in AA women and 2073 (284) in non-AA women. Mean intake was 94.7 kcal higher in AA women than in non-AA women (P<.05). After adjustment for potential confounders, there was no difference in caloric intake between AA and non-AA women (\u0394 = -2.8 kcal, P = .95).\nDo African American women require fewer calories to maintain weight?",
        "answer": "no",
        "answer_rationale": "These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether African American (AA) women require fewer calories than non-AA women to maintain their weight. The hypothesis was that because of a possibly lower resting metabolic rate, AA women might need fewer calories. \n\nThe study included 206 women, 73% AA. They were part of the DASH trial, which compared different diets. The key point here is that during the feeding study, the calorie intake was adjusted to maintain stable weight. So the idea is that if AA women have a lower RMR, they would need fewer calories to maintain weight, right?\n\nLooking at the results: the mean calorie intake during the intervention was 2168 for AA women and 2073 for non-AA. That's a difference of about 95 kcal, which was statistically significant (P<0.05). But then, after adjusting for confounders, the difference went away. The adjusted result showed a delta of -2.8 kcal, which isn't significant (P=0.95). \n\nSo the raw data showed AA women ate more calories, but that might be because they were heavier. When they adjusted for factors like weight or BMI, the difference disappeared. The conclusion here is that after accounting for those variables, there's no real difference in the calories needed between the two groups. Therefore, the answer should be no, AA women don't require fewer calories. The initial thought was maybe their lower RMR would mean less, but the study's adjusted results didn't support that. The correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 334
        },
        "time_elapsed": 4.081624507904053
    },
    {
        "realidx": "22680064",
        "question": "To determine the ability of early sonogram to predict the presentation of twin A at birth.\nA retrospective cohort study was conducted on all twin pregnancies evaluated at our Fetal Evaluation Unit from 2007 to 2009. Sonogram records were reviewed for the presentation of twin A at seven gestational age intervals and inpatient medical records were reviewed for the presentation of twin A at delivery. The positive predictive value, sensitivity, and specificity of presentation as determined by ultrasound, at each gestational age interval, for the same presentation at delivery were calculated.\nTwo hundred and thirty-eight twin pregnancies met inclusion criteria. A total of 896 ultrasounds were reviewed. The positive predictive value of cephalic presentation of twin A as determined by ultrasound for the persistence of cephalic presentation at delivery reached 95% after 28 weeks gestation. The positive predictive value for noncephalic presentation as established by sonogram for noncephalic at delivery was>90% after 32 weeks gestation.\nCan third trimester ultrasound predict the presentation of the first twin at delivery?",
        "answer": "yes",
        "answer_rationale": "The presentation of the first twin at delivery can be determined by sonogram by the 32nd week of gestation in over 90% of twin pregnancies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether third trimester ultrasound can predict the presentation of the first twin at delivery. The provided information is from a study.\n\nFirst, I need to recall what the positive predictive value (PPV) means. PPV is the probability that a positive result on the test (ultrasound here) is indeed true. So if the PPV is high, it means that when the ultrasound says the baby is in a certain position, it's likely to be correct at delivery.\n\nThe study says that for twin A's cephalic (head-down) presentation, the PPV reached 95% after 28 weeks. For noncephalic (like breech or transverse) presentation, the PPV was over 90% after 32 weeks. The third trimester typically starts at 27 weeks, so both 28 and 32 weeks fall within that period. \n\nSince the PPV is high after those gestational ages, that suggests that the ultrasound is quite accurate in predicting the presentation at delivery once the pregnancy is past those weeks. The question is about the third trimester in general. Since after 28 weeks (well into the third trimester) the PPV is 95% for cephalic and even higher for noncephalic by 32 weeks, it seems the answer would be yes. The options are A, B, C. The correct answer should be A (yes) because the study's results show high predictive values in the third trimester.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 315,
            "completion_tokens": 325
        },
        "time_elapsed": 4.129636287689209
    },
    {
        "realidx": "22683044",
        "question": "Some studies suggest that open access articles are more often cited than non-open access articles. However, the relationship between open access and citations count in a discipline such as intensive care medicine has not been studied to date. The present article analyzes the effect of open access publishing of scientific articles in intensive care medicine journals in terms of citations count.\nWe evaluated a total of 161 articles (76% being non-open access articles) published in Intensive Care Medicine in the year 2008. Citation data were compared between the two groups up until April 30, 2011. Potentially confounding variables for citation counts were adjusted for in a linear multiple regression model.\nThe median number (interquartile range) of citations of non-open access articles was 8 (4-12) versus 9 (6-18) in the case of open access articles (p=0.084). In the highest citation range (>8), the citation count was 13 (10-16) and 18 (13-21) (p=0.008), respectively. The mean follow-up was 37.5 \u00b1 3 months in both groups. In the 30-35 months after publication, the average number (mean \u00b1 standard deviation) of citations per article per month of non-open access articles was 0.28 \u00b1 0.6 versus 0.38 \u00b1 0.7 in the case of open access articles (p=0.043). Independent factors for citation advantage were the Hirsch index of the first signing author (\u03b2=0.207; p=0.015) and open access status (\u03b2=3.618; p=0.006).\nDoes open access publishing increase the impact of scientific articles?",
        "answer": "yes",
        "answer_rationale": "Open access publishing and the Hirsch index of the first signing author increase the impact of scientific articles. The open access advantage is greater for the more highly cited articles, and appears in the 30-35 months after publication.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether open access publishing increases the impact of scientific articles based on the provided study.\n\nFirst, I need to look at the study's results. The study compared 161 articles in intensive care medicine from 2008, split into open access (OA) and non-OA. The median citations were 8 vs. 9, but the p-value was 0.084, which is not statistically significant. However, when looking at the highest citation range (>8), OA articles had a higher median (18 vs. 13) with a p=0.008, which is significant. Also, in the regression model, open access status had a significant beta coefficient (\u03b2=3.618; p=0.006), indicating it's an independent factor for citation advantage. The mean citations per month over 30-35 months were higher for OA (0.38 vs 0.28, p=0.043), another significant result.\n\nThe question is whether OA increases impact. The key here is the statistical significance. Even though the initial median comparison wasn't significant, the higher citation range and the regression analysis both show significant effects. The p-values below 0.05 in those cases suggest that OA does have a positive effect. The Hirsch index also played a role, but OA was still significant independently. So the answer should be yes (A). The study's results support that OA articles have a citation advantage, especially in the longer term and higher citation brackets.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 478,
            "completion_tokens": 338
        },
        "time_elapsed": 4.019718408584595
    },
    {
        "realidx": "22694248",
        "question": "Although the retroperitoneal approach has been the preferred choice for open urological procedures, retroperitoneoscopy is not the preferred approach for laparoscopy. This study aims to develop a training model for retroperitoneoscopy and to establish an experimental learning curve.\nFifteen piglets were operated on to develop a standard retroperitoneoscopic nephrectomy (RPN) training model. All procedures were performed with three ports. Intraoperative data (side, operative time, blood loss, peritoneal opening) were recorded. Animals were divided into groups A, the first eight, and B, the last seven cases. Data were statistically analyzed.\nWe performed fifteen RPNs. The operative time varied from 15 to 50 minutes (median 30 minutes). Blood loss varied from 5 to 100 mL (median 20 mL). We experienced five peritoneal openings; we had two surgical vascular complications managed laparoscopically. There was statistical difference between groups A and B for peritoneal opening (p = 0.025), operative time (p = 0.0037), and blood loss (p = 0.026).\nRPN in a porcine model could simulate the whole procedure, from creating the space to nephrectomy completion. Experimental learning curve was eight cases, after statistical data analysis.\nIs there a model to teach and practice retroperitoneoscopic nephrectomy?",
        "answer": "yes",
        "answer_rationale": "RPN in a porcine model is feasible and could be very useful for teaching and practicing retroperitoneoscopy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a model to teach and practice retroperitoneoscopic nephrectomy based on the provided study.\n\nFirst, I need to read through the study details carefully. The study used 15 piglets to develop a standard RPN training model. They recorded data like operative time, blood loss, and peritoneal openings. The results showed improvements between groups A (first 8) and B (last 7), with statistical differences in peritoneal opening, time, and blood loss. The conclusion mentions that the RPN in a porcine model could simulate the entire procedure and that the learning curve was established after 8 cases.\n\nThe question is whether a model exists for teaching this procedure. The study's own conclusion states that the porcine model successfully simulated the procedure, which implies that such a model does exist. The answer options are yes, no, maybe. Since the study developed and validated the model, the correct answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 396,
            "completion_tokens": 216
        },
        "time_elapsed": 3.1769096851348877
    },
    {
        "realidx": "22720085",
        "question": "Several studies have shown associations between hyperglycemia and risk of cardiovascular disease (CVD) and mortality, yet glucose-lowering treatment does little to mitigate this risk. We examined whether associations between hyperglycemia and CVD risk were explained by underlying insulin resistance.\nIn 60 middle-aged individuals without diabetes we studied the associations of fasting plasma glucose, 2-hour post oral glucose tolerance test plasma glucose, insulin sensitivity as well as body fat percentage with CVD risk. Insulin sensitivity was measured as the glucose infusion rate during a euglycemic hyperinsulinemic clamp, body fat percentage was measured by dual X-ray absorptiometry, and CVD risk was estimated using the Framingham risk score. Associations of fasting plasma glucose, 2-hour plasma glucose, insulin sensitivity and body fat percentage with the Framingham risk score were assessed in linear regression models.\nBoth fasting and 2-hour plasma glucose levels were associated with higher Framingham risk score (fasting glucose: r(2) = 0.21; 2-hour glucose: r(2) = 0.24; P<0.001 for both), and insulin sensitivity with lower Framingham risk score (r(2) = 0.36; P<0.001). However, adjustment for insulin sensitivity and 2-hour glucose made the effect of fasting glucose non-significant (P = 0.060). Likewise, when adjusting for insulin sensitivity and fasting glucose, the association between 2-hour glucose and Framingham risk score disappeared (P = 0.143). In contrast, insulin sensitivity was still associated with Framingham risk score after adjusting for glucose levels (P<0.001). Body fat was not associated with Framingham risk score when taking insulin sensitivity into account (P = 0.550).\nDoes insulin resistance drive the association between hyperglycemia and cardiovascular risk?",
        "answer": "yes",
        "answer_rationale": "The association between plasma glucose levels and CVD risk is mainly explained by insulin resistance, which raises the question of whether glucose lowering per se without changes in the processes that underlie hyperglycemia should be the sole clinical paradigm in the treatment of type 2 diabetes or its prevention.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether insulin resistance explains the link between hyperglycemia and cardiovascular disease risk. The key points from the study are that both fasting and 2-hour glucose levels were associated with higher Framingham risk scores. But when they adjusted for insulin sensitivity, the effects of fasting and 2-hour glucose became non-significant. However, insulin sensitivity remained significant even after adjusting for glucose levels. \n\nSo the question is asking if insulin resistance (which is the opposite of insulin sensitivity) is driving the association between hyperglycemia and CVD risk. Since when you account for insulin sensitivity, the glucose levels' effects go away, that suggests that the hyperglycemia's association with CVD is actually mediated through insulin resistance. Because once you control for insulin sensitivity (or resistance), the direct effect of glucose isn't significant anymore. The insulin sensitivity still matters on its own, implying that it's the underlying factor. Therefore, the answer should be yes, insulin resistance is driving that association. The body fat not being significant when adjusting for insulin sensitivity also supports that insulin resistance is the main player here.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 488,
            "completion_tokens": 238
        },
        "time_elapsed": 3.4883453845977783
    },
    {
        "realidx": "22758782",
        "question": "Hip fracture in geriatric patients has a substantial economic impact and represents a major cause of morbidity and mortality in this population. At our institution, a regional anesthesia program was instituted for patients undergoing surgery for hip fracture. This retrospective cohort review examines the effects of regional anesthesia (from mainly after July 2007) vs general anesthesia (mainly prior to July 2007) on morbidity, mortality and hospitalization costs.\nThis retrospective cohort study involved data collection from electronic and paper charts of 308 patients who underwent surgery for hip fracture from September 2006 to December 2008. Data on postoperative morbidity, in-patient mortality, and cost of hospitalization (as estimated from data on hospital charges) were collected and analyzed. Seventy-three patients received regional anesthesia and 235 patients received general anesthesia. During July 2007, approximately halfway through the study period, a regional anesthesia and analgesia program was introduced.\nThe average cost of hospitalization in patients who received surgery for hip fracture was no different between patients who receive regional or general anesthesia ($16,789 + 631 vs $16,815 + 643, respectively, P = 0.9557). Delay in surgery and intensive care unit (ICU) admission resulted in significantly higher hospitalization costs. Age, male gender, African American race and ICU admission were associated with increased in-hospital mortality. In-hospital mortality and rates of readmission are not statistically different between the two anesthesia groups.\nRegional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs?",
        "answer": "no",
        "answer_rationale": "There is no difference in postoperative morbidity, rates of rehospitalization, in-patient mortality or hospitalization costs in geriatric patients undergoing regional or general anesthesia for repair of hip fracture. Delay in surgery beyond 3 days and ICU admission both increase cost of hospitalization.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether regional anesthesia compared to general anesthesia in geriatric hip fracture patients decreases morbidity, mortality, and healthcare costs. The options are yes, no, maybe.\n\nFirst, I need to look at the study details provided. The study was a retrospective cohort review with 308 patients. 73 had regional, 235 general. The key results mentioned are that the average cost wasn't different between the two groups (p-value 0.9557, which is way above 0.05, so no statistical difference). Also, in-hospital mortality and readmission rates weren't statistically different either. The factors associated with higher mortality were age, male gender, African American race, and ICU admission, but not the type of anesthesia. \n\nThe question is whether regional anesthesia decreases those outcomes. Since the study found no significant differences in costs, mortality, or morbidity between the two groups, the answer would be that it doesn't decrease them. So the answer should be B) no. The options are A (yes), B (no), C (maybe). The study's results don't support a benefit, so B is correct.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 445,
            "completion_tokens": 254
        },
        "time_elapsed": 3.135704517364502
    },
    {
        "realidx": "22825590",
        "question": "Longitudinal cohort studies in sub-Saharan Africa are urgently needed to understand cardiovascular disease development. We, therefore, explored health behaviours and conventional risk factors of African individuals with optimal blood pressure (BP) (\u2264 120/80 mm Hg), and their 5-year prediction for the development of hypertension.\nThe Prospective Urban Rural Epidemiology study in the North West Province, South Africa, started in 2005 and included African volunteers (n = 1994; aged>30 years) from a sample of 6000 randomly selected households in rural and urban areas.\nAt baseline, 48% of the participants were hypertensive (\u2265 140/90 mmHg). Those with optimal BP (n = 478) were followed at a success rate of 70% for 5 years (213 normotensive, 68 hypertensive, 57 deceased). Africans that became hypertensive smoked more than the normotensive individuals (68.2% vs 49.8%), and they also had a greater waist circumference [ratio of geometric means of 0.94 cm (95% CI: 0.86-0.99)] and greater amount of \u03b3-glutamyltransferase [0.74 U/l (95% CI: 0.62-0.88)]at baseline. The 5-year change in BP was independently explained by baseline \u03b3-glutamyltransferase [R(2) = 0.23, \u03b2 = 0.13 U/l (95% CI: 0.01-0.19)]. Alcohol intake also predicted central systolic BP and carotid cross-sectional wall area (CSWA) at follow-up. Waist circumference was another predictor of BP changes [\u03b2 = 0.18 cm (95% CI: 0.05-0.24)]and CSWA. HIV infection was inversely associated with increased BP.\nAre behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans?",
        "answer": "yes",
        "answer_rationale": "During the 5 years, 24% of Africans with optimal BP developed hypertension. The surge in hypertension in Africa is largely explained by modifiable risk factors. Public health strategies should focus aggressively on lifestyle to prevent a catastrophic burden on the national health system.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether behavioral risk factors are to blame for the conversion from optimal blood pressure to hypertensive status in Black South Africans based on the study provided.\n\nFirst, I need to recall the details from the study summary. The study followed participants with optimal BP (\u2264120/80) and looked at factors predicting the development of hypertension over five years. The key findings mentioned were that those who became hypertensive smoked more (68.2% vs 49.8%), had greater waist circumference, and higher \u03b3-glutamyltransferase. Also, alcohol intake predicted some BP changes and carotid wall area. HIV was inversely related, so maybe not a behavioral factor here.\n\nThe question is about behavioral risk factors. Smoking and alcohol intake are definitely behavioral. Waist circumference could be related to diet and physical activity, which are also behavioral. \u03b3-glutamyltransferase might be linked to alcohol use or other lifestyle factors. Since the study shows that higher smoking and alcohol use were associated with developing hypertension, that points to behavioral factors playing a role. The answer options are yes, no, maybe. The study's data supports that behavioral factors (smoking, alcohol, possibly waist circumference via diet/activity) are contributing. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 541,
            "completion_tokens": 276
        },
        "time_elapsed": 3.473832368850708
    },
    {
        "realidx": "22876568",
        "question": "Celiac disease (CD) is an autoimmune enteropathy characterized by villus atrophy and malabsorption of essential nutrients. Vitamin D deficiency has been described in autoimmune diseases, but its status in prepubertal children with CD has not been adequately studied.\nTo determine the vitamin D status of prepubertal children with CD.\nA retrospective study of prepubertal children aged 3-12 years with CD (n=24) who were compared to prepubertal, non-CD children of the same age (n=50). Children were included in the study if they had a diagnosis of CD by intestinal biopsy, and were not on a gluten-free diet (GFD). Patients were excluded if they had diseases of calcium or vitamin D metabolism, or were receiving calcium or vitamin D supplementation or had other autoimmune diseases. All subjects had their serum 25-hydroxyvitamin D [25(OH)D] level measured.\nThere was no difference in 25(OH)D level between the CD and non-CD children (27.58 +/- 9.91 versus 26.20 +/- 10.45, p = 0.59). However, when the patients were subdivided into obese and non-obese groups, the non-obese CD patients had a significantly higher 25(OH)D level than the obese normal children (28.39 +/- 10.26 versus 21.58 +/- 5.67, p = 0.009). In contrast, there was no difference in 25(OH)D level between non-obese CD patients and non-obese normal children (28.39 +/- 10.26 versus 30.64 +/-12.08, p = 0.52). The season of 25(OH)D measurement was not a significant confounder (p =0.7).\nIs vitamin D deficiency a feature of pediatric celiac disease?",
        "answer": "no",
        "answer_rationale": "Our data showed no difference in 25(OH) D levels between normal children and those with CD when adjusted for body mass index.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether vitamin D deficiency is a feature of pediatric celiac disease based on the provided study.\n\nFirst, I need to recall the study's findings. The study compared prepubertal children with CD (not on a gluten-free diet) to those without CD. The main results were that there was no significant difference in 25(OH)D levels between the CD and non-CD groups overall (p=0.59). That already suggests that, on average, vitamin D levels aren't different between the two groups. \n\nBut then there's a subdivision into obese and non-obese. The non-obese CD patients had higher vitamin D than obese normal children, but that's comparing across groups. The key point here is that when comparing non-obese CD to non-obese non-CD, there was no difference (p=0.52). So within the same obesity category, the CD kids aren't different from controls. \n\nThe question is whether vitamin D deficiency is a feature of CD. Since the overall levels aren't different between CD and non-CD kids, and even when split by obesity (except when comparing non-obese CD to obese controls, which isn't relevant to CD itself), the data doesn't support that CD leads to lower vitamin D. The study's main conclusion would be that vitamin D deficiency isn't a\u7279\u5f81 of CD in these children. \n\nThe options are yes, no, maybe. The study's results don't show a deficiency linked to CD. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 517,
            "completion_tokens": 330
        },
        "time_elapsed": 4.210664749145508
    },
    {
        "realidx": "22902073",
        "question": "The purpose of this study was to investigate whether knowledge of ultrasound-obtained estimated fetal weight (US-EFW) is a risk factor for cesarean delivery (CD).\nRetrospective cohort from a single center in 2009-2010 of singleton, term live births. CD rates were compared for women with and without US-EFW within 1 month of delivery and adjusted for potential confounders.\nOf the 2329 women in our cohort, 50.2% had US-EFW within 1 month of delivery. CD was significantly more common for women with US-EFW (15.7% vs 10.2%; P<.001); after we controlled for confounders, US-EFW remained an independent risk factor for CD (odds ratio, 1.44; 95% confidence interval, 1.1-1.9). The risk increased when US-EFW was>3500 g (odds ratio, 1.8; 95% confidence interval, 1.3-2.7).\nEstimated fetal weight by ultrasound: a modifiable risk factor for cesarean delivery?",
        "answer": "yes",
        "answer_rationale": "Knowledge of US-EFW, above and beyond the impact of fetal size itself, increases the risk of CD. Acquisition of US-EFW near term appears to be an independent and potentially modifiable risk factor for CD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether knowing the ultrasound-estimated fetal weight (US-EFW) is a risk factor for cesarean delivery. The key points here are that it's a retrospective cohort study from a single center between 2009-2010, focusing on singleton term births.\n\nThe results show that 50.2% of the 2329 women had a US-EFW within a month of delivery. The CD rate was higher in those who had the ultrasound (15.7% vs 10.2%, p<0.001). Even after adjusting for confounders, the odds ratio was 1.44, which is statistically significant. Also, when the EFW was over 3500g, the risk increased further (OR 1.8). \n\nThe question is asking if US-EFW is a modifiable risk factor for CD. Now, a modifiable risk factor is something that can be changed or influenced. But here, the US-EFW is just a measurement. The knowledge of the fetal weight might influence the decision to perform a cesarean, like if the baby is estimated to be large (macrosomia), leading to more CD decisions. However, the actual EFW itself isn't something you can modify; it's a diagnostic result. The modifiable part would be the clinical decision based on that information. \n\nWait, but the question is phrased as \"Estimated fetal weight by ultrasound: a modifiable risk factor for cesarean delivery?\" So the study shows that knowing the EFW (even if it's accurate) is associated with higher CD rates. But the EFW is just a measurement. The decision to do a CD based on that could be modifiable. However, the question is about the EFW itself being a modifiable risk factor. Since the EFW is a measurement, not an intervention, it's not modifiable. The study's conclusion suggests that knowing the EFW leads to more CDs, but the EFW isn't something you can change. So the answer would be no, because the EFW itself isn't modifiable. The risk factor here is the knowledge of EFW influencing clinical decisions, but the EFW as a measurement isn't a modifiable factor. Therefore, the correct answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 340,
            "completion_tokens": 494
        },
        "time_elapsed": 6.119236469268799
    },
    {
        "realidx": "23025584",
        "question": "That alcohol consumption is strongly influenced by the drinking behavior of social company has been demonstrated in observational research. However, not everyone is equally vulnerable to other people's drinking, and it is important to unravel which factors underlie these individual differences. This study focuses on the role of psychosocial stress in attempting to explain individual differences in the propensity to imitate alcohol consumption.\nWith a 2 (confederate's drinking condition: alcohol vs. soda) \u00d7 2 (participant's stress condition: stress vs. no stress) experimental design, we tested whether the tendency to imitate other people's drinking was related to participants' induced stress levels. The young male adults (N = 106) were randomly assigned to each of the conditions. In each session, directly after the stress or no-stress period, confederates and participants entered a bar laboratory where we observed their drinking behavior. Prior to entering the session, confederates were instructed to drink alcohol or soda.\nParticipants in both stress and no-stress conditions consumed substantially more alcohol when confederates drank alcohol than when they drank soda. There was no difference in alcohol consumed between stress and no-stress conditions. No moderating effect of stress on the tendency to drink along with peers was found.\nDoes stress increase imitation of drinking behavior?",
        "answer": "no",
        "answer_rationale": "Generally, it appears that among young male adults, imitation of alcohol consumption is a robust phenomenon not dependent on individual stress levels.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether stress affects how much someone imitates others' drinking behavior. The setup was a 2x2 design: confederates drinking alcohol vs soda, and participants under stress or no stress.\n\nThe key results mentioned are that in both stress and no-stress groups, participants drank more alcohol when the confederates had alcohol compared to soda. Also, there was no difference in alcohol consumption between the stress and no-stress conditions. Importantly, they found no moderating effect of stress on the tendency to imitate peers. \n\nThe question is asking if stress increases imitation. Since the study says there was no moderating effect, that means stress didn't make the imitation stronger. Even though both groups imitated, the stress didn't enhance it. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 353,
            "completion_tokens": 178
        },
        "time_elapsed": 2.4694910049438477
    },
    {
        "realidx": "23076787",
        "question": "To explain China's cigarette pricing mechanism and the role of the Chinese State Tobacco Monopoly Administration (STMA) on cigarette pricing and taxation.\nPublished government tobacco tax documentation and statistics published by the Chinese STMA are used to analyse the interrelations among industry profits, taxes and retail price of cigarettes in China.\nThe 2009 excise tax increase on cigarettes in China has not translated into higher retail prices because the Chinese STMA used its policy authority to ensure that retail cigarette prices did not change. The government tax increase is being collected at both the producer and wholesale levels. As a result, the 2009 excise tax increase in China has resulted in higher tax revenue for the government and lower profits for the tobacco industry, with no increase in the retail price of cigarettes for consumers.\nCan increases in the cigarette tax rate be linked to cigarette retail prices?",
        "answer": "no",
        "answer_rationale": "Numerous studies have found that taxation is one of the most effective policy instruments for tobacco control. However, these findings come from countries that have market economies where market forces determine prices and influence how cigarette taxes are passed to the consumers in retail prices. China's tobacco industry is not a market economy; therefore, non-market forces and the current Chinese tobacco monopoly system determine cigarette prices. The result is that tax increases do not necessarily get passed on to the retail price.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether increases in the cigarette tax rate can be linked to cigarette retail prices based on the provided information.\n\nFirst, I need to recall the details from the given scenario. The key points are about China's cigarette pricing mechanism and the role of the STMA. The example given is the 2009 excise tax increase. According to the text, even though the tax went up, the STMA used its policy authority to keep retail prices the same. The tax increase was absorbed at the producer and wholesale levels, leading to higher government revenue and lower industry profits, but no change in what consumers paid.\n\nThe question is whether tax rate increases are linked to retail prices. The example here shows that in this case, the tax hike didn't result in a retail price increase because the STMA intervened. So the answer would be that they aren't necessarily linked because the authority can control retail prices independently of tax changes. The options are yes, no, maybe. Since the example directly states that the tax increase didn't translate to higher retail prices, the correct answer should be B) no. The STMA's role here is crucial because they have the power to keep prices stable even when taxes go up. Therefore, the link isn't automatic; it depends on the STMA's policies. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 266,
            "completion_tokens": 283
        },
        "time_elapsed": 4.031044006347656
    },
    {
        "realidx": "23149821",
        "question": "A higher prevalence of cardiovascular risk factors (CRFs) in HIV-infected patients, together with chronic infection and treatments, has resulted in an increased risk of silent myocardial ischaemia (SMI). The objective of this study was to evaluate whether myocardial SPECT should be used for screening HIV-infected patients with no clinical symptoms of coronary artery disease.\nThe prevalence of SMI detected by myocardial SPECT was determined in 94 HIV-infected patients with a normal clinical cardiovascular examination in relation to anthropomorphic parameters, CRFs, inflammatory and HIV infection status, and treatment.\nCoronary artery disease was detected in nine patients (eight with ischaemia, one with myocardial infarction), corresponding to 9.6 % positivity. All but two of the scintigraphic diagnoses of ischaemia were confirmed by coronarography. Univariate analysis revealed that the overall number of CRFs and the combination of gender and age were associated with a diagnosis of SMI (p<0.05). According to multivariate analysis, the only independent parameter significantly associated with the scintigraphic diagnosis of SMI was the combination of gender and age (p = 0.01). All the positive myocardial SPECT scans were in men older than 52 years with at least two other CRFs. In this subpopulation of 47 patients, the prevalence of SMI detected by myocardial SPECT reached 19.2 %.\nShould HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT?",
        "answer": "maybe",
        "answer_rationale": "In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether HIV-infected patients should be screened for silent myocardial ischemia (SMI) using gated myocardial perfusion SPECT. The options are yes, no, or maybe.\n\nFirst, I need to look at the study's findings provided. The study included 94 HIV patients with no clinical symptoms of coronary artery disease. They found that 9.6% had SMI or myocardial infarction. Out of those, most were confirmed by coronarography. The key point here is that the prevalence was 9.6% overall, but in a subgroup of men over 52 with at least two other cardiovascular risk factors (CRFs), the prevalence was 19.2%. \n\nThe study's objective was to evaluate if SPECT should be used for screening. The results show that SMI can be detected in asymptomatic patients, especially in those with higher risk factors. The multivariate analysis pointed to age, gender (being male), and the number of CRFs as significant factors. \n\nNow, considering screening recommendations. Generally, screening tests are recommended when they can detect a condition early enough to improve outcomes, and when the prevalence is high enough in the target population to make it worthwhile. Here, the overall prevalence is around 10%, but in the high-risk subgroup (older men with multiple CRFs), it's nearly 20%. That's a significant enough rate to consider targeted screening. \n\nHowever, the question is about screening all HIV-infected patients. The study's results suggest that SPECT might be more appropriate for those in the higher-risk subgroup rather than the entire HIV population. Since the answer options are yes, no, or maybe, the study's data supports that it's not necessary for everyone but might be for certain subgroups. The options don't specify subgroup screening, so if the question is about screening all HIV patients, the answer might be \"no\" because the overall prevalence isn't that high. But \"maybe\" could be if considering specific high-risk individuals. Wait, the options are (A) yes, (B) no, (C) maybe. The study's conclusion here is that in the subgroup, the prevalence is higher. The question is whether to screen all HIV patients. Since the majority (especially younger or without CRFs) have a lower risk, maybe the answer is \"maybe\" because it's conditional on certain factors. The study's results indicate that SPECT is useful in",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 413,
            "completion_tokens": 512
        },
        "time_elapsed": 6.151741981506348
    },
    {
        "realidx": "23177368",
        "question": "Immediate breast reconstruction (IBR) provides psychological benefit to many early breast cancer patients however concerns persist regarding its potential impact on chemotherapy delivery. We investigated the association between IBR, complications and adjuvant chemotherapy delivery.\nRetrospective analysis of patients in an academic breast service, who underwent mastectomy, with or without reconstruction, and received adjuvant chemotherapy.\nComparisons were made between 107 patients who received IBR and 113 who received mastectomy alone. Those receiving IBR were on average younger, with lower body mass index (BMI) and better prognoses. Overall complication rates were comparable (mastectomy alone: 45.1% versus IBR: 35.5%, p = 0.2). There was more return to surgery in the IBR group with 11.5% of tissue expanders requiring removal, whilst more seromas occurred in the mastectomy group. There was no significant difference in the median time to chemotherapy.\nDoes immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?",
        "answer": "no",
        "answer_rationale": "We found no evidence that IBR compromised the delivery of adjuvant chemotherapy, although there was a significant incidence of implant infection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether immediate breast reconstruction (IBR) compromises the delivery of adjuvant chemotherapy. The study provided compares two groups: those who had IBR and mastectomy alone.\n\nFirst, I need to look at the key findings from the study. The abstract mentions that the complication rates were comparable between the two groups\u201445.1% for mastectomy alone vs. 35.5% for IBR, but the p-value is 0.2, which isn't statistically significant. That means the difference in complication rates isn't enough to say one group has more complications than the other. \n\nThen, it says there was no significant difference in the median time to chemotherapy. That's important because if IBR delayed chemo, that would be a problem. But since the median time is the same, that suggests that having IBR didn't delay starting chemotherapy. \n\nThe question is about whether IBR compromises chemotherapy delivery. The study's results show that the time to start chemo wasn't different, and complications didn't affect that timeline. The options are yes, no, or maybe. Since the study found no significant difference in the median time, the answer should be no. The complications were similar, so they probably didn't interfere with chemo delivery. The answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 304,
            "completion_tokens": 278
        },
        "time_elapsed": 3.4534730911254883
    },
    {
        "realidx": "23224030",
        "question": "Individuals with type 1 diabetes have a high risk of developing cardiovascular diseases, and it has been reported that they consume a high atherogenic diet. We examined how nutrient intake and adherence to current European nutritional recommendations evolved in a large cohort of European individuals with type 1 diabetes over a period of 7 years.SUBJECTS/\nWe analysed data from the EURODIAB Prospective Complications Study, a European multicentre prospective cohort study. Standardized 3-day dietary records were employed in individuals with type 1 diabetes. One thousand one hundred and two patients (553 men, 549 women, baseline age 33 \u00b1 10 years, duration 15 \u00b1 9 years) had complete nutritional data available at baseline and after 7 years. We calculated mean differences in reported nutrients over time and adjusted these for age, gender, HbA1c and BMI with ANOVA models.\nCompared to baseline, there were minor changes in nutrients. Reported protein (-0.35% energy (en), fat (-1.07% en), saturated fat (-0.25% en) and cholesterol (-7.42 mg/1000 kcal) intakes were lower, whereas carbohydrate (+1.23% en) and fibre (+0.46 g/1000 kcal) intakes were higher at the 7-year follow-up. European recommendations for adequate nutrient intakes were followed in individuals with type 1 diabetes for protein (76% at baseline and 78% at follow-up), moderately for fat (34, 40%), carbohydrate (34, 41%) and cholesterol (39, 47%), but poorly for fibre (1.4, 2.4%) and saturated fat (11, 13%).\nDo European people with type 1 diabetes consume a high atherogenic diet?",
        "answer": "yes",
        "answer_rationale": "European individuals with type 1 diabetes consume a high atherogenic diet as few patients met recommendations for dietary fibre and saturated fat. This study showed minor changes in dietary nutrients and energy intakes over a period of 7 years. Nutrition education needs particular focus on strategies to increase dietary fibre and reduce saturated fat to exploit their potential benefit.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether European people with type 1 diabetes consume a high atherogenic diet. The options are yes, no, or maybe.\n\nFirst, I need to recall what an atherogenic diet consists of. Atherogenic diets are typically high in saturated fats, cholesterol, and trans fats, which contribute to the buildup of plaques in arteries, increasing the risk of cardiovascular diseases. So, the key here is to look at the nutrient intake data provided in the study.\n\nLooking at the study results: compared to baseline, after 7 years, there were minor changes. The reported intakes of protein, fat, saturated fat, and cholesterol decreased, while carbohydrates and fiber increased. But the important part is how they compare to the European recommendations.\n\nThe study mentions that adherence to recommendations was poor for fiber (1.4% to 2.4%) and saturated fat (11% to 13%). Wait, the numbers here might be percentages of people meeting the recommendations? Let me check again. The text says \"European recommendations... were followed in individuals... for protein (76% at baseline and 78% at follow-up), moderately for fat (34, 40%), carbohydrate (34, 41%) and cholesterol (39, 47%), but poorly for fibre (1.4, 2.4%) and saturated fat (11, 13%).\" So those percentages are the proportion of individuals meeting the recommendations. \n\nSo for saturated fat, only 11% at baseline and 13% at follow-up met the recommendations. That's very low. High saturated fat intake is atherogenic. Similarly, cholesterol adherence was 39% and 47%, which is still not great but maybe moderate. But since saturated fat is a major atherogenic factor and only a small percentage are meeting the recommendations, that suggests that most are consuming too much. \n\nAdditionally, even though the absolute intake of saturated fat decreased by 0.25% en over 7 years, that's a small change. The main point is whether their current intake is high. Since adherence is poor, their intake is likely above recommended levels, contributing to atherogenicity. \n\nThe question is whether they consume a high atherogenic diet. Since they're not meeting the recommendations for saturated fat and cholesterol (even if cholesterol's adherence went up a bit), and given that these are key components of",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 484,
            "completion_tokens": 512
        },
        "time_elapsed": 6.070434093475342
    },
    {
        "realidx": "23283159",
        "question": "To investigate the effect of obesity at the start of adolescence on the prevalence, incidence and maintenance of chest wheezing among individuals aged 11-15 years in a birth cohort in a developing country.\nThe seventh follow-up of the 1993 Pelotas birth cohort occurred in 2004 (individuals aged 10-11 years). Between January and August 2008, the eighth follow-up of the cohort was conducted. All the individuals of the original cohort who were alive (who were then adolescents aged between 14 and 15 years) were targets for the study. The International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire was used to define wheezing. In addition to the body mass index (BMI), used to define obesity by the World Health Organization (WHO) criteria, we assessed skinfold thickness.\nFrom the original cohort, 4,349 individuals were located (85.7% follow-up rate). The prevalence of chest wheezing at 11 and 15 years were 13.5% (95% CI: 12.5%-14.5%) and 12.1% (95% CI: 11.1%-13.1%), respectively. The prevalence of wheezing at both times was 4.5% (95% CI: 3.9%-5.1%) and the incidence of wheezing was 7.5% (95% CI: 6.7%-8.3%). Independent of the effect of various confounding variables, the prevalence of wheezing at 15 years was 50% greater among obese individuals than among eutrophic individuals at 11 years (RR 1.53; 95% CI: 1.14-2.05). The greater the skinfold tertile at 11 years, the higher the prevalence of wheezing at 15 years was (p = .011). Weight status and skinfolds did not present any association with incident wheezing. After controlling for confounding factors, the risk of persistent wheezing among obese individuals at 11 years was 1.82 (95% CI: 1.30-2.54).\nIs obesity a risk factor for wheezing among adolescents?",
        "answer": "yes",
        "answer_rationale": "Since obesity at the start of adolescence is associated with asthma symptom persistence, prevention and treatment of obesity may reduce avoidable healthcare costs and disease burden.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether obesity is a risk factor for wheezing among adolescents based on the provided study.\n\nFirst, I need to recall what the study found. The study followed a birth cohort from 1993, and specifically looked at the 7th and 8th follow-ups when the kids were around 11 and 15 years old. They used the ISAAC questionnaire for wheezing and measured obesity via BMI and skinfold thickness.\n\nThe key results mentioned are that the prevalence of wheezing at 15 was 50% higher in obese kids compared to eutrophic (normal weight) ones at age 11. The relative risk (RR) was 1.53 with a 95% CI of 1.14-2.05. Since the CI doesn't include 1, that's statistically significant. Also, higher skinfold tertiles (which indicate more body fat) at 11 were linked to higher wheezing at 15 (p=0.011). \n\nAdditionally, obesity at 11 was associated with a higher risk of persistent wheezing (RR 1.82). However, they found no link between obesity and incident wheezing (new cases). \n\nThe question is whether obesity is a risk factor. A risk factor means that having the factor (obesity here) increases the probability of the outcome (wheezing). The study shows that obese kids at 11 had higher prevalence of wheezing at 15, even after adjusting for confounders. The RR is above 1 and significant. So even though incident wheezing wasn't associated, the prevalence and persistence were. \n\nTherefore, the answer should be yes (A). The study supports obesity as a risk factor for wheezing in adolescents, especially regarding prevalence and persistence.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 597,
            "completion_tokens": 401
        },
        "time_elapsed": 4.709053993225098
    },
    {
        "realidx": "23321509",
        "question": "To evaluate surgical outcome and survival benefit after quaternary cytoreduction (QC) in epithelial ovarian cancer (EOC) relapse.\nWe systematically evaluated all consecutive patients undergoing QC in our institution over a 12-year period (October 2000-January 2012). All relevant surgical and clinical outcome parameters were systematically assessed.\nForty-nine EOC patients (median age: 57; range: 28-76) underwent QC; in a median of 16 months (range:2-142) after previous chemotherapy. The majority of the patients had an initial FIGO stage III (67.3%), peritoneal carcinomatosis (77.6%) and no ascites (67.3%). At QC, patients presented following tumour pattern: lower abdomen 85.7%; middle abdomen 79.6% and upper abdomen 42.9%. Median duration of surgery was 292 min (range: a total macroscopic tumour clearance could be achieved. Rates of major operative morbidity and 30-day mortality were 28.6% and 2%, respectively.Mean follow-up from QC was 18.41 months (95% confidence interval (CI):12.64-24.18) and mean overall survival (OS) 23.05 months (95% CI: 15.5-30.6). Mean OS for patients without vs any tumour residuals was 43 months (95% CI: 26.4-59.5) vs 13.4 months (95% CI: 7.42-19.4); P=0.001. Mean OS for patients who received postoperative chemotherapy (n=18; 36.7%) vs those who did not was 40.5 months (95% CI: 27.4-53.6) vs 12.03 months (95% CI: 5.9-18.18); P<0.001.Multivariate analysis indentified multifocal tumour dissemination to be of predictive significance for incomplete tumour resection, higher operative morbidity and lower survival, while systemic chemotherapy subsequent to QC had a protective significant impact on OS. No prognostic impact had ascites, platinum resistance, high grading and advanced age.\nQuaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?",
        "answer": "yes",
        "answer_rationale": "Even in this highly advanced setting of the third EOC relapse, maximal therapeutic effort combining optimal surgery and chemotherapy appear to significantly prolong survival in a selected patients 'group'.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether quaternary cytoreductive surgery (QC) in ovarian cancer still matters in terms of surgical effort. The options are yes, no, or maybe.\n\nFirst, I need to look at the study's findings provided. The study evaluated 49 patients who underwent QC. The key points from the results are:\n\n- The mean overall survival (OS) was 23.05 months. But when they broke it down, patients with no residual tumor (R0 resection) had a much better OS of 43 months compared to those with residual tumor (13.4 months). The p-value is 0.001, which is statistically significant. That suggests that achieving complete resection is beneficial.\n\n- Also, those who received postoperative chemotherapy had a mean OS of 40.5 months versus 12 months for those who didn't. The p-value here is <0.001, so even more significant. But the question is about the surgical effort, so the chemotherapy effect is a confounder, but the study's multivariate analysis says that post-QC chemotherapy had a protective effect on OS. However, the main point here is that the surgery's success (complete resection) is a major factor.\n\nThe multivariate analysis found that multifocal tumor dissemination predicted incomplete resection, higher morbidity, and lower survival. But the key point is that surgical effort (achieving no residual tumor) is associated with better survival. The study's conclusion seems to support that cytoreduction matters because when they could do a complete resection, survival was better. \n\nThe question is asking if surgical effort \"still\" matters. The study's results show that it does because complete resection leads to better outcomes. The answer should be yes (A). The options are (A) yes, (B) no, (C) maybe. The data clearly shows a benefit when surgery is successful, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 625,
            "completion_tokens": 417
        },
        "time_elapsed": 5.247220754623413
    },
    {
        "realidx": "23347337",
        "question": "To provide equality of cancer care to rural patients, Townsville Cancer Centre administers intensive chemotherapy regimens to rural patients with node-positive breast and metastatic colorectal cancers at the same doses as urban patients. Side-effects were usually managed by rural general practitioners locally.AIM: The aim is to determine the safety of this practice by comparing the profile of serious adverse events and dose intensities between urban and rural patients at the Townsville Cancer Centre.\nA retrospective audit was conducted in patients with metastatic colorectal and node-positive breast cancers during a 24-month period. Fisher's exact test was used for analysis. Rurality was determined as per rural, remote and metropolitan classification.\nOf the 121 patients included, 70 and 51 patients had breast and colon cancers respectively. The urban versus rural patient split among all patients, breast and colorectal cancer subgroups was 68 versus 53, 43 versus 27 and 25 versus 26 respectively. A total of 421 cycles was given with dose intensity of>95% for breast cancer in both groups (P>0.05). Rate of febrile neutropenia was 9.3% versus 7.4% (P = 0.56). For XELOX, rate of diarrhoea was 20% versus 19% (P = 0.66) and rate of vomiting was 20% versus 11% (P = 0.11). Only two patients were transferred to Townsville for admission. No toxic death occurred in either group.\nIs intensive chemotherapy safe for rural cancer patients?",
        "answer": "yes",
        "answer_rationale": "It appears safe to administer intensive chemotherapy regimens at standard doses to rural patients without increased morbidity or mortality. Support for general practitioners through phone or videoconferencing may reduce the safety concerns.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether intensive chemotherapy is safe for rural cancer patients based on the study described. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The aim was to compare serious adverse events and dose intensities between urban and rural patients. The results showed that the dose intensity was over 95% for breast cancer in both groups, and the p-value was greater than 0.05, meaning there's no statistically significant difference between the two groups in terms of dose intensity. \n\nLooking at the side effects: febrile neutropenia rates were 9.3% vs 7.4% (p=0.56), which isn't significant. For XELOX regimen, diarrhea was 20% vs 19% (p=0.66) and vomiting 20% vs 11% (p=0.11). The p-values here are all above 0.05, so no significant differences in adverse events. Also, only two patients were admitted to the hospital, and there were no toxic deaths. \n\nThe question is about safety. Since the adverse event rates are comparable between urban and rural patients, and there were no deaths, the study's results suggest that the rural patients didn't have worse outcomes. The fact that side effects were managed locally and most didn't need transfer indicates that the approach is feasible and safe. The p-values show no statistical difference, so the safety profile is similar. Therefore, the answer should be yes, it's safe. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 436,
            "completion_tokens": 353
        },
        "time_elapsed": 4.064929723739624
    },
    {
        "realidx": "23359100",
        "question": "Heterotopic ossification is a common complication after total hip arthroplasty. Non-steroidal anti-inflammatory drugs (NSAIDs) are known to prevent heterotopic ossifications effectively, however gastrointestinal complaints are reported frequently. In this study, we investigated whether etoricoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor that produces fewer gastrointestinal side effects, is an effective alternative for the prevention of heterotopic ossification.\nWe investigated the effectiveness of oral etoricoxib 90 mg for seven days in a prospective two-stage study design for phase-2 clinical trials in a small sample of patients (n\u2009=\u200942). A cemented primary total hip arthroplasty was implanted for osteoarthritis. Six months after surgery, heterotopic ossification was determined on anteroposterior pelvic radiographs using the Brooker classification.\nNo heterotopic ossification was found in 62 % of the patients that took etoricoxib; 31 % of the patients had Brooker grade 1 and 7 % Brooker grade 2 ossification.\nIs etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?",
        "answer": "yes",
        "answer_rationale": "Etoricoxib seems effective in preventing heterotopic ossification after total hip arthroplasty. This finding further supports the use of COX-2 inhibitors for the prevention of heterotopic ossification following total hip arthroplasty.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether etoricoxib is effective in preventing heterotopic ossification after a total hip arthroplasty based on the study described.\n\nFirst, I need to recall what the study found. The study used a prospective two-stage design with 42 patients. They gave etoricoxib 90 mg orally for seven days. At six months, they checked for heterotopic ossification using the Brooker classification. The results showed 62% had no ossification, 31% had grade 1, and 7% grade 2. \n\nHeterotopic ossification is graded from 0 to 4 in Brooker, where 0 is none, 1 is minimal, 2 is more but not bridging the joint, 3 is bridging but not obliterating the joint space, and 4 is with joint space obliteration. So grades 1 and 2 are considered some degree of ossification, but not severe. \n\nThe question is whether this shows effectiveness. The key here is the percentage of patients without ossification. 62% had no ossification (grade 0), which is a majority. The rest had mild to moderate. Since NSAIDs are known to be effective, and etoricoxib as a COX-2 inhibitor is being tested here. The study's results show a significant portion without ossification, which suggests it's effective. However, the sample size is small (n=42), so the study might not have high statistical power. But the question is whether it's effective based on the study's findings, not the study's limitations. The options are yes, no, maybe. Since the majority had no ossification, and the rest had only low grades, the answer would lean towards yes. The study's results support effectiveness, even if further studies are needed. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 353,
            "completion_tokens": 405
        },
        "time_elapsed": 4.689063787460327
    },
    {
        "realidx": "23361217",
        "question": "There are a number of factors responsible for the longevity of unicompartmental knee replacements (UKR). These include the magnitude of postoperative alignment and the type of material used. The effect of component design and material on postoperative alignment, however, has not been explored.\nWe retrospectively reviewed 89 patients who underwent UKR with robotic guidance. Patients were divided into two groups, according to whether they had received an all-polyethylene inlay component (Inlay group) or a metal-backed onlay component (Onlay group). We explored the magnitude of mechanical alignment correction obtained in both groups.\nMean postoperative mechanical alignment was significantly closer to neutral in the Onlay group (mean=2.8\u00b0; 95% CI=2.4\u00b0, 3.2\u00b0) compared to the Inlay group (mean=3.9\u00b0; 95% CI=3.4\u00b0, 4.4\u00b0) (R2=0.65; P=0.003), adjusting for gender, BMI, age, side and preoperative mechanical alignment (Fig. 2). Further exploration revealed that the thickness of the tibial polyethyelene insert had a significant effect on postoperative alignment when added to the model (R2=0.68; P=0.01).\nDoes the type of tibial component affect mechanical alignment in unicompartmental knee replacement?",
        "answer": "yes",
        "answer_rationale": "Patients who received a metal-backed Onlay tibial component obtained better postoperative mechanical alignment compared to those who received all-polyethylene Inlay prostheses. The thicker overall construct of Onlay prostheses appears to be an important determinant of postoperative alignment. Considering their higher survivorship rates and improved postoperative mechanical alignment, Onlay prostheses should be the first option when performing medial UKR.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the type of tibial component affects mechanical alignment in unicompartmental knee replacements based on the provided study.\n\nFirst, I need to recall the details from the scenario. The study compared two groups: one with all-polyethylene inlay components and the other with metal-backed onlay components. The key findings were that the Onlay group had a mean postoperative mechanical alignment of 2.8\u00b0, which was significantly closer to neutral compared to the Inlay group's 3.9\u00b0. The p-value was 0.003, which is statistically significant. Additionally, the R-squared increased when considering the thickness of the tibial polyethylene insert, further supporting the influence of component design.\n\nThe question is specifically about the type of tibial component. Since the Onlay group (metal-backed) had better alignment, and the study adjusted for other factors like age and BMI, it suggests that the component type does play a role. The mention of the insert thickness also being a factor ties into the component design, which is part of the type of component used. \n\nThe options are yes, no, maybe. The study's results show a significant difference, so the answer should be yes. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 386,
            "completion_tokens": 272
        },
        "time_elapsed": 3.3535823822021484
    },
    {
        "realidx": "23375036",
        "question": "To determine whether the OraQuick\u00ae HIV-1/2 Assay (OraSure Technologies, Inc., Bethlehem, PA, USA) in sputum is a valid tool for HIV surveillance among TB patients.\nA cross sectional study was carried out on sputa of patients diagnosed with tuberculosis. Sputa were tested for antibodies to HIV using OraQuick\u00ae HIV-1/2 Assay (OraSure Technologies, Inc., Bethlehem, PA, USA). The results were compared with results of serum ELISA.\nCompared to serum ELISA, the OraQuick\u00ae HIV-1/2 Assay in sputum specimens reported 90% sensitivity (9/10) and 100% specificity (307/307), with a positive predictive value of 100% (95%CI: 66.37%-100.00%) and a negative predictive value of 99.68% (95%CI: 98.20%-99.99%).\nAn HIV1/2 point of care test on sputum for screening TB/HIV co-infection in Central India - Will it work?",
        "answer": "yes",
        "answer_rationale": "This testing method may provide a useful strategy for conducting HIV surveillance in possible co-infected TB patients at peripheral centres. Since there is no investment on infrastructure, it may be possible for paramedical health professionals to carry out the test, particularly in areas with low HIV endemicity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the OraQuick HIV test in sputum is a valid tool for HIV surveillance among TB patients in Central India. The study provided has some key statistics.\n\nFirst, the sensitivity is 90% (9/10). That means it correctly identified 9 out of 10 HIV-positive cases. But wait, the sample size here is really small\u2014only 10 positive cases. A small sample might affect the reliability of the sensitivity value. The specificity is 100% (307/307), which is great because it means all the HIV-negative cases were correctly identified. The positive predictive value (PPV) is 100%, which is high, but the confidence interval is wide (66.37%-100%), so there's some uncertainty there. The negative predictive value (NPV) is 99.68%, which is very high, and the CI is narrower, so that's more reliable.\n\nNow, considering the context of TB patients, co-infection with HIV is common. A test used for screening needs to have high sensitivity to avoid missing cases, but here the sensitivity is 90%, which is decent but not perfect. However, the low number of positive cases in the study might mean the sensitivity estimate isn't very stable. The high specificity is good because it reduces false positives, which is important to prevent unnecessary treatment. \n\nThe question is whether this test would work for screening in Central India. The high NPV suggests that a negative result is very likely correct, which is useful in a screening context where you want to rule out HIV. The PPV being 100% is good when the prevalence is low, but if the prevalence is higher, the PPV might drop. However, the study's data shows that in their sample, it worked perfectly. \n\nBut the main issue here is the small number of positive cases (only 10) which might not be enough to confirm the test's reliability. The sensitivity could be overestimated because with such a small sample, missing one case would drop it to 80%. So, while the numbers look good on paper, the study's limitations (small sample size) might mean that the test isn't yet validated conclusively. \n\nThe options are yes, no, maybe. The study's results are promising but the sample size for positives is very small. So, maybe the answer is \"",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 343,
            "completion_tokens": 512
        },
        "time_elapsed": 6.008330345153809
    },
    {
        "realidx": "23379759",
        "question": "The aims of the study were to report the rates of recurrent and residual cholesteatoma following primary CAT surgery and to report the rate of conversion to a modified radical mastoidectomy.\nThis was a retrospective review of a single surgeon series between 2006 and 2012.\nIn total 132 second-look operations were undertaken, with a mean interval between primary surgery and second-look procedures of 6 months. The rate of cholesteatoma at second-look surgery was 19.7%, which was split into residual disease (10.6%) and recurrent disease (9.09%). New tympanic membrane defects with cholesteatoma were considered as recurrent disease. Residual disease was defined as cholesteatoma present behind an intact tympanic membrane. The majority of recurrent and residual disease was easily removed at second look (73.1%). Only four cases were converted to a modified radical mastoidectomy (3%) and three cases required a third-look procedure.\nCan early second-look tympanoplasty reduce the rate of conversion to modified radical mastoidectomy?",
        "answer": "yes",
        "answer_rationale": "Combined approach tympanoplasty (CAT) allows for successful treatment of cholesteatoma with rates of recurrent and residual disease comparable to open mastoid surgery. Early timing of second-look procedures allows easier removal of any recurrent or residual disease, which reduces the conversion rate to open mastoidectomy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether early second-look tympanoplasty can reduce the rate of conversion to modified radical mastoidectomy. The provided information is from a study.\n\nFirst, I need to understand the key points from the study. The study looked at 132 second-look operations after primary CAT surgery. The mean time between the first surgery and the second-look was 6 months. They found that 19.7% had cholesteatoma at the second-look: 10.6% residual (behind intact drum) and 9.09% recurrent (new defects). Most of these (73.1%) were easily removed during the second-look. Only 4 cases (3%) needed conversion to modified radical mastoidectomy, and 3 required a third-look.\n\nThe question is whether early second-look reduces conversion to modified radical. The study's conversion rate here is 3%, which is pretty low. The fact that most cases were managed at second-look without needing a more radical procedure suggests that doing the second-look early (since the interval was 6 months) might prevent needing a bigger surgery. Because they caught and addressed the residual or recurrent disease early, they didn't have to do the more extensive mastoidectomy in most cases. The low conversion rate here compared to maybe higher rates without second-looks implies that early intervention helps. So the answer would be yes (A). But wait, the options are (A) yes, (B) no, (C) maybe. The study's data shows that with second-look, conversion was only 3%, which is low. So the answer should be A. The study's results support that early second-look reduces the need for conversion.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 324,
            "completion_tokens": 376
        },
        "time_elapsed": 4.608044385910034
    },
    {
        "realidx": "23412195",
        "question": "This study was designed to compare clinical effectiveness of operative with nonoperative treatment for displaced midshaft clavicular fractures (DMCF).\nWe systematically searched electronic databases (MEDILINE, EMBASE, CLINICAL, OVID, BIOSIS and Cochrane registry of controlled clinical trials) to identify randomized controlled trials (RCTs) in which operative treatment was compared with nonoperative treatment for DMCF from 1980 to 2012. The methodologic quality of trials was assessed. Data from chosen studies were pooled with using of fixed-effects and random-effects models with mean differences and risk ratios for continuous and dichotomous variables, respectively.\nFour RCTs with a total of 321 patients were screened for the present study. Results showed that the operative treatment was superior to the nonoperative treatment regarding the rate of nonunion [95\u00a0% confidence interval (CI) (0.05, 0.43), P\u00a0=\u00a00.0004], malunion [95\u00a0% CI (0.06, 0.34), P\u00a0<\u00a00.00001] and overall complication [95\u00a0% CI (0.43-0.76), P\u00a0=\u00a00.0001]. Subgroup analyses of complications revealed that significant differences were existed in the incidence of neurologic symptoms [95\u00a0% CI (0.20, 0.74), P\u00a0=\u00a00.004] and dissatisfaction with appearance [95\u00a0% CI (0.19, 0.65), P\u00a0=\u00a00.001]. Lack of consistent and standardized assessment data, insufficiency analysis that carried out showed improved functional outcomes (P\u00a0<\u00a00.05) in operative treatment.\nShould displaced midshaft clavicular fractures be treated surgically?",
        "answer": "yes",
        "answer_rationale": "The available evidence suggests that the operative treatment for DMCF is associated with a lower rate of nonunion, malunion and complication than nonoperative treatment. This study supports traditional primary operative treatment for DMCF in active adults.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether displaced midshaft clavicular fractures should be treated surgically based on the provided study.\n\nFirst, I need to understand the study's findings. The study compared operative vs nonoperative treatments for DMCF. They did a systematic review of RCTs from 1980 to 2012. Four RCTs with 321 patients were included. \n\nThe results showed that operative treatment was better in terms of lower rates of nonunion, malunion, and overall complications. Specifically, the confidence intervals for these outcomes didn't include 1 (for risk ratios), and the p-values were significant. Also, subgroup analyses found lower incidence of neurologic symptoms and patient dissatisfaction with appearance in the operative group. Additionally, there was improved functional outcomes with surgery, though they mentioned some limitations like lack of standardized data.\n\nThe question is whether to treat surgically. The options are yes, no, maybe. The study's results favor surgery for better outcomes in those specific areas. However, the answer might depend on clinical judgment. But the study's conclusion seems to support surgery. The options don't mention considering case-by-case, but \"maybe\" could imply that it's not always the case. Wait, but the study's results are pretty strong. The answer options are (A) yes, (B) no, (C) maybe. Since the study shows operative is better in key areas, the answer would lean towards yes. But maybe the \"maybe\" is because of the study's limitations? The study mentions lack of consistent data and insufficient analysis, but the results still showed significance. The question is whether based on the study's results, the answer is yes. The study's conclusion suggests that surgery is better for those outcomes, so the answer should be A. But I need to check if the question is a trick. The study says operative is better for nonunion, malunion, complications, neuro symptoms, and appearance. So the answer is yes. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 484,
            "completion_tokens": 425
        },
        "time_elapsed": 4.853078842163086
    },
    {
        "realidx": "23422012",
        "question": "Vancomycin is the primary treatment for infections caused by methicilin-resistant Staphylococcus aureus (MRSA). The association of vancomycin treatment failures with increased vancomycin minimum inhibitory concentration (MIC) is a well-recognized problem. A number of single-centre studies have identified progressive increases in glycopeptide MICs for S. aureus strains over recent years - a phenomenon known as vancomycin MIC creep. It is unknown if this is a worldwide phenomenon or if it is localized to specific centers.\nThe aim of this study was to evaluate the trend of vancomycin MIC for isolates of MRSA over a 3-year period in a tertiary university hospital in Portugal. MRSA isolates from samples of patients admitted from January 2007 to December 2009 were assessed. Etest method was used to determine the respective vancomycin MIC. Only one isolate per patient was included in the final analysis.\nA total of 93 MRSA isolates were studied. The vancomycin MICs were 0.75, 1, 1.5 and 2 mg/L for 1 (1.1%), 19 (20.4%), 38 (40.9%), 35 (37.6%) isolates, respectively. During the 3 year period, we observed a significant fluctuation in the rate of MRSA with a vancomycin MIC\u2009>\u20091 mg/L (2007: 86.2%; 2008: 93.3%; 2009: 58.8%, p\u2009=\u20090.002). No MRSA isolate presented a MIC\u2009>\u20092 mg/L.\nIs vancomycin MIC creep a worldwide phenomenon?",
        "answer": "no",
        "answer_rationale": "We were unable to find in our institution data compatible to the presence of vancomycin MIC creep during the study period. This phenomenon seems not to be generalized; as a result each institution should systematically monitor MRSA vancomycin MIC over time.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether vancomycin MIC creep is a worldwide phenomenon based on the provided study.\n\nFirst, I need to recall what the passage said. The study was conducted in a tertiary university hospital in Portugal over three years. They found fluctuations in the vancomycin MIC values. The MICs were mostly 1 mg/L and above, but none went over 2 mg/L. The key point here is that the study observed a significant fluctuation in MICs over the three years, which they refer to as MIC creep. However, the passage also mentions that it's unknown if this is a worldwide issue or just specific to certain centers. \n\nThe question is asking if the MIC creep is worldwide. The study's results are from one hospital in Portugal. The passage states that previous studies were single-center, and it's not known if it's a global phenomenon. The current study adds another single-center experience. Since the answer options are yes, no, or maybe, the correct answer would be \"maybe\" because the study doesn't provide evidence for worldwide occurrence, only that it happened in their center. The fact that the study's authors mention it's unknown suggests that more data is needed globally. So the answer should be C.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 472,
            "completion_tokens": 263
        },
        "time_elapsed": 3.378246784210205
    },
    {
        "realidx": "23448747",
        "question": "To examine whether a history of cancer increased the likelihood of a fall in community-dwelling older adults, and if cancer type, stage, or time since diagnosis increased falls.\nA longitudinal, retrospective, cohort study.\nA home- and community-based waiver program in Michigan.\n862 older adults aged 65 years or older with cancer compared to 8,617 older adults without cancer using data from the Minimum Data Set-Home Care and Michigan cancer registry.\nReports of falls were examined for 90-180 days. Generalized estimating equations were used to compare differences between the groups.\nCancer, falls, patient characteristics, comorbidities, medications, pain, weight loss, vision, memory recall, and activities, as well as cancer type, stage, and time since diagnosis.\nA fall occurred at a rate of 33% in older adults with cancer compared to 29% without cancer (p<0.00). Those with a history of cancer were more likely to fall than those without cancer (adjusted odds ratio 1.16; 95% confidence interval [1.02, 1.33]; p = 0.03). No differences in fall rates were determined by cancer type or stage, and the odds of a fall did not increase when adding time since cancer diagnosis.\nDo older adults with cancer fall more often?",
        "answer": "yes",
        "answer_rationale": "The fall rate was higher in older adults with cancer than in older adults without cancer.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether older adults with cancer fall more often based on the provided study.\n\nFirst, I need to look at the study details. The study is a longitudinal, retrospective cohort study comparing 862 older adults with cancer to 8,617 without. The key results mentioned are that 33% of those with cancer fell compared to 29% without, and the adjusted odds ratio was 1.16 with a p-value of 0.03. The p-value being less than 0.05 indicates statistical significance. The odds ratio above 1 means that having cancer is associated with an increased likelihood of falling. \n\nThe question is straightforward: does having a history of cancer increase the chance of falls? The study's results show a statistically significant increase (since the confidence interval doesn't include 1 and the p-value is significant). The answer should be yes. The options are A, B, C. The options given are (A) yes, (B) no, (C) maybe. \n\nWait, the study says the adjusted OR is 1.16, which is significant. So even after adjusting for other factors like comorbidities, the association holds. Therefore, the correct answer is A. The other options don't fit. The study didn't find differences by cancer type or stage, but the main effect of cancer history is present. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 376,
            "completion_tokens": 307
        },
        "time_elapsed": 3.6704208850860596
    },
    {
        "realidx": "23455575",
        "question": "The so-called \"globulomaxillary cyst\", described as a fissural cyst, caused by entrapped epithelium between the nasal and maxillary process, is no longer considered for its own entity. Nevertheless, cystic lesions, which correspond to the previous image of globulomaxillary cysts, do still occur in daily practice. This raises the question to which entities pathological processes in this particular region actually belong to.\nIn a retrospective study, 17 cases (12 men and 5 women, 12-59\u00a0years old) of primarily diagnosed globulomaxillary cysts are analysed according to clinical, radiological and histological aspects, catamnestic processed and assigned to a new entity. The results are compared with the international literature and draws conclusions on the diagnostic and therapeutic procedure.\nSeven lateral periodontal cysts, four radicular cysts, two keratocystic odontogenic tumours, one adenomatoid odontogenic tumour, one periapical granuloma, one residual cyst and one undefined jaw cyst were determined.\nGlobulomaxillary cysts--do they really exist?",
        "answer": "no",
        "answer_rationale": "According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether globulomaxillary cysts really exist based on the provided information.\n\nFirst, I need to recall what the question states. The passage mentions that the \"globulomaxillary cyst,\" also called a fissural cyst, was thought to be caused by entrapped epithelium between the nasal and maxillary processes. However, it's noted that this entity is no longer considered valid. Despite that, cystic lesions in that area still occur, leading to uncertainty about their classification.\n\nThe study analyzed 17 cases initially diagnosed as globulomaxillary cysts. Upon examination, they found various other cysts and tumors instead, like lateral periodontal cysts, radicular cysts, keratocystic odontogenic tumors, etc. Only one was undefined. This suggests that what was previously called globulomaxillary cysts are actually other known entities. \n\nThe key point here is that the study's results show that these cysts don't form a distinct entity but are instead other recognized conditions. The question is whether they \"really exist\" as their own entity. Since the study and the passage state that the entity is no longer considered valid, the answer should be \"no.\" The options are A (yes), B (no), C (maybe). So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 328,
            "completion_tokens": 286
        },
        "time_elapsed": 3.4208550453186035
    },
    {
        "realidx": "23495128",
        "question": "The aim of the present study was to explore patients' views on the acceptability and feasibility of using colour to describe osteoarthritis (OA) pain, and whether colour could be used to communicate pain to healthcare professionals.\nSix group interviews were conducted with 17 patients with knee OA. Discussion topics included first impressions about using colour to describe pain, whether participants could associate their pain with colour, how colours related to changes to intensity and different pain qualities, and whether they could envisage using colour to describe pain to healthcare professionals.\nThe group interviews indicated that, although the idea of using colour was generally acceptable, it did not suit all participants as a way of describing their pain. The majority of participants chose red to describe high-intensity pain; the reasons given were because red symbolized inflammation, fire, anger and the stop signal in a traffic light system. Colours used to describe the absence of pain were chosen because of their association with positive emotional feelings, such as purity, calmness and happiness. A range of colours was chosen to represent changes in pain intensity. Aching pain was consistently identified as being associated with colours such as grey or black, whereas sharp pain was described using a wider selection of colours. The majority of participants thought that they would be able to use colour to describe their pain to healthcare professionals, although issues around the interpretability and standardization of colour were raised.\nThe colour of pain: can patients use colour to describe osteoarthritis pain?",
        "answer": "yes",
        "answer_rationale": "For some patients, using colour to describe their pain experience may be a useful tool to improve doctor-patient communication.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether patients can use colors to describe their osteoarthritis pain. The options are yes, no, or maybe.\n\nFirst, I need to look at the study's findings. The key points from the passage are that while the idea was generally acceptable, it didn't suit everyone. Most participants used red for high-intensity pain, associating it with things like inflammation or anger. Colors like white or blue were for no pain because they represented calmness or happiness. There was a range of colors for pain intensity changes. Aching pain was grey or black, sharp pain had more varied colors. Most thought they could use color to communicate with healthcare pros, but there were concerns about standardization and interpretation.\n\nThe question is asking if patients can use color to describe OA pain. The answer options are yes, no, maybe. The study says the majority thought they could use color, even though not everyone found it suitable and there were issues with standardization. Since the majority said they could, the answer is probably yes. But wait, the question is about the study's conclusion. The study's aim was to explore acceptability and feasibility. The results showed that while not all participants found it suitable, the majority could. So the answer would be yes, but maybe the options are tricky. The options are (A) yes, (B) no, (C) maybe. The study's conclusion seems to support that it is possible for many, so the answer is A. But the question is phrased as \"can patients use color\"\u2014since the majority said they could, the answer is yes. The issues raised (interpretability and standardization) might make someone think maybe, but the question is about the patients' ability, not whether it's perfect. The study's results indicate that they can, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 387,
            "completion_tokens": 388
        },
        "time_elapsed": 5.222595691680908
    },
    {
        "realidx": "23497210",
        "question": "Although record linkage of routinely collected health datasets is a valuable research resource, most datasets are established for administrative purposes and not for health outcomes research. In order for meaningful results to be extrapolated to specific populations, the limitations of the data and linkage methodology need to be investigated and clarified. It is the objective of this study to investigate the differences in ascertainment which may arise between a hospital admission dataset and a dispensing claims dataset, using major depression in pregnancy as an example. The safe use of antidepressants in pregnancy is an ongoing issue for clinicians with around 10% of pregnant women suffer from depression. As the birth admission will be the first admission to hospital during their pregnancy for most women, their use of antidepressants, or their depressive condition, may not be revealed to the attending hospital clinicians. This may result in adverse outcomes for the mother and infant.\nPopulation-based de-identified data were provided from the Western Australian Data Linkage System linking the administrative health records of women with a delivery to related records from the Midwives' Notification System, the Hospital Morbidity Data System and the national Pharmaceutical Benefits Scheme dataset. The women with depression during their pregnancy were ascertained in two ways: women with dispensing records relating to dispensed antidepressant medicines with an WHO ATC code to the 3rd level, pharmacological subgroup, 'N06A Antidepressants'; and, women with any hospital admission during pregnancy, including the birth admission, if a comorbidity was recorded relating to depression.\nFrom 2002 to 2005, there were 96698 births in WA. At least one antidepressant was dispensed to 4485 (4.6%) pregnant women. There were 3010 (3.1%) women with a comorbidity related to depression recorded on their delivery admission, or other admission to hospital during pregnancy. There were a total of 7495 pregnancies identified by either set of records. Using data linkage, we determined that these records represented 6596 individual pregnancies. Only 899 pregnancies were found in both groups (13.6% of all cases). 80% of women dispensed an antidepressant did not have depression recorded as a comorbidity on their hospital records. A simple capture-recapture calculation suggests the prevalence of depression in this population of pregnant women to be around 16%.\nAre women with major depression in pregnancy identifiable in population health data?",
        "answer": "no",
        "answer_rationale": "No single data source is likely to provide a complete health profile for an individual. For women with depression in pregnancy and dispensed antidepressants, the hospital admission data do not adequately capture all cases.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether women with major depression during pregnancy are identifiable in population health data. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study used two datasets: one from dispensing claims (antidepressants) and another from hospital admissions where depression was recorded as a comorbidity. \n\nThe key points from the study are:\n- 4.6% (4485) of pregnant women had antidepressants dispensed.\n- 3.1% (3010) had depression recorded in hospital records.\n- Combining both datasets gave 7495 pregnancies, but after linkage, they found 6596 unique pregnancies. Only 13.6% (899) were in both groups.\n- 80% of those who got antidepressants didn't have depression noted in their hospital records.\n- The capture-recapture estimate suggests a 16% prevalence, which is higher than either dataset alone.\n\nThe question is whether they are identifiable. The study shows that using both datasets captures more cases than either alone, but there's a significant discrepancy. However, the fact that they can identify some cases through each method and combine them suggests that it's possible to identify them, albeit with limitations. The answer might be \"yes\" because they can be identified through at least one of the datasets, even if not all cases are captured in both. The study's purpose was to investigate differences, but the conclusion implies that using both sources gives a better picture, so they are identifiable to some extent. The options don't ask if all cases are captured, just if they are identifiable. Since the data allows identification through either method, the answer is A (yes).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 597,
            "completion_tokens": 371
        },
        "time_elapsed": 4.678837060928345
    },
    {
        "realidx": "23517744",
        "question": "To our knowledge there are no evidence-based medicine data to date to critically judge the vulnerability of a solitary kidney to warm ischemia compared to paired kidneys.\nTen dogs were exposed to open right nephrectomy to create a solitary kidney model (group 1). Ten dogs with both kidneys were considered group 2. All dogs underwent warm ischemia by open occlusion of the left renal artery for 90 minutes. Dogs were sacrificed at different intervals (3 days to 4 weeks). All dogs were reevaluated by renogram before sacrifice and histopathology of the investigated kidney. The proinflammatory markers CD95 and tumor necrosis factor-\u03b1 were assessed using real-time polymerase chain reaction.\nIn group 1 clearance decreased by 20% at 1 week but basal function was regained starting at week 2. In group 2 clearance decreased more than 90% up to week 2. Recovery started at week 3 and by 4 weeks there was a 23% clearance reduction. Histopathological examination in group 1 revealed significant tubular necrosis (60%) at 3 days with regeneration starting at 1 week. In group 2 there was more pronounced tubular necrosis (90%) with regeneration starting at 2 weeks. The expression of proinflammatory markers was up-regulated in each group with higher, more sustained expression in group 2.\nIs solitary kidney really more resistant to ischemia?",
        "answer": "yes",
        "answer_rationale": "Solitary kidney in a canine model is more resistant to ischemia than paired kidneys based on radiological, pathological and genetic evidence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a solitary kidney is more resistant to ischemia based on the study described. \n\nFirst, I need to understand the study setup. They had two groups of dogs: group 1 had a solitary kidney (after right nephrectomy) and group 2 had both kidneys. Both groups underwent 90 minutes of warm ischemia on the left renal artery. Then they were followed up at different times up to 4 weeks. They measured clearance, histopathology, and proinflammatory markers.\n\nLooking at the results for group 1 (solitary kidney): Clearance dropped by 20% at week 1 but recovered by week 2. Histologically, there was 60% tubular necrosis at 3 days, but regeneration started by week 1. \n\nGroup 2 (paired kidneys) had a much worse outcome: over 90% decrease in clearance up to week 2, starting to recover at week 3, but still had a 23% reduction at 4 weeks. Their tubular necrosis was 90%, and regeneration started later (week 2). Also, their proinflammatory markers were higher and more sustained.\n\nThe question is whether the solitary kidney is more resistant. The data shows that group 1 (solitary) had less severe damage and faster recovery compared to group 2. The clearance recovered quicker, and the histology showed less necrosis and earlier regeneration. The proinflammatory response was also less in group 1. So, this suggests that the solitary kidney handled the ischemia better. \n\nTherefore, the answer should be yes (A), because the solitary kidney group had better outcomes in terms of function and histology compared to the paired kidneys. The study's results indicate that the solitary kidney is more resistant to the effects of warm ischemia in this model.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 387,
            "completion_tokens": 392
        },
        "time_elapsed": 4.497097730636597
    },
    {
        "realidx": "23539689",
        "question": "To characterize the use and delivery of cough and cold medicines in children younger than 6 presenting to an inner-city pediatric emergency department (PED) following 2007 FDA warnings.\nA cross-sectional observational study was performed using a convenience sampling of PED patients during the fall of 2010. Caregivers were presented with 6 commonly used cough medicine preparations and were asked to demonstrate if and how they would administer these to their children.\nIn all, 65 patients and their caregivers consented and participated in the study. During the demonstration, 82% (53/65) stated that they would treat with cough or cold medicines, and 72% (38/53) incorrectly dosed the medication they desired to give.\nCold preparation use in young children after FDA warnings: do concerns still exist?",
        "answer": "yes",
        "answer_rationale": "Despite current recommendations, cough and cold medicines are still used in children younger than 6 years of age. A significant portion of caregivers report that they are still unaware of public warnings, potential side effects, and interactions with other medications.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The study is about the use of cough and cold medicines in children under 6 after the 2007 FDA warnings. The study was done in 2010, so a few years after the warnings. They looked at 65 patients in an inner-city PED. 82% said they would use these medicines, and 72% of those couldn't dose correctly. The question is asking if concerns still exist after the FDA warnings.\n\nHmm, the FDA warnings were probably about the safety or effectiveness of these meds in young kids. If even after the warnings, a majority still use them and a significant portion (72%) are dosing wrong, that suggests there's still a problem. The high incorrect dosing rate is a big red flag. So the answer should be \"yes\" because the study shows continued misuse despite the warnings. The options are A, B, C. So A is yes, which would be correct.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 262,
            "completion_tokens": 208
        },
        "time_elapsed": 2.7868998050689697
    },
    {
        "realidx": "23568387",
        "question": "Bicompartmental knee arthroplasty features bone and ligament sparing as unicompartmental knee arthroplasty and is presumably better in the recovery of muscle strength and function compared to total knee arthroplasty (TKA) though not previously reported in the literature. The aim of the study was to compare isokinetic knee muscle strength and physical performance in patients who underwent either bicompartmental knee arthroplasty or TKA.\nEach of 24 patients (31 knees) was prospectively examined preoperatively, at 6 and 12 months after each surgery. Isokinetic knee extensor and flexor strength as well as position sense were measured using the Biodex system. Timed up and go test, stair climbing test, and the 6-min walk test were used to assess physical performance. The results of each group were also compared with those from the corresponding healthy control, respectively.\nDemography showed significant difference in the mean age between bicompartment (54.8 \u00b1 5.6 years) and TKA groups (65.7 \u00b1 6.7 years). Comparing between the two groups, knee extensor and flexor torque, hamstring/Quadriceps ratio, position sense, and physical performance were not significantly different preoperatively, at 6 and 12 months after surgery. In intra-group analysis, muscle strength and position sense at each time point were not different in both groups. In physical performance, both groups resulted in improvement in the 6-min walk test, and only TKA group showed enhancement in stair climbing test.\nIs bicompartmental knee arthroplasty more favourable to knee muscle strength and physical performance compared to total knee arthroplasty?",
        "answer": "no",
        "answer_rationale": "Although theoretically plausible, bicompartmental knee arthroplasty was not superior in knee muscle strength and physical performance at 1 year compared with total knee arthroplasty.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether bicompartmental knee arthroplasty is more favorable for knee muscle strength and physical performance compared to total knee arthroplasty (TKA) based on the study described.\n\nFirst, I need to recall the details from the provided study. The study compared 24 patients (31 knees) who had either bicompartmental or TKA. They measured things like isokinetic muscle strength (extensor and flexor), position sense, and physical performance tests like the timed up and go, stair climbing, and 6-minute walk. The key points from the results are:\n\n- Preoperatively, there were no significant differences between the groups in the measured outcomes.\n- At 6 and 12 months post-surgery, the comparison between the two groups showed no significant differences in knee extensor and flexor torque, hamstring/quadriceps ratio, position sense, or most physical performance measures except for the stair climb test where TKA improved. Both groups improved in the 6-minute walk.\n- The intra-group analysis (looking within each group over time) didn't show differences in muscle strength or position sense at each time point.\n\nThe question is whether bicompartmental is more favorable. The study's results indicate that there were no significant differences between the two groups in muscle strength parameters or most physical performance tests. The only exception was the stair climb test where TKA showed improvement, but that might be due to other factors. Also, the age difference between groups (bicompartmental patients were younger) could be a confounder, but the study didn't mention adjusting for that in their analysis. Since the results didn't show bicompartmental being better in the measured outcomes, the answer would be \"no\" because there's no evidence here that it's more favorable. The study's conclusion seems to suggest that there's no significant advantage in the parameters they measured.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 448,
            "completion_tokens": 402
        },
        "time_elapsed": 5.140162229537964
    },
    {
        "realidx": "23571528",
        "question": "This study aims to examine the accuracy of a new sternal skin conductance (SSC) device in measuring hot flashes and to assess the acceptability of the device by women.\nThree small descriptive pilot studies were performed using two sequential prototypes of the SSC device developed by an engineering device company in the Midwest. The devices were worn either in a monitored setting for 24 hours or in an ambulatory setting for 5 weeks. During the study period, women recorded hot flashes in a prospective hot flash diary and answered questions about the acceptability of wearing the SSC device.\nThe first prototype was not able to collect any analyzable skin conductance data owing to various malfunction issues, including poor conductance and battery failure. However, 16 women wore the device for 5 weeks and reported that wearing the device was acceptable, although 31% stated that it interfered with daily activities. Hot flash data from the second prototype revealed a 24% concordance rate between self-reported and device-recorded hot flashes.\nSternal skin conductance: a reasonable surrogate for hot flash measurement?",
        "answer": "no",
        "answer_rationale": "Findings from these studies support discordance between device-recorded and self-reported hot flashes. In addition, the studies reveal further limitations of SSC monitoring, including difficulties with data collection and lack of consistency in interpretation. Based on these results and other recent trials identifying issues with SSC methodology, it is time to find a better physiologic surrogate measure for hot flashes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether sternal skin conductance is a reasonable surrogate for measuring hot flashes based on the study described.\n\nFirst, I need to recall what the study found. The first prototype had issues like poor conductance and battery failure, so it couldn't collect data. But even though the women found it mostly acceptable, 31% said it interfered with daily activities. The second prototype had a 24% concordance between self-reports and the device. \n\nHmm, a 24% agreement doesn't sound very high. If the device is only capturing about a quarter of the hot flashes that the women reported, that's a problem. A good surrogate should have a much higher correlation. Also, the first device's failure indicates technical issues. Even though the second one had some data, the low concordance suggests it's not accurately measuring the hot flashes. The question is about whether it's a \"reasonable\" surrogate. Since the accuracy is low, the answer is probably no. The acceptability is one thing, but accuracy is crucial here. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 312,
            "completion_tokens": 241
        },
        "time_elapsed": 3.3594303131103516
    },
    {
        "realidx": "23621776",
        "question": "Unintended pregnancy has been significantly associated with subsequent female sterilization. Whether women who are sterilized after experiencing an unintended pregnancy are less likely to express desire for sterilization reversal is unknown.\nThis study used national, cross-sectional data collected by the 2006-2010 National Survey of Family Growth. The study sample included women ages 15-44 who were surgically sterile from a tubal sterilization at the time of interview. Multivariable logistic regression was used to examine the relationship between a history of unintended pregnancy and desire for sterilization reversal while controlling for potential confounders.\nIn this nationally representative sample of 1,418 women who were sterile from a tubal sterilization, 78% had a history of at least one unintended pregnancy and 28% expressed a desire to have their sterilization reversed. In unadjusted analysis, having a prior unintended pregnancy was associated with higher odds of expressing desire for sterilization reversal (odds ratio [OR]: 1.80; 95% confidence interval [CI]: 1.15-2.79). In adjusted analysis controlling for sociodemographic factors, unintended pregnancy was no longer significantly associated with desire for reversal (OR: 1.46; 95% CI: 0.91-2.34).\nDoes a history of unintended pregnancy lessen the likelihood of desire for sterilization reversal?",
        "answer": "no",
        "answer_rationale": "Among women who had undergone tubal sterilization, a prior history of unintended pregnancy did not decrease desire for sterilization reversal.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a history of unintended pregnancy lessens the likelihood of wanting a sterilization reversal. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study found that in unadjusted analysis, having a prior unintended pregnancy was associated with higher odds of wanting reversal (OR 1.80). But when they adjusted for sociodemographic factors, the association wasn't significant anymore (OR 1.46, CI includes 1). \n\nThe key here is understanding the difference between unadjusted and adjusted analyses. The adjusted model controls for variables that might influence the outcome, like age, education, income, etc. Since the adjusted OR's confidence interval includes 1 (0.91-2.34), it means the association isn't statistically significant after controlling for those factors. \n\nThe question is whether unintended pregnancy \"lessens\" the likelihood. The data shows that in the raw data, there was a higher odds, but after adjustment, it's not significant. So the answer would be that it doesn't lessen the likelihood. The study's conclusion suggests that when considering confounders, the prior unintended pregnancy isn't a significant factor. Therefore, the answer should be B) no, because the history doesn't lessen the likelihood once other factors are accounted for. Wait, but the OR in adjusted was 1.46, which is still a positive association, but not significant. The question is phrased as \"lessen the likelihood\"\u2014so if the OR was less than 1, that would mean lower likelihood. But here, even though the association isn't significant, the OR is still above 1. So the correct interpretation is that the study found no significant association after adjustment. Therefore, the answer is B) no, because the history doesn't make them less likely. The question is whether the history lessens (reduces) the desire. Since the adjusted analysis shows no significant association, the answer is no, it doesn't lessen it. Alternatively, maybe the answer is maybe? Wait, the options are yes, no, maybe. The study's adjusted analysis didn't find a significant association, so we can't say yes or no definitively. But the question is phrased as \"does a history... lessen the likelihood?\" The study's adjusted analysis shows that when controlling for factors, the association isn't there. So the answer would be no, because the history isn",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 385,
            "completion_tokens": 512
        },
        "time_elapsed": 5.718365669250488
    },
    {
        "realidx": "23677366",
        "question": "Anteroposterior, lateral, and right and left oblique lumbar spine radiographs are often a standard part of the evaluation of children who are clinically suspected of having spondylolysis. Recent concerns regarding radiation exposure and costs have brought the value of oblique radiographs into question. The purpose of the present study was to determine the diagnostic value of oblique views in the diagnosis of spondylolysis.\nRadiographs of fifty adolescents with L5 spondylolysis without spondylolisthesis and fifty controls were retrospectively reviewed. All controls were confirmed not to have spondylolysis on the basis of computed tomographic scanning, magnetic resonance imaging, or bone scanning. Anteroposterior, lateral, and right and left oblique radiographs of the lumbar spine were arranged into two sets of slides: one showing four views (anteroposterior, lateral, right oblique, and left oblique) and one showing two views (anteroposterior and lateral only). The slides were randomly presented to four pediatric spine surgeons for diagnosis, with four-view slides being presented first, followed by two-view slides. The slides for twenty random patients were later reanalyzed in order to calculate of intra-rater agreement. A power analysis demonstrated that this study was adequately powered. Inter-rater and intra-rater agreement were assessed on the basis of the percentage of overall agreement and intraclass correlation coefficients (ICCs). PCXMC software was used to generate effective radiation doses. Study charges were determined from radiology billing data.\nThere was no significant difference in sensitivity and specificity between four-view and two-view radiographs in the diagnosis of spondylolysis. The sensitivity was 0.59 for two-view studies and 0.53 for four-view studies (p = 0.33). The specificity was 0.96 for two-view studies and 0.94 for four-view studies (p = 0.60). Inter-rater agreement, intra-rater agreement, and agreement with gold-standard ICC values were in the moderate range and also demonstrated no significant differences. Percent overall agreement was 78% for four-view studies and 82% for two-view studies. The radiation effective dose was 1.26 mSv for four-view studies and 0.72 mSv for two-view studies (difference, 0.54 mSv). The charge for four-view studies was $145 more than that for two-view studies.\nDo oblique views add value in the diagnosis of spondylolysis in adolescents?",
        "answer": "no",
        "answer_rationale": "There is no difference in sensitivity and specificity between four-view and two-view studies. Although oblique views have long been considered standard practice by some, our data could not identify a diagnostic benefit that might outweigh the additional cost and radiation exposure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether oblique views add value in diagnosing spondylolysis in adolescents based on the provided study.\n\nFirst, I need to recall the key points from the study. The study compared four-view (AP, lateral, right and left oblique) vs. two-view (AP and lateral) radiographs. The main outcomes were sensitivity, specificity, radiation dose, cost, and inter/intra-rater agreement.\n\nLooking at the results: the sensitivity for two-view was 0.59 vs 0.53 for four-view. The p-value here is 0.33, which is not statistically significant. Similarly, specificity was 0.96 vs 0.94, with p=0.60, also not significant. That suggests that adding the oblique views doesn't improve diagnostic accuracy. \n\nThe radiation dose was higher for four-view (1.26 mSv vs 0.72 mSv), and the cost was $145 more. Since the study found no significant difference in diagnostic performance but the four-view has higher radiation and cost, the conclusion would be that oblique views don't add enough value to justify their use. \n\nThe question is whether they \"add value\". Since the study shows no significant improvement in sensitivity or specificity, and the agreement between reviewers was similar, the answer should be no. The options are (A) yes, (B) no, (C) maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 626,
            "completion_tokens": 323
        },
        "time_elapsed": 6.538920879364014
    },
    {
        "realidx": "23690198",
        "question": "Social and cultural factors combined with little information may prevent the diffusion of epidural analgesia for pain relief during childbirth. The present study was launched contemporarily to the implementation of analgesia for labor in our Department in order to perform a 2 years audit on its use. The goal is to evaluate the epidural acceptance and penetration into hospital practice by women and care givers and safety and efficacy during childbirth.\nThis audit cycle measured epidural analgesia performance against 4 standards: (1) Implementation of epidural analgesia for labor to all patients; (2) Acceptance and good satisfaction level reported by patients and caregivers. (3) Effectiveness of labor analgesia; (4) No maternal or fetal side effects.\nDuring the audit period epidural analgesia increased from 15.5% of all labors in the first trimester of the study to 51% in the last trimester (p<0.005). Satisfaction levels reported by patients and care givers were good. A hierarchical clustering analysis identified two clusters based on VAS (Visual Analogue Scale) time course: in 226 patients (cluster 1) VAS decreased from 8.5\u00b11.4 before to 4.1\u00b11.3 after epidural analgesia; in 1002 patients (cluster 2) VAS decreased from 8.12\u00b11.7 before (NS vs cluster 1), to 0.76\u00b10.79 after (p<0.001 vs before and vs cluster 2 after). No other differences between clusters were observed.\nImplementation of epidural analgesia for labor: is the standard of effective analgesia reachable in all women?",
        "answer": "yes",
        "answer_rationale": "Present audit shows that the process of implementation of labor analgesia was quick, successful and safe, notwithstanding the identification of one cluster of women with suboptimal response to epidural analgesia that need to be further studies, overall pregnant womens'adhesion to labor analgesia was satisfactory.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the standard of effective analgesia with epidural is reachable in all women based on the study provided.\n\nFirst, I need to look at the study's results. The audit showed that epidural use increased from 15.5% to 51% over two years. That's a significant jump, but it's still not 100%. The question is about whether the standard of effective analgesia is reachable for all women. \n\nThe study mentions four standards. The first is implementing epidural to all patients. But even after the audit period, only 51% used it. So they didn't reach 100%, which suggests that maybe it's not achievable for everyone. \n\nLooking at the other points: satisfaction was good, effectiveness was there (VAS scores dropped a lot in both clusters), and no side effects. But the key here is the first standard: implementing to all. Since they only got to 51%, maybe there are still barriers. The question's first sentence also mentions social and cultural factors and lack of information preventing diffusion. Even after the audit, those factors might still exist, so not everyone might accept it. \n\nThe clusters show that in cluster 1, VAS went down to 4.1, which is still moderate pain, while cluster 2 had almost no pain. So maybe some women aren't getting as effective relief, but the question is about whether the standard is reachable for all. The study's data shows that even with increased use, not all women are opting for it, so the standard of implementing to all isn't met. Therefore, the answer would be B) no, because they can't reach all women, possibly due to the mentioned factors.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 454,
            "completion_tokens": 370
        },
        "time_elapsed": 4.398723125457764
    },
    {
        "realidx": "23736032",
        "question": "A multidisciplinary team (MDT) approach to breast cancer management is the gold standard. The aim is to evaluate MDT decision making in a modern breast unit.\nAll referrals to the breast MDT where breast cancer was diagnosed from 1 July 2009 to 30 June 2011 were included. Multidisciplinary team decisions were compared with subsequent patient management and classified as concordant or discordant.\nOver the study period, there were 3230 MDT decisions relating to 705 patients. Overall, 91.5% (2956 out of 3230) of decisions were concordant, 4.5% (146 out of 3230), were discordant and 4% (128 out of 3230) had no MDT decision. Of 146 discordant decisions, 26 (17.8%) were considered 'unjustifiable' as there was no additional information available after the MDT to account for the change in management. The remaining 120 discordant MDT decisions were considered 'justifiable', as management was altered due to patient choice (n=61), additional information available after MDT (n=54) or MDT error (n=5).\nMultidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?",
        "answer": "yes",
        "answer_rationale": "The vast majority of MDT decisions are implemented. Management alteration was most often due to patient choice or additional information available after the MDT. A minority of management alterations were 'unjustifiable' and the authors recommend that any patient whose treatment is subsequently changed should have MDT rediscussion prior to treatment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether patients receive what the multidisciplinary team (MDT) recommends for breast cancer treatment. The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided. The study included 3230 MDT decisions. Out of these, 91.5% were concordant, meaning the patient management matched the MDT's decision. That's a majority, so in most cases, the answer would lean towards \"yes.\" \n\nBut then there's the 8.5% that were either discordant or had no decision. The discordant cases were split into justifiable and unjustifiable. Most of the discordant (120 out of 146) were justifiable, which means the change was due to patient choice, new information, or MDT error. The question is whether these justifiable changes mean the patient didn't get the original recommendation. Since the management was altered, even for justifiable reasons, that would count as discordant. \n\nThe question is phrased as \"does the patient receive what the team has recommended?\" The key here is that while most (91.5%) do follow the recommendation, there's a significant minority (8.5%) where they don't. The options are yes, no, or maybe. Since the majority do follow, but it's not 100%, the answer might be \"maybe.\" However, the question is phrased in a general sense. The study shows that in the majority of cases, yes, but there are exceptions. But the options don't have a \"mostly yes\" option. The options are yes, no, maybe. \n\nAlternatively, the question might be interpreted as whether they \"usually\" receive the recommendation, but the options don't include that. Since the question is a general \"does the patient receive...\", the answer would have to consider that it's not always, so the correct answer is \"maybe.\" But wait, the options are (A) yes, (B) no, (C) maybe. The study shows that 91.5% are concordant, so the majority of the time they do. But the question is phrased as a general statement. The answer would be \"yes\" because the majority follow, but the presence of discordant cases might make it \"maybe.\" However, the options don't have a \"mostly yes,\" so maybe the answer is",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 389,
            "completion_tokens": 512
        },
        "time_elapsed": 6.2612340450286865
    },
    {
        "realidx": "23761381",
        "question": "Testosterone measurement by liquid chromatography tandem mass spectrometry (LC-MS/MS) is well accepted as the preferred technique for the analysis of testosterone. Variation is seen between assays and this may be due to differences in calibration as commercial calibrators for this assay are not readily available. We investigated the effects calibration in routine clinical LC-MS/MS assays.\nAll LC-MS/MS users that were registered with the UKNEQAS external quality assurance scheme for testosterone were invited to take part in the study. A set of seven serum samples and serum-based calibrators were sent to all laboratories that expressed an interest. The laboratories were instructed to analyse all samples using there own calibrators and return the results and a method questionnaire for analysis.\nFifteen laboratories took part in the study. There was no consensus on supplier of testosterone or matrix for the preparation of calibrators and all were prepared in-house. Also, a wide variety of mass spectrometers, internal standards, chromatography conditions and sample extractions were used. The variation in results did not improve when the results were corrected with a common calibrator.\nIs calibration the cause of variation in liquid chromatography tandem mass spectrometry testosterone measurement?",
        "answer": "no",
        "answer_rationale": "The variation in results obtained could not be attributed to variations in calibrators. The differences in methodologies between laboratories must be the reason for this variation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether calibration is the cause of variation in LC-MS/MS testosterone measurements based on the study described.\n\nFirst, I need to recall the details from the provided information. The study involved 15 labs participating, all using their own calibrators. They were sent the same samples and calibrators but prepared their own. The key points are that there was no consensus on suppliers or matrix for calibrators, all were in-house. They used different mass spectrometers, internal standards, chromatography conditions, and sample extractions. Importantly, even when correcting with a common calibrator, the variation didn't improve.\n\nThe question is whether calibration is the cause. The study's result says that when they applied a common calibrator, the variation didn't get better. If calibration were the main issue, using a common calibrator should have reduced variation. Since it didn't, that suggests that calibration isn't the primary source of variation. Instead, other factors like the different instruments, methods, or procedures might be contributing more. So the answer would be B) no, because the variation persisted even after calibration correction, implying other factors are at play.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 337,
            "completion_tokens": 252
        },
        "time_elapsed": 3.103365182876587
    },
    {
        "realidx": "23794696",
        "question": "To investigate the effect of bracket-ligature combination on the amount of orthodontic space closure over three months.\nRandomized clinical trial with three parallel groups.\nA hospital orthodontic department (Chesterfield Royal Hospital, UK).\nForty-five patients requiring upper first premolar extractions.\nInformed consent was obtained and participants were randomly allocated into one of three groups: (1) conventional pre-adjusted edgewise brackets and elastomeric ligatures; (2) conventional pre-adjusted edgewise brackets and Super Slick(\u00ae) low friction elastomeric ligatures; (3) Damon 3MX(\u00ae) passive self-ligating brackets. Space closure was undertaken on 0\u00b7019\u00d70\u00b7025-inch stainless steel archwires with nickel-titanium coil springs. Participants were recalled at four weekly intervals. Upper alginate impressions were taken at each visit (maximum three). The primary outcome measure was the mean amount of space closure in a 3-month period.\nA one-way ANOVA was undertaken [dependent variable: mean space closure (mm); independent variable: group allocation]. The amount of space closure was very similar between the three groups (1 mm per 28 days); however, there was a wide variation in the rate of space closure between individuals. The differences in the amount of space closure over three months between the three groups was very small and non-significant (P\u200a=\u200a0\u00b7718).\nDoes the bracket-ligature combination affect the amount of orthodontic space closure over three months?",
        "answer": "no",
        "answer_rationale": "The hypothesis that reducing friction by modifying the bracket/ligature interface increases the rate of space closure was not supported. The major determinant of orthodontic tooth movement is probably the individual patient response.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the bracket-ligature combination affects the amount of orthodontic space closure over three months based on the provided study.\n\nFirst, I need to recall the details from the study description. The study was a randomized clinical trial with three groups using different bracket and ligature systems. The primary outcome was the mean space closure over three months. The statistical test used was a one-way ANOVA, which compares means across groups. The key results mentioned are that the amount of space closure was very similar between the groups, about 1 mm per 28 days. Also, the P-value was 0.718, which is way higher than the typical threshold of 0.05 for statistical significance. \n\nThe question is whether the bracket-ligature combination has an effect. Since the ANOVA showed no significant difference (P=0.718), that means there's no statistically significant evidence that the different groups performed differently. The wide variation between individuals might mean that other factors are at play, but the specific combinations tested here didn't lead to different outcomes on average. \n\nLooking at the options: (A) yes, (B) no, (C) maybe. The study's conclusion is that the differences were non-significant, so the answer should be (B) no. The \"maybe\" might be tempting if the study had some limitations or if the effect was borderline, but here the P-value is clearly high, indicating no effect. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 413,
            "completion_tokens": 324
        },
        "time_elapsed": 3.8283119201660156
    },
    {
        "realidx": "23806388",
        "question": "To examine the ability of various postoperative nomograms to predict prostate cancer-specific mortality (PCSM) and to validate that they could predict aggressive biochemical recurrence (BCR). Prostate-specific antigen (PSA), grade, and stage are the classic triad used to predict BCR after radical prostatectomy (RP). Multiple nomograms use these to predict risk of BCR. A previous study showed that several nomograms could predict aggressive BCR (prostate-specific antigen doubling time [PSADT]\u00a0<9 months) more accurately than BCR. However, it remains unknown if they can predict more definitive endpoints, such as PCSM.\nWe performed Cox analyses to examine the ability of 4 postoperative nomograms, the Duke Prostate Center (DPC) nomogram, the Kattan postoperative nomogram, the Johns Hopkins Hospital (JHH) nomogram, and the joint Center for Prostate Disease Research(CPDR)/Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) nomogram to predict BCR and PCSM among 1778 men in the Shared Equal Access Regional Cancer Hospital (SEARCH) database who underwent RP between 1990 and 2009. We also compared their ability to predict BCR and aggressive BCR in a subset of men. We calculated the c-index for each nomogram to determine its predictive accuracy for estimating actual outcomes.\nWe found that each nomogram could predict aggressive BCR and PCSM in a statistically significant manner and that they all predicted PCSM more accurately than they predicted BCR (ie, with higher c-index values).\nDo nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR?",
        "answer": "yes",
        "answer_rationale": "Currently available nomograms used to predict BCR accurately predict PCSM and other more clinically relevant endpoints. Moreover, not only do they significantly predict PCSM, but do so with generally greater accuracy than BCR.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether nomograms designed to predict biochemical recurrence (BCR) do a better job at predicting more clinically relevant outcomes like prostate cancer-specific mortality (PCSM) than BCR itself.\n\nFirst, I need to recall the study details provided. The question mentions that the study looked at four postoperative nomograms. The key findings were that each nomogram could predict both aggressive BCR and PCSM in a statistically significant way. Importantly, they found that all nomograms predicted PCSM more accurately than BCR, as indicated by higher c-index values for PCSM. \n\nThe c-index is a measure of predictive accuracy, similar to the area under the ROC curve. A higher c-index means better discrimination between events and non-events. So if the c-index for PCSM is higher than for BCR, that suggests the nomograms are better at predicting PCSM. \n\nThe question is asking if the nomograms do a better job predicting more clinically relevant outcomes (like PCSM) than BCR. Since the study's results show that the nomograms had higher accuracy (higher c-index) for PCSM compared to BCR, the answer should be yes. The options are (A) yes, (B) no, (C) maybe. \n\nWait, but I need to make sure I'm not missing anything. The study's conclusion states that they predict PCSM more accurately than BCR. The question is phrased as \"do a better job of predicting more clinically relevant... than BCR.\" Since PCSM is a more definitive and clinically significant endpoint than BCR, and the nomograms were better at predicting PCSM, the answer is yes. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 452,
            "completion_tokens": 359
        },
        "time_elapsed": 4.615588426589966
    },
    {
        "realidx": "23810330",
        "question": "Intraoperative neuromonitoring (IONM) aims to control nerve-sparing total mesorectal excision (TME) for rectal cancer in order to improve patients' functional outcome. This study was designed to compare the urogenital and anorectal functional outcome of TME with and without IONM of innervation to the bladder and the internal anal sphincter.\nA consecutive series of 150 patients with primary rectal cancer were analysed. Fifteen match pairs with open TME and combined urogenital and anorectal functional assessment at follow up were established identical regarding gender, tumour site, tumour stage, neoadjuvant radiotherapy and type of surgery. Urogenital and anorectal function was evaluated prospectively on the basis of self-administered standardized questionnaires, measurement of residual urine volume and longterm-catheterization rate.\nNewly developed urinary dysfunction after surgery was reported by 1 of 15 patients in the IONM group and by 6 of 15 in the control group (p\u00a0=\u00a00.031). Postoperative residual urine volume was significantly higher in the control group. At follow up impaired anorectal function was present in 1 of 15 patients undergoing TME with IONM and in 6 of 15 without IONM (p\u00a0=\u00a00.031). The IONM group showed a trend towards a lower rate of sexual dysfunction after surgery.\nIs intraoperative neuromonitoring associated with better functional outcome in patients undergoing open TME?",
        "answer": "yes",
        "answer_rationale": "In this study TME with IONM was associated with significant lower rates of urinary and anorectal dysfunction. Prospective randomized trials are mandatory to evaluate the definite role of IONM in rectal cancer surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether intraoperative neuromonitoring (IONM) is associated with better functional outcomes in patients undergoing open total mesorectal excision (TME) for rectal cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study compared two groups: one with IONM and one without. They had 15 matched pairs, so that's a controlled setup which is good. The key outcomes measured were urogenital and anorectal functions. \n\nThe results mentioned are that in the IONM group, only 1 out of 15 patients had new urinary dysfunction, compared to 6 out of 15 in the control group. The p-value here is 0.031, which is statistically significant. Also, the residual urine volume was higher in the control group. For anorectal function, again, 1 vs 6 in the control group with impaired function, same p-value. There's also a trend towards lower sexual dysfunction in the IONM group, though that might not be statistically significant since they mention it as a trend.\n\nSince both the urinary and anorectal outcomes were significantly better in the IONM group (as the p-values are below 0.05), this suggests that using IONM does lead to better functional outcomes. The question is whether the answer is yes (A), no (B), or maybe (C). The study's results show a clear association with better outcomes when using IONM. The p-values are significant, and the differences are notable (like 6 vs 1 in both categories). So the answer should be A) yes. The \"maybe\" option might be there if the results were inconclusive or non-significant, but here the data supports a positive association.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 416,
            "completion_tokens": 391
        },
        "time_elapsed": 4.601953744888306
    },
    {
        "realidx": "23848044",
        "question": "This study represents a subset of a complete data set, considering only those children aged admitted to the Pediatric Surgery and Pediatric Nephrology Clinics during the period January 2011 to July 2012.\nIn this study, we have determined that the QT interval changes significantly depending on the use of oxybutynin. The QT changes increased cardiac arrhythmia in children.\nDoes oxybutynin hydrochloride cause arrhythmia in children with bladder dysfunction?",
        "answer": "yes",
        "answer_rationale": "For this reason, children using such drugs should be closely monitored for cardiac arrhythmia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether oxybutynin hydrochloride causes arrhythmia in children with bladder dysfunction based on the study described.\n\nFirst, I need to parse the information given. The study looked at children admitted to Pediatric Surgery and Nephrology Clinics from January 2011 to July 2012. The key finding was that the QT interval changes significantly with oxybutynin use, and these QT changes increased the risk of cardiac arrhythmias in these children.\n\nNow, the question is whether oxybutynin causes arrhythmia. The options are yes, no, maybe. The study says that QT changes (which are known to be associated with arrhythmias) increased due to oxybutynin. QT prolongation is a well-known risk factor for certain types of arrhythmias, like Torsades de Pointes. So if the drug is causing the QT interval to change (presumably prolong), that's a strong indicator it could lead to arrhythmias. \n\nThe study's conclusion directly states that the QT changes increased cardiac arrhythmia in the children. So the answer should be yes. The options are A, B, C. The answer is A) yes. But wait, I need to make sure there's no ambiguity. The study says \"determined that the QT interval changes significantly depending on the use of oxybutynin. The QT changes increased cardiac arrhythmia in children.\" So the\u56e0\u679c\u5173\u7cfb here is clear: oxybutynin use leads to QT changes, which in turn lead to increased arrhythmias. Therefore, the drug does cause the arrhythmia via this mechanism. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 189,
            "completion_tokens": 357
        },
        "time_elapsed": 4.328747510910034
    },
    {
        "realidx": "23870157",
        "question": "Precursor events are undesirable events that can lead to a subsequent adverse event and have been associated with postoperative mortality. The purpose of the present study was to determine whether precursor events are associated with a composite endpoint of major adverse cardiac events (MACE) (death, acute renal failure, stroke, infection) in a low- to medium-risk coronary artery bypass grafting, valve, and valve plus coronary artery bypass grafting population. These events might be targets for strategies aimed at quality improvement.\nThe present study was a retrospective cohort design performed at the Queen Elizabeth Health Science Centre. Low- to medium-risk patients who had experienced postoperative MACE were matched 1:1 with patients who had not experienced postoperative MACE. The operative notes, for both groups, were scored by 5 surgeons to determine the frequency of 4 precursor events: bleeding, difficulty weaning from cardiopulmonary bypass, repair or regrafting, and incomplete revascularization or repair. A univariate comparison of \u22651 precursor events in the matched groups was performed.\nA total of 311 MACE patients (98.4%) were matched. The primary outcome occurred more frequently in the MACE group than in the non-MACE group (33% vs 24%; P\u00a0=\u00a0.015). The incidence of the individual events of bleeding and difficulty weaning from cardiopulmonary bypass was significantly higher in the MACE group. Those patients with a precursor event in the absence of MACE also appeared to have a greater prevalence of other important postoperative outcomes.\nAre intraoperative precursor events associated with postoperative major adverse events?",
        "answer": "yes",
        "answer_rationale": "Patients undergoing cardiac surgery who are exposed to intraoperative precursor events were more likely to experience a postoperative MACE. Quality improvement techniques aimed at mitigating the consequences of precursor events might improve the surgical outcomes for cardiac surgical patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether intraoperative precursor events are associated with postoperative major adverse events (MACE) based on the provided study.\n\nFirst, I need to recall the details from the study description. The study was a retrospective cohort design comparing patients who had MACE with those who didn't, matched 1:1. They looked at four precursor events: bleeding, difficulty weaning from bypass, repair/regrafting, and incomplete revascularization. \n\nThe results mentioned that the primary outcome (having \u22651 precursor event) occurred more in the MACE group (33% vs 24%, P=0.015). Also, bleeding and difficulty weaning were significantly higher in the MACE group. Additionally, even those without MACE but with precursor events had more other postop issues. \n\nThe question is whether the precursor events are associated with MACE. Since the study found a statistically significant higher incidence in the MACE group for both the overall precursor events and specific ones like bleeding and weaning difficulty, the answer should be yes. The p-value of .015 indicates statistical significance, supporting an association. The fact that even non-MACE patients with precursors had more issues also suggests precursors are markers for adverse outcomes. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 424,
            "completion_tokens": 276
        },
        "time_elapsed": 3.4601826667785645
    },
    {
        "realidx": "23916653",
        "question": "Recently, orthostatic myoclonus (OM) has been suggested as a cause of gait impairment and unsteadiness in neurodegenerative diseases. The aim of this study was to investigate the frequency of orthostatic myoclonus, its clinical characteristics and the underlying associated neurological disorders.\nA retrospective analysis of clinical data and electromyogram surface recordings from subjects with unexplained unsteadiness/gait impairment was performed. Diagnosis of OM was made when a pattern of non-rhythmic bursts was observed (duration range 20-100 ms; bursts per second \u226416).\nAmong 93 subjects studied, OM was the most frequent disorder (n = 16; 17.2%), followed by orthostatic tremor (13.9%) and low frequency tremors during orthostatism (12.9%). All patients with OM complained about unsteadiness during orthostatism and/or during gait. Leg jerking was only observed by visual inspection during orthostatism in four subjects and two also presented falls. Eleven out of 16 patients (68.7%) with OM had an associated neurodegenerative disease, such as multiple system atrophy (n = 3) Parkinson's disease (n = 2), Alzheimer's disease (n = 2), mild cognitive impairment (n = 2) and normal pressure hydrocephalus (n = 2). Although four subjects showed improvement of orthostatic myoclonus with antimyoclonic treatment, the follow-up was not systematic enough to evaluate their therapeutic effect on OM.\nOrthostatic myoclonus: an underrecognized cause of unsteadiness?",
        "answer": "yes",
        "answer_rationale": "Orthostatic myoclonus is often underdiagnosed and can be considered a possible cause of unsteadiness in subjects with neurodegenerative diseases. Electromyography surface recording is thereby an aid for investigating unsteadiness of unknown origin.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether orthostatic myoclonus (OM) is an underrecognized cause of unsteadiness based on the provided study.\n\nFirst, I need to understand the key points from the study summary. The study looked at 93 subjects with unexplained unsteadiness or gait issues. They found that OM was the most frequent disorder, affecting 17.2% of the subjects. That's higher than orthostatic tremor (13.9%) and low-frequency tremors (12.9%). The patients with OM had unsteadiness when standing or walking, and many had associated neurodegenerative diseases. However, treatment effects weren't well studied due to insufficient follow-up.\n\nThe question is whether OM is an underrecognized cause. The study's findings suggest that OM is a significant contributor (being the most common in this group) but might not be widely recognized because the patients were selected for having unexplained issues. The title of the study itself poses the question, implying that it's possible that OM is underrecognized. The fact that 17% of these cases were due to OM, which might not have been diagnosed before, supports the idea that it's underrecognized. The options are yes, no, maybe. The study's results indicate that since it was found as a common cause in this cohort, but perhaps wasn't previously recognized, the answer is likely \"yes\". The title's phrasing as a question might be hinting that the answer is affirmative based on their findings. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 437,
            "completion_tokens": 332
        },
        "time_elapsed": 3.897280693054199
    },
    {
        "realidx": "23949294",
        "question": "Recently, there has been increasing interest in the role of \"treatment as prevention\" (TasP). Some of the questions regarding TasP strategies arise from the perceived difficulties in achieving and maintaining viral load (VL) suppression over time and the risk of emergence of viral resistance that could compromise future treatment options. This study was conducted to assess these questions in a resource-limited setting.\nWe performed a retrospective observational study of HIV-infected patients diagnosed in the pre-HAART era on follow-up at a private center from Buenos Aires, Argentina. Socio-demographic, clinical, and laboratory data were extracted from clinical charts. Analyses were performed to test for potential associations of selected variables with current virologic failure or use of third-line drugs.\nOf 619 patients on follow-up, 82 (13.2%) were diagnosed in the pre-HAART era. At the time of our study, 79 (96.3%) patients were on HAART, with a median duration of 14 years (IQR 12-15) of therapy, and exposure to mono or dual nucleoside reverse transcriptase inhibitors regimens in 47.8% of cases.\u00a0Sixty-nine patients (87.3%) had undetectable VL, 37 (46.8%) never presented virologic failure, and 19 (24.1%) experienced only one failure. Thirteen patients (16.5%) were receiving third-line ART regimens, with an average of 2.7-fold more virologic failures than those on first- or second-line regimens (p = 0.007).\nTreatment as prevention in resource-limited settings: is it feasible to maintain HIV viral load suppression over time?",
        "answer": "yes",
        "answer_rationale": "Maintaining viral load suppression over time in resource-limited-settings is feasible.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether \"treatment as prevention\" (TasP) is feasible to maintain HIV viral load suppression over time in resource-limited settings, based on the provided study.\n\nFirst, I need to understand the study's findings. The study looked at patients diagnosed in the pre-HAART era, so before HAART (Highly Active Antiretroviral Therapy) was widely used. Now, most of them are on HAART for a long time\u2014median 14 years. Out of 82 patients, 79 (96.3%) are on HAART. The results show that 69 (87.3%) had undetectable viral loads. That's a high percentage. Also, 46.8% never had virologic failure, which is good. However, 24.1% had one failure, and 16.5% were on third-line drugs, which might indicate some issues with resistance or treatment failure over time. The third-line group had more virologic failures, but the majority still had undetectable VL.\n\nThe question is about feasibility in resource-limited settings. The study's setting is a private center in Buenos Aires, which might have better resources than typical resource-limited areas. But the results here show that even with long-term HAART, most maintained suppression. However, the study mentions that third-line use and resistance are concerns. The answer options are yes, no, maybe.\n\nThe study's high rate of undetectable VL (87.3%) suggests that maintaining suppression is possible. But the emergence of resistance and need for third-line drugs (which might be harder to access in resource-limited settings) complicates things. The study's context is a private center, so maybe in a resource-limited public setting, it's harder. The question is about feasibility in resource-limited settings. The study's results are positive but the abstract mentions that challenges like maintaining suppression and resistance are concerns. The answer might be \"maybe\" because while the study shows it's possible, there are challenges, especially with third-line drugs and viral resistance. Alternatively, since the majority did maintain suppression, maybe the answer is yes. But the study's setting might not be truly resource-limited. The question states \"resource-limited settings\" but the study was in a private center in Argentina. Hmm, the study was conducted in a resource-limited setting? Wait, the first",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 459,
            "completion_tokens": 512
        },
        "time_elapsed": 6.106453895568848
    },
    {
        "realidx": "23992109",
        "question": "The solitary kidney (SK) is currently debated in the literature, as living kidney donation is extensively used and the diagnosis of congenital SK is frequent. Tubulointerstitial lesions associated with adaptive phenomena may occur early within the SK.\nAnalysis of the significance of urinary biomarkers in the assessment of tubulointerstitial lesions of the SK.\nA cross-sectional study of 37 patients with SK included 18 patients-acquired SK (mean age 56.44\u2009\u00b1\u200912.20 years, interval from nephrectomy 10.94\u2009\u00b1\u20099.37 years), 19 patients-congenital SK (mean age 41.52\u2009\u00b1\u200910.54 years). Urinary NAG, urinary alpha-1-microglobulin, albuminuria, eGFR (CKD-EPI equation) were measured.\nIn acquired SK, NAG increased in 60.66%, urinary alpha 1-microglobulin in 16.66%, albuminuria in 55.55% of patients. Inverse correlation with eGFR presented NAG (R(2\u2009)=\u20090.537, p\u2009=\u20090.022), urinary alpha 1-microglobulin (R(2\u2009)=\u20090.702, p\u2009=\u20090.001), albuminuria (R(2\u2009)=\u20090.655, p\u2009=\u20090.003). In congenital SK, NAG increased in 52.63%, urinary alpha 1-microglobulin in 5.26%, albuminuria in 47.36% of patients. In this group, urinary biomarkers correlated inversely with eGFR: NAG (R(2\u2009)=\u20090.743, p\u2009<\u20090.001), urinary alpha 1-microglobulin (R(2\u2009)=\u20090.701, p\u2009=\u20090.001), albuminuria (R(2\u2009)=\u20090.821, p\u2009<\u20090.001). Significant correlations were found between the urinary biomarkers in both groups.\nIs the urinary biomarkers assessment a non-invasive approach to tubular lesions of the solitary kidney?",
        "answer": "yes",
        "answer_rationale": "Urinary biomarkers allow a non-invasive, sensitive, early assessment of the tubular lesions of the SK. Urinary biomarkers of PT injury parallel renal function decline, thus complementing the estimation of GFR. Monitoring of PT dysfunction is mandatory in patients with SK.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether urinary biomarkers are a non-invasive way to assess tubular lesions in solitary kidneys. The study provided gives data on NAG, alpha-1-microglobulin, and albuminuria in both acquired and congenital SK patients. \n\nFirst, I need to recall what these biomarkers indicate. NAG and alpha-1-microglobulin are markers of tubular damage. Albuminuria is typically a sign of glomerular damage, but maybe in this context, since they're looking at tubulointerstitial lesions, it's part of the assessment too.\n\nThe study shows that in both groups (acquired and congenital), these biomarkers correlated inversely with eGFR. That means as eGFR (a measure of kidney function) goes down, the biomarker levels go up, which makes sense if the biomarkers are indicating kidney damage. The correlations are statistically significant with p-values less than 0.05, which is good. Also, the R-squared values are pretty high, especially for albuminuria in congenital SK (R\u00b2=0.821), indicating a strong relationship.\n\nThe question is whether this assessment is non-invasive. Urinary tests are definitely non-invasive because they just require a urine sample. The study's results support that these biomarkers are useful indicators of tubulointerstitial lesions. Since the answer options are yes, no, maybe, the key points here are the significant correlations found and the non-invasive nature of urine tests. \n\nThe options: (A) yes, (B) no, (C) maybe. The study's findings suggest that these biomarkers are valid, so the answer should be yes. The fact that they found significant correlations in both groups supports that the biomarkers are effective. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 616,
            "completion_tokens": 392
        },
        "time_elapsed": 4.669379472732544
    },
    {
        "realidx": "24013712",
        "question": "Platelet count is inversely related to prognosis in many cancers; however, its role in esophageal cancer is still controversial. The purpose of this study was to determine the prognostic value of preoperative platelet count in esophageal squamous cell carcinoma (ESCC).\nFrom January 2006 to December 2008, a retrospective analysis of 425 consecutive patients with ESCC was conducted. A receiver operating characteristic (ROC) curve for survival prediction was plotted to verify the optimum cutoff point for preoperative platelet count. Univariate and multivariate analyses were performed to evaluate the prognostic parameters.\nA ROC curve for survival prediction was plotted to verify the optimum cutoff point for platelet count, which was 205 (\u00d7 10(9)/L). Patients with platelet count \u2264 205 had a significantly better 5-year survival than patients with a platelet count>205 (60.7 vs. 31.6 %, P<0.001). The 5-year survival of patients either with platelet count \u2264 205 or>205 were similar (68.6 vs. 58.8 %, P = 0.085) when the nodes were negative. However, the 5-year survival of patients with platelet count \u2264 205 was better than that of patients with a platelet count>205 when the nodes were involved (32.0 vs. 12.7 %, P = 0.004). Multivariate analysis showed that platelet count (P = 0.013), T grade (P = 0.017), and N staging (P<0.001) were independent prognostic factors.\nPreoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor?",
        "answer": "yes",
        "answer_rationale": "Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether preoperative platelet count is a prognostic factor in esophageal squamous cell carcinoma (ESCC) based on the provided study.\n\nFirst, I need to recall what the study found. The study's purpose was to determine if platelet count before surgery could predict prognosis in ESCC. They looked at 425 patients between 2006 and 2008. They used a ROC curve to find the optimal cutoff for platelet count, which came out to 205\u00d710^9/L. \n\nThe results showed that patients with platelet counts \u2264205 had better 5-year survival (60.7%) compared to those above 205 (31.6%), and this difference was statistically significant (P<0.001). That's a big difference. \n\nBut then they broke it down by whether the nodes were involved. For node-negative patients, the survival between the two platelet groups wasn't significantly different (68.6 vs 58.8, P=0.085). However, when nodes were involved, the platelet count made a significant difference again: 32% vs 12.7% (P=0.004). \n\nMultivariate analysis, which adjusts for other factors, showed that platelet count was an independent prognostic factor (P=0.013), along with T grade and N staging. \n\nThe question is whether platelet count is a prognostic factor. The study clearly shows that in the overall group and especially in node-positive cases, higher platelet counts are linked to worse survival. Even though in node-negative it wasn't significant, the multivariate analysis still included platelet count as independent. So the answer should be yes. The options are A, B, C. The correct answer is A (yes).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 492,
            "completion_tokens": 406
        },
        "time_elapsed": 4.714859247207642
    },
    {
        "realidx": "24014276",
        "question": "Studies examining predictors of survival among the oldest-old have primarily focused on objective measures, such as physical function and health status. Only a few studies have examined the effect of personality traits on survival, such as optimism. The aim of this study was to examine whether an optimistic outlook predicts survival among the oldest-old.\nThe Danish 1905 Cohort Survey is a nationwide, longitudinal survey comprising all individuals born in Denmark in 1905. At baseline in 1998, a total of 2,262 persons aged 92 or 93 agreed to participate in the intake survey. The baseline in-person interview consisted of a comprehensive questionnaire including physical functioning and health, and a question about whether the respondent had an optimistic, neutral or pessimistic outlook on his or her own future.\nDuring the follow-up period of 12 years (1998-2010) there were 2,239 deaths (99 %) in the 1905 Cohort Survey. Univariable analyses revealed that optimistic women and men were at lower risk of death compared to their neutral counterparts [HR 0.82, 95 % CI (0.73-0.93) and 0.81, 95 % CI (0.66-0.99), respectively]. When confounding factors such as baseline physical and cognitive functioning and disease were taken into account the association between optimism and survival weakened in both sexes, but the general pattern persisted. Optimistic women were still at lower risk of death compared to neutral women [HR 0.85, 95 % CI (0.74-0.97)]. The risk of death was also decreased for optimistic men compared to their neutral counterparts, but the effect was non-significant [HR 0.91, 95 % CI (0.73-1.13)].\nOptimism and survival: does an optimistic outlook predict better survival at advanced ages?",
        "answer": "yes",
        "answer_rationale": "An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether optimism predicts survival in the oldest-old, specifically those born in 1905 who were around 92-93 at baseline. The key points from the study are the hazard ratios (HR) provided.\n\nFirst, the univariable analysis showed that both optimistic men and women had lower risk of death compared to neutral individuals. The HRs were 0.82 for women and 0.81 for men, both below 1, indicating reduced risk. But then when they adjusted for confounders like physical function, cognitive function, and disease, the associations weakened. For women, the adjusted HR was 0.85 (still significant since the CI is 0.74-0.97, which doesn't include 1). For men, the adjusted HR was 0.91, but the CI was 0.73-1.13, which includes 1, so not significant.\n\nThe question is asking if optimism predicts better survival at advanced ages. The options are yes, no, maybe. The study's main conclusion would be that for women, even after adjusting, there's a significant association (since the CI for women's adjusted HR doesn't include 1). For men, it's not significant. But the question doesn't specify gender. The overall answer might depend on whether the effect is present in at least one group. Since the study's aim was to see if optimism predicts survival in the oldest-old generally, and the women's results are significant, the answer would lean towards yes. The fact that in adjusted models the effect persists in women suggests that optimism does have a predictive value, at least in women. The question might be looking for the overall conclusion, so the answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 508,
            "completion_tokens": 379
        },
        "time_elapsed": 4.904322624206543
    },
    {
        "realidx": "24061619",
        "question": "It has been demonstrated that hiatal hernia repair (HHR) during laparoscopic adjustable gastric banding (LAGB) decreases the rate of reoperation. However, the technical aspects (location and number of sutures) are not standardized. It is unknown whether such technical details are associated with differing rates of reoperation for band-related problems.\nA retrospective analysis was performed from a single institution, including 2,301 patients undergoing LAGB with HHR from July 1, 2007 to December 31, 2011. Independent variables were number and location of sutures. Data collected included demographics, operating room (OR) time, length of stay (LOS), follow-up time, postoperative BMI/%EWL, and rates of readmission/reoperation. Statistical analyses included ANOVA and Chi squared tests. Kaplan-Meier, log-rank, and Cox regression tests were used for follow-up data and reoperation rates, in order to account for differential length of follow-up and confounding variables.\nThere was no difference in length of follow-up among all groups. The majority of patients had one suture (range 1-6; 55 %). Patients with fewer sutures had shorter OR time (1 suture 45 min vs. 4+ sutures 56 min, p<0.0001). LOS, 30-day readmission, band-related reoperation, and postop BMI/%EWL were not statistically significant. Anterior suture placement (vs. posterior vs. both) was most common (61 %). OR time was shorter in those with anterior suture (41 min vs. posterior 56 min vs. both 59 min, p<0.0001). Patients with posterior suture had a longer LOS (84 % 1 day vs. anterior 74 % 1 day vs. both 74 % 1 day, p<0.0001). There was no difference in 30-day readmission, band-related reoperation, and postoperative BMI/%EWL.\nLocation and number of sutures placed for hiatal hernia repair during laparoscopic adjustable gastric banding: does it matter?",
        "answer": "no",
        "answer_rationale": "Patients with fewer or anterior sutures have shorter OR times. However, 30-day readmission, band-related reoperation, and postoperative weight loss were unaffected by number or location of suture. The technical aspects of HHR did not appear to be associated with readmission or reoperation, and therefore a standardized approach may not be necessary.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether the number and location of sutures during hiatal hernia repair (HHR) when doing laparoscopic adjustable gastric banding (LAGB) affect reoperation rates. The options are yes, no, or maybe.\n\nFirst, I need to look at the results presented. The key outcomes here are the rates of reoperation for band-related problems. The question is asking if the suture details (number and location) matter in terms of those reoperation rates.\n\nThe study found that patients with fewer sutures had shorter operating room times compared to those with more sutures. But when looking at the important outcomes like 30-day readmission, band-related reoperation, and postoperative BMI or excess weight loss, there were no statistically significant differences. So the main issue the question is concerned with\u2014reoperation rates\u2014didn't differ based on the number of sutures.\n\nThen, looking at suture location: anterior was most common. Again, OR time was shorter for anterior, and posterior sutures led to a bit longer LOS (more patients stayed longer than 1 day). But again, the critical points like reoperations and readmissions didn't differ between anterior, posterior, or both locations. The study's conclusion seems to be that while the number and location affect OR time and maybe LOS a little, they don't impact the reoperation rates or other key outcomes. \n\nThe question is asking if the technical details (location and number) matter regarding reoperation rates. Since the study found no significant differences in those outcomes based on sutures' number or location, the answer would be that it doesn't matter. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 558,
            "completion_tokens": 355
        },
        "time_elapsed": 4.249239683151245
    },
    {
        "realidx": "24073931",
        "question": "In recent years, many advances in pancreatic surgery have been achieved. Nevertheless, the rate of pancreatic fistula following pancreatic tail resection does not differ between various techniques, still reaching up to 30% in prospective multicentric studies. Taking into account contradictory results concerning the usefulness of covering resection margins after distal pancreatectomy, we sought to perform a systematic, retrospective analysis of patients that underwent distal pancreatectomy at our center.\nWe retrospectively analysed the data of 74 patients that underwent distal pancreatectomy between 2001 and 2011 at the community hospital in Neuss. Demographic factors, indications, postoperative complications, surgical or interventional revisions, and length of hospital stay were registered to compare the outcome of patients undergoing distal pancreatectomy with coverage of the resection margins vs. patients undergoing distal pancreatectomy without coverage of the resection margins. Differences between groups were calculated using Fisher's exact and Mann-Whitney U test.\nMain indications for pancreatic surgery were insulinoma (n=18, 24%), ductal adenocarcinoma (n=9, 12%), non-single-insulinoma-pancreatogenic-hypoglycemia-syndrome (NSIPHS) (n=8, 11%), and pancreatic cysts with pancreatitis (n=8, 11%). In 39 of 74 (53%) patients no postoperative complications were noted. In detail we found that 23/42 (55%) patients with coverage vs. 16/32 (50%) without coverage of the resection margins had no postoperative complications. The most common complications were pancreatic fistulas in eleven patients (15%), and postoperative bleeding in nine patients (12%). Pancreatic fistulas occurred in patients without coverage of the resection margins in 7/32 (22%) vs. 4/42 (1011%) with coverage are of the resection margins, yet without reaching statistical significance. Postoperative bleeding ensued with equal frequency in both groups (12% with coverage versus 13% without coverage of the resection margins). The reoperation rate was 8%. The hospital stay for patients without coverage was 13 days (5-60) vs. 17 days (8-60) for patients with coverage.\nIs the covering of the resection margin after distal pancreatectomy advantageous?",
        "answer": "no",
        "answer_rationale": "The results show no significant difference in the fistula rate after covering of the resection margin after distal pancreatectomy, which contributes to the picture of an unsolved problem.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether covering the resection margin after a distal pancreatectomy is advantageous based on the provided study.\n\nFirst, I need to look at the data given. The study compared two groups: those with coverage (42 patients) and those without (32 patients). The main outcomes considered were postoperative complications, specifically pancreatic fistulas and bleeding, as well as hospital stay length.\n\nLooking at pancreatic fistulas, which are a key concern here. The study states that 7 out of 32 (22%) in the no-coverage group had fistulas, versus 4 out of 42 (about 9.5%) in the coverage group. Wait, the text says \"1011%\" which must be a typo. Probably meant 10%, since 4/42 is roughly 9.5%. That's a noticeable difference, but the study mentions it didn't reach statistical significance. So even though the rate is lower with coverage, the result isn't statistically significant, meaning the difference could be due to chance.\n\nFor postoperative bleeding, both groups had similar rates (12% vs 13%), so no difference there. The reoperation rate was 8% overall, but not broken down by group. The hospital stay was longer in the coverage group (17 days vs 13 days). Longer stay might be a downside unless justified by better outcomes, but since the main complications didn't show a significant benefit, that's a point against coverage.\n\nThe question is whether covering is advantageous. The primary endpoint here seems to be reducing pancreatic fistulas. Since the reduction wasn't statistically significant, the study's results don't support a clear advantage. The authors also mentioned contradictory results in prior studies, and their analysis didn't find a significant benefit. The hospital stay being longer might even suggest a disadvantage, but that's a secondary factor.\n\nSo the answer would be that there's no clear advantage, so the answer is B) no. But wait, the options are (A) yes, (B) no, (C) maybe. The study's data shows a trend towards fewer fistulas with coverage but not significant. So maybe the answer is \"maybe\" because there's a trend but not enough evidence? Hmm. The question is whether it's advantageous. Since the study's results didn't reach statistical significance, the conclusion would be that there's no proven advantage, so the answer is B) no",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 614,
            "completion_tokens": 512
        },
        "time_elapsed": 5.816219329833984
    },
    {
        "realidx": "24139705",
        "question": "Each patient received a smartphone with an insulin dose advisor (IDA) and with (G3 group) or without (G2 group) the telemonitoring/teleconsultation function. Patients were classified as \"high users\" if the proportion of \"informed\" meals using the IDA exceeded 67% (median) and as \"low users\" if not. Also analyzed was the respective impact of the IDA function and teleconsultations on the final HbA1c levels.\nAmong the high users, the proportion of informed meals remained stable from baseline to the end of the study 6months later (from 78.1\u00b121.5% to 73.8\u00b125.1%; P=0.107), but decreased in the low users (from 36.6\u00b129.4% to 26.7\u00b128.4%; P=0.005). As expected, HbA1c improved in high users from 8.7% [range: 8.3-9.2%] to 8.2% [range: 7.8-8.7%]in patients with (n=26) vs without (n=30) the benefit of telemonitoring/teleconsultation (-0.49\u00b10.60% vs -0.52\u00b10.73%, respectively; P=0.879). However, although HbA1c also improved in low users from 9.0% [8.5-10.1] to 8.5% [7.9-9.6], those receiving support via teleconsultation tended to show greater improvement than the others (-0.93\u00b10.97 vs -0.46\u00b11.05, respectively; P=0.084).\nTelemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?",
        "answer": "yes",
        "answer_rationale": "The Diabeo system improved glycaemic control in both high and low users who avidly used the IDA function, while the greatest improvement was seen in the low users who had the motivational support of teleconsultations.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether telemedicine helps improve glycemic control in type 1 diabetes patients using an insulin dose advisor (IDA). The groups are G2 (without telemonitoring/teleconsultation) and G3 (with it). They split patients into high and low users based on how often they used the IDA for meals.\n\nFirst, looking at high users: their HbA1c improved a bit, but the difference between those with and without teleconsultation wasn't significant (P=0.879). So telemedicine didn't make a difference here. But for low users, those with teleconsultation had a bigger drop in HbA1c (-0.93 vs -0.46), though the p-value was 0.084, which is trending towards significance but not quite there. \n\nThe question is asking if telemedicine alone is enough. The high users didn't benefit more from telemedicine, but maybe the low users did, but the result wasn't significant. The study's title is questioning if the technology itself (IDA) is sufficient. Since in high users, the tech use was stable but telemedicine didn't add benefit, and in low users it might help but wasn't statistically significant, the answer might be that technology (IDA) isn't sufficient on its own. The telemedicine part (adding teleconsultation) might help some, but the results aren't conclusive. The options are yes, no, maybe. Since the study shows that even with the IDA, telemedicine didn't make a significant difference in high users, and only a trend in low users, the answer is probably \"no\" because the technology (IDA alone) isn't enough, and adding telemedicine didn't show a significant benefit overall. Wait, but the question is phrased as \"is technology per se sufficient?\" So the IDA is the tech, and maybe the telemedicine is an add-on. The high users had better HbA1c improvement, but tele didn't help them more. The low users who had tele had better improvement but not significant. So the tech (IDA) alone might not be enough, and adding tele didn't make a significant difference overall. So the answer would be B) no, because the technology alone (IDA) isn't sufficient, and even with tele, it's not a clear yes. The study's results don't support that tech alone is enough, so the answer",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 508,
            "completion_tokens": 512
        },
        "time_elapsed": 6.473160743713379
    },
    {
        "realidx": "24191126",
        "question": "Surgical excision of ovarian endometriomas in patients desiring pregnancy has recently been criticized because of the risk of damage to healthy ovarian tissue and consequent reduction of ovarian reserve. A correct diagnosis in cases not scheduled for surgery is therefore mandatory in order to avoid unexpected ovarian cancer misdiagnosis. Endometriosis is often associated with high levels of CA125. This marker is therefore not useful for discriminating ovarian endometrioma from ovarian malignancy. The aim of this study was to establish if the serum marker CA72-4 could be helpful in the differential diagnosis between ovarian endometriosis and epithelial ovarian cancer.\nSerums CA125 and CA72-4 were measured in 72 patients with ovarian endometriomas and 55 patients with ovarian cancer.\nHigh CA125 concentrations were observed in patients with ovarian endometriosis and in those with ovarian cancer. A marked difference in CA72-4 values was observed between women with ovarian cancer (71.0%) and patients with endometriosis (13.8%) (P<0.0001).\nIs CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?",
        "answer": "yes",
        "answer_rationale": "This study suggests that CA72-4 determination can be useful to confirm the benign nature of ovarian endometriomas in women with high CA125 levels.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether CA72-4 is a useful biomarker for differentiating between ovarian endometriomas and epithelial ovarian cancer. \n\nFirst, I need to recall the information given in the question. The study compared CA125 and CA72-4 levels in 72 endometrioma patients and 55 ovarian cancer patients. They mentioned that CA125 is high in both, so it's not helpful. But the key point here is the difference in CA72-4. The results showed that 71% of cancer patients had high CA72-4 versus only 13.8% of endometriosis patients, and the p-value was less than 0.0001, which is statistically significant.\n\nSo the question is whether this difference makes CA72-4 useful. Since there's a marked and statistically significant difference, that suggests CA72-4 could help distinguish between the two. High CA72-4 would be more indicative of cancer, while lower levels might point to endometriomas. Since the options are yes, no, maybe, the answer should be yes. The study's results support using CA72-4 as a helpful marker here. I don't see any conflicting info here. The high percentage in cancer vs. endometriosis with such a low p-value indicates it's a useful tool. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 350,
            "completion_tokens": 310
        },
        "time_elapsed": 3.956027030944824
    },
    {
        "realidx": "24245816",
        "question": "To compare the primary stability of miniscrews inserted into bone blocks of different bone mineral densities (BMDs) with and without cortical bone, and investigate whether some trabecular properties could influence primary stability.\nFifty-two bone blocks were extracted from fresh bovine pelvic bone. Four groups were created based on bone type (iliac or pubic region) and presence or absence of cortical bone. Specimens were micro-computed tomography imaged to evaluate trabecular thickness, trabecular number, trabecular separation, bone volume density (BV/TV), BMD, and cortical thickness. Miniscrews 1.4 mm in diameter and 6 mm long were inserted into the bone blocks, and primary stability was evaluated by insertion torque (IT), mini-implant mobility (PTV), and pull-out strength (PS).\nIntergroup comparison showed lower levels of primary stability when the BMD of trabecular bone was lower and in the absence of cortical bone (P\u2264.05). The Pearson correlation test showed correlation between trabecular number, trabecular thickness, BV/TV, trabecular BMD, total BMD, and IT, PTV, and PS. There was correlation between cortical thickness and IT and PS (P\u2264.05).\nIs trabecular bone related to primary stability of miniscrews?",
        "answer": "yes",
        "answer_rationale": "Cancellous bone plays an important role in primary stability of mini-implants in the presence or absence of cortical bone.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether trabecular bone is related to the primary stability of miniscrews based on the provided study.\n\nFirst, I need to recall what the study found. The question mentions that the study compared primary stability in different bone densities and the presence or absence of cortical bone. The key results from the study are that lower BMD in trabecular bone and absence of cortical bone led to lower primary stability. Also, the Pearson correlation test showed correlations between trabecular properties like trabecular number, thickness, BV/TV, BMD, and the stability metrics (IT, PTV, PS). Additionally, cortical thickness was correlated with IT and PS.\n\nThe question specifically asks about trabecular bone's relation. The study's results clearly state that there were correlations between several trabecular properties and the primary stability parameters. Since correlation implies a relationship, even if it's not causal, the answer should be \"yes\". The options are A, B, C. The correct answer here is A (yes) because the study found significant correlations, indicating a relationship exists.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 371,
            "completion_tokens": 235
        },
        "time_elapsed": 3.223954439163208
    },
    {
        "realidx": "24270957",
        "question": "Our aim was to investigate the effects of growth hormone (GH), hyperbaric oxygen and combined therapy on normal and ischemic colonic anastomoses in rats.\nEighty male Wistar rats were divided into eight groups (n\u200a=\u200a10). In the first four groups, non-ischemic colonic anastomosis was performed, whereas in the remaining four groups, ischemic colonic anastomosis was performed. In groups 5, 6, 7, and 8, colonic ischemia was established by ligating 2 cm of the mesocolon on either side of the anastomosis. The control groups (1 and 5) received no treatment. Hyperbaric oxygen therapy was initiated immediately after surgery and continued for 4 days in groups 3 and 4. Groups 2 and 6 received recombinant human growth hormone, whereas groups 4 and 8 received GH and hyperbaric oxygen treatment. Relaparotomy was performed on postoperative day 4, and a perianastomotic colon segment 2 cm in length was excised for the detection of biochemical and mechanical parameters of anastomotic healing and histopathological evaluation.\nCombined treatment with hyperbaric oxygen and GH increased the mean bursting pressure values in all of the groups, and a statistically significant increase was noted in the ischemic groups compared to the controls (p<0.05). This improvement was more evident in the ischemic and normal groups treated with combined therapy. In addition, a histopathological evaluation of anastomotic neovascularization and collagen deposition showed significant differences among the groups.\nIs combined therapy more effective than growth hormone or hyperbaric oxygen alone in the healing of left ischemic and non-ischemic colonic anastomoses?",
        "answer": "yes",
        "answer_rationale": "Combined treatment with recombinant human growth hormone and hyperbaric oxygen resulted in a favorable therapeutic effect on the healing of ischemic colonic anastomoses.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about comparing the effects of growth hormone (GH), hyperbaric oxygen (HBO), and their combination on colonic anastomosis healing in rats, both with and without ischemia.\n\nThe question is whether combined therapy (GH + HBO) is more effective than either treatment alone in healing both ischemic and non-ischemic colonic anastomoses. The options are yes, no, or maybe.\n\nLooking at the results provided: the combined treatment increased the mean bursting pressure, especially in ischemic groups compared to controls (p<0.05). The improvement was more evident in both ischemic and normal groups that had combined therapy. Also, histopathological evaluations showed better neovascularization and collagen deposition. \n\nSince the question asks if combined therapy is more effective than either alone, the results indicate that the combination worked better, especially in ischemic cases. The key point is that the combined therapy's effect was statistically significant in ischemic groups versus controls and was more pronounced than when using GH or HBO alone. Therefore, the answer should be yes (A).\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 464,
            "completion_tokens": 236
        },
        "time_elapsed": 3.0373260974884033
    },
    {
        "realidx": "24298614",
        "question": "The clinical and prognostic value of the previous node classification of TNM staging in early gastric cancer (EGC) has been less definitive. The aim was to assess the suitability of the revised node staging for prediction of clinical behavior of EGC.\nBetween 2005 and 2008, 1,845 patients were diagnosed with EGC and underwent surgery at Severance Hospitals. Clinicopathological characteristics were analyzed with comparisons between sixth and seventh TNM staging.\nWhen comparing IB with IIA upstaged based on seventh staging, poor differentiation, signet ring cell, diffuse, undifferentiated types, perineural invasion (PNI), larger size and younger age, were more significantly associated with IIA. Clinicopathological factors were compared between N0/N1 and N2/N3 based on both staging. In mucosal cancer, younger age, diffuse and undifferentiated types were more significantly associated with N2/N3 based on seventh staging. In submucosal cancer, larger size, poor differentiation, signet ring cell, diffuse, undifferentiated types, PNI and deeper submucosal invasion, were more significantly associated with N2/N3 based on seventh staging.\nIs the 7th TNM edition suitable for biological predictor in early gastric cancer?",
        "answer": "yes",
        "answer_rationale": "Upstaging in EGC based on the revised TNM staging reflects more aggressive biological behavior of cancer. The new TNM staging system may be informative in prediction of biological behavior of EGC as well as prognosis and survival.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the 7th TNM edition is suitable as a biological predictor in early gastric cancer (EGC) based on the provided study.\n\nFirst, I need to recall what TNM staging does. TNM stands for Tumor, Node, Metastasis, and each edition updates the staging criteria based on new evidence. The question is about comparing the 6th and 7th editions, specifically regarding node classification (N categories) in EGC.\n\nThe study mentioned included 1,845 patients from 2005-2008. They compared the sixth and seventh staging systems. The key findings were that when using the seventh edition, certain factors like poor differentiation, signet ring cell type, diffuse/undifferentiated histology, perineural invasion, larger tumor size, and younger age were more significantly associated with the upstaged groups (like IIA instead of IB). \n\nIn mucosal cancer, younger age and certain histological types were linked to higher N categories (N2/N3) in the seventh staging. For submucosal cancers, factors like larger size, poor differentiation, and deeper invasion were also associated with higher N stages under the seventh system. \n\nThe question is whether the 7th edition is a good biological predictor. The study's results show that the seventh staging system's node classification (N categories) correlates better with these pathological factors that are known to have worse prognoses. Since these factors are biologically significant (like tumor aggressiveness markers: undifferentiated types, PNI, etc.), the revised staging (7th edition) seems to capture these predictors more effectively than the sixth. \n\nThe options are yes, no, maybe. The study's results support that the 7th edition's N staging is better at predicting clinical behavior because it's associated with these adverse features. Therefore, the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 356,
            "completion_tokens": 404
        },
        "time_elapsed": 4.914441823959351
    },
    {
        "realidx": "24318956",
        "question": "Digoxin is a commonly used medication for heart failure and cardiac arrhythmias that has recently been suggested as a novel chemotherapeutic agent. Preclinical studies of prostate cancer (PCa) have shown anti-tumor activity with digoxin. We explore the relationship between use of digoxin and PCa risk.\nData from a population-based case-control study of incident cases aged 35-74 years at PCa diagnosis in 2002-2005 in King County, Washington were available. Controls were identified by random digit dialing and frequency matched by age. Use of digoxin was determined from in-person questionnaires regarding medical and prescription history. The relationship of digoxin use with PCa risk was evaluated with logistic regression.\nOne thousand one cases of PCa and 942 controls were analyzed. The prevalence of digoxin use in controls was 2.7%, and use was positively correlated with age. In multivariate analysis adjusting for age, race, PSA screening, and family history of PCa, digoxin use was associated with a reduction in the odds ratio of PCa (OR 0.58, 95% CI: 0.30-1.10). Among those with \u22653 PSA tests over the preceding 5 years (546 cases, 380 controls), digoxin use was associated with a stronger reduction of PCa risk (OR 0.44, 95% CI: 0.20-0.98).\nIs digoxin use for cardiovascular disease associated with risk of prostate cancer?",
        "answer": "yes",
        "answer_rationale": "These data indicate digoxin use may be associated with a reduction in risk of PCa. Given the potential mechanisms by which digoxin may exert an anti-neoplastic effect and other recent studies showing a negative association between digoxin use and PCa, further research is warranted.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether digoxin use for cardiovascular disease is associated with the risk of prostate cancer. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided study details. The study is a case-control study looking at incident prostate cancer cases between 2002-2005. They compared 1100 cases and 942 controls. The key point here is the odds ratios (OR) given. \n\nIn the multivariate analysis, which adjusted for age, race, PSA screening, and family history, the OR was 0.58 with a 95% CI of 0.30-1.10. The confidence interval here includes 1 (since 1.10 is just over 1), which means the result is not statistically significant. So that might suggest no significant association, but the point estimate is below 1, indicating a possible reduced risk.\n\nHowever, when they looked at those with more PSA tests (\u22653 in 5 years), the OR was 0.44 with a CI of 0.20-0.98. This CI doesn't include 1, so that's statistically significant. The OR is less than 1, meaning digoxin use is associated with a lower risk here. \n\nThe question is whether digoxin use is associated with prostate cancer risk. The study shows that in the subgroup with more PSA screening, there's a significant reduction. But the overall result isn't significant. However, the question is phrased generally. The options are yes, no, maybe. \n\nThe study's main analysis (the first OR) was not statistically significant (since CI includes 1), but the subgroup analysis was. The answer might depend on whether the overall result is considered. Since the question is about the association in general, the main analysis's OR of 0.58 (non-significant) and the subgroup's significant result. The answer options are yes/no/maybe. The study's conclusion would probably say that there's a suggestion of reduced risk, especially in those with more screening, but the overall isn't significant. However, the question is whether it's associated. Since the subgroup shows a significant association (lower risk), but the overall isn't, maybe the answer is \"maybe\" (C). But wait, the options are (A) yes, (B) no, (C)",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 426,
            "completion_tokens": 512
        },
        "time_elapsed": 5.650038242340088
    },
    {
        "realidx": "24336869",
        "question": "The 'law of spatiotemporal concentrations of events' introduced major preventative shifts in policing communities. 'Hotspots' are at the forefront of these developments yet somewhat understudied in emergency medicine. Furthermore, little is known about interagency 'data-crossover', despite some developments through the Cardiff Model. Can police-ED interagency data-sharing be used to reduce community-violence using a hotspots methodology?\n12-month (2012) descriptive study and analysis of spatiotemporal clusters of police and emergency calls for service using hotspots methodology and assessing the degree of incident overlap. 3775 violent crime incidents and 775 assault incidents analysed using spatiotemporal clustering with k-means++ algorithm and Spearman's rho.\nSpatiotemporal location of calls for services to the police and the ambulance service are equally highly concentrated in a small number of geographical areas, primarily within intra-agency hotspots (33% and 53%, respectively) but across agencies' hotspots as well (25% and 15%, respectively). Datasets are statistically correlated with one another at the 0.57 and 0.34 levels, with 50% overlap when adjusted for the number of hotspots. At least one in every two police hotspots does not have an ambulance hotspot overlapping with it, suggesting half of assault spatiotemporal concentrations are unknown to the police. Data further suggest that more severely injured patients, as estimated by transfer to hospital, tend to be injured in the places with the highest number of police-recorded crimes.\nCan routinely collected ambulance data about assaults contribute to reduction in community violence?",
        "answer": "maybe",
        "answer_rationale": "A hotspots approach to sharing data circumvents the problem of disclosing person-identifiable data between different agencies. Practically, at least half of ambulance hotspots are unknown to the police; if causal, it suggests that data sharing leads to both reduced community violence by way of prevention (such as through anticipatory patrols or problem-oriented policing), particularly of more severe assaults, and improved efficiency of resource deployment.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether routinely collected ambulance data about assaults can contribute to reducing community violence. The study mentioned in the question analyzed both police and ambulance data using hotspots methodology.\n\nFirst, the study found that there's a significant overlap between police and ambulance hotspots. Specifically, 25% and 15% of the hotspots across agencies overlapped, and the datasets were statistically correlated at 0.57 and 0.34. Also, there's a 50% overlap when adjusted. This suggests that ambulance data does capture some of the same high-crime areas as police data. \n\nBut the key point here is that about half of the police hotspots don't have overlapping ambulance hotspots. That means ambulance data might be identifying different areas where severe injuries occur, which the police aren't fully capturing. Since more severely injured patients are in areas with high crime, ambulance data could highlight areas the police aren't aware of, allowing for targeted interventions. \n\nThe question is whether this data can help reduce violence. Since the study shows a correlation and that ambulance data provides additional information (like areas with severe injuries not known to police), sharing this data between agencies could help in focusing prevention efforts. The options are yes, no, maybe. The study's findings support that ambulance data does contribute because it adds new information and overlaps enough to be useful. So the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 434,
            "completion_tokens": 301
        },
        "time_elapsed": 3.574646472930908
    },
    {
        "realidx": "24340838",
        "question": "Sudden death in athletes can occur during sport activities and is presumably related to ventricular arrhythmias.\nTo investigate the long-term follow-up ofathletes with ventricular arrhythmias during an exercise test.\nFrom a database of 56,462 athletes we identified 192 athletes (35 years old who had ventricular arrhythmias during an exercise test. Ninety athletes had>or =3 ventricular premature beats (VPB) (group A) and 102 athletes had ventricular couplets or non-sustained ventricular tachycardia during an exercise test (group B). A control group of 92 athletesfrom without ventricular arrhythmias was randomly seleclted from the database (group C). Of the 192 athletes 39 returnied for a repeat exercise test after a mean follow-up period of 70 +/- 25 months and they constitute the study population.\nTwelve athletes from group A, 21 fromgroup B and 6 from group C returned for a repeat exercise test. The athletes reached a significantly lower peak heart rate during their follow-up exercise test (P = 0.001). More athletes were engaged in competitive sports during their initialexercise test than in the follow-up test (P = 0.021). Most of theathletes who had VPB and/orventricular couplets and/or NSVT during their initial exercise test had far fewer ventricular arrhythmias in the follow-up exercise test (P = 0.001).\nDo ventricular arrhythmias in athletes subside over time?",
        "answer": "yes",
        "answer_rationale": "Athletes engaged in competitive sports are more likely to develop ventricular arrhythmias during exercise. These arrhythmias subside over time when athletes are engaged in non-competitive sports.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether ventricular arrhythmias in athletes subside over time based on the provided study.\n\nFirst, I need to understand the study details. The study followed athletes who had ventricular arrhythmias during an exercise test. They were divided into groups A and B based on the type and number of arrhythmias. Group C was the control without arrhythmias. \n\nThe key point here is the follow-up data. The study mentions that when the athletes had their repeat test after about 70 months, most of those who initially had arrhythmias (VPB, couplets, NSVT) had far fewer during the follow-up. The p-value of 0.001 indicates this reduction was statistically significant. \n\nThe question is whether this means the arrhythmias subside over time. The results show a significant decrease in arrhythmias during the follow-up tests. The answer should be \"yes\" because the data supports that the arrhythmias reduced over the long-term follow-up period. The other options, like \"no\" or \"maybe,\" don't fit because the study's results are statistically significant in showing a decrease. \n\nI should also check if there's any conflicting data. The peak heart rate was lower, and fewer were in competitive sports, but the main finding is the reduction in arrhythmias. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 428,
            "completion_tokens": 293
        },
        "time_elapsed": 3.7064666748046875
    },
    {
        "realidx": "24352924",
        "question": "The purpose of this study was to investigate the efficacy of ultrasonography to confirm Schanz pin placement in a cadaveric model, and the interobserver repeatability of the ultrasound methodology.\nThis investigation is a repeated measures cadaveric study with multiple examiners.\nCadaveric preparation and observations were done by an orthopaedic traumatologist and resident, and two general surgery traumatologists.\nA total of 16 Schanz pins were equally placed in bilateral femora and tibiae. Four examiners took measurements of pin protrusion beyond the distal cortices using first ultrasonography and then by direct measurement after gross dissection.MAIN OUTCOME MEASURE(S): Distal Schanz pin protrusion length measurements from both ultrasonography and direct measurement post dissection.\nSchanz pin protrusion measurements are underestimated by ultrasonography (p<0.01) by an average of 10 percent over the range of 5 to 18 mm, and they display a proportional bias that increases the under reporting as the magnitude of pin protrusion increases. Ultrasound data demonstrate good linear correlation and closely represent actual protrusion values in the 5 to 12 mm range. Interobserver repeatability analysis demonstrated that all examiners were not statistically different in their measurements despite minimal familiarity with the ultrasound methodology (p>0.8).\nIs portable ultrasonography accurate in the evaluation of Schanz pin placement during extremity fracture fixation in austere environments?",
        "answer": "yes",
        "answer_rationale": "Despite the statistical imparity of pin protrusion measurement via ultrasound compared to that of gross dissection, a consideration of the clinical relevance of ultrasound measurement bias during an austere operating theatre leads to the conclusion that ultrasonography is an adequate methodology for Schanz pin protrusion measurement.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The study is about using ultrasonography to check Schanz pin placement in a cadaver model. The main outcome was comparing ultrasound measurements to the actual measurements after dissection.\n\nThe results say that ultrasound underestimates the protrusion by 10% on average, especially more as the protrusion gets bigger. But there's a good linear correlation, and it's close in the 5-12mm range. Also, the interobserver repeatability was good since all examers weren't statistically different, even with little experience.\n\nThe question is whether portable ultrasound is accurate in austere settings. The key here is the definition of \"accurate.\" The study shows underestimation, which is a systematic error. Even though there's a proportional bias and underreporting, especially beyond 12mm, the correlation is good in some ranges. However, underestimation by 10% might be clinically significant, especially if precise measurements are needed. The repeatability is good, but accuracy (compared to the true value) is off. So maybe the answer is no because it's not accurate enough, but the options are yes, no, maybe. The study says \"underestimated\" which suggests inaccuracy. But the question is about accuracy in evaluation. Since it's underestimating, maybe it's not accurate. But the answer options might consider the correlation and repeatability as sufficient for some uses. Wait, the main point is the underestimation. The conclusion says \"underestimated by 10% (p<0.01)\" which is statistically significant. So the answer would be B) no, because it's not accurate. But the study also says in 5-12mm it's close. Maybe in some cases it's okay, but the question is general. The study's conclusion would probably say it's not accurate enough, so the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 390,
            "completion_tokens": 403
        },
        "time_elapsed": 5.067713260650635
    },
    {
        "realidx": "24359102",
        "question": "Skin diseases are the most frequently recognized occupational diseases in Denmark. The prognosis for occupational contact dermatitis is often poor.\nTo investigate the prognosis, assessed by eczema, job status and skin-related quality of life, among patients allergic to rubber chemicals and latex (ubiquitous allergens) and epoxy (nonubiquitous allergen), 2\u00a0years after recognition of occupational allergic contact dermatitis.\nFrom a cohort of all patients recognized as having occupational dermatitis by the Danish National Board of Industrial Injuries in 2010, 199 patients with relevant rubber allergy (contact allergy to rubber chemicals or contact urticaria from latex) or epoxy allergy were identified. Follow-up consisted of a questionnaire covering current severity of eczema, employment, exposure and quality of life.\nThe response rate was 75%. Clearance of eczema was reported by 11% of patients and 67% reported improvement. Overall 22% of patients with allergy to a nonubiquitous allergen had total clearance of eczema compared with 10% of cases allergic to ubiquitous allergens and 0% of those with contact urticaria (P\u00a0=\u00a00\u00b7116). Improvement was significantly more frequent in those who had changed jobs compared with those who had not (P\u00a0=\u00a00\u00b701).\nTwo-year follow-up survey of patients with allergic contact dermatitis from an occupational cohort: is the prognosis dependent on the omnipresence of the allergen?",
        "answer": "yes",
        "answer_rationale": "At follow-up, patients with contact urticaria had significantly poorer prognosis than those with contact allergy, and there was a trend towards a poorer prognosis for those with contact allergy to rubber chemicals than those with allergy to epoxy. A significant positive association between job change and improvement was found.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the prognosis for occupational contact dermatitis depends on whether the allergen is ubiquitous or not. The study mentioned compared patients allergic to rubber chemicals/latex (which are ubiquitous) and epoxy (nonubiquitous). \n\nLooking at the results: 22% of nonubiquitous (epoxy) had clearance vs 10% of ubiquitous and 0% for contact urticaria. But the P-value was 0.116, which is higher than 0.05, so not statistically significant. However, improvement was significant when they changed jobs. \n\nThe question is about the dependence on the allergen's omnipresence. Since the clearance rates between groups didn't reach statistical significance (P=0.116), the answer would be that the prognosis isn't dependent, so the answer is B) no. Even though there's a numerical difference, the stats don't support a significant effect. The job change factor is separate.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 398,
            "completion_tokens": 215
        },
        "time_elapsed": 2.7851593494415283
    },
    {
        "realidx": "24449622",
        "question": "This study aimed to show the relationship between serum paraoxonase 1 level and the epicardial fat tissue thickness.\nTwo hundred and seven patients without any atherosclerotic disease history were included in this cross-sectional observational study. Correlation analysis was performed to determine the correlation between epicardial fat tissue thickness, which was measured by echocardiography and serum paraoxonase 1 level. Also correlation analysis was performed to show correlation between patients' clinical and laboratory findings and the level of serum paraoxonase 1 (PON 1) and the epicardial fat tissue thickness. Pearson and Spearman test were used for correlation analysis.\nNo linear correlation between epicardial fat tissue thickness and serum PON 1 found (correlation coefficient: -0.127, p=0.069). When epicardial fat tissue thickness were grouped as 7 mm and over, and below, and 5 mm and over, and below, serum PON 1 level were significantly lower in \u22657 mm group (PON1 : 168.9 U/L) than<7 mm group (PON 1: 253.9 U/L) (p<0.001). Also hypertension prevalence was increased in \u22657 mm group (p=0.001). Serum triglyceride was found to be higher in \u22657 mm group (p=0.014), body mass index was found higher in \u22655 mm group (p=0.006).\nIs there a relationship between serum paraoxonase level and epicardial fat tissue thickness?",
        "answer": "no",
        "answer_rationale": "Serum PON 1 level is not correlated with the epicardial fat tissue thickness. But PON 1 level is lower in patients with epicardial fat tissue thickness 7 mm and over. Therefore, increased atherosclerosis progression can be found among patients with 7 mm and higher epicardial fat tissue thickness.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at the relationship between serum paraoxonase 1 (PON1) levels and epicardial fat tissue thickness. The key here is to understand the results presented.\n\nFirst, the question is whether there's a relationship between PON1 and epicardial fat thickness. The study mentions that a correlation analysis using Pearson and Spearman tests found no linear correlation. The correlation coefficient was -0.127 with a p-value of 0.069. Since the p-value is greater than 0.05, that's not statistically significant. So, on a linear scale, there's no significant correlation.\n\nBut then, when they grouped the epicardial fat into categories (like \u22657mm and <7mm), they found that the PON1 levels were significantly lower in the \u22657mm group (168.9 U/L vs 253.9 U/L, p<0.001). That's a notable difference. So even though the linear correlation wasn't significant, the grouped analysis shows a significant difference. \n\nHmm, so the question is asking if there's a relationship. The linear correlation didn't show it, but the grouped analysis did. The answer might depend on how the question is phrased. The options are yes, no, maybe. The study's main result (the linear correlation) says no, but the subgroup analysis says yes. Since the question is general, maybe the correct answer is yes because there is an association when considering thresholds. But the first part says no linear correlation. Wait, the question is whether there's a relationship. The presence of a significant difference between groups suggests that there is a relationship, even if it's not linear. For example, maybe it's a non-linear relationship. The correlation coefficient being -0.127 is a weak negative correlation, but not statistically significant. However, when they split into groups, the means differ significantly. So the answer might be yes because there is an association when considering the groups. The study's conclusion would likely state that while there's no linear correlation, there is a significant difference in PON1 levels when epicardial fat exceeds 7mm. Therefore, the answer is yes (A). But wait, the options are (A) yes, (B) no, (C) maybe. The question is whether there's a relationship. The study found that when divided into groups, there is a",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 430,
            "completion_tokens": 512
        },
        "time_elapsed": 6.8176422119140625
    },
    {
        "realidx": "24476003",
        "question": "Although its excellent results, laparoscopic sleeve gastrectomy (LSG) presents major complications ranging from 0% to 29%. Among them, the staple line leak presents an incidence varying from 0% to 7%. Many trials debated about different solutions in order to reduce leaks' incidence. No author has investigated the role of gastric decompression in the prevention of this complication. Aim of our work is to evaluate if this procedure can play a role in avoiding the occurrence of staple line leaks after LSG.\nBetween January 2008 and November 2012, 145 patients were prospectively and randomly included in the study. Seventy patients composed the group A, whose operations were completed with placement of nasogastric tube; the other 75 patients were included in the group B, in which no nasogastric tube was placed.\nNo statistical differences were observed between group A and group B regarding gender distribution, age, weight, and BMI. No intraoperative complications and no conversion occurred in both groups. Intraoperative blood loss (50.1 \u00b1 42.3 vs. 52.5 \u00b1 37.6 ml, respectively) and operative time (65.4 \u00b1 25.5 vs. 62.6 \u00b1 27.8 min, respectively) were comparable between the two groups (p: NS). One staple line leak (1.4%) occurred on 6th postoperative day in group A patients. No leak was observed in group B patients. Postoperative hospital stay was significantly longer in group A vs. group B patients (7.6 \u00b1 3.4 vs. 6.2 \u00b1 3.1 days, respectively, p: 0.04).\nIs nasogastric decompression useful in prevention of leaks after laparoscopic sleeve gastrectomy?",
        "answer": "no",
        "answer_rationale": "Routine placement of nasogastric tube in patients operated of LSG seems not useful in reducing leaks' incidence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether nasogastric decompression helps prevent staple line leaks after laparoscopic sleeve gastrectomy (LSG). The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided. The study had two groups: Group A with nasogastric tubes and Group B without. The key results are the incidence of leaks and hospital stay. \n\nIn Group A (with NG tube), there was 1 leak out of 70 patients, which is 1.4%. Group B had zero leaks out of 75. So the group without the tube actually had fewer leaks. That seems counterintuitive. If the NG tube was supposed to prevent leaks by decompressing the stomach, but the group without it had no leaks, maybe the tube isn't helpful here. \n\nAlso, the hospital stay was longer in Group A. That might be because having a nasogastric tube could lead to longer recovery or more complications, but the main point here is the leak rate. Since the group without the tube had no leaks, it suggests that the decompression didn't prevent leaks better. \n\nThe question is whether nasogastric decompression is useful. Since the group without it had a better outcome (no leaks vs. 1.4%), the answer would lean towards no. The study's results don't support the use of NG tubes for preventing leaks. The fact that the leak rate was higher (though still low) in the group with the tube might even suggest it's not helpful, but the difference here isn't statistically significant because the numbers are small. However, the question is based on the study's findings. Since the group without had zero, and the other had 1.4%, but the p-value for leaks isn't mentioned. Wait, the problem states that the leak in group A was 1.4% and none in B. The p-value for that comparison isn't given, so we can't say if it's statistically significant. But the question is asking based on the study's results. The authors might conclude that there's no benefit since the group without had no leaks. Also, the hospital stay was longer with NG, which is a downside. \n\nThe options are yes, no, maybe. Since the study's data shows that the group without NG tubes had fewer leaks (none vs. 1.4%), even if the difference isn't statistically significant, the answer would be",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 479,
            "completion_tokens": 512
        },
        "time_elapsed": 6.196574926376343
    },
    {
        "realidx": "24481006",
        "question": "79 adjacent proximal surfaces without restorations in permanent teeth were examined. Patients suspected to have carious lesions after a visual clinical and a bitewing examination participated in a CBCT examination (Kodak 9000 3D, 5 \u00d7 3.7 cm field of view, voxel size 0.07 mm). Ethical approval and informed consent were obtained according to the Helsinki Declaration. Radiographic assessment recording lesions with or without cavitation was performed by two observers in bitewings and CBCT sections. Orthodontic separators were placed interdentally between two lesion-suspected surfaces. The separator was removed after 3 days and the surfaces recorded as cavitated (yes/no), i.e. validated clinically. Differences between the two radiographic modalities (sensitivity, specificity and overall accuracy) were estimated by analyzing the binary data in a generalized linear model.\nFor both observers, sensitivity was significantly higher for CBCT than for bitewings (average difference 33%, p<0.001) while specificity was not significantly different between the methods (p = 0.19). The overall accuracy was also significantly higher for CBCT (p<0.001).\nShould cavitation in proximal surfaces be reported in cone beam computed tomography examination?",
        "answer": "yes",
        "answer_rationale": "CBCT was more accurate in detecting cavitation in proximal surfaces than bitewing radiographs; therefore a CBCT examination performed for other clinical applications should also be assessed for proximal surface cavities in teeth without restorations, and when detected, this pathology must be part of the dentist's report.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether cavitation in proximal surfaces should be reported in a CBCT examination based on the study provided.\n\nFirst, I need to recall what the study found. The question mentions that they compared CBCT with bitewing exams. The key results were that CBCT had significantly higher sensitivity than bitewings (average difference 33%, p<0.001). Sensitivity here refers to the ability of the test to correctly identify those with the disease (cavitation in this case). So CBCT is better at detecting actual cavitations. Specificity wasn't significantly different, meaning both are about as good at avoiding false positives. The overall accuracy was also higher for CBCT.\n\nThe question is whether cavitation should be reported in CBCT. Since CBCT is more sensitive and accurate, it's better at detecting cavitations. Therefore, reporting cavitation using CBCT makes sense because it's more reliable. The study's results support that CBCT is better at identifying true cavitations, so clinicians should use the CBCT findings to report cavitation. The options are yes, no, maybe. The answer should be yes (A) because the higher sensitivity and accuracy indicate that CBCT is better at detecting cavitations, so reporting them is appropriate.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 358,
            "completion_tokens": 272
        },
        "time_elapsed": 4.351367712020874
    },
    {
        "realidx": "24495711",
        "question": "More than 50,000 new HIV infections occur annually in the United States. Injection drug users represent twelve percent of incident HIV infections each year. Pharmacy sales of over-the-counter (OTC) syringes have helped prevent HIV transmission among injection drug users in many states throughout the United States. However, concerns exist among some law enforcement officials, policymakers, pharmacists, and community members about potential links between OTC syringe sales and crime.\nWe used a geographic information system and novel spatial and longitudinal analyses to determine whether implementation of pharmacy-based OTC syringe sales were associated with reported crime between January 2006 and December 2008 in Los Angeles Police Department Reporting Districts. We assessed reported crime pre- and post-OTC syringe sales initiation as well as longitudinal associations between crime and OTC syringe-selling pharmacies.\nBy December 2008, 9.3% (94/1010) of Los Angeles Police Department Reporting Districts had at least one OTC syringe-selling pharmacy. Overall reported crime counts and reported crime rates decreased between 2006 and 2008 in all 1010 Reporting Districts. Using generalized estimating equations and adjusting for potential confounders, reported crime rates were negatively associated with OTC syringe sales (adjusted rate ratio: 0.89; 95% confidence interval: 0.81, 0.99).\nIs crime associated with over-the-counter pharmacy syringe sales?",
        "answer": "yes",
        "answer_rationale": "Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether crime is associated with over-the-counter (OTC) pharmacy syringe sales. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentioned used a geographic information system and spatial analyses to see if OTC syringe sales in pharmacies were linked to crime in Los Angeles between 2006 and 2008. The key points here are the results of their analysis. \n\nThe study found that by 2008, about 9.3% of the reporting districts had these pharmacies. Overall crime counts and rates decreased in all districts during that period. The important statistical part is the adjusted rate ratio of 0.89 with a 95% confidence interval of 0.81 to 0.99. \n\nNow, interpreting that: a rate ratio below 1 means that areas with OTC syringe sales had lower crime rates compared to those without, after adjusting for other factors. The confidence interval includes values all below 1 (since the upper limit is 0.99), which suggests that the association is statistically significant. So the data shows that areas with OTC syringes had a lower crime rate. \n\nThe question is whether crime is associated with OTC sales. The study's conclusion here is that there's a negative association\u2014meaning that OTC sales are linked to lower crime, not higher. Therefore, the answer would be \"no\" because the association is negative, so OTC sales aren't associated with increased crime. The options are (A) yes, (B) no, (C) maybe. The correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 404,
            "completion_tokens": 358
        },
        "time_elapsed": 4.206088066101074
    },
    {
        "realidx": "24507422",
        "question": "Patients presenting with transient ischemic attack or stroke may have symptom-related lesions on acute computed tomography angiography (CTA) such as free-floating intraluminal thrombus (FFT). It is difficult to distinguish FFT from carotid plaque, but the distinction is critical as management differs. By contouring the shape of these vascular lesions (\"virtual endarterectomy\"), advanced morphometric analysis can be performed. The objective of our study is to determine whether quantitative shape analysis can accurately differentiate FFT from atherosclerotic plaque.\nWe collected 23 consecutive cases of suspected carotid FFT seen on CTA (13 men, 65 \u00b1 10 years; 10 women, 65.5 \u00b1 8.8 years). True-positive FFT cases (FFT+) were defined as filling defects resolving with anticoagulant therapy versus false-positives (FFT-), which remained unchanged. Lesion volumes were extracted from CTA images and quantitative shape descriptors were computed. The five most discriminative features were used to construct receiver operator characteristic (ROC) curves and to generate three machine-learning classifiers. Average classification accuracy was determined by cross-validation.\nFollow-up imaging confirmed sixteen FFT+ and seven FFT- cases. Five shape descriptors delineated FFT+ from FFT- cases. The logistic regression model produced from combining all five shape features demonstrated a sensitivity of 87.5% and a specificity of 71.4% with an area under the ROC curve = 0.85 \u00b1 0.09. Average accuracy for each classifier ranged from 65.2%-76.4%.\nCan shape analysis differentiate free-floating internal carotid artery thrombus from atherosclerotic plaque in patients evaluated with CTA for stroke or transient ischemic attack?",
        "answer": "yes",
        "answer_rationale": "We identified five quantitative shape descriptors of carotid FFT. This shape \"signature\" shows potential for supplementing conventional lesion characterization in cases of suspected FFT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether shape analysis can differentiate free-floating intraluminal thrombus (FFT) from atherosclerotic plaque in the carotid artery using CTA in stroke/TIA patients. \n\nFirst, I need to look at the study details provided. The study had 23 cases, with 16 confirmed as FFT+ (those that resolved with anticoagulants) and 7 as FFT- (didn't change). They used shape descriptors and machine learning models. The key results were a logistic regression model with 87.5% sensitivity and 71.4% specificity, and an AUC of 0.85. The accuracy ranged from 65-76%.\n\nThe question is whether shape analysis can differentiate the two. The options are yes, no, maybe. The study's results show that the model had decent sensitivity and specificity, and the AUC is above 0.8, which is considered good. The accuracy, even at the lower end (65%), suggests some effectiveness. Since the question is whether it can differentiate, the answer would be yes, because the study's results support that the shape analysis had significant discriminative power. The fact that the accuracy isn't 100% doesn't mean it can't differentiate, just that it's not perfect. The options don't have a \"partially\" so \"yes\" is the best answer here.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 456,
            "completion_tokens": 307
        },
        "time_elapsed": 3.7029836177825928
    },
    {
        "realidx": "24516646",
        "question": "The ImmunoCAP ISAC 112 is a fluoro-immunoassay that allows detection of specific IgE to 112 molecular components from 51 allergenic sources. We studied the reliability of this technique intra- and inter- assay, as well as inter-batch- and inter-laboratory-assay.\nTwenty samples were studied, nineteen sera from polysensitized allergic patients, and the technique calibrator provided by the manufacturer (CTR02). We measured the sIgE from CTR02 and three patients' sera ten times in the same and in different assays. Furthermore, all samples were tested in two laboratories and with two batches of ISAC kit. To evaluate the accuracy of ISAC 112, we contrasted the determinations of CTR02 calibrator with their expected values by T Student test. To analyse the precision, we calculated the coefficient of variation (CV) of the 15 allergens that generate the calibration curve, and to analyse the repeatability and the reproducibility, we calculated the intraclass coefficient correlation (ICC) to each allergen.\nThe results obtained for CTR02 were similar to those expected in 7 of 15 allergens that generate the calibration curve, whereas in 8 allergens the results showed significant differences. The mean CV obtained in the CTR02 determinations was of 9.4%, and the variability of sera from patients was of 22.9%. The agreement in the intra- and inter-assay analysis was very good to 94 allergens and good to one. In the inter-batch analyse, we obtained a very good agreement to 82 allergens, good to 14, moderate to 5 allergens, poor to one, and bad to 1 allergen. In the inter-laboratory analyse, we obtained a very good agreement to 73 allergens, good to 22, moderate to 6 and poor to two allergens.\nIs the determination of specific IgE against components using ISAC 112 a reproducible technique?",
        "answer": "yes",
        "answer_rationale": "The allergen microarray immunoassay, ISAC 112, is a repeatable and reproducible in vitro diagnostic tool for determination of sIgE beyond the own laboratory.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the ImmunoCAP ISAC 112 is a reproducible technique for determining specific IgE against allergens. The options are yes, no, or maybe.\n\nFirst, I need to recall what reproducibility means. Reproducibility generally refers to the ability to get consistent results under varying conditions, like different labs, batches, or assays. The question is about whether the technique is reproducible based on the study's results.\n\nLooking at the provided information, the study evaluated intra-assay, inter-assay, inter-batch, and inter-laboratory reliability. The key results mentioned are:\n\n- For the calibrator (CTR02), 7 out of 15 allergens in the calibration curve matched expected values, but 8 had significant differences. That's a point against accuracy, but the question is about reproducibility, not accuracy.\n\n- The mean CV for CTR02 was 9.4%, which is acceptable for many lab tests. The patient sera had a higher CV of 22.9%, which is more variable but still might be considered acceptable depending on standards.\n\n- Intra- and inter-assay agreement was very good for 94 allergens and good for 1. That's high, so good reproducibility within and between assays.\n\n- Inter-batch analysis showed very good for 82, good 14, moderate 5, poor 1, bad 1. So most were good or very good, but some had issues. \n\n- Inter-lab analysis: very good 73, good 22, moderate 6, poor 2. Again, majority are good, but some moderate and poor.\n\nThe question is whether the technique is reproducible. Reproducibility across different labs and batches is crucial. While there were some allergens with moderate, poor, or bad agreement in inter-batch and inter-lab, the majority (especially in inter-batch: 82+14=96 out of 112) had good or very good agreement. Similarly, inter-lab had 73+22=95 out of 112. The fact that most allergens showed good reproducibility, even if not all, might lead to the conclusion that overall it is considered reproducible, especially since the majority are acceptable. The answer options are yes, no, maybe. The study's results show",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 525,
            "completion_tokens": 512
        },
        "time_elapsed": 5.723555564880371
    },
    {
        "realidx": "24577079",
        "question": "Older adults typically perform worse on measures of working memory (WM) than do young adults; however, age-related differences in WM performance might be reduced if older adults use effective encoding strategies.\nThe purpose of the current experiment was to evaluate WM performance after training individuals to use effective encoding strategies.\nParticipants in the training group (older adults: n = 39; young adults: n = 41) were taught about various verbal encoding strategies and their differential effectiveness and were trained to use interactive imagery and sentence generation on a list-learning task. Participants in the control group (older: n = 37; young: n = 38) completed an equally engaging filler task. All participants completed a pre- and post-training reading span task, which included self-reported strategy use, as well as two transfer tasks that differed in the affordance to use the trained strategies - a paired-associate recall task and the self-ordered pointing task.\nBoth young and older adults were able to use the target strategies on the WM task and showed gains in WM performance after training. The age-related WM deficit was not greatly affected, however, and the training gains did not transfer to the other cognitive tasks. In fact, participants attempted to adapt the trained strategies for a paired-associate recall task, but the increased strategy use did not benefit their performance.\nDoes strategy training reduce age-related deficits in working memory?",
        "answer": "no",
        "answer_rationale": "Strategy training can boost WM performance, and its benefits appear to arise from strategy-specific effects and not from domain-general gains in cognitive ability.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether strategy training reduces age-related deficits in working memory based on the study described.\n\nFirst, I need to recall the details from the experiment. The study had two groups: a training group and a control group, each with older and younger adults. The training involved teaching encoding strategies like interactive imagery and sentence generation. They measured WM performance before and after training using a reading span task, and also looked at transfer tasks.\n\nThe key results mentioned are that both age groups improved their WM performance after training. However, the age-related deficit wasn't greatly affected. So even though both got better, the gap between older and younger adults didn't close much. Also, the training gains didn't transfer to other tasks. The older adults tried using the strategies on the paired-associate task but it didn't help their performance.\n\nThe question is whether the strategy training reduces the age deficit. The answer hinges on whether the age difference (deficit) was significantly reduced. The study says the deficit wasn't \"greatly affected,\" implying that while both improved, the difference remained notable. Since the training didn't substantially close the gap, the answer would be no. The options are A (yes), B (no), C (maybe). The study's results don't support a yes, so B is correct.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 371,
            "completion_tokens": 277
        },
        "time_elapsed": 3.6645448207855225
    },
    {
        "realidx": "24591144",
        "question": "To determine if elderly patients with oropharyngeal squamous cell carcinoma (OPSCC) are receiving less treatment and to evaluate the benefit of aggressive therapy in this population.\nRetrospective analysis of a large population database.\nPatients in the Surveillance, Epidemiology, and End Results database with OPSCC diagnosed from 2004 to 2009 were included. The patients were categorized into age groups 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 years and older, then further categorized by treatment status. Kaplan-Meier analysis of disease-specific survival (DSS) for late-stage (III and IV) OPSCC was performed for all age and treatment categories, followed by a multivariate cox regression of treatment status, tumor site, race, stage, and sex per age group.\nA total of 14,909 patients with OPSCC were identified. In our demographic data, we observed a significant increase in the number of patients who did not receive treatment (surgery, radiation, or combined therapy) after age 55. Kaplan-Meier analysis showed that age groups 65 to 74 and 75 to 84 had substantial benefits in DSS with surgery, radiation, or combined therapy. Multivariable analysis did not demonstrate any statistically significant difference in the hazard ratios for combined treatment among age groups 45 to 54, 55 to 64, 65 to 74, and 75 to 84.\nAre the elderly with oropharyngeal carcinoma undertreated?",
        "answer": "maybe",
        "answer_rationale": "Proportionally fewer elderly patients with OPSCC are being treated than younger individuals. These patients can have significant benefits from aggressive treatments despite their older age as shown by our survival analysis. We recommend the use of objective measures to assess patient fitness to reduce the potential for undertreatment in the elderly population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether elderly patients with oropharyngeal carcinoma are undertreated based on the study described.\n\nFirst, I need to parse the information given. The study looked at patients from the SEER database diagnosed between 2004-2009. They were divided into age groups, and treatment status was categorized. The key findings mentioned are that after age 55, there's a significant increase in patients not receiving treatment (surgery, radiation, or combined). The Kaplan-Meier analysis showed that the 65-74 and 75-84 groups had better disease-specific survival when they did get treatment. The multivariate analysis didn't find a difference in hazard ratios for combined treatment across the age groups except maybe the oldest (85+ isn't mentioned here). \n\nThe question is whether the elderly are undertreated. The data shows that starting at 55, more patients aren't getting treatment. Since the survival benefits exist even in older groups, the fact that treatment rates drop off suggests that perhaps they are undertreated. The study's results indicate that treatment is beneficial even in the older age groups, so not giving treatment could be undertreatment. The answer should be yes (A). The multivariate analysis not showing a difference in hazard ratios means that treatment is equally beneficial across age groups, so withholding it in the elderly isn't justified by lower benefit. Therefore, the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 441,
            "completion_tokens": 307
        },
        "time_elapsed": 3.8257124423980713
    },
    {
        "realidx": "24614789",
        "question": "Postoperative CSF fistulas were described in 16 of 198 patients (8%) who underwent spine surgery between 2009 and 2010. The choice of the therapeutic strategy was based on the clinical condition of the patients, taking into account the possibility to maintain the prone position continuously and the risk of morbidity due to prolonged bed rest. Six patients were treated conservatively (position prone for three weeks), ten patients were treated by positioning an external CSF lumbar drainage for ten days. The mean follow-up period was ten months.\nAll patients healed their wound properly and no adverse events were recorded. Patients treated conservatively were cured in a mean period of 30 days, while patients treated with CSF drainage were cured in a mean period of 10 days.\nIs lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective?",
        "answer": "yes",
        "answer_rationale": "Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether lumbar drainage is effective for postoperative CSF fistulas after spine surgery. The study provided has 198 patients, with 16 developing a CSF fistula. Out of those, 6 were treated conservatively (prone position for three weeks) and 10 had lumbar drainage for ten days.\n\nThe key points here are the healing times. The conservative group took a mean of 30 days to heal, while the drainage group healed in 10 days. Also, all patients healed without adverse events. The question is about the effectiveness of lumbar drainage. Since the drainage group had a significantly shorter healing time (10 vs 30 days), that suggests the drainage was more effective. The answer options are yes, no, maybe. The data shows a clear benefit in terms of time, so the answer should be A) yes. But wait, maybe there's a catch? The study is small, only 16 patients split into 6 and 10. However, the question is whether it's effective, not necessarily proven beyond a doubt. Since the results show faster healing without complications, the answer is yes. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 274,
            "completion_tokens": 263
        },
        "time_elapsed": 3.4886324405670166
    },
    {
        "realidx": "24622801",
        "question": "Implant-related infections represent one of the most severe complications in orthopaedics. A fast-resorbable, antibacterial-loaded hydrogel may reduce or prevent bacterial colonization and biofilm formation of implanted biomaterials.QUESTIONS/\nWe asked: (1) Is a fast-resorbable hydrogel able to deliver antibacterial compounds in vitro? (2) Can a hydrogel (alone or antibacterial-loaded) coating on implants reduce bacterial colonization? And (3) is intraoperative coating feasible and resistant to press-fit implant insertion?\nWe tested the ability of Disposable Antibacterial Coating (DAC) hydrogel (Novagenit Srl, Mezzolombardo, Italy) to deliver antibacterial agents using spectrophotometry and a microbiologic assay. Antibacterial and antibiofilm activity were determined by broth microdilution and a crystal violet assay, respectively. Coating resistance to press-fit insertion was tested in rabbit tibias and human femurs.\nComplete release of all tested antibacterial compounds was observed in less than 96 hours. Bactericidal and antibiofilm effect of DAC hydrogel in combination with various antibacterials was shown in vitro. Approximately 80% of the hydrogel coating was retrieved on the implant after press-fit insertion.\nDoes implant coating with antibacterial-loaded hydrogel reduce bacterial colonization and biofilm formation in vitro?",
        "answer": "yes",
        "answer_rationale": "Implant coating with an antibacterial-loaded hydrogel reduces bacterial colonization and biofilm formation in vitro.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether implant coating with an antibacterial-loaded hydrogel reduces bacterial colonization and biofilm formation in vitro. The options are yes, no, or maybe.\n\nFirst, I need to look back at the information provided in the question. The study tested the DAC hydrogel. The key points mentioned are:\n\n1. They tested the hydrogel's ability to deliver antibacterial compounds using spectrophotometry and microbiologic assays. The results showed complete release of antibacterial agents in less than 96 hours. That's important because if the hydrogel can release the antibiotics effectively, that's a good sign for fighting bacteria.\n\n2. The antibacterial and antibiofilm activities were determined by broth microdilution and crystal violet assays. The results stated that the DAC hydrogel in combination with various antibacterials showed bactericidal and antibiofilm effects in vitro. \n\nSo the question is specifically about in vitro results. The answer should be based on the in vitro findings mentioned here. The study's own results say that the hydrogel with antibacterials did have those effects in vitro. \n\nThe third part of their testing was about coating resistance during implant insertion, which had an 80% retrieval rate. But that's more about the physical durability of the coating, not the antibacterial effect itself. The question isn't about that part, just the reduction in bacterial colonization and biofilm in vitro.\n\nSo the answer should be \"yes\" because the study's own results state that the combination showed bactericidal and antibiofilm effects in vitro. The options are A, B, C. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 368,
            "completion_tokens": 345
        },
        "time_elapsed": 4.958048105239868
    },
    {
        "realidx": "24625433",
        "question": "Noise exposure in the neonatal intensive care unit is believed to be a risk factor for hearing loss in preterm neonates. Continuous positive airway pressure (CPAP) devices exceed recommended noise levels. High flow nasal cannulae (HFNC) are an increasingly popular alternative to CPAP for treating preterm infants, but there are no in vivo studies assessing noise production by HFNC.\nTo study whether HFNC are noisier than bubble CPAP (BCPAP) for preterm infants.\nAn observational study of preterm infants receiving HFNC or BCPAP. Noise levels within the external auditory meatus (EAM) were measured using a microphone probe tube connected to a calibrated digital dosimeter. Noise was measured across a range of frequencies and reported as decibels A-weighted (dBA).\nA total of 21 HFNC and 13 BCPAP noise measurements were performed in 21 infants. HFNC gas flows were 2-5 L/min, and BCPAP gas flows were 6-10 L/min with set pressures of 5-7 cm of water. There was no evidence of a difference in average noise levels measured at the EAM: mean difference (95% CI) of -1.6 (-4.0 to 0.9) dBA for HFNC compared to BCPAP. At low frequency (500 Hz), HFNC was mean (95% CI) 3.0 (0.3 to 5.7) dBA quieter than BCPAP. Noise increased with increasing BCPAP gas flow (p=0.007), but not with increasing set pressure. There was a trend to noise increasing with increasing HFNC gas flows.\nAre high flow nasal cannulae noisier than bubble CPAP for preterm infants?",
        "answer": "no",
        "answer_rationale": "At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether high flow nasal cannulae (HFNC) are noisier than bubble CPAP (BCPAP) for preterm infants based on the provided study.\n\nFirst, I need to recall the key findings from the study described. The study compared noise levels in the external auditory meatus between HFNC and BCPAP. The main results mentioned are:\n\n1. The average noise levels (in dBA) didn't show a significant difference between HFNC and BCPAP. The mean difference was -1.6 dBA with a 95% CI of -4.0 to 0.9. Since the confidence interval includes zero, this suggests no statistically significant difference in average noise levels.\n\n2. At low frequencies (500 Hz), HFNC was actually quieter by about 3 dBA. \n\n3. The study also noted that noise increased with higher BCPAP gas flow rates but not with pressure settings. For HFNC, there was a trend towards increased noise with higher gas flows, but it's not clear if that reached significance.\n\nThe question is whether HFNC is noisier than BCPAP. The key here is the average noise levels. Since the mean difference wasn't significant, the study didn't find evidence that HFNC is louder on average. The low frequency part shows HFNC is quieter there, but the overall average isn't different. \n\nThe options are (A) yes, (B) no, (C) maybe. The correct answer would be (B) no, because the study found no significant difference in average noise levels. Even though HFNC might be quieter at certain frequencies and BCPAP's noise increases with flow, the overall conclusion from the data presented is that there's no evidence HFNC is noisier. The \"maybe\" option might be tempting if there were conflicting data, but the study's main result is the lack of difference in the mean. So the answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 468,
            "completion_tokens": 417
        },
        "time_elapsed": 4.857041358947754
    },
    {
        "realidx": "24666444",
        "question": "The \"July effect\" refers to the phenomenon of adverse impacts on patient care arising from the changeover in medical staff that takes place during this month at academic medical centres in North America. There has been some evidence supporting the presence of the July effect, including data from surgical specialties. Uniformity of care, regardless of time of year, is required for patients undergoing major cancer surgery. We therefore sought to perform a population-level assessment for the presence of a July effect in this field.\nWe used the Nationwide Inpatient Sample to abstract data on patients undergoing 1 of 8 major cancer surgeries at academic medical centres between Jan. 1, 1999, and Dec. 30, 2009. The primary outcomes examined were postoperative complications and in-hospital mortality. Univariate analyses and subsequently multivariate analyses, controlling for patient and hospital characteristics, were performed to identify whether the time of surgery was an independent predictor of outcome after major cancer surgery.\nOn univariate analysis, the overall postoperative complication rate, as well as genitourinary and hematologic complications specifically, was higher in July than the rest of the year. However, on multivariate analysis, only hematologic complications were significantly higher in July, with no difference in overall postoperative complication rate or in-hospital mortality for all 8 surgeries considered separately or together.\nIs there any evidence of a \"July effect\" in patients undergoing major cancer surgery?",
        "answer": "no",
        "answer_rationale": "On the whole, the data confirm an absence of a July effect in patients undergoing major cancer surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question about the July effect in major cancer surgery. The user provided a study's methodology and results, and we need to determine if there's evidence of the July effect based on the options given.\n\nFirst, I need to recall what the July effect is. From the question, it's the idea that patient care suffers when new medical staff start in July, especially in academic centers. The study looked at major cancer surgeries between 1999 and 2009 using a large database. The main outcomes were complications and mortality.\n\nThe key part here is the difference between univariate and multivariate analyses. The univariate analysis showed higher overall complications and specific ones like genitourinary and hematologic in July. But when they did multivariate analysis, which controls for other variables like patient and hospital characteristics, only hematologic complications remained significant. The overall complication rate and mortality didn't show a difference.\n\nThe question is whether this counts as evidence of a July effect. The options are yes, no, maybe. The study's conclusion says that after adjusting for variables, only one type of complication (hematologic) was higher. But the primary outcomes they were checking for were the overall complication rate and mortality, which didn't differ. Since the main question is about the July effect's presence in major cancer surgery, and the key outcomes (overall and mortality) weren't significant after adjustment, the answer would lean towards no. The hematologic complication might be a minor point, but the primary outcomes are what the study focused on for the main conclusion. So the correct answer is B, no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 381,
            "completion_tokens": 334
        },
        "time_elapsed": 4.092860698699951
    },
    {
        "realidx": "24669960",
        "question": "Women have been reported to show more frequent recanalization and better recovery after intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment for acute stroke compared with men. To investigate this we studied a series of stroke patients receiving IV rt-PA and undergoing acute transcranial doppler (TCD) examination.\nAcute stroke patients received IV rt-PA and had acute TCD examination within 4 hours of symptom onset at 4 major stroke centers. TCD findings were interpreted using the Thrombolysis in Brain Ischemia (TIBI) flow grading system. The recanalization rates, and poor 3-month outcomes (modified Rankin scale>2) of men and women were compared using the chi-square test. Multiple regression analysis was used to assess sex as a predictor of recanalization and poor 3-month outcome after controlling for age, baseline NIH Stroke Scale (NIHSS), time to treatment, hypertension, and blood glucose.\n369 patients had TCD examinations before or during IV rt-PA treatment. The 199 (53.9%) men and 170 (46.1%) women had mean ages of 67\u2009\u00b1\u200913 and 70\u2009\u00b1\u200914 years, respectively. The sexes did not differ significantly in baseline stroke severity, time to TCD examination, or time to thrombolysis. Of the men, 68 (34.2%) had complete recanalization, 58 (29.1%) had partial recanalization, and 73 (36.6%) had no recanalization. Of the women, 53 (31.2%) had complete recanalization, 46 (27%) had partial recanalization, and 71 (41.8%) had no recanalization (p\u2009=\u20090.6). Multiple regression analyses showed no difference between the sexes in recanalization rate, time to recanalization, or clinical outcome at 3 months.\nDoes the sex of acute stroke patients influence the effectiveness of rt-PA?",
        "answer": "no",
        "answer_rationale": "In our study; sex is not a significant predictor of recanalization rate, time to recanalization or 3-month outcome in stroke patients following IV rt-PA.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the sex of acute stroke patients influences the effectiveness of rt-PA. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The question mentions that women were reported to have better recovery and more recanalization, but the study's results might contradict that. Let me parse the data given.\n\nThe study included 369 patients, with 199 men and 170 women. The mean ages were 67 and 70, which isn't a huge difference. The key points are the recanalization rates. For men: 34.2% complete, 29.1% partial, 36.6% no recanalization. For women: 31.2% complete, 27% partial, 41.8% no. The p-value here is 0.6, which is not statistically significant. That suggests no difference between the sexes in recanalization rates. \n\nThen, the multiple regression analysis controlled for factors like age, NIHSS, time to treatment, etc., and still found no difference in recanalization rate, time to recanalization, or 3-month outcomes. The modified Rankin scale outcome (poor outcome being >2) also didn't show a sex-based difference. \n\nThe initial report might have suggested women do better, but this study's results, especially with the statistical analysis, indicate that there's no significant difference. The p-value of 0.6 is way above the typical 0.05 threshold, so the null hypothesis isn't rejected. Therefore, the answer should be that sex doesn't influence effectiveness. The correct answer is B (no).\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 540,
            "completion_tokens": 371
        },
        "time_elapsed": 4.545259237289429
    },
    {
        "realidx": "24671913",
        "question": "SYNTAX score (SxS) has been demonstrated to predict long-term outcomes in stable patients with coronary artery disease. But its prognostic value for patients with acute coronary syndrome remains unknown.AIM: To evaluate whether SxS could predict in-hospital outcomes for patients admitted with ST elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (pPCI).\nThe study included 538 patients with STEMI who underwent pPCI between January 2010 and December 2012. The patients were divided into two groups: low SxS (<22) and high SxS (>22). The SxS of all patients was calculated from aninitial angiogram and TIMI flow grade of infarct related artery was calculated after pPCI. Left ventricular systolic functions of the patients were evaluated with an echocardiogram in the following week. The rates of reinfarction and mortality during hospitalisation were obtained from the medical records of our hospital.\nThe high SxS group had more no-reflow (41% and 25.1%, p<0.001, respectively), lower ejection fraction (38.2 \u00b1 7.5% and 44.6 \u00b1 8.8%, p<0.001, respectively), and greater rates of re-infarction (9.5% and 7.3%, p = 0.037, respectively) and mortality (0.9% and 0.2%, p = 0.021, respectively) during hospitalisation compared to the low SxS group. On multivariate logistic regression analysis including clinical variables, SxS was an independent predictor of no-reflow (OR 1.081, 95% CI 1.032-1.133, p = 0.001).\nDoes SYNTAX score predict in-hospital outcomes in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention?",
        "answer": "yes",
        "answer_rationale": "SxS is a useful tool that can predict in-hospital outcomes of patients with STEMI undergoing pPCI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the SYNTAX score predicts in-hospital outcomes in STEMI patients undergoing primary pPCI. The study provided some data.\n\nFirst, the study divided patients into low and high SYNTAX score groups. The high SxS group had higher rates of no-reflow (41% vs 25.1%, p<0.001), lower ejection fraction (38.2 vs 44.6, p<0.001), more reinfarction (9.5% vs 7.3%, p=0.037), and higher mortality (0.9% vs 0.2%, p=0.021). Also, multivariate analysis showed SxS was an independent predictor of no-reflow with an OR of 1.081. \n\nThe question is whether SxS predicts these outcomes. The results show significant differences between the groups for several outcomes, especially no-reflow and others. Since the high SxS group had worse outcomes, the answer should be yes. The options are A, B, C. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 520,
            "completion_tokens": 251
        },
        "time_elapsed": 3.2794413566589355
    },
    {
        "realidx": "24698298",
        "question": "To assess pain intensity with and without subcutaneous local anesthesia prior to intraarticular administration of contrast medium for magnetic resonance arthrography (MRa) of the shoulder.\nThis single-center study was conducted after an IRB waiver of authorization, between January 2010 and December 2012. All patients provided written, informed consent for the procedure. Our prospectively populated institutional database was searched, based on our inclusion criteria. There were 249 outpatients (178 men and 71 women; mean age, 44.4 years \u00b1 14.6; range, 15-79) who underwent MRa and were enrolled in this study. Patients were excluded if they had received surgery of the shoulder before MRa, had undergone repeated MRa of the same shoulder, and/or had undergone MRa of both shoulders on the same day. Patients were randomly assigned into one of three groups. Patients in group A (n=61) received skin infiltration with local anesthesia. Patients in control group B (n=92) and group C (n=96) did not receive local anesthesia. Pain levels were immediately assessed after the injection for MRa using a horizontal visual analog scale (VAS) that ranged from 0 to 10. To compare the pain scores of the three groups for male and female patients, a two-way analysis of variance was used. A p-value equal to or less than 0.05 was considered to indicate a significant result.\nPatients who received local anesthesia (group A) showed a mean pain level on the VAS of 2.6 \u00b1 2.3. In patients who did not receive local anesthetics (groups B and C), a mean pain level on the VAS of 2.6 \u00b1 2.2 and 2.7 \u00b1 2.4 were detected, respectively. Between the three groups, no statistically significant difference in pain intensity was detected (p=.960). There were significant differences in subjective pain perception between men and women (p=.009). Moreover, the sex difference in all three groups was equal (p=.934).\nMR arthrography of the shoulder: do we need local anesthesia?",
        "answer": "no",
        "answer_rationale": "Local anesthesia is not required to lower a patient's pain intensity when applying intra-articular contrast media for MR arthrography of the shoulder. This could result in reduced costs and a reduced risk of adverse reactions, without an impact on patient comfort.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether local anesthesia is needed for MR arthrography of the shoulder. The key points here are the results of the study they conducted.\n\nFirst, the setup: They had three groups. Group A got local anesthesia, while B and C didn't. The pain was measured using a VAS scale from 0-10. The mean pain scores were 2.6 for group A, 2.6 for B, and 2.7 for C. The p-value between the groups was 0.960, which is way higher than 0.05. That means there's no statistically significant difference in pain levels between the groups that had local anesthesia and those that didn't. \n\nThe other part mentions that there was a difference between men and women's pain perception (p=0.009), but the interaction effect (whether the sex difference was the same across all groups) had a p of 0.934, meaning the effect of sex was consistent regardless of the group. \n\nSo the main question is whether local anesthesia is needed. Since the study found no significant difference in pain when using it versus not, the conclusion would be that local anesthesia isn't necessary. The answer should be B) no. The options are yes, no, maybe. The study's results don't support the need for local anesthesia because the pain levels were similar without it. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 555,
            "completion_tokens": 310
        },
        "time_elapsed": 3.9982104301452637
    },
    {
        "realidx": "24739448",
        "question": "In January 2008, the Food and Drug Administration (FDA) communicated concerns and, in May 2009, issued a warning about an increased risk of suicidality for all antiepileptic drugs (AEDs). This research evaluated the association between the FDA suicidality communications and the AED prescription claims among members with epilepsy and/or psychiatric disorder.\nA longitudinal interrupted time-series design was utilized to evaluate Oklahoma Medicaid claims data from January 2006 through December 2009. The study included 9289 continuously eligible members with prevalent diagnoses of epilepsy and/or psychiatric disorder and at least one AED prescription claim. Trends, expressed as monthly changes in the log odds of AED prescription claims, were compared across three time periods: before (January 2006 to January 2008), during (February 2008 to May 2009), and after (June 2009 to December 2009) the FDA warning.\nBefore the FDA warning period, a significant upward trend of AED prescription claims of 0.01% per month (99% CI: 0.008% to 0.013%, p<0.0001) was estimated. In comparison to the prewarning period, no significant change in trend was detected during (-20.0%, 99% CI: -70.0% to 30.0%, p=0.34) or after (80.0%, 99% CI: -20.0% to 200.0%, p=0.03) the FDA warning period. After stratification, no diagnostic group (i.e., epilepsy alone, epilepsy and comorbid psychiatric disorder, and psychiatric disorder alone) experienced a significant change in trend during the entire study period (p>0.01).\nHave antiepileptic drug prescription claims changed following the FDA suicidality warning?",
        "answer": "no",
        "answer_rationale": "During the time period considered, the FDA AED-related suicidality warning does not appear to have significantly affected prescription claims of AED medications for the study population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether antiepileptic drug (AED) prescription claims changed after the FDA's suicidality warning. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study used a longitudinal interrupted time-series design with Oklahoma Medicaid data from 2006 to 2009. The key periods are before the FDA warning (up to Jan 2008), during (Feb 2008 to May 2009), and after (June 2009 to Dec 2009). \n\nThe results mention that before the warning, there was an upward trend of 0.01% per month. Then, during the period leading up to and including the warning (Feb 2008 to May 2009), there was no significant change in trend compared to before. The confidence interval for the during period was -70.0% to 30.0%, which includes zero, so no significant change. \n\nAfter the warning (June 2009 to Dec 2009), the change was 80.0%, but the confidence interval here was -20% to 200%, which also includes zero. The p-value was 0.03, but wait, the problem states that after stratification, none of the diagnostic groups had a significant change (p>0.01). So even though the p-value for the post period was 0.03, which is below 0.05, the study might be using a more stringent threshold (like p<0.01) after stratification. \n\nThe question is whether there was a change following the warning. The study says that compared to the pre-warning period, there was no significant change during or after. Even the post-period's 80% change wasn't significant when considering the confidence intervals and the adjusted p-values after stratification. \n\nTherefore, the answer should be \"no\" because the study found no significant changes in the trends after the FDA warning when considering all groups. The options are (A) yes, (B) no, (C) maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 511,
            "completion_tokens": 480
        },
        "time_elapsed": 6.399765253067017
    },
    {
        "realidx": "24751724",
        "question": "Ageing is a growing issue for people from UK black, Asian and minority ethnic (BAME) groups. The health experiences of these groups are recognised as a 'tracer' to measure success in end of life patient-preferred outcomes that includes place of death (PoD).AIM: To examine patterns in PoD among BAME groups who died of cancer.\nMortality data for 93,375 cancer deaths of those aged \u226565 years in London from 2001-2010 were obtained from the UK Office for National Statistics (ONS). Decedent's country of birth was used as a proxy for ethnicity. Linear regression examined trends in place of death across the eight ethnic groups and Poisson regression examined the association between country of birth and place of death.\n76% decedents were born in the UK, followed by Ireland (5.9%), Europe(5.4%) and Caribbean(4.3%). Most deaths(52.5%) occurred in hospital, followed by home(18.7%). During the study period, deaths in hospital declined with an increase in home deaths; trend for time analysis for those born in UK(0.50%/yr[0.36-0.64%]p<0.001), Europe (1.00%/yr[0.64-1.30%]p<0.001), Asia(1.09%/yr[0.94-1.20%]p<0.001) and Caribbean(1.03%/yr[0.72-1.30%]p<0.001). However, time consistent gaps across the geographical groups remained. Following adjustment hospital deaths were more likely for those born in Asia(Proportion ratio(PR)1.12[95%CI1.08-1.15]p<0.001) and Africa(PR 1.11[95%CI1.07-1.16]p<0.001). Hospice deaths were less likely for those born in Asia(PR 0.73 [0.68-0.80] p<0.001), Africa (PR 0.83[95%CI0.74-0.93]p<0.001), and 'other' geographical regions (PR0.90[95% 0.82-0.98]p<0.001). Home deaths were less likely for those born in the Caribbean(PR0.91[95%CI 0.85-0.98]p<0.001).\nDoes ethnicity affect where people with cancer die?",
        "answer": "yes",
        "answer_rationale": "Location of death varies by country of birth. BAME groups are more likely to die in a hospital and less likely to die at home or in a hospice. Further investigation is needed to determine whether these differences result from patient-centred preferences, or other environment or service-related factors. This knowledge will enable strategies to be developed to improve access to relevant palliative care and related services, where necessary.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether ethnicity affects where people with cancer die, based on the provided study.\n\nFirst, I need to recall the study's findings. The study looked at cancer deaths in London among people over 65 from 2001-2010. They used country of birth as a proxy for ethnicity. The main results were that while overall hospital deaths decreased over time and home deaths increased, there were persistent differences between groups. \n\nSpecifically, the adjusted analysis showed that people born in Asia and Africa were more likely to die in hospitals (PR 1.12 and 1.11 respectively). Meanwhile, those from Asia, Africa, and other regions were less likely to die in hospices. Also, Caribbean-born individuals were less likely to die at home. \n\nThe question is whether ethnicity (here proxied by country of birth) affects place of death. The study's results clearly show different probabilities across these groups even after adjustment. The fact that there are consistent gaps and significant PRs greater or less than 1 indicates that ethnicity does play a role. \n\nThe options are yes, no, maybe. Since the study found statistically significant associations (p<0.001 in all cases mentioned), the answer should be \"yes\". The \"maybe\" might be a distractor if someone thinks about other factors, but the study's adjusted analysis accounts for that, showing the effect remains. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 681,
            "completion_tokens": 310
        },
        "time_elapsed": 4.055192947387695
    },
    {
        "realidx": "24799031",
        "question": "The objective was to evaluate the efficacy of diffusion-weighted imaging (DWI) in predicting the development of vascularization in hypovascular hepatocellular lesions (HHLs).\nForty-two HHLs that were diagnosed by computed tomographic (CT) arteriography were evaluated retrospectively. The lesion on DWI was classified as isointense, hypointense, or hyperintense. Follow-up studies that included intravenous dynamic CT or magnetic resonance imaging were performed.\nThe 730-day cumulative developments of vascularization in hypointense, isointense, and hyperintense lesions were 17%, 30%, and 40%, respectively. The differences among these developments were not statistically significant.\nIs diffusion-weighted imaging a significant indicator of the development of vascularization in hypovascular hepatocellular lesions?",
        "answer": "no",
        "answer_rationale": "The signal intensity on DWI showed no significant difference in the development of vascularization.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether diffusion-weighted imaging (DWI) is a significant indicator for predicting vascularization in hypovascular hepatocellular lesions (HHLs). The study mentioned looked at 42 HHLs diagnosed via CT arteriography. They classified the lesions on DWI as isointense, hypointense, or hyperintense. Then they followed up with more imaging over 730 days.\n\nThe results showed that the cumulative development of vascularization was 17% for hypointense, 30% for isointense, and 40% for hyperintense lesions. But the key point here is that the differences between these percentages weren't statistically significant. \n\nSo the question is, does DWI's classification predict vascularization development? The options are yes, no, maybe. Since the study found no statistically significant differences among the groups, that means the variations in vascularization rates could be due to chance, not the DWI findings. Therefore, DWI isn't a significant indicator here. The answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 262,
            "completion_tokens": 234
        },
        "time_elapsed": 2.928344964981079
    },
    {
        "realidx": "24809662",
        "question": "Midurethral sling (MUS) can improve overactive bladder (OAB) symptoms. It is unclear if anterior/apical prolapse (AA) repair provides additional benefit. We hypothesized that women with mixed urinary incontinence (MUI) experience greater improvement in the OAB component of their symptoms after concomitant MUS and AA repair compared with MUS alone.\nThis is a retrospective cohort study of women with bothersome MUI (defined by objective stress test and validated questionnaire) undergoing MUS alone (\"MUS-only\") or concomitant MUS and AA repair (\"MUS + AA\"). Our primary outcome was the Overactive Bladder Questionnaire Symptom Severity (OAB-q SS) change score 6\u00a0weeks after surgery.\nOf 151 women, 67 (44\u00a0%) underwent MUS-only and 84 (56\u00a0%) underwent MUS + AA. The MUS-only cohort was younger and had less severe baseline prolapse (p\u2009<\u20090.05 for both). Postoperative complications (predominantly UTI) occurred in 35 (23\u00a0%) patients and were similar between cohorts. For all subjects mean OAB-q SS scores significantly improved postoperatively (p\u2009<\u20090.05). Our primary outcome, OAB-q SS change score, showed no significant differences between cohorts (30\u2009\u00b1\u200926 MUS-only vs 25\u2009\u00b1\u200925 MUS + AA, p\u2009=\u20090.20), indicating similar improvements in OAB symptoms. Multivariate linear regression analysis revealed no difference in OAB-q SS change score between cohorts; however, OAB-q SS change scores were lower for women with a postoperative complication (\u03b2\u2009=\u2009-19, 95\u00a0% CI -31 to -6; p\u2009<\u20090.01).\nDoes concomitant anterior/apical repair during midurethral sling improve the overactive bladder component of mixed incontinence?",
        "answer": "no",
        "answer_rationale": "In women with bothersome MUI, concomitant AA repair does not result in additional improvement in OAB symptoms over MUS alone. Patients with postoperative complications exhibit less improvement in OAB symptoms.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether concomitant anterior/apical repair during a midurethral sling improves the overactive bladder component in mixed incontinence. \n\nFirst, I need to recall the study details provided. The study compared two groups: those who had MUS alone versus MUS plus AA repair. The primary outcome was the change in OAB-q SS scores at 6 weeks.\n\nThe key results mentioned are that both groups had significant improvements in OAB symptoms, but there was no significant difference between the two groups. The p-value for the primary outcome was 0.20, which is not statistically significant. Also, the multivariate analysis didn't show a difference either. The only factor that affected the OAB improvement was having a postoperative complication, which led to lower improvement.\n\nThe question is whether adding the AA repair helps with OAB symptoms. Since the study found no significant difference between the groups, the answer should be that it doesn't provide additional benefit. So the answer would be B) no.\n\nWait, but let me make sure I didn't miss anything. The hypothesis was that MUS + AA would be better, but the results didn't support that. The primary outcome's p-value was 0.20, which is greater than 0.05, so no significant difference. The regression also confirmed no difference. So yes, the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 521,
            "completion_tokens": 298
        },
        "time_elapsed": 3.8148977756500244
    },
    {
        "realidx": "24922528",
        "question": "To explore the extent to which parent-adolescent emotional closeness, family conflict, and parental permissiveness moderate the association of puberty and alcohol use in adolescents (aged 10-14).\nCross-sectional survey of 7631 adolescents from 231 Australian schools. Measures included pubertal status, recent (30day) alcohol use, parent-adolescent emotional closeness, family conflict, parental permissiveness of alcohol use and peer alcohol use. The analysis was based on a two-level (individuals nested within schools) logistic regression model, with main effects entered first, and interaction terms added second.\nThe interaction of family factors and pubertal stage did not improve the fit of the model, so a main effect model of family factors and pubertal stage was adopted. There were significant main effects for pubertal stage with boys in middle puberty at increased odds of alcohol use, and girls in advanced puberty at increased odds of alcohol use.\nThe association of puberty and young adolescent alcohol use: do parents have a moderating role?",
        "answer": "no",
        "answer_rationale": "Puberty and family factors were strong predictors of adolescent alcohol use, but family factors did not account for variation in the association of pubertal stage and alcohol use.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether parent-adolescent emotional closeness, family conflict, and parental permissiveness moderate the link between puberty and alcohol use in 10-14 year olds. The key here is understanding what \"moderate\" means in a statistical sense. A moderator variable changes the strength or direction of the relationship between an independent and dependent variable.\n\nThe study used a logistic regression model. They first included main effects and then added interaction terms to see if the family factors (the potential moderators) affected the association between puberty and alcohol use. The crucial point mentioned is that the interaction of family factors and pubertal stage did NOT improve the model fit. That means the interaction terms weren't significant, so the main effects model was used instead. \n\nThe main effects showed that puberty stage was associated with alcohol use (middle puberty for boys, advanced for girls). But since the interactions didn't improve the model, the family factors aren't moderating the relationship. So the answer should be \"no\" because the parents' factors don't moderate the association. The question is asking if parents have a moderating role, and since the interactions weren't significant, the answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 309,
            "completion_tokens": 257
        },
        "time_elapsed": 3.366603136062622
    },
    {
        "realidx": "24977765",
        "question": "Concussions are commonly diagnosed in pediatric patients presenting to the emergency department (ED). The primary objective of this study was to evaluate compliance with ED discharge instructions for concussion management.\nA prospective cohort study was conducted from November 2011 to November 2012 in a pediatric ED at a regional Level 1 trauma center, serving 35,000 pediatric patients per year. Subjects were aged 8 years to 17 years and were discharged from the ED with a diagnosis of concussion. Exclusion criteria included recent (past 3 months) diagnosis of head injury, hospital admission, intracranial injury, skull fracture, suspected nonaccidental trauma, or preexisting neurologic condition. Subjects were administered a baseline survey in the ED and were given standardized discharge instructions for concussion by the treating physician. Telephone follow-up surveys were conducted at 2 weeks and 4 weeks after ED visit.\nA total of 150 patients were enrolled. The majority (67%) of concussions were sports related. Among sports-related concussions, soccer (30%), football (11%), lacrosse (8%), and basketball (8%) injuries were most common. More than one third (39%) reported return to play (RTP) on the day of the injury. Physician follow-up was equivalent for sport and nonsport concussions (2 weeks, 58%; 4 weeks, 64%). Sports-related concussion patients were more likely to follow up with a trainer (2 weeks, 25% vs. 10%, p = 0.06; 4 weeks, 29% vs. 8%, p<0.01). Of the patients who did RTP or normal activities at 2 weeks (44%), more than one third (35%) were symptomatic, and most (58%) did not receive medical clearance. Of the patients who had returned to activities at 4 weeks (64%), less than one quarter (23%) were symptomatic, and most (54%) received medical clearance.\nAre pediatric concussion patients compliant with discharge instructions?",
        "answer": "yes",
        "answer_rationale": "Pediatric patients discharged from the ED are mostly compliant with concussion instructions. However, a significant number of patients RTP on the day of injury, while experiencing symptoms or without medical clearance.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pediatric concussion patients are compliant with discharge instructions based on the study provided.\n\nFirst, I need to recall the key points from the study. The study was a prospective cohort looking at compliance with ED discharge instructions for concussions in kids. They enrolled 150 patients. The main things to check are how well they followed the instructions, like return to play (RTP) guidelines and medical clearance.\n\nThe results mentioned that 39% returned to play on the same day of injury. That's a red flag because standard guidelines usually recommend no RTP the same day. Then, at 2 weeks, 44% had returned to activities, but 35% were still symptomatic, and 58% didn't have medical clearance. By 4 weeks, 64% were back, but even then, 23% were still symptomatic and 54% didn't have clearance. Also, only about half followed up with a physician at both 2 and 4 weeks. \n\nThe question is about compliance. Since a significant portion (like over a third) went back to play too early without clearance, and many didn't get medical follow-up, it seems like they weren't following the instructions properly. The options are yes, no, maybe. The data shows non-compliance, so the answer should be B) no. The study's findings indicate that a lot of patients weren't adhering to the discharge instructions, especially regarding RTP and medical clearance. Even at 4 weeks, over half didn't have clearance. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 525,
            "completion_tokens": 339
        },
        "time_elapsed": 4.16388726234436
    },
    {
        "realidx": "24995509",
        "question": "To investigate the association between age-related macular degeneration (AMD) and the polymorphisms of HIF1A, a major vascular epithelial growth factor regulator under hypoxic conditions. The associations of AMD and polymorphisms of genes CFH, SKIV2L and MYRIP were also studied.\nProspective study.\nEighty-seven AMD patients and 80 healthy subjects admitted to the Department of Ophthalmology at Pamukkale University Hospital, Denizli, Turkey, were included: 45 (52%) had wet type AMD, and 42 (48%) had dry type AMD.\nPolymorphisms rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) were investigated in DNA isolated from peripheral blood samples of the cases and controls by dye-termination DNA sequencing.\nGenotype distribution of rs1061170 (CFH), rs429608 (SKIV2L), rs2679798 (MYRIP) and both rs11549465 and rs11549467 (HIF1A) in AMD cases and healthy controls; association between genotypes and AMD subtypes.\nGiven the significant difference between the mean age of case and control groups (72.13\u2009\u00b1\u20095.77 vs. 62.80\u2009\u00b1\u20095.22, respectively) (P\u2009=\u2009.000), subsequent analyses were adjusted for age. We found that having at least one C allele for polymorphism rs1061170 increases AMD risk independent of age (OR\u2009=\u20092.42, 95% confidence interval [CI], 1.22-4.81). The ancestral T allele for polymorphism rs1061170 has a protective effect for AMD (OR\u2009=\u20090.53, 95% CI, 0.34-0.83). No statistically significant difference for distributions of other single nucleotide polymorphisms (SNPs) emerged between patients and healthy subjects.\nHIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age-related macular degeneration?",
        "answer": "maybe",
        "answer_rationale": "No associations appeared between HIF1A SNPs and AMD, which were studied here for the first time; however, polymorphism rs1061170 of the CFH gene is associated with AMD in our population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the polymorphisms of HIF1A are associated with age-related macular degeneration (AMD) based on the provided study.\n\nFirst, I need to recall the details from the study description. The study investigated several genes: CFH, SKIV2L, MYRIP, and HIF1A. Specifically for HIF1A, they looked at the polymorphisms rs11549465 and rs11549467. \n\nThe key results mentioned are that the CFH polymorphism (rs1061170) had a significant association with AMD risk. The OR for having at least one C allele was 2.42, which is statistically significant. Also, the T allele had a protective effect. However, the study states that \"No statistically significant difference for distributions of other single nucleotide polymorphisms (SNPs) emerged between patients and healthy subjects.\" \n\nSince HIF1A's polymorphisms (rs11549465 and rs11549467) are included in the \"other SNPs\" mentioned here, that means they didn't show a significant association. The question is specifically about HIF1A's polymorphisms, so the answer would be that there's no association. \n\nThe options are (A) yes, (B) no, (C) maybe. The correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 624,
            "completion_tokens": 314
        },
        "time_elapsed": 4.588267803192139
    },
    {
        "realidx": "24996865",
        "question": "Reconstructing the natural joint line in knee revision surgery improves clinical and functional outcome but may be challenging when both cartilage and bone were removed during previous operations. Assessing joint lines (JLs) by means of bony landmarks is inadvisable because of large variations in human anatomy. Because of the inherent symmetry of the human body, we hypothesised that JLs may be directly assessed by measuring the distances from the bony landmarks to the JL of the contralateral knee by means of radiographic images.\nUsing scaled weight-bearing radiographs in anteroposterior view of both knees, two independent observers measured the distances from the fibular head, the medial and lateral epicondyle, and the adductor tubercle to the JL. A two-sided p value of \u22640.05 was considered statistically significant.\nTwo hundred knees of 100 patients (50 men and 50 women) were examined. For the fibular head, the mean difference between the treated and the control knee was 0.0 mm with narrow confidence limits ranging from -1.1 to 1.1.\nAssessing joint line positions by means of the contralateral knee: a new approach for planning knee revision surgery?",
        "answer": "yes",
        "answer_rationale": "As a new assessment method, we have suggested to assess the JL by means of radiographs of the contralateral knee. The most precise parameter was found to be the distance between the fibular head and the JL. The level of arthritis, age, gender, visibility of the landmarks, and misalignment did not influence measurement accuracy. This parameter is the first tibia-related landmark for assessing the JL, which advantageously corresponds to the tibia-first technique in revision surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about reconstructing the joint line in knee revision surgery. The main issue is that using bony landmarks alone isn't reliable because of anatomical variations. The hypothesis here is that by looking at the contralateral (opposite) knee's joint line distances from certain landmarks, you can more accurately assess the joint line on the affected knee.\n\nThe study used 200 knees from 100 patients, with two observers measuring distances from landmarks like the fibular head, epicondyles, and adductor tubercle. The key result given is for the fibular head: the mean difference between treated and control knees was 0.0 mm, with confidence intervals from -1.1 to 1.1. That's a very narrow range, suggesting little difference. Since the confidence interval includes zero and the range is tight, this implies that the distances on the affected knee are similar to the contralateral side. \n\nThe question is whether this approach (using the contralateral knee's measurements) is a good method for planning surgery. The options are yes, no, maybe. The study's results support the hypothesis because the mean difference is near zero, meaning the contralateral knee's landmarks can predict the joint line accurately. Since the p-value would be significant (as the CI doesn't include values beyond the range here, but the problem states that p \u22640.05 was the threshold), this suggests statistical significance. Therefore, the answer should be A) yes. The other options don't fit because the data here shows the method works as per the hypothesis.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 346,
            "completion_tokens": 339
        },
        "time_elapsed": 3.9224343299865723
    },
    {
        "realidx": "25007420",
        "question": "Francophones may experience poorer health due to social status, cultural differences in lifestyle and attitudes, and language barriers to health care. Our study sought to compare mental health indicators between Francophones and non-Francophones living in the province of Manitoba.\nTwo populations were used: one from administrative datasets housed at the Manitoba Centre for Health Policy and the other from representative survey samples. The administrative datasets contained data from physician billings, hospitalizations, prescription drug use, education, and social services use, and surveys included indicators on language variables and on self-rated health.\nOutside urban areas, Francophones had lower rates of diagnosed substance use disorder (rate ratio [RR] = 0.80; 95% CI 0.68 to 0.95) and of suicide and suicide attempts (RR = 0.59; 95% CI 0.43 to 0.79), compared with non-Francophones, but no differences were found between the groups across the province in rates of diagnosed mood disorders, anxiety disorders, dementia, or any mental disorders after adjusting for age, sex, and geographic area. When surveyed, Francophones were less likely than non-Francophones to report that their mental health was excellent, very good, or good (66.9%, compared with 74.2%).\nAre there mental health differences between francophone and non-francophone populations in manitoba?",
        "answer": "maybe",
        "answer_rationale": "The discrepancy in how Francophones view their mental health and their rates of diagnosed mental disorders may be related to health seeking behaviours in the Francophone population. Community and government agencies should try to improve the mental health of this population through mental health promotion and by addressing language and cultural barriers to health services.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there are mental health differences between Francophone and non-Francophone populations in Manitoba based on the provided study.\n\nFirst, I need to look at the study's findings. The question mentions that in rural areas, Francophones had lower rates of diagnosed substance use disorder and suicide/suicide attempts compared to non-Francophones. The rate ratios are given with confidence intervals that don't include 1, so those differences are statistically significant. However, when looking at the entire province, after adjusting for age, sex, and geography, there were no differences in rates of mood disorders, anxiety, dementia, or overall mental disorders. \n\nBut there's another part: the self-reported mental health. The survey shows that Francophones were less likely to report their mental health as excellent, very good, or good (66.9% vs 74.2%). That's a self-rated measure, which is subjective but still a valid mental health indicator. \n\nSo the options are yes, no, or maybe. The study found both some differences (lower rates of certain disorders in rural Francophones and lower self-reported mental health) and no differences in other areas. The question is whether these count as \"mental health differences\". Since there are some significant differences in specific areas (substance use, suicide, and self-report), the answer should be yes. The fact that some measures didn't show a difference doesn't negate the existence of differences in others. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 393,
            "completion_tokens": 321
        },
        "time_elapsed": 3.9619288444519043
    },
    {
        "realidx": "25043083",
        "question": "Recently, increasing number of literature has identified the posterior tibial slope (PTS) as one of the risk factors of primary anterior cruciate ligament (ACL) injury. However, few studies concerning the association between failure of ACL reconstruction (ACLR) and PTS have been published. The objective of this study was to explore the association between the failure of ACLR and PTS at a minimum of two years follow-up.\nTwo hundred and thirty eight eligible patients from June 2009 to October 2010 were identified from our database. A total of 20 failure cases of ACLR and 20 randomly selected controls were included in this retrospective study. The demographic data and the results of manual maximum side-to-side difference with KT-1000 arthrometer at 30\u00b0 of knee flexion and pivot-shift test before the ACLR and at the final follow-up were collected. The medial and lateral PTSs were measured using the magnetic resonance imaging (MRI) scan, based on Hudek's measurement. A comparison of PTS between the two groups was performed.\nThe overall failure rate of the present study was 8.4%. Of the 40 participants, the mean medial PTS was 4.1\u00b0 \u00b1 3.2\u00b0 and the mean lateral PTS was 4.6\u00b0 \u00b1 2.6\u00b0. The medial PTS of the ACLR failure group was significantly steeper than the control group (3.5\u00b0 \u00b1 2.5\u00b0 vs. 6.1\u00b0 \u00b1 2.1\u00b0, P = 0.000). Similarly, the lateral PTS of the ACLR failure group was significantly steeper than the control group (2.9\u00b0 \u00b1 2.1\u00b0 vs. 5.5\u00b0 \u00b1 3.0\u00b0, P = 0.006). For medial PTS \u2265 5\u00b0, the odds ratio of ACLR failure was 6.8 (P = 0.007); for lateral PTS \u22655\u00b0, the odds ratio of ACLR failure was 10.8 (P = 0.000).\nAre failures of anterior cruciate ligament reconstruction associated with steep posterior tibial slopes?",
        "answer": "yes",
        "answer_rationale": "Both medial and lateral PTS were significantly steeper in failures of ACLR than the control group. Medial or lateral PTS \u22655\u00b0 was a new risk factor of ACLR failure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether failures of anterior cruciate ligament (ACL) reconstruction are associated with steep posterior tibial slopes (PTS). The options are yes, no, or maybe.\n\nFirst, I need to look at the provided study details. The study's objective was to explore the association between ACLR failure and PTS. They had 238 patients, with 20 failures and 20 controls. The key results mentioned are that both medial and lateral PTS were significantly steeper in the failure group compared to the control group. The medial PTS in the failure group was 6.1 vs 3.5 (p=0.000), and lateral was 5.5 vs 2.9 (p=0.006). Also, the odds ratios were 6.8 for medial PTS \u22655\u00b0 and 10.8 for lateral PTS \u22655\u00b0, both statistically significant.\n\nSo, the study found that steeper PTS (both medial and lateral) was associated with higher failure rates. The question is whether the answer is yes, no, or maybe. Since the study's results show a significant association with steeper slopes leading to higher odds of failure, the answer should be yes. The options given are A, B, C corresponding to yes, no, maybe. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 550,
            "completion_tokens": 290
        },
        "time_elapsed": 3.4437525272369385
    },
    {
        "realidx": "25079920",
        "question": "As parents of young children are often unaware their child is overweight, screening provides the opportunity to inform parents and provide the impetus for behaviour change. We aimed to determine if parents could recall and understand the information they received about their overweight child after weight screening.\nRandomised controlled trial of different methods of feedback.\nParticipants were recruited through primary and secondary care but appointments took place at a University research clinic.\n1093 children aged 4-8\u2005years were screened. Only overweight children (n=271, 24.7%) are included in this study. Parents of overweight children were randomised to receive feedback regarding their child's weight using best practice care (BPC) or motivational interviewing (MI) at face-to-face interviews typically lasting 20-40\u2005min. 244 (90%) parents participated in a follow-up interview 2\u2005weeks later to assess recall and understanding of information from the feedback session.\nInterviews were audio-taped and transcribed verbatim before coding for amount and accuracy of recall. Scores were calculated for total recall and sub-categories of interest.\nOverall, 39% of the information was recalled (mean score 6.3 from possible score of 16). Parents given feedback via BPC recalled more than those in the MI group (difference in total score 0.48; 95% CI 0.05 to 0.92). Although 94% of parents were able to correctly recall their child's weight status, fewer than 10 parents could accurately describe what the measurements meant. Maternal education (0.81; 0.25 to 1.37) and parental ratings of how useful they found the information (0.19; 0.04 to 0.35) were significant predictors of recall score in multivariate analyses.\nDo parents recall and understand children's weight status information after BMI screening?",
        "answer": "maybe",
        "answer_rationale": "While parents remember that their child's body mass index is higher than recommended, they are unable to remember much of the information and advice provided about the result.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether parents recall and understand their child's weight status after BMI screening based on the study provided.\n\nFirst, I need to look at the study details. The study was a randomized controlled trial comparing two feedback methods: Best Practice Care (BPC) and Motivational Interviewing (MI). They had 271 overweight children's parents involved. At follow-up two weeks later, 244 parents participated. \n\nThe key results mentioned are that overall, parents recalled 39% of the information, with a mean score of 6.3 out of 16. The BPC group recalled slightly more than the MI group, but the difference wasn't huge. However, 94% correctly recalled their child's weight status. But here's the catch: fewer than 10 parents could accurately describe what the measurements meant. So while they knew the status (like \"overweight\"), they didn't understand the implications or details of those measurements. \n\nThe question is about both recall AND understanding. The recall part seems partially there (since 94% knew the status), but the understanding part is low. The options are yes, no, maybe. The answer hinges on whether \"understand\" is met. Since the study says fewer than 10 (out of 244) could accurately describe the meaning, that's a very low number. So even though they remembered the status, they didn't understand it. Therefore, the answer would be \"no\" because understanding is a key part of the question. The options are (A) yes, (B) no, (C) maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 493,
            "completion_tokens": 355
        },
        "time_elapsed": 4.372185945510864
    },
    {
        "realidx": "25103647",
        "question": "To examine whether government-funded, low-income vision care programs improve use of eye care services by low-income individuals in Canada.\nCross-sectional survey.\n27,375 white respondents to the Canadian Community Health Survey (CCHS) Healthy Aging 2008/2009.\nGovernment-funded, low-income vision care programs were reviewed. The amount of assistance provided was compared with professional fee schedules for general/routine eye examinations and market prices for eyeglasses. The utilization of eye care providers was derived from the CCHS.\nTo receive low-income vision care assistance, individuals must be in receipt of social assistance. Criteria for receiving social assistance are stringent. The Canadian Financial Capability Survey revealed that 7.9% of Canadians aged 45 to 64 years and 5.5% aged \u226565 years received social assistance in 2009. The CCHS found in 2008/2009 that 12.5% of citizens aged 45 to 64 years and 13.2% of those aged \u226565 years had difficulty paying for basic expenses such as food. In 5 provinces, low-income vision care assistance fully covers a general/routine eye examination. In the remainder, the assistance provided is insufficient for a general/routine eye examination. The assistance for eyeglasses is inadequate in 5 provinces, requiring out-of-pocket copayments. Among middle-aged whites who self-reported not having glaucoma, cataracts, diabetes, or vision problems not corrected by lenses, utilization of eye care providers was 28.1% among those with financial difficulty versus 41.9% among those without (p<0.05), giving a prevalence ratio 0.68 (95% CI 0.57-0.80) adjusted for age, sex and education.\nDoes government assistance improve utilization of eye care services by low-income individuals?",
        "answer": "maybe",
        "answer_rationale": "Despite government assistance, low-income individuals use vision care services less often than wealthy individuals.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether government-funded low-income vision care programs in Canada actually improve the use of eye care services among low-income individuals. The options are yes, no, or maybe.\n\nFirst, I need to understand the study's setup. It's a cross-sectional survey with over 27,000 white respondents from the Canadian Community Health Survey (CCHS) from 2008/2009. The key points here are the comparison between those who receive social assistance and those who don't, and how that relates to their ability to access eye care.\n\nThe study mentions that to get the vision care assistance, you have to be on social assistance, which has strict criteria. The data shows that only around 5-8% of the older age groups are on social assistance, but a higher percentage (12.5-13.2%) had trouble paying for basics like food. That might indicate that even those not on social assistance are still struggling financially but don't qualify for the programs.\n\nNow, looking at the provinces: in five provinces, the assistance fully covers an eye exam, but in others, it's not enough. For eyeglasses, five provinces require copayments. So coverage varies by province.\n\nThe key result is that among middle-aged individuals without certain conditions, those with financial difficulty had a 28.1% utilization rate versus 41.9% without difficulty. The adjusted prevalence ratio is 0.68, which is a significant difference (p<0.05). That suggests that people with financial issues are less likely to use eye care services. But the question is whether government assistance helps.\n\nWait, the study is about whether the programs improve utilization. The data shows that even in provinces where assistance covers exams, maybe the problem is that not enough people qualify for social assistance. The financial difficulty group (12-13%) is larger than those on social assistance (5-8%), so many in need aren't getting the help. The study's result shows lower utilization among those with financial trouble, but does the assistance help those who do get it?\n\nThe prevalence ratio of 0.68 means that those with financial difficulty are 32% less likely to use services. But the question is whether the assistance (for those who qualify) improves it. The study might not directly compare assisted vs non-assisted individuals, but rather looks at those with financial difficulty. Since the",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 494,
            "completion_tokens": 512
        },
        "time_elapsed": 5.841138601303101
    },
    {
        "realidx": "25277731",
        "question": "Sternal fractures in childhood are rare. The aim of the study was to investigate the accident mechanism, the detection of radiological and sonographical criteria and consideration of associated injuries.\nIn the period from January 2010 to December 2012 all inpatients and outpatients with sternal fractures were recorded according to the documentation.\nA total of 4 children aged 5-14\u00a0years with a sternal fracture were treated in 2\u00a0years, 2\u00a0children were hospitalized for pain management and 2 remained in outpatient care.\nSternal fracture in growing children : A rare and often overlooked fracture?",
        "answer": "maybe",
        "answer_rationale": "Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether sternal fractures in growing children are considered a rare and often overlooked fracture. The options are yes, no, maybe.\n\nFirst, I need to look at the information provided in the question. The study mentions that sternal fractures in childhood are rare. They looked at a two-year period and found only four cases among children aged 5-14. That's a pretty small number, which supports the idea of rarity. \n\nThe question also mentions the study's aim was to investigate accident mechanisms, radiological and sonographical criteria, and associated injuries. The fact that they had to specifically record these cases over two years and only found four suggests that these fractures don't occur often. Additionally, two of the children were hospitalized, and two were outpatients, but the key point here is the rarity.\n\nThe options are about whether it's rare and often overlooked. The first part of the question statement already says sternal fractures in childhood are rare, so the answer probably aligns with that. The study's findings back up the rarity. The term \"overlooked\" might refer to whether they are misseddiagnoses. The study's purpose might imply that because they're rare, they might be missed, hence the need to look into detection criteria. So combining both aspects, the answer would be \"yes\" because the question is phrased as a statement that they are rare and overlooked, and the study's context supports that. The correct answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 218,
            "completion_tokens": 315
        },
        "time_elapsed": 4.442325115203857
    },
    {
        "realidx": "25280365",
        "question": "Clinical pathologists (CPs) report RBC morphologic (RBC-M) changes to assist clinicians in prioritizing differential diagnoses. However, reporting is subjective, semiquantitative, and potentially biased. Reporting decisions vary among CPs, and reports may not be interpreted by clinicians as intended.\nThe aims of this study were to survey clinicians and CPs about RBC-M terms and their clinical value, and identify areas of agreement and discordance.\nOnline surveys were distributed to small animal clinicians via the Veterinary Information Network and to CPs via the ASVCP listserv. A quiz assessed understanding of RBC-M terms among respondent groups. Descriptive statistics were used to analyze responses to survey questions, and quiz scores were compared among groups.\nAnalyzable responses were obtained from 1662 clinicians and 82 CPs. Both clinicians and CPs considered some terms, e.g., agglutination, useful, whereas only CPs considered other terms, e.g., ghost cells, useful. All groups interpreted certain terms, e.g., Heinz bodies, correctly, whereas some clinicians misinterpreted others, e.g., eccentrocytes. Responses revealed that CPs often do not report RBC-M they consider insignificant, when present in low numbers. Twenty-eight percent of clinicians think CPs review all blood smears while only 19% of CPs report reviewing all smears.\nReporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians?",
        "answer": "yes",
        "answer_rationale": "Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether there's discordance between clinical pathologists (CPs) and clinicians regarding reporting and interpreting RBC morphology. The options are yes, no, or maybe.\n\nFirst, I need to recall the key points from the provided information. The study's aim was to find areas of agreement and discordance. The results mentioned that both groups found some terms useful, like agglutination, but CPs considered terms like ghost cells useful while clinicians didn't. Also, there were differences in how terms were interpreted\u2014some were correct across groups, but clinicians misinterpreted eccentrocytes. Additionally, CPs don't always report RBC-M they see as insignificant even if present in low numbers. A significant point is that 28% of clinicians think CPs review all smears, but only 19% of CPs actually do that. \n\nSo, the question is whether there's discordance. The study found differences in which terms each group finds useful, discrepancies in interpretation, and differing practices in reporting. The fact that there are areas where they don't agree or have different practices would mean there is discordance. The answer should be yes (A). The other options, no or maybe, don't fit because the study clearly identified areas of disagreement and differences in understanding and reporting practices.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 395,
            "completion_tokens": 282
        },
        "time_elapsed": 3.871647834777832
    },
    {
        "realidx": "25311479",
        "question": "It is uncertain whether the inverse equity hypothesis-the idea that new health interventions are initially primarily accessed by the rich, but that inequalities narrow with diffusion to the poor-holds true for cancer screening in low and middle income countries (LMICs).This study examines the relationship between overall coverage and economic inequalities in coverage of cancer screening in four middle-income countries.\nSecondary analyses of cross-sectional data from the WHO study on Global Ageing and Adult Health in China, Mexico, Russia and South Africa (2007-2010). Three regression-based methods were used to measure economic inequalities: (1) Adjusted OR; (2) Relative Index of Inequality (RII); and (3) Slope Index of Inequality.\nCoverage for breast cancer screening was 10.5% in South Africa, 19.3% in China, 33.8% in Russia and 43% in Mexico, and coverage for cervical cancer screening was 24% in South Africa, 27.2% in China, 63.7% in Mexico and 81.5% in Russia. Economic inequalities in screening participation were substantially lower or non-existent in countries with higher aggregate coverage, for both breast cancer screening (RII: 14.57 in South Africa, 4.90 in China, 2.01 in Mexico, 1.04 in Russia) and cervical cancer screening (RII: 3.60 in China, 2.47 in South Africa, 1.39 in Mexico, 1.12 in Russia).\nThe inverse equity hypothesis: does it apply to coverage of cancer screening in middle-income countries?",
        "answer": "yes",
        "answer_rationale": "Economic inequalities in breast and cervical cancer screening are low in LMICs with high screening coverage. These findings are consistent with the inverse equity hypothesis and indicate that high levels of equity in cancer screening are feasible even in countries with high income inequality.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the inverse equity hypothesis applies to cancer screening coverage in middle-income countries based on the provided study.\n\nFirst, I need to recall what the inverse equity hypothesis is. From the question, it's the idea that new health interventions are first used more by the rich, but as they become more widespread, the inequalities decrease. So, as coverage increases (diffusion), the gap between rich and poor narrows.\n\nLooking at the data given: The study looked at four countries\u2014China, Mexico, Russia, and South Africa for both breast and cervical cancer screenings. The key points are the coverage percentages and the RII (Relative Index of Inequality) values. \n\nFor breast cancer screening coverage:\n- South Africa has 10.5% coverage with an RII of 14.57 (high inequality)\n- China 19.3% and RII 4.90\n- Mexico 33.8% RII 2.01\n- Russia 43% RII 1.04 (lowest inequality)\n\nFor cervical cancer:\n- South Africa 24% coverage, RII 2.47\n- China 27.2% RII 3.60\n- Mexico 63.7% RII 1.39\n- Russia 81.5% RII 1.12\n\nThe pattern here is that as the overall coverage increases (from South Africa to Russia, for example), the RII decreases. RII measures inequality; a higher RII means more inequality (rich have much higher access). So in countries with higher coverage (like Russia and Mexico), the RII is closer to 1, indicating less inequality. This supports the inverse equity hypothesis because as the intervention (screening) becomes more widespread (higher coverage), the economic inequalities decrease. \n\nThe study's conclusion seems to show that in countries with lower coverage, there's a bigger gap (rich access more), but as coverage increases, the gap narrows. That's exactly what the inverse equity hypothesis suggests. Therefore, the answer should be \"yes\" the hypothesis applies here. The options are A, B, C. The correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 442,
            "completion_tokens": 471
        },
        "time_elapsed": 5.563508033752441
    },
    {
        "realidx": "25371231",
        "question": "The aetiology of osteochondritis dissecans is still unclear. The aim of this prospective pilot study was to analyse whether vitamin D insufficiency, or deficiency, might be a contributing etiological factor in the development of an OCD lesion.\nThe serum level of vitamin D3 in 23 consecutive patients (12 male and 11 female) suffering from a stage III, or stages III and IV, OCD lesion (mostly stage III) admitted for surgery was measured.\nThe patients' mean age was 31.3\u00a0years and most of them already exhibited closed epiphyseal plates. In the majority of patients (18/23), a distinct vitamin D3 deficiency was found, two patients were vitamin D3-insufficient and, in three patients, the vitamin D3 level reached the lowest normal value.\nIs vitamin D insufficiency or deficiency related to the development of osteochondritis dissecans?",
        "answer": "maybe",
        "answer_rationale": "These first data show that a vitamin D3 deficiency rather than an insufficiency may be involved in the development of OCD lesions. Probably, with a vitamin D3 substitution, the development of an advanced OCD stage could be avoided. Further analyses, including morphological analyses regarding a possible osteomalacia, and examination of the PTH and other determinants of the bone metabolism, should be undertaken to either confirm or refute these data.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether vitamin D insufficiency or deficiency is related to the development of osteochondritis dissecans (OCD) based on the provided study.\n\nFirst, I need to understand the study's setup. The study is a prospective pilot study looking at 23 patients with stage III or IV OCD, mostly stage III. They measured their vitamin D3 levels. The patients had a mean age of 31.3 years, and most had closed epiphyseal plates, which suggests they're done growing. \n\nThe results showed that 18 out of 23 had a vitamin D deficiency, 2 were insufficient, and 3 were at the lowest normal. So, the majority had low vitamin D. The question is whether this implies a relationship between vitamin D levels and OCD development.\n\nNow, the options are yes, no, or maybe. The study found a high prevalence of deficiency/insufficiency in these patients. But correlation doesn't equal causation. The study's design is observational, so it can't prove causality. The study's aim was to see if there's a contributing factor, but the results here show an association. However, since it's a pilot study with a small sample size (23 patients), the results might not be statistically significant or generalizable. Also, the study didn't compare with a control group of people without OCD. Without a control group, we can't know if the vitamin D levels in OCD patients are actually different from the general population. For example, maybe the general population also has similar rates of deficiency. \n\nThe answer options are yes, no, maybe. The study's data suggests an association, but can't confirm causation. Since the question is about whether it's a contributing factor, the study's findings are preliminary. The correct answer here would be \"maybe\" because the study shows a possible link but needs more research, especially with a control group and larger sample. The answer isn't a definitive yes because of the lack of control and the study's limitations. So the answer should be C.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 281,
            "completion_tokens": 438
        },
        "time_elapsed": 5.022804260253906
    },
    {
        "realidx": "25394614",
        "question": "To compare two treatment strategies in preterm infants with or at risk of respiratory distress syndrome: early surfactant administration (within one hour of birth) versus late surfactant administration, in a geographically defined population.\nThe primary outcome was chronic lung disease (CLD) and mortality before/at 36 weeks. Secondary outcomes included: duration of mechanical ventilation and continuous positive airway pressure (CPAP), post-natal steroids for CLD and major neonatal morbidities.\nPremature infants born at 22-32 weeks' gestation between January 2006 and December 2009.\nTen neonatal intensive care units (NICUs) in New South Wales (NSW) and Australian Capital Territory (ACT), Australia.\nRetrospective analysis of prospectively collected data from the regional NICU database in NSW and ACT.\nOf the 2170 infants who received surfactant, 1182 (54.5%) and 988 (45.5%) received early and late surfactant, respectively. The early surfactant group was less mature (27.1\u2009\u00b1\u20092.1 versus 29.4\u2009\u00b1\u20092.1 weeks) and had more CLD and mortality (40.2% versus 20.0%). The multivariable analysis showed early surfactant to be associated with less duration of ventilation, longer duration of CPAP and longer hospital stay but had little or no impact on CLD/mortality.\nDoes timing of initial surfactant treatment make a difference in rates of chronic lung disease or mortality in premature infants?",
        "answer": "maybe",
        "answer_rationale": "Early surfactant administration is associated with shorter duration of ventilation but does not appear to be significantly protective against CLD/mortality among premature infants. This may support the growing evidence for consideration of CPAP as an alternative to routine intubation and early surfactant administration. Further investigation from large randomized clinical trials is warranted to confirm these results.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the timing of initial surfactant treatment affects the rates of chronic lung disease (CLD) or mortality in premature infants. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study compared early surfactant (within an hour of birth) versus late administration in preterm infants. The primary outcome was CLD and mortality before or at 36 weeks. \n\nThe results mentioned that the early surfactant group had a higher rate of CLD and mortality (40.2% vs 20.0%). Wait, that's interesting because you might expect early treatment to be better. But the infants in the early group were less mature (27.1 weeks vs 29.4 weeks). So maybe the groups weren't perfectly comparable. The study used multivariable analysis, which should adjust for some confounders. The analysis showed that early surfactant was linked to less ventilation time, longer CPAP use, and longer hospital stays, but had \"little or no impact on CLD/mortality.\" \n\nHmm, the raw data showed higher CLD/mortality in the early group, but after adjusting, the impact was minimal? The key here is the multivariable analysis conclusion. The question is about whether timing makes a difference. The study's conclusion from the adjusted analysis says that timing didn't have a significant effect on CLD/mortality. So the answer would be no, timing doesn't make a difference in those outcomes, even though there were differences in other aspects like ventilation duration. \n\nWait, but the initial numbers were so different. But since the early group was less mature, which is a risk factor for CLD and mortality, the multivariable analysis probably accounted for gestational age. So the adjusted results suggest that when you control for those factors, timing itself doesn't affect CLD/mortality. Therefore, the answer should be B (no).\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 432,
            "completion_tokens": 415
        },
        "time_elapsed": 4.980810642242432
    },
    {
        "realidx": "25475395",
        "question": "For women, the correlation between circulating androgens and sexual desire is inconclusive. Substitution with androgens at physiological levels improves sexual function in women who experience decreased sexual desire and androgen deficiency from surgical menopause, pituitary disease, and age-related decline in androgen production in the ovaries. Measuring bioactive testosterone is difficult and new methods have been proposed, including measuring the primary androgen metabolite androsterone glucuronide (ADT-G).AIM: The aim of this study was to investigate a possible correlation between serum levels of androgens and sexual desire in women and whether the level of ADT-G is better correlated than the level of circulating androgens with sexual desire.\nThis was a cross-sectional study including 560 healthy women aged 19-65 years divided into three age groups. Correlations were considered to be statistically significant at P<0.05.\nSexual desire was determined as the total score of the sexual desire domain of the Female Sexual Function Index. Total testosterone (TT), calculated free testosterone (FT), androstenedione, dehydroepiandrosterone sulfate (DHEAS), and ADT-G were analyzed using mass spectrometry.\nSexual desire correlated overall with FT and androstenedione in the total cohort of women. In a subgroup of women aged 25-44 years with no use of systemic hormonal contraception, sexual desire correlated with TT, FT, androstenedione, and DHEAS. In women aged 45-65 years, androstenedione correlated with sexual desire. No correlations between ADT-G and sexual desire were identified.\nIs there a correlation between androgens and sexual desire in women?",
        "answer": "yes",
        "answer_rationale": "In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a correlation between androgens and sexual desire in women based on the provided study.\n\nFirst, I need to recall the details from the study summary. The study was cross-sectional with 560 women divided into three age groups. The main aim was to see if androgens correlate with sexual desire and if ADT-G is a better marker than circulating androgens.\n\nThe key findings mentioned are that in the total cohort, sexual desire correlated with FT (free testosterone) and androstenedione. Then, in the subgroup of women aged 25-44 not on hormonal contraception, there were correlations with TT, FT, androstenedione, and DHEAS. For the older group (45-65), only androstenedione correlated. However, ADT-G didn't show any correlation with sexual desire.\n\nThe question is whether there's a correlation between androgens and sexual desire. The options are yes, no, maybe. The study found correlations in certain groups (like the 25-44 age group and the total cohort), so the answer should be yes. Even though the correlation wasn't universal across all age groups and ADT-G didn't correlate, the presence of correlations in some groups means the answer isn't \"no\" or \"maybe.\" The study's results support that there is a correlation in some cases, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 445,
            "completion_tokens": 306
        },
        "time_elapsed": 3.8344197273254395
    },
    {
        "realidx": "25481573",
        "question": "To assess the extent to which the title and font of participant information sheets (PISs) can influence pregnant women's and trainee midwives' perceptions of an antenatal intervention.\nPregnant women (n=35) and trainee midwives (n=36) were randomly presented with one of four PISs where the title and font of the PIS had been manipulated to create four experimental conditions (i.e., Double Fluent; Double Awkward; Fluent Title-Awkward Font; Awkward Title-Fluent Font). After reading the PIS, participants rated their perceptions of the intervention (i.e., Attractiveness, Complexity, Expected Risk, Required Effort) using five-point Likert scales.\nA 4\u00d72 factorial multivariate analysis of variance revealed that pregnant women rated the Double Awkward condition as significantly more complex than the Double Fluent (p=.024) and Awkward Title-Fluent Font (p=.021) conditions.\nProcessing fluency effects: can the content and presentation of participant information sheets influence recruitment and participation for an antenatal intervention?",
        "answer": "yes",
        "answer_rationale": "Font influenced pregnant women's ratings of intervention complexity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at how the title and font of participant information sheets (PISs) affect pregnant women and trainee midwives' perceptions of an antenatal intervention. The key here is the results from the factorial MANOVA. They found that pregnant women found the Double Awkward condition more complex compared to the Double Fluent and Awkward Title-Fluent Font conditions, with significant p-values.\n\nThe question is whether processing fluency effects (which relate to how easily information is processed) can influence recruitment and participation. Since the study shows that the presentation (font and title) affected perceptions like complexity, which are factors that could influence someone's decision to participate, the answer would lean towards yes. The significant differences in ratings suggest that how the information is presented does matter. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 322,
            "completion_tokens": 182
        },
        "time_elapsed": 2.7993903160095215
    },
    {
        "realidx": "25488308",
        "question": "The proper angle of miniscrew insertion is important for cortical anchorage, patient safety, and biomechanical control. The purposes of this study are to report the alveolar process thickness and inter-radicular space in the posterior region of the mandible, to assess the impact of different miniscrew insertion angle protocols, and to identify differences between the genders or types of malocclusion.\nIn this retrospective study, 100 individuals were selected for orthodontic treatment at a radiology clinic. Cone-beam computed tomography data were imported into 3-dimensional software. The predictor variable was the location in the mandible and insertion angle. The demographic variables collected included age, gender, and malocclusion (Angle Classes I and II). The primary outcome variables were bone thickness and inter-radicular space. The inter-radicular spaces were evaluated 5 mm from the cement-enamel junction. The bone thicknesses were taken at 45\u00b0, 60\u00b0, and 90\u00b0 in relation to the alveolar ridge, simulating a miniscrew insertion. These factors were evaluated for sexual dimorphism and malocclusion (Angle Classes I and II). Sexual dimorphism and malocclusion were evaluated with t tests. To compare the inter-radicular space and the thickness of bone between areas, an analysis of variance for repeated measures was used.\nThe sample was composed of 100 patients with a mean age of 17.4 \u00b1 6.74 years. There were 61 female and 39 male patients and 60 Class I and 40 Class II molar relationships. The inter-radicular space ranged from 2.46 to 3.31 mm, and alveolar bone thickness ranged from 8.01 to 13.77 mm. The thickness tended to decrease with the increase in insertion angle from 45\u00b0 to 90\u00b0. No significant differences between the genders or types of malocclusion were found.\nCan bone thickness and inter-radicular space affect miniscrew placement in posterior mandibular sites?",
        "answer": "no",
        "answer_rationale": "The results of this study suggest that the safest areas for the placement of miniscrews are between the first and second premolars and between the first and second molars, regardless of the angle of insertion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether bone thickness and inter-radicular space affect miniscrew placement in the posterior mandibular sites based on the provided study.\n\nFirst, I need to recall the details from the study description. The study's purpose was to report alveolar process thickness and inter-radicular space in the posterior mandible, assess the impact of different insertion angles, and check for gender or malocclusion differences. \n\nThe key points from the results: The inter-radicular space was between 2.46-3.31 mm, and bone thickness varied from 8.01-13.77 mm. They noted that bone thickness decreased as the insertion angle increased from 45\u00b0 to 90\u00b0. Also, no significant differences were found between genders or malocclusion classes (Class I vs II).\n\nThe question is whether bone thickness and inter-radicular space affect miniscrew placement. The study's primary outcomes were these variables. Since the thickness changes with angle and the inter-radicular space is a measured factor, it implies that these anatomical features do influence where and how the miniscrews can be placed. The fact that they evaluated these factors in relation to insertion angles suggests that they are important for successful placement. The study didn't find differences based on gender or malocclusion, but that doesn't negate the effect of bone thickness and space themselves. The answer should be yes because the variables are directly related to the placement's feasibility and safety. The options are A (yes), B (no), C (maybe). The study's data supports that these factors do have an impact, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 523,
            "completion_tokens": 351
        },
        "time_elapsed": 4.416450262069702
    },
    {
        "realidx": "25499207",
        "question": "Current evidence suggests that neck pain is negatively associated with health-related quality of life (HRQoL). However, these studies are cross-sectional and do not inform the association between neck pain and future HRQoL.\nThe purpose of this study was to investigate the association between increasing grades of neck pain severity and HRQoL 6 months later. In addition, this longitudinal study examines the crude association between the course of neck pain and HRQoL.\nThis is a population-based cohort study.\nEleven hundred randomly sampled Saskatchewan adults were included.\nOutcome measures were the mental component summary (MCS) and physical component summary (PCS) of the Short-Form-36 (SF-36) questionnaire.\nWe formed a cohort of 1,100 randomly sampled Saskatchewan adults in September 1995. We used the Chronic Pain Questionnaire to measure neck pain and its related disability. The SF-36 questionnaire was used to measure physical and mental HRQoL 6 months later. Multivariable linear regression was used to measure the association between graded neck pain and HRQoL while controlling for confounding. Analysis of variance and t tests were used to measure the crude association among four possible courses of neck pain and HRQoL at 6 months. The neck pain trajectories over 6 months were no or mild neck pain, improving neck pain, worsening neck pain, and persistent neck pain. Finally, analysis of variance was used to examine changes in baseline to 6-month PCS and MCS scores among the four neck pain trajectory groups.\nThe 6-month follow-up rate was 74.9%. We found an exposure-response relationship between neck pain and physical HRQoL after adjusting for age, education, arthritis, low back pain, and depressive symptomatology. Compared with participants without neck pain at baseline, those with mild (\u03b2=-1.53, 95% confidence interval [CI]=-2.83, -0.24), intense (\u03b2=-3.60, 95% CI=-5.76, -1.44), or disabling (\u03b2=-8.55, 95% CI=-11.68, -5.42) neck pain had worse physical HRQoL 6 months later. We did not find an association between neck pain and mental HRQoL. A worsening course of neck pain and persistent neck pain were associated with worse physical HRQoL.\nIs neck pain associated with worse health-related quality of life 6 months later?",
        "answer": "yes",
        "answer_rationale": "We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether neck pain is associated with worse health-related quality of life (HRQoL) six months later based on the provided study.\n\nFirst, I need to recall the key points from the study description. The study was longitudinal, following 1,100 adults in Saskatchewan over six months. They used the SF-36 to measure HRQoL, focusing on the physical component summary (PCS) and mental component summary (MCS). The analysis controlled for confounders like age, education, arthritis, etc.\n\nThe results mentioned an exposure-response relationship between neck pain severity and physical HRQoL. The beta coefficients for mild, intense, and disabling neck pain were all negative, indicating lower PCS scores (worse physical HRQoL) compared to those without neck pain. The confidence intervals didn't include zero, so the associations were statistically significant. Also, worsening or persistent neck pain was linked to worse physical HRQoL. However, there was no association found with mental HRQoL (MCS).\n\nThe question specifically asks about HRQoL in general, but the options are yes, no, maybe. Since the physical component is part of HRQoL and the study shows a clear negative association with physical HRQoL, the answer should be yes. The mental part wasn't affected, but the question doesn't specify physical or mental. However, HRQoL encompasses both, but since physical is worse, the overall answer would still be yes. The options don't allow for a split answer, so the correct choice is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 616,
            "completion_tokens": 339
        },
        "time_elapsed": 3.9548652172088623
    },
    {
        "realidx": "25503376",
        "question": "Obstructive sleep apnea (OSA) is tightly linked to increased cardiovascular disease. Surgery is an important method to treat OSA, but its effect on serum lipid levels in OSA patients is unknown. We aimed to evaluate the effect of upper airway surgery on lipid profiles.\nWe performed a retrospective review of 113 adult patients with OSA who underwent surgery (nasal or uvulopalatopharyngoplasty [UPPP]) at a major, urban, academic hospital in Beijing from 2012 to 2013 who had preoperative and postoperative serum lipid profiles.\nSerum TC (4.86\u00b10.74 to 4.69\u00b10.71) and LP(a) (median 18.50 to 10.90) all decreased significantly post-operatively (P<0.01, 0.01, respectively), with no changes in serum HDL, LDL, or TG (P>0.05, all). For UPPP patients (n=51), serum TC, HDL and LP(a) improved (P=0.01, 0.01,<0.01, respectively). For nasal patients (n=62), only the serum LP(a) decreased (P<0.01). In patients with normal serum lipids at baseline, only serum LP(a) decreased (P<0.01). In contrast, in patients with isolated hypertriglyceridemia, the serum HDL, TG and LP(a) showed significant improvements (P=0.02, 0.03,<0.01, respectively). In patients with isolated hypercholesterolemia, the serum LP(a) decreased significantly (P=0.01), with a similar trend for serum TC (P=0.06). In patients with mixed hyperlipidemia, the serum TC and LDL also decreased (P=0.02, 0.03, respectively).\nDoes airway surgery lower serum lipid levels in obstructive sleep apnea patients?",
        "answer": "yes",
        "answer_rationale": "Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether airway surgery lowers serum lipid levels in OSA patients based on the provided study.\n\nFirst, I need to recall the study's findings. The abstract mentions that after surgery, serum TC (total cholesterol) and LP(a) decreased significantly. For the UPPP group, TC, HDL, and LP(a) improved. In nasal surgery patients, LP(a) decreased. Even in those with normal lipids, LP(a) went down. For those with hypertriglyceridemia, HDL, TG, and LP(a) improved. In hypercholesterolemia, LP(a) decreased and TC trended down. Mixed hyperlipidemia patients saw TC and LDL drop. \n\nThe question is whether surgery lowers lipid levels. The answer seems yes because multiple lipid markers (TC, LP(a), HDL, TG, LDL) decreased significantly in various subgroups. The study's results show statistically significant reductions (p-values <0.05) in several lipids post-surgery. So the correct answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 531,
            "completion_tokens": 232
        },
        "time_elapsed": 2.9673256874084473
    },
    {
        "realidx": "25521278",
        "question": "Identifying eating behaviors which contribute to excess weight gain will inform obesity prevention strategies. A tendency to clear one's plate when eating may be a risk factor for obesity in an environment where food is plentiful. Whether plate clearing is associated with increased body weight in a cohort of US participants was examined.\nNine hundred and ninety-three US adults (60% male, 80% American European, mean age=31 years) completed self-report measures of habitual plate clearing together with behavioral and demographic characteristics known to be associated with obesity.\nPlate clearing tendencies were positively associated with BMI and remained so after accounting for a large number of other demographic and behavioral predictors of BMI in analyses (\u03b2=0.18, 95% CIs=0.07, 0.29, P<0.001); an increased tendency to plate clear was associated with a significantly higher body weight.\nIs plate clearing a risk factor for obesity?",
        "answer": "yes",
        "answer_rationale": "The tendency to clear one's plate when eating is associated with increased body weight and may constitute a risk factor for weight gain.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether plate clearing is a risk factor for obesity based on the provided study.\n\nFirst, I need to recall what the study found. The question states that the study examined 993 US adults. They used self-report measures for plate clearing and other factors. The key result was that plate clearing was positively associated with BMI. The beta coefficient is 0.18 with a 95% CI of 0.07 to 0.29, and the p-value is less than 0.001. Even after adjusting for other predictors, the association remained significant. \n\nSo, the study's results show that a higher tendency to clear the plate is linked to higher BMI. Since BMI is a measure related to body weight, and the association holds even after controlling for other variables, this suggests that plate clearing does contribute to higher body weight. \n\nThe question is whether this makes plate clearing a risk factor. A risk factor is something that increases the probability of developing a disease or condition\u2014in this case, obesity. Since the study found a positive and significant association, even after accounting for other factors, it supports the idea that plate clearing is a risk factor. \n\nLooking at the options: A is yes, B is no, C is maybe. The study's results are statistically significant, so the answer should be A. The confidence interval doesn't include zero, which means the effect is likely real. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 282,
            "completion_tokens": 313
        },
        "time_elapsed": 3.8049638271331787
    },
    {
        "realidx": "25571931",
        "question": "Among patients with acute stroke symptoms, delay in hospital admission is the main obstacle for the use of thrombolytic therapy and other interventions associated with decreased mortality and disability. The primary aim of this study was to assess whether an elderly clinical population correctly endorsed the response to call for emergency services when presented with signs and symptoms of stroke using a standardized questionnaire.\nWe performed a cross-sectional study among elderly out-patients (\u226560 years) in Buenos Aires, Argentina randomly recruited from a government funded health clinic. The correct endorsement of intention to call 911 was assessed with the Stroke Action Test and the cut-off point was set at \u226575%. Knowledge of stroke and clinical and socio-demographic indicators were also collected and evaluated as predictors of correct endorsement using logistic regression.\nAmong 367 elderly adults, 14% correctly endorsed intention to call 911. Presented with the most typical signs and symptoms, only 65% reported that they would call an ambulance. Amaurosis Fugax was the symptom for which was called the least (15%). On average, the correct response was chosen only 37% of the time. Compared to lower levels of education, higher levels were associated to correctly endorsed intention to call 911 (secondary School adjusted OR 3.53, 95% CI 1.59-7.86 and Tertiary/University adjusted OR 3.04, 95% CI 1.12-8.21).\nDo elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke?",
        "answer": "maybe",
        "answer_rationale": "These results suggest the need to provide interventions that are specifically designed to increase awareness of potential stroke signs and symptoms and appropriate subsequent clinical actions.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke, based on the study provided.\n\nFirst, I need to look at the data from the study. The key points mentioned are that among 367 elderly adults, only 14% correctly endorsed the intention to call 911. Even when presented with the most typical symptoms, 65% said they would call an ambulance. But amaurosis fugax had the lowest response at 15%. The average correct response was 37%. \n\nThe question is asking if they do call 911. The options are yes, no, maybe. The study's results show that the majority did not correctly endorse calling 911. The correct endorsement was only 14%, which is very low. Even the highest for typical symptoms was 65%, which is under majority. Since the question is whether they \"call\" in such scenarios, the data suggests that the majority do not. So the answer should be no (B). The \"maybe\" might be a trap if there's some ambiguity, but the numbers clearly show low rates, so B is correct.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 422,
            "completion_tokens": 258
        },
        "time_elapsed": 3.7889564037323
    },
    {
        "realidx": "25588461",
        "question": "Disorders of consciousness (DOC) diagnosis relies on the presence or absence of purposeful motor responsiveness, which characterizes the minimally conscious state (MCS) and the unresponsive wakefulness syndrome (UWS), respectively. Functional neuroimaging studies have raised the question of possible residual conscious awareness also in clinically-defined UWS patients. The aim of our study was to identify electrophysiological parameters, by means of a transcranial magnetic stimulation approach, which might potentially express the presence of residual networks sustaining fragmentary behavioral patterns, even when no conscious behavior can be observed.\nWe enrolled 25 severe DOC patients, following post-anoxic or traumatic brain injury and 20 healthy individuals (HC) as control group. Baseline electrophysiological evaluation evidenced, in comparison to HC, a partial preservation of cortical effective connectivity and excitability in clinically defined MCS, whereas these components were absent in clinically defined UWS. Then, we applied an anodal transcranial direct current stimulation (a-tDCS) protocol over the orbitofrontal cortex.\na-tDCS was able to boost cortical connectivity and excitability in all HC, MCS, and to unmask such excitability/connectivity in some UWS patients.\nCan transcranial direct current stimulation be useful in differentiating unresponsive wakefulness syndrome from minimally conscious state patients?",
        "answer": "yes",
        "answer_rationale": "a-tDCS could be useful in identifying residual connectivity markers in clinically-defined UWS, who may lack of purposeful behavior as a result of a motor-output failure.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether transcranial direct current stimulation (tDCS) can help differentiate between unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS) patients based on the study described.\n\nFirst, I need to recall the key points from the provided information. The study involved 25 DOC patients (divided into MCS and UWS) and 20 healthy controls. They used electrophysiological evaluations and applied a-tDCS over the orbitofrontal cortex. The results showed that in MCS patients, there was partial preservation of cortical connectivity and excitability compared to healthy controls, while UWS patients lacked these. However, after a-tDCS, some UWS patients showed unmasked excitability and connectivity. \n\nThe question is whether tDCS can differentiate UWS from MCS. The study's findings suggest that while MCS already had some preserved connectivity, UWS didn't, but tDCS could \"unmask\" these in some UWS cases. This implies that the response to tDCS might reveal underlying neural activity in UWS that isn't apparent otherwise, which could help distinguish them from MCS. Since the study found that a-tDCS boosted connectivity in MCS and HC, and in some UWS patients, the presence or absence of this response after stimulation might be a differentiating factor. Therefore, the answer would be yes (A), because the stimulation's effect can show differences between the two groups.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 363,
            "completion_tokens": 311
        },
        "time_elapsed": 3.7467100620269775
    },
    {
        "realidx": "25604390",
        "question": "Dickkopf-3 (DKK3) may act as a tumor suppressor as it is down-regulated in various types of cancer. This study assessed the DKK3 protein expression in gastric cancer and its potential value as a prognostic marker.\nDKK3 expression was evaluated by immunohistochemistry in 158 gastric cancer samples from patients who underwent gastrectomy from 2002 to 2008. Clinicopathological parameters and survival data were analyzed.\nLoss of DKK3 expression was found in 64 of 158 (40.5%) samples, and it was associated with advanced T stage (p<0.001), lymph node metastasis (p<0.001), UICC TNM stage (p<0.001), tumor location (p = 0.029), lymphovascular invasion (p = 0.035), and perineural invasion (p = 0.032). Patients without DKK3 expression in tumor cells had a significantly worse disease-free and overall survival than those with DKK3 expression (p<0.001, and p = 0.001, respectively). TNM stage (p = 0.028 and p<0.001, respectively) and residual tumor (p<0.001 and p = 0.003, respectively) were independent predictors of disease-free and overall survival. Based on the preoperative clinical stage assessed by computed tomography (CT), loss of DKK3 expression was predominantly associated with worse prognosis in patients with clinically node-negative advanced gastric cancer (AGC). The combination of DKK3 expression status and CT increased the accuracy of CT staging for predicting lymph node involvement from 71.5 to 80.0% in AGC patients.\nAberrant loss of dickkopf-3 in gastric cancer: can it predict lymph node metastasis preoperatively?",
        "answer": "yes",
        "answer_rationale": "Loss of DKK3 protein expression was significantly associated with poor survival in patients with gastric cancer and was strongly correlated with the TNM stage. DKK3 might be a potential biomarker of lymph node involvement that can improve the predictive power of CT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the loss of DKK3 in gastric cancer can predict lymph node metastasis preoperatively. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study evaluated DKK3 expression in 158 gastric cancer samples. They found that loss of DKK3 was associated with several factors, including lymph node metastasis (p<0.001). That's a strong statistical significance. \n\nThe results also mention that in patients with clinically node-negative advanced gastric cancer (AGC), the loss of DKK3 was linked to a worse prognosis. Additionally, combining DKK3 expression status with CT scans improved the accuracy of predicting lymph node involvement from 71.5% to 80%. \n\nSo, the key points here are the association between DKK3 loss and lymph node metastasis, and the improvement in CT staging accuracy when considering DKK3. The question is about predicting lymph node metastasis preoperatively. Since the study shows that DKK3 loss is associated with lymph node metastasis and that combining it with CT improves prediction, it suggests that DKK3 can indeed help predict this. \n\nThe options are (A) yes, (B) no, (C) maybe. The study's results support that DKK3 loss is a predictor, so the answer should be A. The fact that combining it with CT increases accuracy further supports that it has predictive value. The question is whether it \"can\" predict, and since the study shows an association and improved accuracy, the answer is yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 508,
            "completion_tokens": 341
        },
        "time_elapsed": 3.962547540664673
    },
    {
        "realidx": "25614468",
        "question": "The aim of this study was to prospectively compare the diagnostic performance of magnetic resonance imaging (MRI), multidetector computed tomography (MDCT) and endoscopic ultrasonography (EUS) in the preoperative locoregional staging of gastric cancer.\nThis study had Institutional Review Board approval, and informed consent was obtained from all patients. Fifty-two patients with biopsy-proven gastric cancer underwent preoperative 1.5-T MRI, 64-channel MDCT and EUS. All images were analysed blind, and the results were compared with histopathological findings according to the seventh edition of the TNM classification. After the population had been divided on the basis of the local invasion (T1-3 vs T4a-b) and nodal involvement (N0 vs N+), sensitivity, specificity, positive and negative predictive value, and accuracy were calculated and diagnostic performance measures were assessed using the McNemar test.\nFor T staging, EUS showed higher sensitivity (94%) than MDCT and MRI (65 and 76%; p = 0.02 and p = 0.08). MDCT and MRI had significantly higher specificity (91 and 89%) than EUS (60%) (p = 0.0009 and p = 0.003). Adding MRI to MDCT or EUS did not result in significant differences for sensitivity. For N staging, EUS showed higher sensitivity (92%) than MRI and MDCT (69 and 73%; p = 0.01 and p = 0.02). MDCT showed better specificity (81%) than EUS and MRI (58 and 73%; p = 0.03 and p = 0.15).\nPreoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging?",
        "answer": "no",
        "answer_rationale": "Our prospective study confirmed the leading role of EUS and MDCT in the staging of gastric cancer and did not prove, at present, the value of the clinical use of MRI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing MRI, MDCT, and EUS for staging gastric cancer. The question is whether there's a place for MRI in preoperative locoregional staging.\n\nFirst, looking at the T staging results: EUS had higher sensitivity than MRI and MDCT. MRI's sensitivity was 76%, which was better than MDCT's 65% but not statistically significant compared to EUS (p=0.08, which is not below 0.05). MDCT and MRI had higher specificity than EUS. For N staging, EUS again had higher sensitivity, and MDCT had better specificity than MRI. \n\nThe key point is whether MRI adds value. The study mentions that adding MRI to MDCT or EUS didn't improve sensitivity. Since EUS is better for sensitivity and MDCT has better specificity, MRI might not be necessary. But maybe in certain cases where specificity is needed, or if EUS isn't available? The question is if MRI has a place. The results show MRI isn't better than the others in key metrics except maybe specificity, but when combined, it doesn't add much. The conclusion might suggest MRI isn't essential, so the answer might be B (no). But wait, the options are (A) yes, (B) no, (C) maybe. The study's results don't show MRI outperforming in any critical area when combined. Since adding MRI didn't help sensitivity, and EUS and MDCT are better in their respective strengths, perhaps MRI isn't needed. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 481,
            "completion_tokens": 337
        },
        "time_elapsed": 4.089010953903198
    },
    {
        "realidx": "25669733",
        "question": "To test the predictive value of distal ureteral diameter (UD) on reflux resolution after endoscopic injection in children with primary vesicoureteral reflux (VUR).\nThis was a retrospective review of patients diagnosed with primary VUR between 2009 and 2012 who were managed by endoscopic injection. Seventy preoperative and postoperative voiding cystourethrograms were reviewed. The largest UD within the false pelvis was measured. The UD was divided by the L1-L3 vertebral body distance to get the UD ratio (UDR). One radiologist interpreted the findings of voiding cystourethrography in all patients. Clinical outcome was defined as reflux resolution.\nSeventy patients were enrolled in this series (17 boys and 53 girls). Mean age was 5.9 years (1.2-13 years). Grade III presented in 37 patients (53%), and 33 patients (47%) were of grade IV. Mean distal UD was 5.5\u00a0mm (2.5-13\u00a0mm). Mean UDR was 37.8% (18%-70%). Macroplastique injection was performed in all. Subureteric injection was performed in 60 patients (86%), whereas intraureteric injection was performed in 10 patients. No postoperative complications were detected. The effect of grade, UD, and UDR on success after endoscopic injection was tested. UD and UDR were significant predictors of reflux resolution on logistic regression analysis (P\u00a0<.007 and .001, respectively).\nCan distal ureteral diameter predict reflux resolution after endoscopic injection?",
        "answer": "yes",
        "answer_rationale": "UDR provides an objective measurement of VUR and appears as a predictive tool of success after endoscopic injection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the distal ureteral diameter (UD) can predict reflux resolution after endoscopic injection in children with VUR. The study mentioned here was a retrospective review of 70 patients.\n\nFirst, I need to look at the key findings from the study provided. The abstract states that they tested the effect of grade, UD, and UDR (ureteral diameter ratio) on success. The results say that both UD and UDR were significant predictors on logistic regression analysis, with p-values less than 0.007 and 0.001 respectively. \n\nSince the p-values are below the significance level (typically 0.05), this indicates that there's a statistically significant association between UD and UDR with the outcome of reflux resolution. The question specifically asks about UD, and since the study found it to be a significant predictor, the answer should be yes. \n\nThe options are A (yes), B (no), C (maybe). The study's results support that UD does predict the outcome, so the correct answer is A. I should make sure there's no confusion between UD and UDR. The question is about UD, and since UD itself was significant, the answer is definitely yes. The UDR is derived from UD, but the question is directly about UD, so the answer holds.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 446,
            "completion_tokens": 288
        },
        "time_elapsed": 3.5680465698242188
    },
    {
        "realidx": "25675614",
        "question": "Diabetes mellitus (DM) is undiagnosed in approximately half of the patients actually suffering from the disease. In addition, the prevalence of DM is more than twice as high as in patients with periodontitis when compared to periodontally healthy subjects. Thus, a high number of patients with periodontitis may have undiagnosed DM. The purpose of the present study was to evaluate whether blood oozing from a gingival crevice during routine periodontal examination can be used for determining glucose levels.\nObservational cross-sectional studies were carried out in 75 patients (43 males and 32 females) with chronic periodontitis who were divided into two groups: Group I and Group II, respectively. Blood oozing from the gingival crevices of anterior teeth following periodontal probing was collected with the stick of glucose self-monitoring device, and the blood glucose levels were measured. At the same time, finger-prick blood was taken for glucometric analysis and subsequent readings were recorded.\nThe patient's blood glucose values ranged from 74 to 256 mg/dl. The comparison between gingival crevicular blood and finger-prick blood showed a very strong correlation, with a t value of 3.97 (at P value = 0.001).\nCan gingival crevicular blood be relied upon for assessment of blood glucose level?",
        "answer": "yes",
        "answer_rationale": "The data from this study has shown that GCB collected during diagnostic periodontal examination can be an excellent source of blood for glucometric analysis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether blood from the gingival crevices (that's the area between the tooth and gum, right?) can be used to measure blood glucose levels instead of the usual finger-prick method. The question is asking if we can rely on gingival crevicular blood for this assessment.\n\nFirst, I need to look at the data provided. The study had 75 patients with chronic periodontitis divided into two groups. They collected blood from both the gingival crevices and via finger-prick, then compared the glucose levels. The results showed a very strong correlation with a t-value of 3.97 and a p-value of 0.001. \n\nHmm, the key here is understanding what those statistical values mean. A p-value less than 0.05 is typically considered statistically significant, so 0.001 is well below that. The t-value being 3.97 suggests that there's a significant difference or association. Wait, but in this context, since they're comparing two measurements (gingival vs finger-prick), a high t-value with a low p-value would indicate that the correlation between the two methods is statistically significant. \n\nThe question is whether this correlation means the gingival blood can be relied upon. A strong correlation would suggest that the two methods give similar results, so if they correlate very strongly, then using gingival blood might be a valid alternative. The study's purpose was to see if gingival blood can be used, and the results support that because the correlation is very strong and statistically significant. \n\nBut wait, maybe I should consider if correlation alone is enough. Sometimes, even if two variables are correlated, there might be a bias or systematic difference. However, the problem states that the comparison showed a \"very strong correlation\" with those stats. The options are yes, no, maybe. Since the study found a strong and significant correlation, the answer would lean towards yes. The options don't ask about clinical applicability beyond the study's findings, so based on the data given, the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 445
        },
        "time_elapsed": 5.258538007736206
    },
    {
        "realidx": "25699562",
        "question": "Our previous work demonstrated that the Transmissible Liability Index (TLI), an instrument designed as an index of liability for substance use disorder (SUD), is associated with risk of substance use disorder. This longitudinal study assessed whether TLI measured in 10-12-year-olds (late childhood) predicts suicidal behavior from age 12-14 (preadolescence) to age 25 (young adulthood). We hypothesized that TLI would predict number and severity of suicide attempts.\nSubjects were sons of men who had lifetime history of SUD (n\u2009=\u2009250), called the High Average Risk (HAR) group, and sons of men with no lifetime history of a SUD (n\u2009=\u2009250), called the Low Average Risk (LAR) group. The TLI was delineated at baseline (age 10-12), and age-specific versions were administered at 12-14, 16, 19, 22, and 25 years of age.\nTLI was significantly associated with number and severity of lifetime suicide attempts.\nDoes the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?",
        "answer": "yes",
        "answer_rationale": "These findings confirm the hypothesis that TLI assessed at late childhood is a predictor of frequency and severity of suicidal behavior from preadolescence to young adulthood.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the Transmissible Liability Index (TLI) measured in late childhood predicts suicidal symptoms at young adulthood. The study mentioned is longitudinal, following two groups: HAR (sons of fathers with SUD) and LAR (sons of fathers without SUD). The TLI was assessed at baseline (ages 10-12) and then at various later points.\n\nThe key point here is the study's hypothesis and results. The hypothesis was that TLI would predict the number and severity of suicide attempts. The results state that TLI was \"significantly associated with number and severity of lifetime suicide attempts.\" \n\nThe question is specifically about whether the TLI in late childhood (the baseline measurement) predicts suicidal symptoms into young adulthood. Since the study followed participants up to age 25 and found a significant association, that supports the idea that the TLI from late childhood does predict these outcomes. The answer options are yes, no, maybe. The study's conclusion directly answers the hypothesis positively, so the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 345,
            "completion_tokens": 227
        },
        "time_elapsed": 3.212346315383911
    },
    {
        "realidx": "25725704",
        "question": "Clinical supervision is widely recognised as a mechanism for providing professional support, professional development and clinical governance for healthcare workers. There have been limited studies about the effectiveness of clinical supervision for allied health and minimal studies conducted within the Australian health context. The aim of the present study was to identify whether clinical supervision was perceived to be effective by allied health professionals and to identify components that contributed to effectiveness. Participants completed an anonymous online questionnaire, administered through the health service's intranet.\nA cross-sectional study was conducted with community allied health workers (n = 82) 8 months after implementation of structured clinical supervision. Demographic data (age, gender), work-related history (profession employment level, years of experience), and supervision practice (number and length of supervision sessions) were collected through an online survey. The outcome measure, clinical supervision effectiveness, was operationalised using the Manchester Clinical Supervision Scale-26 (MCSS-26). Data were analysed with Pearson correlation (r) and independent sample t-tests (t) with significance set at 0.05 (ie the probability of significant difference set at P<0.05).\nThe length of the supervision sessions (r(s) \u2265 0.44), the number of sessions (r(s) \u2265 0.35) and the total period supervision had been received (r(s) \u2265 0.42) were all significantly positively correlated with the MCSS-26 domains of clinical supervision effectiveness. Three individual variables, namely 'receiving clinical supervision', 'having some choice in the allocation of clinical supervisor' and 'having a completed clinical supervision agreement', were also significantly associated with higher total MCSS-26 scores (P(s)<0.014).\nCan clinical supervision sustain our workforce in the current healthcare landscape?",
        "answer": "yes",
        "answer_rationale": "The results of the study demonstrate that when clinical supervision uses best practice principles, it can provide professional support for allied health workers, even during times of rapid organisational change.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether clinical supervision can sustain the healthcare workforce based on the study described.\n\nFirst, I need to recall the study's findings. The study found that several factors like session length, number of sessions, duration of supervision, and certain variables (like having a choice in supervisor and a completed agreement) were positively correlated with higher effectiveness scores on the MCSS-26. The correlations were significant, which means they're not likely due to chance. \n\nThe question is whether this implies that clinical supervision can sustain the workforce. The study shows that when these elements are present, supervision is perceived as more effective. Since effective clinical supervision contributes to professional support and development, it's reasonable to infer that it helps in sustaining the workforce by improving job satisfaction, reducing burnout, and enhancing skills. The study's positive correlations support the idea that effective supervision can play a role in workforce sustainability. The options are yes, no, maybe. The study's results are positive, so the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 455,
            "completion_tokens": 218
        },
        "time_elapsed": 3.2204763889312744
    },
    {
        "realidx": "25752725",
        "question": "Schizophrenia patients are typically found to have low IQ both pre- and post-onset, in comparison to the general population. However, a subgroup of patients displays above average IQ pre-onset. The nature of these patients' illness and its relationship to typical schizophrenia is not well understood. The current study sought to investigate the symptom profile of high-IQ schizophrenia patients.\nWe identified 29 schizophrenia patients of exceptionally high pre-morbid intelligence (mean estimated pre-morbid intelligence quotient (IQ) of 120), of whom around half also showed minimal decline (less than 10 IQ points) from their estimated pre-morbid IQ. We compared their symptom scores (SAPS, SANS, OPCRIT, MADRS, GAF, SAI-E) with a comparison group of schizophrenia patients of typical IQ using multinomial logistic regression.\nThe patients with very high pre-morbid IQ had significantly lower scores on negative and disorganised symptoms than typical patients (RRR=0.019; 95% CI=0.001, 0.675, P=0.030), and showed better global functioning and insight (RRR=1.082; 95% CI=1.020, 1.148; P=0.009). Those with a minimal post-onset IQ decline also showed higher levels of manic symptoms (RRR=8.213; 95% CI=1.042, 64.750, P=0.046).\nSchizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia?",
        "answer": "yes",
        "answer_rationale": "These findings provide evidence for the existence of a high-IQ variant of schizophrenia that is associated with markedly fewer negative symptoms than typical schizophrenia, and lends support to the idea of a psychosis spectrum or continuum over boundaried diagnostic categories.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether schizophrenia patients with high intelligence represent a clinically distinct subtype of schizophrenia based on the study described.\n\nFirst, I need to recall what the study found. The study compared high pre-morbid IQ schizophrenia patients (mean IQ 120) with typical IQ patients. The key results were that the high-IQ group had lower negative and disorganized symptoms, better global functioning, and better insight. Additionally, those with minimal IQ decline had more manic symptoms.\n\nThe question is whether these differences indicate a distinct subtype. The options are yes, no, or maybe. \n\nIn psychiatry, a distinct subtype would require consistent and significant differences in symptoms, course, or response to treatment. The study shows that high-IQ patients have different symptom profiles (lower negative/disorganized symptoms, more manic symptoms in some), and better functioning. These are notable differences. However, the study's sample size is small (29 patients), and the confidence intervals for some results (like the manic symptoms) are quite wide (e.g., 1.042 to 64.750), which might indicate less statistical power. Also, the study uses multinomial logistic regression, but the interpretation here is about whether these differences are enough to classify them as a distinct subtype. \n\nThe fact that their symptoms are different in key areas (less negative symptoms, better insight) might suggest they are a different subtype. However, the question is whether the evidence from this study is sufficient to conclude that. The study's results are statistically significant, but the sample size is small. Also, the presence of manic symptoms in some might suggest a possible overlap with schizoaffective disorder, but the question is about schizophrenia subtypes. \n\nThe answer options are yes, no, maybe. The study's findings do support that there are clinical differences, so the answer might lean towards \"yes\". But since the question is about whether they are a \"clinically distinct subtype\", and given that the study's results are significant but perhaps not definitive (especially with a small sample), maybe \"maybe\" is the cautious answer. However, the question is phrased as \"A clinically distinct sub-type of schizophrenia?\" based on the study's findings. Since the study found significant differences in symptoms and functioning, the answer might be \"yes\". But I need to check the options again. The options are (A) yes, (B) no, (C) maybe. The study's results do show",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 441,
            "completion_tokens": 512
        },
        "time_elapsed": 5.934287071228027
    },
    {
        "realidx": "25752912",
        "question": "To compare the probability of prenatal diagnosis (PND) and termination of pregnancy for fetal anomaly (TOPFA) between fetuses conceived by assisted reproductive techniques (ART) and spontaneously-conceived fetuses with congenital heart defects (CHD).\nPopulation-based observational study.\nParis and surrounding suburbs.\nFetuses with CHD in the Paris registry of congenital malformations and cohort of children with CHD (Epicard).\nComparison of ART-conceived and spontaneously conceived fetuses taking into account potential confounders (maternal characteristics, multiplicity and year of birth or TOPFA).\nProbability and gestational age at PND and TOPFA for ART-conceived versus spontaneously conceived fetuses.\nThe probability of PND (28.1% versus 34.6%, P = 0.077) and TOPFA (36.2% versus 39.2%, P = 0.677) were not statistically different between ART-conceived (n = 171) and spontaneously conceived (n = 4620) fetuses. Estimates were similar after adjustment for potential confounders. Gestational age at PND tended to be earlier for ART fetuses (23.1 versus 24.8 weeks, P = 0.05) but no statistical difference was found after adjustment for confounders. Gestational age at TOPFA was comparable between ART-conceived and spontaneously conceived fetuses.\nIs the probability of prenatal diagnosis or termination of pregnancy different for fetuses with congenital anomalies conceived following assisted reproductive techniques?",
        "answer": "no",
        "answer_rationale": "In our population, ART conception was not significantly associated with the probability of PND or TOPFA for CHD. One implication of our results is that live births may be adequate for assessing the overall risk of CHD related to ART. However, total prevalence, in particular of severe CHD, would not be adequately assessed if TOPFA are not included.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the probability of prenatal diagnosis (PND) or termination of pregnancy for fetal anomaly (TOPFA) is different between fetuses conceived via assisted reproductive techniques (ART) and those conceived spontaneously, specifically for those with congenital heart defects (CHD).\n\nLooking at the provided study details: The study compared 171 ART-conceived fetuses with 4620 spontaneously conceived ones. The key results are the percentages for PND: 28.1% vs 34.6%, with a p-value of 0.077. For TOPFA, it's 36.2% vs 39.2%, p=0.677. Both p-values are above the typical 0.05 threshold for statistical significance. The study also mentions that after adjusting for confounders, the estimates remained similar. Additionally, the gestational age at PND had a p-value of 0.05 before adjustment but wasn't significant after adjustment. The TOPFA gestational age was comparable.\n\nThe question is whether there's a statistically significant difference. Since both p-values for PND and TOPFA probabilities are not significant (p=0.077 and 0.677), the answer would be that there's no difference. The options are (A) yes, (B) no, (C) maybe. The correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 414,
            "completion_tokens": 307
        },
        "time_elapsed": 3.69336199760437
    },
    {
        "realidx": "25756710",
        "question": "To validate a clinical diagnostic tool, used by emergency physicians (EPs), to diagnose the central cause of patients presenting with vertigo, and to determine interrater reliability of this tool.\nA convenience sample of adult patients presenting to a single academic ED with isolated vertigo (i.e. vertigo without other neurological deficits) was prospectively evaluated with STANDING (SponTAneousNystagmus, Direction, head Impulse test, standiNG) by five trained EPs. The first step focused on the presence of spontaneous nystagmus, the second on the direction of nystagmus, the third on head impulse test and the fourth on gait. The local standard practice, senior audiologist evaluation corroborated by neuroimaging when deemed appropriate, was considered the reference standard. Sensitivity and specificity of STANDING were calculated. On the first 30 patients, inter-observer agreement among EPs was also assessed.\nFive EPs with limited experience in nystagmus assessment volunteered to participate in the present study enrolling 98 patients. Their average evaluation time was 9.9 \u00b1 2.8\u2009min (range 6-17). Central acute vertigo was suspected in 16 (16.3%) patients. There were 13 true positives, three false positives, 81 true negatives and one false negative, with a high sensitivity (92.9%, 95% CI 70-100%) and specificity (96.4%, 95% CI 93-38%) for central acute vertigo according to senior audiologist evaluation. The Cohen's kappas of the first, second, third and fourth steps of the STANDING were 0.86, 0.93, 0.73 and 0.78, respectively. The whole test showed a good inter-observer agreement (k = 0.76, 95% CI 0.45-1).\nCan emergency physicians accurately and reliably assess acute vertigo in the emergency department?",
        "answer": "yes",
        "answer_rationale": "In the hands of EPs, STANDING showed a good inter-observer agreement and accuracy validated against the local standard of care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether emergency physicians can accurately and reliably assess acute vertigo in the ED based on the study provided.\n\nFirst, I need to look at the study details. The study validated the STANDING tool used by five EPs with limited experience. The key metrics here are sensitivity and specificity. The results show a high sensitivity of 92.9% and specificity of 96.4%, which are both very good. That suggests the tool is accurate in diagnosing central vertigo.\n\nThen there's the interrater reliability, measured by Cohen's kappa. The kappas for each step were 0.86, 0.93, 0.73, 0.78, and the overall was 0.76. Kappa values above 0.6 are generally considered good agreement, and these are all in the substantial or almost perfect range. The overall 0.76 is solid, indicating good reliability among the EPs.\n\nThe question is whether EPs can do this accurately and reliably. The study's results support both accuracy (high sensitivity/specificity) and reliability (good kappa scores). The fact that even those with limited experience achieved this suggests that with training, they can. The answer should be yes, so option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 523,
            "completion_tokens": 278
        },
        "time_elapsed": 4.00756311416626
    },
    {
        "realidx": "25779009",
        "question": "There is no standard protocol for the evaluation of antiseptics used for skin and mucous membranes in the presence of interfering substances. Our objective was to suggest trial conditions adapted from the NF EN 13727 standard, for the evaluation of antiseptics used in gynecology and dermatology.\nThree antiseptic solutions were tested in vitro: a chlorhexidine-benzalkonium (CB) combination, a hexamidine-chlorhexidine-chlorocresol (HCC) combination, and povidone iodine (P). The adaptation of trial conditions to the standard involved choosing dilutions, solvent, and interfering substances. The activity of solutions was assessed on the recommended strains at concentrations of 97% (pure solution), 50%, and 10% (diluted solution), and 1%. A logarithmic reduction \u2265 5 was expected after 60seconds of contact, to meet requirements of bactericidal activity.\nHCC did not present any bactericidal activity except on P. aeruginosa at a concentration of 97%. P was not bactericidal on E. hirae at any concentration and on S. aureus at 97%. CB had the most homogeneous bactericidal activity with a reduction>5 log on the 4 bacterial strains at concentrations of 97%, 50% and 10%.\nBactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?",
        "answer": "maybe",
        "answer_rationale": "Adapting the NF EN 13727 standard allowed assessing the 3 tested solutions: only CB was bactericidal in dirty conditions. This study proved the possibility of validating antiseptic choice in vitro, in current practice conditions, for adjunctive treatment of skin and mucous membranes disorders, primarily of bacterial origin or with a potential of superinfection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the study's findings suggest an improvement to the NF EN 13727 European Standard. The options are yes, no, or maybe.\n\nFirst, I need to recall what the question and the study's objective were. The objective was to suggest trial conditions adapted from the NF EN 13727 standard for evaluating antiseptics in gynecology and dermatology. The study tested three antiseptic solutions under different concentrations and looked at their bactericidal activity with interfering substances.\n\nThe key points from the results: \n\n- HCC only worked on P. aeruginosa at 97% concentration.\n- Povidone iodine (P) wasn't effective on E. hirae at any concentration and S. aureus at 97%.\n- CB (chlorhexidine-benzalkonium) was the most consistent, showing >5 log reduction on all four strains even at 10% concentration.\n\nThe question is whether these results indicate an improvement to the standard. The original standard (NF EN 13727) might have certain criteria, but the study adapted the conditions (like dilutions, solvents, interfering substances) to better suit gynecological and dermatological uses. Since the current standard doesn't have a protocol for these specific uses with interfering substances, the study's adapted conditions allowed them to evaluate the antiseptics more appropriately. \n\nThe fact that they found variability in effectiveness (like HCC and P not meeting the 5 log reduction except in specific cases) suggests that the original standard's conditions might not be sufficient for these specific antiseptics or use cases. The CB's performance under diluted conditions shows that adjusting the test conditions (like lower concentrations) is important. Therefore, the adaptations they made (which are part of improving the standard) would lead to better evaluation methods. \n\nSince the study's purpose was to suggest improved trial conditions based on their findings, the answer should be \"yes\" because they demonstrated that modifying the standard's conditions (like using different concentrations and considering interfering substances) provides a more accurate assessment, thus improving the standard.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 418,
            "completion_tokens": 451
        },
        "time_elapsed": 6.477134466171265
    },
    {
        "realidx": "25793749",
        "question": "Although the Internet is commonly used to recruit samples in studies of human immunodeficiency virus (HIV)-related risk behaviors, it has not been used to measure patient-reported well-being. As the burden of long-term chronic HIV infection rises, the Internet may offer enormous potential for recruitment to research and interventions.\nThis study aimed to compare two samples of gay men living with HIV, one recruited via the Web and the other recruited in outpatient settings, in terms of self-reported physical and psychological symptom burden.\nThe Internet sample was recruited from a UK-wide Web-based survey of gay men with diagnosed HIV. Of these, 154 respondents identified themselves as resident in London and were included in this analysis. The HIV clinic sample was recruited from five HIV outpatient clinics. Of these participants, 400 gay men recruited in London clinics were included in this analysis.\nThe Web-based sample was younger than the clinic sample (37.3 years, SD 7.0 vs 40.9 years, SD 8.3), more likely to be in paid employment (72.8%, 99/136 vs 60.1%, 227/378), less likely to be on antiretroviral therapy (ART) (58.4%, 90/154 vs 68.0%, 266/391), and had worse mean psychological symptom burden compared to the clinic sample (mean scores: 1.61, SD 1.09 vs 1.36, SD 0.96) but similar physical symptom burden (mean scores: 0.78, SD 0.65 vs 0.70, SD 0.74). In multivariable logistic regression, for the physical symptom burden model, adjusted for age, ethnicity, employment status, and ART use, the recruitment setting (ie, Web-based vs clinic) was not significantly associated with high physical symptom score. The only variable that remained significantly associated with high physical symptom score was employment status, with those in employment being less likely to report being in the upper (worst) physical symptom tertile versus the other two tertiles (adjusted OR 0.41, 95% CI 0.28-0.62, P<.001). For the psychological symptom burden model, those recruited via the Web were significantly more likely to report being in the upper (worst) tertile (adjusted OR 2.20, 95% CI 1.41-3.44, P=.001). In addition, those in employment were less likely to report being in the upper (worst) psychological symptom tertile compared to those not in employment (adjusted OR 0.32, 95% CI 0.21-0.49, P<.001).\nDo Web-based and clinic samples of gay men living with HIV differ on self-reported physical and psychological symptoms?",
        "answer": "maybe",
        "answer_rationale": "Our data have revealed a number of differences. Compared to the clinic sample, the Web-based sample had worse psychological symptom burden, younger average age, higher prevalence of employment, and a lower proportion on ART. For future research, we recommend that Web-based data collection should include the demographic variables that we note differed between samples. In addition, we recognize that each recruitment method may bring inherent sampling bias, with clinic populations differing by geographical location and reflecting those accessing regular medical care, and Web-based sampling recruiting those with greater Internet access and identifying survey materials through specific searches and contact with specific websites.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Web-based and clinic samples of gay men with HIV differ in self-reported physical and psychological symptoms. The options are yes, no, or maybe.\n\nFirst, I need to look back at the study details provided. The study compared two groups: one recruited online and the other from clinics. The key results mentioned are about their physical and psychological symptom burdens. \n\nThe physical symptom burden had a mean of 0.78 (SD 0.65) for the Web group versus 0.70 (SD 0.74) for the clinic group. The text says that in the multivariable model, recruitment setting (Web vs clinic) wasn't significantly associated with high physical symptoms. The only significant factor there was employment status. So for physical symptoms, the answer might be no difference because the setting didn't matter after adjusting variables.\n\nBut for psychological symptoms, the Web group had a higher mean (1.61 vs 1.36). The logistic regression showed that being in the Web sample was significantly associated with higher psychological symptom tertile (OR 2.20). So here, there is a difference. \n\nThe question asks if they differ on either or both. Since psychological symptoms do differ, the answer should be yes. The physical part doesn't show a difference when adjusted, but psychological does. So overall, the answer is yes (A). The options are (A) yes, so that's the correct choice.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 718,
            "completion_tokens": 314
        },
        "time_elapsed": 4.453662633895874
    },
    {
        "realidx": "25810292",
        "question": "Traditional resectional techniques and chordal transfer are difficult to apply in video-assisted mitral valve repair. Using artificial chords appears easier in this setting. The purpose of this study was to review the effectiveness and reproducibility of neochordal repair as a routine approach to minimally invasive mitral repair, and to assess the stability of neochord implantation using the figure-of-eight suture without pledgets in this setting.\nThis is a retrospective review of all patients who underwent minimally invasive video-assisted mitral valve repair from 2008 to 2013. The primary endpoints were recurrent mitral regurgitation and reoperation.\nA total of 426 consecutive patients were included during the study period, with a mean age of 55 \u00b1 18 years. Neochords were used in all patients, and in association with leaflet resection in 47 patients. One patient was not repairable and underwent valve replacement (repair rate, 99.8%). Fifteen patients had Grade I (3.5%) regurgitation, whereas the remainder had none. Patients were fast-tracked, with 25% extubated in the operation theatre and the remainder within 6 h. There were 5 deaths within 30 days (1.2%). Follow-up ranged 3-60 months, during which all of the patients remained with no or trace mitral regurgitation. No de-insertion or rupture of any neochords was found, and no patients required a reoperation.\nIs minimally invasive mitral valve repair with artificial chords reproducible and applicable in routine surgery?",
        "answer": "yes",
        "answer_rationale": "Minimally invasive mitral valve repair using neochords provided a high rate of repair, reproducible results in a routine cardiac surgery setting and stable repair during follow-up. This has become our preferred technique for mitral valve surgery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether minimally invasive mitral valve repair using artificial chords is reproducible and suitable for routine surgery based on the study provided.\n\nFirst, I need to look at the study details. The study is a retrospective review from 2008 to 2013 with 426 patients. The key points here are the primary endpoints: recurrent mitral regurgitation and reoperation. The results show that 99.8% repair rate, which is very high. Most patients had no or minimal regurgitation (Grade I in 3.5%). There were 5 deaths (1.2%), but the follow-up showed no need for reoperation and no chord issues. \n\nThe question is about reproducibility and routine application. The study's outcomes seem positive: high success rate, low complications, and no need for reoperations. The fact that they used neochords in all patients and had good results suggests that the technique is feasible. The authors probably conclude that it's effective and reproducible since they didn't encounter issues like chord de-insertion or rupture. The options are yes, no, maybe. The data supports \"yes\" because the study's results indicate success and stability over time. The high repair rate and lack of reoperations point towards it being applicable in routine surgery. So the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 429,
            "completion_tokens": 291
        },
        "time_elapsed": 4.2065749168396
    },
    {
        "realidx": "25887165",
        "question": "Patients usually complain about numbness in the nasal tip after microfat injections. The present study evaluated the severity of the numbness in the nasal tip after the procedure.\nTo address the research question, a prospective study of young women was designed and performed at the Beijing Anzhen Hospital. Time was the primary predictor variable. The nasal tip sensation, which was evaluated using objective and subjective assessments, was used as the primary outcome variable. The McNemar-Bowker test (time vs nasal tip sensation) was used to detect statistical significance.\nA total of 30 young women (age 20.04 \u00b1 3.63 years) were recruited for the present study. The preoperative mean touch threshold value was 3.60 units. One week after the injection, the women experienced a decrease in the touch threshold value by 2.50 units. However, the sensation recovered gradually during the follow-up period (1.51 units at week 2, 2.39 units at week 4, 3.01 units at week 8, and 3.35 units at week 12). Significant differences were detected between multiple different measurement points (P<.05). The percentage of those experiencing paresthesia after the microfat injections also gradually diminished to none.\nDoes Sensation Return to the Nasal Tip After Microfat Grafting?",
        "answer": "yes",
        "answer_rationale": "Postoperative numbness occurs in most patients receiving nasal microfat injections. Partial to complete recovery of nasal tip sensation can be expected to occur over a 3-month period.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether sensation returns to the nasal tip after microfat grafting based on the provided study.\n\nFirst, I need to look at the details given. The study followed 30 young women who had microfat injections. They measured the touch threshold, which is an objective measure of sensation. The preoperative mean was 3.60 units. Right after the procedure (one week), the touch threshold dropped to 2.50, which means lower sensation (numbness). But then, over time, the values went up again: 1.51 at week 2, 2.39 at 4 weeks, 3.01 at 8 weeks, and 3.35 at 12 weeks. The study mentions that the sensation recovered gradually. Also, the paresthesia (abnormal sensation) percentages decreased to none.\n\nThe key here is that the touch threshold is returning closer to the original value over time. By week 12, it's 3.35, which is close to the original 3.60. The study also says there were significant differences between measurement points, but since the trend is recovery, that suggests that sensation does come back. The answer should be yes, so option A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 378,
            "completion_tokens": 276
        },
        "time_elapsed": 3.7920801639556885
    },
    {
        "realidx": "25940336",
        "question": "More than 1000 candidates applied for orthopaedic residency positions in 2014, and the competition is intense; approximately one-third of the candidates failed to secure a position in the match. However, the criteria used in the selection process often are subjective and studies have differed in terms of which criteria predict either objective measures or subjective ratings of resident performance by faculty.QUESTIONS/\nDo preresidency selection factors serve as predictors of success in residency? Specifically, we asked which preresidency selection factors are associated or correlated with (1) objective measures of resident knowledge and performance; and (2) subjective ratings by faculty.\nCharts of 60 orthopaedic residents from our institution were reviewed. Preresidency selection criteria examined included United States Medical Licensing Examination (USMLE) Step 1 and Step 2 scores, Medical College Admission Test (MCAT) scores, number of clinical clerkship honors, number of letters of recommendation, number of away rotations, Alpha Omega Alpha (AOA) honor medical society membership, fourth-year subinternship at our institution, and number of publications. Resident performance was assessed using objective measures including American Board of Orthopaedic Surgery (ABOS) Part I scores and Orthopaedics In-Training Exam (OITE) scores and subjective ratings by faculty including global evaluation scores and faculty rankings of residents. We tested associations between preresidency criteria and the subsequent objective and subjective metrics using linear correlation analysis and Mann-Whitney tests when appropriate.\nObjective measures of resident performance namely, ABOS Part I scores, had a moderate linear correlation with the USMLE Step 2 scores (r = 0.55, p<0.001) and number of clinical honors received in medical school (r = 0.45, p<0.001). OITE scores had a weak linear correlation with the number of clinical honors (r = 0.35, p = 0.009) and USMLE Step 2 scores (r = 0.29, p = 0.02). With regards to subjective outcomes, AOA membership was associated with higher scores on the global evaluation (p = 0.005). AOA membership also correlated with higher global evaluation scores (r = 0.60, p = 0.005) with the strongest correlation existing between AOA membership and the \"interpersonal and communication skills\" subsection of the global evaluations.\nDoes Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency?",
        "answer": "yes",
        "answer_rationale": "We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether preresidency selection criteria predict performance in an orthopaedic surgery residency. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study reviewed 60 residents' charts and looked at various selection factors like USMLE scores, MCAT, clerkship honors, etc. They checked both objective measures (like ABOS Part I and OITE scores) and subjective ones (global evaluations, faculty rankings).\n\nThe results mentioned that ABOS Part I had a moderate correlation with USMLE Step 2 and clinical honors. OITE had weak correlations with clinical honors and Step 2. For subjective outcomes, AOA membership was linked to higher global eval scores, especially in communication skills. \n\nSo, the study found some statistically significant correlations. The question is whether these findings answer the main question: do the selection factors predict residency performance? Since there are moderate and weak correlations, even if some are small, the answer would be yes, because they do show associations. The fact that some factors like Step 2 and clinical honors correlate with objective measures, and AOA with subjective ones, indicates that the selection criteria do have predictive value. Therefore, the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 613,
            "completion_tokens": 266
        },
        "time_elapsed": 3.387293577194214
    },
    {
        "realidx": "25986020",
        "question": "Adoption and implementation of evidence-based measures for catheter care leads to reductions in central line-associated bloodstream infection (CLABSI) rates in the NICU. The purpose of this study is to evaluate whether this rate reduction is sustainable for at least 1 year and to identify key determinants of this sustainability at the NICU of the Floating Hospital for Children at Tufts Medical Center.\nWe reviewed the incidence of CLABSIs in the NICU temporally to the implementation of new practice policies and procedures, from July 2008 to December 2013.\nAdoption of standardized care practices, including bundles and checklists, was associated with a significant reduction of the CLABSI rate to zero for>370 consecutive days in our NICU in 2012. Overall, our CLABSI rates decreased from 4.1 per 1000 line days in 2009 (13 infections; 3163 line days) to 0.94 in 2013 (2 infections; 2115 line days), which represents a 77% reduction over a 5-year period. In the first quarter of 2013, there was a brief increase in CLABSI rate to 3.3 per 1000 line days; after a series of interventions, the CLABSI rate was maintained at zero for>600 days. Ongoing training, surveillance, and vigilance with catheter insertion and maintenance practices and improved documentation were identified as key drivers for success.\nIs zero central line-associated bloodstream infection rate sustainable?",
        "answer": "yes",
        "answer_rationale": "High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether a zero central line-associated bloodstream infection (CLABSI) rate is sustainable based on the provided study.\n\nFirst, I need to look at the details given in the study. The key points are that after implementing evidence-based measures like bundles and checklists, the CLABSI rate dropped to zero for over 370 days in 2012. Then, by 2013, the rate was 0.94, which is a 77% reduction from 2009. However, there was a brief increase in early 2013 to 3.3, but after interventions, they got it back to zero for over 600 days. The study also mentions that ongoing training, surveillance, and documentation were key factors.\n\nThe question is whether zero is sustainable. The study shows that after the initial drop to zero, there was a temporary increase, but they managed to bring it back down and maintain it for even longer (600 days). The fact that they had to implement more interventions suggests that maintaining zero requires continuous effort. However, the study's conclusion states that with those ongoing measures, they succeeded. The answer options are yes, no, maybe.\n\nThe study's results indicate that they did sustain zero after addressing the temporary rise. The key drivers mentioned (training, surveillance, etc.) imply that with these in place, sustainability is possible. So the answer should be (A) yes. The temporary increase doesn't negate the sustainability because they recovered from it through their strategies. The question is about whether it's sustainable, and the study's outcome shows that it can be maintained over a year and beyond with the right measures.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 425,
            "completion_tokens": 362
        },
        "time_elapsed": 4.405804872512817
    },
    {
        "realidx": "26037986",
        "question": "Emergency surgery is associated with poorer outcomes and higher mortality with recent studies suggesting the 30-day mortality to be 14-15%. The aim of this study was to analyse the 30-day mortality, age-related 30-day mortality and 1-year mortality following emergency laparotomy. We hope this will encourage prospective data collection, improvement of care and initiate strategies to establish best practice in this area.\nThis was a retrospective study of patients who underwent emergency laparotomy from June 2010 to May 2012. The primary end point of the study was 30-day mortality, age-related 30-day mortality and 1-year all-cause mortality.\n477 laparotomies were performed in 446 patients. 57% were aged<70 and 43% aged>70 years. 30-day mortality was 12, 4% in those aged<70 years and 22% in those>70 years (p<0.001). 1-year mortality was 25, 15% in those aged under 70 years and 38% in those aged>70 years (p<0.001).\n30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement?",
        "answer": "maybe",
        "answer_rationale": "Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user provided a study about emergency laparotomy outcomes. The question is whether 30-day and 1-year mortality in these surgeries are areas of concern needing improvement. The options are yes, no, maybe.\n\nFirst, I need to look at the data given. The study had 446 patients with 477 laparotomies. The 30-day mortality was 12.4% for under 70 and 22% for over 70. The 1-year mortality was 25.15% (maybe that's a typo, perhaps 25.1% or 25.15? Not sure, but the exact number might not matter here) for under 70 and 38% for over 70. Both differences are statistically significant (p<0.001). \n\nThe question is asking if these mortality rates are a concern and if improvement is needed. The study's aim was to analyze these mortalities to encourage better care and strategies. The results show higher mortality, especially in the older group. The 30-day rate is around 12-22%, which aligns with the mentioned 14-15% in the intro, but the 1-year is even higher. Since the study's own results show significant mortality, especially in older patients, and they mention the aim is to improve care, the answer would likely be \"yes\" it's a concern needing improvement. The options are A, B, C. So the correct answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 339
        },
        "time_elapsed": 4.117355108261108
    },
    {
        "realidx": "26113007",
        "question": "Orthodontic patients show high prevalence of tooth-size discrepancy. This study investigates the possible association between arch form, clinically significant tooth-size discrepancy, and sagittal molar relationship.\nPretreatment orthodontic casts of 230 Saudi patients were classified into one of three arch form types (tapered, ovoid, and square) using digitally scanned images of the mandibular arches. Bolton ratio was calculated, sagittal molar relationship was defined according to Angle classification, and correlations were analyzed using ANOVA, chi-square, and t-tests.\nNo single arch form was significantly more common than the others. Furthermore, no association was observed between the presence of significant Bolton discrepancy and the sagittal molar relationship or arch form. Overall Bolton discrepancy is significantly more prevalent in males.\nIs arch form influenced by sagittal molar relationship or Bolton tooth-size discrepancy?",
        "answer": "no",
        "answer_rationale": "Arch form in a Saudi patient group is independent of gender, sagittal molar relationship, and Bolton discrepancy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether arch form is influenced by sagittal molar relationship or Bolton tooth-size discrepancy. The study mentioned here looked at 230 Saudi orthodontic patients. They classified the arch forms into tapered, ovoid, and square. They also checked Bolton ratios, molar relationships (using Angle classification), and used statistical tests like ANOVA and chi-square.\n\nThe key results from the study, as stated, are that no single arch form was significantly more common. Also, there was no association found between Bolton discrepancy and the sagittal molar relationship or the arch form. Additionally, they noted that Bolton discrepancy is more prevalent in males. \n\nThe question is specifically about whether arch form is influenced by the sagittal molar relationship or Bolton discrepancy. Since the study found no association between arch form and either of those factors, the answer should be that there's no influence. The options are (A) yes, (B) no, (C) maybe. The correct answer here would be B, no, because the study didn't find any link. The fact that they checked using appropriate statistical methods and found no significant association supports that conclusion. The mention of Bolton discrepancy being more in males is a separate point but doesn't affect the arch form question. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 267,
            "completion_tokens": 277
        },
        "time_elapsed": 4.016109466552734
    },
    {
        "realidx": "26126304",
        "question": "To compare in vitro fertilization (IVF) outcomes in low responders stimulated with microdose leuprolide protocol (ML) following pretreatment with either oral contraceptive pill (OCP) or luteal estradiol (E2) + GnRH antagonist (E2 + antag) for follicular synchronization prior to controlled ovarian hyperstimulation (COH).\nThis was a retrospective study of 130 women, who were poor responders, undergoing IVF with either OCP/ML or E2+ antag/ML protocols. The main outcome measures were ongoing pregnancy rates, number of oocytes retrieved, and cancellation rate.\nBoth groups were similar in baseline characteristics. There were no significant differences in gonadotropin requirement, cancellation rate, and number of embryos transferred. Ongoing pregnancy rates (40% vs. 15%) were significantly higher in the OCP/ML group. Trends toward greater number of oocytes retrieved (7.7 \u00b1 3.4 vs. 5.9 \u00b1 4.2) and improved implantation rates (20% vs. 12%) were also noted, but these did not reach statistical significance.\nEstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?",
        "answer": "no",
        "answer_rationale": "E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing two protocols for IVF in poor responders: OCP/ML versus E2 + antag/ML. The main outcomes were ongoing pregnancy rates, oocytes retrieved, and cancellation rate.\n\nThe results say that the OCP/ML group had a significantly higher ongoing pregnancy rate (40% vs 15%). The number of oocytes and implantation rates were better in OCP/ML but not statistically significant. The cancellation rate and other factors were similar. \n\nThe question is asking if using E2 and antagonist pretreatment (the E2 + antag group) improves outcomes compared to OCP. Since the OCP group did better in pregnancy rates, which is a key outcome, the answer would be that E2 + antagonist doesn't improve outcomes. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 181
        },
        "time_elapsed": 2.4127871990203857
    },
    {
        "realidx": "26134053",
        "question": "Outcome feedback is the process of learning patient outcomes after their care within the emergency department. We conducted a national survey of Canadian Royal College emergency medicine (EM) residents and program directors to determine the extent to which active outcome feedback and follow-up occurred. We also compared the perceived educational value of outcome feedback between residents and program directors.\nWe distributed surveys to all Royal College-accredited adult and pediatric EM training programs using a modified Dillman method. We analyzed the data using student's t-test for continuous variables and Fisher's exact test for categorical variables.\nWe received 210 completed surveys from 260 eligible residents (80.8%) and 21 of 24 program directors (87.5%) (overall 81.3%). Mandatory active outcome feedback was not present in any EM training program for admitted or discharged patients (0/21). Follow-up was performed electively by 89.4% of residents for patients admitted to the hospital, and by 44.2% of residents for patients discharged home. A majority of residents (76.9%) believed that patient follow-up should be mandatory compared to 42.9% of program directors (p=0.002). The perceived educational value of outcome feedback was 5.8/7 for residents and 5.1/7 for program directors (difference 0.7; p=0.002) based on a seven-point Likert scale (1=not important; 7=very important).\nOutcome Feedback within Emergency Medicine Training Programs: An Opportunity to Apply the Theory of Deliberate Practice?",
        "answer": "maybe",
        "answer_rationale": "While Canadian EM training programs do not mandate follow-up, it is performed electively by the majority of residents surveyed. Residents place a significantly greater educational value on outcome feedback than their program directors, and believe that follow-up should be a mandatory component of EM residencies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether outcome feedback in EM training programs is an opportunity to apply the Theory of Deliberate Practice. The options are yes, no, maybe.\n\nFirst, I need to recall what the Theory of Deliberate Practice entails. From what I remember, deliberate practice involves activities designed to improve performance, often through targeted, repetitive exercises with feedback. The key elements are clear goals, immediate feedback, and repeated attempts to improve.\n\nLooking at the study's findings: The survey shows that currently, no programs have mandatory outcome feedback. Residents mostly do follow-up on their own, and they strongly believe it should be mandatory. They also rate the educational value higher than program directors. The p-values indicate statistically significant differences in both the belief that follow-up should be mandatory and the perceived educational value.\n\nThe question is whether this scenario presents an opportunity to apply deliberate practice. Since deliberate practice emphasizes structured feedback for improvement, and the study points out that such feedback isn't currently mandatory but is seen as valuable by residents, it suggests that implementing systematic outcome feedback could align with deliberate practice principles. The title of the study itself seems to pose this as a question, implying that there's potential here. The data shows that there's a gap (no current mandate) and that residents see value, so applying deliberate practice methods here would make sense. Therefore, the answer is likely \"yes\" because the study highlights an opportunity where deliberate practice could be applied by instituting mandatory outcome feedback, which residents support and find educational.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 424,
            "completion_tokens": 316
        },
        "time_elapsed": 3.850430965423584
    },
    {
        "realidx": "26163474",
        "question": "Sublingual varices have earlier been related to ageing, smoking and cardiovascular disease. The aim of this study was to investigate whether sublingual varices are related to presence of hypertension.\nIn an observational clinical study among 431 dental patients tongue status and blood pressure were documented. Digital photographs of the lateral borders of the tongue for grading of sublingual varices were taken, and blood pressure was measured. Those patients without previous diagnosis of hypertension and with a noted blood pressure \u2265 140 mmHg and/or \u2265 90 mmHg at the dental clinic performed complementary home blood pressure during one week. Those with an average home blood pressure \u2265 135 mmHg and/or \u2265 85 mmHg were referred to the primary health care centre, where three office blood pressure measurements were taken with one week intervals. Two independent blinded observers studied the photographs of the tongues. Each photograph was graded as none/few (grade 0) or medium/severe (grade 1) presence of sublingual varices. Pearson's Chi-square test, Student's t-test, and multiple regression analysis were applied. Power calculation stipulated a study population of 323 patients.\nAn association between sublingual varices and hypertension was found (OR = 2.25, p<0.002). Mean systolic blood pressure was 123 and 132 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.0001, CI 95 %). Mean diastolic blood pressure was 80 and 83 mmHg in patients with grade 0 and grade 1 sublingual varices, respectively (p<0.005, CI 95 %). Sublingual varices indicate hypertension with a positive predictive value of 0.5 and a negative predictive value of 0.80.\nIs there a connection between sublingual varices and hypertension?",
        "answer": "yes",
        "answer_rationale": "An association was found between sublingual varices and hypertension. Examining the lateral borders of the tongue is easily done, causes no harm and could be a valuable method for the dental profession to take active part in preventive healthcare.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a connection between sublingual varices and hypertension based on the provided study.\n\nFirst, I need to recall the details from the study description. The study was observational with 431 dental patients. They checked for sublingual varices via photos and measured blood pressure. They even had a follow-up with home monitoring and then referrals for confirmation. The key results mentioned are the OR of 2.25 with a p-value less than 0.002, which is statistically significant. Also, the mean systolic and diastolic pressures were higher in those with grade 1 varices, both with significant p-values. The positive predictive value was 0.5 and negative predictive value 0.80. \n\nThe question is straightforward: does the study show a connection? The OR being over 2 suggests that having sublingual varices increases the odds of hypertension. The p-values are below the typical 0.05 threshold, so the association is statistically significant. The higher mean BP in the group with varices also supports this. Even though predictive values are given, the main point here is the association found. The answer should be yes, so option A. I need to make sure there's no confounding factors mentioned that might weaken the conclusion, but the study used multiple regression, which adjusts for variables. The power calculation was met since they had over the required 323 participants. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 508,
            "completion_tokens": 317
        },
        "time_elapsed": 4.030564785003662
    },
    {
        "realidx": "26200172",
        "question": "In recent years, biofeedback has become increasingly popular for its proven success in peak performance training - the psychophysiological preparation of athletes for high-stakes sport competitions, such as the Olympic games. The aim of this research was to test whether an 8-week period of exposure to biofeedback training could improve the psychophysiological control over competitive anxiety and enhance athletic performance in participating subjects.\nParticipants of this study were highly competent athletes, each training in different sport disciplines. The experimental group consisted of 18 athletes (4 women, 14 men), whereas the Control group had 21 athletes (4 women, 17 men). All athletes were between 16 and 34 years old. The biofeedback device, Nexus 10, was used to detect and measure the psychophysiological responses of athletes. Athletes from both groups (control and experimental) were subjected to stress tests at the beginning of the study and once again at its conclusion. In between, the experimental group received training in biofeedback techniques. We then calculated the overall percentage of athletes in the experimental group compared with those in the control group who were able to control respiration, skin conductance, heart rate, blood flow amplitude, heart rate variability, and heart respiration coherence. One year following completion of the initial study, we questioned athletes from the experimental group, to determine whether they continued to use these skills and if they could detect any subsequent enhancement in their athletic performance.\nWe demonstrated that a greater number of participants in the experimental group were able to successfully control their psychophysiological parameters, in comparison to their peers in the control group. Significant results (p<0.05) were noted in regulation of GSR following short stress test conditions (p = 0.037), in regulation of HR after exposure to STROOP stressor (p = 0.037), in regulation of GSR following the Math and GSR stressors (p = 0.033, p = 0.409) and in achieving HR - breathing coherence following the math stressor (p = 0.042).\nCan biofeedback training of psychophysiological responses enhance athletes' sport performance?",
        "answer": "yes",
        "answer_rationale": "One year following completion of the training program, all participants from the experimental group indicated that they were still using the biofeedback - psycho-regulation skills. Furthermore, these participants uniformly reported believing that these skills had enhanced their athletic performance and general well-being.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether biofeedback training can enhance athletes' sport performance based on the provided study.\n\nFirst, I need to recall the details from the study. The study had two groups: experimental and control. The experimental group received 8 weeks of biofeedback training. Both groups underwent stress tests before and after. The results showed that the experimental group had significant improvements in controlling parameters like GSR, HR, and coherence, with p-values below 0.05, which is statistically significant. Also, they mentioned that more participants in the experimental group could control their psychophysiological parameters compared to the control group. Additionally, when they followed up a year later, the experimental group continued using the skills and noted performance enhancements.\n\nThe question is whether this implies that biofeedback enhances performance. The options are yes, no, maybe. The study's results show statistically significant improvements in the areas measured, which are related to managing stress and anxiety. Since competitive anxiety can hinder performance, better control over these parameters would likely lead to better performance. The follow-up also suggests that athletes felt their performance improved. The answer should be 'yes' because the study's findings support the effectiveness of biofeedback in this context. The p-values are below the threshold, indicating the results aren't due to chance. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 542,
            "completion_tokens": 280
        },
        "time_elapsed": 3.503796339035034
    },
    {
        "realidx": "26209118",
        "question": "Children with sickle cell disease (SCD) are at risk of bone infarcts and acute osteomyelitis. The clinical differentiation between a bone infarct and acute osteomyelitis is a diagnostic challenge. Unenhanced T1-W fat-saturated MR images have been proposed as a potential tool to differentiate bone infarcts from osteomyelitis.\nTo evaluate the reliability of unenhanced T1-W fat-saturated MRI for differentiation between bone infarcts and acute osteomyelitis in children with SCD.\nWe retrospectively reviewed the records of 31 children (20 boys, 11 girls; mean age 10.6 years, range 1.1-17.9 years) with SCD and acute bone pain who underwent MR imaging including unenhanced T1-W fat-saturated images from 2005 to 2010. Complete clinical charts were reviewed by a pediatric hematologist with training in infectious diseases to determine a clinical standard to define the presence or absence of osteomyelitis. A pediatric radiologist reviewed all MR imaging and was blinded to clinical information. Based on the signal intensity in T1-W fat-saturated images, the children were further classified as positive for osteomyelitis (low bone marrow signal intensity) or positive for bone infarct (high bone marrow signal intensity).\nBased on the clinical standard, 5 children were classified as positive for osteomyelitis and 26 children as positive for bone infarct (negative for osteomyelitis). The bone marrow signal intensity on T1-W fat-saturated imaging was not significant for the differentiation between bone infarct and osteomyelitis (P\u2009=\u20090.56). None of the additional evaluated imaging parameters on unenhanced MRI proved reliable in differentiating these diagnoses.\nUtility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell disease -- can it differentiate bone infarcts from acute osteomyelitis?",
        "answer": "no",
        "answer_rationale": "The bone marrow signal intensity on unenhanced T1-W fat-saturated MR images is not a reliable criterion to differentiate bone infarcts from osteomyelitis in children.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether unenhanced fat-suppressed T1-weighted MRI can differentiate bone infarcts from acute osteomyelitis in children with sickle cell disease. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study mentioned here involved 31 children with SCD and acute bone pain. They used MRI with unenhanced T1-W fat-saturated images. The clinical standard determined 5 had osteomyelitis and 26 had bone infarcts. The key result was that the bone marrow signal intensity on those T1-W images wasn't significant for differentiation (P=0.56). Also, none of the other imaging parameters were reliable either.\n\nSo the question is about the utility of that specific MRI technique. The study's conclusion says that the T1-W fat-saturated imaging didn't help tell the difference between the two conditions. Since the p-value is 0.56, which is higher than 0.05, it's not statistically significant. That means there's no significant difference in the signal intensities between the two groups as per this study. Therefore, the answer should be that it's not reliable, so the answer is B) no.\n\nWait, let me make sure I didn't miss anything. The options are (A) yes, (B) no, (C) maybe. The study clearly states that the T1-W images weren't significant, and no other parameters helped. So the correct answer is B. Yeah, that's right. The study's conclusion directly answers the question by saying the utility isn't there. So the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 505,
            "completion_tokens": 356
        },
        "time_elapsed": 4.641362905502319
    },
    {
        "realidx": "26215326",
        "question": "The objective of the study was to determine whether risk of recurrent preterm birth differs based on the clinical presentation of a prior spontaneous preterm birth (SPTB): advanced cervical dilatation (ACD), preterm premature rupture of membranes (PPROM), or preterm labor (PTL).\nThis retrospective cohort study included singleton pregnancies from 2009 to 2014 complicated by a history of prior SPTB. Women were categorized based on the clinical presentation of their prior preterm delivery as having ACD, PPROM, or PTL. Risks for sonographic short cervical length and recurrent SPTB were compared between women based on the clinical presentation of their prior preterm birth. Log-linear regression was used to control for confounders.\nOf 522 patients included in this study, 96 (18.4%) had prior ACD, 246 (47.1%) had prior PPROM, and 180 (34.5%) had prior PTL. Recurrent PTB occurred in 55.2% of patients with a history of ACD compared with 27.2% of those with PPROM and 32.2% with PTL (P = .001). The mean gestational age at delivery was significantly lower for those with a history of ACD (34.0 weeks) compared with women with prior PPROM (37.2 weeks) or PTL (37.0 weeks) (P = .001). The lowest mean cervical length prior to 24 weeks was significantly shorter in patients with a history of advanced cervical dilation when compared with the other clinical presentations.\nDoes the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy?",
        "answer": "yes",
        "answer_rationale": "Patients with a history of ACD are at an increased risk of having recurrent preterm birth and cervical shortening in a subsequent pregnancy compared with women with prior preterm birth associated PPROM or PTL.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether the clinical presentation of a prior spontaneous preterm birth (SPTB) affects the risk of recurrent SPTB in a subsequent pregnancy. The clinical presentations they considered were advanced cervical dilatation (ACD), preterm premature rupture of membranes (PPROM), and preterm labor (PTL).\n\nThe results showed that recurrent preterm birth occurred in 55.2% of those with prior ACD, which is much higher than the 27.2% for PPROM and 32.2% for PTL. The p-value here is 0.001, which is statistically significant. Also, the mean gestational age at delivery was lower for ACD (34 weeks) compared to the others (37 weeks), again significant. The cervical length was also shorter in the ACD group. \n\nSo, since there's a clear difference in recurrence rates based on the prior presentation, the answer should be yes. The study's results support that the clinical presentation does predict the risk. The options are A, B, C, with A being yes. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 459,
            "completion_tokens": 249
        },
        "time_elapsed": 3.836435079574585
    },
    {
        "realidx": "26304701",
        "question": "The effect of preoperative education on anxiety and postoperative outcomes of cardiac surgery patients remains unclear.AIM: The aim of the study was to estimate the effectiveness of a nurse-led preoperative education on anxiety and postoperative outcomes.\nA randomised controlled study was designed. All the patients who were admitted for elective cardiac surgery in a general hospital in Athens with knowledge of the Greek language were eligible to take part in the study. Patients in the intervention group received preoperative education by specially trained nurses. The control group received the standard information by the ward personnel. Measurements of anxiety were conducted on admission-A, before surgery-B and before discharge-C by the state-trait anxiety inventory.\nThe sample consisted of 395 patients (intervention group: 205, control group: 190). The state anxiety on the day before surgery decreased only in the intervention group (34.0 (8.4) versus 36.9 (10.7); P=0.001). The mean decrease in state score during the follow-up period was greater in the intervention group (P=0.001). No significant difference was found in the length of stay or readmission. Lower proportions of chest infection were found in the intervention group (10 (5.3) versus 1 (0.5); P=0.004). Multivariate linear regression revealed that education and score in trait anxiety scale on admission are independent predictors of a reduction in state anxiety.\nCan nurse-led preoperative education reduce anxiety and postoperative complications of patients undergoing cardiac surgery?",
        "answer": "yes",
        "answer_rationale": "Preoperative education delivered by nurses reduced anxiety and postoperative complications of patients undergoing cardiac surgery, but it was not effective in reducing readmissions or length of stay.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether nurse-led preoperative education can reduce anxiety and postoperative complications in cardiac surgery patients based on the study described.\n\nFirst, I need to look at the study details provided. The study was a randomized controlled trial with two groups: intervention (205 patients) and control (190). The intervention group got preoperative education from trained nurses, while the control got standard info from ward staff.\n\nThe key outcomes measured were anxiety (using the state-trait anxiety inventory) at three points: admission, before surgery, and before discharge. The results showed that state anxiety decreased more in the intervention group before surgery (34.0 vs 36.9, p=0.001). The mean decrease in state anxiety over time was also greater in the intervention group (p=0.001). So that's a clear positive effect on anxiety.\n\nFor postoperative outcomes, the study mentions no significant difference in length of stay or readmission. However, there was a lower rate of chest infections in the intervention group (10 vs 1, p=0.004). Wait, actually, looking at the numbers: 10 (5.3%) in control and 1 (0.5%) in intervention. That's a statistically significant lower rate in the intervention group. So that's a reduction in a postoperative complication.\n\nThe regression analysis also found that education and trait anxiety scores were independent predictors of reduced state anxiety. \n\nThe question is whether the education reduces anxiety and complications. The study shows that anxiety was reduced in the intervention group, and complications (specifically chest infections) were lower there too. The answer should be yes (option A). The other options: \"no\" is incorrect because the data supports the positive effect. \"Maybe\" might be considered if results were mixed, but here the anxiety reduction and lower infections are both positive, so \"yes\" is the right choice.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 414,
            "completion_tokens": 410
        },
        "time_elapsed": 7.315927982330322
    },
    {
        "realidx": "26348845",
        "question": "Rapid prescreening (RPS) is one of the quality assurance (QA) methods used in gynecologic cytology. The efficacy of RPS has been previously studied but mostly with respect to squamous lesions; in fact, there has been no study so far specifically looking at the sensitivity of RPS for detecting glandular cell abnormalities.\nA total of 80,565 Papanicolaou (Pap) smears underwent RPS during a 25-month period. A sample was designated as \"review for abnormality\" (R) if any abnormal cells (at the threshold of atypical squamous cells of undetermined significance/atypical glandular cells [AGC]) were thought to be present or was designated as negative (N) if none were detected. Each sample then underwent full screening (FS) and was designated as either R or N and also given a cytologic interpretation.\nThe final cytologic interpretation was a glandular cell abnormality (\u2265AGC) in 107 samples (0.13%); 39 of these (36.4%) were flagged as R on RPS. Twenty-four patients (33.8%) out of 71 who had histologic follow-up were found to harbor a high-grade squamous intraepithelial lesion or carcinoma; 13 of those 24 Pap smears (54.2%) had been flagged as R on RPS. Notably, 11 AGC cases were picked up by RPS only and not by FS and represented false-negative cases; 2 of these showed endometrial adenocarcinoma on histologic follow-up.\nPap smears with glandular cell abnormalities: Are they detected by rapid prescreening?",
        "answer": "yes",
        "answer_rationale": "Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether Pap smears with glandular cell abnormalities are detected by rapid prescreening (RPS). The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided. The study involved 80,565 Pap smears. Out of these, 107 had glandular cell abnormalities (like AGC or worse). The key point here is that 39 of these 107 (which is about 36.4%) were flagged as \"review for abnormality\" (R) during RPS. That means RPS did detect some of them. However, there's also a mention that 11 AGC cases were only found by RPS and not by FS, but those were false negatives in FS. Wait, actually, the wording says \"11 AGC cases were picked up by RPS only and not by FS and represented false-negative cases.\" Hmm, so maybe FS missed them but RPS caught them? Or does \"false-negative\" here refer to something else?\n\nWait, let me parse that again. The 11 cases were picked up by RPS but not by FS. So FS missed them, but RPS found them. So that would mean RPS did detect them. The false-negative part might be referring to FS missing them. The question is about whether RPS detects them. Since 39 out of 107 were flagged by RPS, that's a significant portion. Also, the 11 cases that RPS found but FS didn't, so RPS did detect those. \n\nAdditionally, in the histologic follow-up part, 24 patients had high-grade lesions or carcinoma, and 13 of those had been flagged as R on RPS. So that's another indication that RPS was able to detect some of the cases that later had significant pathology. \n\nHowever, the question is specifically about glandular cell abnormalities. The 107 samples with glandular abnormalities had 39 flagged by RPS. So the answer would be yes, because RPS did detect some of them. The fact that it's not 100% sensitive (since 36.4% is the sensitivity here) doesn't mean it doesn't detect them at all. The options are yes, no, maybe. Since there are cases where RPS did detect them, the answer should be yes. The presence of",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 453,
            "completion_tokens": 512
        },
        "time_elapsed": 6.087444305419922
    },
    {
        "realidx": "26370095",
        "question": "To investigate the cost-effectiveness of up to \u00a3400 worth of financial incentives for smoking cessation in pregnancy as an adjunct to routine health care.\nCost-effectiveness analysis based on a Phase II randomized controlled trial (RCT) and a cost-utility analysis using a life-time Markov model.\nThe RCT was undertaken in Glasgow, Scotland. The economic analysis was undertaken from the UK National Health Service (NHS) perspective.\nA total of 612 pregnant women randomized to receive usual cessation support plus or minus financial incentives of up to \u00a3400 vouchers (US $609), contingent upon smoking cessation.\nComparison of usual support and incentive interventions in terms of cotinine-validated quitters, quality-adjusted life years (QALYs) and direct costs to the NHS.\nThe incremental cost per quitter at 34-38 weeks pregnant was \u00a31127 ($1716).This is similar to the standard look-up value derived from Stapleton&West's published ICER tables, \u00a31390 per quitter, by looking up the Cessation in Pregnancy Incentives Trial (CIPT) incremental cost (\u00a3157) and incremental 6-month quit outcome (0.14). The life-time model resulted in an incremental cost of \u00a317 [95% confidence interval (CI)\u2009=\u2009-\u00a393, \u00a3107] and a gain of 0.04 QALYs (95% CI\u2009=\u2009-0.058, 0.145), giving an ICER of \u00a3482/QALY ($734/QALY). Probabilistic sensitivity analysis indicates uncertainty in these results, particularly regarding relapse after birth. The expected value of perfect information was \u00a330 million (at a willingness to pay of \u00a330\u2009000/QALY), so given current uncertainty, additional research is potentially worthwhile.\nAre financial incentives cost-effective to support smoking cessation during pregnancy?",
        "answer": "yes",
        "answer_rationale": "Financial incentives for smoking cessation in pregnancy are highly cost-effective, with an incremental cost per quality-adjusted life years of \u00a3482, which is well below recommended decision thresholds.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether financial incentives are cost-effective for smoking cessation during pregnancy based on the provided study details.\n\nFirst, I need to recall what makes something cost-effective. Typically, in healthcare, an intervention is considered cost-effective if the incremental cost-effectiveness ratio (ICER) is below a certain threshold, often around \u00a320,000 to \u00a330,000 per QALY gained in the UK. The NHS usually uses \u00a320,000 to \u00a330,000 as the threshold. \n\nLooking at the data given, the life-time model's ICER is \u00a3482 per QALY. That's way below the threshold. Even if I consider the confidence intervals, the upper limit is around \u00a3107, but the ICER is still under the threshold. The incremental cost was \u00a317 with a gain of 0.04 QALYs. The Stapleton & West table's standard ICER was higher, but the study's result is better. \n\nHowever, the question mentions uncertainty due to relapse after birth and the EVPI of \u00a330 million. But the EVPI suggests that more research could be useful, but doesn't negate the current ICER. Since the ICER is under the threshold, the answer should be \"yes\" (A). The probabilistic sensitivity analysis shows some uncertainty, but the main result is below the threshold. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 511,
            "completion_tokens": 314
        },
        "time_elapsed": 3.962594509124756
    },
    {
        "realidx": "26418441",
        "question": "Polyps identified at colonoscopy are predominantly diminutive (<5\u2009mm) with a small risk (>1%) of high-grade dysplasia or carcinoma; however, the cost of histological assessment is substantial.AIM: The aim of this study was to determine whether prediction of colonoscopy surveillance intervals based on real-time endoscopic assessment of polyp histology is accurate and cost effective.\nA prospective cohort study was conducted across a tertiary care and private community hospital. Ninety-four patients underwent colonoscopy and polypectomy of diminutive (\u22645\u2009mm) polyps from October 2012 to July 2013, yielding a total of 159 polyps. Polyps were examined and classified according to the Sano-Emura classification system. The endoscopic assessment (optical diagnosis) of polyp histology was used to predict appropriate colonoscopy surveillance intervals. The main outcome measure was the accuracy of optical diagnosis of diminutive colonic polyps against the gold standard of histological assessment.\nOptical diagnosis was correct in 105/108 (97.2%) adenomas. This yielded a sensitivity, specificity and positive and negative predictive values (with 95%CI) of 97.2% (92.1-99.4%), 78.4% (64.7-88.7%), 90.5% (83.7-95.2%) and 93% (80.9-98.5%) respectively. Ninety-two (98%) patients were correctly triaged to their repeat surveillance colonoscopy. Based on these findings, a cut and discard approach would have resulted in a saving of $319.77 per patient.\nCan we ease the financial burden of colonoscopy?",
        "answer": "yes",
        "answer_rationale": "Endoscopists within a tertiary care setting can accurately predict diminutive polyp histology and confer an appropriate surveillance interval with an associated financial benefit to the healthcare system. However, limitations to its application in the community setting exist, which may improve with further training and high-definition colonoscopes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether we can ease the financial burden of colonoscopy based on the study described. The options are yes, no, or maybe.\n\nFirst, I need to recall the details from the provided study. The study talks about using real-time endoscopic assessment (optical diagnosis) to determine if polyps are adenomas or not. The goal was to see if this method could accurately predict surveillance intervals without needing histological assessment for all polyps. \n\nThe results showed that optical diagnosis was correct in 97.2% of adenomas. The sensitivity and specificity were high, which means it's good at identifying true positives and negatives. The study also mentions that 98% of patients were correctly triaged to their repeat colonoscopy intervals. Importantly, they calculated that using a \"cut and discard\" approach (where they don't send all polyps for histology if they can tell they're benign endoscopically) would save $319.77 per patient. \n\nThe question is about reducing financial burden. Since the study's main outcome included a cost-saving figure, and the accuracy is high enough, it suggests that adopting this method could indeed reduce costs. The options are whether the answer is yes, no, or maybe. The study's conclusion supports that the approach is both accurate and cost-effective, so the answer should be yes. The high accuracy (especially the negative predictive value) would mean that they can safely discard some polyps without histology, thus saving on histological costs. Therefore, the correct answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 476,
            "completion_tokens": 335
        },
        "time_elapsed": 4.684451341629028
    },
    {
        "realidx": "26419377",
        "question": "The purpose of this study was to evaluate safe depth for suture anchor insertion during acetabular labral repair and to determine the neighbouring structures at risk during drilling and anchor insertion.\nTen human cadaveric hips (six males and four females) were obtained. Acetabular labral surface was prepared and marked for right hips as 12, 1 and 3 o'clock positions, for left hips 12, 11 and 9 o'clock positions. Those were defined as anterior, anterior-superior and superior zones, respectively. These labral positions were drilled at defined zones. After measurements, depth of the bone at 10\u00b0 and 20\u00b0 drill angles on zones was compared statistically.\nAcetabular bone widths at investigated labral insertion points did not statistically differ. A total of 14 injuries in 60 penetrations occurred (23.3\u00a0%) with free drill penetrations, and no injuries occurred with stopped drill penetrations. The bone depth was gradually decreasing from 10\u00b0 to 20\u00b0 drill angles and from anterior to superior inserting zones without significant importance. The risk of perforation to the pelvic cavity started with 20\u00a0mm drill depth, and the mean depth for all insertions was calculated as 31.7\u00a0mm (SD 2.6).\nAre pelvic anatomical structures in danger during arthroscopic acetabular labral repair?",
        "answer": "yes",
        "answer_rationale": "It is anatomically possible that some pelvic structures sustain iatrogenic injury during acetabular drilling for anchor placement. Being aware of mean pelvic vault is important in which drilling after excessive pincer rim trimming could easily decrease the depth of acetabular bone without a standard. Careful drilling by using stopped drill bit is crucial to prevent iatrogenic injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pelvic anatomical structures are in danger during arthroscopic acetabular labral repair based on the study provided.\n\nFirst, I need to recall the key points from the study summary. The study's purpose was to evaluate the safe depth for suture anchor insertion and identify neighboring structures at risk. They used cadaveric hips and drilled at specific clock positions (like 12, 1, 3 for right hips and similar for left). They found that with free drill penetrations, there were 14 injuries out of 60 (23.3%), but none with stopped drills. The risk of perforation to the pelvic cavity started at 20mm depth, and the mean depth was 31.7mm. \n\nThe question is whether pelvic structures are in danger. The study mentions that perforations occurred when using free drills, which probably means the drill went too deep. The injuries here likely refer to perforations into the pelvic cavity. Since the risk starts at 20mm and the mean insertion depth is higher (31.7mm), that suggests that if the surgeon goes beyond 20mm, there's a risk. But the study also says that when they used stopped drills (maybe controlled depth?), there were no injuries. \n\nSo the answer hinges on whether the procedure, as performed, poses a danger. Since the study found that when they drilled beyond certain depths (free penetration), there were injuries, that implies that structures are at risk. The fact that 23% of those free drills caused injuries shows that there's a danger if the depth isn't controlled. Therefore, the answer should be yes (A). The options are (A) yes, (B) no, (C) maybe. The study clearly indicates that there is a risk, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 384,
            "completion_tokens": 392
        },
        "time_elapsed": 4.609156370162964
    },
    {
        "realidx": "26460153",
        "question": "We retrospectively identified 84 consecutive patients aged \u226580 years, who underwent a cardiac reoperation at the department for Cardiothoracic Surgery in the Heart&Vessel Center Bad Bevensen between January 2007 and 2013. Demographic profiles as well as operative data were analyzed, and the patients were prospectively followed. Patient's functional status and quality of life were assessed with the Barthel Index, New York Heart Association class and the short form-12 questionnaire.\nThe mean age of the study group (61 men, 23 women) was 81.9\u2009\u00b1\u20091.9 years. Most redo-procedures were carried out after primary coronary artery bypass grafting (65%), primary aortic valve replacement (21%) and primary mitral valve replacement (6%). The most frequent actual surgical procedures were combined coronary artery bypass grafting and aortic valve replacement (26%), isolated coronary artery bypass grafting (19%), and isolated aortic valve replacement (19%). The mean length of hospital stay was 17\u2009\u00b1\u200915 days. In-hospital mortality counted for 32.1%. During follow up (29\u2009\u00b1\u200920 months) a further 19.0% of the patients died. The Barthel Index of the survivors was 89\u2009\u00b1\u200917 and their mean New York Heart Association class was 2\u2009\u00b1\u20091. A total of 93% of the patients were living at home. Summary scores of physical and mental health of the short form-12 questionnaire equalled those of an age- and sex-matched normative population.\nCardiac reoperations in octogenarians: Do they really benefit?",
        "answer": "yes",
        "answer_rationale": "Despite high perioperative mortality, results document a sustainable recovery of the survivors offering the prospect of a highly independent and satisfying life. Therefore, advanced age alone should not be a contraindication for redo cardiac interventions. Geriatr Gerontol Int 2016; 16: 1138-1144.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about cardiac reoperations in patients who are 80 years or older. The question is asking whether these reoperations really benefit the patients. The options are yes, no, maybe.\n\nFirst, I need to look at the data provided. The study included 84 patients with a mean age of 81.9 years. The in-hospital mortality was 32.1%, which is quite high. Then, during follow-up (which averaged about 29 months), another 19% died. So total mortality might be around 32% plus 19%, but maybe some of those who survived in-hospital but died later might not be overlapping. Still, the in-hospital mortality alone is over a third, which is really high. \n\nBut then looking at the survivors: their Barthel Index was 89/100, which is pretty good. The Barthel Index measures activities of daily living; a higher score means more independence. A score of 89 suggests they're mostly independent. The NYHA class was 2 on average, which is considered mild symptoms, so not too bad. Also, 93% were living at home, which is a positive sign. The SF-12 scores were similar to the general population, meaning their physical and mental health were comparable to others their age and sex who didn't have such surgeries.\n\nSo even though the mortality rate is high, the survivors seem to have a decent quality of life. The question is whether the reoperations \"really benefit.\" The high mortality is a downside, but for those who survive, their functional status and quality of life are maintained. The study's results show that while there's significant risk, the survivors do well. So the answer might be yes because the ones who make it through have good outcomes, suggesting that for those who survive, the surgery does benefit them. Alternatively, maybe the high mortality makes the overall benefit questionable, but the question is phrased as \"do they really benefit?\" without specifying overall or for survivors. The study's conclusion probably leans towards the fact that despite high risks, the survivors have good outcomes, so the procedure can be beneficial. Therefore, the answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 460,
            "completion_tokens": 470
        },
        "time_elapsed": 5.237121820449829
    },
    {
        "realidx": "26471488",
        "question": "Limited and conflicting data exist on an association between mammographic density (MD) and re-excision rates after breast-conserving surgery (BCS). Additionally, the correlation of MD with resection of unnecessary margins during initial BCS is unknown.\nAll women with a diagnosis of breast cancer from 2003 to 2012 and enrolled in a larger study on MD were evaluated. Operative and pathology reports were reviewed to determine margin resection and involvement. Mammographic density was determined both by breast imaging-reporting and data system (BI-RADS) classification and by an automated software program (Volpara Solutions). Additional margins were deemed unnecessary if the lumpectomy specimen margin was free of invasive tumor [\u22652 mm for ductal carcinoma in situ (DCIS)] or if further re-excision was needed.\nOf 655 patients, 398 (60.8%) had BCS, whereas 226 (34.5%) underwent initial mastectomy. The women with denser breasts (BI-RADS 3 or 4) underwent initial mastectomy more frequently than the women with less dense breasts (40.0 vs. 30.5%, respectively; p = 0.0118). Of the patients with BCS, 166 (41.7%) required separate re-excision. Additional margins were taken during BCS in 192 (48.2%) patients, with 151 (78.6%) proving to be unnecessary. In the bivariable analysis, the patients with denser breasts according to BI-RADS classification and volumetric density showed a trend toward requiring more frequent re-excision, but this association was not seen in the multivariable analysis. The rate of unnecessary margins did not differ by breast density. In the multivariate analysis, the re-excision rates increased with DCIS (p<0.0003) and decreased with resection of additional margins (p = 0.0043).\nDoes Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?",
        "answer": "no",
        "answer_rationale": "Mammographic density is not associated with an increased need for re-excision or resection of unnecessary margins at initial BCS.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether mammographic density impacts the margin re-excision rate after breast-conserving surgery (BCS). The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study included 655 patients, with about 60% having BCS. The key points here are the findings from both bivariable and multivariable analyses. \n\nIn the bivariable analysis, there was a trend toward denser breasts (BI-RADS 3 or 4) leading to more re-excisions. However, the crucial part is that in the multivariable analysis, this association wasn't present. The multivariable analysis adjusts for other variables, so that's the more reliable result. \n\nAdditionally, the rate of unnecessary margins didn't differ by breast density. The re-excision rates were influenced by DCIS (more) and resection of additional margins (less), but not by density. \n\nSo the question is whether density has an impact. Since the multivariable analysis (which controls for confounders) didn't show an association, the answer should be no. The initial trend in bivariable might suggest maybe, but the correct answer follows the adjusted analysis. Therefore, the answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 532,
            "completion_tokens": 275
        },
        "time_elapsed": 3.7830443382263184
    },
    {
        "realidx": "26516021",
        "question": "Evidence-based practice (EBP) is widely promoted, but does EBP produce better patient outcomes? We report a natural experiment when part of the internal medicine service in a hospital was reorganized in 2003 to form an EBP unit, the rest of the service remaining unchanged. The units attended similar patients until 2012 permitting comparisons of outcomes and activity.\nWe used routinely collected statistics (2004-11) to compare the two different methods of practice and test whether patients being seen by the EBP unit differed from standard practice (SP) patients. Data were available by doctor and year. To check for differences between the EBP and SP doctors prior to reorganization, we used statistics from 2000 to 2003. We looked for changes in patient outcomes or activity following reorganization and whether the EBP unit was achieving significantly different results from SP. Data across the periods were combined and tested using Mann-Whitney test.\nNo statistically significant differences in outcomes were detected between the EBP and the SP doctors prior to reorganization. Following the unit's establishment, the mortality of patients being treated by EBP doctors compared with their previous performance dropped from 7.4% to 6.3% (P\u2009<\u20090.02) and length of stay from 9.15 to 6.01 days (P\u2009=\u20090.002). No statistically significant improvements were seen in SP physicians' performance. No differences in the proportion of patients admitted or their complexity between the services were detected. Despite this, EBP patients had a clinically significantly lower risk of death 6.27% versus 7.75% (P\u2009<\u20090.001) and a shorter length of stay 6.01 versus 8.46 days (P\u2009<\u20090.001) than SP patients. Readmission rates were similar: 14.4% (EBP); 14.5% (SP). EBP doctors attended twice as many patients/doctor as SP doctors.\nDoes evidence-based practice improve patient outcomes?",
        "answer": "yes",
        "answer_rationale": "The EBP unit was associated with better patient outcomes and more efficient performance than achieved by the same physicians previously or by SP concurrently.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether evidence-based practice (EBP) improves patient outcomes based on the provided study. \n\nFirst, I need to understand the study's setup. The hospital reorganized part of their internal medicine service into an EBP unit in 2003, while the rest stayed as standard practice (SP). They compared outcomes from 2004 to 2011. The key here is that the two groups were treating similar patients, so the variables should be controlled except for the EBP implementation.\n\nLooking at the results: Before the reorganization (2000-2003), there were no significant differences between EBP and SP doctors. After EBP was implemented, the mortality rate for EBP dropped from 7.4% to 6.3% (p<0.02), which is statistically significant. Length of stay also decreased significantly from 9.15 to 6.01 days (p=0.002). Meanwhile, SP doctors didn't show improvements. \n\nComparing EBP vs SP post-reorganization, EBP had lower mortality (6.27% vs 7.75%, p<0.001) and shorter stays (6.01 vs 8.46 days, p<0.001). Readmission rates were similar, so that's a neutral point. Also, EBP doctors saw more patients without worse outcomes, which is a plus.\n\nThe question is whether EBP improves outcomes. The study shows statistically significant improvements in mortality and length of stay for EBP compared to SP. Since the study controlled for patient complexity and admission rates, the difference is likely due to EBP. The answer should be \"yes\" (option A). But wait, the options are (A) yes, (B) no, (C) maybe. The study's results support a positive effect, so A is correct. The \"maybe\" might be a trap if there were confounders, but the study accounted for those. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 540,
            "completion_tokens": 441
        },
        "time_elapsed": 5.353288173675537
    },
    {
        "realidx": "26536001",
        "question": "It is unknown whether tumoral somatostatin receptor subtype 2a (sst2a) immunohistochemistry (IHC) has additional value compared to somatostatin receptor scintigraphy (SRS) uptake using OctreoScan\u00ae in predicting response to peptide receptor radiotherapy using 177Lu-octreotate (PRRT) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The aims of this study were: (1) to establish the percentage of sst2a immunopositivity in GEP-NET samples of PRRT-treated patients, (2) to determine the relationship between best GEP-NET response using RECIST 1.0 criteria 1 year after PRRT and tumoral sst2a IHC, and (3) to compare characteristics of patients with sst2a IHC-negative and -positive tumors.\nAll 73 consecutive patients were selected for PRRT based on a positive SRS. Radiological response was scored according to RECIST 1.0 criteria. sst2a status was detected on tumor samples by IHC.\nIn total, 93% of GEP-NET samples showed sst2a IHC positivity. No statistically significant relationship was observed between in vitro sst2a expression and in vivo best GEP-NET response 1 year after PRRT (p = 0.47). Sex, primary tumor site, disease stage, ENETS TNM classification, Ki-67 index, highest serum chromogranin-A level, and highest neuron-specific enolase level were not significantly different between patients with negative and positive sst2a tumoral IHC with the exception of age at diagnosis (p = 0.007).\nIs There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?",
        "answer": "no",
        "answer_rationale": "sst2a IHC of tumor samples has no additional value compared to SRS uptake using OctreoScan\u00ae in predicting tumor response after PRRT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether sst2a immunohistochemistry (IHC) adds more value than somatostatin receptor scintigraphy (SRS) in predicting response to PRRT in GEP-NETs.\n\nFirst, the key points from the study: All 73 patients had a positive SRS before PRRT. The results showed that 93% were sst2a positive via IHC. But the important part is that there was no statistically significant relationship between sst2a expression and treatment response (p=0.47). Also, other factors like age, tumor site, etc., didn't differ except age at diagnosis. \n\nThe question is whether IHC adds additional value beyond SRS. Since SRS was already used to select patients for PRRT, and the IHC results (even though most were positive) didn't correlate with response, it suggests that IHC doesn't add predictive value. The study's conclusion here would be that since there's no significant link between IHC and response, the answer is no. So the correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 512,
            "completion_tokens": 240
        },
        "time_elapsed": 3.147294521331787
    },
    {
        "realidx": "26548832",
        "question": "Longitudinally following patients requires a full-time employee (FTE)-dependent data inflow infrastructure. There are efforts to capture patient-reported outcomes (PROs) by the use of non-FTE-dependent methodologies. In this study, we set out to assess the reliability of PRO data captured via FTE-dependent compared with non-FTE-dependent methodologies.\nA total of 119 adult patients (65 men) who underwent 1-and 2-level lumbar fusions at Duke University Medical Center were enrolled in this prospective study. Enrollment criteria included available demographic, clinical, and PRO data. All patients completed 2 sets of questionnaires--the first a phone interviews and the second a self-survey. There was at least a 2-week period between the phone interviews and self-survey. Questionnaires included the Oswestry Disability Index (ODI), the visual analog scale for back pain (VAS-BP), and the visual analog scale for leg pain (VAS-LP). Repeated-measures analysis of variance was used to compare the reliability of baseline PRO data captured.\nA total of 39.49% of patients were smokers, 21.00% had diabetes, and 11.76% had coronary artery disease; 26.89% reported history of anxiety disorder, and 28.57% reported history of depression. A total of 97.47% of patients had a high-school diploma or General Education Development, and 49.57% attained a 4-year college degree or postgraduate degree. We observed a high correlation between baseline PRO data captured between FTE-dependent versus non-FTE dependent methodologies (ODI: r = -0.89, VAS-BP: r = 0.74, VAS-LP: r = 0.70). There was no difference in PROs of baseline pain and functional disability between FTE-dependent and non-FTE-dependent methodologies: baseline ODI (FTE-dependent: 47.73 \u00b1 16.77 [mean \u00b1 SD] vs. non-FTE-dependent: 45.81 \u00b1 12.11, P = 0.39), VAS-LP (FTE-dependent: 6.13 \u00b1 2.78 vs. non-FTE-dependent: 6.46 \u00b1 2.79, P = 0.36) and VAS-BP (FTE-dependent: 6.33 \u00b1 2.90 vs. non-FTE-dependent: 6.53 \u00b1 2.48, P = 0.57).\nAssessing Patient Reported Outcomes Measures via Phone Interviews Versus Patient Self-Survey in the Clinic: Are We Measuring the Same Thing?",
        "answer": "yes",
        "answer_rationale": "Our study suggests that there is great reliability between PRO data captured between FTE-dependent and non-FTE-dependent methodologies.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing two methods of collecting Patient-Reported Outcomes (PROs): FTE-dependent (like phone interviews by staff) versus non-FTE-dependent (self-surveys). The key here is to see if the two methods yield the same results.\n\nThe results mentioned show high correlations between the two methods for all three measures: ODI (r = -0.89), VAS-BP (0.74), and VAS-LP (0.70). Also, the mean scores for each measure between the two groups didn't show statistically significant differences (p-values were 0.39, 0.36, and 0.57, all above 0.05). That means there's no significant difference in the baseline PROs between the two methods. \n\nThe question is asking if they're measuring the same thing. Since the results are highly correlated and the means aren't different, the answer should be yes. The options are (A) yes, (B) no, (C) maybe. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 675,
            "completion_tokens": 237
        },
        "time_elapsed": 3.566356658935547
    },
    {
        "realidx": "26556589",
        "question": "Achilles tendon structure deteriorates 2-days after maximal loading in elite athletes. The load-response behaviour of tendons may be altered in type 1 diabetes mellitus (T1DM) as hyperglycaemia accelerates collagen cross-linking. This study compared Achilles tendon load-response in participants with T1DM and controls.\nAchilles tendon structure was quantified at day-0, day-2 and day-4 after a 10\u00a0km run. Ultrasound tissue characterisation (UTC) measures tendon structural integrity by classifying pixels as echo-type I, II, III or IV. Echo-type I has the most aligned collagen fibrils and IV has the least.\nParticipants were 7 individuals with T1DM and 10 controls. All regularly ran distances greater than 5\u00a0km and VISA-A scores indicated good tendon function (T1DM\u2009=\u200994\u2009\u00b1\u200911, control\u2009=\u200994\u2009\u00b1\u200910). There were no diabetic complications and HbA1c was 8.7\u2009\u00b1\u20092.6\u00a0mmol/mol for T1DM and 5.3\u2009\u00b1\u20090.4\u00a0mmol/mol for control groups. Baseline tendon structure was similar in T1DM and control groups - UTC echo-types (I-IV) and anterior-posterior thickness were all p\u2009>\u20090.05. No response to load was seen in either T1DM or control group over the 4-days post exercise.\nDoes type 1 diabetes mellitus affect Achilles tendon response to a 10\u00a0km run?",
        "answer": "no",
        "answer_rationale": "Active individuals with T1DM do not have a heightened Achilles tendon response to load, which suggests no increased risk of tendon injury. We cannot extrapolate these findings to sedentary individuals with T1DM.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether type 1 diabetes mellitus (T1DM) affects the Achilles tendon's response to a 10km run based on the study provided.\n\nFirst, I need to recall the key points from the study description. The study compared participants with T1DM and controls. They measured Achilles tendon structure at day 0, 2, and 4 after a 10km run using UTC, which categorizes echo-types based on collagen alignment. The hypothesis was that hyperglycemia in T1DM might alter the tendon's load response because of accelerated collagen cross-linking.\n\nLooking at the results: The baseline tendon structures (echo-types and thickness) were similar between the two groups (p >0.05), meaning no differences at the start. Then, after the run, neither group showed a response over the four days. The study found \"no response to load was seen in either T1DM or control group over the 4-days post exercise.\"\n\nThe question is whether T1DM affects the response. Since both groups had no response, the effect of T1DM here doesn't change the outcome. The study's conclusion would be that T1DM doesn't alter the load-response in this context. The answer should be \"no,\" which is option B. I need to make sure there's no nuance I'm missing. The HbA1c levels were different, but the study's results didn't show a difference in tendon response. The key is that the response (or lack thereof) was the same in both groups. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 434,
            "completion_tokens": 341
        },
        "time_elapsed": 4.368407964706421
    },
    {
        "realidx": "26561905",
        "question": "To compare the dose intensity and toxicity profiles for patients undergoing chemotherapy at the Townsville Cancer Centre (TCC), a tertiary cancer centre in northern Queensland, with those for patients treated in Mount Isa, supervised by the same medical oncologists via teleoncology.\nA quasi-experimental design comparing two patient groups.\nTCC and Mount Isa Hospital, which both operate under the auspices of the Townsville Teleoncology Network (TTN).\nEligible patients who received chemotherapy at TCC or Mt Isa Hospital between 1 May 2007 and 30 April 2012.\nTeleoncology model for managing cancer patients in rural towns.\nDose intensity (doses, number of cycles and lines of treatment) and toxicity rates (rate of serious side effects, hospital admissions and mortality).\nOver 5 years, 89 patients received a total of 626 cycles of various chemotherapy regimens in Mount Isa. During the same period, 117 patients who received a total of 799 cycles of chemotherapy at TCC were eligible for inclusion in the comparison group. There were no significant differences between the Mount Isa and TCC patients in most demographic characteristics, mean numbers of treatment cycles, dose intensities, proportions of side effects, and hospital admissions. There were no toxicity-related deaths in either group.\nDo teleoncology models of care enable safe delivery of chemotherapy in rural towns?",
        "answer": "yes",
        "answer_rationale": "It appears safe to administer chemotherapy in rural towns under the supervision of medical oncologists from larger centres via teleoncology, provided that rural health care resources and governance arrangements are adequate.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether teleoncology models of care enable safe delivery of chemotherapy in rural towns based on the provided study.\n\nFirst, I need to recall the details from the study described. The study compared patients treated at the Townsville Cancer Centre (TCC) with those treated in Mount Isa via teleoncology. The key outcomes were dose intensity and toxicity profiles. \n\nThe results mentioned that over five years, both groups had similar demographics, number of treatment cycles, dose intensities, side effects, hospital admissions, and no toxicity-related deaths in either group. Since there were no significant differences in these critical factors, it suggests that the teleoncology approach is as safe as the traditional in-person care. \n\nThe question is whether this means teleoncology is safe. The options are yes, no, maybe. The study's findings show no significant negative differences, so the answer should be yes. The \"maybe\" might be a trap if there were some uncertainties, but the data here indicates equivalence. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 382,
            "completion_tokens": 227
        },
        "time_elapsed": 3.035935401916504
    },
    {
        "realidx": "26578404",
        "question": "Breathlessness is one of the most distressing symptoms experienced by patients with advanced cancer and noncancer diagnoses alike. Often, severity of breathlessness increases quickly, calling for rapid symptom control. Oral, buccal, and parenteral routes of provider-controlled drug administration have been described. It is unclear whether patient-controlled therapy (PCT) systems would be an additional treatment option.\nTo investigate whether intravenous opioid PCT can be an effective therapeutic method to reduce breathlessness in patients with advanced disease. Secondary aims were to study the feasibility and acceptance of opioid PCT in patients with refractory breathlessness.\nThis was a pilot observational study with 18 inpatients with advanced disease and refractory breathlessness receiving opioid PCT. Breathlessness was measured on a self-reported numeric rating scale. Richmond Agitation Sedation Scale scores, Palliative Performance Scale scores, vital signs, and a self-developed patient satisfaction questionnaire were used for measuring secondary outcomes. Descriptive and interference analyses (Friedman test) and post hoc analyses (Wilcoxon tests and Bonferroni corrections) were performed.\nEighteen of 815 patients (advanced cancer; median age\u00a0=\u00a057.5\u00a0years [range 36-81]; 77.8% female) received breathlessness symptom control with opioid PCT; daily morphine equivalent dose at Day 1 was median\u00a0=\u00a020.3\u00a0mg (5.0-49.6\u00a0mg); Day 2: 13.0\u00a0mg (1.0-78.5\u00a0mg); Day 3: 16.0\u00a0mg (8.3-47.0\u00a0mg). Numeric rating scale of current breathlessness decreased (baseline: median\u00a0=\u00a05 [range 1-10]; Day 1: median\u00a0=\u00a04 [range 0-8], P\u00a0<\u00a00.01; Day 2: median\u00a0=\u00a04 [range 0-5], P\u00a0<\u00a00.01). Physiological parameters were stable over time. On Day 3, 12/12 patients confirmed that this mode of application provided relief of breathlessness.\nPatient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?",
        "answer": "yes",
        "answer_rationale": "Opioid PCT is a feasible and acceptable therapeutic method to reduce refractory breathlessness in palliative care patients.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether patient-controlled therapy (PCT) with intravenous opioids can help reduce breathlessness in advanced disease patients. The options are yes, no, maybe.\n\nFirst, I need to look at the study's results. The key points are that 18 patients were part of the pilot. The Numeric Rating Scale (NRS) for breathlessness went down from a median of 5 at baseline to 4 on Day 1 and Day 2, both with P < 0.01. That's a statistically significant decrease. Also, on Day 3, 12 out of 12 patients said it provided relief. Vital signs stayed stable, so no major side effects. The secondary outcomes like satisfaction might also be positive, but the main thing is the NRS improvement.\n\nThe question is asking if PCT is a new therapeutic concept here. The study's primary aim was to see if it's effective, and the results show a reduction in breathlessness. The secondary aims about feasibility and acceptance also seem positive since patients found it acceptable and effective. Since the study's results support that PCT with opioids helps, the answer should be yes. But wait, it's a pilot study with a small sample size (18 patients). However, the question is whether it's a \"new therapeutic concept,\" and the study's findings suggest it's effective and feasible. The answer options don't question the study's limitations, just whether based on the study's results, it's a valid option. So the answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 569,
            "completion_tokens": 330
        },
        "time_elapsed": 3.9548747539520264
    },
    {
        "realidx": "26601554",
        "question": "To investigate the role of viral infection in benign paroxysmal positional vertigo (BPPV).\nIn this retrospective study, 483 patients with BPPV were included in the study group. The control group consisted of 461 healthy subjects. In both groups, serologic analysis of viral agents (HSV1, HSV2, Herpes zoster, EBV, CMV, adenovirus, influenza, and parainfluenza virus) was performed.\nWith the exception of influenza and parainfluenza, all viral serology values were higher in the BBPV group than the control group. We also observed seasonal variation. The BPPV group exhibited elevated values for HSV1 and adenovirus in March and May, for Herpes zoster, adenovirus, and influenza in April, for HSV1 in June, and for HSV1 and CMV in September, compared to the control group. In October, the BPPV group showed increased values for all of the viruses studied, compared to the control group.\nDo viral infections have a role in benign paroxysmal positional vertigo?",
        "answer": "yes",
        "answer_rationale": "BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether viral infections play a role in benign paroxysmal positional vertigo (BPPV) based on the study described.\n\nFirst, I need to recall what BPPV is. It's a common inner ear disorder causing brief episodes of dizziness related to head position changes. The usual understanding is that it's due to calcium crystals (otoconia) dislodging in the semicircular canals. But the question is about a possible viral link.\n\nLooking at the study details: They compared 483 BPPV patients with 461 controls. They checked for antibodies to several viruses. The results showed that except for influenza and parainfluenza, all other viruses (HSV1, HSV2, Herpes zoster, EBV, CMV, adenovirus) had higher serology in the BPPV group. Also, there were seasonal variations where certain viruses were elevated in specific months in BPPV patients compared to controls. In October, all viruses were higher in BPPV group.\n\nThe key here is interpreting the data. Higher seropositivity in BPPV group suggests prior exposure to these viruses might be associated. The seasonal variations could imply that viral infections might trigger BPPV episodes. However, correlation doesn't equal causation. The study is observational and retrospective, so it can't prove causality. But the question is whether the study's findings support a role. Since the BPPV group had higher antibody levels for most viruses, especially seasonally, it's pointing towards a possible association. The answer options are yes, no, maybe. The study's results indicate that there is an association, so the answer would lean towards \"yes\" even if it's not definitive proof. The options don't have \"possibly yes\" so \"maybe\" might be considered, but the question is phrased as \"have a role\"\u2014the data suggests a role exists. The elevated levels and seasonal links support that viruses might contribute. So the answer is A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 322,
            "completion_tokens": 430
        },
        "time_elapsed": 5.2188756465911865
    },
    {
        "realidx": "26606599",
        "question": "To determine the relationship between injury severity surrogates and other patient factors with the development and severity of heterotopic ossification (HO) following open reduction internal fixation of acetabular fractures treated with a posterior approach.\nRetrospective review.\nAcademic level 1 trauma center.\nTwo hundred forty-one patients who were treated through a posterior approach with a minimum of 6-month radiographic follow-up were identified from an acetabular fracture database.\nNone.\nThe occurrence and severity (Brooker Grade III/IV) of HO 6 months postsurgery.\nLength of stay (LOS) in the intensive care unit (ICU), non-ICU LOS>10 days, and HO prophylaxis with external radiation beam therapy (XRT) were significantly associated with the development of HO in a multivariate model [\n1-2 days, odds ratio (OR) = 4.33, 95% confidence interval (CI): 1.03-18.25; 3-6 days, OR = 4.1, 95% CI, 1.27-13.27;>6 days, OR = 11.7, 95% CI, 3.24-42.22; non-ICU LOS>10 days (vs. 0-6 days): OR = 7.6, 95% CI, 2.6-22.25; XRT HO prophylaxis: OR = 0.29, 95% CI, 0.10-0.85]. Other variables evaluated in multivariate modeling not significantly associated with development and severity of HO included age, gender, mechanism of injury, injury severity score, presence of neurologic injury, Letournel fracture type, occurrence of hip dislocation, interval from injury to surgery, operative time, and estimated blood loss.\nDo Surrogates of Injury Severity Influence the Occurrence of Heterotopic Ossification in Fractures of the Acetabulum?",
        "answer": "maybe",
        "answer_rationale": "Surrogates of injury severity, including days in the ICU and non-ICU hospital LOS>10 days, were associated with the development of HO in our cohort of acetabular fracture patients. Prophylaxis with XRT was significantly protective against the development of HO, and the ability to provide prophylaxis is very likely related to the severity of injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether surrogates of injury severity influence the occurrence of heterotopic ossification (HO) in acetabular fractures based on the provided study.\n\nFirst, I need to understand what the study found. The question refers to a retrospective review of 241 patients with acetabular fractures treated via a posterior approach. The main outcome was the development and severity of HO at 6 months. The study's results mention that certain factors were significantly associated with HO in a multivariate model. \n\nLooking at the variables listed, the significant ones were ICU length of stay (LOS), non-ICU LOS over 10 days, and the use of XRT for HO prophylaxis. The other variables evaluated, which included injury severity score (ISS), age, gender, mechanism of injury, neurologic injury, fracture type, hip dislocation, time to surgery, operative time, and blood loss, were not significantly associated. \n\nThe key here is that the question is about \"surrogates of injury severity.\" The injury severity score (ISS) is a well-known surrogate for injury severity. Since the study states that ISS was not significantly associated with HO development in the multivariate analysis, that suggests that injury severity surrogates (like ISS) do not influence HO occurrence here. The other factors like ICU stay might be related to the complexity of care but not the injury's severity itself. \n\nSo the answer would be \"no\" because the injury severity score, a surrogate, wasn't a significant factor. The correct option is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 520,
            "completion_tokens": 330
        },
        "time_elapsed": 4.3953211307525635
    },
    {
        "realidx": "26708803",
        "question": "Treatment of neonatal testicular torsion has two objectives: salvage of the involved testicle (which is rarely achieved) and preservation of the contralateral gonad. The second goal universally involves contralateral testicular scrotal fixation to prevent the future occurrence of contralateral torsion. However, there is controversy with regards to management of a synchronous contralateral hydrocele. It has been our policy not to address the contralateral hydrocele through an inguinal incision to minimize potential injury to the spermatic cord. Our objective in this study was to determine whether the decision to manage a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal approach is safe and effective.\nWe reviewed all cases of neonatal testicular torsion occurring at our institution between the years 1999 and 2006. Age at presentation, physical examination, ultrasonographic and intraoperative findings were recorded. Patients were followed after initial surgical intervention to determine the likelihood of developing a subsequent hydrocele or hernia.\nThirty-seven patients were identified as presenting with neonatal torsion. Age of presentation averaged 3.5 days (range 1-14 days). Left-sided pathology was seen more commonly than the right, with a 25:12 distribution. All torsed testicles were nonviable. Twenty-two patients were noted to have a contralateral hydrocele at presentation. All hydroceles were opened through a scrotal approach at the time of contralateral scrotal fixation. No patient underwent an inguinal exploration to examine for a patent process vaginalis. None of the patients who presented with a hydrocele have developed a clinical hydrocele or hernia after an average 7.5 years (range 4.3-11.2) follow-up.\nTreatment of contralateral hydrocele in neonatal testicular torsion: Is less more?",
        "answer": "maybe",
        "answer_rationale": "We have demonstrated that approaching a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal incision is safe and effective. Inguinal exploration was not performed in our study and our long-term results demonstrate that such an approach would have brought no additional benefit. In avoiding an inguinal approach we did not subject our patients to unnecessary risk of testicular or vasal injury. Contralateral hydrocele is commonly seen in cases of neonatal testicular torsion. In our experience this is a condition of minimal clinical significance and does not warrant formal inguinal exploration for treatment. This conservative management strategy minimizes the potential of contralateral spermatic cord injury in the neonate. The aims of the study were met.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking about the management of a contralateral hydrocele in cases of neonatal testicular torsion. The study mentioned here looked at whether using a scrotal approach instead of an inguinal one is safe and effective.\n\nFirst, the background: Neonatal testicular torsion usually requires fixing the affected testicle and the contralateral one to prevent future torsion. The controversy is about how to handle a hydrocele on the other side. The authors' policy was to avoid inguinal incision to prevent injury, so they used a scrotal approach for the hydrocele.\n\nThe study reviewed 37 cases. All the torsed testes were nonviable. 22 had a contralateral hydrocele, which they addressed via scrotal approach. None had inguinal exploration. After follow-up averaging 7.5 years, none developed a hydrocele or hernia.\n\nThe question is whether \"less is more\" here. The options are yes, no, maybe. The study's results show that by not doing the inguinal approach and just using scrotal, they didn't have issues. Since none developed hernias or hydroceles later, it suggests that their approach (not doing more invasive inguinal) was safe. So the answer would be yes, meaning that the decision to manage via scrotal approach is safe, so \"less\" (not doing inguinal) is better. So the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 488,
            "completion_tokens": 319
        },
        "time_elapsed": 4.040939092636108
    },
    {
        "realidx": "26778755",
        "question": "Although dose-volume parameters in image-guided brachytherapy have become a standard, the use of posterior-inferior border of the pubic symphysis (PIBS) points has been recently proposed in the reporting of vaginal doses. The aim was to evaluate their pertinence.\nNineteen patients who received image-guided brachytherapy after concurrent radiochemotherapy were included. Per treatment, CT scans were performed at Days 2 and 3, with reporting of the initial dwell positions and times. Doses delivered to the PIBS points were evaluated on each plan, considering that they were representative of one-third of the treatment. The movements of the applicator according to the PIBS point were analysed.\nMean prescribed doses at PIBS -2, PIBS, PIBS +2 were, respectively, 2.23 \u00b1 1.4, 6.39 \u00b1 6.6, and 31.85 \u00b1 36.06 Gy. Significant differences were observed between the 5 patients with vaginal involvement and the remaining 14 at the level of PIBS +2 and PIBS: +47.60 Gy and +7.46 Gy, respectively (p = 0.023 and 0.03). The variations between delivered and prescribed doses at PIBS points were not significant. However, at International commission on radiation units and measurements rectovaginal point, the delivered dose was decreased by 1.43 \u00b1 2.49 Gy from the planned dose (p = 0.019). The delivered doses at the four points were strongly correlated with the prescribed doses with R(2) ranging from 0.93 to 0.95. The movements of the applicator in regard of the PIBS point assessed with the Digital Imaging and Communications in Medicine coordinates were insignificant.\nVaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?",
        "answer": "maybe",
        "answer_rationale": "The doses evaluated at PIBS points are not impacted by intrafractional movements. PIBS and PIBS +2 dose points allow distinguishing the plans of patients with vaginal infiltration. Further studies are needed to correlate these parameters with vaginal morbidity.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The study is about evaluating the use of PIBS points in reporting vaginal doses during image-guided brachytherapy for cervical cancer. The main question is whether relying on dose-point evaluation (like PIBS points) is valid.\n\nFirst, looking at the results: The mean prescribed doses at different PIBS points showed some variation, but the key point is that the delivered doses at the PIBS points weren't significantly different from the prescribed ones. The R-squared values (0.93-0.95) indicate a strong correlation between prescribed and delivered doses at these points. That suggests the PIBS points are reliable in this aspect.\n\nHowever, there's a mention that at the ICRU rectovaginal point, the delivered dose was lower than planned. But the question is specifically about vaginal doses and the PIBS points. The applicator movement wasn't significant either, so the positions probably stayed consistent. The study also found differences between patients with and without vaginal involvement, but that might relate to treatment planning rather than the reliability of the PIBS points themselves.\n\nThe options are yes, no, maybe. The study's conclusion seems to support that the PIBS points are pertinent because the delivered doses correlated well. So the answer should be yes (A). Wait, but the question is phrased as \"Can we really rely...\" The study's results show that the delivered doses at PIBS points were strongly correlated, so yes. The ICRU point's discrepancy might be a distractor, but the question is about vaginal doses via PIBS points. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 514,
            "completion_tokens": 347
        },
        "time_elapsed": 4.303186416625977
    },
    {
        "realidx": "26820719",
        "question": "The incidence of colorectal cancer in young patients is increasing. It remains unclear if the disease has unique features in this age group.\nThis was a single-center, retrospective cohort study which included patients diagnosed with colorectal cancer at age \u226440\u00a0years in 1997-2013 matched 1:2 by year of diagnosis with consecutive colorectal cancer patients diagnosed at age>50\u00a0years during the same period. Patients aged 41-50\u00a0years were not included in the study, to accentuate potential age-related differences. Clinicopathological characteristics, treatment, and outcome were compared between groups.\nThe cohort included 330 patients, followed for a median time of 65.9\u00a0months (range 4.7-211). Several significant differences were noted. The younger group had a different ethnic composition. They had higher rates of family history of colorectal cancer (p\u00a0=\u00a00.003), hereditary colorectal cancer syndromes (p\u00a0<\u00a00.0001), and inflammatory bowel disease (p\u00a0=\u00a00.007), and a lower rate of polyps (p\u00a0<\u00a00.0001). They were more likely to present with stage III or IV disease (p\u00a0=\u00a00.001), angiolymphatic invasion, signet cell ring adenocarcinoma, and rectal tumors (p\u00a0=\u00a00.02). Younger patients more frequently received treatment. Young patients had a worse estimated 5-year disease-free survival rate (57.6\u00a0 vs. 70\u00a0%, p\u00a0=\u00a00.039), but this did not retain significance when analyzed by stage (p\u00a0=\u00a00.092). Estimated 5-year overall survival rates were 59.1 and 62.1\u00a0% in the younger and the control group, respectively (p\u00a0=\u00a00.565).\nColorectal cancer in young patients: is it a distinct clinical entity?",
        "answer": "yes",
        "answer_rationale": "Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study compared colorectal cancer in patients \u226440 years versus those over 50. The key findings were that younger patients had different characteristics: more family history, hereditary syndromes, IBD, more stage III/IV disease, different tumor types (like signet ring), and rectal location. They also had worse 5-year disease-free survival, though it didn't hold when adjusted by stage. Overall survival was similar.\n\nThe question is whether this makes it a distinct clinical entity. The answer would be yes because the study shows significant differences in factors like presentation stage, tumor features, and underlying conditions. Even though survival wasn't significantly different when adjusted, the other factors are notable. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 517,
            "completion_tokens": 163
        },
        "time_elapsed": 2.5516247749328613
    },
    {
        "realidx": "26852225",
        "question": "Anchoring vignettes are brief texts describing a hypothetical character who illustrates a certain fixed level of a trait under evaluation. This research uses vignettes to elucidate factors associated with sleep disorders in adult Japanese before and after adjustment for reporting heterogeneity in self-reports. This study also evaluates the need for adjusting for reporting heterogeneity in the management of sleep and energy related problems in Japan.\nWe investigated a dataset of 1002 respondents aged 18 years and over from the Japanese World Health Survey, which collected information through face-to-face interview from 2002 to 2003. The ordered probit model and the Compound Hierarchical Ordered Probit (CHOPIT) model, which incorporated anchoring vignettes, were employed to estimate and compare associations of sleep and energy with socio-demographic and life-style factors before and after adjustment for differences in response category cut-points for each individual.\nThe prevalence of self-reported problems with sleep and energy was 53 %. Without correction of cut-point shifts, age, sex, and the number of comorbidities were significantly associated with a greater severity of sleep-related problems. After correction, age, the number of comorbidities, and regular exercise were significantly associated with a greater severity of sleep-related problems; sex was no longer a significant factor. Compared to the ordered probit model, the CHOPIT model provided two changes with a subtle difference in the magnitude of regression coefficients after correction for reporting heterogeneity.\nIs adjustment for reporting heterogeneity necessary in sleep disorders?",
        "answer": "no",
        "answer_rationale": "Sleep disorders are common in the general adult population of Japan. Correction for reporting heterogeneity using anchoring vignettes is not a necessary tool for proper management of sleep and energy related problems among Japanese adults. Older age, gender differences in communicating sleep-related problems, the presence of multiple morbidities, and regular exercise should be the focus of policies and clinical practice to improve sleep and energy management in Japan.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether adjustment for reporting heterogeneity is necessary in sleep disorders based on the study described.\n\nFirst, I need to recall what the study found. The study used two models: the ordered probit model and the CHOPIT model which includes anchoring vignettes to adjust for reporting differences. The key point here is the difference in results before and after adjustment.\n\nThe results mentioned that without correction (so using the ordered probit model), factors like age, sex, and comorbidities were significant. But after adjusting with CHOPIT, sex was no longer significant, while regular exercise became significant. Also, the CHOPIT model showed changes in regression coefficients, indicating that the adjustment affected the associations.\n\nThe question is whether adjustment is necessary. The study's findings suggest that not adjusting (using the standard model) can lead to incorrect conclusions, like considering sex as a significant factor when it's actually not after accounting for reporting biases. Since the CHOPIT model provided different results, especially removing sex as a factor and adding exercise, this implies that reporting heterogeneity does exist and adjusting for it gives a more accurate picture. Therefore, the conclusion would be that adjustment is necessary, so the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 401,
            "completion_tokens": 264
        },
        "time_elapsed": 3.477466583251953
    },
    {
        "realidx": "26864326",
        "question": "In this single-centre prospective study, triage nurses estimated the probability of admission using a 100\u2005mm visual analogue scale (VAS), and GAPS was generated automatically from triage data. We compared calibration using rank sum tests, discrimination using area under receiver operating characteristic curves (AUC) and accuracy with McNemar's test.\nOf 1829 attendances, 745 (40.7%) were admitted, not significantly different from GAPS' prediction of 750 (41.0%, p=0.678). In contrast, the nurses' mean VAS predicted 865 admissions (47.3%), overestimating by 6.6% (p<0.0001). GAPS discriminated between admission and discharge as well as nurses, its AUC 0.876 compared with 0.875 for VAS (p=0.93). As a binary predictor, its accuracy was 80.6%, again comparable with VAS (79.0%), p=0.18. In the minority of attendances, when nurses felt at least 95% certain of the outcome, VAS' accuracy was excellent, at 92.4%. However, in the remaining majority, GAPS significantly outperformed VAS on calibration (+1.2% vs +9.2%, p<0.0001), discrimination (AUC 0.810 vs 0.759, p=0.001) and accuracy (75.1% vs 68.9%, p=0.0009). When we used GAPS, but 'over-ruled' it when clinical certainty was \u226595%, this significantly outperformed either method, with AUC 0.891 (0.877-0.907) and accuracy 82.5% (80.7%-84.2%).\nPredicting admission at triage: are nurses better than a simple objective score?",
        "answer": "yes",
        "answer_rationale": "GAPS, a simple clinical score, is a better predictor of admission than triage nurses, unless the nurse is sure about the outcome, in which case their clinical judgement should be respected.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study compares triage nurses using a VAS scale versus the GAPS system in predicting hospital admissions. The key points from the study are:\n\nFirst, the actual admission rate was 40.7% (745/1829), while GAPS predicted 41.0% (750), which wasn't significantly different (p=0.678). The nurses' VAS overestimated at 47.3%, which was significantly higher (p<0.0001). So calibration-wise, GAPS was better here.\n\nFor discrimination, both had almost the same AUC: 0.876 for GAPS vs 0.875 for VAS, and the p-value was 0.93, meaning no significant difference. So they're about equal in discrimination.\n\nAccuracy as binary predictors: GAPS was 80.6% vs VAS 79.0%, and the p=0.18, so not significantly different. But when looking at cases where nurses were 95% certain, their accuracy was 92.4%, which is high. However, in the majority of cases where they weren't that certain, GAPS outperformed VAS in calibration, discrimination, and accuracy. \n\nThe study also mentions that combining GAPS with nurse override when they were 95% certain improved performance further. But the question is whether nurses are better than GAPS. \n\nThe main results show that overall, GAPS is at least as good as nurses, and better in most areas except when nurses are very certain. But since the majority of cases aren't in that high certainty group, GAPS is better overall. The question asks if nurses are better than the score. Since the study shows GAPS is comparable or better except in a minority, the answer would be no. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 534,
            "completion_tokens": 406
        },
        "time_elapsed": 5.27964448928833
    },
    {
        "realidx": "26879871",
        "question": "Studies have linked ethnic differences in depression rates with neighbourhood ethnic density although results have not been conclusive. We looked at this using a novel approach analysing whole population data covering just over one million GP patients in four London boroughs.\nUsing a dataset of GP records for all patients registered in Lambeth, Hackney, Tower Hamlets and Newham in 2013 we investigated new diagnoses of depression and antidepressant use for: Indian, Pakistani, Bangladeshi, black Caribbean and black African patients. Neighbourhood effects were assessed independently of GP practice using a cross-classified multilevel model.\nBlack and minority ethnic groups are up to four times less likely to be newly diagnosed with depression or prescribed antidepressants compared to white British patients. We found an inverse relationship between neighbourhood ethnic density and new depression diagnosis for some groups, where an increase of 10% own-ethnic density was associated with a statistically significant (p<0.05) reduced odds of depression for Pakistani [odds ratio (OR) 0.81, 95% confidence interval (CI) 0.70-0.93], Indian (OR 0.88, CI 0.81-0.95), African (OR 0.88, CI 0.78-0.99) and Bangladeshi (OR 0.94, CI 0.90-0.99) patients. Black Caribbean patients, however, showed the opposite effect (OR 1.26, CI 1.09-1.46). The results for antidepressant use were very similar although the corresponding effect for black Caribbeans was no longer statistically significant (p = 0.07).\nDoes depression diagnosis and antidepressant prescribing vary by location?",
        "answer": "yes",
        "answer_rationale": "New depression diagnosis and antidepressant use was shown to be less likely in areas of higher own-ethnic density for some, but not all, ethnic groups.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether depression diagnosis and antidepressant prescribing vary by location based on the study described.\n\nFirst, I need to recall the study's findings. The study looked at different ethnic groups in London boroughs and found that for some groups like Pakistani, Indian, African, and Bangladeshi patients, higher ethnic density in their neighborhood was linked to lower odds of a depression diagnosis. The opposite was true for Black Caribbean patients, who had higher odds with more ethnic density. For antidepressant use, similar patterns were seen except the effect on Black Caribbeans wasn't significant anymore.\n\nThe question is specifically about variation by location. Since neighborhood ethnic density (which is a location factor) showed different effects on diagnosis and prescribing rates across ethnic groups, that implies that location does matter. The study's results show that where someone lives (in terms of ethnic density) affects their likelihood of being diagnosed or prescribed antidepressants. So the answer should be yes, there is variation based on location. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 465,
            "completion_tokens": 228
        },
        "time_elapsed": 3.031676769256592
    },
    {
        "realidx": "26907557",
        "question": "This clinical study investigated whether the vascular-guided multilayer preauricular approach (VMPA) to the temporomandibular joint (TMJ) could improve access and decrease complications.\nThis retrospective evaluation consisted of a consecutive series of patients who underwent TMJ surgeries through the VMPA from January through December 2013. Patients with a history of TMJ surgery were excluded. Clinical data, including operating times, subjective complaints of incision scars, functional conditions of the auriculotemporal nerve and facial nerve, and other complications, were recorded and analyzed. All patients in this study were followed for at least 6\u00a0months.\nAll patients (606 joints) had successful TMJ surgeries through the VMPA. All incisions healed favorably with an uneventful recovery. No patient developed permanent weakness of the facial nerve or other severe complications.\nCan a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications?",
        "answer": "yes",
        "answer_rationale": "The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether the VMPA approach for TMJ surgery improves access and reduces complications. The key points from the study are that all 606 joints had successful surgeries, incisions healed well, and there were no permanent facial nerve issues or severe complications. The question is asking if the novel approach (VMPA) achieves those two goals.\n\nThe options are yes, no, maybe. The study's results show that there were no complications mentioned, and all surgeries were successful. So the answer should be yes, right? Because the results support that the approach worked as intended. But wait, the study is retrospective and only one year's data. However, the question is based on the given information, which states that all outcomes were positive. The answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 292,
            "completion_tokens": 175
        },
        "time_elapsed": 2.391127824783325
    },
    {
        "realidx": "26923375",
        "question": "Esophageal varices are present in 30% to 40% of patients in compensated cirrhosis (Child-Pugh class A) and in 60% to 85% of patients in decompensated cirrhosis (Child-Pugh classes B and C). It is important to identify patients with compensated cirrhosis at risk for esophageal varix development. We evaluated the accuracy of a duplex Doppler ultrasonographic index for predicting the presence or absence of esophageal varices in patients with compensated hepatic cirrhosis (Child-Pugh class A) by using endoscopy as the reference standard.\nFifty-six enrolled patients underwent duplex Doppler ultrasonography followed by screening endoscopy. Mean portal vein velocity (PVV), splenic index (SI), splenoportal index (SPI), hepatic and splenic arterial resistive, and pulsatility indices (hepatic artery resistive index [HARI], hepatic artery pulsatility index [HAPI], splenic artery resistive index [SARI], splenic artery pulsatility index [SAPI]) were recorded. Univariate logistic regression analysis was followed by receiver operating characteristic (ROC) curve construction for the indices that were significant.\nThe indices HARI, HAPI, SARI, SAPI were not helpful (p\u2009>\u20090.05). Mean PVV, SI, and SPI were all predictive of the presence of esophageal varices (p\u2009<\u20090.05) and SPI was found to be the most accurate parameter. Of the various cut-off levels of SPI evaluated, a cut-off value of SPI at 5.0, offered the highest diagnostic accuracy (88%). For the 28 patients with SPI<5.0, the absence of esophageal varices in 27 of them could be correctly diagnosed using only SPI without invasive screening endoscopy, with high negative predictive value (96%) and sensitivity (96%). Of the remaining 28 patients with SPI \u22655.0, presence of esophageal varices could be similarly correctly diagnosed in 22 of them by using SPI without screening endoscopy, with high positive predictive value (79%) and specificity (82%).\nIs non-invasive diagnosis of esophageal varices in patients with compensated hepatic cirrhosis possible by duplex Doppler ultrasonography?",
        "answer": "yes",
        "answer_rationale": "The SPI was accurate in predicting the presence or absence of esophageal varices in patients with compensated cirrhosis.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether non-invasive diagnosis of esophageal varices in compensated hepatic cirrhosis patients is possible using duplex Doppler ultrasonography. The provided information is from a study they mentioned.\n\nFirst, I need to recall what the study found. The key points are that they looked at several indices: HARI, HAPI, SARI, SAPI, PVV, SI, and SPI. The first four (HARI, HAPI, etc.) weren't helpful (p >0.05), so they weren't significant. But the mean PVV, SI, and SPI were predictive (p <0.05). Among these, SPI was the most accurate. \n\nThe study found that using a SPI cutoff of 5.0 gave 88% accuracy. For patients with SPI <5.0, 27 out of 28 didn't have varices, so the negative predictive value was 96% and sensitivity 96%. For those with SPI \u22655.0, 22 out of 28 had varices, with a positive predictive value of 79% and specificity 82%. \n\nThe question is whether non-invasive diagnosis is possible. Since the SPI cutoff allows for high sensitivity and NPV, meaning it can effectively rule out varices when SPI is low, and has decent specificity for ruling in when high, it seems like the answer is yes. The study's results support that duplex Doppler can be used non-invasively because they achieved good accuracy without needing endoscopy in some cases. The options are A (yes), B (no), C (maybe). The correct answer should be A because the study's results show that SPI can accurately predict varices, making non-invasive diagnosis feasible.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 589,
            "completion_tokens": 381
        },
        "time_elapsed": 4.491933107376099
    },
    {
        "realidx": "26965932",
        "question": "This study sought to investigate the ischemic and bleeding outcomes of patients fulfilling high bleeding risk (HBR) criteria who were randomized to zotarolimus-eluting Endeavor Sprint stent (E-ZES) or bare-metal stent (BMS) implantation followed by an abbreviated dual antiplatelet therapy (DAPT) duration for stable or unstable coronary artery disease.\nDES instead of BMS use remains controversial in HBR patients, in whom long-term DAPT poses safety concerns.\nThe ZEUS (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates) is a multinational, randomized single-blinded trial that randomized among others, in a stratified manner, 828 patients fulfilling pre-defined clinical or biochemical HBR criteria-including advanced age, indication to oral anticoagulants or other pro-hemorrhagic medications, history of bleeding and known anemia-to receive E-ZES or BMS followed by a protocol-mandated 30-day DAPT regimen. The primary endpoint of the study was the 12-month major adverse cardiovascular event rate, consisting of death, myocardial infarction, or target vessel revascularization.\nCompared with patients without, those with 1 or more HBR criteria had worse outcomes, owing to higher ischemic and bleeding risks. Among HBR patients, major adverse cardiovascular events occurred in 22.6% of the E-ZES and 29% of the BMS patients (hazard ratio: 0.75; 95% confidence interval: 0.57 to 0.98; p = 0.033), driven by lower myocardial infarction (3.5% vs. 10.4%; p<0.001) and target vessel revascularization (5.9% vs. 11.4%; p = 0.005) rates in the E-ZES arm. The composite of definite or probable stent thrombosis was significantly reduced in E-ZES recipients, whereas bleeding events did not differ between stent groups.\nIs Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?",
        "answer": "yes",
        "answer_rationale": "Among HBR patients with stable or unstable coronary artery disease, E-ZES implantation provides superior efficacy and safety as compared with conventional BMS. (Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates [ZEUS]; NCT01385319).",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study in question is the ZEUS trial, which compared zotarolimus-eluting stents (E-ZES) versus bare-metal stents (BMS) in high bleeding risk (HBR) patients. The primary endpoint was the 12-month major adverse cardiovascular event (MACE) rate, which includes death, myocardial infarction, or target vessel revascularization.\n\nThe results showed that the E-ZES group had a lower MACE rate (22.6% vs. 29% in BMS, HR 0.75, p=0.033). The reduction was mainly due to fewer heart attacks (3.5% vs. 10.4%) and fewer target vessel revascularizations (5.9% vs. 11.4%). Also, stent thrombosis was lower in the E-ZES group, and there was no difference in bleeding events between the groups. \n\nThe question is whether BMS is still justifiable in HBR patients. Since the study found that E-ZES had better outcomes without increasing bleeding, it suggests that DES might be preferable. The traditional concern with DES is the need for longer DAPT, but in this trial, DAPT was only 30 days, which might mitigate bleeding risk. Since the ischemic events were lower with DES and bleeding didn't increase, BMS might not be as justifiable now. So the answer is probably B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 557,
            "completion_tokens": 318
        },
        "time_elapsed": 3.824571132659912
    },
    {
        "realidx": "27040842",
        "question": "To measure the dimensions of compensatory hypertrophy of the middle turbinate in patients with nasal septal deviation, before and after septoplasty.\nThe mucosal and bony structures of the middle turbinate and the angle of the septum were measured using radiological analysis before septoplasty and at least one year after septoplasty. All pre- and post-operative measurements of the middle turbinate were compared using the paired sample t-test and Wilcoxon rank sum test.\nThe dimensions of bony and mucosal components of the middle turbinate on concave and convex sides of the septum were not significantly changed by septoplasty. There was a significant negative correlation after septoplasty between the angle of the septum and the middle turbinate total area on the deviated side (p = 0.033).\nDoes septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate?",
        "answer": "no",
        "answer_rationale": "The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether septoplasty changes the dimensions of compensatory hypertrophy of the middle turbinate. The provided information says that the study measured the middle turbinate's mucosal and bony structures before and after surgery. The key point here is that the dimensions on both the concave and convex sides of the septum didn't show significant changes after the surgery. They used statistical tests like the paired t-test and Wilcoxon, but the results weren't significant. Also, there was a significant negative correlation between the septum angle and the turbinate area on the deviated side, but that correlation existing doesn't mean the dimensions changed. The question is specifically about whether the dimensions changed, and the study's results indicate they didn't. So the answer should be no, which is option B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 277,
            "completion_tokens": 177
        },
        "time_elapsed": 2.4280169010162354
    },
    {
        "realidx": "27044366",
        "question": "The technique of induced sputum has allowed to subdivide asthma patients into inflammatory phenotypes according to their level of granulocyte airway infiltration. There are very few studies which looked at detailed sputum and blood cell counts in a large cohort of asthmatics divided into inflammatory phenotypes. The purpose of this study was to analyze sputum cell counts, blood leukocytes and systemic inflammatory markers in these phenotypes, and investigate how those groups compared with healthy subjects.\nWe conducted a retrospective cross-sectional study on 833 asthmatics recruited from the University Asthma Clinic of Liege and compared them with 194 healthy subjects. Asthmatics were classified into inflammatory phenotypes.\nThe total non-squamous cell count per gram of sputum was greater in mixed granulocytic and neutrophilic phenotypes as compared to eosinophilic, paucigranulocytic asthma and healthy subjects (p\u2009<\u20090.005). Sputum eosinophils (in absolute values and percentages) were increased in all asthma phenotypes including paucigranulocytic asthma, compared to healthy subjects (p\u2009<\u20090.005). Eosinophilic asthma showed higher absolute sputum neutrophil and lymphocyte counts than healthy subjects (p\u2009<\u20090.005), while neutrophilic asthmatics had a particularly low number of sputum macrophages and epithelial cells. All asthma phenotypes showed an increased blood leukocyte count compared to healthy subjects (p\u2009<\u20090.005), with paucigranulocytic asthmatics having also increased absolute blood eosinophils compared to healthy subjects (p\u2009<\u20090.005). Neutrophilic asthma had raised CRP and fibrinogen while eosinophilic asthma only showed raised fibrinogen compared to healthy subjects (p\u2009<\u20090.005).\nDetailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?",
        "answer": "maybe",
        "answer_rationale": "This study demonstrates that a significant eosinophilic inflammation is present across all categories of asthma, and that paucigranulocytic asthma may be seen as a low grade inflammatory disease.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether paucigranulocytic asthmatics are really non-inflammatory based on the study described.\n\nFirst, I need to recall what the study found. The question mentions that the study compared different asthma phenotypes with healthy subjects. The key points from the study's results are:\n\n- Total non-squamous cells were higher in mixed and neutrophilic groups compared to eosinophilic, paucigranulocytic asthma, and healthy subjects. But paucigranulocytic is still part of the asthma group here.\n\n- Sputum eosinophils (both absolute and percentages) were increased in all asthma phenotypes, including paucigranulocytic, compared to healthy subjects. That's a crucial point because even paucigranulocytic asthma had higher eosinophils than healthy people.\n\n- Paucigranulocytic asthmatics had increased blood eosinophils compared to healthy subjects. Also, all asthma phenotypes had higher blood leukocytes than healthy subjects.\n\nThe question is whether paucigranulocytic asthma is \"non-inflammatory.\" The term \"paucigranulocytic\" might suggest low granulocytes in sputum, but the study shows that even in this group, eosinophils (a type of granulocyte) are elevated compared to healthy subjects. Plus, their blood eosinophils and leukocytes are up. So even if their sputum granulocytes are lower than other asthma types, they still have more inflammation than healthy people. The study's results indicate that all asthma phenotypes, including paucigranulocytic, have increased inflammatory markers. Therefore, the answer should be \"no\" because they are still inflammatory, just maybe a different type or lower level but not non-inflammatory. The options are (A) yes, (B) no, (C) maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 539,
            "completion_tokens": 414
        },
        "time_elapsed": 5.0594000816345215
    },
    {
        "realidx": "27050489",
        "question": "Misty mesentery appearance is commonly reported in daily practice, usually as a secondary finding of various pathological entities, but sometimes it is encountered as an isolated finding that cannot be attributed to any other disease entity. We aimed to assess the prevalence of cases with incidentally detected idiopathic misty mesentery on computed tomography (CT) and to summarize the pathologies leading to this appearance.\nMedical records and initial and follow-up CT features of patients with misty mesentery appearance between January 2011 and January 2013 were analysed. The study included cases with no known cause of misty mesentery according to associated CT findings, clinical history, or biochemical manifestations, and excluded patients with diseases known to cause misty mesentery, lymph nodes greater than a short-axis diameter of 5\u00a0mm, discrete mesenteric masses, or bowel wall thickening.\nThere were a total of 561 patients in whom misty mesentery appearance was depicted on abdominopelvic CT scans. A total of 80 cases were found to have isolated incidental idiopathic misty mesentery, giving a prevalence of 7%. The common indication for CT examination was abdominal pain. There was a slight female predominance (51.3%). 67.5% of all patients were classified as obese and 17.5% as overweight.\nThe Prevalence of Incidentally Detected Idiopathic Misty Mesentery on\u00a0Multidetector Computed Tomography: Can Obesity Be the Triggering Cause?",
        "answer": "yes",
        "answer_rationale": "The results of the present study show that idiopathic incidental misty mesentery appearance has a significant prevalence. Also, the high body mass index of these patients and the growing evidence of obesity-induced inflammatory changes in adipose tissue are suggestive of an association between obesity and misty mesentery appearance on CT.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether obesity can be the triggering cause of idiopathic misty mesentery based on the study described.\n\nFirst, I need to recall what the study found. The study's aim was to assess the prevalence of idiopathic misty mesentery and the associated pathologies. They found that out of 561 patients with misty mesentery, 80 (14%) were idiopathic. The prevalence was 7%, and among these, 67.5% were obese and 17.5% overweight. The question is whether obesity is the triggering cause.\n\nThe key here is understanding the study's findings. The high percentage of obese patients in the idiopathic group might suggest a correlation, but the study's conclusion isn't explicitly stated here. The title of the study actually poses the question: \"Can Obesity Be the Triggering Cause?\" So the study is presenting data but not definitively concluding causation. The options are yes, no, maybe. Since the study's results show a high prevalence in obese patients, but the question is about whether it's the cause. The answer options are based on the information given. The study's data shows an association but doesn't prove causation. Therefore, the correct answer would be \"maybe\" because the study is exploring the possibility, not confirming it. The answer isn't a definitive yes or no, so the answer is C.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 410,
            "completion_tokens": 303
        },
        "time_elapsed": 4.211892127990723
    },
    {
        "realidx": "27096199",
        "question": "Multiple viruses are often detected in children with respiratory infection but the significance of co-infection in pathogenesis, severity and outcome is unclear.\nTo correlate the presence of viral co-infection with clinical phenotype in children admitted with acute respiratory infections (ARI).\nWe collected detailed clinical information on severity for children admitted with ARI as part of a Spanish prospective multicenter study (GENDRES network) between 2011-2013. A nested polymerase chain reaction (PCR) approach was used to detect respiratory viruses in respiratory secretions. Findings were compared to an independent cohort collected in the UK.\n204 children were recruited in the main cohort and 97 in the replication cohort. The number of detected viruses did not correlate with any markers of severity. However, bacterial superinfection was associated with increased severity (OR: 4.356; P-value = 0.005), PICU admission (OR: 3.342; P-value = 0.006), higher clinical score (1.988; P-value = 0.002) respiratory support requirement (OR: 7.484; P-value<0.001) and longer hospital length of stay (OR: 1.468; P-value<0.001). In addition, pneumococcal vaccination was found to be a protective factor in terms of degree of respiratory distress (OR: 2.917; P-value = 0.035), PICU admission (OR: 0.301; P-value = 0.011), lower clinical score (-1.499; P-value = 0.021) respiratory support requirement (OR: 0.324; P-value = 0.016) and oxygen necessity (OR: 0.328; P-value = 0.001). All these findings were replicated in the UK cohort.\nDoes Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?",
        "answer": "no",
        "answer_rationale": "The presence of more than one virus in hospitalized children with ARI is very frequent but it does not seem to have a major clinical impact in terms of severity. However bacterial superinfection increases the severity of the disease course. On the contrary, pneumococcal vaccination plays a protective role.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether viral co-infection influences the severity of acute respiratory infection in children, based on the provided study.\n\nFirst, I need to recall the key points from the study summary. The main finding here is that the number of detected viruses (so, co-infections) didn't correlate with any markers of severity. The study mentions that they looked at things like severity markers, PICU admission, clinical scores, respiratory support, and hospital stay. The results showed no correlation between the number of viruses (co-infections) and these outcomes. \n\nHowever, the study did find that bacterial superinfection was associated with increased severity. That's a different factor\u2014bacterial, not viral. Also, pneumococcal vaccination had protective effects, but again, that's about vaccination, not the viral co-infections themselves.\n\nThe question specifically asks about viral co-infections. The answer should be based on whether the presence of multiple viruses (co-infections) affects severity. Since the study states there was no correlation between the number of viruses and severity markers, the answer would be \"no\". The options are A (yes), B (no), C (maybe). \n\nWait, but maybe I should check again. The study says \"the number of detected viruses did not correlate with any markers of severity.\" So even if they had two or more viruses, it didn't make the illness worse. So the answer is B, no. The other factors like bacterial infection do matter, but the question is specifically about viral co-infections. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 528,
            "completion_tokens": 332
        },
        "time_elapsed": 4.4113428592681885
    },
    {
        "realidx": "27131771",
        "question": "The alterations of echocardiography and electrocardiogram (ECG) in patients received left atrial appendage LAA occlusion therapy are still unclear. The present study was to evaluate the influence of LAA occlusion device on echocardiography and ECG changes in patients with atrial fibrillation (AF).\nSeventy-three patients who had undergone Watchman, LAmbre and Lefort were enrolled in this study. Echocardiography and ECG results at pre- and post-operation were collected. Besides, echocardiography was also performed during follow-up visits at 1, 6 and 12months after discharge.\nAfter LAA occlusion, a slight and measureable movement of QRS electric axis was observed in most patients. The significant differences were also observed in heart rate (HR) and the mean-mean QT interval between pre- and post-operation for all patients. There existed no significant difference in echocardiographic parameters between before and after device implantation. However, a larger left atrial (LA) diameter was detected by echocardiography during follow-up visit at 6months when compared with pre-operation parameters. Similarly, aortic root diameter (ARD) was also larger during follow-up at 12months than the baseline dimension in pre-operation.\nDoes left atrial appendage (LAA) occlusion device alter the echocardiography and electrocardiogram parameters in patients with atrial fibrillation?",
        "answer": "yes",
        "answer_rationale": "LAA occlusion device resulted in a slightly movement in QRS axis, reduced HR and increased the mean-mean QT interval duration. In addition, LA diameter and ARD seemed to be larger after device implantation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether left atrial appendage (LAA) occlusion devices alter echocardiography and ECG parameters in AF patients. The study mentioned included 73 patients who had the Watchman, LAmbre, or Lefort devices implanted. They looked at pre-op and post-op ECG and echo results, plus follow-ups at 1, 6, and 12 months.\n\nThe results say that after the procedure, there was a slight but measurable change in the QRS axis in most patients. Also, there were significant differences in heart rate and mean QT interval between pre and post-op. However, the echocardiographic parameters didn't show significant changes right after the implantation. But wait, at the 6-month follow-up, the left atrial diameter was larger than before, and the aortic root diameter was bigger at 12 months compared to baseline.\n\nSo the question is whether the device alters these parameters. The answer hinges on whether any changes were observed. The ECG did show changes in QRS axis, HR, and QT interval. The echo didn't show changes immediately, but there were increases in LA and ARD over time. Since the question is about any alteration, the presence of these changes (even if some are later) would mean the answer is yes. The options are A (yes), B (no), C (maybe). The study found changes in ECG parameters and some echocardiographic parameters over follow-up, so the answer should be A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 390,
            "completion_tokens": 325
        },
        "time_elapsed": 19.10091996192932
    },
    {
        "realidx": "27136599",
        "question": "Patient data were retrospectively collected from a database for gynaecological cancer procedures carried out between January 2013 and July 2015. All patients who underwent a colorectal resection during cytoreduction were included in the study. The primary outcome was anastomotic leakage in the presence or absence of a diverting stoma. Secondary outcome parameters were complications and reoperations.\nIn the period of study, 43 major colorectal procedures were performed on 37 women. The most common colorectal procedure was low rectal resection (n\u00a0=\u00a022; 59%) followed by anterior rectal resection (n\u00a0=\u00a07; 19%) and sigmoid resection (n\u00a0=\u00a04; 11%). Five (14%) patients underwent Hartmann's procedure. In three (8%) patients, a diverting loop ileostomy was created.\nIs it safe to perform rectal anastomosis in gynaecological debulking surgery without a diverting stoma?",
        "answer": "yes",
        "answer_rationale": "Low rectal resection during debulking procedures for gynaecological cancers with peritoneal carcinomatosis can safely be performed by an experienced surgeon without a diverting stoma.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether it's safe to perform a rectal anastomosis during gynecological debulking surgery without a diverting stoma. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided data from the study. The study collected data from 2013 to 2015 on gynecological cancer procedures where colorectal resections were done during cytoreduction. The primary outcome was anastomotic leakage, which is a serious complication where the surgical connection between the intestines fails. They also looked at other complications and reoperations.\n\nThe numbers given: 43 procedures on 37 women. The most common was low rectal resection (22 out of 43, so 59%). Then anterior rectal (7, 19%), sigmoid (4, 11%), and Hartmann's (5, 14%). Only 3 patients (8%) had a diverting loop ileostomy. \n\nThe key point here is the primary outcome: anastomotic leakage. The question is whether doing the anastomosis without a stoma is safe. The study's data would presumably include the rate of leakage in those who did or didn't have a stoma. But the problem is the question doesn't give the actual leakage rates. Wait, the user hasn't provided the results of the study's outcomes, just the demographics. Hmm, that's a problem. Wait, the user's question is based on the data given, but the data provided doesn't include the actual outcomes like leakage rates. The question is whether it's safe, but without knowing the complication rates between those with and without stomas, how can we answer?\n\nWait, maybe I missed something. Let me check again. The primary outcome was anastomotic leakage in presence or absence of a diverting stoma. But the data given in the question only tells us how many had stomas (3 out of 43). The rest (40 procedures) didn't have a stoma. The question is whether it's safe to do the anastomosis without a stoma. But the answer would depend on the leakage rates in those groups. Since the study's primary outcome is that, but the user hasn't provided the actual results (like how many had leaks in each group), maybe the answer is inferred from the fact that they did perform many without stom",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 307,
            "completion_tokens": 512
        },
        "time_elapsed": 5.721656799316406
    },
    {
        "realidx": "27217036",
        "question": "Longer duration of neoadjuvant (NA) imatinib\u00a0(IM) used for locally advanced (LA) gastrointestinal stromal tumours (GIST) is not based on biology of the tumour reflected by kit mutation analysis.\nLA or locally recurrent (LR) GIST treated with NA IM from May 2008 to March 2015 from a prospective database were included in\u00a0the analysis. Archived formalin-fixed paraffin-embedded tissues (FFPE) were used for testing KIT exons 9, 11, 13 and 17 by PCR.\nOne hundred twenty-five patients with LA or LR GIST were treated with NA IM. Forty-five patients (36\u00a0%) had undergone c-kit mutation testing. Exon 11 was seen in 25 patients (55.5\u00a0%), 3 with exon 9 (6.7\u00a0%) and 2 with exon 13 (4.4\u00a0%). Twelve were wild type (26.6\u00a0%) and \u00a03 (6.7 %) were declared uninterpretable. Response rate (RR) for the exon 11 mutants was higher than the non-exon 11 mutant group (84 vs. 40\u00a0%, p\u2009=\u20090.01). Disease stabilization rate (DSR) rates were also higher in the exon 11 subgroup than non-exon 11 group (92 vs. 75\u00a0%). Eighty-four per cent exon 11 and 75\u00a0% non-exon 11 mutants were surgical candidates. Patients undergoing surgery had significantly improved event free survival (EFS) (p\u2009<\u20090.001) compared to patients not undergoing surgery, with the same trend seen in OS (p\u2009=\u20090.021). Patients with a SD on response to NA IM had a lower EFS (p\u2009=\u20090.076) and OS compared to patients achieving CR/PR. There were no differences between the various exon variants in terms of outcomes and responses\nNeoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?",
        "answer": "yes",
        "answer_rationale": "Upfront evaluation of kit mutation status may help us in delineating separate treatment strategies for potentially biologically different tumours and assessing the correct timing of surgery for this subset of GIST.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The main point here is whether Kit mutation analysis can be a \"pathfinder\" for neoadjuvant imatinib in locally advanced GIST. The question is asking if the duration of using NA imatinib isn't based on the tumor's biology as shown by KIT mutations.\n\nLooking at the study details: They tested KIT exons in some patients. The exon 11 mutations had higher response rates (84% vs 40%) and disease stabilization. Also, more patients with exon 11 mutations were surgical candidates. Surgery improved EFS and OS. But the key part is that despite these differences in response, the conclusion says \"there were no differences between the various exon variants in terms of outcomes and responses.\" Wait, that seems conflicting. Wait, let me check again.\n\nWait, the response rate was higher for exon 11, so that does indicate a difference. But the last sentence says \"there were no differences between the various exon variants in terms of outcomes and responses.\" Hmm, maybe I misread. Let me look again.\n\nThe last sentence says: \"There were no differences between the various exon variants in terms of outcomes and responses.\" Wait, but the data shows that exon 11 had better response rates. Maybe the author is referring to other variants? Like between exon 9, 13, 17, etc., but the main comparison was between exon 11 and non-11. The question is whether KIT mutation analysis helps in deciding the duration of NA imatinib. The first sentence of the question states that longer duration isn't based on tumor biology (KIT mutations). The study's results show that exon 11 had better responses, so maybe mutation analysis does help. But the conclusion of the study might be that despite some response differences, the overall outcomes (like EFS and OS) didn't differ between exon variants. Wait, the EFS and OS were better for those who had surgery, but the mutation status didn't affect those outcomes beyond response? The question is whether Kit mutation analysis is a pathfinder. The study's abstract says that longer duration isn't based on biology (KIT mutations), but the data shows that exon 11 has better response. So maybe the answer is that the study suggests that even though there are some differences in response, the overall outcomes (like EFS and OS) didn't differ between the variants. Therefore, maybe the answer is \"no\" because",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 563,
            "completion_tokens": 512
        },
        "time_elapsed": 5.98232102394104
    },
    {
        "realidx": "27281318",
        "question": "This study aims to study femoral tunnel lengths drilled with a flexible reamer and the distance to important lateral structures obtained by flexing the knee at various angles and by drilling the guide pins arthroscopically to resemble clinical practice. The purpose of this cadaveric study was twofold: 1. to determine whether femoral tunnel lengths of greater than 20 mm can be created with a flexible reamer system at 90 \u00b0 of knee flexion and 2. to determine whether the lateral structures of the knee are safe with this technique.\nTen fresh cadaveric knees were utilized. The intra-osseous length can be measured with a specially de - signed flexible guide pin. Flexible pins were inserted with the knee at 70\u00b0, 90\u00b0, and 120\u00b0 of flexion. The intra-osseous length was measured with the measuring device. Each speci - men was dissected around the lateral aspect of the knee to identify the critical structures, the common peroneal nerve, and the LCL. The distance from the guide pins to the com - mon peroneal nerve and femoral attachment of the LCL were measured with a standard flexible paper ruler to the nearest millimeter.\nThere is a trend for progressively increasing mean intra-osseous length associated with increased flexion of the knee. The mean intra-osseous length for 70\u00b0 flexion was 25.2 mm (20 mm to 32 mm), which was statistically significant when compared to mean intra-osseous lengths of 32.1 mm (22 mm to 45 mm) and 38.0 mm (34 mm to 45 mm) in the 90\u00b0 and 120\u00b0 flexion groups, respectively (p<0.05). There were no significant differences among the groups with respect to distance to the LCL. There is a trend toward longer distances to the common peroneal nerve with increased flexion. There was a statistically significant dif - ference when comparing 120\u00b0 versus 70\u00b0 (p<0.05).\nCan Flexible Instruments Create Adequate Femoral Tunnel Lengths at 90\u00b0 of Knee Flexion in Anterior Cruciate Ligament Reconstruction?",
        "answer": "yes",
        "answer_rationale": "This study that shows that adequate femoral tunnel lengths can be safely created without knee hyperflex - ion using flexible instruments via an anteromedial portal.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about using a flexible reamer to create femoral tunnels in ACL reconstruction, specifically looking at whether they can make tunnels longer than 20mm at 90 degrees of knee flexion, and also checking safety regarding lateral structures.\n\nThe question is asking if flexible instruments can create adequate tunnel lengths at 90\u00b0. The options are yes, no, maybe. \n\nLooking at the results: the mean intra-osseous length at 90\u00b0 was 32.1 mm, which is well above 20mm. The range given is 22 to 45, so even the lower end in that group is 22, which is over 20. The study says there's a trend of increasing length with more flexion. Since 90\u00b0 had a mean of 32.1, which is significantly higher than 70\u00b0, and the question is whether they can create lengths greater than 20mm at 90\u00b0, the answer should be yes. Also, the first purpose of the study was to see if over 20mm can be achieved at 90\u00b0, and the results support that. The second part about safety (distance to nerves/LCL) seems separate, but the question is only about tunnel length. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 563,
            "completion_tokens": 287
        },
        "time_elapsed": 3.6329400539398193
    },
    {
        "realidx": "27287237",
        "question": "Little is known about the validity and reliability of expert assessments of the quality of antimicrobial prescribing, despite their importance in antimicrobial stewardship. We investigated how infectious disease doctors' assessments compared with a reference standard (modal expert opinion) and with the assessments of their colleagues.\nTwenty-four doctors specialized in infectious diseases or clinical microbiology (16 specialists and 8 residents) from five hospitals were asked to assess the appropriateness of antimicrobial agents prescribed for a broad spectrum of indications in 56 paper cases. They were instructed how to handle guideline applicability and deviations. We created a reference standard of antimicrobial appropriateness using the modal assessment of 16 specialists. We calculated criterion validity and interrater and intrarater overall and specific agreement with an index expert (senior infectious disease physician) and analysed the influence of doctor characteristics on validity.\nSpecialists agreed with the reference standard in 80% of cases (range 75%-86%), with a sensitivity and specificity of 75% and 84%, respectively. This did not differ by clinical specialty, hospital or years of experience, and residents had similar results. Specialists agreed with the index expert in 76% of cases and the index expert agreed with his previous assessments in 71% of cases.\nAssessment of appropriate antimicrobial prescribing: do experts agree?",
        "answer": "yes",
        "answer_rationale": "Doctors specialized in infectious diseases and clinical microbiology assess the appropriateness of antimicrobials prescribed for a broad spectrum of indications with acceptable agreement and validity, regardless of their experience or hospital of employment. However, there is room for improvement, which merits attention in multidisciplinary discussions and education.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether experts agree on the assessment of appropriate antimicrobial prescribing based on the study described.\n\nFirst, I need to recall the details from the provided information. The study involved 24 doctors, including specialists and residents, who evaluated 56 cases. The reference standard was the modal opinion of the 16 specialists. The specialists agreed with this reference standard 80% of the time, with sensitivity 75% and specificity 84%. Also, their agreement didn't vary by specialty, hospital, or experience. Residents had similar results. The index expert (a senior physician) had 76% agreement with other specialists and 71% agreement with his own past assessments.\n\nThe question is whether experts agree. The options are yes, no, maybe. The key here is looking at the agreement percentages. 80% agreement with the reference (which is their own modal opinion) suggests a reasonable level of agreement, but not perfect. However, the question is phrased as \"do experts agree?\" The study shows that there is a significant level of agreement (80% overall), but there's also variability (since it's not 100%). However, in research terms, agreement levels like 80% might be considered substantial. The options are yes/no/maybe. The answer options might hinge on whether the agreement is considered sufficient. The study's results indicate that there is agreement, but not perfect. Since the question is whether they agree, and the answer options are yes/no/maybe, the correct answer would be \"yes\" because the majority (80%) agreed. The fact that there's some disagreement (20% not agreeing) might make someone think \"maybe,\" but in medical studies, even 80% agreement is often considered acceptable. The options don't have a \"partially\" so the best fit is \"yes.\" The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 366,
            "completion_tokens": 405
        },
        "time_elapsed": 4.660871505737305
    },
    {
        "realidx": "27338535",
        "question": "Current risk assessment models for surgical site occurrence (SSO) and surgical site infection (SSI) after open ventral hernia repair (VHR) have limited external validation. Our aim was to determine (1) whether existing models stratify patients into groups by risk and (2) which model best predicts the rate of SSO and SSI.\nPatients who underwent open VHR and were followed for at least 1\u00a0mo were included. Using two data sets-a retrospective multicenter database (Ventral Hernia Outcomes Collaborative) and a single-center prospective database (Prospective)-each patient was assigned a predicted risk with each of the following models: Ventral Hernia Risk Score (VHRS), Ventral Hernia Working Group (VHWG), Centers for Disease Control and Prevention Wound Class, and Hernia Wound Risk Assessment Tool (HW-RAT). Patients in the Prospective database were also assigned a predicted risk from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Areas under the receiver operating characteristic curve (area under the curve [AUC]) were compared to assess the predictive accuracy of the models for SSO and SSI. Pearson's chi-square was used to determine which models were able to risk-stratify patients into groups with significantly differing rates of actual SSO and SSI.\nThe Ventral Hernia Outcomes Collaborative database (n\u00a0=\u00a0795) had an overall SSO and SSI rate of 23% and 17%, respectively. The AUCs were low for SSO (0.56, 0.54, 0.52, and 0.60) and SSI (0.55, 0.53, 0.50, and 0.58). The VHRS (P\u00a0=\u00a00.01) and HW-RAT (P\u00a0<\u00a00.01) significantly stratified patients into tiers for SSO, whereas the VHWG (P\u00a0<\u00a00.05) and HW-RAT (P\u00a0<\u00a00.05) stratified for SSI. In the Prospective database (n\u00a0=\u00a088), 14% and 8% developed an SSO and SSI, respectively. The AUCs were low for SSO (0.63, 0.54, 0.50, 0.57, and 0.69) and modest for SSI (0.81, 0.64, 0.55, 0.62, and 0.73). The ACS-NSQIP (P\u00a0<\u00a00.01) stratified for SSO, whereas the VHRS (P\u00a0<\u00a00.01) and ACS-NSQIP (P\u00a0<\u00a00.05) stratified for SSI. In both databases, VHRS, VHWG, and Centers for Disease Control and Prevention overestimated risk of SSO and SSI, whereas HW-RAT and ACS-NSQIP underestimated risk for all groups.\nDo risk calculators accurately predict surgical site\u00a0occurrences?",
        "answer": "no",
        "answer_rationale": "All five existing predictive models have limited ability to risk-stratify patients and accurately assess risk of SSO. However, both the VHRS and ACS-NSQIP demonstrate modest success in identifying patients at risk for SSI. Continued model refinement is needed to improve the two highest performing models (VHRS and ACS-NSQIP) along with investigation to determine whether modifications to perioperative management based on risk stratification can improve outcomes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether risk calculators accurately predict surgical site occurrences (SSO) and infections (SSI) based on the provided study.\n\nFirst, I need to recall the details from the study summary. The study evaluated several models: VHRS, VHWG, CDC Wound Class, HW-RAT, and ACS-NSQIP in two databases. The key metrics here are the AUC values and whether the models could stratify patients into risk groups.\n\nLooking at the AUCs, which measure predictive accuracy, the study mentions that in the Ventral Hernia Outcomes Collaborative database, the AUCs for SSO were all around 0.5 to 0.6, which is not great because an AUC of 0.5 is like random chance. Similarly, the SSI AUCs were also low. The Prospective database had slightly better AUCs, especially for SSI with ACS-NSQIP at 0.73, which is better but still maybe not high enough. \n\nThe study also notes that some models could stratify patients into groups with different risk levels (like VHRS and HW-RAT for SSO in the first database), but others couldn't. However, the main point is about accuracy. The fact that AUCs were low (most under 0.7) suggests the models aren't very accurate. Additionally, the models either overestimated or underestimated the risks, which means their predictions weren't matching real outcomes. \n\nThe question is whether they \"accurately predict.\" Since the AUCs are generally low and the models have issues with over/underestimation, the answer would lean towards \"no.\" The options are (A) yes, (B) no, (C) maybe. The study's results indicate that the models aren't accurate enough, so the correct answer should be B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 759,
            "completion_tokens": 396
        },
        "time_elapsed": 4.76387357711792
    },
    {
        "realidx": "27394685",
        "question": "The prevalence of combined humeral and glenoid defects varies between 79 and 84\u00a0% in case of chronic posttraumatic anterior shoulder instability. The main goal of this study was to evaluate the relationship between humeral and glenoid defects based on quantitative radiological criteria.\nA retrospective study was performed between 2000 and 2011 including patients who underwent primary surgical shoulder stabilization for chronic posttraumatic anterior shoulder instability, with bone defects in both the glenoid and humerus and a healthy contralateral shoulder. The following measurements were taken: D/R ratio (Hill-Sachs lesion depth/humeral head radius) on an AP X-ray in internal rotation and the D1/D2 ratio [diameter of the involved glenoid articular surfaces (D1)/the healthy one (D2)] on a comparative Bernageau glenoid profile view. Measurements were taken by two observers. Correlations were determined by the Spearman correlation coefficients (r), Bland and Altman diagrams, and intra-class correlation coefficients (ICC). A sample size calculation was done.\nThirty patients were included, 25 men/5 women, mean age 29.8\u00a0\u00b1\u00a011.2\u00a0years. The mean D/R was 23\u00a0\u00b1\u00a012\u00a0% for observer 1 and 23\u00a0\u00b1\u00a010\u00a0% for observer 2. The mean D1/D2 was 95\u00a0\u00b1\u00a04\u00a0% for observer 1 and 94\u00a0\u00b1\u00a06\u00a0% for observer 2. No significant correlation was found between humeral and glenoid bone defects by observer 1 (r\u00a0=\u00a00.23, p\u00a0=\u00a00.22) or observer 2 (r\u00a0=\u00a00.05, p\u00a0=\u00a00.78). Agreement of the observers for the D/R ratio was excellent (ICC\u00a0=\u00a00.89\u00a0\u00b1\u00a00.04, p\u00a0<\u00a00.00001) and good for the D1/D2 ratio (ICC\u00a0=\u00a00.54\u00a0\u00b1\u00a00.14, p\u00a0=\u00a00.006).\nBony defects in chronic anterior posttraumatic dislocation of the shoulder: Is there a correlation between humeral and glenoidal lesions?",
        "answer": "no",
        "answer_rationale": "Humeral and glenoid bone defects were not correlated. Inter-observer reliability was excellent for the D/R ratio and good for the D1/D2 ratio.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether there's a correlation between humeral and glenoid bone defects in chronic anterior posttraumatic shoulder instability based on the provided study.\n\nFirst, I need to recall the key points from the study description. The main goal was to evaluate the relationship between these two types of bone defects. The study included 30 patients who had surgery for chronic instability with defects in both the humerus and glenoid. They measured the D/R ratio (for the humeral Hill-Sachs lesion) and the D1/D2 ratio (for the glenoid defect). \n\nThe results section is crucial here. The question is about correlation, so I should look at the correlation coefficients reported. The study mentions that there was no significant correlation found between the two defects by either observer. Specifically, observer 1 had a Spearman r of 0.23 with p=0.22, and observer 2 had r=0.05 with p=0.78. Since both p-values are above the typical 0.05 threshold, these results don't support a statistically significant correlation. \n\nThe options are (A) yes, (B) no, (C) maybe. The study's conclusion clearly states no significant correlation, so the answer should be B. \n\nWait, just to be thorough, the question is phrased as \"Is there a correlation...\" and the study's findings are negative. The answer options are straightforward. The Bland-Altman and ICC values relate to inter-observer agreement, which is good to excellent for the measurements, but that's about the reliability of the measurements, not the correlation between the two defects. So the main point is the lack of correlation. Therefore, the correct answer is B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 582,
            "completion_tokens": 376
        },
        "time_elapsed": 4.746957302093506
    },
    {
        "realidx": "27456836",
        "question": "To explore whether electrochemiluminescence (ECL) assays can help improve prediction of time to type 1 diabetes in the TrialNet autoantibody-positive population.\nTrialNet subjects who were positive for one or more autoantibodies (microinsulin autoantibody, GAD65 autoantibody [GADA], IA-2A, and ZnT8A) with available ECL-insulin autoantibody (IAA) and ECL-GADA data at their initial visit were analyzed; after a median follow-up of 24 months, 177 of these 1,287 subjects developed diabetes.\nUnivariate analyses showed that autoantibodies by radioimmunoassays (RIAs), ECL-IAA, ECL-GADA, age, sex, number of positive autoantibodies, presence of HLA DR3/4-DQ8 genotype, HbA1c, and oral glucose tolerance test (OGTT) measurements were all significantly associated with progression to diabetes. Subjects who were ECL positive had a risk of progression to diabetes within 6 years of 58% compared with 5% for the ECL-negative subjects (P<0.0001). Multivariate Cox proportional hazards models were compared, with the base model including age, sex, OGTT measurements, and number of positive autoantibodies by RIAs. The model with positivity for ECL-GADA and/or ECL-IAA was the best, and factors that remained significantly associated with time to diabetes were area under the curve (AUC) C-peptide, fasting C-peptide, AUC glucose, number of positive autoantibodies by RIAs, and ECL positivity. Adding ECL to the Diabetes Prevention Trial risk score (DPTRS) improved the receiver operating characteristic curves with AUC of 0.83 (P<0.0001).\nDo Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?",
        "answer": "yes",
        "answer_rationale": "ECL assays improved the ability to predict time to diabetes in these autoantibody-positive relatives at risk for developing diabetes. These findings might be helpful in the design and eligibility criteria for prevention trials in the future.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The main point is whether ECL assays improve prediction of time to type 1 diabetes in TrialNet subjects who are autoantibody-positive.\n\nFirst, the study included 1,287 subjects with autoantibodies and ECL data. Out of these, 177 developed diabetes after 24 months. The univariate analysis showed several factors were associated, including ECL-IAA and ECL-GADA. The key result here is that ECL-positive subjects had a 58% risk over 6 years versus 5% for ECL-negative, which is a huge difference (p<0.0001). \n\nThen, in the multivariate analysis, the best model included ECL-GADA and/or ECL-IAA along with other factors. The AUC increased to 0.83 when adding ECL to the DPTRS, which is a significant improvement (p<0.0001). Since the question is asking if ECL improves prediction, the answer should be yes because the study's results show that including ECL positivity significantly enhances the model's predictive ability. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 521,
            "completion_tokens": 262
        },
        "time_elapsed": 3.2720775604248047
    },
    {
        "realidx": "27549226",
        "question": "The \"health workforce\" crisis has led to an increased interest in health professional education, including MPH programs. Recently, it was questioned whether training of mid- to higher level cadres in public health prepared graduates with competencies to strengthen health systems in low- and middle-income countries. Measuring educational impact has been notoriously difficult; therefore, innovative methods for measuring the outcome and impact of MPH programs were sought. Impact was conceptualized as \"impact on workplace\" and \"impact on society,\" which entailed studying how these competencies were enacted and to what effect within the context of the graduates' workplaces, as well as on societal health.\nThis is part of a larger six-country mixed method study; in this paper, the focus is on the qualitative findings of two English language programs, one a distance MPH program offered from South Africa, the other a residential program in the Netherlands. Both offer MPH training to students from a diversity of countries. In-depth interviews were conducted with 10 graduates (per program), working in low- and middle-income health systems, their peers, and their supervisors.\nImpact on the workplace was reported as considerable by graduates and peers as well as supervisors and included changes in management and leadership: promotion to a leadership position as well as expanded or revitalized management roles were reported by many participants. The development of leadership capacity was highly valued amongst many graduates, and this capacity was cited by a number of supervisors and peers. Wider impact in the workplace took the form of introducing workplace innovations such as setting up an AIDS and addiction research center and research involvement; teaching and training, advocacy, and community engagement were other ways in which graduates' influence reached a wider target grouping. Beyond the workplace, an intersectoral approach, national reach through policy advisory roles to Ministries of Health, policy development, and capacity building, was reported. Work conditions and context influenced conduciveness for innovation and the extent to which graduates were able to have effect. Self-selection of graduates and their role in selecting peers and supervisors may have resulted in some bias, some graduates could not be traced, and social acceptability bias may have influenced findings.\nImpact of MPH programs: contributing to health system strengthening in low- and middle-income countries?",
        "answer": "yes",
        "answer_rationale": "There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether MPH programs contribute to health system strengthening in low- and middle-income countries based on the provided study.\n\nFirst, I need to recall the details from the passage. The study looked at two MPH programs, one in South Africa (distance) and one in the Netherlands (residential). They did in-depth interviews with graduates, their peers, and supervisors. The key findings were that graduates reported significant impact on their workplaces, like moving into leadership roles, introducing new initiatives such as research centers, teaching, advocacy, and community engagement. There was also mention of broader societal impacts like policy advisory roles and capacity building. \n\nThe question is whether this impact means the MPH programs are contributing to health system strengthening. The options are yes, no, maybe. \n\nThe passage states that the impact on the workplace was considered considerable by all parties involved\u2014graduates, peers, supervisors. They mention specific positive outcomes like leadership roles and innovations. Even though there were limitations like possible bias from self-selection and some graduates not being traced, the overall findings seem to support a positive impact. The study's conceptualization of impact (workplace and society) shows that the programs did lead to changes that strengthen health systems. \n\nThe answer should be (A) yes because the evidence from the qualitative findings points to positive contributions despite some methodological limitations. The question is asking if the programs are contributing, and the study's results indicate they are, even if there are some biases. The limitations might affect the extent or generalizability, but the question isn't about the study's validity but whether the impact exists based on the given info. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 535,
            "completion_tokens": 348
        },
        "time_elapsed": 5.320626497268677
    },
    {
        "realidx": "27592038",
        "question": "Tinnitus can be related to many different aetiologies such as hearing loss or a noise trauma, but it can also be related to the somatosensory system of the cervical spine, called cervicogenic somatic tinnitus (CST). Case studies suggest a positive effect of cervical spine treatment on tinnitus complaints in patients with CST, but no experimental studies are available.\nTo investigate the effect of a multimodal cervical physical therapy treatment on tinnitus complaints in patients with CST.\nRandomized controlled trial.\nPatients with a combination of severe subjective tinnitus (Tinnitus Functional Index (TFI): 25-90 points) and neck complaints (Neck Bournemouth Questionnaire (NBQ)\u00a0>\u00a014 points).\nAll patients received cervical physical therapy for 6 weeks (12 sessions). Patients were randomized in an immediate-start therapy group (n\u00a0=\u00a019) and a 6-week delayed-start therapy group (n\u00a0=\u00a019).\nTFI and NBQ-scores were documented at baseline, after the wait-and-see period in the delayed-start group, after treatment and after 6 weeks follow-up. The Global Perceived Effect (GPE) was documented at all measuring moments, except at baseline.\nIn all patients (n\u00a0=\u00a038) TFI and NBQ-scores decreased significantly after treatment (p\u00a0=\u00a00.04 and p\u00a0<\u00a00.001). NBQ-scores remained significantly lower after follow-up (p\u00a0=\u00a00.001). Immediately after treatment, 53% (n\u00a0=\u00a038) experienced substantial improvement of tinnitus. This effect was maintained in 24% of patients after follow-up at six weeks.\nDoes multi-modal cervical physical therapy improve tinnitus in patients with cervicogenic somatic tinnitus?",
        "answer": "yes",
        "answer_rationale": "Cervical physical therapy can have a positive effect on subjective tinnitus complaints in patients with a combination of tinnitus and neck complaints. Larger studies, using more responsive outcome measures, are however necessary to prove this effect.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether multi-modal cervical physical therapy improves tinnitus in patients with cervicogenic somatic tinnitus (CST). The provided information is from a study.\n\nFirst, I need to recall the study details. The study was a randomized controlled trial with two groups: immediate-start and delayed-start. Both groups received the treatment eventually. The main outcomes measured were TFI (Tinnitus Functional Index) and NBQ (Neck Bournemouth Questionnaire) scores. \n\nThe results showed that after treatment, TFI scores (which measure tinnitus impact) decreased significantly (p=0.04) and NBQ scores (neck complaints) also decreased a lot (p<0.001). The improvement in neck scores was maintained at follow-up. For tinnitus, 53% of all patients had substantial improvement right after treatment, but this dropped to 24% at six weeks follow-up. \n\nThe question is whether the therapy improves tinnitus in CST. The options are yes, no, maybe. \n\nThe key here is the wording of the question. The study shows a significant decrease in TFI after treatment, which indicates improvement. However, the follow-up shows that the effect wasn't as sustained (only 24% maintained it). But the question is about whether the therapy \"improves\" tinnitus. Since the immediate effect was significant, even if not all maintained it, the answer would lean towards yes. The study's own conclusion probably supports that the therapy does have an effect, even if not long-lasting. The options don't ask about long-term, just improvement. So the answer should be (A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 468,
            "completion_tokens": 352
        },
        "time_elapsed": 4.960047483444214
    },
    {
        "realidx": "27615402",
        "question": "Parental drinking has been shown to be associated with offspring drinking. However, the relationship appears to be more complex than often assumed and few studies have tracked it over longer time periods.\nTo explore the long-term (10-year) transmission of familial drinking during adolescence to offspring drinking patterns in young adulthood.\nSwedish longitudinal study, assessing the relationship between familial drinking in 2000 and offspring drinking in 2010 using simultaneous quantile regression analysis (n=744).DATA: Data on familial drinking was gathered from the Swedish level-of-living surveys (LNU) and from partner LNU in 2000 while data on offspring drinking in young adulthood was gathered from LNU 2010. Drinking among offspring, parents and potential stepparents was measured through identical quantity-frequency indices referring to the past 12 months in 2010 and 2000 respectively.\nYoung adults whose families were abstainers in 2000 drank substantially less across quintiles in 2010 than offspring of non-abstaining families. The difference, however, was not statistically significant between quintiles of the conditional distribution. Actual drinking levels in drinking families were not at all or weakly associated with drinking in offspring. Supplementary analyses confirmed these patterns.\nDoes the familial transmission of drinking patterns persist into young adulthood?",
        "answer": "maybe",
        "answer_rationale": "The association between familial drinking and offspring drinking in young adulthood exhibits clear non-linear trends. Changes in the lower part of the familial drinking distribution are strongly related to drinking in young adults, but the actual levels of drinking in drinking families appear less important in shaping the drinking patterns of the offspring in young adulthood.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "C",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether the familial transmission of drinking patterns persists into young adulthood based on the provided study.\n\nFirst, I need to understand the study's findings. The study tracked families over 10 years, from 2000 to 2010. They looked at parental drinking in 2000 and compared it to their offspring's drinking in 2010. The key points from the study are:\n\n1. Offspring from abstaining families drank less in 2010, but the difference wasn't statistically significant across quintiles.\n2. Actual drinking levels in families (non-abstaining) weren't strongly linked to the offspring's drinking.\n\nThe question is whether the transmission persists. The options are yes, no, or maybe. \n\nThe study says that even though there was a trend (abstaining families had kids who drank less), the difference wasn't statistically significant. Also, the actual levels of drinking in the families didn't have a strong association. So the main conclusion here is that the familial transmission isn't really persisting because the effect isn't statistically significant and the association is weak. \n\nTherefore, the answer should be \"no\" because the study's results don't support a significant or strong persistent transmission. The correct option is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 368,
            "completion_tokens": 277
        },
        "time_elapsed": 3.9939072132110596
    },
    {
        "realidx": "27642458",
        "question": "Polio eradication is now feasible after removal of Nigeria from the list of endemic countries and global reduction of cases of wild polio virus in 2015 by more than 80%. However, all countries must remain focused to achieve eradication. In August 2015, the Catholic bishops in Kenya called for boycott of a polio vaccination campaign citing safety concerns with the polio vaccine. We conducted a survey to establish if the coverage was affected by the boycott.\nA cross sectional survey was conducted in all the 32 counties that participated in the campaign. A total of 90,157 children and 37,732 parents/guardians were sampled to determine the vaccination coverage and reasons for missed vaccination.\nThe national vaccination coverage was 93% compared to 94% in the November 2014 campaign. The proportion of parents/guardians that belonged to Catholic Church was 31% compared to 7% of the children who were missed. Reasons for missed vaccination included house not being visited (44%), children not being at home at time of visit (38%), refusal by parents (12%), children being as leep (1%), and various other reasons (5%). Compared to the November 2014 campaign, the proportion of children who were not vaccinated due to parent's refusal significantly increased from 6% to 12% in August 2015.\nDid the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015?",
        "answer": "no",
        "answer_rationale": "The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety issues are addressed accordingly.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the boycott called by the Catholic bishops in Kenya affected the polio vaccination coverage in 2015. The options are yes, no, or maybe.\n\nFirst, I need to look at the data provided. The national vaccination coverage was 93% in August 2015 compared to 94% in November 2014. That's a slight decrease, but maybe not significant? The key point here is the reason for the missed vaccinations. The proportion of parents refusing vaccination doubled from 6% to 12% between the two campaigns. The Catholic Church members made up 31% of the parents, but only 7% of the missed children. Wait, that might be a bit confusing. Let me parse that again.\n\nThe survey found that 31% of the parents/guardians were Catholic, but only 7% of the missed children were attributed to that. Hmm, maybe the refusal rate among Catholics was higher? But the data given says that the overall refusal rate went up to 12% from 6%, which is a significant increase. The problem states that the bishops called for a boycott, so if the refusal rate doubled around the same time, that's a strong indicator that the boycott had an effect. However, the total coverage only dropped by 1%, which might not seem like much. But the key is the reason for the drop. Since the refusal rate specifically increased, and that's exactly what a boycott would cause, it's likely that the boycott contributed. The answer options are yes, no, maybe. The data shows a significant increase in refusal, which aligns with the boycott's impact. So the answer should be A) yes. Wait, but the coverage didn't drop by a huge amount. But the question is whether the boycott affected it. Since the refusal rate doubled, that's a direct effect. So the answer is yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 413,
            "completion_tokens": 409
        },
        "time_elapsed": 4.625082731246948
    },
    {
        "realidx": "27643961",
        "question": "Comorbid major depression (MD) and alcohol use disorder (AUD), particularly in adolescents, have been shown to be associated with poorer subsequent MD outcomes.\nLongitudinal data were used to model associations between a four-level classification of MD/AUD during the period 15-18 years (neither; MD-only; AUD-only; comorbid MD/AUD) and MD over the period 18-35 years. These associations were then adjusted for confounding by a series of factors measured in childhood.\nThe three disorder groups had rates of adult MD during the period 18-35 years that were significantly (p<.05) higher than that of the group with no disorder. Furthermore, those in the comorbid MD/AUD group had significantly (p<.05) higher rates of adult MD than those in the AUD-only group, and marginally (p<.10) higher rates of adult MD than those in the MD-only group. After adjustment for confounding, the difference in rates of adult MD between the MD-only group and the MD/AUD group were no longer statistically significant. The factors that explained the associations were gender, childhood behavior problems, and exposure to physical and sexual abuse.\nThe data were obtained by self-report, and may have been subject to biases.\nMajor depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression?",
        "answer": "no",
        "answer_rationale": "The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether comorbidity of major depression and alcohol use disorder in adolescence leads to poorer outcomes of depression. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study used longitudinal data from 15-18 years and followed up until 35. The groups were: neither disorder, MD-only, AUD-only, and comorbid. The key findings were that all three disorder groups had higher adult MD rates than the no-disorder group. The comorbid group had significantly higher rates than AUD-only and marginally higher than MD-only. However, after adjusting for confounders like gender, childhood behavior problems, and abuse, the difference between MD-only and comorbid groups wasn't significant anymore.\n\nSo, the question is whether comorbidity leads to worse outcomes. The raw data shows comorbid had worse outcomes than MD-only, but after adjusting for those factors, the difference went away. That suggests that the comorbidity's effect might be explained by those confounders, not the comorbidity itself. So the answer might be that comorbidity doesn't independently lead to worse outcomes once those factors are considered. But the question is phrased as \"Does comorbidity lead to poorer outcomes?\" The study's adjusted results say that when controlling for those variables, the difference between comorbid and MD-only isn't significant. So the comorbidity's effect is not independent. Therefore, the answer would be \"no\" because the association isn't there after adjusting. But wait, the original question is about whether comorbidity leads to poorer outcomes. The study's initial analysis (before adjustment) showed comorbid had worse outcomes, but after adjustment, it's not significant. So the conclusion is that the comorbidity itself isn't the cause; it's the confounding variables. Therefore, the answer is B (no), because the adjusted analysis shows that comorbidity doesn't independently predict worse outcomes. The factors like abuse and behavior problems explain the difference. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 380,
            "completion_tokens": 441
        },
        "time_elapsed": 5.731830596923828
    },
    {
        "realidx": "27757987",
        "question": "Recent studies have found a choroidal thickening in amblyopic eyes and suggested that there might be a relationship between the choroid and amblyopia. The present study aimed to evaluate the effect of a six-month treatment of amblyopia on choroidal thickness in anisometropic hyperopic amblyopic children.\nThirty-two anisometropic hyperopic children with unilateral amblyopia were included in this prospective study. Subfoveal choroidal thickness was measured as the distance between the retinal pigment epithelium and the chorioscleral edge, by using spectral domain enhanced depth imaging optical coherence tomography. The treatment of amblyopia was performed based on the full correction of the refractive error with eyeglasses, a refractive adaptation phase and occlusion by patching the fellow eye.\nThe mean visual acuity of the amblyopic eyes significantly increased from 0.35\u2009\u00b1\u20090.3 to 0.16\u2009\u00b1\u20090.2 logMAR after the treatment (p\u2009<\u20090.001). The mean initial choroidal thickness was significantly higher in the amblyopic eyes than in the fellow eyes (p\u2009=\u20090.019). There were no significant differences between the pre- and post-treatment mean choroidal thickness in the amblyopic eyes (p\u2009=\u20090.428) and in the fellow eyes (p\u2009=\u20090.343). The mean choroidal thickness was still higher in the amblyopic eyes than in the fellow eyes after the treatment (p\u2009=\u20090.006).\nDoes the treatment of amblyopia normalise subfoveal choroidal thickness in amblyopic children?",
        "answer": "no",
        "answer_rationale": "Although a six-month treatment of amblyopia increased the visual acuity of the anisometropic hyperopic amblyopic eyes, it could not significantly change choroidal thickness. Our results were in accordance with the conventional explanation, which suggests visual cortex and lateral geniculate nucleus abnormalities in the pathophysiology of amblyopia.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether treating amblyopia in children normalizes the choroidal thickness. The key points from the study are:\n\nFirst, the amblyopic eyes had a thicker choroid initially compared to the fellow eyes (p=0.019). After six months of treatment, the visual acuity improved significantly. But when looking at choroidal thickness, there was no significant change in the amblyopic eyes (p=0.428) or the fellow eyes (p=0.343). However, even after treatment, the amblyopic eyes still had a thicker choroid than the fellow eyes (p=0.006). \n\nThe question is asking if the treatment normalizes the choroidal thickness. Since the choroidal thickness didn't decrease to the level of the fellow eyes (it remained significantly thicker), the answer should be no. The treatment improved vision but didn't bring the choroidal thickness back to normal levels. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 455,
            "completion_tokens": 217
        },
        "time_elapsed": 2.8722598552703857
    },
    {
        "realidx": "27818079",
        "question": "This study evaluated the outcomes and complications of the surgical treatment of condylar fractures by the retromandibular transparotid approach. The authors hypothesized that such an approach would be safe and reliable for the treatment of most condylar fractures.\nA retrospective evaluation of patients who underwent surgical reduction of a condylar fracture from January 2012 to December 2014 at the Clinic of Dentistry and Maxillofacial Surgery of the University Hospital of Verona (Verona, Italy) was performed. Inclusion criteria were having undergone surgical treatment of condylar fractures with a retromandibular transparotid approach and the availability of computed tomograms of the preoperative and postoperative facial skeleton with a minimum follow-up of 1\u00a0year. Static and dynamic occlusal function, temporomandibular joint health status, presence of neurologic impairments, and esthetic outcomes were evaluated in all patients.\nThe sample was composed of 25 patients. Preinjury occlusion and temporomandibular joint health were restored in most patients. Esthetic outcomes were deemed satisfactory by clinicians and patients. Neither permanent neurologic impairments nor major postoperative complications were observed.\nIs the Retromandibular Transparotid Approach a Reliable Option for the Surgical Treatment of Condylar Fractures?",
        "answer": "yes",
        "answer_rationale": "According to the results of the present study, the retromandibular transparotid approach is a viable and safe approach for the surgical treatment of condylar fractures.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study in question is evaluating the retromandibular transparotid approach for treating condylar fractures. The authors hypothesized that this approach is safe and reliable. The study was retrospective, looking at patients from 2012 to 2014 at a specific hospital. They included 25 patients who had this surgery and had the necessary follow-up data.\n\nThe key outcomes they looked at were occlusal function, TMJ health, neurological issues, and esthetics. The results showed that pre-injury occlusion and TMJ health were mostly restored. Esthetics were satisfactory for both clinicians and patients, and there were no permanent neurological problems or major complications. \n\nThe question is whether this approach is a reliable option. The options are yes, no, maybe. The study's results support the hypothesis since they didn't find major issues and outcomes were positive. The sample size is 25, which is small, but the results are positive. Since the study's conclusion aligns with the hypothesis, the answer should be yes. The options don't mention sample size as a reason to doubt, so based on the given info, the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 367,
            "completion_tokens": 254
        },
        "time_elapsed": 3.080348491668701
    },
    {
        "realidx": "27858166",
        "question": "Traumatic aortic injury (TAI) is a rare but life-threatening type of injury. We investigate whether the anatomy of the aortic arch influences the severity of aortic injury.\nThis is a retrospective study of twenty-two cases treated with TEVAR for TAI in our department from 2009 to 2014. Aortic injury was assessed in accordance with the recommendations of the Society of Vascular Surgery. We measured the aortic arch angle and the aortic arch index, based on the initial angio-CT scan, in each of the analyzed cases.\nThe mean aortic arch index and mean aortic arch angle were 6.8\u00a0cm and 58.3\u00b0, respectively, in the type I injury group; 4.4\u00a0cm and 45.9\u00b0 in the type III group; 3.3\u00a0cm and 37\u00b0 in the type IV group. There were substantial differences in both the aortic arch index and the aortic arch angle of the type III and IV groups. A multivariate analysis confirmed that the aortic arch angle was significantly associated with the occurrence of type III damage (OR 1.5; 95% CI 1.03-2.2).\nTraumatic aortic injury: does the anatomy of the aortic arch influence aortic trauma severity?",
        "answer": "yes",
        "answer_rationale": "The severity of TAI is influenced by the sharpness of the aortic arch. There is an inverse relationship between the severity of aortic injury and the aortic arch index.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the anatomy of the aortic arch influences the severity of aortic trauma based on the provided study.\n\nFirst, I need to understand the study's findings. The study looked at 22 cases of TAI treated with TEVAR. They measured the aortic arch angle and index. The results showed that the mean values for these parameters varied between different injury types (I, III, IV). Specifically, type I had higher values (6.8 cm and 58.3\u00b0), while types III and IV had lower ones (4.4/45.9 and 3.3/37 respectively). The key point here is that there were substantial differences between types III and IV. \n\nThe multivariate analysis found that the aortic arch angle was significantly associated with type III injury (OR 1.5, 95% CI 1.03-2.2). The OR being over 1 suggests that as the angle increases, the odds of type III injury also increase. The confidence interval doesn't include 1, so the association is statistically significant. \n\nThe question is whether the aortic arch anatomy (angle and index) influences trauma severity. Since the study shows that different injury types have different anatomical measurements and that the angle is a significant predictor for type III, this implies that anatomy does play a role. The answer should be \"yes\" because the data supports an association between the aortic arch's anatomical features and the severity (type) of the injury. The options are A, B, C, so the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 369,
            "completion_tokens": 341
        },
        "time_elapsed": 4.074957370758057
    },
    {
        "realidx": "27989969",
        "question": "The relationship between the use of an endoscope during ventriculoperitoneal shunt (VPS) procedures and infection remains poorly defined. In this study, we sought to analyze whether the simultaneous use of an endoscope could in fact increase the infection rate associated with VPS procedures.\nThis study included 438 VPS procedures, 49 in which an endoscope was used (11.2%) and 389 in which an endoscope was not used (88.8%). The infection rates in these 2 main groups were calculated and compared. Subsequently, 4 new groups were created, composed of patients with a shunt inserted for the first time (groups 1A and 1B) and patients with a shunt reviewed or inserted for a second time (groups 2A and 2B). Groups 1A and 2A comprised patients in whom an endoscope was used simultaneously with VPS surgery, and groups 1B and 2B comprised patients in whom an endoscope was not used. These groups were compared to determine the infection rate.\nThe overall infection rate was 18.5%, including 22.4% in the groups in which an endoscope was used and 18% in those in which an endoscope was not used (P\u00a0=\u00a00.449). Groups 1A and 1B and groups 2A and 2B were matched for possible intervening risk factors. The infection rate was 28.6% in group 1A and 16.2% in group 1B (P\u00a0= 0.27), and 20% in group 2A and 19.8% in group 2B (P\u00a0= 0.977).\nDoes the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection?",
        "answer": "no",
        "answer_rationale": "In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the simultaneous use of a neuroendoscope influences the incidence of ventriculoperitoneal shunt (VPS) infection based on the provided study.\n\nFirst, I need to look at the data given. The study had 438 VPS procedures. 49 used an endoscope (11.2%) and 389 didn't. The overall infection rates were 22.4% in the endoscope group and 18% without. But the p-value here is 0.449, which is greater than 0.05, meaning the difference isn't statistically significant. \n\nThen they split into first-time vs. repeat shunts. For first-time (groups 1A and 1B), the infection rates were 28.6% with endoscope vs 16.2% without. The p-value here is 0.27, still not significant. For the repeat groups (2A and 2B), the rates were 20% vs 19.8%, with a p of 0.977, which is definitely not significant. \n\nAll the p-values are above the typical 0.05 threshold, so there's no statistical evidence that the endoscope increases infection rates. The question is whether the use \"influences\" the incidence. Since the study found no significant difference, the answer should be \"no\". The options are A (yes), B (no), C (maybe). So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 493,
            "completion_tokens": 334
        },
        "time_elapsed": 4.477323055267334
    },
    {
        "realidx": "28056802",
        "question": "It has recently been shown that non-high density lipoprotein cholesterol (non-HDL-C) may be a better predictor of cardiovascular risk than low density lipoprotein cholesterol (LDL-C). Based on known ethic differences in lipid parameters and cardiovascular risk prediction, we sought to study the predictability of attaining non-HDL-C target and long-term major adverse cardiovascular event (MACE) in Thai patients after acute myocardial infarction (AMI) compared to attaining LDL-C target.\nWe retrospectively obtained the data of all patients who were admitted at Maharaj Nakorn Chiang Mai hospital due to AMI during 2006-2013. The mean non-HDL-C and LDL-C during long-term follow-up were used to predict MACE at each time point. The patients were classified as target attainment if non-HDL-C\u2009<100\u00a0mg/dl and/or LDL-C\u2009<70\u00a0mg/dl. The MACE was defined as combination of all-cause death, nonfatal coronary event and nonfatal stroke.\nDuring mean follow-up of 2.6\u2009\u00b1\u20091.6\u00a0years among 868 patients after AMI, 34.4% achieved non-HDL-C target, 23.7% achieved LDL-C target and 21.2% experienced MACEs. LDL-C and non-HDL-C were directly compared in Cox regression model. Compared with non-HDL-C\u2009<100\u00a0mg/dl, patients with non-HDL-C of>130\u00a0mg/dl had higher incidence of MACEs (HR 3.15, 95% CI 1.46-6.80, P\u2009=\u20090.003). Surprisingly, LDL-C\u2009>100\u00a0mg/dl was associated with reduced risk of MACE as compared to LDL\u2009<70\u00a0mg/dl (HR 0.42, 95% CI 0.18-0.98, p\u2009=\u20090.046) after direct pairwise comparison with non-HDL-C level.\nIs non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol?",
        "answer": "yes",
        "answer_rationale": "Non-attaining non-HDL-C goal predicted MACE at long-term follow-up after AMI whereas non-attaining LDL-C goal was not associated with the higher risk. Therefore, non-HDL-C may be a more suitable target of dyslipidemia treatment than LDL-C in patients after AMI.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing non-HDL-C and LDL-C as predictors of MACE after AMI in Thai patients. The key results from the Cox regression are important here.\n\nFirst, the HR for non-HDL-C >130 vs <100 was 3.15, which is a significant increased risk. That supports non-HDL-C being a good predictor. But then, for LDL-C, when comparing >100 to <70, the HR was 0.42, meaning higher LDL-C here was associated with lower MACE risk. Wait, that's unexpected. Normally, higher LDL is bad, but here higher LDL (above 100) had a lower HR than the target. That's confusing. Maybe there's a reverse causality or some confounding factors? Like maybe patients with very low LDL might have other issues, or the categorization is off. But the question is which is a better predictor. Since non-HDL-C showed a clear dose-response (higher levels mean more MACE), while LDL-C here had an inverse association which is counterintuitive, perhaps non-HDL-C is indeed a better predictor. The study's conclusion would lean towards non-HDL-C being better, so the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 579,
            "completion_tokens": 272
        },
        "time_elapsed": 3.2783520221710205
    },
    {
        "realidx": "28143468",
        "question": "Prior literature identified the use of Performance Measurement Systems (PMS) as crucial in addressing improved processes of care. Moreover, a strategic use of PMS has been found to enhance quality, compared to non-strategic use, although a clear understanding of this linkage is still to be achieved. This paper deals with the test of direct and indirect models related to the link between the strategic use of PMS and the level of improved processes in health care organizations. Indirect models were mediated by the degree of perceived managerial discretion.\nA PLS analysis on a survey of 97 Italian managers working for health care organizations in the Lombardy region was conducted. The response rate was 77.6%.\nThe strategic use of PMS in health care organizations directly and significantly (p\u2009<\u20090.001) enhances performance in terms of improved processes. Perceived managerial discretion is positively and significantly (p\u2009<\u20090.001) affected by the strategic use of PMS, whereas the mediation effect is non-significant.\nAre performance measurement systems useful?",
        "answer": "yes",
        "answer_rationale": "This study contributes to the literature investigating the design and implementation of a non-financial measurement tool, such as the non-financial information included into a balanced scorecard (BSC), in health care organizations. Managers in health care organizations can benefit from the strategic use of PMS to effectively allocate their time to strategic opportunities and threats, which might arise and affect organizational, output-related performance, such as improving processes.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking if performance measurement systems (PMS) are useful based on the provided study. The question seems straightforward, but I need to make sure I understand the details given in the passage.\n\nFirst, the study mentions that prior literature shows PMS is crucial for improved processes of care. That already suggests they are useful. Then the study's own findings from a survey of Italian managers in Lombardy found that strategic use of PMS directly and significantly enhances performance in terms of improved processes. The p-value is less than 0.001, which is a strong statistical significance. \n\nThe options are yes, no, maybe. The key here is the direct and significant effect mentioned. Even though the mediation effect through managerial discretion wasn't significant, the direct effect is there. So the answer should be yes. The study supports the usefulness of PMS because strategic use leads to better processes. The question is whether they are useful, and the answer from the study's results is clearly yes. The other options don't fit because there's clear evidence provided here. So the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 310,
            "completion_tokens": 236
        },
        "time_elapsed": 3.1281843185424805
    },
    {
        "realidx": "28196511",
        "question": "Recent studies have shown that early antiretroviral therapy (ART) initiation results in significant HIV transmission reduction. This is the rationale behind the \"test and treat\" policy of the World Health Organization (WHO). Implementation of this policy will lead to an increased incidence of ART-related adverse effects, especially in sub-Saharan Africa (SSA). Is the region yet ready to cope with such a challenging issue?\nThe introduction and widespread use of ART have drastically changed the natural history of HIV/AIDS, but exposure to ART leads to serious medication-related adverse effects mainly explained by mitochondrial toxicities, and the situation will get worse in the near future. Indeed, ART is associated with an increased risk of developing cardiovascular disease, lipodystrophy, prediabetes and overt diabetes, insulin resistance and hyperlactatemia/lactic acidosis. The prevalence of these disorders is already high in SSA, and the situation will be exacerbated by the implementation of the new WHO recommendations. Most SSA countries are characterized by (extreme) poverty, very weak health systems, inadequate and low quality of health services, inaccessibility to existing health facilities, lack of (qualified) health personnel, lack of adequate equipment, inaccessibility and unaffordability of medicines, and heavy workload in a context of a double burden of disease. Additionally, there is dearth of data on the incidence and predictive factors of ART-related adverse effects in SSA, to anticipate on strategies that should be put in place to prevent the occurrence of these conditions or properly estimate the upcoming burden and prepare an adequate response plan. These are required if we are to anticipate and effectively prevent this upcoming burden.\nAntiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new \"test and treat\" policy of the World Health Organization?",
        "answer": "no",
        "answer_rationale": "While SSA would be the first region to experience the huge benefits of implementing the \"test and treat\" policy of the WHO, the region is not yet prepared to manage the consequential increased burden of ART-related toxic and metabolic complications. Urgent measures should be taken to fill the lacunae if SSA is not to become over-burdened by the consequences of the \"test and treat\" policy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether sub-Saharan Africa (SSA) is ready to cope with the increased incidence of ART-related adverse effects due to the WHO's \"test and treat\" policy. \n\nFirst, I need to recall the information provided. The passage mentions several challenges in SSA: poverty, weak health systems, inadequate and low-quality health services, inaccessibility to health facilities, lack of qualified personnel, equipment, and medicines. Also, there's a double burden of diseases, meaning they're dealing with both infectious diseases and now more non-communicable diseases (like those from ART side effects). Plus, there's a lack of data on the incidence and predictive factors of these adverse effects, making it hard to plan prevention or response strategies.\n\nThe question is whether SSA can cope. The options are yes, no, maybe. The passage seems to outline a lot of challenges. The key points are the existing weaknesses in health systems, the high prevalence of conditions like diabetes already, and the lack of data and preparedness. The conclusion in the text suggests that without anticipating and preventing these issues, the situation will get worse. The question is whether they are \"yet ready\"\u2014the passage's tone is cautionary, pointing out that they aren't adequately prepared. \n\nThe options are (A) yes, (B) no, (C) maybe. The answer should be based on the given information. Since the passage lists many obstacles and mentions that strategies are \"required if we are to anticipate,\" implying that currently they aren't ready, the answer is likely B) no. But wait, maybe \"maybe\" if there's a possibility with some effort? However, the text emphasizes the current lack of readiness. The question is whether they are \"yet\" ready, so the answer would be no unless there's indication they can overcome these issues quickly, which the passage doesn't suggest. So B is the answer.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 450,
            "completion_tokens": 398
        },
        "time_elapsed": 4.857126474380493
    },
    {
        "realidx": "28247485",
        "question": "The aim of this study was to determine the prognostic value of the first urinary albumin/creatinine ratio (ACR) for adverse maternal and neonatal outcomes and how it relates to other prognostic factors.\nWe performed a retrospective cohort study from December 2009 to February 2012 with analysis of demographic, clinical and biochemical data from two obstetric day assessment units in hospitals in Southeast Scotland. We included 717 pregnant women, with singleton pregnancies after 20 weeks' gestation, referred for evaluation of suspected preeclampsia and having their first ACR performed. The ability of ACR to predict future outcomes was assessed in both univariable and multivariable logistic regression models. The latter assessed its prognostic value independent of (adjusting for) existing prognostic factors. Primary outcome measures were maternal and neonatal composite adverse outcomes, and a secondary outcome was gestation at delivery.\nIn all, 204 women (28.5%) experienced a composite adverse maternal outcome and 146 women (20.4%) experienced a composite adverse neonatal outcome. Multivariate analysis of log-transformed ACR demonstrated that a 1-unit increase in log ACR is associated with an increased odds of adverse maternal [odds ratio 1.60, 95% confidence interval (CI) 1.45-1.80] and adverse neonatal (odds ratio 1.15, 95% CI 1.02-1.29) composite outcomes, and with reduced gestational age at delivery (coefficient: -0.46, 95% CI -0.54 to -0.38).\nIs the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome?",
        "answer": "yes",
        "answer_rationale": "ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is a prognostic factor for adverse maternal and neonatal outcomes. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The study was a retrospective cohort with 717 pregnant women referred for suspected preeclampsia. They measured the first ACR and looked at outcomes. The primary outcomes were composite adverse maternal and neonatal events. The key results from the multivariate analysis showed that a 1-unit increase in log ACR was associated with increased odds of adverse maternal outcomes (OR 1.60, 95% CI 1.45-1.80) and adverse neonatal outcomes (OR 1.15, 95% CI 1.02-1.29). Also, there was a reduction in gestational age at delivery.\n\nThe question is whether ACR is a prognostic factor. The study's multivariable analysis adjusted for other factors and still found a significant association. The confidence intervals for both ORs don't include 1, which means the associations are statistically significant. So, the ACR does predict these outcomes independently. Therefore, the answer should be yes. The options are A, B, C, but the correct answer is A (yes). The other options don't fit because the data clearly shows a significant association. \"Maybe\" would be if the results were inconclusive or non-significant, but here the ORs are significant. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 489,
            "completion_tokens": 351
        },
        "time_elapsed": 4.074339866638184
    },
    {
        "realidx": "28359277",
        "question": "Governments are urged to determine methods to control the use of medical resources and curb the rise of healthcare costs. The question is, do health behaviors have an impact on the use of medical resources? This study aims to identify and understand the difference in the number of outpatient visits and health examinations based on various health behaviors and to determine whether patients seek medical care for illness from the same physicians.\nThis study used the dataset derived from the Department of Budget, Accounting and Statistics of Kaohsiung, Taiwan in 2005. Persons older than 15\u00a0years were surveyed using an on-site questionnaire. A total of 2911 persons were enrolled in this study. Independent t-tests, chi-square tests, one-way ANOVA, multiple linear regression and binominal logistic regression were used in the data analysis.\nThe regression model for the frequency of doctor visits, health examinations, and whether the same physician is sought for medical care has demonstrated significant correlations with gender, age and education-level variables. Four health behaviors (i.e., exercise habits, dietary habits, regular blood pressure measurement, drinking habits) exhibited a significant correlation with healthcare utilization (P<0.05).\nDo healthier lifestyles lead to less utilization of healthcare resources?",
        "answer": "no",
        "answer_rationale": "Healthy lifestyles lead to an increase in the utilization of preventive health services. However, there is not much significantly reducing the number of outpatient visits in people with health behaviors. Specifically, people with regular exercise habits and who take their blood pressure measurement regularly have an increased number of outpatient visits. It is suggested that more available and accessible health consultation services be provided to inculcate in the general public the importance of maintaining a healthy lifestyle.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether healthier lifestyles lead to less utilization of healthcare resources based on the provided study.\n\nFirst, I need to recall the study's findings. The study looked at health behaviors like exercise, diet, blood pressure checks, and drinking habits. They found that these four behaviors had significant correlations with healthcare utilization (P<0.05). The question is whether healthier behaviors mean less use of resources.\n\nThe options are yes, no, maybe. The study says the health behaviors are significantly correlated. But the direction of the correlation isn't explicitly stated. Wait, the question is phrased as \"do healthier lifestyles lead to less utilization?\" So, if the study found that better health behaviors (which are part of a healthier lifestyle) are associated with lower healthcare use, then the answer would be yes. But if the correlation is the other way around, maybe more utilization, then no.\n\nLooking back at the study description: The aim was to see if health behaviors affect outpatient visits and health exams. The regression models showed significant correlations. The key point here is that the four health behaviors \"exhibited a significant correlation with healthcare utilization.\" But the direction isn't given. However, in many studies, healthier behaviors like exercising and good diet are often linked to lower healthcare use because they prevent illness. But sometimes, people who are health-conscious might get more check-ups, which would increase utilization. \n\nWait, the study mentions \"the frequency of doctor visits, health examinations, and whether the same physician is sought.\" So, if someone exercises and has good dietary habits, maybe they go for more check-ups (health exams) which would be part of healthcare utilization. But the question is about \"less utilization.\" The study's results are significant, but the direction isn't clear from the given info. However, the question is whether healthier lifestyles lead to less use. The options are yes, no, maybe. The study found a significant correlation, but without knowing the direction, maybe the answer is \"maybe\"? But the options might expect an answer based on typical findings. Alternatively, perhaps the study's results, given that they mention \"control the use of medical resources and curb costs,\" implies that healthier behaviors reduce utilization. The question is from the study's data. Since the study found that the four health behaviors are significantly correlated, but the direction is not stated, but the options are yes/no/maybe. Since the question is whether healthier lifestyles lead to less use, and the study found a significant correlation",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 341,
            "completion_tokens": 512
        },
        "time_elapsed": 6.799174547195435
    },
    {
        "realidx": "28707539",
        "question": "Measurement of visceral adipose tissue (VAT) needs to be accurate and sensitive to change for risk monitoring. The purpose of this study is to determine the CT slice location where VAT area can best reflect changes in VAT volume and body weight.\n60 plain abdominal CT images from 30 males\u00a0[mean age (range) 51 (41-68) years, mean body weight (range) 71.1 (101.9-50.9) kg] who underwent workplace screenings twice within a 1-year interval were evaluated. Automatically calculated and manually corrected areas of the VAT of various scan levels using \"freeform curve\" region of interest on CT were recorded and compared with body weight changes.\nThe strongest correlations of VAT area with VAT volume and body weight changes were shown in a slice 3 cm above the lower margin of L3 with r values of 0.853 and 0.902, respectively.\nVisceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume?",
        "answer": "yes",
        "answer_rationale": "VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about measuring visceral adipose tissue (VAT) using CT scans. The main goal was to find the best CT slice location that can accurately reflect changes in VAT volume and body weight. They looked at 60 CT images from 30 males who had two scans a year apart.\n\nThe key finding here is that the strongest correlations were at a slice 3 cm above the lower margin of L3. The r values were 0.853 for VAT volume and 0.902 for body weight changes. Now, the question is asking if a single level VAT area measurement can represent VAT volume. \n\nHmm, correlation coefficients close to 1 indicate a strong relationship. An r of 0.85 is pretty high, which suggests that the VAT area at that specific slice is a good indicator of the total VAT volume. The question is whether a single slice can \"represent\" the volume. Since the correlation is strong, it implies that changes in the area at that slice are closely tied to changes in the total volume. But wait, the options are yes, no, maybe. \n\nThe study's purpose was to determine if the single slice can best reflect the changes. The results show that at 3 cm above L3, the correlation is strong. So the answer would be yes, because the high correlation suggests that the single slice area is a good proxy for the volume. But maybe there's a catch. The question is phrased as \"can it represent\" \u2013 does a high correlation mean it's sufficient? The study's conclusion probably supports that this specific slice is effective. So the answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 311,
            "completion_tokens": 351
        },
        "time_elapsed": 4.31709098815918
    },
    {
        "realidx": "29112560",
        "question": "It is unclear whether traveling long distances to high-volume centers would compensate for travel burden among patients undergoing rectal cancer resection.\nThe purpose of this study was to determine whether operative volume outweighs the advantages of being treated locally by comparing the outcomes of patients with rectal cancer treated at local, low-volume centers versus far, high-volume centers.\nThis was a population-based study.\nThe National Cancer Database was queried for patients with rectal cancer.\nPatients with stage II or III rectal cancer who underwent surgical resection between 2006 and 2012 were included.\nThe outcomes of interest were margins, lymph node yield, receipt of neoadjuvant chemoradiation, adjuvant chemotherapy, readmission within 30 days, 30-day and 90-day mortality, and 5-year overall survival.\nA total of 18,605 patients met inclusion criteria; 2067 patients were in the long-distance/high-volume group and 1362 in the short-distance/low-volume group. The median travel distance was 62.6 miles for the long-distance/high-volume group and 2.3 miles for the short-distance/low-volume group. Patients who were younger, white, privately insured, and stage III were more likely to have traveled to a high-volume center. When controlled for patient factors, stage, and hospital factors, patients in the short-distance/low-volume group had lower odds of a lymph node yield \u226512 (OR = 0.51) and neoadjuvant chemoradiation (OR = 0.67) and higher 30-day (OR = 3.38) and 90-day mortality (OR = 2.07) compared with those in the long-distance/high-volume group. The short-distance/low-volume group had a 34% high risk of overall mortality at 5 years compared with the long-distance/high-volume group.\nWe lacked data regarding patient and physician decision making and surgeon-specific factors.\nIs the Distance Worth It?",
        "answer": "yes",
        "answer_rationale": "Our results indicate that when controlled for patient, tumor, and hospital factors, patients who traveled a long distance to a high-volume center had improved lymph node yield, neoadjuvant chemoradiation receipt, and 30- and 90-day mortality compared with those who traveled a short distance to a low-volume center. They also had improved 5-year survival. See Video Abstract at http://links.lww.com/DCR/A446.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether traveling long distances to high-volume centers for rectal cancer surgery is worth the trouble compared to local low-volume centers. The key outcomes they looked at include things like lymph node yield, receipt of chemotherapy, mortality rates, and survival.\n\nFrom the data given, the short-distance/low-volume group had worse outcomes. They had lower odds of getting enough lymph nodes sampled (which is important for staging) and less likely to get neoadjuvant treatment. Also, their 30-day and 90-day mortality was higher. Plus, their 5-year survival was worse. The study controlled for factors like patient characteristics and hospital factors, so the results are adjusted for those. The conclusion seems to suggest that even though traveling is a burden, the high-volume centers provide better outcomes. So the answer would be \"yes\" the distance is worth it. The options are A, B, C. So A is yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 514,
            "completion_tokens": 204
        },
        "time_elapsed": 2.877401351928711
    },
    {
        "realidx": "7482275",
        "question": "The accepted treatment protocol for necrotizing fasciitis (NF) consists of extensive surgery and wide spectrum antibiotics. Hyperbaric oxygenation (HBO) has been recommended as adjuvant therapy for NF, improving patient mortality and outcome. However, the beneficial effect of HBO for NF remains controversial.\nA retrospective evaluation of treatment outcome in 37 patients treated for NF between 1984 and 1993 was carried out. The mortality rate, morbidity criteria, and risk factors for grave prognosis were compared between a group of 25 patients who received HBO as part of their treatment protocol and a group of the remaining 12 patients treated by surgical excision and antibiotics alone.\nThe two groups were found to be similar with regard to age, gender, the incidence of individual risk factors for ominous prognosis, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score for disease's severity on presentation. The mortality rate among the HBO-treated patients was 36%, as opposed to 25% in the non-HBO group. The mean number of surgical d\u00e9bridements required per patient was significantly higher in the HBO group: 3.3 compared with 1.5 in the non-HBO-treated patients. Although the average length of hospitalization for survivors was shorter for the HBO group, the difference between the groups did not reach statistical significance.\nNecrotizing fasciitis: an indication for hyperbaric oxygenation therapy?",
        "answer": "no",
        "answer_rationale": "The results of this study cast doubt on the suggested advantage of HBO in reducing patient mortality and morbidity when used as adjuvant therapy for NF.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether hyperbaric oxygen therapy (HBO) is an indication for necrotizing fasciitis (NF) based on the provided study.\n\nFirst, I need to recall what the question is about. The study compared two groups: one treated with HBO plus surgery and antibiotics, and the other with just surgery and antibiotics. The key points from the study are the mortality rates, number of surgeries, and hospital stay.\n\nThe mortality rate in the HBO group was 36% versus 25% in the non-HBO group. Wait, that's actually higher in the HBO group. But the difference might not be statistically significant. The problem states that the two groups were similar in age, gender, risk factors, and APACHE II scores, so they were comparable. \n\nThe number of surgical d\u00e9bridements was higher in the HBO group (3.3 vs 1.5), which is a significant difference. However, the average hospital stay for survivors was shorter in HBO but not statistically significant. \n\nThe question is whether HBO is indicated. The options are yes, no, maybe. The study's results show that HBO didn't improve mortality (it was worse, though maybe not significantly) and required more surgeries. The hospital stay wasn't better either. Since the mortality is higher in HBO group, even if not significant, and more surgeries needed, the study might suggest HBO isn't beneficial. The conclusion here would lean towards not recommending HBO, so the answer would be B (no). But I need to check if there's any other factor. The question mentions that HBO's benefit is controversial. The study's results don't support HBO's efficacy, so the answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 390,
            "completion_tokens": 359
        },
        "time_elapsed": 4.379744291305542
    },
    {
        "realidx": "7497757",
        "question": "To determine if temperature during cardiopulmonary bypass (CPB) has an effect on perioperative and postoperative thyroid function.\nProspective study comparing thyroid function during and after hypothermic and normothermic CPB.\nCardiac surgical unit at a university-affiliated hospital.\nTwelve patients scheduled to undergo cardiac operations with normothermic (n = 6) or hypothermic (n = 6) CPB.\nBlood was analyzed for serum concentration of total thyroxine (TT4), total triiodothyronine (TT3), free T3 (fT3), reverse T3 (rT3), and thyroid stimulating hormone (TSH) preoperatively, 60 min after CPB was initiated, 30 min after discontinuing CPB, and on postoperative days (POD) 1, 3, and 5.\nPatients who underwent either cold (26 degrees +/- 5 degrees C) or warm (35 degrees +/- 1 degree C) CPB were comparable with regard to age, body weight, duration of CPB, cross-clamp time, use of inotropes, total heparin dose, and length of hospital stay. Incidence of postoperative myocardial infarction, congestive heart failure, and death were similar. In both groups, TT4 and TT3 were reduced below baseline values beginning with CPB and persisting for up to 5 days after CPB (p<0.05), free T3 was reduced for up to 3 days after CPB (p<0.05), mean serum rT3 was elevated on POD 1 and POD 3 (p<0.05), and TSH remained unchanged.\nCardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome?",
        "answer": "no",
        "answer_rationale": "The results of this study suggest that normothermic CPB does not prevent the development of the \"euthyroid sick syndrome\" during and after CPB. Despite these changes in thyroid function, most patients in both groups had a normal postoperative recovery.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the temperature during cardiopulmonary bypass (CPB) affects the postoperative euthyroid sick syndrome. The options are yes, no, or maybe.\n\nFirst, I need to recall what euthyroid sick syndrome (ESS) is. ESS is a condition where there are abnormal thyroid function tests in the setting of non-thyroidal illness. Common changes include low T3, low T4, and high reverse T3 (rT3), with normal or low TSH. It's often seen in critical illnesses or major surgeries.\n\nThe study mentioned here compares hypothermic (cold) vs. normothermic (warm) CPB. The key results from the study are that in both groups, TT4 and TT3 were reduced below baseline from the start of CPB and lasted up to 5 days. Free T3 was down for 3 days, rT3 was elevated on days 1 and 3, and TSH didn't change. Importantly, the groups (cold vs. warm CPB) were comparable in various factors like age, CPB duration, etc., and outcomes like myocardial infarction were similar.\n\nThe question is whether the temperature during CPB affects the development of ESS. Since the study found that both groups had similar changes in thyroid function parameters (TT4, TT3, fT3, rT3) over time, and TSH remained unchanged in both, this suggests that the temperature didn't make a difference. The fact that the outcomes were similar between the two groups implies that the temperature during CPB doesn't influence the postoperative ESS. Therefore, the answer would be \"yes\" because the temperature doesn't affect it. Wait, but the options are (A) yes, (B) no, (C) maybe. Wait, the question is phrased as \"Cardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome?\" So the statement is saying that temperature doesn't have an effect. The correct answer would be whether that statement is true. Since the study found no differences between the two groups in the thyroid parameters, the conclusion is that temperature doesn't affect ESS. Therefore, the answer is A (yes, the statement is correct). But wait, the options are phrased as the answer to the question: \"does not affect...\" So if the study shows that temperature doesn't make a difference, then the answer",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 512
        },
        "time_elapsed": 6.194189548492432
    },
    {
        "realidx": "7547656",
        "question": "Bolus intravenous injection of epinephrine can decrease uterine blood flow. This study examined the effects of intravenous infusion of epinephrine on uterine blood flow in the gravid ewe.\nMaternal and fetal vascular catheters and a maternal electromagnetic uterine artery flow probe were implanted in 10 near-term gravid ewes. After recovery, saline, 0.125% bupivacaine, 0.125% bupivacaine with 1:200,000 epinephrine, 0.125% bupivacaine with 1:400,000 epinephrine, and 0.125% bupivacaine with 1:800,000 epinephrine were infused into the maternal superior vena cava. Drugs were infused at 10 mL/h for 30 minutes and then at 20 mL/h for an additional 30 minutes. Animals also received an intravenous bolus of epinephrine 15 micrograms. Throughout all infusions, maternal heart rate, systemic and pulmonary blood pressures, uterine blood flow, cardiac output, and acid-base balance were measured, as well as fetal heart rate, blood pressure, and acid-base balance.\nEpinephrine 15 micrograms decreased uterine blood flow to 68 +/- 14% of baseline (mean +/- SD). Infusion of all solutions had no effect on any measured hemodynamic variable.\nDoes continuous intravenous infusion of low-concentration epinephrine impair uterine blood flow in pregnant ewes?",
        "answer": "no",
        "answer_rationale": "In gravid ewes, intravenous infusion of<or = 1.67 micrograms/min epinephrine altered neither maternal hemodynamics nor uterine blood flow. To the extent that sheep data can be extrapolated to humans, these results suggest that continuous intravenous infusion of epinephrine in local anesthetic solutions is safe if the epidural catheter should enter a blood vessel during the infusion.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether continuous intravenous infusion of low-concentration epinephrine impairs uterine blood flow in pregnant ewes. The options are yes, no, or maybe.\n\nFirst, I need to look at the study details provided. The question mentions that a bolus injection of epinephrine decreases uterine blood flow. But the study here is about intravenous infusion, not a bolus. The study used 10 pregnant ewes. They infused various solutions into the superior vena cava. The solutions included saline, bupivacaine with different concentrations of epinephrine (1:200,000, 1:400,000, 1:800,000), and plain bupivacaine. The infusion rates were 10 mL/h for 30 minutes, then 20 mL/h for another 30 minutes. They also gave a bolus of 15 micrograms epinephrine, which did reduce uterine blood flow to 68% of baseline. However, the key part here is the results of the infusions. The study states that \"Infusion of all solutions had no effect on any measured hemodynamic variable.\" That includes uterine blood flow. So even though the bolus caused a decrease, the continuous infusion of the low concentrations of epinephrine in the solutions didn't affect uterine blood flow. The question is specifically about the infusion, not the bolus. Therefore, the answer should be no, because the infusions didn't impair uterine blood flow. The options are (A) yes, (B) no, (C) maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 443,
            "completion_tokens": 377
        },
        "time_elapsed": 4.4686925411224365
    },
    {
        "realidx": "7664228",
        "question": "To determine whether decreasing lengths of stay over time for selected diagnostic categories were associated with increased hospital readmission rates and mean number of physician visits after discharge.\nRetrospective descriptive study.\nThe seven large (125 beds or more) acute care hospitals in Winnipeg.\nManitoba residents admitted to any one of the seven hospitals because acute myocardial infarction (AMI), bronchitis or asthma, transurethral prostatectomy (TURP) and uterine or adnexal procedures for nonmalignant disease during the fiscal years 1989-90 to 1992-93. Patients from out of province, those who died in hospital, those with excessively long stays (more than 60 days) and those who were transferred to or from another institution were excluded.\nLength of hospital stay, and rate of readmission within 30 days after discharge for all four categories and mean number of physician visits within 30 days after discharge for two categories (AMI and bronchitis or asthma.\nThe length of stay decreased significantly over the 4 years for all of the four categories, the smallest change being observed for patients with AMI (11.1%) and the largest for those with bronchitis or asthma (22.0%). The readmission rates for AMI, bronchitis or asthma, and TURP showed no consistent change over the 4 years. The readmission rate for uterine or adnexal procedures increased significantly between the first and second year (chi 2 = 4.28, p = 0.04) but then remained constant over the next 3 years. The mean number of physician visits increased slightly for AMI in the first year (1.92 to 2.01) and then remained virtually the same. It decreased slightly for bronchitis or asthma over the 4 years. There was no significant correlation between length of stay and readmission rates for individual hospitals in 1992-93 in any of the four categories. Also, no correlation was observed between length of stay and mean number of physician visits for individual hospitals in 1992-93 in the categories AMI and bronchitis or asthma.\nDischarging patients earlier from Winnipeg hospitals: does it adversely affect quality of care?",
        "answer": "no",
        "answer_rationale": "Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether shorter hospital stays are linked to higher readmission rates or more doctor visits after discharge. The options are yes, no, or maybe.\n\nFirst, I need to recall the study's findings. The length of stay decreased over four years for all four categories. But the readmission rates didn't show a consistent increase. For AMI, bronchitis/asthma, and TURP, the readmissions didn't really change much. Only the uterine/adnexal group had an increase in the first year, but then it stayed the same. Also, the physician visits for AMI went up a bit at first but stayed, while for bronchitis they actually decreased. \n\nThe key point here is that the study found no significant correlation between shorter stays and higher readmissions or more doctor visits. The question is asking if discharging patients earlier adversely affects quality of care. Since the data shows that even with shorter stays, the readmissions and visits didn't go up consistently, the answer would lean towards no adverse effect. So the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 572,
            "completion_tokens": 237
        },
        "time_elapsed": 2.971026659011841
    },
    {
        "realidx": "7860319",
        "question": "We compare 30-day and 180-day postadmission hospital mortality rates for all Medicare patients and those in three categories of cardiac care: coronary artery bypass graft surgery, acute myocardial infarction, and congestive heart failure. DATA SOURCES/\nHealth Care Financing Administration (HCFA) hospital mortality data for FY 1989.\nUsing hospital level public use files of actual and predicted mortality at 30 and 180 days, we constructed residual mortality measures for each hospital. We ranked hospitals and used receiver operating characteristic (ROC) curves to compare 0-30, 31-180, and 0-180-day postadmission mortality.\nFor the admissions we studied, we found a broad range of hospital performance when we ranked hospitals using the 30-day data; some hospitals had much lower than predicted 30-day mortality rates, while others had much higher than predicted mortality rates. Data from the time period 31-180 days postadmission yield results that corroborate the 0-30 day postadmission data. Moreover, we found evidence that hospital performance on one condition is related to performance on the other conditions, but that the correlation is much weaker in the 31-180-day interval than in the 0-30-day period. Using ROC curves, we found that the 30-day data discriminated the top and bottom fifths of the 180-day data extremely well, especially for AMI outcomes.\nMeasuring hospital mortality rates: are 30-day data enough?",
        "answer": "yes",
        "answer_rationale": "Using data on cumulative hospital mortality from 180 days postadmission does not yield a different perspective from using data from 30 days postadmission for the conditions we studied.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether 30-day mortality data is enough for measuring hospital mortality rates based on the provided study.\n\nFirst, I need to understand the study's findings. The study compared 30-day and 180-day postadmission mortality rates for Medicare patients, specifically looking at cardiac care categories like CABG, AMI, and CHF. They used HCFA data from 1989 and constructed residual mortality measures. They ranked hospitals and used ROC curves to compare different time periods: 0-30 days, 31-180 days, and 0-180 days.\n\nThe key points from the study are:\n1. The 30-day data showed a broad range of hospital performance. Some had much lower or higher mortality than predicted.\n2. The 31-180 day data corroborated the 0-30 day results. So the longer period data supports the shorter one.\n3. However, the correlation between hospital performance on different conditions was weaker in the 31-180 day interval compared to the first 30 days.\n4. The ROC curves showed that 30-day data discriminated the top and bottom fifths of the 180-day data extremely well, especially for AMI.\n\nThe question is whether 30-day data is enough. The study's results suggest that the 30-day data does a good job in discriminating performance, especially since the 31-180 day data aligns with it. But the fact that there's a weaker correlation in the longer period might indicate that some aspects aren't captured in 30 days. However, the strong discrimination in ROC curves for the top and bottom fifths of 180-day data using 30-day data might mean that 30 days is sufficient. But the study also mentions that the correlation between conditions is weaker later, so maybe longer-term data adds something. The title of the study is a question: \"Measuring hospital mortality rates: are 30-day data enough?\" The answer would depend on whether the 30-day data captures enough to assess overall performance. Since the 30-day data's results are corroborated by the longer period and they discriminate well, maybe the answer is yes. But wait, the study also found that the correlation between conditions is weaker in the longer period. That might mean that hospitals' performance in the longer",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 420,
            "completion_tokens": 512
        },
        "time_elapsed": 6.40229344367981
    },
    {
        "realidx": "8165771",
        "question": "As part of the staging procedure in squamous cell carcinoma of the penis, we assessed the role of ultrasound examination, in particular its role in assessing the extent and the invasion into the corpora.\nFrom 1988 until 1992, all patients referred for primary treatment underwent ultrasound assessment with a 7.5 MHz linear array small parts transducer as part of the clinical workup. All ultrasound images were reviewed by one radiologist, without knowledge of the clinical outcome and were compared with the results obtained at histopathologic examination.\nIn 16 patients the primary tumor and in 1 patient a recurrent cancer after primary therapy were examined. All tumors were identified as hypoechoic lesions. Ultrasound examination in the region of the glans was not able to differentiate between invasion of the subepithelial tissue and invasion into the corpus spongiosum, but absence or presence of invasion into the tunica albuginea of the corpus cavernosum was clearly demonstrated. Accurate measurement by ultrasound of maximum tumor thickness was seen in seven of sixteen examinations.\nUltrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging?",
        "answer": "yes",
        "answer_rationale": "While ultrasound examination is inexpensive and easily done, it is not accurate enough for staging small penile cancers located at the glans penis. However, for larger tumors ultrasound can be a useful addition to physical examination by delineating reliably the anatomic relations of the tumor to structures such as the tunica albuginea, corpus cavernosum, and urethra.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether ultrasound is a useful addition to clinical staging for squamous cell carcinoma of the penis based on the provided study.\n\nFirst, I need to understand the study's findings. The study was done from 1988 to 1992, using a 7.5 MHz transducer. They looked at 16 primary tumors and 1 recurrence. All tumors showed up as hypoechoic, which is a key point. \n\nThe main points from the study: \n- Ultrasound couldn't differentiate between invasion into the subepithelial tissue and the corpus spongiosum in the glans area. That's a limitation.\n- However, it could clearly show whether the tumor invaded the tunica albuginea of the corpus cavernosum. That's a significant finding because the tunica albuginea is a deeper structure, so detecting that invasion would help in staging.\n- They also mention that accurate tumor thickness measurement was possible in 7 out of 16 cases. So not perfect, but some success.\n\nThe question is whether this makes ultrasound a useful addition. Even though there are limitations (like not distinguishing between two layers in the glans), the ability to assess invasion into the tunica albuginea is important for staging. Staging often relies on how deep the tumor has invaded. Since ultrasound can show that, it adds value. The fact that it's not perfect in all measurements doesn't negate its utility where it does work. The study's results suggest that ultrasound provides some critical information that clinical examination alone might miss. Therefore, the answer should be yes (A). The options are (A) yes, (B) no, (C) maybe. The study's positive findings support \"yes\" despite the limitations mentioned.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 326,
            "completion_tokens": 375
        },
        "time_elapsed": 4.320847749710083
    },
    {
        "realidx": "8199520",
        "question": "To explore expressed needs, both formal and informal, of family caregivers of frail elderly. To evaluate roles of physicians.\nQuestionnaire survey of members of the Montreal Jewish community providing care for frail elderly family members.\nJewish community of Montreal.\nVolunteer caregivers who were caring for a family member or friend 60 years or older, who had greatest responsibility for providing physical or emotional support to an elderly person, who saw themselves as caregivers, and who could speak English or French were studied. Of 118 volunteers, 32 were excluded because they withdrew for personal reasons or because they did not meet study criteria.\nDemographic variables, functional status of the care receiver, use of home care services, and needs assessment to identify additional services.\nAn average of 75.4% respondents did not use formal support services. Just under half of caregivers were dissatisfied with the attention they received from the health care system, and more than one third expressed feelings of stress, depression, guilt, and isolation.\nAre physicians meeting the needs of family caregivers of the frail elderly?",
        "answer": "no",
        "answer_rationale": "Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether physicians are meeting the needs of family caregivers of frail elderly based on the study described.\n\nFirst, I need to look at the study details. The study was a questionnaire survey of caregivers in the Montreal Jewish community. They had 118 volunteers, but 32 were excluded, so the sample size is 86. The key findings were that 75.4% didn't use formal services. Also, almost half were dissatisfied with the healthcare system's attention, and over a third felt stressed, depressed, guilty, or isolated.\n\nThe question is about whether physicians are meeting their needs. The data shows high dissatisfaction and emotional strain. If physicians were meeting their needs, we might expect lower dissatisfaction and perhaps more use of formal services. Since a majority aren't using formal services, maybe they aren't aware of them, or the services aren't sufficient. The dissatisfaction directly points to unmet needs. The stress and other negative emotions suggest that caregivers aren't getting the support they need, which could be related to physician involvement. The study's results indicate that there's a problem, so the answer is likely \"no\" because the data shows issues that suggest physicians aren't adequately addressing the caregivers' needs.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 306,
            "completion_tokens": 264
        },
        "time_elapsed": 3.278531312942505
    },
    {
        "realidx": "8375607",
        "question": "Previous studies reported that breast-feeding protects children against a variety of diseases, but these studies were generally conducted on \"high-risk\" or hospitalized children. This paper describes the results of our study on the effects of breast-feeding on rate of illness in normal children with a family history of atopy.\nA historic cohort approach of 794 children with a family history of atopy was used to assess the effects of breast-feeding on illness rates. Family history of atopy was based on allergic diseases in family members as registered by the family physician. Illness data from birth onwards were available from the Continuous Morbidity Registration of the Department of Family Medicine. Information on breast-feeding was collected by postal questionnaire. We then compared rates of illness between children with a family history of atopy who were and who were not breast-fed.\nBreast-feeding was related to lower levels of childhood illness both in the first and the first three years of life. In the first year of life they had fewer episodes of gastroenteritis, lower respiratory tract infections, and digestive tract disorders. Over the next three years of life they had fewer respiratory tract infections and skin infections.\nIs the breast best for children with a family history of atopy?",
        "answer": "yes",
        "answer_rationale": "Our results suggest a protective effect of breast-feeding among children with a family history of atopy that is not confined to the period of breast-feeding but continues during the first three years of life. Breast-feeding should be promoted in children with a family history of atopy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether breast-feeding is best for children with a family history of atopy based on the provided study.\n\nFirst, I need to recall what the study found. The study was a historic cohort of 794 children with a family history of atopy. They compared breast-fed and non-breast-fed kids. The results showed that breast-fed children had lower illness rates. Specifically, in the first year, they had fewer gastroenteritis, lower respiratory infections, and digestive issues. Over the first three years, they also had fewer respiratory and skin infections. \n\nThe question is whether breast is best for these children. The options are yes, no, or maybe. The study's results clearly indicate benefits of breast-feeding in reducing illness rates. The family history of atopy is a risk factor, and the study was conducted on such children, so the answer should align with the findings. Since the study shows positive outcomes, the answer should be yes. The options don't have any qualifiers here, so unless there's a reason to doubt the study's validity, which the text doesn't mention, the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 339,
            "completion_tokens": 244
        },
        "time_elapsed": 3.1472668647766113
    },
    {
        "realidx": "8521557",
        "question": "The insertion/deletion (ID) polymorphism of the angiotensin-converting enzyme (ACE) gene has been associated with increased coronary heart disease (CHD), although the mechanism of this association is not apparent. We tested the hypothesis that the deletion allele of the ACE gene is associated with insulin resistance.\nWe related ACE genotype to components of the insulin-resistance syndrome in 103 non-insulin-dependent diabetic (NIDDM) and 533 nondiabetic white subjects. NIDDM subjects with the DD genotype had significantly lower levels of specific insulin (DD 38.6, ID 57.1, and II 87.4 pmol.L-1 by ANOVA, P = .011). Non-insulin-treated subjects with the DD genotype had increased insulin sensitivity by HOMA % (DD 56.4%, II 29.4%, P = .027) and lower levels of des 31,32 proinsulin (DD 3.3, II 7.6 pmol.L-1, P = .012) compared with II subjects. There were no differences in prevalence of CHD or levels of blood pressure, serum lipids, or plasminogen activator inhibitor-1 (PAI-1) activity between the three ACE genotypes. In nondiabetic subjects there were no differences in insulin sensitivity, levels of insulin-like molecules, blood pressure, PAI-1, serum lipids, or CHD prevalence between the three ACE genotypes.\nThe insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?",
        "answer": "no",
        "answer_rationale": "We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the insertion allele of the ACE gene I/D polymorphism is a candidate gene for insulin resistance. The options are yes, no, or maybe.\n\nFirst, I need to recall the study details provided. The study looked at the ACE gene's ID polymorphism and its association with insulin resistance. The ACE gene has two alleles: the insertion (I) and deletion (D) alleles. The question is about the insertion allele, so I need to focus on the I allele's effects.\n\nThe study included both NIDDM (non-insulin-dependent diabetic) and nondiabetic subjects. In NIDDM subjects with the DD genotype (two deletion alleles), they had lower specific insulin levels compared to II (insertion) genotype. Wait, lower specific insulin might mean they're producing less insulin, but the HOMA% (which estimates insulin resistance) was higher in DD compared to II. HOMA% higher suggests more insulin resistance. Wait, HOMA-IR (insulin resistance) is calculated using fasting insulin and glucose. A higher HOMA% might indicate higher insulin resistance. Wait, actually, HOMA-%B is beta-cell function, and HOMA-IR is insulin resistance. The question mentions HOMA%, so maybe the exact metric here is important. The text says non-insulin-treated subjects with DD had increased insulin sensitivity by HOMA% (56.4% vs 29.4% for II, P=0.027). Wait, if the DD group has higher HOMA% for insulin sensitivity, that would mean they are more insulin sensitive. But the question is about insulin resistance. So if the DD genotype (deletion allele carriers) have higher insulin sensitivity, then the insertion allele (II) might be associated with lower insulin sensitivity (i.e., more resistance). \n\nWait, let me parse the data again. The NIDDM subjects with DD had lower specific insulin levels. Lower insulin but higher HOMA% for insulin sensitivity? That might be conflicting. Wait, maybe I need to clarify the HOMA parameters. HOMA-%B is beta-cell function, and HOMA-IR is insulin resistance. If the study says \"insulin sensitivity by HOMA%\", perhaps they are using a version that calculates sensitivity. Higher HOMA% would mean better sensitivity. So in the DD group (deletion homozygous), they have higher insulin",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 433,
            "completion_tokens": 512
        },
        "time_elapsed": 6.624002933502197
    },
    {
        "realidx": "8566975",
        "question": "To determine whether the host immune response to gonorrhoea provides limited serovar specific protection from reinfection.\n508 episodes of gonorrhoea diagnosed at a city centre genitourinary medicine clinic including 22 patients with multiple infections over a 4 year period.\nPatients with recurrent gonococcal infection were analysed with respect to the initial and subsequent serovars isolated.\nNo significant difference was seen in the prevalence of serovars isolated following a repeat infection compared with those without repeat infections. The site of the initial infection did not appear to influence the subsequent serovar isolated.\nSerovar specific immunity to Neisseria gonorrhoeae: does it exist?",
        "answer": "no",
        "answer_rationale": "We found no evidence of serovar specific immunity in our population. It remains possible that populations with a higher prevalence of gonorrhoea and more frequent infections may have a quantitatively greater immune response.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether the host's immune response to gonorrhoea gives any serovar-specific protection against reinfection. So, the key here is understanding what the results of the study showed.\n\nThe question is asking if serovar-specific immunity exists based on the provided information. The study had 508 episodes, including 22 patients with multiple infections over four years. They analyzed the serovars from initial and subsequent infections. The results say there's no significant difference in the prevalence of serovars after a repeat infection compared to those without repeats. Also, the initial infection site didn't affect the subsequent serovar.\n\nHmm, so if there was serovar-specific immunity, you'd expect that after a first infection with a certain serovar, the person would be less likely to get reinfected with the same or similar serovars. But since the study found no difference, that suggests that the immune response doesn't provide protection specific to the serovar. The fact that the site of infection didn't matter either adds to that, meaning the body's response isn't targeting specific serovars. \n\nSo the answer should be B) no, because the study's results don't support the existence of serovar-specific immunity. The options are yes, no, maybe. Since the data shows no significant difference, the conclusion is that such immunity doesn't exist here.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 231,
            "completion_tokens": 301
        },
        "time_elapsed": 3.9875411987304688
    },
    {
        "realidx": "8738894",
        "question": "The purpose of this study was to search for evidence of an association between occupational arsenic exposure and diabetes mellitus, as implied by the relation of this disease to arsenic in drinking water in a recent study from Taiwan.\nA case-referent analysis on death records of 5498 individuals in the art glass producing part of southeastern Sweden was performed. Out of all the enrolled subjects, 888 were glass workers. According to occupational title, glassblowers, foundry workers, and unspecified workers were regarded as potentially exposed to arsenic. Persons with a diagnosis of diabetes mellitus either as an underlying or contributing cause of death were considered cases. Referents were decedents without any indication of cancer, cardiovascular disease, or diabetes.\nA slightly elevated risk [Mantel-Haenszel odds ratio (MH-OR) 1.2, 95% confidence interval (95% CI) 0.82-1.8] was found for diabetes mellitus among the glassworks employees, especially in combination with cardiovascular disease (MH-OR 1.4, 95% CI 0.81-2.3). For the glassblowers, other foundry workers and unspecified glassworkers probably exposed to arsenic, the M-H odds ratio was 1.4 (95% CI 0.92-2.2). Unspecified glass workers, who probably included persons with high exposure, carried the higher risk (MH-OR 1.8, 95% CI 1.1-2.8).\nDiabetes mellitus among Swedish art glass workers--an effect of arsenic exposure?",
        "answer": "no",
        "answer_rationale": "The observations from this study provide limited support for the possibility that occupational arsenic exposure could play a role in the development of diabetes mellitus. Many other metallic compounds are also used in art glass production, however, and there is a possibility of confounding.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether there's a link between occupational arsenic exposure and diabetes, similar to what was found in the Taiwan study with drinking water. The study used death records from 5498 people in Sweden's art glass industry. Out of these, 888 were glass workers. They categorized certain jobs like glassblowers, foundry workers, and others as possibly exposed to arsenic.\n\nThe cases were people who had diabetes as a cause of death, and referents were those without cancer, cardiovascular disease, or diabetes. The results showed a slightly elevated risk with a Mantel-Haenszel odds ratio (MH-OR) of 1.2, but the confidence interval (CI) was 0.82-1.8. That interval includes 1, which means the result isn't statistically significant. Then, when looking at those with both diabetes and cardiovascular disease, the MH-OR was 1.4 with a CI of 0.81-2.3, which also includes 1. For the specific groups like glassblowers and others exposed, the OR was 1.4 (CI 0.92-2.2), still including 1. However, the unspecified workers had an OR of 1.8 with a CI of 1.1-2.8, which doesn't include 1, so that's significant.\n\nBut the question is whether the study found evidence that diabetes among these workers is an effect of arsenic exposure. The main issue here is the confidence intervals. The overall OR for glassworkers was 1.2 but not significant. The subgroup of unspecified workers had a significant OR of 1.8. However, the study's conclusion might be cautious because not all exposed groups showed a significant association. The title asks if it's an effect, but the data is mixed. The elevated risk in one subgroup is significant, but the overall and others aren't. Since the question is whether the study found evidence, the answer might be \"maybe\" because there's some indication but not conclusive. The options are yes, no, maybe. The study's results are suggestive but not definitive because of overlapping CIs with 1 in most groups except the unspecified. So the answer is C) maybe.\n</think>\n\nC",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 432,
            "completion_tokens": 481
        },
        "time_elapsed": 5.760421276092529
    },
    {
        "realidx": "8847047",
        "question": "The purpose of this study is to examine whether or not well differentiated (w-d) hepatocellular carcinoma (HCC) is indeed clinically early cancer.\nSeventy six patients with solitary small HCCs up to 3 cm in diameter, who underwent hepatectomy, were observed for at least 2 years for possible recurrence. These patients were divided into two groups: 10 patients with w-d HCCs (Edmondson and Steiner's grade I) and 66 patients with less differentiated (l-d) HCCs (Edmondson and Steiner's grade I-II, II-III, and III).\nThe histological analysis revealed that w-d HCCs had lower incidences of fibrous capsule formation (P<0.01), when compared to l-d HCCs. There were no significant differences in the incidence of intrahepatic metastasis, or portal vein invasion. In a resected specimen of w-d HCC, barium sulfate and gelatin were injected into portal vein and a transparent specimen was made. The transparent specimen showed that the portal vein in the tumor seemed to be intact. Microscopically, cancer cell infiltration into the fibrous frame of the portal tract was present. There were no significant differences in the disease free survival between the two groups. An analysis of tumor volume doubling time in recurrent foci suggested that minute cancerous foci had been present at the time of operation.\nPrognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?",
        "answer": "no",
        "answer_rationale": "W-d HCCs were clinically demonstrated not to be early cancer, because there was no significant difference in disease free survival between the patients with w-d and l-d HCCs.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether well-differentiated hepatocellular carcinoma (HCC) is considered clinically early cancer based on the study provided.\n\nFirst, I need to recall what defines an early cancer. Typically, early-stage cancers are those that are small, localized, and haven't spread, which usually have a better prognosis. The study here looked at patients with solitary small HCCs up to 3 cm who underwent hepatectomy. They were divided into well-differentiated (w-d) and less differentiated (l-d) groups.\n\nThe key points from the study: \n- The w-d HCCs had lower fibrous capsule formation (which might suggest they are less encapsulated and possibly more invasive? But the study says lower incidence, so maybe they are less likely to have a capsule, which could mean they are more likely to invade surrounding tissue? Hmm, not sure yet.)\n- No significant differences in intrahepatic metastasis or portal vein invasion between the two groups. So even though the w-d group had less fibrous capsule, their metastasis and portal vein invasion rates were similar to the less differentiated group. That's interesting because you might expect less differentiated to have more aggressive features.\n- The transparent specimen from the w-d HCC showed the portal vein seemed intact, but microscopically there was cancer cell infiltration into the portal tract's fibrous frame. So even if the vein looks okay macroscopically, microscopically there's invasion. That's a red flag for recurrence or metastasis.\n- Disease-free survival didn't differ between the two groups. So even though the tumors were small and well-differentiated, their prognosis wasn't better than the less differentiated ones. That's a key point because if early cancer should have better survival, but here it's the same.\n- The analysis of tumor doubling time suggested that at the time of surgery, there were already minute cancer foci present. That implies that even when the tumor was small and well-differentiated, there were micro-metastases or residual cancer cells, leading to recurrence later.\n\nPutting this together: The study's findings suggest that even though the well-differentiated tumors are small and have some features (like less fibrous capsule) that might seem like they're less aggressive, their behavior in terms of recurrence and survival is similar to the less differentiated ones. The presence of microscopic infiltration and existing micro-foci at surgery indicates that they might not be as \"early",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 412,
            "completion_tokens": 512
        },
        "time_elapsed": 6.791055917739868
    },
    {
        "realidx": "8910148",
        "question": "The brain-dead donor supply has become one of the criteria limiting the performance of heart transplantation. Conventional screening criteria are too limiting and exclude suitable heart donors. Echocardiography is now widely available and is a reliable tool to assess left ventricular dysfunction in brain-dead donors. Yet few data are available on the degree of left ventricular dysfunction where a transplantation is possible.\nFifty-five potential brain-dead heart donors (age 38 +/- 11 years) were prospectively evaluated by transesophageal echocardiography (TEE) before harvesting. Fractional area change (FAC) was used to assess left ventricular function in potential brain-dead donors. Transplanted hearts were evaluated on the fifth postoperative day. The transplantation was considered a success if the recipient was alive, not retransplanted, without an assistance device or an epinephrine infusion of more than 1 mg/h and showed an ejection fraction above 40%.\nOf the 55 potential heart donors, 20 exhibited an FAC of less than 50%. Forty hearts were harvested, 36 of which were successfully transplanted. Nine patients had an FAC below 50% (group H2) and 27 had an FAC over 50% (group H1). Four patients died: 2 from hemorrhage (FAC>50% in donors); 1 from right and one from left ventricular dysfunction (FAC<50% in donors). The FAC increased significantly from 51 +/- 15% to 57 +/- 11% in 18 hearts that underwent TEE in donors and afterwards in recipients. Overall actuarial survival was 86.2% versus 64.6% at 1 and 2 years in group H1 and group H2, respectively (p = NS).\nTransesophageal echocardiographic assessment of left ventricular function in brain-dead patients: are marginally acceptable hearts suitable for transplantation?",
        "answer": "yes",
        "answer_rationale": "TEE is useful to assess left ventricular function in potential brain-dead donors. An FAC less than 50% is present in 36% of potential heart donors. Because left ventricular dysfunction is often reversible shortly after transplantation, an FAC below 50% may not necessarily preclude the use of hearts for transplantation.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The main point is whether marginally acceptable hearts (those with lower FAC) are suitable for transplantation based on the study provided.\n\nFirst, the study looked at 55 brain-dead donors. They used TEE to assess FAC. The cutoff mentioned is FAC less than 50% (group H2) versus over 50% (group H1). Out of 55, 20 had FAC <50%, but only 9 of those were actually transplanted. The total harvested was 40, with 36 successful transplants. \n\nLooking at the outcomes: 4 patients died. Two from the H1 group (FAC>50) died from hemorrhage, and two from H2 (FAC<50) died from ventricular dysfunction. The survival rates at 1 and 2 years were 86.2% vs 64.6% for H1 vs H2, but the p-value was not significant (p=NS), meaning the difference might not be statistically significant. Also, the FAC improved post-transplant in the recipients, which is interesting. \n\nThe question is whether these marginally acceptable hearts (H2 with FAC <50) are suitable. The study shows that even some with FAC below 50% were transplanted successfully. The survival rates are lower in H2 but not statistically significant. Since the question is about whether they are \"suitable,\" the answer might lean towards yes, because some were successfully transplanted. However, the lower survival could suggest caution. But the fact that the study's results didn't show a significant difference in survival (p=NS) might mean that the outcomes aren't worse enough to exclude them. The key point is that the conventional criteria were too limiting, and the study's results suggest that even with lower FAC, some hearts can work. The answer options are yes, no, maybe. Since the study shows that 9 out of 20 with FAC <50 were used and had some success (since 4 died but 36 total successful, with 9 in H2, so maybe 9-2 deaths? Wait, the four deaths include two in H1 and two in H2. So of the 9 in H2, two died from LV dysfunction. So 7 survived? The overall success is 36 out of 40, so 90% success rate.",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 509,
            "completion_tokens": 512
        },
        "time_elapsed": 6.118096828460693
    },
    {
        "realidx": "8916748",
        "question": "To assess the risk of death associated with work based and non-work based measures of socioeconomic status before and after retirement age.\nFollow up study of mortality in relation to employment grade and car ownership over 25 years.\nThe first Whitehall study.\n18,133 male civil servants aged 40-69 years who attended a screening examination between 1967 and 1970.\nDeath.\nGrade of employment was a strong predictor of mortality before retirement. For men dying at ages 40-64 the lowest employment grade had 3.12 times the mortality of the highest grade (95% confidence interval 2.4 to 4.1). After retirement the ability of grade to predict mortality declined (rate ratio 1.86; 1.6 to 2.2). A non-work based measure of socioeconomic status (car ownership) predicted mortality less well than employment grade before retirement but its ability to predict mortality declined less after retirement. Using a relative index of inequality that was sensitive to the distribution among socioeconomic groups showed employment grade and car ownership to have independent associations with mortality that were of equal magnitude after retirement. The absolute difference in death rates between the lowest and highest employment grades increased with age from 12.9 per 1000 person years at ages 40-64 to 38.3 per 1000 at ages 70-89.\nDo socioeconomic differences in mortality persist after retirement?",
        "answer": "yes",
        "answer_rationale": "Socioeconomic differences in mortality persist beyond retirement age and in magnitude increase with age. Social differentials in mortality based on an occupational status measure seem to decrease to a greater degree after retirement than those based on a non-work measure. This suggests that alongside other socioeconomic factors work itself may play an important part in generating social inequalities in health in men of working age.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether socioeconomic differences in mortality persist after retirement based on the provided study.\n\nFirst, I need to recall the key points from the study summary. The study followed male civil servants over 25 years, looking at employment grade (work-based) and car ownership (non-work-based) as measures of socioeconomic status (SES). \n\nBefore retirement, employment grade was a strong predictor of mortality. The lowest grade had 3.12 times the mortality rate of the highest. After retirement, the predictive power of employment grade decreased to a rate ratio of 1.86. However, car ownership, which was a weaker predictor before retirement, didn't decline as much post-retirement. \n\nThe study also mentions a relative index of inequality showing that both employment grade and car ownership had independent associations with mortality of equal magnitude after retirement. Additionally, the absolute difference in death rates between the lowest and highest employment grades increased with age, going up to 38.3 per 1000 person years for ages 70-89.\n\nThe question is whether these SES differences persist after retirement. The key here is that even though the effect of employment grade lessened, it still had a significant association (rate ratio 1.86 is still higher than 1). Also, car ownership's predictive ability didn't decline as much, and when using the relative index, both measures showed equal magnitude after retirement. The absolute difference also increased with age, which includes post-retirement ages. \n\nSo, the answer should be yes, because even after retirement, there are still significant differences in mortality related to SES, just measured through different indicators. The study's results don't negate the existence of differences but show a shift in which measures are more predictive. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 397,
            "completion_tokens": 379
        },
        "time_elapsed": 4.643630504608154
    },
    {
        "realidx": "8921484",
        "question": "After 34 weeks gestation, summary measures of location for birthweight (e.g means and centiles) increase more slowly for Australian Aborigines than for whites. A similar pattern has been observed for blacks in the US. This study tests whether the reported pattern is due to differential misclassification of gestational age.\nSimulation was used to measure the potential effect of differential misclassification of gestational age. Reported gestational age data were obtained from Queensland Perinatal Data Collection (QPDC). Estimates of the true distributions of gestational age were obtained by assuming various (plausible) types of misclassification and applying these to the reported distributions. Previous studies and data from the QPDC were used to help specify the birthweight distributions used in the simulations.\nAt full term, the parameters of the birthweight distributions were robust to gestational age misclassification. At preterm, the 10th centiles were robust to misclassification. In contrast, the 90th centiles were sensitive to even minor misclassification. Extreme types of misclassification were required to remove the divergence in median birthweights for Aborigines and whites.\nDoes gestational age misclassification explain the difference in birthweights for Australian aborigines and whites?",
        "answer": "no",
        "answer_rationale": "Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether gestational age misclassification explains the difference in birthweights between Australian Aborigines and whites. The study mentioned used simulations to test this.\n\nFirst, I need to recall the key findings from the study as described. The question states that after 34 weeks, the birthweight measures increase more slowly for Aborigines and US blacks compared to whites. The study's goal was to see if this difference is due to misclassification of gestational age.\n\nThe results from the study's simulations showed that at full term, the parameters of birthweight distributions were robust to misclassification. That means even if there were errors in gestational age reporting, the full-term birthweights didn't change much. For preterm, the 10th centiles were also robust, but the 90th centiles were sensitive to even minor misclassification. However, the crucial point is that extreme types of misclassification were required to remove the divergence in median birthweights between the groups. \n\nSo, the study's conclusion here is that unless the misclassification is extremely large, which isn't supported by the data, the difference in medians (which are the 50th centiles) can't be explained by gestational age errors. Since the question is whether misclassification explains the difference, and the study found that even with plausible misclassification (not extreme), the divergence remains, the answer would be that it doesn't explain it. Therefore, the answer should be B) no.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 341,
            "completion_tokens": 317
        },
        "time_elapsed": 3.74853253364563
    },
    {
        "realidx": "9100537",
        "question": "Cytologic criteria reported to be helpful in the distinction of proliferative breast disease without atypia (PBD) from nonproliferative breast disease (NPBD) have not been rigorously tested.\nFifty-one air-dried, Diff-Quik-stained fine-needle aspirates (FNA) of palpable breast lesions with biopsy-proven diagnoses of NPBD (34 cases) or PBD (17 cases) were reviewed. The smears were evaluated for the cellularity, size, and architectural arrangement of the epithelial groups; the presence of single epithelial cells and myoepithelial cells; and nuclear characteristics.\nThe only cytologic feature found to be significantly different between PBD and NPBD was a swirling pattern of epithelial cells. A swirling pattern was noted in 13 of 17 PBD cases (76%) and 12 of 34 NPBD cases (35%) (P = 0.008).\nCan nonproliferative breast disease and proliferative breast disease without atypia be distinguished by fine-needle aspiration cytology?",
        "answer": "no",
        "answer_rationale": "Because there is significant overlap in cytologic features between NPBD and PBD, the distinction between the two entities is difficult in cytologic sampling.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether nonproliferative breast disease (NPBD) and proliferative breast disease without atypia (PBD) can be distinguished using fine-needle aspiration cytology (FNAC). The provided study gives some data to help answer this.\n\nFirst, I need to recall what the question is about. The key point here is the ability to differentiate between these two conditions based on cytology findings. The study mentions that they looked at various cytologic features like cellularity, size, architectural arrangement, presence of single and myoepithelial cells, and nuclear characteristics. The only significant difference found was the swirling pattern of epithelial cells. \n\nIn the results, 76% of PBD cases showed a swirling pattern compared to 35% of NPBD cases, and the p-value was 0.008, which is statistically significant. But the question is whether this difference is enough to distinguish between the two. \n\nThe options are yes, no, or maybe. The study's conclusion here is that the swirling pattern was significantly different, but does that mean FNAC can reliably distinguish them? The problem is that even though there's a statistical difference, the overlap is still considerable. For instance, 35% of NPBD cases also had the swirling pattern. So if a sample shows a swirling pattern, there's still a chance it's NPBD. Conversely, some PBD cases might not show it. \n\nThe question is whether this feature is sufficient for distinction. Since the swirling pattern isn't 100% specific or sensitive, maybe the answer is that it's not reliably distinguishable. The first sentence of the question also mentions that the cytologic criteria haven't been rigorously tested, which might imply that current evidence isn't conclusive. The study's result shows a significant difference, but perhaps not enough for clinical distinction. The answer options are yes, no, maybe. The study's data suggests that there is a difference, so maybe the answer is yes? Wait, but the question is whether they \"can be distinguished\" based on the study's findings. Since the swirling pattern is a significant feature, even if not perfect, maybe the answer is yes. But the options might be tricky here. Alternatively, the fact that the swirling pattern is present in a third of NPBD cases might mean that it's not reliable enough, so the answer would be no. The study's conclusion might be that the swirling pattern is a",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 322,
            "completion_tokens": 512
        },
        "time_elapsed": 6.387194633483887
    },
    {
        "realidx": "9142039",
        "question": "To assess the relationship between the experience of pediatric housestaff and tests ordered on infants in the neonatal intensive care unit (ICU).\nProspective, cohort study over one full academic year.\nOne academic Level III neonatal intensive care nursery.\nData were collected prospectively on all 785 infants admitted to the neonatal ICU from July 1993 to June 1994. These infants were cared for by 14 different categorical pediatric housestaff.\nOur neonatal ICU has either a resident or an intern on-call by himself/herself at night, affording us a natural setting to compare intern vs. resident test ordering. The outcomes of interest were number of arterial blood gases, radiographs, and electrolytes ordered per infant by the on-call pediatric houseofficer, as tabulated the morning after the call night. Control variables included the severity-of-illness of the individual infant (using the Neonatal Therapeutic Intervention Scoring System), the workload of the houseofficer (number of patients, number of admissions), and supervision (rounding frequency and on-call attending). Controlling for the severity-of-illness of the infant, the workload on the call night, and supervision with multiple linear regression, we found that interns ordered significantly (p = .02) greater numbers of arterial blood gases per infant than residents, amounting to some 0.33 blood gases per infant per call night (3.22 vs. 2.89 arterial blood gases per infant per night). This increase of 0.33 blood gases per infant amounts to interns ordering $169 more arterial blood gases per call night at our institution. There was no difference between interns and residents in ordering radiographs or electrolytes.\nDoes pediatric housestaff experience influence tests ordered for infants in the neonatal intensive care unit?",
        "answer": "yes",
        "answer_rationale": "Interns order significantly more arterial blood gases per infant than junior and senior residents on-call in the neonatal ICU. Additional study is required to see if the experience of housestaff is associated with a broader array of neonatal outcomes, such as morbidity and mortality.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether pediatric housestaff experience influences the tests ordered for infants in the neonatal ICU. The study mentioned compares interns and residents.\n\nFirst, I need to recall the study's findings. The key point here is that they used a prospective cohort study over an academic year. They controlled for variables like severity of illness, workload, and supervision. The results showed that interns ordered significantly more arterial blood gases than residents (p=0.02). The difference was 0.33 more ABGs per infant per night, which translated to an extra $169. However, there was no difference in radiographs or electrolytes.\n\nThe question is specifically about the influence of experience. Since interns are less experienced than residents, the fact that they ordered more ABGs suggests that experience does play a role. The significant p-value supports that this difference isn't by chance. The other tests didn't show a difference, but the question is general\u2014does experience influence tests ordered? The answer would be yes because at least in one category (ABGs), experience (intern vs resident) made a difference. The other tests not showing a difference doesn't negate the overall influence, just that it's specific to certain tests. So the correct answer should be A) yes.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 466,
            "completion_tokens": 271
        },
        "time_elapsed": 3.8836510181427
    },
    {
        "realidx": "9199905",
        "question": "We observed an endoscopic abnormally in a group of children with histological esophagitis. We termed this finding \"vertical lines in esophageal mucosa\" (VLEM). We examined the relationship between the presence of VLEM and significant histologic changes in esophageal mucosal biopsies.\nBetween January 1, 1992, and August 31, 1994, the senior author (JFF) performed 255 esophageal biopsies. The procedure reports, available endoscopic photographs, and histology reports were reviewed to establish the endoscopic and histologic appearance of the esophageal mucosa. Intraepithelial cells were counted in a blind review of 42 randomly selected biopsies.\nThe esophageal mucosa had a normal appearance on 160 endoscopic studies (Group 1) and VLEM were the only mucosal abnormalities in 41 endoscopies (Group 2). Histology was normal in 92 of 160 biopsies (57.5%) from Group 1, and 1 of 41 biopsies (2.4%) from Group 2. Most patients in Group 2 had eosinophilic esophagitis (34 of 41, 83%, specificity 0.85, sensitivity 0.5, p>0.001) which was of moderate to severe intensity (31 of 34, 91.2%, specificity 0.88, sensitivity 0.73, p<0.001).\nVertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?",
        "answer": "yes",
        "answer_rationale": "Histology usually demonstrated moderate to severe inflammation when VLEM were present. VLEM may be a highly specific endoscopic feature of esophagitis in children.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether vertical lines in the esophageal mucosa (VLEM) are a true sign of esophagitis in children. The options are yes, no, or maybe.\n\nFirst, looking at the data provided. They did 255 biopsies. Group 1 had normal endoscopic appearance (160 cases), and Group 2 had VLEM as the only abnormality (41 cases). \n\nIn Group 1, 92 out of 160 (57.5%) had normal histology. That means almost half of the normal-looking endoscopies actually had some histologic abnormality. But in Group 2, only 1 out of 41 had normal histology. So 39 out of 41 had abnormal biopsies. The majority (34/41) had eosinophilic esophagitis, which is a type of esophagitis. The study also mentions that the specificity was 0.85 and sensitivity 0.5 for eosinophilic esophagitis. \n\nSpecificity being high (85%) means that if VLEM is present, it's likely the patient has the condition (eosinophilic esophagitis here). The sensitivity of 0.5 means it's not perfect at detecting all cases, but when it's present, it's a strong indicator. The p-values are significant (p<0.001), so the association isn't by chance. \n\nThe question is whether VLEM is a true endoscopic manifestation of esophagitis. Since in Group 2, which had VLEM, most had histologic esophagitis (especially eosinophilic), it suggests that VLEM is indeed associated with actual inflammation. The high specificity supports that VLEM is a reliable sign. Even though sensitivity isn't 100%, it's still a significant indicator. So the answer should be yes (A). The study's results show a strong link between VLEM and histologic esophagitis, particularly eosinophilic type. Therefore, the correct answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 459,
            "completion_tokens": 456
        },
        "time_elapsed": 5.409379243850708
    },
    {
        "realidx": "9363244",
        "question": "To determine the effect of occupational exposure in a nuclear power plant in Griefswald, Germany on male and female fecundity.\nThe frequency of men and women exposed to ionizing radiation through work in a nuclear power plant among 270 infertile couples was retrospectively compared to a control fertile population using a pair-matched analysis. The total cumulative equivalent radiation dose was determined. In addition, the spermiograms of the male partners in both groups were compared and correlated to the degree of exposure.\nNo differences were noted in the frequency of nuclear power plant exposure between sterile and fertile groups. There was a higher rate of anomalous spermiograms in nuclear power plant workers. However, abnormalities were temporary. No correlation was found between the cumulative equivalent radiation dose and abnormal spermiograms.\nDoes occupational nuclear power plant radiation affect conception and pregnancy?",
        "answer": "yes",
        "answer_rationale": "The data suggest that occupational exposure due to ionizing radiation should be investigated as a possible cause for involuntary temporary sterility and as a risk factor for early pregnancy disorders.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is looking at whether working in a nuclear power plant affects fertility in men and women. The key points from the study are:\n\nFirst, they compared infertile couples to fertile ones, matching them. They found no difference in the frequency of exposure between the groups. So, the exposure rate among those who were infertile wasn't higher than the controls. That suggests that being exposed doesn't make you more likely to be infertile.\n\nThen, they looked at spermiograms. The workers had more abnormal ones, but these were temporary. Also, there was no link between the radiation dose and the sperm issues. So even though there was a higher rate of sperm problems, they went away over time, and the amount of radiation didn't matter. \n\nThe question is whether the radiation affects conception and pregnancy. Since the main comparison between infertile and fertile groups showed no difference in exposure rates, that's a big point. The sperm abnormalities were there but temporary, so maybe they don't lead to long-term issues. Also, since the dose didn't correlate, the radiation might not be the cause of those sperm issues. \n\nThe options are yes, no, maybe. The study's main conclusion seems to be that there's no effect because the exposure wasn't more common in the infertile group. The temporary sperm issues might not impact conception long-term. So the answer is probably B, no. But wait, the higher rate of anomalous spermiograms in workers\u2014could that affect conception even if temporary? The study says no correlation with dose, so maybe the abnormalities aren't caused by radiation. Or maybe the fact that they were temporary means that when not exposed, sperm is normal. Since the overall infertility rates didn't differ, the answer is no. So B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 262,
            "completion_tokens": 377
        },
        "time_elapsed": 4.656996011734009
    },
    {
        "realidx": "9427037",
        "question": "The most common primary brain tumors in children and adults are of astrocytic origin. Classic histologic grading schemes for astrocytomas have included evaluating the presence or absence of nuclear abnormalities, mitoses, vascular endothelial proliferation, and tumor necrosis.\nWe evaluated the vascular pattern of 17 astrocytoma surgical specimens (seven from children and 10 from adults), and four normal brains obtained at autopsy, utilizing antibody to glial fibrillary acidic protein (GFAP) and von Willebrand factor (vWF) utilizing confocal microscopy. A modified WHO classification was used.\nAll tumor cases showed cells positive for GFAP. Control tissues showed a few, widely separated vessels. Pilocytic astrocytomas (four cases) showed lacy clusters of small-to-medium sized vessels, with intact vessel wall integrity. Diffuse, low grade astrocytoma (three cases) showed a staining pattern similar to control tissue; intermediate grade (one case), anaplastic astrocytoma (three cases) and gliobastoma multiforme (six cases) showed an increased vessel density with multiple small vessels (glomeruloid clusters), some with prominent intimal hyperplasia, loss of vessel wall integrity, and with numerous vWF-positive single cells/microvessels within the tumor substance.\nAre endothelial cell patterns of astrocytomas indicative of grade?",
        "answer": "yes",
        "answer_rationale": "Evaluation of astrocytomas utilizing antibody to vWF and confocal microscopy aids in the grading of these neoplasms.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the endothelial cell patterns of astrocytomas are indicative of their grade. The options are yes, no, or maybe.\n\nFirst, I need to recall what the question provided. The study looked at vascular patterns in astrocytoma specimens using GFAP and vWF with confocal microscopy. The WHO classification was modified. All tumor cases had GFAP-positive cells. The control tissues had few, spread-out vessels. \n\nLooking at the different tumor types: Pilocytic astrocytomas (which are low-grade, I think) showed lacy clusters of small to medium vessels with intact walls. The diffuse low-grade astrocytomas were similar to controls. Then, the intermediate, anaplastic, and glioblastoma (which are higher grades) showed increased vessel density, glomeruloid clusters, intimal hyperplasia, loss of vessel integrity, and lots of vWF-positive cells. \n\nSo the key here is that the vascular patterns differ based on the grade. The higher the grade (like anaplastic or GBM), the more abnormal the vessels\u2014more dense, glomeruloid structures, loss of integrity. Lower grades like pilocytic or diffuse low-grade have more normal-looking vessels. \n\nThe question is whether these endothelial patterns indicate the grade. Since the study shows that as the grade increases, the vascular features become more abnormal, that suggests that the pattern is indeed indicative of the tumor grade. So the answer should be yes, option A. \n\nWait, but I should make sure there's no ambiguity. The options are yes, no, maybe. The study's results directly correlate grade with vascular changes. The higher grades have distinct vascular features. Therefore, the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 372,
            "completion_tokens": 369
        },
        "time_elapsed": 5.548169851303101
    },
    {
        "realidx": "9465206",
        "question": "We investigated the actual role of MRI versus arthroscopy in the detection and characterization of occult bone and/or cartilage injuries in patients with previous musculoskeletal trauma of the knee, pain and severe functional impairment. Occult post-traumatic osteochondral injuries of the knee are trauma-related bone and/or cartilage damage missed at plain radiography.\nWe retrospectively selected 70 patients (men:women = 7:3; age range: 35 +/- 7 years) with a history of acute musculoskeletal trauma, negative conventional radiographs, pain and limited joint movements. All patients were submitted to conventional radiography, arthroscopy and MRI, the latter with 0.5 T units and T1-weighted SE. T2-weighted GE and FIR sequences with fat suppression.\nWe identified three types of occult post-traumatic injuries by morpho-topographic and signal intensity patterns: bone bruises (no. 25), subchondral (no. 33) and osteochondral (no. 35) injuries. Arthroscopy depicted 45 osteochondral and 19 chondral injuries. A bone bruise was defined as a typical subcortical area of signal loss, with various shapes, on T1-weighted images and of increased signal intensity on T2-weighted and FIR images. The cortical bone and articular cartilage were normal in all cases, while osteochondral injuries exhibited associated bone and cartilage damage with the same abnormal MR signal intensity. Sprain was the mechanism of injury in 52 cases, bruise in 12 and stress in 6. In 52 sprains (30 in valgus), the injury site was the lateral compartment in 92.3% of cases (100% in valgus), associated with meniscal damage in 73% of cases (90% in valgus) and with ligament injury in 90.4% (100% in valgus). In 12 bruises, the injury site was the lateral compartment in 58.3% of cases, the knee cap in 25% and the medial compartment in 16.7%; meniscal damage was associated in 25% of cases and ligament damage in 8.3%. In 6 stress injuries, the injury site was localized in the medial tibial condyle in 80% of cases, while meniscal and ligament tears were absent.\n\"Occult\" posttraumatic lesions of the knee: can magnetic resonance substitute for diagnostic arthroscopy?",
        "answer": "yes",
        "answer_rationale": "After comparing MR with arthroscopic findings and reviewing the available literature, we conclude that arthroscopy permits the direct visualization of even fine articular surface changes but does not depict the subchondral bone, the most frequent site of injury detected with MRI. MRI was a very useful tool in the detection and characterization of the different types of occult bone and/or cartilage injuries and showed a statistically significant correlation between site and distribution of bone and cartilage injuries and between internal damage and trauma mechanisms. Therefore, we believe that MRI can help avoid diagnostic arthroscopy in the patients with a history of post-traumatic pain, acute articular blocks and negative radiographic findings.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is comparing MRI and arthroscopy in detecting occult bone and cartilage injuries in the knee after trauma. The key point here is whether MRI can replace arthroscopy for diagnosis.\n\nFirst, the study included 70 patients with negative X-rays but persistent symptoms. Both MRI and arthroscopy were performed. The MRI found three types of injuries: bone bruises, subchondral, and osteochondral. Arthroscopy found 45 osteochondral and 19 chondral injuries. \n\nLooking at the details, MRI uses specific sequences (T1, T2, FIR with fat suppression) which are known to be good for soft tissue and bone bruises. The description of bone bruises on MRI matches what's typical\u2014signal changes on T1 and T2. Osteochondral injuries on MRI showed both bone and cartilage damage with abnormal signals, which aligns with arthroscopy findings. \n\nThe study's results show that MRI identified the same types of injuries as arthroscopy. The locations and associated injuries (like meniscal and ligament tears) also correlate. Since arthroscopy is the current gold standard but is invasive, if MRI has comparable accuracy, it could substitute. The question is whether the data supports that MRI can replace arthroscopy here. \n\nThe answer options are yes, no, maybe. The study's results suggest MRI is effective in detecting these injuries, so the answer might be A (yes). But wait, the question is about substituting. The study's design is retrospective, and maybe there's some discrepancy. However, since the MRI findings matched the arthroscopy results in terms of types and locations, it's likely that MRI can be a substitute. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 632,
            "completion_tokens": 368
        },
        "time_elapsed": 5.174543857574463
    },
    {
        "realidx": "9483814",
        "question": "Uterus-specific synthetic Prostaglandin analogues (gemeprost, sulproston etc.) have been widely employed for termination of pregnancy in the second trimester. Since paracervical anaesthesia may be useful during this procedure, we investigated in this prospective randomised study its impact on the clinical course of abortion and pain especially in the late first and second stage of labour.\n20 women scheduled for elective abortion (fetal reasons) between the 16th and 23rd week of gestation were to be given 1 mg gemeprost vaginally every 6 hours. They were allocated at random: 10 women received only Pethidin intravenously and Butylscopolamine rectally, another 10 women were additionally treated by paracervical anaesthesia (2 x 10 ml 0.5% Bupivacain solution) at a cervical dilatation of 2-3 cm.\nA median of 3 gemeprost applications were administered in both groups. In the group without paracervical anaesthesia the median induction to abortion interval was 20 hours (range: 8-44 hours), 13 hours (range: 8-36 hours, NS) resulting for the paracervical anaesthesia group. The intervals from the last application of prostaglandin until abortion and from 3 cm cervical dilatation to abortion were slightly, but not significantly shorter in the paracervical anaesthesia group. The requirement of Butylscopolamine was higher in the latter group (p<0.05). The requirement of Pethidin and the intensity of pain (measured by pain scale according to Huskisson) especially in the late first stage of labour were not statistically different between both groups. Side effects of paracervical anaesthesia did not occur.\nDoes para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?",
        "answer": "yes",
        "answer_rationale": "Paracervical anaesthesia is a method for analgesia during second trimester abortion with a low rate of side effects. It can shorten the duration of last period of second trimester abortion in some cases but has no impact on the perception of pain nor requirement of analgesics and so with only limited benefit in second trimester abortion with vaginal gemeprost.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The study is about whether paracervical anesthesia offers additional advantages when using gemeprost for second-trimester abortions. The key points from the study are:\n\n- Both groups received gemeprost, with one getting paracervical block (PCB) and the other not.\n- The median time from induction to abortion was 20 hours without PCB and 13 hours with PCB, but it's noted as not significant (NS). \n- The time from last prostaglandin dose and from 3cm dilation to abortion were slightly shorter with PCB but still not significant.\n- Butylscopolamine use was higher in the PCB group (p<0.05), which might be a downside.\n- Pain (measured by Huskisson scale) and Pethidin requirement didn't differ between groups.\n- No side effects from PCB were observed.\n\nThe question is whether PCB offers additional advantages. The main outcomes like time to abortion weren't significantly better. The only notable difference was higher Butylscopolamine use, which isn't an advantage. Since the study found no significant benefits in the key areas (time, pain reduction) and the question asks for \"additional advantages,\" the answer would be no. The options are (A) yes, (B) no, (C) maybe. So the correct answer is B.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 501,
            "completion_tokens": 290
        },
        "time_elapsed": 3.9083051681518555
    },
    {
        "realidx": "9488747",
        "question": "Apparent life-threatening events in infants are a difficult and frequent problem in pediatric practice. The prognosis is uncertain because of risk of sudden infant death syndrome.\nEight infants aged 2 to 15 months were admitted during a period of 6 years; they suffered from similar maladies in the bath: on immersion, they became pale, hypotonic, still and unreactive; recovery took a few seconds after withdrawal from the bath and stimulation. Two diagnoses were initially considered: seizure or gastroesophageal reflux but this was doubtful. The hypothesis of an equivalent of aquagenic urticaria was then considered; as for patients with this disease, each infant's family contained members suffering from dermographism, maladies or eruption after exposure to water or sun. All six infants had dermographism. We found an increase in blood histamine levels after a trial bath in the two infants tested. The evolution of these \"aquagenic maladies\" was favourable after a few weeks without baths. After a 2-7 year follow-up, three out of seven infants continue to suffer from troubles associated with sun or water.\nSyncope during bathing in infants, a pediatric form of water-induced urticaria?",
        "answer": "yes",
        "answer_rationale": "\"Aquagenic maladies\" could be a pediatric form of the aquagenic urticaria.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\n\nOkay, let's tackle this question. The case describes eight infants with apparent life-threatening events during baths. Their symptoms include pallor, hypotonia, and unresponsiveness when immersed, which resolve quickly after being taken out and stimulated. The initial considerations were seizures or reflux, but those were doubted. Then they thought of aquagenic urticaria, which is a type of hives triggered by water. The families had a history of dermographism or reactions to water/sun. All six tested infants had dermographism, and two had increased histamine after a test bath. The problem improved when they stopped baths, and some still had issues later.\n\nThe question is whether this is a form of water-induced urticaria, with options yes, no, maybe. \n\nAquagenic urticaria is a condition where contact with water triggers hives and other symptoms. The key points here are the reaction during baths, family history of similar skin issues, presence of dermographism (which is a form of physical urticaria), and the histamine increase. The fact that stopping baths helped supports that water was the trigger. The term \"aquagenic maladies\" mentioned in the case aligns with aquagenic urticaria. The syncope (fainting) part might be due to the allergic reaction causing a drop in blood pressure or other systemic response. Since the clinical presentation and test results point towards an allergic reaction to water, the answer should be yes. The follow-up also shows that some still had issues with water or sun, reinforcing it's a chronic condition like urticaria. So the answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 337,
            "completion_tokens": 341
        },
        "time_elapsed": 4.072747230529785
    },
    {
        "realidx": "9542484",
        "question": "To determine whether successful completion of the Perinatal Education Programme (PEP) improves obstetric practice.\nThe three midwife obstetric units (MOUs) in a health district of Mpumalanga were included in the study. Two MOUs enrolled in the PEP and the third did not. A 'before-and-after' study design was used to assess any changes in practice, and to monitor whether any changes occurred in the district during the time of the study; data were also collected at the third MOU. Data were collected by scoring of the obstetric files after the patient had delivered.\nWe ascertained whether the obstetric history, syphilis testing, blood group testing, haemoglobin measurement and uterine growth assessment were performed during antenatal care along with whether appropriate action was taken. For intrapartum care, estimation of fetal weight, the performance of pelvimetry, blood pressure monitoring, urine testing, evaluation of head above pelvis, fetal heart rate monitoring, monitoring of contractions and plotting of cervical dilatation, and whether the appropriate actions were taken, were assessed.\nEight of the 13 midwives at the two MOUs completed the PEP and all demonstrated an improvement in knowledge. Case notes of 303 patients from the various clinics were studied. There was no change in the referral patterns of any of the clinics during the study period. The obstetric history was well documented, but in no group was there a satisfactory response to a detected problem; appropriate action was taken in between 0% and 12% of cases. Syphilis testing was performed in 56-82% of cases, with no difference between the groups. The haemoglobin level was measured in only 4-15% of patients, with no difference before or after completion of the PEP. Where a problem in uterine growth was detected, an appropriate response occurred in 0-8% of patients and no difference before or after completion of the PEP was ascertained. In all groups, estimation of fetal weight and pelvimetry were seldom performed, the urine and fetal heart rate documentation were moderately well done and the blood pressure monitoring, assessment of head above pelvis, monitoring of contractions and plotting of cervical dilatation were usually performed. No differences before or after the PEP were detected. Where problems were detected, appropriate actions taken during labour improved, but not significantly.\nDoes successful completion of the Perinatal Education Programme result in improved obstetric practice?",
        "answer": "no",
        "answer_rationale": "Completion of the obstetric manual of the PEP improved the knowledge of the midwives but no alteration in practice was detected.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether completing the Perinatal Education Programme (PEP) leads to improved obstetric practice based on the study described.\n\nFirst, I need to understand the study design. It's a before-and-after study across three midwife units. Two units participated in PEP, and one didn't. They collected data on various obstetric care practices both before and after the PEP, and also from the third unit that didn't do PEP.\n\nLooking at the results: The key points are that even though 8 out of 13 midwives showed improved knowledge after PEP, the actual practice metrics didn't change much. For example, appropriate actions when problems were detected were between 0-12%, which didn't improve after PEP. Syphilis testing rates were 56-82%, but no difference between groups. Haemoglobin measurements were very low (4-15%) and no change post-PEP. Uterine growth issues had 0-8% appropriate action, again no change. \n\nIntrapartum care aspects like fetal weight estimation and pelvimetry were rarely done, and other measures like urine testing and fetal heart rate were moderately done but no difference after PEP. The only mention of improvement was in actions during labor, but it wasn't significant. \n\nThe question is whether PEP led to improved practice. The study's results show that despite knowledge improvement, actual practice metrics didn't show significant changes. The answer should be \"no\" because the data doesn't support that PEP led to better practices. The options are A (yes), B (no), C (maybe). Since there's no significant difference, B is correct.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 606,
            "completion_tokens": 361
        },
        "time_elapsed": 4.250944375991821
    },
    {
        "realidx": "9582182",
        "question": "To investigate the relevance of the Symptom Checklist 90-R Obsessive-Compulsive subscale to cognition in individuals with brain tumor.\nA prospective study of patients assessed with a neuropsychological test battery.\nA university medical center.\nNineteen adults with biopsy-confirmed diagnoses of malignant brain tumors were assessed prior to aggressive chemotherapy.\nIncluded in the assessment were the Mattis Dementia Rating Scale, California Verbal Learning Test, Trail Making Test B, Symptom Checklist 90-R, Mood Assessment Scale, Beck Anxiety Inventory, and Chronic Illness Problem Inventory.\nThe SCL 90-R Obsessive-Compulsive subscale was not related to objective measures of attention, verbal memory, or age. It was related significantly to symptoms of depression (r = .81, P<.005), anxiety (r = .66, P<.005), and subjective complaints of memory problems (r = .75, P<.005). Multivariate analyses indicated that reported symptoms of depression contributed 66% of the variance in predicting SCL 90-R Obsessive-Compulsive Scores, whereas symptoms of anxiety contributed an additional 6% (P<.0001).\nDoes the SCL 90-R obsessive-compulsive dimension identify cognitive impairments?",
        "answer": "yes",
        "answer_rationale": "Our data suggest that the SCL 90-R is best viewed as an indicator of unidimensional emotional distress and somatic effects of structural brain injury.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether the SCL 90-R obsessive-compulsive dimension identifies cognitive impairments based on the study provided.\n\nFirst, I need to recall what the SCL-90-R's Obsessive-Compulsive (OC) subscale measures. Generally, this subscale assesses symptoms like obsessions, compulsions, and repetitive thoughts or behaviors. But the question is about its relation to cognitive impairments.\n\nLooking at the study details: The participants are adults with malignant brain tumors assessed before chemotherapy. They used several tests. The key findings here are that the SCL-90-R OC subscale wasn't related to objective measures of attention, verbal memory, or age. However, it was significantly related to depression, anxiety, and subjective memory complaints. The multivariate analysis showed that depression contributed most to the OC scores, with anxiety adding a bit more.\n\nSo, the OC subscale's correlation is with psychological symptoms (depression, anxiety) and subjective memory issues, not the actual objective cognitive test results. The question is whether the OC dimension identifies cognitive impairments. Since the OC scores didn't correlate with the objective cognitive tests (like Mattis Dementia Rating Scale, CVLT, Trail Making Test B), which are measures of actual cognitive function, it suggests that the OC subscale isn't picking up on actual cognitive impairments. Instead, it's more linked to emotional symptoms and self-reported memory problems, which might not be objective impairments.\n\nTherefore, the answer should be \"no\" because the OC subscale isn't identifying the objective cognitive impairments measured by the neuropsychological tests. The correlations with depression and anxiety mean it's more about psychological symptoms rather than cognitive deficits.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 362,
            "completion_tokens": 359
        },
        "time_elapsed": 4.25251841545105
    },
    {
        "realidx": "9603166",
        "question": "Human immunodeficiency virus (HIV)-infected patients have generally been excluded from transplantation. Recent advances in the management and prognosis of these patients suggest that this policy should be reevaluated.\nTo explore the current views of U.S. transplant centers toward transplanting asymptomatic HIV-infected patients with end-stage renal disease, a written survey was mailed to the directors of transplantation at all 248 renal transplant centers in the United States.\nAll 148 responding centers said they require HIV testing of prospective kidney recipients, and 84% of these centers would not transplant an individual who refuses HIV testing. The vast majority of responding centers would not transplant a kidney from a cadaveric (88%) or a living donor (91%) into an asymptomatic HIV-infected patient who is otherwise a good candidate for transplantation. Among the few centers that would consider transplanting an HIV-infected patient, not a single center had performed such a transplant in the year prior to the survey. Most centers fear that transplantation in the face of HIV infection would be harmful to the individual, and some believe that it would be a waste of precious organs.\nShould all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation?",
        "answer": "no",
        "answer_rationale": "The great majority of U.S. renal transplant centers will not transplant kidneys to HIV-infected patients with end-stage renal disease, even if their infection is asymptomatic. However, advances in the management of HIV infection and a review of relevant ethical issues suggest that this approach should be reconsidered.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "B",
        "completion": "<think>\n\nOkay, let's tackle this question. The user is asking whether all HIV-infected patients with end-stage renal disease should be excluded from transplantation. The options are yes, no, or maybe.\n\nFirst, I need to look at the information provided. The question mentions that historically, HIV patients were excluded from transplants, but recent advances in HIV management might change that. The survey of U.S. transplant centers shows that most centers require HIV testing and wouldn't transplant someone who refuses it. Also, a majority wouldn't use cadaveric or living donor kidneys for HIV-positive patients even if they're asymptomatic and otherwise good candidates. However, a few centers might consider it, but none had actually done so in the past year. The main concerns are that transplantation could be harmful and a waste of organs.\n\nThe key point here is the question of whether they \"should\" be excluded. The survey reflects current practices and attitudes, but the question is about whether they *should* be excluded. The options are about the recommendation, not the current policy. The passage says that recent advances in managing HIV and prognosis suggest reevaluating the exclusion policy. So even though most centers still exclude them, the reasoning given in the question's premise suggests that maybe the policy isn't the best anymore. The fact that some centers are considering it, even if they haven't done it yet, implies that exclusion might not be necessary for all. The answer might be \"no\" because the question's own premise argues for reevaluation, implying that exclusion isn't absolute. The correct answer would align with the idea that not all should be excluded, hence B) no. But I need to make sure I'm not missing anything. The survey shows most centers still exclude, but the question is asking if they \"should\" be excluded, not what's currently done. Since the premise says the policy should be reevaluated, the answer would be B) no, they shouldn't all be excluded.\n</think>\n\nB",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 343,
            "completion_tokens": 403
        },
        "time_elapsed": 4.7577064037323
    },
    {
        "realidx": "9616411",
        "question": "To assess whether populations with access to general practitioner hospitals (GP hospitals) utilise general hospitals less than populations without such access.\nObservational study comparing the total rates of admissions and of occupied bed days in general hospitals between populations with and without access to GP hospitals. Comparisons were also made separately for diagnoses commonly encountered in GP hospitals.\nTwo general hospitals serving the population of Finnmark county in north Norway.\n35,435 admissions based on five years' routine recordings from the two hospitals.\nThe total rate of admission to general hospitals was lower in peripheral municipalities with a GP hospital than in central municipalities without this kind of institution, 26% and 28% lower for men and women respectively. The corresponding differences were 38% and 52%, when analysed for occupied bed days. The differences were most pronounced for patients with respiratory diseases, cardiac failure, and cancer who are primarily or intermediately treated or cared for in GP hospitals, and for patients with stroke and fractures, who are regularly transferred from general hospitals to GP hospitals for longer term follow up care.\nDo general practitioner hospitals reduce the utilisation of general hospital beds?",
        "answer": "yes",
        "answer_rationale": "GP hospitals seem to reduce the utilisation of general hospitals with respect to admissions as well as occupied bed days.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether general practitioner hospitals (GP hospitals) reduce the utilisation of general hospital beds. The study provided compares populations with and without access to GP hospitals.\n\nFirst, I need to look at the data given. The total admission rates to general hospitals were lower in areas with GP hospitals: 26% lower for men and 28% for women. Even more significant, the occupied bed days were 38% and 52% lower. That's a substantial difference. The study also mentions that the differences were most pronounced for conditions like respiratory diseases, cardiac failure, cancer, stroke, and fractures, which are typically managed or followed up in GP hospitals. \n\nSo, the key point here is that when GP hospitals are available, people in those areas are admitted less often and spend fewer days in general hospitals. The study's results show a clear correlation between having GP hospitals and reduced usage of general hospital resources. The options are yes, no, or maybe. Since the data shows lower rates in both admissions and bed days, the answer should be yes. The study's findings support the idea that GP hospitals do reduce general hospital utilisation. There's no mention of confounding variables or alternative explanations that would make the answer uncertain, so \"maybe\" isn't needed here. The answer is A.\n</think>\n\nA",
        "predicted_answer": "A",
        "token_usage": {
            "prompt_tokens": 320,
            "completion_tokens": 281
        },
        "time_elapsed": 3.4693470001220703
    },
    {
        "realidx": "9722752",
        "question": "To evaluate the outcome of a new modification of percutaneous needle suspension, using a bone anchor system for fixing the suture at the public bone, and to compare the results with those published previously.\nFrom March 1996, 37 patients with stress urinary incontinence (>2 years) were treated using a bone anchor system. On each side the suture was attached to the pubocervical fascia and the vaginal wall via a broad 'Z'-stitch. A urodynamic investigation performed preoperatively in all patients confirmed stress incontinence and excluded detrusor instability. The outcome was assessed by either by a clinical follow-up investigation or using a standardized questionnaire, over a mean follow-up of 11 months (range 6-18).\nIn the 37 patients, the procedure was successful in 25 (68%), with 16 (43%) of the patients completely dry and nine (24%) significantly improved. Removal of the bone anchor and suture was necessary in two patients, because of unilateral bacterial infection in one and a bilateral soft tissue granuloma in the other. One bone anchor became dislocated in a third patient. In two cases where the treatment failed, new detrusor instability was documented urodynamically. Minor complications were prolonged wound pain in 10 (26%) and transient urinary retention or residual urine in 12 patients (32%).\nDoes bone anchor fixation improve the outcome of percutaneous bladder neck suspension in female stress urinary incontinence?",
        "answer": "yes",
        "answer_rationale": "The poor success rate in the study corresponds with the long-term results of conventional or modified needle suspension procedures and does not reinforce the optimistic results of bone anchoring published recently. Because of the poorer long-term results from percutaneous needle suspension than from other techniques of open retropubic bladder neck suspension, it remains questionable whether percutaneous needle suspension should be considered a first-line procedure for the treatment of female stress urinary incontinence.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether bone anchor fixation improves the outcome of percutaneous bladder neck suspension in female stress urinary incontinence. The options are yes, no, or maybe.\n\nFirst, I need to look at the provided information. The study involved 37 patients treated with this new method. The success rate was 68%, with 43% completely dry and 24% improved. That's a decent success rate, but I should compare it to previous methods mentioned. The question mentions comparing with \"those published previously,\" but the data given here doesn't include the historical success rates. Wait, the problem states that the study's purpose is to evaluate this new modification and compare it to previous results. However, the data provided only gives the outcomes of this study, not the prior ones. \n\nHmm, so without knowing the previous success rates, how can we determine if this new method is an improvement? The answer might hinge on whether the 68% success is better than prior methods. Since the question is from a test, maybe the implication is that the 68% is considered an improvement. Alternatively, maybe the complications or other factors suggest it's not better. The complications here include infections, granulomas, dislocation, and some minor issues like pain and retention. But the success rate is still over 60%, which might be on par or better than older techniques. \n\nWait, the options are yes, no, maybe. The study's results show a 68% success, but without knowing the previous outcomes, can we definitively say it's an improvement? The question might be testing if the reader can recognize that the study's own results are presented, but without a direct comparison group (like the previous method's success rate), we can't conclusively say if it's better. The answer might be \"maybe\" because the data isn't provided for prior studies. However, sometimes in such questions, the success rate given is compared to standard outcomes. For instance, if the standard success rate for older methods is lower, then 68% would be an improvement. But since the problem doesn't state that, maybe the answer is \"maybe\" because we don't have the prior data. Alternatively, maybe the question assumes that the bone anchor system is the modification, and the 68% is considered acceptable, so the answer is yes. But without knowing the previous results, the correct answer might be \"maybe\" because the",
        "predicted_answer": "C",
        "token_usage": {
            "prompt_tokens": 408,
            "completion_tokens": 512
        },
        "time_elapsed": 6.806872367858887
    },
    {
        "realidx": "9920954",
        "question": "\"America's Best Hospitals,\" an influential list published annually by U.S. News and World Report, assesses the quality of hospitals. It is not known whether patients admitted to hospitals ranked at the top in cardiology have lower short-term mortality from acute myocardial infarction than those admitted to other hospitals or whether differences in mortality are explained by differential use of recommended therapies.\nUsing data from the Cooperative Cardiovascular Project on 149,177 elderly Medicare beneficiaries with acute myocardial infarction in 1994 or 1995, we examined the care and outcomes of patients admitted to three types of hospitals: those ranked high in cardiology (top-ranked hospitals); hospitals not in the top rank that had on-site facilities for cardiac catheterization, coronary angioplasty, and bypass surgery (similarly equipped hospitals); and the remaining hospitals (non-similarly equipped hospitals). We compared 30-day mortality; the rates of use of aspirin, beta-blockers, and reperfusion; and the relation of differences in rates of therapy to short-term mortality.\nAdmission to a top-ranked hospital was associated with lower adjusted 30-day mortality (odds ratio, 0.87; 95 percent confidence interval, 0.76 to 1.00; P=0.05 for top-ranked hospitals vs. the others). Among patients without contraindications to therapy, top-ranked hospitals had significantly higher rates of use of aspirin (96.2 percent, as compared with 88.6 percent for similarly equipped hospitals and 83.4 percent for non-similarly equipped hospitals; P<0.01) and beta-blockers (75.0 percent vs. 61.8 percent and 58.7 percent, P<0.01), but lower rates of reperfusion therapy (61.0 percent vs. 70.7 percent and 65.6 percent, P=0.03). The survival advantage associated with admission to top-ranked hospitals was less strong after we adjusted for factors including the use of aspirin and beta-blockers (odds ratio, 0.94; 95 percent confidence interval, 0.82 to 1.08; P=0.38).\nDo \"America's Best Hospitals\" perform better for acute myocardial infarction?",
        "answer": "yes",
        "answer_rationale": "Admission to a hospital ranked high on the list of \"America's Best Hospitals\" was associated with lower 30-day mortality among elderly patients with acute myocardial infarction. A substantial portion of the survival advantage may be associated with these hospitals' higher rates of use of aspirin and beta-blocker therapy.",
        "options": {
            "A": "yes",
            "B": "no",
            "C": "maybe"
        },
        "answer_idx": "A",
        "completion": "<think>\nOkay, let's tackle this question. The user is asking whether \"America's Best Hospitals\" perform better for acute myocardial infarction (AMI). The study mentioned compares three types of hospitals: top-ranked in cardiology, similarly equipped but not top-ranked, and non-similarly equipped.\n\nFirst, the study found that top-ranked hospitals had a lower adjusted 30-day mortality rate with an odds ratio of 0.87 (95% CI 0.76-1.00, p=0.05). That's a statistically significant result, but the confidence interval is close to 1.0, so the effect might be small. \n\nHowever, when they adjusted for the use of aspirin and beta-blockers, the survival advantage decreased. The adjusted odds ratio became 0.94 (CI 0.82-1.08, p=0.38), which is not statistically significant. This suggests that part of the initial benefit was due to better use of these therapies. The top hospitals used more aspirin and beta-blockers but less reperfusion therapy. \n\nThe question is whether they \"perform better.\" The raw data shows a slight benefit, but after adjusting for therapy use, the benefit disappears. The answer hinges on whether the adjusted model is the correct way to interpret performance. Since the adjusted OR isn't significant, the mortality difference might be explained by the better use of therapies. But the initial unadjusted result was significant. \n\nThe options are yes, no, maybe. The study's conclusion seems to suggest that the survival advantage is less strong after adjusting for therapies, implying that the better outcomes are at least partly due to those therapies. However, the original question is whether they perform better. The unadjusted data says yes, but adjusted says no. The study's authors might argue that the difference isn't independent of therapy use. The answer options don't have a \"partially\" choice, so maybe the correct answer is (A) yes because the initial result was significant, but after adjustment, it's not. Wait, the question is whether they perform better. The study's conclusion after adjustment shows that the advantage is less, so maybe the answer is (B) no? Or (C) maybe?\n\nLooking back at the study's results: the adjusted OR is 0.94, which is not significant. So after accounting for the therapies, there's no significant difference. Therefore, the mortality difference in the unadjusted",
        "predicted_answer": "B",
        "token_usage": {
            "prompt_tokens": 592,
            "completion_tokens": 512
        },
        "time_elapsed": 5.859498500823975
    }
]